data_6th8_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6th8 _Structure_validation_residue.Date_analyzed 2019-11-22 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 110.315 -0.254 . . . . 2.16 110.315 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.45 155.08 54.7 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.525 1.483 . . . . 0.5 112.026 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -105.4 136.85 44.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.403 -0.362 . . . . 1.86 110.559 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 m -134.34 145.18 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.57 0.7 . . . . 1.06 111.753 176.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.1 tp -106.03 135.28 47.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.874 -1.057 . . . . 1.03 110.193 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.7 mt -103.44 134.68 43.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.242 -0.436 . . . . 1.11 110.275 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 87.0 mtp -96.75 134.02 40.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.148 -0.478 . . . . 1.1 110.438 173.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -59.21 144.3 46.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.297 -0.411 . . . . 3.26 110.705 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.08 175.11 36.07 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.963 -0.855 . . . . 0.56 110.963 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.69 -33.26 54.81 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.579 0.215 . . . . 2.15 111.579 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.78 175.84 33.67 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.915 -0.874 . . . . 0.64 110.915 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.87 117.92 4.9 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.437 -0.665 . . . . 0.61 111.437 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -57.15 -41.72 79.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.84 0.352 . . . . 3.52 110.533 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -61.16 -41.65 97.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 1.91 111.034 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -62.14 -56.09 22.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.856 0.36 . . . . 4.03 111.225 -176.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.25 -42.74 95.95 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.698 -0.401 . . . . 2.32 110.85 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.41 -40.26 95.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.325 -0.398 . . . . 1.06 110.936 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.08 -42.31 94.33 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.918 -0.313 . . . . 1.91 110.502 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -59.88 -51.65 68.81 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 120.568 -0.453 . . . . 3.79 111.256 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.9 mt -62.65 -37.65 87.18 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.538 -0.465 . . . . 1.07 111.025 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -62.83 -43.08 99.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.646 0.26 . . . . 4.13 110.894 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.33 -30.69 68.24 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 121.063 -0.589 . . . . 0.3 111.924 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -88.12 10.44 19.27 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.513 0.931 . . . . 0.42 113.513 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.04 20.23 47.28 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 121.25 -0.5 . . . . 0.28 113.127 174.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -101.04 139.86 21.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 117.552 0.676 . . . . 1.05 110.191 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -81.9 129.15 34.67 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.108 -0.701 . . . . 0.36 109.108 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -119.02 132.2 69.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.289 0.566 . . . . 1.07 111.512 -173.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -137.58 133.58 34.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.13 -0.941 . . . . 1.12 109.271 170.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -115.54 138.26 51.23 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.861 0.362 . . . . 1.06 110.968 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.1 tp -119.13 132.03 24.12 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-O 118.632 -0.699 . . . . 1.09 109.608 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.05 138.77 31.55 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.202 1.268 . . . . 0.71 111.903 174.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 77.4 mt -60.1 -9.22 2.97 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.397 0.888 . . . . 1.35 113.397 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -77.07 -7.41 55.67 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.262 0.838 . . . . 1.2 113.262 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -63.31 148.71 92.87 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 118.555 0.616 . . . . 1.07 110.357 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -80.3 158.04 22.88 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.556 1.504 . . . . 0.34 113.191 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.12 151.5 4.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.866 -0.606 . . . . 1.04 111.277 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.31 -38.0 3.25 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.599 -0.6 . . . . 0.19 111.599 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -62.22 -37.27 84.72 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 120.595 -0.442 . . . . 1.77 111.09 -177.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.0 tp -58.84 -48.13 82.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.978 0.418 . . . . 1.09 110.211 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 19.8 tp -64.36 -45.19 88.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 1.16 111.141 -175.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.83 -44.25 97.21 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.623 -0.431 . . . . 1.05 110.774 -176.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.2 ttm-85 -61.13 -42.7 99.02 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.945 -0.302 . . . . 2.87 110.706 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.23 -45.3 98.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.814 -0.354 . . . . 1.08 110.198 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -67.94 -50.71 54.37 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.352 0.407 . . . . 4.35 111.919 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.04 -44.4 80.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.662 -0.245 . . . . 1.04 111.554 -174.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -78.34 -10.11 59.54 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.968 0.729 . . . . 1.88 112.968 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 54.18 55.86 7.69 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.561 0.696 . . . . 4.29 110.602 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 93.6 mt -66.35 141.63 57.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.729 -0.669 . . . . 1.14 111.402 -175.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -89.81 -39.77 12.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.251 -0.886 . . . . 0.31 110.611 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.7 159.67 28.09 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.219 -0.991 . . . . 0.23 113.194 -175.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.2 mt -126.27 140.64 52.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.64 -0.78 . . . . 1.06 109.611 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.3 t -119.85 131.02 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 121.126 -0.229 . . . . 1.05 110.635 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.3 m -119.41 131.16 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.25 0.547 . . . . 1.09 110.998 175.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.4 m -71.54 -33.01 68.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.338 -0.846 . . . . 1.73 111.725 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 72.6 p -157.56 169.92 23.59 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.354 0.597 . . . . 0.93 111.767 -173.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.57 -36.62 64.89 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.176 -0.769 . . . . 0.45 111.176 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -59.24 -46.08 89.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.937 0.369 . . . . 2.57 110.68 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.84 -44.29 97.19 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.439 -1.064 . . . . 0.29 110.439 177.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 30.4 tp -56.34 -44.24 79.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.15 0.5 . . . . 1.16 110.824 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.6 -43.23 99.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.065 -0.516 . . . . 0.45 110.546 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -58.71 -39.1 79.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.72 110.65 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.0 tp -57.32 -45.18 84.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.295 0.569 . . . . 1.12 110.192 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -60.47 -47.05 87.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.562 -0.744 . . . . 0.88 110.586 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -61.78 -43.55 98.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.078 -0.51 . . . . 1.6 111.094 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.74 -34.94 78.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.458 -0.337 . . . . 1.07 111.468 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.72 -39.11 79.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.052 0.453 . . . . 1.04 110.684 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.07 -143.74 0.59 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.617 -0.512 . . . . 1.08 109.617 174.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.7 -18.77 45.09 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.367 0.985 . . . . 1.08 112.659 -175.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -91.88 10.13 30.02 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.366 0.876 . . . . 1.09 113.366 -174.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -47.88 -46.62 63.5 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 118.554 -0.736 . . . . 0.22 112.565 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -44.73 -41.39 14.79 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.472 1.448 . . . . 0.27 113.261 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.2 mp0 -77.0 -48.75 17.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.941 0.4 . . . . 1.86 110.795 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 88.0 mt -59.04 -40.6 81.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.136 -0.484 . . . . 1.04 110.76 -176.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.95 -15.66 36.5 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 116.315 -0.402 . . . . 0.22 113.162 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 -64.94 -30.48 71.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.351 0.575 . . . . 3.0 112.032 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 27.3 mt -74.04 150.5 87.98 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 121.077 -0.249 . . . . 1.12 111.519 -173.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.83 126.25 17.01 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.611 1.541 . . . . 1.05 112.349 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.5 tp -104.89 127.34 52.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.345 -0.389 . . . . 1.1 110.578 175.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -92.07 125.29 36.69 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.669 -0.493 . . . . 0.19 109.669 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.8 m -116.78 145.67 35.99 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-O 119.35 -0.357 . . . . 1.02 110.145 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.17 -22.86 8.11 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.531 1.487 . . . . 0.36 113.634 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.0 p -143.64 158.38 56.96 Favored Pre-proline 0 C--N 1.331 -0.236 0 C-N-CA 120.693 -0.403 . . . . 0.76 111.25 -171.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.37 -44.09 51.93 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.309 1.339 . . . . 0.76 111.689 176.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -58.12 -47.42 83.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.856 0.36 . . . . 3.5 110.939 -177.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.2 t -60.12 -39.9 81.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.796 -0.362 . . . . 1.05 110.093 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.43 -41.85 81.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.966 0.413 . . . . 0.96 110.383 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.86 -40.43 92.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.439 . . . . 1.56 110.549 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.0 mmm -58.12 -44.96 88.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.412 0.625 . . . . 1.36 110.061 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.05 -41.16 97.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.695 -0.684 . . . . 1.04 110.792 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 75.9 ttt-85 -61.85 -44.76 96.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.333 -0.394 . . . . 3.66 110.824 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.58 -36.1 77.69 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.925 -0.31 . . . . 2.1 111.348 -177.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.2 mt -65.9 -23.9 66.73 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.241 0.46 . . . . 1.09 112.241 177.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.83 13.3 16.54 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 119.413 -0.659 . . . . 0.23 113.163 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.82 121.98 11.79 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.499 1.149 . . . . 1.03 109.917 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -69.31 -36.01 76.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.629 -0.714 . . . . 0.71 111.24 -171.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -131.59 113.91 14.2 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.024 0.44 . . . . 3.58 110.36 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.9 t -112.53 131.06 65.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.15 -0.477 . . . . 1.05 109.876 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 85.9 mt -119.27 123.33 71.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.856 -0.611 . . . . 1.09 110.026 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -94.93 118.28 31.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.406 -0.361 . . . . 1.13 110.248 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 32.0 p -96.11 -6.56 38.18 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.158 0.799 . . . . 0.97 113.158 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -55.32 -39.83 70.42 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 118.211 0.46 . . . . 4.21 110.812 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -93.72 -35.02 6.3 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.599 -0.6 . . . . 0.69 111.599 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -78.16 132.28 37.56 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.828 0.347 . . . . 1.17 110.632 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.2 m -74.86 162.83 28.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 1.4 110.659 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.76 -54.32 24.36 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 112.891 0.7 . . . . 1.07 112.891 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.94 -34.15 98.99 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 CA-C-N 119.987 1.031 . . . . 0.34 111.692 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.02 -43.07 95.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.037 0.446 . . . . 1.08 109.953 177.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.0 mt -59.19 -40.45 85.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 1.02 110.425 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 37.7 tp -56.98 -43.58 81.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.272 0.558 . . . . 1.06 110.183 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.58 -40.93 93.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.744 -0.662 . . . . 1.04 110.491 178.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.83 -42.19 93.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.328 -0.396 . . . . 1.05 110.684 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.5 mt -57.99 -50.21 74.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.177 0.513 . . . . 1.1 110.427 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.3 p -62.7 -40.89 98.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.798 -0.637 . . . . 1.06 111.231 -175.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.9 t -62.24 -45.15 94.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.766 0.317 . . . . 1.58 111.412 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.59 -38.61 88.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.449 -0.341 . . . . 1.01 111.179 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.473 -0.33 . . . . 1.11 111.368 179.742 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.6 p30 . . . . . 0 CA--C 1.536 0.411 0 N-CA-C 110.405 -0.22 . . . . 15.0 110.405 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.58 155.02 27.87 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.596 1.531 . . . . 15.0 112.065 -177.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -113.03 137.36 51.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.307 -0.406 . . . . 15.0 110.581 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.3 m -135.3 145.94 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.563 0.696 . . . . 15.0 111.709 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.0 tp -105.75 136.74 44.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.027 -0.988 . . . . 15.0 110.332 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.7 mt -104.52 133.86 47.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.972 0.415 . . . . 15.0 110.695 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 83.7 mtp -101.45 134.46 44.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.279 -0.873 . . . . 15.0 110.714 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -57.33 143.33 40.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.129 0.49 . . . . 15.0 110.772 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.86 175.09 29.14 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.852 -0.899 . . . . 15.0 110.852 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.81 -32.54 67.67 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.684 0.253 . . . . 15.0 111.684 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.34 -173.74 22.25 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.033 -0.827 . . . . 15.0 111.033 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.93 114.7 3.99 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.031 -0.828 . . . . 15.0 111.031 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -57.52 -44.84 85.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.273 0.558 . . . . 15.0 110.228 -176.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.99 -41.46 99.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.856 -0.611 . . . . 15.0 111.273 -177.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -60.01 -49.89 75.9 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.861 -0.335 . . . . 15.0 111.085 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.3 mt -57.64 -44.49 85.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.129 0.49 . . . . 15.0 110.43 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.43 -42.27 91.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 15.0 110.688 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -58.53 -41.51 85.67 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.031 -0.268 . . . . 15.0 110.475 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 69.0 mtm180 -59.31 -51.46 69.85 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.447 -0.501 . . . . 15.0 110.878 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.1 -37.57 83.2 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.519 -0.472 . . . . 15.0 110.988 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 40.2 mtp180 -64.21 -42.49 96.58 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.921 -0.312 . . . . 15.0 111.184 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.0 -30.67 67.04 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.007 -0.616 . . . . 15.0 111.967 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -88.14 8.87 24.87 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.6 0.963 . . . . 15.0 113.6 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.08 17.12 58.26 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 121.235 -0.507 . . . . 15.0 113.234 176.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.7 t -101.03 139.06 23.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 117.748 0.774 . . . . 15.0 109.95 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -78.65 134.64 37.13 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.346 -0.612 . . . . 15.0 109.346 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.7 t -119.24 131.55 71.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.345 0.593 . . . . 15.0 111.331 -173.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -131.59 122.81 26.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.174 -0.921 . . . . 15.0 109.216 170.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -107.88 129.98 55.04 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.904 0.383 . . . . 15.0 110.812 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.3 tp -120.64 113.31 33.42 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 118.892 -0.575 . . . . 15.0 110.672 -175.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.19 135.2 67.85 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.27 1.313 . . . . 15.0 112.372 172.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.1 mt -58.95 -11.87 3.88 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.28 0.844 . . . . 15.0 113.28 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -77.16 -6.22 52.1 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.417 0.895 . . . . 15.0 113.417 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -69.31 150.92 97.09 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 118.558 0.617 . . . . 15.0 110.771 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.63 151.29 32.25 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.616 1.544 . . . . 15.0 113.715 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.76 152.57 3.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.305 -0.861 . . . . 15.0 111.453 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.67 -38.14 3.21 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 115.72 -0.673 . . . . 15.0 111.871 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.3 -37.09 86.26 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 120.323 -0.551 . . . . 15.0 111.103 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.4 tp -58.75 -47.71 83.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.98 0.419 . . . . 15.0 110.168 -178.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 16.3 tp -62.65 -45.36 93.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.974 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.9 -45.04 95.46 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.577 -0.449 . . . . 15.0 110.871 -175.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -62.71 -40.05 95.94 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.768 -0.373 . . . . 15.0 111.07 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 91.4 t -61.78 -45.24 99.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.807 -0.357 . . . . 15.0 110.289 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -69.56 -47.51 63.42 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.205 0.446 . . . . 15.0 112.205 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.8 -44.27 77.72 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.977 -0.289 . . . . 15.0 111.609 -175.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -79.67 -10.11 59.74 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.053 0.76 . . . . 15.0 113.053 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 56.29 55.93 6.23 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.488 0.661 . . . . 15.0 109.989 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.29 145.18 53.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.836 -0.62 . . . . 15.0 111.302 -176.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -92.36 -40.54 10.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.323 -0.853 . . . . 15.0 111.061 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.63 161.87 28.6 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.012 -1.089 . . . . 15.0 113.651 -173.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.2 mt -126.08 144.06 50.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.494 -0.853 . . . . 15.0 109.934 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.7 t -120.87 129.91 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 O-C-N 122.353 -0.217 . . . . 15.0 110.712 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.5 m -124.72 141.43 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-O 121.042 0.449 . . . . 15.0 110.471 172.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.8 m -96.59 -14.16 22.4 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.901 0.704 . . . . 15.0 112.901 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.5 p -157.57 163.25 38.54 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 121.414 0.626 . . . . 15.0 111.914 -174.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.23 -37.3 72.25 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.98 -0.848 . . . . 15.0 110.98 176.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -58.99 -44.98 91.69 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 122.666 -0.314 . . . . 15.0 110.633 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.81 -43.54 97.84 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.476 -1.049 . . . . 15.0 110.476 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.8 tp -56.85 -45.1 82.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.145 0.498 . . . . 15.0 110.699 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.64 -43.53 98.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.086 -0.506 . . . . 15.0 110.644 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -59.08 -39.25 81.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.274 -0.421 . . . . 15.0 110.682 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.3 tp -57.63 -44.84 85.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.179 0.514 . . . . 15.0 110.061 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -61.09 -47.61 85.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.735 -0.666 . . . . 15.0 110.585 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.88 -43.13 99.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.108 -0.496 . . . . 15.0 111.159 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.92 -35.53 80.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.443 -0.344 . . . . 15.0 111.426 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.77 -37.91 80.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.029 0.442 . . . . 15.0 110.856 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.51 -144.19 0.55 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 109.51 -0.552 . . . . 15.0 109.51 174.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.53 -19.56 49.14 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.349 0.977 . . . . 15.0 112.575 -174.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -91.9 12.16 22.55 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.32 0.859 . . . . 15.0 113.32 -174.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 -47.79 -46.36 62.05 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 118.551 -0.737 . . . . 15.0 112.587 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -44.72 -41.43 14.76 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 121.417 1.412 . . . . 15.0 113.247 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -77.0 -48.72 17.16 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.544 -0.462 . . . . 15.0 110.836 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 93.0 mt -59.74 -40.45 82.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.451 . . . . 15.0 110.903 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.44 -16.4 35.72 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 116.401 -0.363 . . . . 15.0 113.11 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.1 mtp-105 -64.67 -30.33 71.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.336 0.568 . . . . 15.0 112.027 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 23.4 mt -76.03 150.54 83.46 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 121.028 -0.269 . . . . 15.0 111.58 -172.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -63.22 128.36 22.53 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.628 1.552 . . . . 15.0 112.39 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.9 tp -108.59 127.56 54.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.511 -0.313 . . . . 15.0 110.657 174.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -88.7 127.31 35.58 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.576 -0.527 . . . . 15.0 109.576 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.1 m -119.16 146.24 40.13 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 110.012 -0.366 . . . . 15.0 110.012 175.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.15 -22.58 8.36 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.608 1.538 . . . . 15.0 113.651 -174.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.7 p -143.47 158.2 57.87 Favored Pre-proline 0 CA--C 1.53 0.196 0 C-N-CA 120.645 -0.422 . . . . 15.0 111.263 -171.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.39 -44.0 52.66 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.32 1.347 . . . . 15.0 111.699 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 -58.37 -47.25 84.43 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.858 -0.337 . . . . 15.0 110.926 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.9 t -59.75 -40.43 82.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.923 0.392 . . . . 15.0 109.965 178.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.46 -42.75 83.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.002 0.43 . . . . 15.0 110.404 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.31 -40.4 90.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 15.0 110.61 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.0 mmm -58.14 -44.39 87.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.428 0.632 . . . . 15.0 110.159 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.49 -40.51 94.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.655 -0.702 . . . . 15.0 110.862 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -62.61 -42.9 99.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.346 -0.388 . . . . 15.0 111.028 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.36 -36.16 77.37 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.832 -0.347 . . . . 15.0 111.274 -177.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.99 -22.78 65.9 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.399 0.518 . . . . 15.0 112.399 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 107.99 13.24 20.35 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 119.373 -0.682 . . . . 15.0 113.128 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.76 122.0 11.8 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 118.494 1.147 . . . . 15.0 109.961 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -69.04 -36.43 77.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.573 -0.74 . . . . 15.0 111.141 -171.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -131.79 112.92 12.92 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.152 0.501 . . . . 15.0 110.536 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.0 t -112.19 130.66 65.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.033 -0.531 . . . . 15.0 109.84 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.6 mt -118.46 122.17 68.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.886 -0.597 . . . . 15.0 109.999 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -94.21 116.56 28.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.429 -0.35 . . . . 15.0 110.433 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.9 p -97.07 4.57 51.31 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.162 0.801 . . . . 15.0 113.162 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 36.2 tpt85 -55.94 -39.92 72.42 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 118.187 0.449 . . . . 15.0 110.648 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.15 -35.13 5.39 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.486 -0.646 . . . . 15.0 111.486 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.65 138.58 44.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.847 0.356 . . . . 15.0 110.549 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.7 p -87.04 165.38 15.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 15.0 110.621 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.69 -54.23 24.77 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 118.552 -0.737 . . . . 15.0 112.923 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.54 -35.98 97.38 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 CA-C-N 120.596 1.249 . . . . 15.0 111.414 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.77 95.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.017 0.437 . . . . 15.0 110.051 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.3 mt -59.23 -40.02 84.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 15.0 110.514 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 42.0 tp -57.08 -44.52 83.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.379 0.609 . . . . 15.0 110.084 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.74 -41.16 94.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.627 -0.715 . . . . 15.0 110.488 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.3 -41.36 93.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.314 -0.403 . . . . 15.0 110.78 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.6 mt -57.89 -50.53 73.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.122 0.487 . . . . 15.0 110.401 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.3 p -63.85 -40.39 96.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.715 -0.675 . . . . 15.0 111.381 -175.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.8 p -65.44 -39.42 92.06 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.025 -0.27 . . . . 15.0 111.398 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.28 96.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.508 -0.315 . . . . 15.0 111.088 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.467 -0.333 . . . . 15.0 110.755 179.65 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.535 0.386 0 N-CA-C 110.28 -0.267 . . . . 15.0 110.28 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.41 152.99 7.93 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.433 1.422 . . . . 15.0 111.857 -176.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -115.63 139.24 50.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.326 -0.397 . . . . 15.0 110.802 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.2 m -133.76 145.97 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.466 0.65 . . . . 15.0 111.652 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.4 tp -105.07 136.5 44.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.048 -0.978 . . . . 15.0 110.375 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.2 mt -104.11 135.14 43.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.972 0.415 . . . . 15.0 110.624 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 96.6 mmm -89.34 134.12 34.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.458 -0.792 . . . . 15.0 110.149 174.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -57.64 141.39 48.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.958 0.408 . . . . 15.0 110.551 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.56 175.11 42.0 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.854 -0.898 . . . . 15.0 110.854 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -54.99 -35.22 64.12 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.205 -0.198 . . . . 15.0 111.217 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.23 162.87 7.45 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.861 -0.895 . . . . 15.0 110.861 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.87 123.56 6.34 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.151 -0.78 . . . . 15.0 111.151 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -56.66 -46.57 80.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.058 0.456 . . . . 15.0 110.422 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.32 -39.33 94.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.899 -0.591 . . . . 15.0 111.235 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -61.23 -56.01 25.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.927 0.394 . . . . 15.0 111.027 -175.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.6 mt -61.7 -41.99 98.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.018 0.437 . . . . 15.0 110.663 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.99 -36.28 79.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 15.0 111.182 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.23 -44.95 95.41 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.963 -0.295 . . . . 15.0 110.616 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -59.77 -51.65 68.86 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.084 -0.646 . . . . 15.0 111.252 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.47 -37.32 87.12 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.517 -0.473 . . . . 15.0 111.137 -176.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -64.02 -43.8 94.51 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.14 -0.224 . . . . 15.0 111.048 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.29 -30.63 68.0 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.043 -0.599 . . . . 15.0 111.923 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -88.14 9.9 21.15 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.515 0.932 . . . . 15.0 113.515 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.11 16.12 56.42 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 121.261 -0.495 . . . . 15.0 113.435 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -101.15 139.77 21.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 117.719 0.759 . . . . 15.0 109.98 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -84.93 133.61 34.28 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.483 -0.562 . . . . 15.0 109.483 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.4 t -115.12 131.45 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.09 0.471 . . . . 15.0 111.005 -174.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -133.78 128.76 35.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.568 -0.742 . . . . 15.0 109.33 171.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -111.38 134.64 52.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.799 0.333 . . . . 15.0 110.652 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.7 tp -112.83 129.95 23.96 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-O 118.492 -0.766 . . . . 15.0 109.732 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -72.08 139.64 33.06 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 CA-C-N 120.431 1.19 . . . . 15.0 111.676 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.2 mt -59.38 -9.35 2.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.631 0.974 . . . . 15.0 113.631 -176.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -77.09 -7.07 55.11 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.396 0.888 . . . . 15.0 113.396 -177.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -65.72 145.89 99.01 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 118.618 0.644 . . . . 15.0 110.633 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.74 159.01 21.66 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 121.629 1.552 . . . . 15.0 113.187 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.28 151.27 5.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.839 -0.618 . . . . 15.0 111.294 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.23 -38.09 3.22 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.71 -0.556 . . . . 15.0 111.71 -178.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -61.05 -36.75 80.4 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 120.595 -0.442 . . . . 15.0 111.213 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.9 tp -59.15 -47.03 86.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.962 0.411 . . . . 15.0 110.254 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.3 tp -62.39 -45.74 91.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 15.0 110.86 -176.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.58 -44.22 97.42 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.659 -0.416 . . . . 15.0 110.774 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.0 ttm-85 -60.74 -41.81 96.1 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.98 -0.288 . . . . 15.0 110.728 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.1 t -60.47 -46.18 95.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.73 -0.388 . . . . 15.0 110.11 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -69.83 -47.7 61.73 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.29 0.478 . . . . 15.0 112.29 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.28 -44.33 79.58 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.03 -0.268 . . . . 15.0 111.538 -174.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -80.34 -10.1 59.75 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.11 0.781 . . . . 15.0 113.11 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 94.2 mtm-85 56.22 55.81 6.38 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.553 0.692 . . . . 15.0 110.111 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 94.6 mt -72.77 146.35 46.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.631 -0.713 . . . . 15.0 111.467 -175.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -94.46 -40.49 9.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.357 -0.838 . . . . 15.0 110.915 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.78 165.53 29.22 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 119.878 -1.153 . . . . 15.0 113.695 -172.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.5 mt -127.89 143.16 51.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.576 -0.812 . . . . 15.0 109.983 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 49.0 t -123.06 133.69 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 110.077 -0.342 . . . . 15.0 110.077 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.9 m -119.24 126.92 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.185 0.517 . . . . 15.0 110.749 174.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.8 m -68.92 -32.73 72.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.476 -0.784 . . . . 15.0 111.686 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.5 p -155.19 166.28 34.06 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.411 0.624 . . . . 15.0 111.887 -173.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.88 -37.51 70.32 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.217 -0.753 . . . . 15.0 111.217 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -58.66 -46.16 87.78 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.742 -0.383 . . . . 15.0 110.72 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.95 -42.61 99.79 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.841 -0.904 . . . . 15.0 110.841 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.9 tp -57.32 -47.18 82.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.053 0.454 . . . . 15.0 110.594 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.77 -44.62 96.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.134 0.492 . . . . 15.0 110.594 -177.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -59.51 -40.11 86.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 15.0 110.616 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.5 tp -56.57 -42.78 79.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.18 0.514 . . . . 15.0 110.195 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -58.55 -46.48 86.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.804 -0.635 . . . . 15.0 110.249 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -60.97 -42.93 99.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.819 -0.628 . . . . 15.0 111.032 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.08 -34.94 78.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.374 -0.375 . . . . 15.0 111.474 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.31 -38.15 79.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.119 0.485 . . . . 15.0 110.677 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.51 -144.43 0.55 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 109.54 -0.541 . . . . 15.0 109.54 173.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.47 -19.57 48.79 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.289 0.95 . . . . 15.0 112.563 -174.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -91.86 10.86 26.94 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.336 0.865 . . . . 15.0 113.336 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -47.83 -47.07 63.42 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 118.544 -0.741 . . . . 15.0 112.536 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -44.78 -40.52 14.58 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 121.422 1.414 . . . . 15.0 113.216 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -76.96 -48.77 17.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.036 0.446 . . . . 15.0 110.735 -177.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 89.1 mt -59.46 -40.11 80.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.511 . . . . 15.0 110.752 -177.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.56 -14.71 36.7 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 116.31 -0.405 . . . . 15.0 113.345 -175.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -65.88 -29.79 70.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.399 0.6 . . . . 15.0 112.037 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.0 mt -74.87 150.02 85.87 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 120.919 -0.312 . . . . 15.0 111.291 -173.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.0 128.27 26.07 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.606 1.537 . . . . 15.0 112.249 176.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.3 tp -105.72 124.91 50.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.387 -0.369 . . . . 15.0 110.497 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -91.71 126.54 36.83 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.796 -0.446 . . . . 15.0 109.796 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.4 m -118.72 146.45 39.99 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-O 119.327 -0.368 . . . . 15.0 110.238 176.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -79.18 -23.49 7.56 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.561 1.507 . . . . 15.0 113.522 -176.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.2 p -143.26 162.78 41.01 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 120.572 -0.451 . . . . 15.0 111.517 -171.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -56.84 -43.97 49.43 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.153 1.236 . . . . 15.0 111.821 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -57.57 -48.15 80.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.882 0.372 . . . . 15.0 110.712 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.5 t -60.37 -39.4 80.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.813 -0.355 . . . . 15.0 110.118 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.31 -41.43 79.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.931 0.396 . . . . 15.0 110.373 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.18 -40.22 93.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.29 -0.414 . . . . 15.0 110.603 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.1 mmm -58.53 -44.53 89.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.378 0.609 . . . . 15.0 110.107 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.74 -42.48 99.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.714 -0.675 . . . . 15.0 110.853 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -61.92 -44.02 97.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 15.0 110.738 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -59.22 -36.16 74.92 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.947 -0.301 . . . . 15.0 111.302 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 77.0 mt -67.26 -23.95 65.74 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.351 0.5 . . . . 15.0 112.351 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.33 13.37 17.45 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 119.263 -0.743 . . . . 15.0 113.096 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.77 122.03 11.88 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 118.564 1.182 . . . . 15.0 109.897 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -68.84 -35.72 77.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.617 -0.719 . . . . 15.0 111.281 -171.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -130.19 113.94 15.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.907 0.384 . . . . 15.0 110.251 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.2 130.3 64.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 15.0 109.953 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 87.6 mt -120.2 120.66 63.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.936 -0.575 . . . . 15.0 110.007 -176.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -95.4 117.79 30.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.41 -0.359 . . . . 15.0 110.323 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.2 p -96.02 -1.49 48.77 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.211 0.819 . . . . 15.0 113.211 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -56.14 -40.28 73.56 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 118.215 0.461 . . . . 15.0 110.527 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.08 -34.98 5.21 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.415 -0.674 . . . . 15.0 111.415 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.46 144.89 53.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.851 0.358 . . . . 15.0 110.52 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.1 t -89.8 158.92 17.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.069 -0.514 . . . . 15.0 110.546 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.65 -54.34 23.73 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 112.992 0.738 . . . . 15.0 112.992 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.72 -35.06 98.95 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 CA-C-N 120.134 1.083 . . . . 15.0 111.78 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.99 -43.13 95.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.124 0.488 . . . . 15.0 109.982 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 78.5 mt -59.06 -40.53 85.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 15.0 110.43 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 38.9 tp -57.19 -43.68 82.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.231 0.538 . . . . 15.0 110.168 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.13 -40.86 91.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.747 -0.661 . . . . 15.0 110.458 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.96 -41.61 92.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.414 . . . . 15.0 110.73 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.5 mt -57.81 -51.11 70.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.195 0.522 . . . . 15.0 110.396 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.3 p -63.6 -39.77 95.23 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.608 -0.724 . . . . 15.0 111.385 -175.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.2 p -65.9 -40.04 91.17 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.921 -0.312 . . . . 15.0 111.453 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.09 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.511 -0.313 . . . . 15.0 111.078 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.428 -0.351 . . . . 15.0 111.398 179.321 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 CA--C 1.534 0.334 0 N-CA-C 110.241 -0.281 . . . . 15.0 110.241 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.01 153.74 30.64 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.385 1.39 . . . . 15.0 111.83 -175.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -112.86 138.33 49.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.456 -0.338 . . . . 15.0 110.782 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.1 m -133.33 143.52 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 121.515 0.674 . . . . 15.0 111.521 176.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.6 tp -103.41 134.76 46.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.011 -0.995 . . . . 15.0 110.417 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.4 mt -99.04 135.0 35.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.024 0.44 . . . . 15.0 110.542 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 83.3 mtp -103.17 134.18 47.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.445 -0.798 . . . . 15.0 109.593 171.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -57.51 144.68 35.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.128 0.49 . . . . 15.0 110.984 -172.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.38 175.15 32.65 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.739 -0.944 . . . . 15.0 110.739 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -54.53 -33.42 59.97 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.517 0.191 . . . . 15.0 111.517 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.06 171.12 36.1 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.898 -0.881 . . . . 15.0 110.898 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.91 133.98 12.26 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.312 -0.715 . . . . 15.0 111.312 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -56.8 -46.04 81.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.086 0.469 . . . . 15.0 110.405 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.18 -41.14 99.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.679 -0.691 . . . . 15.0 111.329 -176.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -61.73 -56.07 23.49 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.746 -0.382 . . . . 15.0 111.224 -175.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.3 mt -61.94 -43.47 98.77 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.739 -0.384 . . . . 15.0 111.052 -176.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.17 -43.27 99.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.392 -0.367 . . . . 15.0 110.573 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -58.72 -41.85 87.34 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.977 -0.289 . . . . 15.0 110.395 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -58.76 -51.69 68.88 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.656 -0.418 . . . . 15.0 111.179 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.2 mt -62.74 -37.77 87.88 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.596 -0.442 . . . . 15.0 111.243 -177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -63.53 -42.4 98.43 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.853 -0.339 . . . . 15.0 111.214 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.43 -30.71 68.63 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.021 -0.609 . . . . 15.0 111.961 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -88.18 9.92 21.21 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.56 0.948 . . . . 15.0 113.56 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.4 16.26 57.42 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 121.18 -0.533 . . . . 15.0 113.436 175.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.1 t -101.1 140.24 20.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 117.803 0.802 . . . . 15.0 110.168 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -83.17 130.5 35.11 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.101 -0.703 . . . . 15.0 109.101 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.1 t -119.72 133.23 67.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.17 0.51 . . . . 15.0 111.191 -172.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -139.23 137.75 36.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.362 -0.836 . . . . 15.0 109.465 171.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -115.41 138.25 51.2 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.916 0.389 . . . . 15.0 111.035 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 tp -119.98 113.29 34.37 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-O 118.677 -0.678 . . . . 15.0 110.354 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.7 135.02 48.73 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 121.23 1.287 . . . . 15.0 112.304 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.42 -16.96 51.88 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.031 0.752 . . . . 15.0 113.031 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -77.14 -4.34 44.01 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.445 0.905 . . . . 15.0 113.445 -175.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -70.61 149.97 95.45 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 118.428 0.558 . . . . 15.0 110.816 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.31 147.14 52.49 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.6 1.533 . . . . 15.0 113.747 -174.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.9 152.55 3.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.429 -0.805 . . . . 15.0 111.291 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.78 -38.09 3.21 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.948 -0.569 . . . . 15.0 111.837 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -62.65 -36.88 84.28 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 120.346 -0.542 . . . . 15.0 111.092 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.2 tp -58.9 -46.9 86.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.915 0.388 . . . . 15.0 110.188 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 20.8 tp -62.25 -43.85 97.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 15.0 110.854 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.64 -45.88 92.16 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.635 -0.426 . . . . 15.0 110.853 -176.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -62.91 -40.03 96.33 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.874 -0.331 . . . . 15.0 111.165 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.4 t -60.56 -44.51 96.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.881 -0.415 . . . . 15.0 109.881 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -65.9 -51.82 55.38 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.369 0.418 . . . . 15.0 111.87 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.09 -44.37 80.18 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.028 -0.269 . . . . 15.0 111.629 -174.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -80.31 -10.04 59.75 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.168 0.803 . . . . 15.0 113.168 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 92.2 mtm-85 55.62 55.81 6.83 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.61 0.719 . . . . 15.0 110.406 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.0 146.23 53.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.656 -0.702 . . . . 15.0 110.965 -177.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -95.98 -40.7 9.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.695 -0.684 . . . . 15.0 110.906 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.7 164.83 28.81 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 119.945 -1.121 . . . . 15.0 113.589 -172.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.7 mt -126.79 145.16 50.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.456 -0.872 . . . . 15.0 109.919 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.1 t -121.0 129.14 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 110.437 -0.208 . . . . 15.0 110.437 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.7 m -126.99 139.24 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 120.955 0.407 . . . . 15.0 110.365 173.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.5 m -101.36 -4.8 26.32 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.055 0.761 . . . . 15.0 113.055 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.0 p -157.45 157.83 34.65 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-O 121.487 0.661 . . . . 15.0 111.977 -175.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.67 -37.75 78.31 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.048 -0.821 . . . . 15.0 111.048 177.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -57.03 -46.11 82.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.774 0.321 . . . . 15.0 110.716 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.69 -44.12 97.19 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.651 -0.98 . . . . 15.0 110.651 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.7 tp -56.01 -46.39 78.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.274 0.559 . . . . 15.0 110.717 -178.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -62.33 -42.9 99.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.911 -0.586 . . . . 15.0 110.874 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -58.89 -38.51 79.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.377 -0.374 . . . . 15.0 110.829 178.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.5 tp -57.58 -45.25 85.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.281 0.562 . . . . 15.0 110.086 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -61.45 -47.6 84.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.667 -0.697 . . . . 15.0 110.628 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -62.05 -43.46 98.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 15.0 111.281 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.1 mt -66.42 -35.63 80.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.382 -0.372 . . . . 15.0 111.379 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.28 -37.74 81.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.012 0.434 . . . . 15.0 110.884 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.72 -144.16 0.54 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.388 -0.597 . . . . 15.0 109.388 174.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.49 -18.64 41.66 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.319 0.963 . . . . 15.0 112.614 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -91.83 11.14 25.79 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.265 0.839 . . . . 15.0 113.265 -174.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -47.7 -46.83 61.87 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 118.6 -0.714 . . . . 15.0 112.592 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -44.64 -41.85 14.54 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.434 1.423 . . . . 15.0 113.22 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -76.99 -48.73 17.18 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.059 0.457 . . . . 15.0 110.807 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 95.2 mt -59.92 -40.03 81.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 15.0 110.855 -176.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.99 -15.74 29.7 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 119.916 -0.38 . . . . 15.0 112.966 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -64.82 -31.47 72.72 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 117.433 0.616 . . . . 15.0 111.884 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.7 mt -73.77 135.38 77.83 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 118.866 -0.587 . . . . 15.0 110.361 -175.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.01 134.18 60.57 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.39 1.393 . . . . 15.0 112.59 177.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.7 tp -107.66 130.18 54.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.974 -0.557 . . . . 15.0 110.65 176.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -89.19 123.9 33.86 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.27 -0.641 . . . . 15.0 109.27 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.7 m -114.53 146.61 36.28 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 119.378 -0.344 . . . . 15.0 110.237 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -79.14 -23.77 7.36 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.52 1.48 . . . . 15.0 113.574 -174.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.0 p -143.44 162.22 43.3 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 120.564 -0.455 . . . . 15.0 111.677 -171.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.0 -44.0 51.35 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.154 1.236 . . . . 15.0 111.791 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -57.95 -47.28 83.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.837 0.351 . . . . 15.0 110.838 -177.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.17 -41.17 85.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 15.0 110.047 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.82 -42.68 84.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.901 0.382 . . . . 15.0 110.411 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.33 -42.08 98.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 15.0 110.604 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 86.7 mtp -59.41 -43.81 92.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.198 0.523 . . . . 15.0 110.44 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.6 94.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.931 -0.577 . . . . 15.0 110.74 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -61.59 -44.44 97.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.336 -0.393 . . . . 15.0 110.674 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.43 -36.1 77.38 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.842 -0.343 . . . . 15.0 111.313 -177.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.7 mt -64.9 -24.12 67.43 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.206 0.447 . . . . 15.0 112.206 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.55 13.33 17.09 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 119.311 -0.716 . . . . 15.0 113.103 -176.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.91 121.98 11.84 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.573 1.187 . . . . 15.0 109.894 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -69.31 -35.18 75.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.659 -0.701 . . . . 15.0 111.267 -171.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -131.08 115.71 16.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.003 0.43 . . . . 15.0 110.182 177.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.9 t -114.69 130.1 69.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.281 -0.418 . . . . 15.0 110.027 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.7 mt -119.48 124.91 73.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.997 -0.547 . . . . 15.0 110.058 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -95.39 118.03 31.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.384 -0.371 . . . . 15.0 110.038 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.4 p -96.73 -0.38 48.3 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.219 0.822 . . . . 15.0 113.219 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -56.0 -40.08 72.81 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 118.186 0.448 . . . . 15.0 110.62 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.02 -35.02 5.21 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.507 -0.637 . . . . 15.0 111.507 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.58 142.32 50.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.815 0.341 . . . . 15.0 110.664 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.6 m -89.89 163.24 15.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.496 . . . . 15.0 110.505 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.78 -54.28 24.72 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 112.977 0.732 . . . . 15.0 112.977 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.23 -34.27 98.41 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 CA-C-N 120.068 1.06 . . . . 15.0 111.635 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.14 -43.14 95.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.058 0.456 . . . . 15.0 110.012 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 78.6 mt -59.38 -40.49 86.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 15.0 110.515 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 42.2 tp -56.88 -44.9 82.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.51 0.671 . . . . 15.0 110.166 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.04 92.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.526 -0.761 . . . . 15.0 110.708 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.57 -42.3 96.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.476 -0.329 . . . . 15.0 110.907 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.6 mt -57.92 -51.47 69.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.171 0.51 . . . . 15.0 110.388 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.7 p -63.5 -40.16 96.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.628 -0.714 . . . . 15.0 111.28 -175.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.0 t -63.18 -44.27 95.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.662 0.268 . . . . 15.0 111.385 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.03 85.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.473 -0.331 . . . . 15.0 110.955 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.496 -0.32 . . . . 15.0 111.277 178.419 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 CA--C 1.536 0.406 0 N-CA-C 110.361 -0.237 . . . . 15.0 110.361 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -58.01 155.03 35.58 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.52 1.48 . . . . 15.0 112.035 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -110.61 139.88 45.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.518 -0.31 . . . . 15.0 110.741 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 m -135.75 142.31 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.556 0.693 . . . . 15.0 111.635 176.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.2 tp -105.0 133.8 49.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.94 -1.027 . . . . 15.0 110.169 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.9 mt -106.02 135.18 45.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.286 -0.415 . . . . 15.0 110.22 -177.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 83.7 mtp -94.37 134.05 37.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.157 -0.474 . . . . 15.0 110.537 175.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -62.79 145.87 53.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.043 0.449 . . . . 15.0 111.536 -174.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.96 175.2 42.85 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.638 -0.985 . . . . 15.0 110.638 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.91 -33.3 68.62 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.725 0.268 . . . . 15.0 111.725 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.95 164.35 3.6 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.165 -0.774 . . . . 15.0 111.165 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.99 104.77 2.81 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.92 -0.872 . . . . 15.0 110.92 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 -69.18 -32.52 71.89 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.794 0.294 . . . . 15.0 111.794 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.33 -45.64 87.71 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.595 -0.442 . . . . 15.0 110.366 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -65.9 -55.21 18.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.359 -0.382 . . . . 15.0 111.233 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.0 tt -56.76 -43.13 80.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.843 0.354 . . . . 15.0 110.959 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.47 -43.02 99.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.388 -0.369 . . . . 15.0 110.575 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.82 -41.02 85.84 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.808 -0.357 . . . . 15.0 110.566 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -60.97 -51.32 69.73 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 120.371 -0.532 . . . . 15.0 111.366 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 70.0 mt -61.15 -37.78 84.08 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.316 -0.554 . . . . 15.0 110.845 -178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -65.03 -41.41 95.27 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 120.694 -0.402 . . . . 15.0 111.356 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.88 -30.68 66.68 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.028 -0.606 . . . . 15.0 111.883 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -88.08 9.97 20.76 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.477 0.917 . . . . 15.0 113.477 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.24 17.09 58.07 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 121.333 -0.46 . . . . 15.0 113.263 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -101.04 139.56 22.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 117.807 0.804 . . . . 15.0 110.126 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -82.0 126.2 31.69 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.393 -0.595 . . . . 15.0 109.393 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.5 t -116.75 129.32 73.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.087 0.47 . . . . 15.0 110.933 -174.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -136.39 132.65 35.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.636 -0.711 . . . . 15.0 109.685 172.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -112.63 133.45 54.66 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.947 0.403 . . . . 15.0 110.789 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.1 tp -116.08 113.33 41.7 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 118.824 -0.607 . . . . 15.0 110.367 -176.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.65 135.81 68.42 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 121.362 1.374 . . . . 15.0 112.692 174.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 73.9 mt -59.48 -10.48 3.37 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.37 0.878 . . . . 15.0 113.37 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -77.16 -6.26 52.25 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.298 0.851 . . . . 15.0 113.298 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -71.78 148.72 92.57 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 118.588 0.631 . . . . 15.0 110.582 -178.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -74.6 152.08 42.46 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.604 1.536 . . . . 15.0 113.782 -174.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.73 152.52 3.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.373 -0.83 . . . . 15.0 111.292 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.31 -38.28 3.15 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.799 -0.637 . . . . 15.0 111.782 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.5 -36.03 82.85 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 117.343 0.571 . . . . 15.0 111.264 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.8 tp -58.74 -46.86 86.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.942 0.401 . . . . 15.0 110.135 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 16.6 tp -63.33 -44.45 94.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 15.0 110.875 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.56 -44.76 96.44 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.706 -0.398 . . . . 15.0 110.871 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 61.7 ttm-85 -60.88 -42.78 98.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.458 -0.337 . . . . 15.0 110.655 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.5 t -60.34 -45.37 96.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.777 -0.369 . . . . 15.0 110.174 -177.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -67.29 -51.78 48.63 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.485 0.491 . . . . 15.0 112.058 -176.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.64 -44.35 82.19 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.986 -0.286 . . . . 15.0 111.565 -174.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -79.83 -10.15 59.75 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.972 0.73 . . . . 15.0 112.972 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 54.78 55.95 7.26 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.595 0.712 . . . . 15.0 110.086 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 97.5 mt -65.09 144.91 56.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.744 -0.662 . . . . 15.0 111.314 -174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -92.84 -39.13 11.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.133 -0.94 . . . . 15.0 110.81 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.69 160.96 28.46 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 120.149 -1.024 . . . . 15.0 113.469 -175.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.1 mt -126.16 144.37 50.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.575 -0.812 . . . . 15.0 109.564 177.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.7 t -122.71 131.51 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 O-C-N 122.315 -0.24 . . . . 15.0 110.93 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.0 m -127.53 150.69 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.08 0.467 . . . . 15.0 110.37 171.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.5 t -107.5 -15.65 14.56 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.605 -0.725 . . . . 15.0 112.711 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.4 p -152.75 160.59 43.13 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.402 0.62 . . . . 15.0 111.917 -173.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.37 -37.78 75.8 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.016 -0.834 . . . . 15.0 111.016 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -57.19 -46.16 83.09 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 122.599 -0.353 . . . . 15.0 110.703 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.14 -45.62 95.68 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.621 -0.991 . . . . 15.0 110.621 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.0 tp -56.94 -44.61 82.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.103 0.478 . . . . 15.0 110.736 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.69 -43.44 98.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.481 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -59.04 -37.31 76.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.124 -0.489 . . . . 15.0 110.858 177.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.1 tp -57.5 -44.96 85.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.286 0.565 . . . . 15.0 110.121 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -60.66 -46.87 88.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.53 -0.759 . . . . 15.0 110.539 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -62.61 -43.96 97.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 15.0 111.347 -176.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.08 -35.07 79.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.476 -0.329 . . . . 15.0 111.266 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.3 -37.95 82.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.007 0.432 . . . . 15.0 110.858 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.37 -144.63 0.55 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.461 -0.57 . . . . 15.0 109.461 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.45 -19.13 45.28 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.29 0.95 . . . . 15.0 112.586 -174.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -91.88 11.76 23.84 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.295 0.85 . . . . 15.0 113.295 -174.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 59.0 t-105 -47.77 -46.85 62.7 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 118.564 -0.731 . . . . 15.0 112.519 177.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -44.66 -41.29 14.58 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 121.431 1.421 . . . . 15.0 113.287 177.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -76.96 -48.75 17.2 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.607 -0.437 . . . . 15.0 110.803 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.5 mt -58.91 -40.18 79.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.197 -0.456 . . . . 15.0 110.796 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.39 -16.99 37.77 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 116.291 -0.413 . . . . 15.0 113.254 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -66.58 -28.93 68.9 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.297 0.548 . . . . 15.0 112.17 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.2 mt -74.85 150.59 86.24 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 121.031 -0.268 . . . . 15.0 111.514 -172.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -63.8 126.52 17.57 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 121.626 1.551 . . . . 15.0 112.309 176.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.8 tp -105.7 127.25 52.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.508 -0.315 . . . . 15.0 110.824 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -89.45 127.13 35.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.589 -0.522 . . . . 15.0 109.589 175.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.5 m -118.53 146.76 40.47 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 110.08 -0.341 . . . . 15.0 110.08 175.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -79.1 -23.45 7.69 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.61 1.54 . . . . 15.0 113.457 -176.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.5 p -144.3 158.44 54.68 Favored Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 120.671 -0.412 . . . . 15.0 111.355 -172.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.07 -44.03 52.18 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.26 1.307 . . . . 15.0 111.737 176.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -57.65 -47.71 81.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.882 0.372 . . . . 15.0 110.929 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.3 t -59.65 -40.69 82.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.906 0.384 . . . . 15.0 109.983 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.55 -42.25 82.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.81 0.338 . . . . 15.0 110.444 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.41 -41.03 93.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.49 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.1 mmm -58.39 -43.95 88.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.401 0.619 . . . . 15.0 110.157 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.28 -40.62 94.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.733 -0.667 . . . . 15.0 110.795 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -62.53 -42.82 99.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.342 -0.39 . . . . 15.0 111.074 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.67 -36.11 77.92 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.897 -0.321 . . . . 15.0 111.33 -177.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.2 mt -67.95 -22.12 65.05 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.404 0.52 . . . . 15.0 112.404 177.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.99 13.39 18.15 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 119.315 -0.714 . . . . 15.0 113.217 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.77 121.98 11.76 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.579 1.189 . . . . 15.0 109.864 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -70.3 -35.37 73.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.55 -0.75 . . . . 15.0 111.275 -171.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -131.84 112.53 12.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.977 0.418 . . . . 15.0 110.486 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.2 t -112.0 130.69 65.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.135 -0.484 . . . . 15.0 109.883 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 84.3 mt -118.95 122.6 69.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.016 -0.538 . . . . 15.0 110.11 -176.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.57 117.07 29.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.457 -0.338 . . . . 15.0 110.431 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.3 p -97.02 6.12 49.18 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.168 0.803 . . . . 15.0 113.168 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 71.9 ttp85 -55.76 -39.37 71.11 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.169 0.441 . . . . 15.0 110.803 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.68 -35.09 5.27 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.6 -0.6 . . . . 15.0 111.6 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.26 139.07 54.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.969 0.414 . . . . 15.0 110.773 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.8 p -89.84 167.84 12.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.996 -0.547 . . . . 15.0 110.464 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.75 -54.2 25.22 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 113.028 0.751 . . . . 15.0 113.028 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.73 -36.6 98.54 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 CA-C-N 120.509 1.218 . . . . 15.0 111.447 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.55 -43.13 97.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.98 0.419 . . . . 15.0 110.183 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.5 mt -59.36 -40.8 87.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.198 -0.456 . . . . 15.0 110.398 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.9 tp -57.67 -44.7 85.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.323 0.583 . . . . 15.0 110.188 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.98 -40.71 94.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.666 -0.697 . . . . 15.0 110.595 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.85 -42.04 97.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.424 -0.353 . . . . 15.0 110.765 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.3 mt -57.87 -50.44 73.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.047 0.451 . . . . 15.0 110.44 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.7 p -65.02 -40.49 94.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.805 -0.634 . . . . 15.0 111.479 -175.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.9 p -64.37 -39.67 94.33 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.98 -0.288 . . . . 15.0 111.28 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.54 -43.27 94.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.634 -0.257 . . . . 15.0 111.037 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.543 -0.299 . . . . 15.0 110.976 179.757 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 CA--C 1.534 0.355 0 N-CA-C 110.194 -0.299 . . . . 15.0 110.194 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -54.09 152.37 24.62 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 121.481 1.454 . . . . 15.0 111.824 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -112.43 135.7 52.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.291 -0.413 . . . . 15.0 110.509 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.8 m -133.1 145.58 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.619 0.723 . . . . 15.0 111.859 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.9 tp -103.66 136.86 42.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.964 -1.016 . . . . 15.0 110.496 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.8 mt -100.79 133.87 42.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.033 0.444 . . . . 15.0 110.683 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 84.8 mtp -102.56 134.62 45.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.242 -0.89 . . . . 15.0 110.09 173.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -57.36 141.16 48.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.213 0.53 . . . . 15.0 110.572 -173.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.13 175.28 31.66 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.551 -1.02 . . . . 15.0 110.551 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.7 mp0 -58.0 -31.68 67.19 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.951 -0.3 . . . . 15.0 111.515 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.49 173.27 33.61 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.908 -0.877 . . . . 15.0 110.908 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.32 132.21 11.05 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.488 -0.645 . . . . 15.0 111.488 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -56.87 -44.08 81.86 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.127 0.489 . . . . 15.0 110.227 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.38 -43.42 97.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.767 -0.651 . . . . 15.0 111.024 -175.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -58.2 -55.93 28.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.012 0.434 . . . . 15.0 110.909 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.1 mt -61.35 -42.85 99.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 15.0 110.91 -175.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.12 -45.0 96.48 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.767 -0.373 . . . . 15.0 111.163 -177.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.23 -38.81 84.56 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.598 -0.441 . . . . 15.0 110.811 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -60.63 -51.51 69.1 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 119.973 -0.691 . . . . 15.0 110.918 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.57 -38.02 89.52 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 120.451 -0.499 . . . . 15.0 111.252 -176.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -63.57 -42.47 98.33 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.91 -0.316 . . . . 15.0 111.266 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.71 -30.72 69.63 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 120.865 -0.684 . . . . 15.0 112.011 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -88.8 10.14 22.11 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.654 0.983 . . . . 15.0 113.654 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.8 17.25 56.89 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 121.251 -0.5 . . . . 15.0 113.295 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.1 t -101.02 141.02 18.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 117.712 0.756 . . . . 15.0 110.088 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -84.8 131.36 34.55 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.297 -0.631 . . . . 15.0 109.297 177.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.3 t -117.72 131.19 71.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.129 0.49 . . . . 15.0 111.121 -173.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -137.4 133.82 35.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.464 -0.789 . . . . 15.0 109.488 171.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -116.06 138.38 51.28 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.968 0.413 . . . . 15.0 111.194 -177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.0 tp -119.21 135.97 24.21 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 109.243 -0.651 . . . . 15.0 109.243 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.22 135.92 25.77 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.182 1.255 . . . . 15.0 111.759 173.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 84.1 mt -59.9 -9.31 2.84 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.41 0.893 . . . . 15.0 113.41 -177.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -77.14 -7.91 56.6 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.415 0.894 . . . . 15.0 113.415 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -64.57 146.55 98.18 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 118.606 0.639 . . . . 15.0 110.552 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.03 159.03 27.15 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.617 1.544 . . . . 15.0 113.221 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.44 150.97 4.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.779 -0.646 . . . . 15.0 111.52 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.2 -38.01 3.25 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.321 -0.712 . . . . 15.0 111.321 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -61.34 -37.82 84.67 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.58 -0.448 . . . . 15.0 111.017 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 28.4 tp -59.0 -46.83 87.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.981 0.42 . . . . 15.0 110.127 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.6 tp -62.51 -43.56 98.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.178 -0.465 . . . . 15.0 110.914 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.17 -45.96 91.06 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.724 -0.39 . . . . 15.0 110.95 -176.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -61.52 -41.5 97.41 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.812 -0.355 . . . . 15.0 110.707 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 94.5 t -61.24 -45.8 97.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.779 -0.368 . . . . 15.0 110.204 -177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -69.11 -49.03 60.76 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.293 0.479 . . . . 15.0 112.293 -175.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.48 -44.3 75.08 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.992 -0.283 . . . . 15.0 111.642 -174.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -78.96 -10.16 59.74 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.09 0.774 . . . . 15.0 113.09 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 55.78 55.83 6.69 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.601 0.715 . . . . 15.0 110.306 -177.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 94.2 mt -74.18 146.91 43.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.552 -0.749 . . . . 15.0 111.306 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -96.78 -40.71 8.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.677 -0.692 . . . . 15.0 110.807 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.63 165.45 28.77 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 119.798 -1.191 . . . . 15.0 113.644 -171.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.7 mt -127.04 144.59 50.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.545 -0.828 . . . . 15.0 110.279 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.5 t -120.22 129.35 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 110.372 -0.233 . . . . 15.0 110.372 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.2 m -126.65 144.53 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.141 0.496 . . . . 15.0 110.657 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.0 t -102.84 -13.27 17.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.493 -0.776 . . . . 15.0 112.747 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.8 p -153.34 159.1 42.4 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.456 0.646 . . . . 15.0 112.075 -173.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.6 -37.9 78.5 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.972 -0.851 . . . . 15.0 110.972 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -58.45 -44.62 89.28 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.848 -0.341 . . . . 15.0 110.635 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.4 -45.38 96.31 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.623 -0.991 . . . . 15.0 110.623 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 42.5 tp -56.4 -45.73 80.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.129 0.49 . . . . 15.0 110.778 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -62.0 -42.73 99.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.043 -0.526 . . . . 15.0 110.89 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -59.22 -39.68 83.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.373 -0.376 . . . . 15.0 110.716 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.6 tp -58.09 -45.02 87.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.166 0.508 . . . . 15.0 110.238 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -60.7 -47.55 85.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.744 -0.662 . . . . 15.0 110.648 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -62.0 -43.19 99.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.014 -0.539 . . . . 15.0 111.136 -176.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.08 -34.95 78.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.451 -0.341 . . . . 15.0 111.453 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.47 -38.94 82.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.953 0.406 . . . . 15.0 110.535 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 58.96 -142.53 0.64 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.626 -0.509 . . . . 15.0 109.626 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.75 -18.58 44.16 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.39 0.996 . . . . 15.0 112.695 -174.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -91.79 9.26 33.42 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.315 0.857 . . . . 15.0 113.315 -175.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -47.74 -46.57 61.84 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.633 -0.699 . . . . 15.0 112.61 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -44.55 -43.04 14.34 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.493 1.462 . . . . 15.0 113.287 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -76.96 -48.81 17.02 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 120.644 -0.422 . . . . 15.0 110.931 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 86.4 mt -59.33 -39.05 77.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.11 -0.496 . . . . 15.0 110.85 -176.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.78 -13.2 38.54 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 119.826 -0.43 . . . . 15.0 113.405 -175.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -70.5 -29.21 65.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 117.578 0.689 . . . . 15.0 112.304 178.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.2 mt -69.86 126.51 92.53 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 118.572 -0.728 . . . . 15.0 109.606 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.23 133.45 52.68 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.106 1.204 . . . . 15.0 112.333 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.8 tp -105.75 129.31 53.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.904 -0.589 . . . . 15.0 110.552 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -90.52 122.45 33.36 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.249 -0.648 . . . . 15.0 109.249 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.9 m -114.99 148.01 39.6 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 119.457 -0.306 . . . . 15.0 110.326 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.21 -24.54 6.59 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.529 1.486 . . . . 15.0 113.614 -174.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.9 p -142.43 161.36 50.45 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 120.594 -0.442 . . . . 15.0 111.58 -172.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -55.32 -44.07 52.44 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.208 1.272 . . . . 15.0 111.76 176.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -57.17 -47.9 80.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.855 0.36 . . . . 15.0 110.639 -177.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.5 t -60.0 -41.37 85.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.904 0.383 . . . . 15.0 109.992 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.94 -42.1 84.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.969 0.414 . . . . 15.0 110.486 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.24 -41.71 97.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.433 . . . . 15.0 110.44 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 86.5 mtp -58.92 -41.82 88.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.101 0.477 . . . . 15.0 110.379 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.69 -41.21 94.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 15.0 110.576 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 -61.74 -43.29 99.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 15.0 110.809 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.24 -36.1 76.98 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.879 -0.328 . . . . 15.0 111.256 -177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 77.5 mt -65.89 -24.41 66.85 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.256 0.465 . . . . 15.0 112.256 176.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 107.67 13.25 20.88 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 119.437 -0.646 . . . . 15.0 113.075 -175.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.94 123.82 17.12 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 118.416 1.108 . . . . 15.0 109.939 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -72.17 -33.5 67.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.843 -0.617 . . . . 15.0 111.425 -172.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 45.9 tpt85 -131.81 114.57 14.87 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.903 0.382 . . . . 15.0 110.404 176.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 40.5 t -114.67 131.62 66.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.822 0.344 . . . . 15.0 110.145 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 87.8 mt -119.7 125.93 74.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.172 -0.467 . . . . 15.0 110.191 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -94.2 118.3 31.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.36 -0.382 . . . . 15.0 110.134 174.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.1 p -94.25 -7.2 42.73 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.17 0.804 . . . . 15.0 113.17 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -55.82 -39.41 71.34 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 118.122 0.419 . . . . 15.0 110.781 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -96.27 -35.04 5.63 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.491 -0.644 . . . . 15.0 111.491 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.24 143.44 40.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.796 0.331 . . . . 15.0 110.478 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.6 m -89.43 163.42 15.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 15.0 110.526 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.72 -54.31 24.23 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 112.878 0.695 . . . . 15.0 112.878 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.6 -34.13 98.65 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 CA-C-N 120.195 1.106 . . . . 15.0 111.646 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.29 -42.96 96.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.107 0.48 . . . . 15.0 110.026 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.8 mt -59.32 -39.88 84.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 15.0 110.495 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 29.4 tp -56.87 -45.04 82.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.399 0.618 . . . . 15.0 110.111 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.98 -39.73 90.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.506 -0.77 . . . . 15.0 110.601 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.63 -42.87 97.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.604 -0.271 . . . . 15.0 110.844 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.8 mt -58.04 -50.36 73.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.119 0.485 . . . . 15.0 110.405 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 71.7 p -63.5 -40.39 96.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.807 -0.633 . . . . 15.0 111.368 -175.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.8 m -64.01 -42.75 97.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.662 0.267 . . . . 15.0 111.292 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.25 -39.01 88.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.474 -0.33 . . . . 15.0 110.998 -178.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.545 -0.298 . . . . 15.0 111.213 178.666 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 110.406 -0.22 . . . . 15.0 110.406 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -56.13 155.05 25.47 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.389 1.393 . . . . 15.0 111.761 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -109.98 138.04 46.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.479 -0.328 . . . . 15.0 110.901 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.8 m -134.06 144.35 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.538 0.685 . . . . 15.0 111.614 175.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.8 tp -103.78 136.74 42.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.949 -1.023 . . . . 15.0 110.274 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.8 mt -101.6 133.8 43.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.137 0.494 . . . . 15.0 111.013 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 98.7 mmm -94.69 134.28 37.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.153 -0.93 . . . . 15.0 109.045 170.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -57.46 140.68 49.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.894 0.378 . . . . 15.0 110.562 -175.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.28 175.1 27.74 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.995 -0.842 . . . . 15.0 110.995 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -58.2 -33.18 69.0 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.546 0.202 . . . . 15.0 111.546 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.94 173.27 35.25 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.979 -0.848 . . . . 15.0 110.979 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.98 131.36 10.37 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.25 -0.74 . . . . 15.0 111.25 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -57.41 -43.76 84.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.082 0.468 . . . . 15.0 110.317 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.18 -42.58 99.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.815 -0.63 . . . . 15.0 111.344 -176.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -61.68 -55.94 25.09 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.804 -0.359 . . . . 15.0 111.292 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.3 mt -59.87 -43.62 94.62 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.662 -0.415 . . . . 15.0 111.021 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.7 -41.31 99.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.491 -0.322 . . . . 15.0 110.995 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -60.04 -41.5 92.43 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.949 -0.3 . . . . 15.0 110.458 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -60.91 -51.73 68.04 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.622 -0.431 . . . . 15.0 111.319 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 72.9 mt -63.63 -36.96 85.54 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.349 -0.54 . . . . 15.0 110.971 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -62.49 -41.87 99.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.648 0.261 . . . . 15.0 111.092 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.7 -30.62 69.41 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.068 -0.587 . . . . 15.0 111.932 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -88.09 10.96 17.46 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.535 0.939 . . . . 15.0 113.535 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.39 17.77 56.54 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 121.279 -0.486 . . . . 15.0 113.368 174.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -101.05 139.0 23.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 117.807 0.803 . . . . 15.0 110.217 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -83.28 130.75 35.09 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.207 -0.664 . . . . 15.0 109.207 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.69 133.94 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.137 0.494 . . . . 15.0 111.401 -172.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -140.21 138.12 34.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.543 -0.753 . . . . 15.0 109.64 171.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -115.81 141.65 47.82 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.825 0.345 . . . . 15.0 110.789 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.9 tp -117.83 113.42 37.98 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 118.814 -0.612 . . . . 15.0 110.585 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -49.67 135.0 34.39 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.208 1.272 . . . . 15.0 111.903 173.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.0 mt -62.87 -13.37 33.17 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.214 0.82 . . . . 15.0 113.214 -176.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -77.14 -5.32 48.6 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.3 0.852 . . . . 15.0 113.3 -177.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -61.25 149.93 81.2 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 118.484 0.584 . . . . 15.0 110.375 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -80.07 151.91 21.26 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.567 1.512 . . . . 15.0 112.891 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.39 150.7 6.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.066 -0.515 . . . . 15.0 111.173 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.08 -38.03 3.24 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.57 -0.612 . . . . 15.0 111.57 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -62.05 -37.98 87.02 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 117.081 0.44 . . . . 15.0 110.995 -177.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.2 tp -59.3 -47.46 85.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.922 0.392 . . . . 15.0 110.155 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.4 tp -63.0 -44.5 95.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.204 -0.453 . . . . 15.0 110.973 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.65 -45.66 93.08 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.702 -0.399 . . . . 15.0 110.675 -176.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 47.2 ttt85 -61.01 -42.03 97.68 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.784 -0.367 . . . . 15.0 110.706 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.8 t -60.88 -45.04 98.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.811 -0.355 . . . . 15.0 110.322 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -68.79 -48.24 64.13 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.235 0.457 . . . . 15.0 112.235 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.03 -44.3 72.99 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.995 -0.282 . . . . 15.0 111.629 -175.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -78.41 -10.03 59.53 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.046 0.758 . . . . 15.0 113.046 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 55.93 55.84 6.57 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.593 0.711 . . . . 15.0 110.252 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.01 144.21 52.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.552 -0.749 . . . . 15.0 110.976 -176.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -90.8 -40.58 11.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.394 -0.821 . . . . 15.0 110.764 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -150.8 166.46 30.34 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 119.797 -1.192 . . . . 15.0 113.774 -173.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.0 mt -125.73 143.05 51.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.519 -0.84 . . . . 15.0 109.888 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.8 t -121.28 131.6 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 110.307 -0.257 . . . . 15.0 110.307 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.0 m -128.46 139.72 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.058 0.456 . . . . 15.0 110.469 173.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.9 t -102.03 -14.93 16.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.566 -0.743 . . . . 15.0 112.81 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 85.2 p -145.9 156.77 43.76 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.28 0.562 . . . . 15.0 111.771 -174.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.18 -39.7 90.41 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.873 -0.891 . . . . 15.0 110.873 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -59.33 -43.54 92.69 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.837 -0.345 . . . . 15.0 110.533 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.41 -46.29 94.13 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.544 -1.023 . . . . 15.0 110.544 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.16 -44.84 83.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.106 0.479 . . . . 15.0 110.685 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.82 -42.64 99.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.025 -0.534 . . . . 15.0 110.93 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -59.97 -40.78 90.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.781 0.324 . . . . 15.0 110.642 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.5 tp -58.15 -44.26 87.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.24 0.543 . . . . 15.0 110.17 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -60.82 -46.95 88.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.833 -0.621 . . . . 15.0 110.769 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.31 -42.63 98.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.083 -0.508 . . . . 15.0 111.123 -176.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 94.8 mt -65.47 -36.19 83.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.404 -0.362 . . . . 15.0 111.332 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.47 -38.08 79.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.145 0.498 . . . . 15.0 110.923 177.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.14 -143.85 0.58 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.627 -0.508 . . . . 15.0 109.627 174.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.54 -20.9 58.92 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.307 0.958 . . . . 15.0 112.694 -173.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -92.47 13.53 19.37 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.222 0.823 . . . . 15.0 113.222 -175.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 53.8 t-105 -47.74 -46.65 62.06 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-O 118.608 -0.711 . . . . 15.0 112.53 176.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -44.61 -40.39 13.92 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 121.475 1.45 . . . . 15.0 113.19 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -77.0 -48.79 16.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.034 0.445 . . . . 15.0 110.808 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.34 -39.08 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 15.0 110.876 -177.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.78 -14.3 29.23 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 119.849 -0.417 . . . . 15.0 113.083 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -65.13 -30.9 71.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 117.461 0.631 . . . . 15.0 111.785 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.3 mt -74.02 139.82 76.65 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 119.068 -0.491 . . . . 15.0 110.397 -175.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -58.9 134.26 59.03 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 121.433 1.422 . . . . 15.0 112.556 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.8 tp -108.87 129.2 55.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.075 -0.512 . . . . 15.0 110.745 176.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -91.1 125.83 36.0 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.54 -0.541 . . . . 15.0 109.54 175.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.7 m -117.1 149.16 43.8 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 119.513 -0.279 . . . . 15.0 110.377 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -79.15 -25.53 5.85 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.645 1.563 . . . . 15.0 113.597 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.6 p -142.7 162.21 45.34 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 120.635 -0.426 . . . . 15.0 111.542 -172.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -56.02 -43.9 52.21 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.11 1.207 . . . . 15.0 111.862 176.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 68.5 mtp85 -58.79 -46.58 87.22 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.868 -0.333 . . . . 15.0 110.871 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.01 -40.85 84.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.959 -0.385 . . . . 15.0 109.959 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.59 -42.04 82.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.886 0.374 . . . . 15.0 110.467 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.46 -41.37 97.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.281 -0.418 . . . . 15.0 110.555 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 86.9 mtp -59.91 -43.4 94.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.223 0.535 . . . . 15.0 110.442 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.48 -40.85 96.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.025 -0.534 . . . . 15.0 110.719 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -61.24 -44.25 97.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 15.0 110.324 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.8 -36.15 74.0 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.986 -0.286 . . . . 15.0 111.251 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.9 mt -65.24 -26.03 67.93 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.113 0.412 . . . . 15.0 112.113 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.67 13.26 16.99 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 119.391 -0.672 . . . . 15.0 113.13 -176.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.92 122.1 12.13 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 118.527 1.163 . . . . 15.0 109.884 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -68.23 -35.32 77.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.764 -0.653 . . . . 15.0 111.23 -171.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.3 tpt85 -131.79 117.45 18.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.907 0.384 . . . . 15.0 110.137 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.7 t -114.41 130.06 69.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.996 0.427 . . . . 15.0 110.091 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 87.0 mt -118.81 125.16 74.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.801 -0.636 . . . . 15.0 110.171 -177.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.82 118.07 31.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.388 -0.369 . . . . 15.0 110.08 175.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.9 p -92.91 -8.21 43.94 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.164 0.802 . . . . 15.0 113.164 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -55.14 -39.54 69.58 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.045 0.384 . . . . 15.0 110.914 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.07 -35.09 5.17 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.513 -0.635 . . . . 15.0 111.513 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.87 145.42 53.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.879 0.371 . . . . 15.0 110.691 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.6 t -89.8 152.01 21.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 15.0 110.406 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.67 -54.43 23.11 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 113.087 0.773 . . . . 15.0 113.087 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.83 -36.17 94.96 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 CA-C-N 120.098 1.071 . . . . 15.0 111.642 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.88 -42.0 92.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.035 0.445 . . . . 15.0 110.078 176.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.6 mt -59.02 -40.16 84.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.243 -0.435 . . . . 15.0 110.517 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.1 tp -57.17 -43.88 82.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.39 0.614 . . . . 15.0 110.146 178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.84 -40.88 90.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.679 -0.691 . . . . 15.0 110.393 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.73 -40.8 89.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.311 -0.404 . . . . 15.0 110.715 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.9 mt -57.82 -50.74 72.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.271 0.558 . . . . 15.0 110.494 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.5 p -63.57 -40.54 97.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.6 -0.727 . . . . 15.0 111.326 -175.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 86.5 p -65.74 -39.17 90.86 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.911 -0.316 . . . . 15.0 111.42 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.62 -39.31 94.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.497 -0.32 . . . . 15.0 111.068 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.418 -0.356 . . . . 15.0 111.163 179.204 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 . . . . . 0 CA--C 1.534 0.355 0 N-CA-C 110.242 -0.281 . . . . 15.0 110.242 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -49.98 151.51 8.54 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.449 1.433 . . . . 15.0 111.937 -175.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -119.93 141.13 49.91 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.334 -0.394 . . . . 15.0 110.703 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.6 m -133.87 145.77 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.474 0.654 . . . . 15.0 111.781 175.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.4 tp -104.9 135.45 46.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.077 -0.965 . . . . 15.0 110.067 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.7 mt -103.04 135.09 42.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.026 0.441 . . . . 15.0 110.545 -177.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 96.7 mmm -88.21 134.12 33.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.422 -0.808 . . . . 15.0 110.123 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -57.81 140.72 51.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 15.0 110.583 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.36 175.07 42.52 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.949 -0.86 . . . . 15.0 110.949 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.61 -34.09 64.55 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.263 -0.175 . . . . 15.0 111.419 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.72 162.19 4.36 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.246 -0.742 . . . . 15.0 111.246 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.95 119.59 5.06 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.202 -0.759 . . . . 15.0 111.202 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -57.07 -43.79 82.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.097 0.475 . . . . 15.0 110.24 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.68 -41.71 98.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.861 -0.609 . . . . 15.0 111.146 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -58.84 -56.09 26.66 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.713 -0.395 . . . . 15.0 110.966 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.9 mt -61.53 -40.62 95.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.32 -0.4 . . . . 15.0 111.051 -176.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.41 -46.2 90.87 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.78 -0.368 . . . . 15.0 111.336 -177.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -60.29 -40.04 89.04 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.532 -0.467 . . . . 15.0 110.688 -177.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -60.57 -51.61 68.67 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 120.27 -0.572 . . . . 15.0 111.134 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.3 mt -66.31 -36.12 82.13 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.474 -0.49 . . . . 15.0 111.256 -176.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -61.66 -43.42 98.89 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 121.111 -0.236 . . . . 15.0 110.699 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.9 -30.7 70.26 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 120.844 -0.694 . . . . 15.0 112.018 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -88.21 8.59 26.41 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.647 0.98 . . . . 15.0 113.647 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.2 12.01 63.95 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 121.241 -0.505 . . . . 15.0 113.462 176.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.11 139.89 21.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 117.886 0.843 . . . . 15.0 110.044 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -86.26 137.44 32.61 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.699 -0.482 . . . . 15.0 109.699 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.6 t -116.78 131.13 70.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.186 0.517 . . . . 15.0 110.96 -174.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -134.81 130.2 35.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.587 -0.733 . . . . 15.0 109.446 171.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -112.01 135.69 52.32 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.896 0.379 . . . . 15.0 110.87 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.0 tp -116.15 113.35 41.53 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-O 118.751 -0.643 . . . . 15.0 110.398 -176.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.35 136.52 63.15 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.189 1.26 . . . . 15.0 112.445 175.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.4 mt -58.62 -10.96 2.56 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.339 0.866 . . . . 15.0 113.339 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -77.15 -5.81 50.52 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.321 0.859 . . . . 15.0 113.321 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -65.75 146.06 99.0 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 118.491 0.587 . . . . 15.0 110.482 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -80.75 157.13 21.25 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.602 1.535 . . . . 15.0 113.142 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.41 151.47 5.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.921 -0.582 . . . . 15.0 111.331 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.13 -38.03 3.24 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.527 -0.629 . . . . 15.0 111.527 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -62.45 -36.69 83.22 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.601 -0.44 . . . . 15.0 111.096 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.4 tp -59.11 -47.12 86.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.962 0.411 . . . . 15.0 110.196 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 19.4 tp -62.71 -45.2 93.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 15.0 110.868 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.68 -44.53 96.77 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.687 -0.405 . . . . 15.0 110.76 -176.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 58.9 ttm-85 -60.72 -42.56 97.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.503 -0.317 . . . . 15.0 110.773 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.9 t -60.46 -45.85 96.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.778 -0.369 . . . . 15.0 110.215 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 62.1 ttm-85 -67.45 -51.63 49.18 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 123.453 0.471 . . . . 15.0 112.005 -176.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.36 -44.31 79.32 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 121.05 -0.26 . . . . 15.0 111.698 -174.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -78.85 -10.18 59.71 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.065 0.765 . . . . 15.0 113.065 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 54.67 55.83 7.46 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.515 0.674 . . . . 15.0 110.568 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 97.8 mt -74.15 143.75 45.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.794 -0.639 . . . . 15.0 111.086 -176.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -90.2 -40.61 12.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.456 -0.793 . . . . 15.0 110.772 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.61 165.89 28.74 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 119.869 -1.158 . . . . 15.0 113.537 -171.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.1 mt -127.09 145.69 50.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.665 -0.768 . . . . 15.0 110.042 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.3 t -122.78 133.2 69.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 110.248 -0.279 . . . . 15.0 110.248 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.2 m -124.57 138.35 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 120.99 0.424 . . . . 15.0 110.609 174.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.1 p -90.05 -18.02 26.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.727 -0.67 . . . . 15.0 112.636 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 77.0 p -156.68 161.43 39.86 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 121.364 0.602 . . . . 15.0 111.719 -176.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.95 -37.25 69.73 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.193 -0.763 . . . . 15.0 111.193 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -59.17 -46.09 89.29 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.899 -0.32 . . . . 15.0 110.789 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.9 -42.78 98.36 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.808 -0.917 . . . . 15.0 110.808 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 28.8 tp -58.11 -47.33 83.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.987 0.423 . . . . 15.0 110.622 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.49 -43.61 98.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.181 -0.463 . . . . 15.0 110.644 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -59.09 -40.91 86.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.104 -0.498 . . . . 15.0 110.527 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.2 tp -56.76 -42.55 79.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.059 0.457 . . . . 15.0 110.194 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -58.74 -46.99 86.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.875 -0.602 . . . . 15.0 110.238 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -61.37 -43.2 99.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.794 -0.639 . . . . 15.0 111.098 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.83 -35.99 82.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.281 -0.418 . . . . 15.0 111.437 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.55 -38.49 81.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.063 0.458 . . . . 15.0 110.816 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.45 -143.56 0.57 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 109.454 -0.572 . . . . 15.0 109.454 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.48 -19.1 45.31 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.347 0.976 . . . . 15.0 112.66 -174.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -91.84 10.39 28.83 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.295 0.85 . . . . 15.0 113.295 -174.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 53.5 t-105 -47.75 -48.13 60.75 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 118.553 -0.737 . . . . 15.0 112.423 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -44.72 -40.37 14.26 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.47 1.447 . . . . 15.0 113.159 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -77.1 -48.6 17.33 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.936 0.398 . . . . 15.0 111.202 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 93.7 mt -59.11 -39.27 78.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 15.0 110.826 -177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.96 0.4 14.92 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 119.693 -0.504 . . . . 15.0 113.22 -175.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.3 mtm105 -90.58 -1.28 57.88 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.013 0.906 . . . . 15.0 112.975 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 23.3 mt -90.09 139.47 27.27 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-O 118.869 -0.586 . . . . 15.0 109.656 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.67 131.23 40.51 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.376 1.384 . . . . 15.0 111.759 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.3 tp -105.43 128.07 53.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.748 0.309 . . . . 15.0 110.9 177.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -92.84 127.13 38.23 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.696 -0.483 . . . . 15.0 109.696 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.8 m -123.15 151.58 62.18 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-O 119.567 -0.254 . . . . 15.0 110.67 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.28 -19.63 10.31 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 121.514 1.476 . . . . 15.0 113.803 -175.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.0 p -148.83 162.47 29.38 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 120.391 -0.524 . . . . 15.0 111.841 -171.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.4 -43.96 47.0 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.2 1.267 . . . . 15.0 111.885 176.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -58.2 -46.75 85.27 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.808 -0.357 . . . . 15.0 110.71 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 50.2 t -60.95 -38.38 79.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.689 -0.404 . . . . 15.0 110.128 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.85 -41.71 78.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.042 0.449 . . . . 15.0 110.427 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -60.88 -40.09 91.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.154 -0.476 . . . . 15.0 110.616 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.1 mmm -58.34 -45.85 87.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.45 0.643 . . . . 15.0 110.173 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.11 98.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.733 -0.667 . . . . 15.0 111.112 -177.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 71.6 ttp85 -62.28 -44.2 97.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.186 -0.461 . . . . 15.0 110.708 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -59.33 -36.15 75.12 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.978 -0.289 . . . . 15.0 111.236 -177.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 81.5 mt -65.46 -25.24 67.42 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.098 0.407 . . . . 15.0 112.098 177.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 111.58 13.2 13.24 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 119.293 -0.726 . . . . 15.0 113.235 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.22 131.08 49.95 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.566 1.183 . . . . 15.0 109.666 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -62.24 -44.42 96.59 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.452 -0.573 . . . . 15.0 109.452 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 47.9 ttt85 -131.84 119.03 20.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.464 -0.789 . . . . 15.0 110.945 -173.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.8 t -114.43 128.78 71.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.829 -0.623 . . . . 15.0 109.503 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 93.2 mt -117.79 123.92 72.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.903 -0.59 . . . . 15.0 110.279 -175.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -94.36 118.22 31.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.364 -0.38 . . . . 15.0 110.22 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.7 p -91.33 -6.94 52.3 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.141 0.793 . . . . 15.0 113.141 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 47.0 tpt85 -55.51 -39.61 70.73 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 118.208 0.458 . . . . 15.0 110.723 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.33 -35.2 5.32 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.48 -0.648 . . . . 15.0 111.48 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.11 144.25 42.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.816 0.341 . . . . 15.0 110.55 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.1 m -89.72 161.8 15.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.04 0.448 . . . . 15.0 110.578 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.65 -54.27 24.25 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 112.976 0.732 . . . . 15.0 112.976 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.05 -34.84 98.9 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 CA-C-N 120.213 1.112 . . . . 15.0 111.601 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.63 94.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.061 0.457 . . . . 15.0 110.048 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.3 mt -59.05 -40.9 86.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.446 . . . . 15.0 110.411 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 40.7 tp -57.31 -44.46 84.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.383 0.611 . . . . 15.0 110.136 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.31 -39.74 88.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.583 -0.735 . . . . 15.0 110.677 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.88 -42.42 97.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.415 -0.357 . . . . 15.0 110.899 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.0 mt -57.88 -50.36 73.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.026 0.441 . . . . 15.0 110.428 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.8 p -65.38 -39.95 92.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.827 -0.624 . . . . 15.0 111.576 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.1 p -66.35 -38.42 87.57 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.999 -0.28 . . . . 15.0 111.28 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.63 -42.59 95.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.41 -0.359 . . . . 15.0 111.133 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.249 0 CA-C-O 120.756 0.313 . . . . 15.0 110.579 179.856 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 . . . . . 0 CA--C 1.535 0.393 0 N-CA-C 110.238 -0.282 . . . . 15.0 110.238 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -50.99 154.53 7.15 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.486 1.457 . . . . 15.0 111.871 -176.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -116.43 140.39 49.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.448 -0.342 . . . . 15.0 110.831 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.2 m -135.4 143.78 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.638 0.732 . . . . 15.0 111.69 175.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 tp -104.72 134.34 48.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.855 -1.066 . . . . 15.0 110.262 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.9 mt -103.35 135.15 42.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 15.0 110.505 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 85.9 mtp -101.08 134.11 44.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.66 -0.7 . . . . 15.0 109.531 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -57.61 146.47 30.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.002 0.429 . . . . 15.0 110.81 -174.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.92 175.14 33.79 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.97 -0.852 . . . . 15.0 110.97 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.56 -32.62 67.31 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.602 0.223 . . . . 15.0 111.602 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.51 177.01 18.25 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.014 -0.835 . . . . 15.0 111.014 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.0 122.09 5.81 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.313 -0.715 . . . . 15.0 111.313 -178.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -57.17 -44.52 83.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.098 0.475 . . . . 15.0 110.27 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.96 -41.13 97.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.927 -0.579 . . . . 15.0 110.958 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -57.88 -55.98 27.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.981 0.42 . . . . 15.0 111.0 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.8 tp -60.54 -42.13 95.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 15.0 111.025 -176.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.06 -43.69 98.51 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.799 -0.36 . . . . 15.0 111.45 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -61.73 -39.46 91.64 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.704 -0.398 . . . . 15.0 110.818 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -61.01 -51.6 68.54 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.381 -0.527 . . . . 15.0 111.232 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 80.9 mt -64.26 -37.58 87.97 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.409 -0.516 . . . . 15.0 111.001 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -63.79 -43.8 95.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.59 0.233 . . . . 15.0 111.121 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.93 -30.66 66.81 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.03 -0.605 . . . . 15.0 111.961 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -88.03 9.33 22.81 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.57 0.952 . . . . 15.0 113.57 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.21 13.63 58.5 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 121.247 -0.501 . . . . 15.0 113.554 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.0 t -101.09 138.15 26.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 117.845 0.822 . . . . 15.0 110.061 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -79.51 132.42 36.32 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.194 -0.669 . . . . 15.0 109.194 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.6 t -116.36 131.17 69.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.194 0.521 . . . . 15.0 111.106 -173.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -137.73 130.8 30.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.413 -0.812 . . . . 15.0 109.377 170.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -114.15 135.11 54.39 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.87 0.366 . . . . 15.0 110.645 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 tp -112.99 136.04 21.7 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.946 -0.55 . . . . 15.0 110.027 -175.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -72.16 135.11 24.36 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.332 1.354 . . . . 15.0 111.976 172.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.4 mt -58.36 -11.94 3.3 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.33 0.863 . . . . 15.0 113.33 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -77.21 -6.64 53.78 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.392 0.886 . . . . 15.0 113.392 -176.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -68.55 150.9 97.52 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 118.524 0.602 . . . . 15.0 110.738 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -78.95 155.9 26.61 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.64 1.56 . . . . 15.0 113.102 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.11 151.99 4.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.763 -0.653 . . . . 15.0 111.226 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.44 -38.03 3.24 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.945 -0.57 . . . . 15.0 111.688 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.68 -38.86 86.35 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 117.172 0.486 . . . . 15.0 110.738 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.2 tp -60.46 -48.3 82.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.954 0.407 . . . . 15.0 110.4 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.3 tp -60.38 -42.38 95.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 15.0 110.772 -175.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.25 -46.24 89.72 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.664 -0.415 . . . . 15.0 110.909 -175.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 -61.1 -41.35 96.52 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.499 -0.48 . . . . 15.0 110.679 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.2 t -60.33 -46.08 95.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.748 -0.381 . . . . 15.0 110.202 -176.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -68.57 -51.32 44.03 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 123.421 0.45 . . . . 15.0 112.066 -175.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.29 -44.25 79.72 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.857 0.317 . . . . 15.0 111.857 -173.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -79.56 -10.07 59.73 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.08 0.77 . . . . 15.0 113.08 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 55.5 55.78 6.96 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.632 0.729 . . . . 15.0 110.219 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.0 mt -68.04 143.56 55.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.671 -0.695 . . . . 15.0 111.364 -174.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -91.16 -40.13 11.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.151 -0.931 . . . . 15.0 110.838 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.37 160.75 28.46 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.023 -1.084 . . . . 15.0 113.788 -174.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 71.3 mt -125.39 143.39 51.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.486 -0.857 . . . . 15.0 109.618 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.6 t -122.11 132.07 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 121.148 -0.221 . . . . 15.0 110.764 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.5 m -124.23 145.78 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.144 0.497 . . . . 15.0 110.524 172.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 t -98.1 -21.45 16.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.479 -0.782 . . . . 15.0 112.426 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 81.3 p -152.73 162.16 41.62 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.414 0.625 . . . . 15.0 111.801 -174.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.86 -37.08 68.36 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.118 -0.793 . . . . 15.0 111.118 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -58.98 -46.08 88.99 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.858 -0.337 . . . . 15.0 110.646 -177.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.56 -44.07 98.18 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.732 -0.947 . . . . 15.0 110.732 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.2 tp -57.04 -45.09 83.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.112 0.482 . . . . 15.0 110.672 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.72 -43.69 98.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 15.0 110.534 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -59.83 -38.1 81.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.706 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.5 tp -56.69 -44.9 81.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.388 0.613 . . . . 15.0 110.155 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -60.0 -46.87 88.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.495 -0.775 . . . . 15.0 110.584 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -61.51 -43.23 99.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.975 -0.557 . . . . 15.0 111.091 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.09 -34.99 78.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.449 -0.342 . . . . 15.0 111.468 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.46 -38.14 80.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.965 0.412 . . . . 15.0 110.69 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.2 -143.93 0.58 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 109.605 -0.517 . . . . 15.0 109.605 174.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.53 -18.87 44.08 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.336 0.971 . . . . 15.0 112.678 -174.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -91.86 10.8 27.17 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.282 0.845 . . . . 15.0 113.282 -175.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 60.0 t-105 -47.81 -46.56 62.65 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-O 118.588 -0.72 . . . . 15.0 112.556 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -44.74 -41.6 14.86 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.438 1.425 . . . . 15.0 113.267 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -77.03 -48.79 16.92 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.954 0.407 . . . . 15.0 110.819 -177.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 90.3 mt -59.57 -40.56 82.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 15.0 110.855 -176.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.68 -15.87 35.37 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 116.392 -0.367 . . . . 15.0 113.144 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -65.06 -29.93 70.85 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.355 0.578 . . . . 15.0 112.073 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.2 mt -75.7 150.51 84.21 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 121.018 -0.273 . . . . 15.0 111.648 -173.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.31 128.23 23.21 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.751 1.634 . . . . 15.0 112.481 176.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.9 tp -106.32 125.66 51.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.343 -0.389 . . . . 15.0 110.516 174.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -90.05 126.56 35.81 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.634 -0.506 . . . . 15.0 109.634 176.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.7 m -119.06 147.28 42.31 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 119.438 -0.315 . . . . 15.0 110.176 176.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.14 -24.27 6.91 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.601 1.534 . . . . 15.0 113.529 -175.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.3 p -142.98 162.54 42.98 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 120.602 -0.439 . . . . 15.0 111.52 -171.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.14 -44.07 50.26 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.184 1.256 . . . . 15.0 111.755 176.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 70.9 ttp85 -57.45 -48.39 79.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.833 0.349 . . . . 15.0 110.845 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.8 t -59.9 -40.07 81.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.99 -0.374 . . . . 15.0 109.99 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.42 -42.29 82.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.903 0.383 . . . . 15.0 110.371 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -60.47 -40.11 90.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 15.0 110.621 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.1 mmm -58.46 -43.68 88.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.364 0.602 . . . . 15.0 110.212 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.16 -42.4 98.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.8 -0.636 . . . . 15.0 110.883 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -62.87 -42.01 99.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 15.0 110.871 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -59.64 -36.19 75.89 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.909 -0.317 . . . . 15.0 111.3 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.9 mt -68.96 -21.43 64.18 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.569 0.581 . . . . 15.0 112.569 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 106.85 13.28 22.28 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 119.376 -0.68 . . . . 15.0 113.086 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.79 122.14 12.15 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.439 1.12 . . . . 15.0 109.989 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -68.13 -36.04 79.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.55 -0.75 . . . . 15.0 111.226 -171.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.7 ttm-85 -131.76 114.03 14.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.045 0.45 . . . . 15.0 110.575 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.0 t -112.39 130.58 65.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.175 -0.466 . . . . 15.0 109.873 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.5 mt -119.74 123.73 71.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.941 -0.572 . . . . 15.0 110.142 -176.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.27 118.47 31.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.381 -0.372 . . . . 15.0 110.193 176.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.5 p -96.04 -3.99 43.86 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.283 0.846 . . . . 15.0 113.283 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -56.02 -39.96 72.7 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 118.199 0.454 . . . . 15.0 110.698 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -92.06 -35.07 6.86 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.505 -0.638 . . . . 15.0 111.505 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.44 142.38 41.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.841 0.353 . . . . 15.0 110.704 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.2 m -89.82 164.07 14.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 15.0 110.327 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.61 -54.22 24.43 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-O 118.523 -0.751 . . . . 15.0 112.963 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.59 -36.18 97.74 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 CA-C-N 120.583 1.244 . . . . 15.0 111.346 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.21 -42.61 95.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.046 0.451 . . . . 15.0 110.165 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.0 mt -58.95 -40.66 85.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 15.0 110.44 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 29.2 tp -57.36 -44.35 84.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.31 0.576 . . . . 15.0 110.181 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.6 -40.99 93.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.656 -0.702 . . . . 15.0 110.556 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.23 92.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.356 -0.384 . . . . 15.0 110.805 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.1 mt -57.9 -51.39 69.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.284 0.564 . . . . 15.0 110.451 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.2 p -64.69 -40.27 95.09 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.585 -0.734 . . . . 15.0 111.38 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.3 p -64.6 -38.88 92.52 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.037 -0.265 . . . . 15.0 111.335 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.81 -42.72 99.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.747 0.308 . . . . 15.0 110.891 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.375 -0.375 . . . . 15.0 110.769 178.556 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.534 0.331 0 N-CA-C 110.421 -0.214 . . . . 15.0 110.421 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.01 153.89 5.91 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.373 1.382 . . . . 15.0 111.918 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -109.98 138.38 46.44 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.552 -0.295 . . . . 15.0 110.866 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.4 m -135.96 144.16 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 121.612 0.72 . . . . 15.0 111.707 177.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.4 tp -104.55 135.84 45.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.936 -1.029 . . . . 15.0 110.233 177.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.3 mt -102.58 135.11 41.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.279 -0.419 . . . . 15.0 110.319 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 86.5 mtp -99.08 134.02 42.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.898 -0.592 . . . . 15.0 110.305 173.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -57.59 140.93 49.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.377 . . . . 15.0 110.641 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.55 175.18 31.26 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.826 -0.91 . . . . 15.0 110.826 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.42 -33.02 65.42 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.163 -0.215 . . . . 15.0 111.424 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.7 176.27 32.65 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.674 -0.97 . . . . 15.0 110.674 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.98 120.66 5.55 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.951 -0.642 . . . . 15.0 111.519 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -57.01 -41.39 78.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.803 0.335 . . . . 15.0 110.575 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -62.23 -41.93 98.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.426 . . . . 15.0 111.229 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -63.42 -55.88 20.76 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.793 -0.363 . . . . 15.0 111.345 -176.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.0 mt -59.55 -43.69 93.45 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.724 -0.39 . . . . 15.0 110.967 -176.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.55 -40.24 96.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 15.0 110.812 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.89 -41.92 92.67 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.962 -0.295 . . . . 15.0 110.505 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -60.0 -51.74 68.36 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.591 -0.443 . . . . 15.0 110.999 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 80.6 mt -62.46 -37.53 86.29 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.497 -0.481 . . . . 15.0 111.103 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -63.32 -44.26 95.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.554 0.216 . . . . 15.0 110.929 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.18 -30.58 67.55 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.019 -0.61 . . . . 15.0 111.92 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -88.09 10.08 20.44 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.556 0.947 . . . . 15.0 113.556 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.09 18.82 41.66 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 121.109 -0.567 . . . . 15.0 113.351 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.3 t -101.02 139.97 20.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 117.665 0.732 . . . . 15.0 110.19 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -82.22 126.0 31.58 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.865 -0.791 . . . . 15.0 108.865 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.3 t -116.02 130.93 69.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.314 0.578 . . . . 15.0 111.331 -171.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -137.23 133.56 35.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.274 -0.875 . . . . 15.0 109.439 170.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -114.08 135.85 53.57 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.92 0.391 . . . . 15.0 110.857 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 tp -116.16 113.3 41.51 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.632 -0.699 . . . . 15.0 110.194 -176.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.0 135.12 50.94 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.159 1.239 . . . . 15.0 112.09 174.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.65 -9.2 3.56 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.325 0.861 . . . . 15.0 113.325 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -77.15 -6.03 51.33 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.184 0.809 . . . . 15.0 113.184 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -64.62 150.11 94.49 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 118.512 0.596 . . . . 15.0 110.378 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -80.04 154.93 22.74 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.544 1.496 . . . . 15.0 113.27 -177.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.72 152.1 3.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.883 -0.599 . . . . 15.0 111.362 -178.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.23 -37.95 3.26 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.611 -0.596 . . . . 15.0 111.611 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -61.23 -36.52 80.17 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.607 -0.437 . . . . 15.0 111.184 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.4 tp -59.16 -48.83 80.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.965 0.412 . . . . 15.0 110.228 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 23.1 tp -62.73 -44.25 96.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 15.0 110.988 -175.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.08 -44.84 95.79 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.67 -0.412 . . . . 15.0 110.907 -176.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 60.0 ttm-85 -60.79 -41.87 96.46 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 121.01 -0.276 . . . . 15.0 110.713 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.4 t -60.68 -45.78 96.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.835 -0.346 . . . . 15.0 110.111 -177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -70.52 -46.86 62.83 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.1 0.408 . . . . 15.0 112.1 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.49 -44.44 82.62 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.047 -0.261 . . . . 15.0 111.442 -175.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -81.15 -10.16 59.69 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.124 0.787 . . . . 15.0 113.124 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 54.66 55.89 7.4 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.582 0.706 . . . . 15.0 110.483 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.4 mt -69.94 150.63 46.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.618 -0.719 . . . . 15.0 111.546 -175.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -95.25 -40.51 9.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.162 -0.926 . . . . 15.0 110.767 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -149.7 165.36 29.62 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 119.955 -1.117 . . . . 15.0 113.75 -174.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 70.7 mt -126.09 142.57 51.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.489 -0.856 . . . . 15.0 109.575 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.39 130.18 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.682 0.277 . . . . 15.0 110.777 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.7 m -128.1 155.68 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.02 0.438 . . . . 15.0 110.575 171.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.3 t -131.34 14.4 5.06 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.681 -0.691 . . . . 15.0 112.408 176.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.6 p -155.0 149.35 26.16 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.267 0.556 . . . . 15.0 111.548 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.89 -40.18 92.74 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.61 -0.996 . . . . 15.0 110.61 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -58.57 -41.4 85.57 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.916 -0.314 . . . . 15.0 110.473 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.91 -47.15 92.67 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.774 -0.93 . . . . 15.0 110.774 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.1 tp -57.06 -44.43 83.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.109 0.48 . . . . 15.0 110.653 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.78 -43.59 98.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.032 -0.531 . . . . 15.0 110.822 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -59.36 -38.93 81.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 15.0 110.767 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.2 tp -57.48 -44.81 85.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.247 0.546 . . . . 15.0 110.172 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -60.68 -47.15 87.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.675 -0.693 . . . . 15.0 110.468 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -61.97 -43.94 97.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 15.0 111.31 -176.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.57 -35.24 79.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.367 -0.379 . . . . 15.0 111.358 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.42 -38.78 81.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.939 0.4 . . . . 15.0 110.646 178.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.11 -143.72 0.59 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.58 -0.526 . . . . 15.0 109.58 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.47 -18.14 37.23 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.417 1.008 . . . . 15.0 112.654 -175.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -91.79 9.61 31.94 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.341 0.867 . . . . 15.0 113.341 -175.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 59.2 t-105 -47.85 -47.35 63.14 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-O 118.629 -0.701 . . . . 15.0 112.546 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -44.78 -40.76 14.77 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 121.482 1.455 . . . . 15.0 113.199 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -76.97 -48.79 17.07 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.044 0.45 . . . . 15.0 110.741 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 92.8 mt -59.59 -39.93 80.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.025 -0.534 . . . . 15.0 110.925 -176.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.51 -15.82 33.9 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 119.944 -0.364 . . . . 15.0 113.116 -176.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -65.87 -30.03 70.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.387 0.593 . . . . 15.0 112.016 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.7 mt -74.49 150.62 87.06 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 111.638 0.236 . . . . 15.0 111.638 -172.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.97 123.58 13.2 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.599 1.533 . . . . 15.0 112.026 176.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.8 tp -103.35 123.44 46.82 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.804 -0.358 . . . . 15.0 110.426 174.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -89.38 123.38 33.48 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.057 -0.72 . . . . 15.0 109.057 175.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.3 m -112.25 151.82 43.99 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 110.341 -0.244 . . . . 15.0 110.341 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.0 -28.65 3.76 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.414 1.409 . . . . 15.0 113.1 -175.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.4 p -144.39 167.91 13.8 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 120.656 -0.418 . . . . 15.0 111.537 -173.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -60.42 -44.0 30.42 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 121.228 1.286 . . . . 15.0 111.6 177.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -57.0 -47.99 79.52 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.88 -0.328 . . . . 15.0 110.777 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.55 -40.07 83.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.604 -0.438 . . . . 15.0 110.027 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.01 -41.71 79.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.928 0.394 . . . . 15.0 110.545 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.27 -41.32 96.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.218 -0.447 . . . . 15.0 110.529 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 87.3 mtp -59.57 -44.04 93.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.307 0.575 . . . . 15.0 110.384 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.5 -40.52 94.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.858 -0.61 . . . . 15.0 110.791 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -61.15 -45.04 96.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.278 -0.419 . . . . 15.0 110.435 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.68 -36.2 76.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.508 -0.315 . . . . 15.0 111.298 -177.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.82 -26.47 68.35 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.108 0.41 . . . . 15.0 112.108 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.21 13.16 10.14 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 119.281 -0.733 . . . . 15.0 113.177 -176.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.9 121.82 11.45 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.597 1.198 . . . . 15.0 109.691 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -71.61 -39.75 70.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.519 -0.764 . . . . 15.0 110.617 -171.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 52.8 ttp85 -132.09 113.9 13.9 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.453 0.644 . . . . 15.0 110.832 178.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.2 t -114.43 133.28 61.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.645 -0.707 . . . . 15.0 110.264 -176.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 87.6 mt -117.54 126.42 74.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.677 -0.692 . . . . 15.0 110.244 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -96.26 117.48 30.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.452 -0.34 . . . . 15.0 110.519 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 30.3 p -69.67 -20.32 63.57 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.574 0.583 . . . . 15.0 112.574 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -53.21 -36.97 61.57 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 122.113 -0.367 . . . . 15.0 111.508 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.27 -35.18 8.19 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 120.824 -0.703 . . . . 15.0 111.648 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -92.18 120.92 33.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.766 0.317 . . . . 15.0 111.121 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.9 m -70.44 165.85 21.65 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.433 -0.58 . . . . 15.0 109.433 174.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.55 -54.4 22.85 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 112.776 0.658 . . . . 15.0 112.776 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -57.49 -34.96 98.84 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 120.9 1.067 . . . . 15.0 111.4 176.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.14 -40.8 95.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.842 0.353 . . . . 15.0 110.365 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.2 mt -58.97 -41.79 88.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.015 0.435 . . . . 15.0 110.169 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.5 tp -57.23 -45.15 84.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.488 0.661 . . . . 15.0 110.169 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.46 91.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.505 -0.77 . . . . 15.0 110.817 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.97 -42.47 98.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.578 -0.283 . . . . 15.0 110.815 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.6 mt -57.94 -52.25 66.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.397 0.617 . . . . 15.0 110.463 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.7 p -66.32 -38.36 87.53 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.454 -0.794 . . . . 15.0 111.656 -174.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.3 p -67.65 -38.19 83.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.709 0.29 . . . . 15.0 111.322 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.7 -40.57 97.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.423 -0.353 . . . . 15.0 110.827 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.395 -0.366 . . . . 15.0 110.797 178.345 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 110.29 -0.263 . . . . 15.0 110.29 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -55.58 154.98 22.91 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 121.439 1.426 . . . . 15.0 111.696 -176.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -111.98 140.11 46.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.582 -0.281 . . . . 15.0 110.815 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.9 m -136.17 143.92 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.647 0.737 . . . . 15.0 111.818 175.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.1 tp -105.07 136.75 43.97 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.924 -1.034 . . . . 15.0 110.245 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.0 mt -104.61 135.14 43.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.096 0.474 . . . . 15.0 111.067 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 99.0 mmm -94.89 134.04 37.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.134 -0.939 . . . . 15.0 109.364 172.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -66.28 145.07 56.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.937 0.398 . . . . 15.0 110.554 -178.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -161.08 175.22 37.74 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.76 -0.936 . . . . 15.0 110.76 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -51.29 -31.2 20.58 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.847 0.314 . . . . 15.0 111.847 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.99 -174.02 1.74 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.938 -0.865 . . . . 15.0 110.938 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -108.4 109.58 2.9 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.49 -0.644 . . . . 15.0 111.49 -177.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.3 mtm-85 -55.2 -38.85 68.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.645 0.26 . . . . 15.0 111.035 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -59.87 -54.98 39.84 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.067 0.395 . . . . 15.0 112.067 -172.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -69.95 -45.09 68.18 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.274 -0.57 . . . . 15.0 111.435 -173.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.1 tp -58.12 -44.84 87.96 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 120.491 -0.484 . . . . 15.0 110.589 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.75 -42.5 99.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 15.0 110.44 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -57.96 -40.46 80.65 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.931 -0.308 . . . . 15.0 110.562 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -59.08 -51.64 69.19 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.959 0.409 . . . . 15.0 111.042 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.7 mt -59.81 -37.32 78.81 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.567 -0.453 . . . . 15.0 110.887 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -62.95 -41.97 99.68 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 121.107 -0.237 . . . . 15.0 111.119 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.25 -30.56 67.75 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 120.981 -0.628 . . . . 15.0 111.966 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -88.18 9.57 22.42 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.557 0.947 . . . . 15.0 113.557 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.32 15.42 58.78 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 121.23 -0.509 . . . . 15.0 113.393 175.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.9 t -101.04 137.84 27.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 117.917 0.858 . . . . 15.0 110.209 178.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -81.17 129.92 34.79 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.367 -0.605 . . . . 15.0 109.367 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.4 t -120.11 132.23 70.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.241 0.543 . . . . 15.0 111.192 -173.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -139.18 135.22 33.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.391 -0.822 . . . . 15.0 109.731 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -114.8 138.78 50.35 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.775 0.322 . . . . 15.0 110.553 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.0 tp -114.85 113.43 44.49 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 118.756 -0.64 . . . . 15.0 110.896 -173.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -49.88 135.07 35.89 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.158 1.238 . . . . 15.0 111.886 172.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.1 mt -66.79 -11.13 53.98 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.216 0.821 . . . . 15.0 113.216 -174.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -77.31 -9.4 58.8 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.169 0.803 . . . . 15.0 113.169 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -65.28 148.02 98.22 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 118.502 0.592 . . . . 15.0 110.544 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.34 148.74 43.93 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.565 1.51 . . . . 15.0 113.58 -174.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.93 152.52 3.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.465 -0.789 . . . . 15.0 111.228 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.2 -38.15 3.21 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.497 -0.641 . . . . 15.0 111.497 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -64.16 -36.38 83.86 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 120.426 -0.51 . . . . 15.0 111.12 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.5 tp -58.66 -45.97 88.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.896 0.379 . . . . 15.0 110.196 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 16.8 tp -63.49 -45.57 90.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 15.0 110.902 -177.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.78 99.25 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.784 -0.367 . . . . 15.0 110.859 -177.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -60.99 -44.14 97.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.428 -0.351 . . . . 15.0 110.511 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 67.3 t -61.5 -46.1 97.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.935 -0.306 . . . . 15.0 110.252 -177.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 70.7 ttp85 -68.53 -48.07 65.28 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.984 0.364 . . . . 15.0 111.984 -176.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.09 -44.47 84.28 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.1 -0.24 . . . . 15.0 111.512 -173.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -81.99 -10.01 59.38 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.249 0.833 . . . . 15.0 113.249 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 55.86 55.82 6.64 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.607 0.718 . . . . 15.0 110.336 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.5 mt -63.53 146.09 54.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.601 -0.727 . . . . 15.0 111.426 -174.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -87.72 -39.76 14.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.982 -1.008 . . . . 15.0 110.685 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.52 166.39 30.7 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.045 -1.074 . . . . 15.0 113.639 -174.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.1 mt -125.91 142.08 51.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.507 -0.846 . . . . 15.0 109.612 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.0 t -121.47 131.37 73.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.282 -0.266 . . . . 15.0 110.282 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.5 m -125.69 130.44 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.009 0.433 . . . . 15.0 110.216 172.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.7 p -92.81 -10.86 35.3 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.915 0.709 . . . . 15.0 112.915 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 82.8 p -152.52 157.6 41.33 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 121.271 0.558 . . . . 15.0 111.561 -176.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.78 -38.92 85.94 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.962 -0.855 . . . . 15.0 110.962 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -58.97 -43.93 91.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.777 0.322 . . . . 15.0 110.416 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.3 -44.84 97.09 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.784 -0.926 . . . . 15.0 110.784 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.9 tp -57.7 -44.61 85.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.095 0.474 . . . . 15.0 110.531 -178.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.26 -42.23 98.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.063 -0.517 . . . . 15.0 110.64 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -58.99 -39.91 83.23 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.834 -0.346 . . . . 15.0 110.628 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.5 tp -58.23 -44.83 88.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.181 0.515 . . . . 15.0 110.109 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -61.6 -47.22 86.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.697 -0.683 . . . . 15.0 110.787 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -61.91 -43.86 97.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 15.0 111.185 -176.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.3 mt -66.3 -34.98 79.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.351 -0.386 . . . . 15.0 111.387 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.0 -39.17 81.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.126 0.489 . . . . 15.0 110.581 177.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.16 -143.3 0.6 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 109.609 -0.515 . . . . 15.0 109.609 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.44 -19.09 44.88 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.391 0.996 . . . . 15.0 112.608 -175.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -91.91 10.44 28.78 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.297 0.851 . . . . 15.0 113.297 -175.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -47.81 -46.9 63.15 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-O 118.666 -0.683 . . . . 15.0 112.494 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -44.68 -40.43 14.15 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.483 1.455 . . . . 15.0 113.283 177.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -77.0 -48.73 17.17 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.691 -0.404 . . . . 15.0 110.803 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.5 mt -59.63 -39.73 80.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 15.0 110.83 -177.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.2 -16.44 34.08 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 116.334 -0.394 . . . . 15.0 113.124 -177.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -64.73 -30.3 71.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 117.365 0.582 . . . . 15.0 111.959 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 27.5 mt -76.45 150.59 82.51 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 120.903 -0.319 . . . . 15.0 111.312 -173.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.4 129.54 28.59 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.63 1.554 . . . . 15.0 112.473 176.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.0 tp -107.78 126.26 52.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.448 -0.342 . . . . 15.0 110.605 175.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -90.97 126.09 35.97 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.721 -0.474 . . . . 15.0 109.721 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.0 m -117.47 147.15 40.08 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 110.079 -0.341 . . . . 15.0 110.079 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.15 -23.25 7.81 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.639 1.56 . . . . 15.0 113.598 -174.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.5 p -143.51 158.15 57.8 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 120.737 -0.385 . . . . 15.0 111.33 -172.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.29 -43.95 53.03 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.238 1.292 . . . . 15.0 111.792 176.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -58.11 -47.37 83.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.779 0.323 . . . . 15.0 110.931 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.89 -40.24 82.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.75 -0.38 . . . . 15.0 110.036 178.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.36 -42.46 82.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.962 0.41 . . . . 15.0 110.422 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.09 -41.87 97.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.144 -0.48 . . . . 15.0 110.506 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 87.1 mtp -59.29 -43.88 92.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.227 0.537 . . . . 15.0 110.353 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.44 94.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.963 -0.562 . . . . 15.0 110.801 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -61.31 -44.36 97.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.298 -0.41 . . . . 15.0 110.629 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.17 -36.1 76.84 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.857 -0.337 . . . . 15.0 111.234 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.8 mt -64.3 -25.69 68.16 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.942 0.349 . . . . 15.0 111.942 176.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.43 13.25 15.26 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 119.314 -0.714 . . . . 15.0 113.095 -176.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.88 121.95 11.75 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 118.566 1.183 . . . . 15.0 109.888 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -69.5 -35.09 75.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.668 -0.696 . . . . 15.0 111.328 -171.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.1 tpt85 -131.79 114.5 14.79 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.957 0.408 . . . . 15.0 110.082 177.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.1 t -110.85 130.25 64.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.045 0.45 . . . . 15.0 109.851 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 85.2 mt -119.61 124.95 73.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.818 -0.628 . . . . 15.0 110.053 -176.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -95.33 117.32 30.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.435 -0.348 . . . . 15.0 110.302 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.9 p -97.05 -1.55 45.15 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.182 0.808 . . . . 15.0 113.182 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 46.9 tpt85 -55.67 -39.7 71.31 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.184 0.447 . . . . 15.0 110.665 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.01 -35.17 5.41 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.53 -0.628 . . . . 15.0 111.53 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.18 140.2 52.49 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.879 0.371 . . . . 15.0 110.651 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.9 p -86.12 163.75 17.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.065 -0.516 . . . . 15.0 110.508 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.71 -54.39 23.63 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 113.0 0.741 . . . . 15.0 113.0 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.29 -35.04 99.11 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 CA-C-N 120.163 1.094 . . . . 15.0 111.63 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.07 -43.4 95.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.091 0.472 . . . . 15.0 110.012 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 76.1 mt -59.36 -40.74 87.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 15.0 110.406 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 33.8 tp -57.2 -43.82 83.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.33 0.586 . . . . 15.0 110.229 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.52 -41.8 95.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.683 -0.69 . . . . 15.0 110.487 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.28 -40.38 90.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 15.0 110.761 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.0 mt -57.81 -51.8 68.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.267 0.556 . . . . 15.0 110.383 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.6 p -63.79 -40.06 95.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.59 -0.732 . . . . 15.0 111.324 -175.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.1 m -62.38 -44.31 96.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.676 0.274 . . . . 15.0 111.426 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.4 -38.25 88.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.432 -0.349 . . . . 15.0 111.156 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.451 -0.34 . . . . 15.0 111.255 179.315 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 CA--C 1.535 0.382 0 N-CA-C 110.34 -0.244 . . . . 15.0 110.34 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -49.87 152.31 7.3 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.387 1.391 . . . . 15.0 111.776 -176.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -117.77 137.88 52.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.354 -0.385 . . . . 15.0 110.385 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.7 m -134.77 146.04 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.501 0.667 . . . . 15.0 111.826 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.6 tp -104.37 135.55 45.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.048 -0.978 . . . . 15.0 110.318 178.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 55.0 mt -103.59 135.02 43.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.407 . . . . 15.0 110.439 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 88.3 mtp -100.15 134.06 43.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.731 -0.668 . . . . 15.0 110.332 174.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -58.24 141.69 50.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.376 -0.375 . . . . 15.0 110.624 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.0 175.14 34.57 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.045 -0.822 . . . . 15.0 111.045 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -54.98 -33.86 62.87 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.549 0.203 . . . . 15.0 111.549 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.9 -179.69 4.76 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.954 -0.859 . . . . 15.0 110.954 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.02 114.31 3.93 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.224 -0.75 . . . . 15.0 111.224 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -55.85 -47.23 77.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.323 0.583 . . . . 15.0 110.339 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.95 -41.38 97.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.739 -0.664 . . . . 15.0 110.839 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -56.51 -55.83 28.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.766 0.317 . . . . 15.0 111.18 -175.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.1 mp -59.99 -42.38 94.1 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.665 -0.414 . . . . 15.0 111.064 -176.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.63 -45.74 91.07 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.643 -0.423 . . . . 15.0 111.447 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.29 -40.99 92.4 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.769 -0.372 . . . . 15.0 110.527 -178.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -58.52 -51.51 69.59 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.589 -0.445 . . . . 15.0 111.126 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.8 mt -63.99 -38.2 90.22 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.436 -0.505 . . . . 15.0 111.262 -176.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -65.28 -40.45 93.9 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 120.521 -0.472 . . . . 15.0 111.254 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.03 -30.57 70.44 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.972 -0.632 . . . . 15.0 112.095 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -88.33 10.03 21.25 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.571 0.952 . . . . 15.0 113.571 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.54 16.41 60.28 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 121.286 -0.483 . . . . 15.0 113.265 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.7 t -101.08 138.85 23.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 117.824 0.812 . . . . 15.0 109.877 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -79.12 133.37 36.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.494 -0.558 . . . . 15.0 109.494 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.1 t -118.37 130.37 73.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.173 0.511 . . . . 15.0 111.117 -173.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -135.35 124.74 24.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.419 -0.809 . . . . 15.0 109.442 170.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -112.79 134.16 54.44 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.857 0.361 . . . . 15.0 110.833 -177.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.1 tp -114.3 139.44 23.83 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.042 -0.527 . . . . 15.0 109.937 -176.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -72.08 136.22 26.67 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 121.409 1.406 . . . . 15.0 111.822 171.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.8 mt -57.89 -12.73 3.42 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.368 0.877 . . . . 15.0 113.368 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -77.22 -5.05 47.79 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.467 0.914 . . . . 15.0 113.467 -175.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -68.06 145.59 97.76 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 118.559 0.618 . . . . 15.0 110.784 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.96 159.09 30.87 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.685 1.59 . . . . 15.0 113.479 -176.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.26 151.52 2.83 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.727 -0.669 . . . . 15.0 111.62 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.14 -36.98 3.58 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.397 -0.681 . . . . 15.0 111.397 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -60.02 -37.05 78.62 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.613 -0.435 . . . . 15.0 110.972 -178.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.3 tp -58.5 -47.13 85.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.022 0.439 . . . . 15.0 110.253 -177.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.1 tp -61.87 -44.68 96.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 15.0 110.745 -177.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.18 97.22 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.682 -0.407 . . . . 15.0 111.018 -176.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -60.96 -41.53 96.51 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.815 -0.354 . . . . 15.0 110.672 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.5 t -60.53 -47.31 93.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.809 -0.356 . . . . 15.0 110.262 -176.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -72.27 -47.65 48.53 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.461 0.541 . . . . 15.0 112.461 -175.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.69 -44.31 82.06 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.051 -0.26 . . . . 15.0 111.557 -174.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -81.78 -10.03 59.46 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.105 0.78 . . . . 15.0 113.105 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 56.64 55.87 6.02 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.593 0.711 . . . . 15.0 110.164 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 94.9 mt -77.9 142.53 38.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.667 -0.697 . . . . 15.0 111.364 -176.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -90.76 -40.65 11.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.55 -0.75 . . . . 15.0 110.64 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.66 167.01 28.72 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 119.908 -1.139 . . . . 15.0 113.396 -171.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 71.4 mt -126.96 146.91 50.15 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.889 -0.656 . . . . 15.0 110.312 -178.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.5 t -122.77 131.48 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.544 0.211 . . . . 15.0 110.495 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 m -124.85 146.99 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.125 0.488 . . . . 15.0 110.735 173.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 t -100.81 -15.98 17.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.535 -0.757 . . . . 15.0 112.835 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.0 p -156.31 161.28 40.21 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-O 121.437 0.637 . . . . 15.0 111.901 -175.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.18 -37.67 73.63 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.056 -0.818 . . . . 15.0 111.056 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -59.25 -44.53 92.37 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.932 -0.307 . . . . 15.0 110.709 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.29 -43.68 98.29 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.611 -0.996 . . . . 15.0 110.611 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 14.3 tp -57.05 -45.82 82.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.153 0.502 . . . . 15.0 110.596 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.35 -43.74 98.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.117 -0.492 . . . . 15.0 110.569 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -59.77 -38.91 83.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 15.0 110.647 178.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.4 tp -57.06 -44.32 82.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.124 0.488 . . . . 15.0 110.161 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -60.24 -47.61 85.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.809 -0.632 . . . . 15.0 110.459 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -61.85 -43.15 99.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.945 -0.571 . . . . 15.0 111.137 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.84 -35.3 79.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.443 -0.344 . . . . 15.0 111.49 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.44 -38.51 80.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.955 0.407 . . . . 15.0 110.75 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.28 -144.09 0.57 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 109.541 -0.54 . . . . 15.0 109.541 174.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.87 -18.56 45.43 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.357 0.981 . . . . 15.0 112.64 -174.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -91.95 10.45 28.84 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.327 0.862 . . . . 15.0 113.327 -175.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -47.74 -47.32 62.01 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 118.69 -0.672 . . . . 15.0 112.586 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -44.81 -40.11 14.35 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.458 1.439 . . . . 15.0 113.233 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -76.94 -48.77 17.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.023 0.439 . . . . 15.0 110.725 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 92.2 mt -59.25 -40.59 81.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 15.0 110.839 -177.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.41 -14.47 34.46 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-N 116.269 -0.423 . . . . 15.0 113.23 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -66.18 -29.8 70.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.415 0.607 . . . . 15.0 112.076 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.9 mt -74.72 145.11 81.3 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-O 119.252 -0.404 . . . . 15.0 110.953 -174.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -60.0 129.54 30.78 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.446 1.431 . . . . 15.0 111.756 174.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.1 tp -106.34 128.16 53.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.609 -0.269 . . . . 15.0 110.852 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -91.01 126.12 36.0 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.618 -0.512 . . . . 15.0 109.618 176.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.7 m -119.43 147.52 43.54 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 110.085 -0.339 . . . . 15.0 110.085 176.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.23 -23.23 7.73 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.471 1.447 . . . . 15.0 113.636 -174.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.9 p -143.36 161.11 49.11 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 120.62 -0.432 . . . . 15.0 111.563 -172.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -54.91 -44.11 52.88 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.2 1.267 . . . . 15.0 111.889 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -58.82 -46.75 86.9 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.895 -0.322 . . . . 15.0 110.973 -177.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.4 t -60.13 -40.3 83.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.737 -0.385 . . . . 15.0 110.066 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.61 -42.31 83.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.0 0.429 . . . . 15.0 110.469 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.92 -40.47 93.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.176 -0.466 . . . . 15.0 110.592 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.1 mmm -58.26 -44.99 88.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.447 0.641 . . . . 15.0 110.159 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.76 -40.64 95.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.642 -0.708 . . . . 15.0 110.825 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -61.64 -44.43 96.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.385 -0.37 . . . . 15.0 110.755 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -60.29 -36.19 77.28 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.872 -0.331 . . . . 15.0 111.262 -177.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 77.0 mt -66.0 -23.87 66.66 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.303 0.483 . . . . 15.0 112.303 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.69 13.28 16.88 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.399 -0.667 . . . . 15.0 113.177 -176.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.81 122.03 11.91 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.481 1.14 . . . . 15.0 109.905 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -67.62 -36.54 81.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.541 -0.754 . . . . 15.0 111.059 -171.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -131.82 117.88 19.13 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.923 0.392 . . . . 15.0 110.62 177.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.2 t -114.65 129.94 69.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.008 0.432 . . . . 15.0 109.952 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 90.5 mt -119.27 122.19 68.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.87 -0.604 . . . . 15.0 110.125 -177.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -92.53 117.7 30.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.483 -0.326 . . . . 15.0 110.166 175.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.8 p -95.69 -3.52 45.9 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.232 0.827 . . . . 15.0 113.232 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -55.88 -40.04 72.4 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.287 0.494 . . . . 15.0 110.699 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -95.59 -35.01 5.8 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.463 -0.655 . . . . 15.0 111.463 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.29 143.77 46.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.791 0.329 . . . . 15.0 110.466 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 65.1 m -89.77 160.75 16.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.228 -0.442 . . . . 15.0 110.567 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.67 -54.24 24.56 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.973 0.731 . . . . 15.0 112.973 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.62 -34.54 98.26 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 CA-C-N 120.318 1.149 . . . . 15.0 111.524 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.03 -42.66 94.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.065 0.46 . . . . 15.0 109.985 176.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 78.3 mt -59.04 -39.98 83.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 15.0 110.489 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 33.7 tp -56.85 -44.85 82.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.547 0.689 . . . . 15.0 110.144 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.4 -40.4 90.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.518 -0.765 . . . . 15.0 110.568 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.2 -42.49 95.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.319 -0.4 . . . . 15.0 110.782 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.1 mt -58.05 -49.16 77.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.031 0.443 . . . . 15.0 110.421 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.4 p -62.51 -40.71 97.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.897 -0.592 . . . . 15.0 111.274 -175.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.9 p -65.99 -39.88 90.72 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.969 -0.292 . . . . 15.0 111.349 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.25 -39.01 93.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.666 0.27 . . . . 15.0 111.117 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.433 -0.349 . . . . 15.0 111.252 178.961 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 110.285 -0.265 . . . . 15.0 110.285 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.94 155.06 8.98 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.347 1.364 . . . . 15.0 111.734 -177.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -114.26 140.74 48.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.412 -0.358 . . . . 15.0 110.837 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.6 m -136.55 144.94 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.598 0.714 . . . . 15.0 111.568 176.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.8 tp -105.69 134.18 49.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.943 -1.026 . . . . 15.0 110.518 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.4 mt -100.79 135.12 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.315 -0.402 . . . . 15.0 110.291 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 82.4 mtp -101.75 132.62 47.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.1 -0.5 . . . . 15.0 110.098 171.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -57.74 147.1 28.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.217 0.532 . . . . 15.0 111.564 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.49 175.19 40.55 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.615 -0.994 . . . . 15.0 110.615 -178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -51.94 -32.61 33.79 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.748 0.277 . . . . 15.0 111.748 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.68 170.29 18.24 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.855 -0.898 . . . . 15.0 110.855 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.95 125.18 7.07 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.35 -0.7 . . . . 15.0 111.35 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -57.09 -46.46 82.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.961 0.41 . . . . 15.0 110.482 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -64.05 -40.83 97.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.974 -0.557 . . . . 15.0 111.318 -175.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -61.8 -55.98 24.33 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.775 -0.37 . . . . 15.0 111.427 -176.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.5 tp -61.07 -45.4 94.89 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.687 -0.405 . . . . 15.0 111.192 -175.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.2 -39.72 95.42 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.669 -0.412 . . . . 15.0 110.82 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -60.75 -41.6 95.72 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.905 -0.318 . . . . 15.0 110.576 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -59.65 -51.76 68.41 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 120.686 -0.406 . . . . 15.0 111.241 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.86 -36.99 85.74 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.478 -0.489 . . . . 15.0 111.062 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -63.54 -42.77 98.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.625 0.25 . . . . 15.0 111.088 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.21 -30.56 67.61 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.119 -0.563 . . . . 15.0 111.987 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -88.04 9.96 20.7 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.559 0.948 . . . . 15.0 113.559 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.26 15.04 56.52 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 121.22 -0.514 . . . . 15.0 113.494 173.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.7 t -101.06 136.18 33.9 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 117.972 0.886 . . . . 15.0 110.072 177.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -77.67 129.63 35.8 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.9 -0.778 . . . . 15.0 108.9 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.7 t -123.07 134.13 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.207 0.527 . . . . 15.0 111.468 -171.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -139.4 139.81 37.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.363 -0.835 . . . . 15.0 109.714 172.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -114.13 136.08 53.32 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.883 0.373 . . . . 15.0 110.891 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.8 tp -113.81 121.18 37.6 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-O 118.705 -0.664 . . . . 15.0 110.314 -175.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.25 135.03 67.83 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 CA-C-N 120.337 1.156 . . . . 15.0 112.223 173.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.9 mt -62.43 -16.72 56.67 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.973 0.731 . . . . 15.0 112.973 -178.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -77.18 -5.06 47.72 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.43 0.9 . . . . 15.0 113.43 -175.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -69.84 148.92 96.59 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 118.545 0.611 . . . . 15.0 110.837 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.43 149.69 50.74 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.573 1.515 . . . . 15.0 113.864 -173.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.23 152.58 4.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.258 -0.883 . . . . 15.0 111.265 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.62 -38.1 3.22 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 115.837 -0.619 . . . . 15.0 111.636 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -63.71 -36.61 84.42 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.392 -0.523 . . . . 15.0 111.16 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.9 tp -59.1 -47.01 86.83 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.86 -0.336 . . . . 15.0 110.174 -178.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 17.6 tp -63.35 -45.76 89.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 15.0 110.917 -176.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.6 -44.22 97.41 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.61 -0.436 . . . . 15.0 110.836 -176.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -62.24 -41.97 98.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.486 -0.325 . . . . 15.0 110.754 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 94.0 t -60.61 -45.18 97.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.946 -0.39 . . . . 15.0 109.946 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -67.83 -47.94 67.61 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.325 0.391 . . . . 15.0 111.687 -177.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.6 -44.48 86.44 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 121.042 -0.263 . . . . 15.0 111.685 -173.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -83.04 -10.01 58.96 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.323 0.86 . . . . 15.0 113.323 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 55.79 55.84 6.69 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.68 0.752 . . . . 15.0 110.333 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.11 144.95 56.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.62 -0.718 . . . . 15.0 111.36 -175.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -89.69 -40.52 12.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.067 -0.969 . . . . 15.0 110.694 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.97 161.14 28.52 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.045 -1.074 . . . . 15.0 113.553 -174.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.2 mt -126.0 140.94 52.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.428 -0.886 . . . . 15.0 109.568 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.3 t -120.69 130.06 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.696 0.284 . . . . 15.0 110.804 -178.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 m -123.56 138.81 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.007 0.432 . . . . 15.0 110.289 173.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.6 m -89.96 -23.89 21.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.729 -0.669 . . . . 15.0 112.413 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.9 p -154.15 165.51 36.01 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.447 0.641 . . . . 15.0 111.964 -173.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.99 -37.76 72.3 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.148 -0.781 . . . . 15.0 111.148 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -57.68 -46.12 84.7 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.736 -0.385 . . . . 15.0 110.632 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.59 -45.31 96.56 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.448 -1.061 . . . . 15.0 110.448 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.0 tp -56.5 -42.66 78.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.137 0.494 . . . . 15.0 110.762 -177.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.82 -43.28 99.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.504 . . . . 15.0 110.584 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -58.05 -39.91 79.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.379 -0.373 . . . . 15.0 110.559 177.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.5 tp -57.8 -45.47 86.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.164 0.507 . . . . 15.0 110.167 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -61.51 -47.68 84.5 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.635 -0.711 . . . . 15.0 110.638 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -61.72 -43.1 99.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.039 -0.528 . . . . 15.0 111.116 -176.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 94.2 mt -66.7 -35.53 80.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.325 -0.398 . . . . 15.0 111.453 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.71 -38.05 80.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.056 0.455 . . . . 15.0 110.781 177.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.4 -143.99 0.56 Allowed 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.527 -0.545 . . . . 15.0 109.527 174.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.67 -19.09 47.19 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.302 0.955 . . . . 15.0 112.652 -174.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -91.81 11.22 25.5 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.285 0.846 . . . . 15.0 113.285 -175.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -47.68 -46.7 61.45 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 118.595 -0.716 . . . . 15.0 112.606 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -44.76 -41.27 14.88 Favored 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 121.439 1.426 . . . . 15.0 113.166 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -76.88 -48.81 17.24 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.664 -0.414 . . . . 15.0 110.831 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 92.3 mt -59.88 -39.32 79.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.17 -0.468 . . . . 15.0 110.873 -176.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.28 -15.96 32.77 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 119.853 -0.415 . . . . 15.0 113.092 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.0 mtm105 -66.04 -30.29 70.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.42 0.61 . . . . 15.0 112.011 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.8 mt -73.6 150.59 88.99 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 121.171 -0.212 . . . . 15.0 111.463 -173.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.49 126.33 17.41 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 121.684 1.589 . . . . 15.0 112.322 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.4 tp -105.4 124.69 49.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.332 -0.395 . . . . 15.0 110.552 175.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -90.74 127.41 36.31 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.802 -0.444 . . . . 15.0 109.802 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.1 m -121.43 145.66 43.08 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 110.118 -0.327 . . . . 15.0 110.118 175.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.18 -22.3 8.54 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.727 1.618 . . . . 15.0 113.64 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.3 p -141.54 157.44 65.48 Favored Pre-proline 0 C--N 1.331 -0.233 0 C-N-CA 120.765 -0.374 . . . . 15.0 111.327 -169.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.24 -44.06 50.13 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.273 1.315 . . . . 15.0 112.338 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -61.3 -43.52 98.73 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 120.603 -0.439 . . . . 15.0 111.116 -177.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.3 t -59.63 -40.92 83.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.657 -0.498 . . . . 15.0 109.657 177.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.66 -41.74 82.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.901 0.381 . . . . 15.0 110.4 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.57 -40.41 91.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.246 -0.434 . . . . 15.0 110.597 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 96.9 mmm -58.3 -45.09 88.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.437 0.637 . . . . 15.0 110.132 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.62 -40.57 95.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.709 -0.678 . . . . 15.0 110.783 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -61.75 -44.2 97.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.315 -0.402 . . . . 15.0 110.765 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -60.31 -36.16 77.26 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.912 -0.315 . . . . 15.0 111.326 -177.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.2 mt -65.79 -23.83 66.79 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.199 0.444 . . . . 15.0 112.199 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.45 13.25 17.49 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-O 119.369 -0.684 . . . . 15.0 113.127 -176.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.87 122.59 13.28 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 118.49 1.145 . . . . 15.0 109.97 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -70.16 -36.17 74.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.667 -0.697 . . . . 15.0 111.188 -172.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 31.0 ttm105 -130.35 111.63 12.53 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.114 0.483 . . . . 15.0 110.382 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.1 130.87 63.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.989 -0.551 . . . . 15.0 109.817 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 85.8 mt -119.78 121.87 67.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.97 -0.559 . . . . 15.0 110.061 -176.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -95.75 116.51 28.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.39 -0.368 . . . . 15.0 110.24 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 28.3 p -97.09 1.29 49.85 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.23 0.826 . . . . 15.0 113.23 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -55.91 -39.89 72.27 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.26 0.482 . . . . 15.0 110.737 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -96.66 -35.17 5.5 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.523 -0.631 . . . . 15.0 111.523 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.6 143.52 53.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.864 0.364 . . . . 15.0 110.604 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.9 m -89.84 161.36 16.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 15.0 110.504 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.73 -54.19 25.22 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-O 118.522 -0.751 . . . . 15.0 112.97 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -56.52 -36.13 97.43 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 CA-C-N 120.559 1.235 . . . . 15.0 111.318 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.31 -42.67 96.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.045 0.45 . . . . 15.0 110.18 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.1 mt -59.28 -41.05 87.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 15.0 110.492 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.7 tp -57.39 -44.02 84.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.339 0.59 . . . . 15.0 110.14 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.63 93.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.617 -0.72 . . . . 15.0 110.542 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.67 89.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.389 -0.368 . . . . 15.0 110.763 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.2 mt -57.86 -52.5 65.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.391 0.615 . . . . 15.0 110.357 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.2 p -63.83 -40.28 96.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.536 -0.756 . . . . 15.0 111.354 -175.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.7 t -62.14 -45.03 95.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.686 0.279 . . . . 15.0 111.422 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.43 -39.4 90.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.509 -0.314 . . . . 15.0 110.99 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.444 -0.344 . . . . 15.0 111.048 178.914 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.9 p30 . . . . . 0 CA--C 1.536 0.406 0 N-CA-C 110.307 -0.257 . . . . 15.0 110.307 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -54.41 155.03 17.47 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.434 1.422 . . . . 15.0 112.004 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -113.75 138.73 49.84 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.222 -0.445 . . . . 15.0 110.751 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.5 m -134.81 145.8 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 121.53 0.681 . . . . 15.0 111.943 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.8 tp -104.7 137.87 41.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.029 -0.987 . . . . 15.0 110.214 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.2 mt -103.07 135.1 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.082 0.467 . . . . 15.0 111.146 -177.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 97.9 mmm -95.5 125.91 40.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.106 -0.952 . . . . 15.0 108.905 169.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.0 mtm180 -59.59 147.67 36.31 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.487 -0.485 . . . . 15.0 110.689 -176.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.28 175.18 34.76 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.776 -0.929 . . . . 15.0 110.776 -178.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -51.59 -32.19 27.75 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.789 0.292 . . . . 15.0 111.789 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.81 173.76 16.78 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.855 -0.898 . . . . 15.0 110.855 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.99 126.38 7.66 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.351 -0.699 . . . . 15.0 111.351 -178.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -56.64 -47.43 79.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.193 0.52 . . . . 15.0 110.417 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.72 -40.99 98.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.642 -0.708 . . . . 15.0 111.202 -176.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -61.1 -55.99 26.12 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.722 -0.391 . . . . 15.0 111.393 -175.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.9 mt -62.19 -45.06 95.07 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.757 -0.377 . . . . 15.0 111.372 -175.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.44 -41.29 98.65 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.699 -0.4 . . . . 15.0 110.904 -177.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -59.87 -41.27 91.13 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.978 -0.289 . . . . 15.0 110.388 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 52.2 ttt85 -60.19 -51.64 68.7 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 120.764 -0.374 . . . . 15.0 111.305 -177.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.72 -36.72 83.92 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.374 -0.53 . . . . 15.0 110.94 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 46.0 tpt85 -61.36 -41.46 97.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.684 0.278 . . . . 15.0 110.399 177.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.83 -30.57 66.35 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.2 -0.524 . . . . 15.0 111.993 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -88.02 9.91 20.8 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.46 0.911 . . . . 15.0 113.46 178.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.1 18.71 58.88 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 121.314 -0.47 . . . . 15.0 113.054 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.1 t -101.06 138.75 24.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 117.77 0.785 . . . . 15.0 109.949 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -81.6 129.63 34.76 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.164 -0.68 . . . . 15.0 109.164 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.4 t -122.66 134.39 65.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.267 0.556 . . . . 15.0 111.418 -172.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -139.61 138.53 36.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.14 -0.936 . . . . 15.0 109.404 171.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -115.5 140.87 48.76 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.832 0.348 . . . . 15.0 110.833 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 33.9 tp -112.67 129.6 24.26 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-O 118.523 -0.751 . . . . 15.0 109.813 -175.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -65.73 134.98 39.85 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 CA-C-N 120.418 1.185 . . . . 15.0 111.38 174.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.8 mt -65.83 -9.19 26.6 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.294 0.85 . . . . 15.0 113.294 -175.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -77.29 -11.33 59.82 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.12 0.785 . . . . 15.0 113.12 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -63.15 148.5 92.8 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 118.416 0.553 . . . . 15.0 110.434 -176.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.89 157.5 31.09 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.523 1.482 . . . . 15.0 113.14 -177.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.44 151.25 5.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.84 -0.618 . . . . 15.0 111.177 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.91 -37.02 3.63 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.354 -0.698 . . . . 15.0 111.354 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.31 -37.78 81.64 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.592 -0.443 . . . . 15.0 110.985 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.4 tp -58.84 -47.31 85.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.028 0.442 . . . . 15.0 110.239 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.8 tp -62.79 -44.58 95.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.106 -0.497 . . . . 15.0 110.951 -176.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.9 -44.72 96.21 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.7 -0.4 . . . . 15.0 110.92 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 -61.61 -40.8 96.12 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.841 -0.344 . . . . 15.0 110.98 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 88.8 t -61.78 -45.74 98.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.829 -0.349 . . . . 15.0 110.375 -177.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -67.42 -50.82 57.73 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.312 0.382 . . . . 15.0 111.936 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.41 -44.35 79.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.674 0.273 . . . . 15.0 111.578 -174.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -78.28 -10.05 59.49 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.043 0.757 . . . . 15.0 113.043 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 56.32 55.9 6.23 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.539 0.685 . . . . 15.0 110.074 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 94.8 mt -69.87 144.73 52.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.846 -0.616 . . . . 15.0 111.381 -176.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -90.9 -40.52 11.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.188 -0.914 . . . . 15.0 110.499 176.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -152.52 168.93 31.64 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 120.129 -1.034 . . . . 15.0 113.216 -174.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 75.8 mt -124.69 141.41 52.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.851 -0.675 . . . . 15.0 110.108 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.5 t -120.25 130.42 74.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.022 -0.362 . . . . 15.0 110.022 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.6 m -122.6 129.39 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 121.047 0.451 . . . . 15.0 110.235 173.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.2 p -95.09 -3.59 47.81 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.931 0.715 . . . . 15.0 112.931 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 81.7 p -154.31 154.71 33.84 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.447 0.567 . . . . 15.0 111.545 -177.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.02 -39.83 90.27 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.887 -0.885 . . . . 15.0 110.887 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -59.19 -42.82 91.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.916 -0.314 . . . . 15.0 110.511 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.88 -44.97 96.6 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.859 -0.896 . . . . 15.0 110.859 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.3 tp -58.16 -47.82 82.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.091 0.472 . . . . 15.0 110.366 -177.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -61.23 -40.71 95.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.018 -0.537 . . . . 15.0 110.695 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -59.74 -40.29 87.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.441 -0.345 . . . . 15.0 110.629 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.1 tp -57.81 -44.16 86.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.235 0.541 . . . . 15.0 110.125 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -60.69 -47.14 87.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.791 -0.64 . . . . 15.0 110.623 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.54 -43.17 99.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.137 -0.483 . . . . 15.0 111.184 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.4 mt -67.04 -34.71 78.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.498 -0.319 . . . . 15.0 111.431 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.97 -39.07 80.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.068 0.461 . . . . 15.0 110.6 177.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 58.83 -143.15 0.62 Allowed 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.736 -0.468 . . . . 15.0 109.736 173.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.61 -19.98 52.79 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.337 0.971 . . . . 15.0 112.639 -174.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -91.88 10.81 27.19 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.265 0.839 . . . . 15.0 113.265 -175.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 56.7 t-105 -47.85 -46.61 63.14 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 118.563 -0.732 . . . . 15.0 112.547 177.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -44.66 -40.71 14.33 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.389 1.393 . . . . 15.0 113.288 177.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -76.96 -48.89 16.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.948 0.404 . . . . 15.0 110.698 -178.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 89.6 mt -59.25 -39.59 79.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 15.0 110.826 -177.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.56 -14.47 35.55 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.817 -0.435 . . . . 15.0 113.23 -176.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -64.96 -30.12 71.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.501 0.651 . . . . 15.0 111.907 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 23.4 mt -76.29 150.42 82.74 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 120.932 -0.307 . . . . 15.0 111.264 -174.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.34 128.97 29.29 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.624 1.55 . . . . 15.0 112.286 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 14.0 tp -107.07 124.54 49.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 15.0 110.533 175.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -92.59 121.95 34.53 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.356 -0.609 . . . . 15.0 109.356 174.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.5 m -107.0 147.38 34.99 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-O 119.345 -0.36 . . . . 15.0 110.207 177.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.18 -25.88 5.56 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.577 1.518 . . . . 15.0 113.404 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.9 p -145.26 163.44 32.26 Favored Pre-proline 0 CA--C 1.531 0.227 0 C-N-CA 120.636 -0.425 . . . . 15.0 111.46 -172.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.3 -44.01 47.07 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 121.13 1.22 . . . . 15.0 111.829 176.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -58.28 -46.74 85.49 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.81 -0.356 . . . . 15.0 110.817 -177.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.0 t -59.9 -41.04 84.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.882 -0.414 . . . . 15.0 109.882 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.87 -39.32 77.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.674 0.273 . . . . 15.0 110.707 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.88 -42.08 97.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.504 -0.316 . . . . 15.0 110.563 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 52.2 mtm -64.89 -42.94 94.36 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 119.871 -0.731 . . . . 15.0 110.129 176.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.5 -43.96 93.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.584 -0.28 . . . . 15.0 111.484 -171.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -67.02 -38.57 86.19 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.161 -0.616 . . . . 15.0 110.443 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -59.76 -35.16 74.04 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 120.653 -0.419 . . . . 15.0 111.246 176.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 67.2 mt -59.88 -29.11 68.1 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.877 -0.329 . . . . 15.0 111.378 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.27 13.08 20.28 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 119.431 -0.649 . . . . 15.0 112.821 -172.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.93 123.33 15.46 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.515 1.157 . . . . 15.0 109.862 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -70.46 -35.1 73.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.971 -0.558 . . . . 15.0 111.323 -172.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -131.62 113.98 14.27 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 110.052 -0.351 . . . . 15.0 110.052 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 45.6 t -109.44 129.79 63.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.036 0.446 . . . . 15.0 110.121 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 82.4 mt -120.92 125.66 74.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.745 -0.661 . . . . 15.0 109.978 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -94.44 114.5 26.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.212 -0.292 . . . . 15.0 110.212 175.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 28.6 p -78.36 -25.84 46.48 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 120.639 -0.424 . . . . 15.0 112.021 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -55.11 -38.17 67.8 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.646 0.26 . . . . 15.0 110.913 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.96 -35.15 7.83 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.597 -0.601 . . . . 15.0 111.597 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.36 127.02 36.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.373 . . . . 15.0 110.908 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.3 m -65.09 156.87 30.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.081 0.467 . . . . 15.0 110.787 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.68 -54.34 23.8 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 113.031 0.752 . . . . 15.0 113.031 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -56.2 -35.48 95.44 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 CA-C-N 120.367 1.167 . . . . 15.0 111.339 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.05 -41.33 92.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.955 0.407 . . . . 15.0 110.235 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 78.0 mt -58.94 -41.9 88.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.97 0.414 . . . . 15.0 110.329 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.61 -44.16 85.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.445 0.64 . . . . 15.0 110.131 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.4 -40.09 89.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.602 -0.726 . . . . 15.0 110.586 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.25 -41.03 92.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.41 -0.359 . . . . 15.0 110.785 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.4 mt -57.85 -51.01 71.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.152 0.501 . . . . 15.0 110.404 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.8 p -63.28 -41.27 98.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.68 -0.691 . . . . 15.0 111.252 -175.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.0 m -63.46 -43.22 97.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.662 0.267 . . . . 15.0 111.389 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.35 -39.03 91.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.478 -0.328 . . . . 15.0 111.05 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.552 -0.295 . . . . 15.0 110.952 179.045 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 . . . . . 0 CA--C 1.534 0.327 0 N-CA-C 110.32 -0.252 . . . . 15.0 110.32 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -59.18 155.06 41.95 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.38 1.387 . . . . 15.0 111.942 -177.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -105.4 136.48 44.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.387 -0.369 . . . . 15.0 110.62 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.8 m -132.68 143.56 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 121.585 0.707 . . . . 15.0 111.587 177.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.8 tp -102.77 135.87 43.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.981 -1.009 . . . . 15.0 110.274 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.9 mt -102.04 134.76 41.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.981 0.42 . . . . 15.0 110.558 -178.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 85.6 mtp -103.52 134.27 47.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.441 -0.8 . . . . 15.0 109.943 173.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 -57.46 144.86 35.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.016 0.436 . . . . 15.0 110.833 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.2 175.24 33.24 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.658 -0.977 . . . . 15.0 110.658 -177.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -50.97 -32.07 19.84 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.88 0.326 . . . . 15.0 111.88 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.95 175.42 47.77 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.782 -0.927 . . . . 15.0 110.782 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.64 131.68 10.81 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.474 -0.65 . . . . 15.0 111.474 -178.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -56.56 -44.35 80.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.869 0.366 . . . . 15.0 110.616 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.83 -43.19 99.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.126 -0.488 . . . . 15.0 111.183 -176.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -62.49 -56.06 21.61 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.8 -0.36 . . . . 15.0 111.384 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.9 tt -61.7 -43.69 98.37 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.777 -0.369 . . . . 15.0 110.985 -175.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.38 -42.43 99.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.414 -0.357 . . . . 15.0 110.84 -177.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.78 -41.21 90.62 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.875 -0.33 . . . . 15.0 110.457 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -59.64 -51.72 68.61 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.565 -0.454 . . . . 15.0 111.34 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.5 mt -62.58 -37.5 86.43 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.436 -0.505 . . . . 15.0 110.933 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 46.9 tpt85 -63.03 -44.8 94.91 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 121.066 -0.254 . . . . 15.0 110.711 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.43 -30.57 68.4 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.955 -0.64 . . . . 15.0 111.894 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -88.11 9.24 23.34 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.626 0.973 . . . . 15.0 113.626 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.77 13.55 54.77 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 121.066 -0.588 . . . . 15.0 113.65 173.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.0 t -101.1 138.52 25.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 117.953 0.876 . . . . 15.0 110.021 177.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -79.33 131.88 36.27 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.348 -0.612 . . . . 15.0 109.348 178.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.9 t -117.68 130.79 72.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.198 0.523 . . . . 15.0 111.528 -171.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -139.33 133.03 30.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.32 -0.855 . . . . 15.0 109.388 170.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -112.66 137.39 51.01 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.9 0.381 . . . . 15.0 110.974 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 40.5 tp -118.9 113.45 35.91 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 118.618 -0.706 . . . . 15.0 109.969 -176.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -56.09 135.26 68.93 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.069 1.179 . . . . 15.0 112.318 177.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 77.3 mt -60.56 -9.21 3.48 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.298 0.851 . . . . 15.0 113.298 -178.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -77.15 -9.98 59.1 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.205 0.817 . . . . 15.0 113.205 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -62.53 147.2 92.8 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 118.338 0.517 . . . . 15.0 110.26 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.29 158.96 33.28 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.559 1.506 . . . . 15.0 113.252 -178.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.84 152.42 3.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.783 -0.644 . . . . 15.0 111.337 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.39 -36.3 3.88 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.489 -0.644 . . . . 15.0 111.489 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -60.01 -37.22 79.09 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.689 -0.404 . . . . 15.0 111.041 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.8 tp -58.65 -46.34 87.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.965 0.412 . . . . 15.0 110.168 -178.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.7 tp -61.78 -44.14 97.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.139 -0.482 . . . . 15.0 110.742 -177.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.01 -43.61 98.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.352 -0.386 . . . . 15.0 111.241 -176.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -61.28 -41.82 97.6 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.751 -0.38 . . . . 15.0 110.625 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.6 t -61.65 -47.03 95.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.88 -0.328 . . . . 15.0 110.491 -175.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -75.42 -43.5 49.57 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.492 0.553 . . . . 15.0 112.492 -174.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.59 -44.37 74.52 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.667 0.247 . . . . 15.0 111.667 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -82.74 -10.09 59.05 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.123 0.786 . . . . 15.0 113.123 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 58.36 55.88 4.73 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.563 0.697 . . . . 15.0 109.553 -177.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 94.1 mt -71.47 145.7 49.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.752 -0.658 . . . . 15.0 111.412 -174.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -95.41 -40.52 9.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.231 -0.895 . . . . 15.0 110.774 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -150.93 166.64 30.44 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 120.057 -1.068 . . . . 15.0 113.412 -173.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.5 mt -126.61 144.17 50.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.732 -0.734 . . . . 15.0 110.046 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.8 t -122.1 129.38 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 110.386 -0.227 . . . . 15.0 110.386 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.5 m -127.65 152.05 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.053 0.454 . . . . 15.0 110.456 172.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.9 m -123.47 7.92 8.97 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.744 -0.662 . . . . 15.0 112.77 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.9 p -155.62 151.69 27.81 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 118.514 0.597 . . . . 15.0 111.772 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.87 -39.75 92.08 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.633 -0.987 . . . . 15.0 110.633 176.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -58.25 -41.8 85.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.702 0.287 . . . . 15.0 110.382 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.82 -47.98 88.54 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.687 -0.965 . . . . 15.0 110.687 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.2 tp -57.13 -44.42 83.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.15 0.5 . . . . 15.0 110.705 -177.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.63 -42.37 98.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.063 -0.517 . . . . 15.0 110.823 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -59.47 -39.89 85.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.393 -0.367 . . . . 15.0 110.576 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.4 tp -58.12 -44.29 87.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.094 0.473 . . . . 15.0 110.274 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -60.67 -47.52 85.91 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.849 -0.614 . . . . 15.0 110.631 -178.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -62.13 -43.41 98.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.085 -0.507 . . . . 15.0 111.113 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.8 mt -66.42 -35.27 79.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.414 -0.357 . . . . 15.0 111.375 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.92 -38.75 79.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.032 0.444 . . . . 15.0 110.672 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.21 -143.54 0.59 Allowed 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 109.515 -0.55 . . . . 15.0 109.515 174.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.43 -19.04 44.38 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.342 0.973 . . . . 15.0 112.609 -175.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -91.88 10.5 28.48 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.299 0.852 . . . . 15.0 113.299 -174.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -47.76 -46.72 62.33 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 118.576 -0.726 . . . . 15.0 112.561 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -44.69 -41.99 14.72 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 121.481 1.454 . . . . 15.0 113.244 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -77.01 -48.69 17.23 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.949 0.405 . . . . 15.0 110.862 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.7 mt -59.01 -40.78 81.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.138 -0.483 . . . . 15.0 110.748 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.51 -16.1 35.05 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 119.896 -0.391 . . . . 15.0 113.048 -177.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -63.66 -30.64 71.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.425 0.612 . . . . 15.0 111.989 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.6 mt -74.89 149.02 85.24 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 120.979 -0.289 . . . . 15.0 111.265 -173.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.85 129.07 24.89 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.558 1.505 . . . . 15.0 112.517 176.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.4 tp -107.77 126.43 52.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 15.0 110.577 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -89.84 125.01 35.17 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.438 -0.579 . . . . 15.0 109.438 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.87 147.56 37.98 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-O 119.373 -0.346 . . . . 15.0 110.319 177.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -79.17 -23.94 7.17 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.574 1.516 . . . . 15.0 113.52 -175.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.7 p -144.4 158.23 54.73 Favored Pre-proline 0 CA--C 1.531 0.232 0 C-N-CA 120.664 -0.414 . . . . 15.0 111.321 -172.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.82 -44.04 51.34 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.255 1.304 . . . . 15.0 111.694 175.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -56.73 -48.56 77.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.847 0.356 . . . . 15.0 110.858 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.2 t -59.61 -40.66 82.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.836 0.351 . . . . 15.0 110.071 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.72 -42.29 83.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.012 0.434 . . . . 15.0 110.505 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.6 -41.67 97.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 15.0 110.658 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 87.1 mtp -59.82 -44.44 94.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.238 0.542 . . . . 15.0 110.432 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.35 -41.2 96.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.993 -0.548 . . . . 15.0 110.725 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 54.0 ttm-85 -61.19 -44.52 97.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.25 -0.432 . . . . 15.0 110.539 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -59.84 -36.26 76.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.527 -0.306 . . . . 15.0 111.397 -177.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 81.9 mt -65.39 -24.15 67.15 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.244 0.461 . . . . 15.0 112.244 177.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.85 13.2 14.41 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-O 119.444 -0.642 . . . . 15.0 113.158 -176.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.89 121.97 11.8 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.466 1.133 . . . . 15.0 109.893 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -70.5 -35.48 73.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.69 -0.686 . . . . 15.0 111.322 -171.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -131.07 112.83 13.24 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.975 0.417 . . . . 15.0 110.115 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.2 t -111.41 129.49 66.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.79 -0.448 . . . . 15.0 109.79 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 83.9 mt -119.53 125.49 74.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.967 -0.56 . . . . 15.0 110.222 -176.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -94.9 117.74 30.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.435 -0.348 . . . . 15.0 110.286 176.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.2 p -88.6 -18.69 27.5 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.574 0.583 . . . . 15.0 112.574 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 tpt85 -55.17 -38.9 68.92 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 122.229 -0.294 . . . . 15.0 110.766 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -93.16 -34.95 6.49 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.633 -0.587 . . . . 15.0 111.633 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -89.51 125.59 35.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.843 0.354 . . . . 15.0 110.705 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.7 m -64.64 158.63 23.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.159 0.504 . . . . 15.0 110.901 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.79 -54.24 25.06 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 113.011 0.745 . . . . 15.0 113.011 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -56.65 -34.84 96.68 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 CA-C-N 120.447 1.196 . . . . 15.0 111.451 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.74 93.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.029 0.442 . . . . 15.0 110.081 176.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 78.8 mt -58.95 -41.13 86.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.077 0.465 . . . . 15.0 110.454 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 30.6 tp -56.98 -44.34 82.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.546 0.689 . . . . 15.0 110.104 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.45 -40.14 90.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.508 -0.769 . . . . 15.0 110.551 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.83 -41.12 90.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.399 -0.364 . . . . 15.0 110.757 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.0 mt -57.89 -52.08 66.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.262 0.553 . . . . 15.0 110.305 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.9 p -63.53 -40.6 97.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.571 -0.741 . . . . 15.0 111.315 -175.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.3 m -62.73 -43.51 98.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.67 0.271 . . . . 15.0 111.443 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.34 -39.87 94.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.414 -0.357 . . . . 15.0 111.045 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.48 -0.327 . . . . 15.0 111.164 179.978 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 . . . . . 0 CA--C 1.535 0.376 0 N-CA-C 110.329 -0.249 . . . . 15.0 110.329 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.7 155.04 28.4 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.393 1.395 . . . . 15.0 111.875 -176.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -111.68 138.13 48.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.795 0.331 . . . . 15.0 110.864 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.1 m -134.66 144.31 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.565 0.698 . . . . 15.0 111.572 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.2 tp -104.38 136.0 44.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.916 -1.038 . . . . 15.0 110.264 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.8 mt -103.53 135.1 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.123 0.487 . . . . 15.0 111.129 -176.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 98.5 mmm -95.3 133.65 38.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.109 -0.95 . . . . 15.0 109.21 171.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -63.91 143.74 57.62 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.76 -0.376 . . . . 15.0 110.479 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.24 175.13 34.02 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.924 -0.871 . . . . 15.0 110.924 -178.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -52.55 -32.45 40.87 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.742 0.275 . . . . 15.0 111.742 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.69 176.39 32.38 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.807 -0.917 . . . . 15.0 110.807 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.0 120.24 5.77 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.504 -0.638 . . . . 15.0 111.504 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -56.89 -41.8 78.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.794 0.331 . . . . 15.0 110.452 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.07 -40.63 98.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 15.0 111.134 -177.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -62.35 -56.0 22.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.984 0.421 . . . . 15.0 111.124 -176.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.3 mt -59.92 -44.82 94.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.942 0.401 . . . . 15.0 110.759 -176.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.53 -37.49 86.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 15.0 111.052 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.0 -42.89 99.32 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.955 -0.298 . . . . 15.0 110.598 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -61.53 -51.52 68.27 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.125 -0.63 . . . . 15.0 110.895 -178.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 84.6 mt -61.46 -37.99 85.6 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.632 -0.427 . . . . 15.0 110.931 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 57.5 ttt85 -63.63 -43.52 96.59 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.196 -0.202 . . . . 15.0 111.084 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.03 -30.6 67.05 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.967 -0.635 . . . . 15.0 111.915 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -88.2 10.1 20.63 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.481 0.919 . . . . 15.0 113.481 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.91 18.27 51.41 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 121.187 -0.53 . . . . 15.0 113.292 174.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.4 t -101.01 140.32 20.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 117.688 0.744 . . . . 15.0 110.131 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -84.78 130.38 34.69 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.475 -0.565 . . . . 15.0 109.475 178.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.2 t -119.97 133.76 65.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.205 0.526 . . . . 15.0 111.271 -173.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -139.08 132.72 30.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.443 -0.799 . . . . 15.0 109.611 171.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -113.01 137.64 51.1 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.89 0.376 . . . . 15.0 110.467 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.7 tp -114.92 113.49 44.28 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.683 -0.675 . . . . 15.0 110.824 -173.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -49.05 135.08 29.97 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.156 1.237 . . . . 15.0 111.881 174.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.2 mt -64.61 -13.36 53.11 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.15 0.796 . . . . 15.0 113.15 -174.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -77.23 -6.01 51.45 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.293 0.849 . . . . 15.0 113.293 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -60.0 151.04 67.24 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 118.559 0.618 . . . . 15.0 110.388 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.75 151.72 25.0 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.548 1.499 . . . . 15.0 113.044 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.53 152.29 5.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.925 -0.58 . . . . 15.0 111.162 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.84 -36.6 3.8 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.449 -0.66 . . . . 15.0 111.449 -177.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.44 -37.94 82.54 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.655 -0.418 . . . . 15.0 110.958 -177.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.9 tp -59.14 -46.32 88.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.952 0.406 . . . . 15.0 110.256 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.1 tp -61.97 -44.64 96.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 15.0 110.824 -176.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.89 -43.93 97.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.348 -0.387 . . . . 15.0 110.91 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.8 mtp85 -61.83 -41.77 98.2 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.811 -0.356 . . . . 15.0 110.888 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.5 t -59.4 -46.08 92.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.868 -0.419 . . . . 15.0 109.868 -177.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.2 tpt85 -71.55 -50.3 32.45 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 123.37 0.419 . . . . 15.0 112.024 -176.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.04 -44.44 92.48 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.089 0.403 . . . . 15.0 112.089 -171.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 mp0 -89.87 -5.61 56.65 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.429 0.899 . . . . 15.0 113.429 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 56.77 55.93 5.89 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.616 0.722 . . . . 15.0 110.167 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.23 140.44 58.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.525 -0.761 . . . . 15.0 111.058 -175.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -84.47 -40.64 17.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.491 -0.777 . . . . 15.0 110.671 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -154.04 168.04 32.36 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 119.872 -1.156 . . . . 15.0 113.773 -173.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.8 mt -123.65 143.51 50.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.502 -0.849 . . . . 15.0 109.671 177.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.9 t -122.66 132.76 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.143 -0.317 . . . . 15.0 110.143 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.2 m -126.47 142.41 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 121.057 0.456 . . . . 15.0 110.547 173.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.6 t -97.44 -19.95 18.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.622 -0.717 . . . . 15.0 112.439 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.2 p -151.27 161.65 42.32 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 121.333 0.587 . . . . 15.0 111.528 -174.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.45 -39.12 83.18 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.946 -0.862 . . . . 15.0 110.946 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -58.82 -44.62 90.91 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.876 -0.329 . . . . 15.0 110.653 -178.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.06 -44.48 97.23 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.545 -1.022 . . . . 15.0 110.545 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.1 tp -57.27 -43.03 82.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.115 0.483 . . . . 15.0 110.639 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.08 -42.73 99.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 15.0 110.692 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -58.95 -41.61 87.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.852 0.358 . . . . 15.0 110.543 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.8 tp -58.67 -43.94 90.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.125 0.488 . . . . 15.0 110.181 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -61.19 -47.32 86.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.955 -0.566 . . . . 15.0 110.725 -178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -61.22 -42.7 99.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 15.0 111.117 -177.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 92.7 mt -65.82 -36.32 83.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.341 -0.391 . . . . 15.0 111.374 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.32 -38.57 80.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.141 0.496 . . . . 15.0 110.85 178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.13 -143.15 0.61 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.648 -0.501 . . . . 15.0 109.648 174.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.52 -19.82 51.0 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.321 0.964 . . . . 15.0 112.734 -174.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -91.97 11.4 25.23 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.217 0.821 . . . . 15.0 113.217 -175.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -47.85 -46.7 63.25 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 118.584 -0.722 . . . . 15.0 112.593 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -44.7 -41.25 14.7 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.474 1.45 . . . . 15.0 113.224 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.5 mp0 -77.03 -48.77 17.0 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.943 0.402 . . . . 15.0 110.827 -178.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 90.8 mt -60.03 -40.52 83.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 15.0 110.902 -176.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.79 -13.72 26.66 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.915 -0.38 . . . . 15.0 113.156 -177.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -64.44 -31.46 72.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 117.359 0.579 . . . . 15.0 111.766 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.3 mt -72.99 141.84 82.11 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 119.204 -0.427 . . . . 15.0 110.456 -176.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -59.33 135.24 64.05 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.342 1.361 . . . . 15.0 112.434 177.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.9 tp -109.34 127.76 54.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 15.0 110.736 176.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -91.35 127.18 36.68 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.821 -0.437 . . . . 15.0 109.821 176.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.6 m -119.6 147.44 43.69 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 119.45 -0.309 . . . . 15.0 110.25 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.24 -24.23 6.83 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.597 1.531 . . . . 15.0 113.478 -175.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.2 p -142.58 158.51 60.06 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 120.71 -0.396 . . . . 15.0 111.27 -171.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.43 -44.05 52.33 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.285 1.323 . . . . 15.0 111.761 176.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -58.29 -47.43 83.67 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.773 -0.371 . . . . 15.0 110.924 -177.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.17 -39.65 81.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.788 -0.365 . . . . 15.0 110.096 178.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.25 -41.84 80.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.925 0.393 . . . . 15.0 110.404 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.75 -40.86 94.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.131 -0.486 . . . . 15.0 110.526 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.0 mmm -58.33 -45.17 88.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.456 0.646 . . . . 15.0 110.177 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.76 -40.32 94.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.704 -0.68 . . . . 15.0 110.937 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.0 ttt-85 -62.07 -44.63 96.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 15.0 110.792 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.76 -36.15 76.06 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.818 -0.353 . . . . 15.0 111.236 -177.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 76.4 mt -65.49 -25.6 67.55 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.088 0.403 . . . . 15.0 112.088 177.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.55 13.37 14.78 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 119.288 -0.729 . . . . 15.0 113.18 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.87 122.68 13.51 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 118.513 1.157 . . . . 15.0 110.002 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -67.52 -35.83 79.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.518 -0.764 . . . . 15.0 111.256 -171.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -131.82 117.67 18.85 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.954 0.407 . . . . 15.0 110.087 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.9 t -114.18 130.36 68.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.975 0.417 . . . . 15.0 109.989 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 89.9 mt -119.16 123.58 71.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.811 -0.631 . . . . 15.0 110.077 -177.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -94.7 117.44 30.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.376 -0.375 . . . . 15.0 110.086 175.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 30.8 p -95.42 -1.65 50.54 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.306 0.854 . . . . 15.0 113.306 -178.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -55.89 -39.88 72.2 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 118.191 0.451 . . . . 15.0 110.672 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -96.24 -35.06 5.63 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 111.511 -0.636 . . . . 15.0 111.511 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.7 143.23 53.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.829 0.347 . . . . 15.0 110.635 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 65.2 m -89.85 160.12 16.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 15.0 110.506 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.66 -54.41 23.21 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 112.945 0.72 . . . . 15.0 112.945 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.54 -34.53 98.88 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 CA-C-N 120.079 1.064 . . . . 15.0 111.708 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.01 96.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.028 0.442 . . . . 15.0 110.034 177.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.7 mt -59.42 -40.77 87.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 15.0 110.399 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 36.6 tp -57.26 -44.03 83.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.272 0.558 . . . . 15.0 110.164 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.18 -40.59 90.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.696 -0.683 . . . . 15.0 110.436 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.09 -40.13 88.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.377 -0.374 . . . . 15.0 110.811 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.6 mt -57.88 -51.4 69.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.174 0.512 . . . . 15.0 110.479 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.9 p -64.74 -41.56 95.84 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.637 -0.71 . . . . 15.0 111.384 -175.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.0 t -61.36 -43.87 98.14 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.051 -0.26 . . . . 15.0 111.26 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.18 -42.5 99.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.472 -0.331 . . . . 15.0 111.066 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 C-N-CA 120.975 -0.29 . . . . 15.0 111.209 -179.889 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 110.173 -0.306 . . . . 15.0 110.173 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.19 152.67 10.64 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.511 1.474 . . . . 15.0 112.214 -174.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -115.12 140.96 48.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.113 -0.494 . . . . 15.0 110.693 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 m -134.36 144.17 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.614 0.721 . . . . 15.0 111.519 176.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.8 tp -105.26 135.08 47.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.91 -1.041 . . . . 15.0 110.381 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.5 mt -99.8 133.02 44.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.034 0.445 . . . . 15.0 110.598 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 83.8 mtp -100.7 134.39 43.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.418 -0.81 . . . . 15.0 109.255 170.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -57.39 145.21 33.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.135 0.493 . . . . 15.0 111.222 -170.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.51 175.08 27.03 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.895 -0.882 . . . . 15.0 110.895 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.27 -32.29 71.04 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.817 0.303 . . . . 15.0 111.817 -178.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.96 -177.68 20.6 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.234 -0.746 . . . . 15.0 111.234 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.9 127.99 8.46 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.9 -0.88 . . . . 15.0 110.9 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 52.4 mmt-85 -60.02 -46.61 88.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.221 0.534 . . . . 15.0 109.648 -176.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.09 -40.01 96.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.59 -0.732 . . . . 15.0 111.235 -176.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -60.81 -55.96 26.86 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.758 -0.377 . . . . 15.0 111.258 -175.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.5 mt -61.91 -44.9 95.82 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.735 -0.386 . . . . 15.0 111.132 -176.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.7 95.48 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.657 -0.417 . . . . 15.0 110.894 -177.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -60.03 -41.52 92.43 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 121.008 -0.277 . . . . 15.0 110.442 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.4 ttt85 -59.96 -51.55 69.19 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.665 -0.414 . . . . 15.0 111.2 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 70.6 mt -60.79 -36.79 79.89 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.518 -0.473 . . . . 15.0 110.937 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 60.4 ttt85 -61.73 -43.16 99.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.693 0.283 . . . . 15.0 110.727 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.19 -30.56 67.55 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.053 -0.594 . . . . 15.0 111.855 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -88.1 9.93 20.95 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.521 0.934 . . . . 15.0 113.521 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.3 12.83 58.16 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 121.189 -0.529 . . . . 15.0 113.689 173.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.9 t -101.06 136.12 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 118.084 0.942 . . . . 15.0 110.115 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -78.04 132.22 37.67 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.076 -0.713 . . . . 15.0 109.076 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 31.3 t -121.09 133.79 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.247 0.546 . . . . 15.0 111.37 -172.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -140.59 142.11 35.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.285 -0.87 . . . . 15.0 109.648 170.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -115.31 138.6 50.79 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.949 0.404 . . . . 15.0 111.03 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.0 tp -119.07 113.34 35.66 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 118.586 -0.721 . . . . 15.0 109.863 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.19 135.2 59.14 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 121.06 1.173 . . . . 15.0 112.257 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 76.1 mt -60.85 -12.03 9.66 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.089 0.774 . . . . 15.0 113.089 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -77.15 -7.78 56.39 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.271 0.841 . . . . 15.0 113.271 -177.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -61.98 150.3 83.58 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 118.45 0.568 . . . . 15.0 110.478 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.93 154.25 25.9 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.555 1.503 . . . . 15.0 113.119 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.3 151.82 5.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.878 -0.601 . . . . 15.0 111.227 -178.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.98 -38.1 3.22 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.498 -0.641 . . . . 15.0 111.498 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.74 -37.96 86.17 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.64 -0.424 . . . . 15.0 110.974 -177.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.4 tp -59.05 -48.93 79.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.916 0.389 . . . . 15.0 110.209 -177.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.5 tp -64.34 -44.96 89.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.138 -0.483 . . . . 15.0 111.215 -175.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.78 -45.51 93.59 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.626 -0.43 . . . . 15.0 110.78 -175.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.3 ttt85 -62.23 -41.81 98.75 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.855 -0.338 . . . . 15.0 110.856 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.6 t -60.93 -43.81 96.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.753 -0.379 . . . . 15.0 110.176 -178.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -68.46 -48.66 63.94 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.117 0.414 . . . . 15.0 112.117 -176.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.58 -44.28 78.54 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.94 -0.304 . . . . 15.0 111.53 -175.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -79.47 -10.13 59.74 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.045 0.757 . . . . 15.0 113.045 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 54.84 55.86 7.34 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.607 0.717 . . . . 15.0 110.418 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 94.1 mt -66.73 148.15 52.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.689 -0.687 . . . . 15.0 111.584 -175.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -95.35 -40.6 9.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.29 -0.868 . . . . 15.0 110.826 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.67 160.32 28.27 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.009 -1.091 . . . . 15.0 113.443 -173.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.4 mt -126.61 141.55 51.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.505 -0.847 . . . . 15.0 109.838 178.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.47 131.22 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 121.143 -0.223 . . . . 15.0 110.702 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 m -123.08 145.56 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.158 0.504 . . . . 15.0 110.562 173.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.3 t -97.83 -20.28 17.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.467 -0.788 . . . . 15.0 112.536 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.8 p -155.93 164.44 38.48 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.442 0.639 . . . . 15.0 111.903 -174.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.91 -37.38 70.0 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.173 -0.771 . . . . 15.0 111.173 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -58.35 -45.72 87.63 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.863 -0.335 . . . . 15.0 110.674 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.17 -46.19 94.68 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.468 -1.053 . . . . 15.0 110.468 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 30.1 tp -56.16 -44.02 78.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.16 0.505 . . . . 15.0 110.831 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.76 -43.1 99.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.039 -0.528 . . . . 15.0 110.672 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -59.03 -39.97 83.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.39 -0.368 . . . . 15.0 110.639 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.9 tp -57.88 -44.56 86.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.189 0.518 . . . . 15.0 110.243 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -60.92 -47.51 86.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.713 -0.676 . . . . 15.0 110.62 -178.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -61.45 -42.99 99.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.014 -0.539 . . . . 15.0 111.053 -177.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.97 -35.91 81.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.352 -0.385 . . . . 15.0 111.405 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.0 -39.22 81.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.975 0.417 . . . . 15.0 110.597 178.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.09 -142.81 0.62 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.591 -0.522 . . . . 15.0 109.591 174.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.49 -19.29 46.81 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.384 0.993 . . . . 15.0 112.601 -174.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -91.82 10.46 28.48 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.355 0.872 . . . . 15.0 113.355 -175.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.9 t-105 -47.84 -46.36 62.62 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 118.598 -0.715 . . . . 15.0 112.665 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -44.73 -41.6 14.83 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 121.525 1.484 . . . . 15.0 113.182 177.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -76.93 -48.8 17.13 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 120.616 -0.434 . . . . 15.0 110.841 -178.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 89.8 mt -59.71 -40.17 81.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 15.0 110.808 -176.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.38 -16.65 36.27 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 119.948 -0.362 . . . . 15.0 113.126 -176.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 60.7 mtp85 -65.31 -30.17 71.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.423 0.611 . . . . 15.0 112.025 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.8 mt -73.52 150.51 89.13 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 111.533 0.197 . . . . 15.0 111.533 -172.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.4 126.35 17.52 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.67 1.58 . . . . 15.0 112.513 176.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.5 tp -105.53 125.75 51.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.473 174.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -89.89 125.89 35.51 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.497 -0.557 . . . . 15.0 109.497 175.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.4 m -116.82 146.07 36.94 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 119.335 -0.364 . . . . 15.0 110.181 176.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.21 -22.97 7.98 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.559 1.506 . . . . 15.0 113.582 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.5 p -144.32 161.77 42.98 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 120.649 -0.421 . . . . 15.0 111.575 -172.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -55.9 -44.01 51.52 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 121.165 1.243 . . . . 15.0 111.821 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -57.56 -47.79 81.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.842 0.353 . . . . 15.0 110.773 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.7 t -59.76 -40.63 83.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.988 -0.375 . . . . 15.0 109.988 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.64 -41.37 81.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.942 0.401 . . . . 15.0 110.484 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.13 -40.0 92.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.425 . . . . 15.0 110.718 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.0 mmm -58.63 -45.09 90.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.383 0.611 . . . . 15.0 110.073 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.73 -41.67 97.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.727 -0.669 . . . . 15.0 110.865 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -61.73 -44.7 96.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.262 -0.426 . . . . 15.0 110.591 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -59.7 -36.11 75.87 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.905 -0.318 . . . . 15.0 111.259 -177.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.97 -23.53 65.96 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.357 0.503 . . . . 15.0 112.357 177.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.7 13.27 16.89 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 119.368 -0.684 . . . . 15.0 113.05 -176.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.78 122.01 11.84 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 118.522 1.161 . . . . 15.0 109.952 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -70.32 -35.7 73.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.677 -0.692 . . . . 15.0 111.22 -172.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -130.87 112.67 13.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.073 0.463 . . . . 15.0 110.422 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.6 t -111.7 130.15 65.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.076 -0.511 . . . . 15.0 109.73 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.1 mt -118.95 122.83 70.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.901 -0.59 . . . . 15.0 110.01 -176.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.33 118.86 32.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.401 -0.363 . . . . 15.0 110.255 176.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.8 p -95.16 -9.63 32.89 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.074 0.768 . . . . 15.0 113.074 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -55.46 -39.79 70.81 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 118.161 0.437 . . . . 15.0 110.843 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -94.77 -35.16 5.96 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.475 -0.65 . . . . 15.0 111.475 178.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.75 145.99 44.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.789 0.328 . . . . 15.0 110.46 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.5 m -89.8 158.88 17.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 15.0 110.451 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.66 -54.24 24.53 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 113.093 0.775 . . . . 15.0 113.093 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -57.48 -35.15 98.88 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 CA-C-N 120.383 1.173 . . . . 15.0 111.5 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.62 95.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.065 0.46 . . . . 15.0 110.091 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.8 mt -59.12 -40.62 85.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 15.0 110.361 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.13 -43.8 82.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.386 0.612 . . . . 15.0 110.113 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.21 -40.58 90.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.7 -0.682 . . . . 15.0 110.495 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.21 -41.58 93.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.358 -0.383 . . . . 15.0 110.808 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.2 mt -57.87 -50.83 71.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.218 0.533 . . . . 15.0 110.408 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.9 p -63.18 -41.3 99.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.719 -0.673 . . . . 15.0 111.265 -175.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.4 m -63.25 -43.45 97.97 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.084 -0.246 . . . . 15.0 111.36 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.6 -38.49 87.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.529 -0.305 . . . . 15.0 111.087 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.45 -0.341 . . . . 15.0 111.685 178.831 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 110.106 -0.331 . . . . 15.0 110.106 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -50.23 151.6 9.18 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.461 1.441 . . . . 15.0 112.101 -174.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -117.75 140.36 49.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.162 -0.472 . . . . 15.0 110.802 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.8 m -134.03 144.29 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.542 0.686 . . . . 15.0 111.68 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.9 tp -104.21 136.78 43.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.131 -0.941 . . . . 15.0 110.233 178.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.9 mt -105.78 135.06 45.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.216 0.531 . . . . 15.0 111.098 -176.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 98.0 mmm -94.43 134.06 37.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.003 -0.998 . . . . 15.0 109.319 171.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -57.55 143.91 39.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.883 0.373 . . . . 15.0 110.673 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.18 175.08 28.57 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.961 -0.856 . . . . 15.0 110.961 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -59.24 -32.27 69.83 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.676 0.25 . . . . 15.0 111.676 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.7 -177.72 24.35 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.934 -0.866 . . . . 15.0 110.934 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.85 119.02 4.89 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.178 -0.769 . . . . 15.0 111.178 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -57.92 -44.57 86.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.303 0.573 . . . . 15.0 110.025 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.47 -42.2 98.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.821 -0.627 . . . . 15.0 111.022 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -57.05 -54.42 46.94 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.959 0.409 . . . . 15.0 110.997 -176.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.8 mt -58.35 -41.67 85.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.391 -0.368 . . . . 15.0 110.696 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.72 -41.92 96.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.362 -0.381 . . . . 15.0 111.573 -178.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.07 -40.84 95.2 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.765 -0.374 . . . . 15.0 110.653 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -59.55 -51.59 69.18 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.437 -0.505 . . . . 15.0 111.054 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 78.6 mt -63.18 -37.02 85.58 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.61 -0.436 . . . . 15.0 111.069 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -61.53 -43.5 98.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.725 0.297 . . . . 15.0 110.552 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.39 -30.62 68.33 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.954 -0.641 . . . . 15.0 111.933 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -88.07 9.71 21.64 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.632 0.975 . . . . 15.0 113.632 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.91 14.44 59.37 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 121.205 -0.521 . . . . 15.0 113.482 174.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.0 t -101.12 138.32 25.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 117.904 0.852 . . . . 15.0 110.163 178.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -83.37 136.98 34.14 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.378 -0.601 . . . . 15.0 109.378 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.1 t -117.03 133.92 62.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.326 0.584 . . . . 15.0 111.516 -173.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -135.33 125.88 26.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.114 -0.948 . . . . 15.0 109.257 169.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -112.34 132.79 54.8 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.762 0.315 . . . . 15.0 110.362 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 tp -115.83 113.5 42.19 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 118.776 -0.63 . . . . 15.0 110.966 -172.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -51.14 135.1 44.86 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.008 1.138 . . . . 15.0 111.769 173.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.3 mt -63.3 -9.23 10.9 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.143 0.794 . . . . 15.0 113.143 -175.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -77.2 -8.79 58.15 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.306 0.854 . . . . 15.0 113.306 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -60.05 150.09 71.71 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 118.417 0.553 . . . . 15.0 110.463 -177.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -80.63 153.14 20.18 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.547 1.498 . . . . 15.0 113.108 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.64 151.33 6.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.924 -0.58 . . . . 15.0 111.221 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.44 -38.06 3.23 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.393 -0.683 . . . . 15.0 111.393 -177.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -61.48 -37.43 83.59 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.658 -0.417 . . . . 15.0 111.068 -177.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.5 tp -60.23 -47.3 86.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.874 0.368 . . . . 15.0 110.332 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 18.3 tp -62.34 -44.66 95.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.896 -176.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.94 -44.08 97.51 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.714 -0.395 . . . . 15.0 110.773 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -60.07 -43.31 95.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.485 -0.325 . . . . 15.0 110.496 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.7 t -61.23 -46.91 95.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.911 -0.316 . . . . 15.0 110.277 -177.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -67.99 -50.12 57.54 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.261 0.351 . . . . 15.0 111.843 -175.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.83 -44.48 77.12 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.727 0.269 . . . . 15.0 111.727 -173.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -78.73 -10.04 59.63 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.213 0.82 . . . . 15.0 113.213 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 56.43 55.83 6.21 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.6 0.714 . . . . 15.0 110.139 -177.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.5 mt -70.57 147.84 48.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.609 -0.723 . . . . 15.0 111.029 -176.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -95.69 -40.66 9.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.597 -0.729 . . . . 15.0 110.798 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -149.22 166.9 29.54 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 119.806 -1.187 . . . . 15.0 113.765 -171.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 74.8 mt -126.81 144.47 50.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.627 -0.786 . . . . 15.0 110.155 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.7 t -122.69 132.11 71.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 110.181 -0.303 . . . . 15.0 110.181 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 m -128.57 141.16 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 121.152 0.501 . . . . 15.0 110.565 173.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.6 t -99.33 -16.4 18.47 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.564 -0.744 . . . . 15.0 112.674 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 81.5 p -151.02 159.71 44.39 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.281 0.562 . . . . 15.0 111.684 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.5 -39.05 83.52 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.929 -0.868 . . . . 15.0 110.929 178.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -58.99 -44.49 91.62 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.801 -0.359 . . . . 15.0 110.636 -178.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.04 -44.62 97.09 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.559 -1.016 . . . . 15.0 110.559 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 31.8 tp -57.35 -43.08 83.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.063 0.459 . . . . 15.0 110.578 -179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.16 -42.44 98.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.116 -0.493 . . . . 15.0 110.734 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -59.34 -41.63 89.62 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.849 -0.34 . . . . 15.0 110.54 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.9 tp -58.39 -44.1 88.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.222 0.534 . . . . 15.0 110.237 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -61.61 -48.01 82.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.845 -0.616 . . . . 15.0 110.836 -178.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -61.27 -42.82 99.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.067 -0.515 . . . . 15.0 111.017 -176.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.31 -35.9 81.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.346 -0.388 . . . . 15.0 111.37 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.86 -39.36 81.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.059 0.457 . . . . 15.0 110.665 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 58.88 -142.18 0.66 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.68 -0.489 . . . . 15.0 109.68 174.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.66 -18.61 43.32 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.426 1.012 . . . . 15.0 112.62 -175.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -91.9 9.36 33.27 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.331 0.863 . . . . 15.0 113.331 -175.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -47.79 -46.94 63.02 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.63 -0.7 . . . . 15.0 112.532 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -44.72 -40.91 14.66 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 C-N-CA 121.357 1.372 . . . . 15.0 113.252 177.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -76.96 -48.78 17.11 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.996 0.427 . . . . 15.0 110.828 -178.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.8 mt -59.84 -40.36 82.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.928 -176.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.0 -13.49 34.39 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 119.877 -0.401 . . . . 15.0 113.197 -176.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 -64.98 -30.61 71.61 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.486 0.643 . . . . 15.0 111.839 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.7 mt -72.52 146.21 88.48 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 119.32 -0.372 . . . . 15.0 110.922 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -61.42 131.15 34.74 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.375 1.383 . . . . 15.0 111.909 175.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.3 tp -107.0 126.97 53.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.581 -0.281 . . . . 15.0 110.697 176.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -89.8 126.79 35.81 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.579 -0.526 . . . . 15.0 109.579 176.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.1 m -119.78 151.35 52.1 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-O 119.513 -0.28 . . . . 15.0 110.602 176.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.2 -22.83 8.1 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.549 1.499 . . . . 15.0 113.869 -176.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.5 p -147.82 162.73 30.39 Favored Pre-proline 0 CA--C 1.531 0.236 0 C-N-CA 120.388 -0.525 . . . . 15.0 111.802 -171.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.17 -44.12 49.69 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.26 1.307 . . . . 15.0 111.792 176.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -57.05 -48.12 79.3 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.849 0.357 . . . . 15.0 110.765 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.6 t -60.22 -39.1 79.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.799 -0.36 . . . . 15.0 110.094 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.92 -41.49 78.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.982 0.42 . . . . 15.0 110.459 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -61.08 -41.0 95.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 15.0 110.429 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.0 mmm -58.13 -45.43 87.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.589 0.709 . . . . 15.0 110.195 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.76 96.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.608 -0.724 . . . . 15.0 110.935 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -61.85 -44.38 96.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.363 -0.38 . . . . 15.0 110.836 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.3 -36.06 77.01 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.851 -0.34 . . . . 15.0 111.339 -177.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.8 mt -66.13 -23.93 66.58 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.289 0.477 . . . . 15.0 112.289 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.24 13.31 17.82 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 119.406 -0.663 . . . . 15.0 113.171 -176.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.01 122.38 12.89 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.551 1.175 . . . . 15.0 109.852 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -67.94 -36.52 80.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.597 -0.729 . . . . 15.0 111.123 -171.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 58.7 ttt85 -131.82 117.54 18.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.956 0.408 . . . . 15.0 110.567 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.55 130.13 69.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.925 0.393 . . . . 15.0 110.038 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 90.6 mt -119.68 124.16 72.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.902 -0.59 . . . . 15.0 110.299 -177.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -92.88 114.85 27.52 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.907 -0.405 . . . . 15.0 109.907 174.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.8 p -81.44 -13.95 57.64 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.95 0.722 . . . . 15.0 112.95 -178.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -54.74 -38.74 67.52 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 122.082 -0.386 . . . . 15.0 111.001 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.53 -35.01 8.13 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.644 -0.583 . . . . 15.0 111.644 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.98 122.38 34.44 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.83 0.348 . . . . 15.0 110.81 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 48.8 m -65.42 161.98 18.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.634 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.63 -54.2 24.71 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 118.49 -0.767 . . . . 15.0 113.033 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.38 -35.99 96.8 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 CA-C-N 120.564 1.237 . . . . 15.0 111.384 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.32 -42.11 94.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.027 0.441 . . . . 15.0 110.125 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.8 mt -59.0 -40.42 84.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.062 0.458 . . . . 15.0 110.57 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 39.8 tp -57.21 -44.52 83.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.408 0.623 . . . . 15.0 110.053 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.21 -39.57 87.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.587 -0.733 . . . . 15.0 110.538 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.48 -41.48 94.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.443 -0.344 . . . . 15.0 110.917 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.0 mt -57.9 -51.16 70.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.161 0.505 . . . . 15.0 110.443 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.6 p -63.61 -40.24 96.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.67 -0.695 . . . . 15.0 111.323 -175.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.9 p -66.34 -38.6 88.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.724 0.297 . . . . 15.0 111.336 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.3 96.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.495 -0.321 . . . . 15.0 110.82 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.478 -0.328 . . . . 15.0 110.616 177.892 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 . . . . . 0 CA--C 1.535 0.379 0 N-CA-C 110.126 -0.324 . . . . 15.0 110.126 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.1 150.27 10.62 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.504 1.469 . . . . 15.0 112.179 -174.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -117.0 140.71 49.16 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.22 -0.446 . . . . 15.0 110.858 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.7 m -134.28 144.62 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.567 0.698 . . . . 15.0 111.67 175.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.6 tp -104.27 137.51 42.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.078 -0.965 . . . . 15.0 110.326 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.5 mt -102.47 134.12 44.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.005 0.431 . . . . 15.0 111.025 -177.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 98.4 mmm -95.01 134.15 38.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.221 -0.9 . . . . 15.0 109.307 171.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -57.65 144.63 37.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.948 0.404 . . . . 15.0 110.678 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -161.68 175.15 38.25 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.801 -0.92 . . . . 15.0 110.801 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.94 -34.72 60.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.536 0.208 . . . . 15.0 111.486 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.81 162.94 29.83 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.9 -0.88 . . . . 15.0 110.9 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.93 130.92 10.1 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.232 -0.747 . . . . 15.0 111.232 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -57.13 -43.82 82.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.985 0.421 . . . . 15.0 110.359 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.23 -43.01 99.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.046 -0.525 . . . . 15.0 111.333 -176.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -61.52 -56.09 23.87 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.858 -0.337 . . . . 15.0 111.341 -176.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.4 mt -60.66 -43.45 97.6 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.708 -0.397 . . . . 15.0 111.031 -176.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.78 -39.4 94.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.389 -0.369 . . . . 15.0 110.92 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -60.76 -43.01 98.53 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.905 -0.318 . . . . 15.0 110.482 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -61.19 -51.57 68.43 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.421 -0.511 . . . . 15.0 110.943 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 69.2 mt -62.61 -36.97 84.48 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.515 -0.474 . . . . 15.0 110.999 -178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -63.05 -43.31 99.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.618 0.247 . . . . 15.0 111.045 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.96 -30.59 66.79 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.035 -0.602 . . . . 15.0 111.932 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -88.09 9.87 21.12 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.494 0.924 . . . . 15.0 113.494 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.27 14.69 58.48 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 121.258 -0.496 . . . . 15.0 113.501 174.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.0 t -101.1 139.07 23.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 117.857 0.828 . . . . 15.0 110.22 178.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -84.45 134.08 34.47 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.04 -0.726 . . . . 15.0 109.04 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.4 t -119.59 133.96 64.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.229 0.537 . . . . 15.0 111.353 -173.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -137.84 136.3 37.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.469 -0.787 . . . . 15.0 109.591 172.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -115.37 140.93 48.69 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.793 0.33 . . . . 15.0 110.827 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.1 tp -119.3 113.43 35.28 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-O 118.741 -0.647 . . . . 15.0 110.715 -175.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.17 135.08 63.36 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 121.168 1.246 . . . . 15.0 111.964 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 50.3 mt -62.53 -9.14 7.72 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.358 0.873 . . . . 15.0 113.358 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -77.09 -9.5 58.78 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.18 0.807 . . . . 15.0 113.18 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -60.78 149.18 80.85 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 118.292 0.496 . . . . 15.0 110.251 -178.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.97 154.18 25.7 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.53 1.487 . . . . 15.0 112.968 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.23 150.77 5.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.955 -0.566 . . . . 15.0 111.163 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.95 -37.65 3.39 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.439 -0.664 . . . . 15.0 111.439 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.89 -36.9 80.41 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.594 -0.442 . . . . 15.0 111.103 -177.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.2 tp -58.97 -45.99 89.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.379 . . . . 15.0 110.201 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.2 tp -62.65 -45.35 93.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.209 -0.45 . . . . 15.0 110.803 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.74 -43.59 98.56 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.731 -0.388 . . . . 15.0 110.852 -176.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -60.52 -43.9 96.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.558 -0.292 . . . . 15.0 110.522 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.3 t -61.18 -46.38 96.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.774 -0.37 . . . . 15.0 110.214 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -68.41 -51.04 48.25 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.348 0.405 . . . . 15.0 112.025 -175.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.83 -44.37 81.26 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.736 0.273 . . . . 15.0 111.736 -173.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -79.37 -10.17 59.75 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.06 0.763 . . . . 15.0 113.06 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.7 mtp180 55.39 55.81 7.0 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.658 0.742 . . . . 15.0 110.273 -177.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.72 146.22 50.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.643 -0.708 . . . . 15.0 111.296 -174.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -93.45 -40.6 10.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.408 -0.814 . . . . 15.0 110.876 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.86 165.11 29.23 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 119.943 -1.122 . . . . 15.0 113.785 -173.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 74.2 mt -125.62 142.16 51.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.466 -0.867 . . . . 15.0 109.837 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.6 t -120.49 129.55 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 110.261 -0.274 . . . . 15.0 110.261 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.5 m -128.27 133.39 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.873 0.368 . . . . 15.0 110.095 172.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.5 p -99.38 -4.22 32.09 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.998 0.74 . . . . 15.0 112.998 177.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 82.7 p -152.46 154.92 36.49 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.366 0.603 . . . . 15.0 111.793 -176.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.03 -38.92 88.43 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.986 -0.846 . . . . 15.0 110.986 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -57.41 -46.14 83.83 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 122.63 -0.336 . . . . 15.0 110.638 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.32 -44.37 96.6 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.7 -0.96 . . . . 15.0 110.7 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 36.5 tp -57.19 -45.27 83.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.123 0.487 . . . . 15.0 110.597 -178.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.35 -42.13 98.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.029 -0.532 . . . . 15.0 110.818 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -60.06 -40.48 89.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.523 -0.308 . . . . 15.0 110.669 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.1 tp -58.42 -44.35 89.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.142 0.496 . . . . 15.0 110.149 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -60.96 -47.35 86.86 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.801 -0.636 . . . . 15.0 110.719 -178.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.43 -43.02 99.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.089 -0.505 . . . . 15.0 111.116 -176.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.3 mt -66.26 -35.44 80.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.354 -0.385 . . . . 15.0 111.375 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.03 -39.0 80.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.095 0.474 . . . . 15.0 110.672 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.02 -142.89 0.62 Allowed 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.691 -0.485 . . . . 15.0 109.691 174.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.56 -19.77 50.94 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.38 0.991 . . . . 15.0 112.697 -174.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -91.9 11.04 26.29 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.307 0.854 . . . . 15.0 113.307 -175.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 55.0 t-105 -47.83 -46.67 63.01 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-O 118.555 -0.736 . . . . 15.0 112.521 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -44.56 -41.09 14.22 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.498 1.465 . . . . 15.0 113.198 177.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -76.93 -48.83 17.05 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.944 0.402 . . . . 15.0 110.849 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.3 mt -59.92 -39.82 81.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 15.0 110.871 -176.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.21 -14.6 33.68 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 119.898 -0.39 . . . . 15.0 113.092 -176.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -64.15 -30.36 71.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.404 0.602 . . . . 15.0 111.963 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.0 mt -75.36 150.57 85.07 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 120.939 -0.305 . . . . 15.0 111.53 -173.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -61.98 128.35 23.94 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.675 1.584 . . . . 15.0 112.457 176.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.1 tp -107.64 126.31 52.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.313 -0.403 . . . . 15.0 110.474 174.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -90.52 125.65 35.67 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.599 -0.519 . . . . 15.0 109.599 176.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.1 m -116.99 147.78 40.83 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 110.154 -0.313 . . . . 15.0 110.154 176.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.24 -24.76 6.36 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.634 1.556 . . . . 15.0 113.538 -174.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.8 p -142.78 162.3 44.7 Favored Pre-proline 0 CA--C 1.531 0.213 0 C-N-CA 120.611 -0.436 . . . . 15.0 111.658 -171.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.0 -44.04 50.96 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.21 1.273 . . . . 15.0 111.841 176.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -58.25 -47.06 84.75 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.915 -0.314 . . . . 15.0 110.737 -177.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.6 t -60.2 -41.02 85.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 110.003 -0.369 . . . . 15.0 110.003 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.74 -42.35 83.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.925 0.393 . . . . 15.0 110.509 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -61.43 -41.8 97.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 15.0 110.563 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 87.1 mtp -59.17 -43.88 92.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.211 0.529 . . . . 15.0 110.268 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.52 94.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.889 -0.596 . . . . 15.0 110.792 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -61.24 -44.39 97.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.274 -0.421 . . . . 15.0 110.566 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.05 -36.15 76.69 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.868 -0.333 . . . . 15.0 111.244 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.1 mt -64.24 -25.94 68.28 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.019 0.378 . . . . 15.0 112.019 176.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.27 13.32 15.49 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 119.313 -0.715 . . . . 15.0 113.045 -176.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.97 122.4 12.91 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.521 1.16 . . . . 15.0 109.91 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -69.9 -35.95 75.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.705 -0.68 . . . . 15.0 111.223 -172.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -131.07 112.63 13.06 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.042 0.449 . . . . 15.0 110.398 178.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.0 t -111.0 130.23 64.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.183 -0.462 . . . . 15.0 109.901 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 84.6 mt -119.3 125.23 74.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.832 -0.622 . . . . 15.0 110.081 -177.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -95.33 118.12 31.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.401 -0.363 . . . . 15.0 110.261 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 32.0 p -95.76 -4.16 44.51 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.184 0.809 . . . . 15.0 113.184 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.1 tpt85 -55.6 -39.54 70.89 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.086 0.403 . . . . 15.0 110.712 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -95.79 -35.14 5.71 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.532 -0.627 . . . . 15.0 111.532 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.64 137.27 40.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.823 0.344 . . . . 15.0 110.68 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.2 p -83.87 164.49 19.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 15.0 110.665 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.72 -54.3 24.33 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 113.018 0.748 . . . . 15.0 113.018 179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.49 -36.0 97.19 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 CA-C-N 120.469 1.203 . . . . 15.0 111.394 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.47 -42.89 97.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.114 0.483 . . . . 15.0 110.103 178.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.3 mt -59.0 -41.2 87.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 15.0 110.414 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 34.3 tp -57.61 -44.55 85.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.37 0.605 . . . . 15.0 110.183 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.78 94.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.673 -0.694 . . . . 15.0 110.514 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.7 -41.08 94.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.416 -0.356 . . . . 15.0 110.811 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.4 mt -57.69 -51.76 68.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.233 0.539 . . . . 15.0 110.459 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.0 p -64.04 -40.57 96.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.647 -0.706 . . . . 15.0 111.33 -175.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.9 m -63.42 -42.86 98.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.732 0.301 . . . . 15.0 111.46 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.64 -39.27 93.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.446 -0.343 . . . . 15.0 111.049 -178.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.555 -0.293 . . . . 15.0 111.14 179.519 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 . . . . . 0 CA--C 1.535 0.394 0 N-CA-C 110.179 -0.304 . . . . 15.0 110.179 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -56.42 152.87 37.39 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.393 1.395 . . . . 15.0 112.0 -175.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -110.78 139.0 46.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.383 -0.371 . . . . 15.0 110.687 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.2 m -135.72 142.74 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.596 0.713 . . . . 15.0 111.695 176.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.3 tp -104.77 135.35 46.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.863 -1.062 . . . . 15.0 110.129 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 57.5 mt -104.75 133.74 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.19 0.519 . . . . 15.0 110.888 -176.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 98.4 mmm -95.2 134.06 38.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.062 -0.972 . . . . 15.0 109.488 173.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -62.09 143.99 55.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.886 0.374 . . . . 15.0 110.677 -178.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.57 175.07 32.83 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.108 -0.797 . . . . 15.0 111.108 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.59 -33.31 66.08 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.576 0.214 . . . . 15.0 111.576 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.4 -178.28 4.6 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.963 -0.855 . . . . 15.0 110.963 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.04 112.6 3.67 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.05 -0.82 . . . . 15.0 111.05 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -56.83 -45.85 82.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.308 0.575 . . . . 15.0 110.146 -177.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.77 -44.31 93.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.694 -0.684 . . . . 15.0 111.122 -177.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -56.61 -53.83 53.06 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.805 -0.358 . . . . 15.0 111.281 -175.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.9 mp -59.88 -43.21 94.87 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 120.649 -0.42 . . . . 15.0 110.883 -177.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.89 -42.52 98.14 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.752 -0.379 . . . . 15.0 111.48 -177.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.21 -39.16 89.2 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.776 -0.37 . . . . 15.0 110.846 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -60.23 -51.49 69.34 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.273 -0.571 . . . . 15.0 111.133 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 80.3 mt -62.89 -38.68 91.87 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.499 -0.48 . . . . 15.0 111.008 -177.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -64.0 -43.64 95.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.574 0.226 . . . . 15.0 110.955 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.24 -30.56 67.7 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.032 -0.604 . . . . 15.0 112.026 -178.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -88.14 9.76 21.63 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.52 0.933 . . . . 15.0 113.52 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.68 16.45 52.05 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 121.12 -0.562 . . . . 15.0 113.444 173.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.06 138.84 23.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 117.784 0.792 . . . . 15.0 110.058 177.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -78.29 125.41 29.32 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.059 -0.719 . . . . 15.0 109.059 177.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.3 t -117.63 131.65 69.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.132 0.492 . . . . 15.0 111.03 -172.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -137.61 131.79 32.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.611 -0.722 . . . . 15.0 109.77 171.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -114.62 134.55 54.97 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.217 -0.29 . . . . 15.0 110.217 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.2 tp -111.34 140.26 22.79 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 119.162 -0.446 . . . . 15.0 110.373 -174.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -72.11 135.13 24.49 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.219 1.279 . . . . 15.0 111.11 170.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.0 mt -63.21 -9.25 10.5 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.122 0.786 . . . . 15.0 113.122 -175.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -77.27 -10.25 59.31 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.263 0.838 . . . . 15.0 113.263 -177.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -62.46 151.07 83.98 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 118.552 0.614 . . . . 15.0 110.855 -177.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -79.11 155.49 25.89 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.479 1.453 . . . . 15.0 113.1 -177.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.24 150.73 8.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.875 -0.602 . . . . 15.0 111.072 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.98 -36.28 4.21 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.514 -0.634 . . . . 15.0 111.514 -177.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -59.54 -40.05 85.94 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 120.498 -0.481 . . . . 15.0 110.697 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.7 tp -61.13 -47.97 83.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.963 0.411 . . . . 15.0 110.458 -177.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 19.0 tp -61.25 -43.44 98.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 15.0 110.888 -175.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.12 -46.01 90.92 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.782 -0.367 . . . . 15.0 110.84 -175.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 46.9 ttt85 -61.1 -41.87 97.47 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.635 -0.426 . . . . 15.0 110.567 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 94.4 t -58.78 -45.59 91.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.753 -0.379 . . . . 15.0 110.022 -177.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -70.59 -50.94 31.93 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.503 0.502 . . . . 15.0 112.275 -176.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.75 -44.4 86.03 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.067 0.395 . . . . 15.0 112.067 -172.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.6 mp0 -89.11 -7.03 56.56 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.391 0.886 . . . . 15.0 113.391 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.8 ttt-85 57.97 56.05 4.92 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.662 0.744 . . . . 15.0 109.829 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.9 mt -60.61 142.69 55.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.595 -0.73 . . . . 15.0 110.891 -175.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -90.56 -40.56 11.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.481 -0.781 . . . . 15.0 110.822 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -149.57 163.57 29.31 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.079 -1.058 . . . . 15.0 113.498 -174.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.4 mt -126.27 141.06 52.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.433 -0.883 . . . . 15.0 109.903 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.4 t -120.83 131.31 73.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 110.294 -0.262 . . . . 15.0 110.294 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.6 m -124.14 130.55 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.134 0.493 . . . . 15.0 110.374 172.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.6 m -87.17 -19.45 28.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.586 -0.734 . . . . 15.0 112.514 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.8 p -151.86 161.04 43.29 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.336 0.588 . . . . 15.0 111.509 -175.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.35 -39.17 82.24 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.992 -0.843 . . . . 15.0 110.992 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -57.93 -45.9 85.85 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.864 -0.334 . . . . 15.0 110.563 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.63 -43.96 97.27 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.734 -0.947 . . . . 15.0 110.734 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.2 tp -57.48 -43.99 84.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.023 0.439 . . . . 15.0 110.559 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.03 -42.17 97.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.077 -0.51 . . . . 15.0 110.641 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -59.51 -40.72 87.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.444 -0.344 . . . . 15.0 110.635 178.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.9 tp -58.61 -44.54 89.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.135 0.493 . . . . 15.0 110.114 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -61.29 -47.26 86.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.852 -0.613 . . . . 15.0 110.703 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -61.36 -42.93 99.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.086 -0.506 . . . . 15.0 111.102 -176.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.7 mt -66.94 -34.95 78.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.34 -0.391 . . . . 15.0 111.478 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.04 -39.49 82.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.076 0.465 . . . . 15.0 110.601 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 58.95 -142.79 0.63 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 109.662 -0.496 . . . . 15.0 109.662 174.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.53 -18.87 44.06 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.417 1.008 . . . . 15.0 112.631 -174.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -91.82 9.65 31.86 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.313 0.857 . . . . 15.0 113.313 -175.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -47.97 -46.62 64.38 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-O 118.559 -0.734 . . . . 15.0 112.521 177.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -44.7 -41.2 14.69 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.481 1.454 . . . . 15.0 113.218 177.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.5 mp0 -77.03 -48.76 17.01 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.688 -0.405 . . . . 15.0 110.755 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 89.8 mt -59.8 -40.2 81.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.279 -0.419 . . . . 15.0 110.858 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.73 -15.14 32.71 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 119.903 -0.387 . . . . 15.0 113.107 -177.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -64.25 -30.61 71.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.417 0.608 . . . . 15.0 111.977 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.5 mt -76.24 150.46 82.9 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 121.065 -0.254 . . . . 15.0 111.397 -173.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.92 128.13 25.68 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 121.695 1.597 . . . . 15.0 112.43 176.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.3 tp -106.68 125.58 51.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 15.0 110.425 174.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -91.56 125.63 36.36 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.607 -0.516 . . . . 15.0 109.607 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.2 m -116.85 148.06 41.3 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 110.114 -0.328 . . . . 15.0 110.114 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -79.12 -24.27 6.92 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.486 1.457 . . . . 15.0 113.592 -175.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.6 p -143.43 162.06 44.15 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 120.564 -0.454 . . . . 15.0 111.644 -172.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.85 -44.04 51.33 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.241 1.294 . . . . 15.0 111.741 176.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -57.62 -47.87 81.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.8 0.333 . . . . 15.0 110.827 -178.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 52.4 t -59.74 -40.64 83.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.767 -0.373 . . . . 15.0 110.03 178.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.46 -42.3 82.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.921 0.391 . . . . 15.0 110.488 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.24 -41.87 97.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.147 -0.479 . . . . 15.0 110.465 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 87.0 mtp -59.34 -43.68 92.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.349 0.595 . . . . 15.0 110.384 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.48 -40.07 93.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.916 -0.584 . . . . 15.0 110.77 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -61.23 -44.28 97.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.335 -0.393 . . . . 15.0 110.61 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.95 -36.17 76.51 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.936 -0.306 . . . . 15.0 111.224 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.0 mt -64.09 -25.73 68.23 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.086 0.402 . . . . 15.0 112.086 176.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.57 13.31 17.06 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 119.336 -0.702 . . . . 15.0 113.098 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.02 122.87 14.07 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.534 1.167 . . . . 15.0 109.92 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -69.91 -35.7 74.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.734 -0.666 . . . . 15.0 111.223 -172.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -130.71 113.31 13.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.938 0.399 . . . . 15.0 110.302 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.09 129.52 66.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.236 -0.438 . . . . 15.0 109.9 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.2 mt -120.11 125.72 74.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.81 -0.632 . . . . 15.0 110.163 -176.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -94.39 117.33 29.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.458 -0.337 . . . . 15.0 110.345 175.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 32.0 p -97.0 -1.53 45.33 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.299 0.852 . . . . 15.0 113.299 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -55.53 -39.57 70.72 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 118.182 0.446 . . . . 15.0 110.785 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -95.21 -35.02 5.88 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.53 -0.628 . . . . 15.0 111.53 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.51 138.89 47.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.802 0.334 . . . . 15.0 110.644 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.5 p -85.77 164.9 17.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.094 -0.503 . . . . 15.0 110.529 179.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.68 -54.33 23.94 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 113.0 0.741 . . . . 15.0 113.0 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.69 -34.59 99.02 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 CA-C-N 120.099 1.071 . . . . 15.0 111.718 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.27 -43.31 96.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.104 0.478 . . . . 15.0 109.989 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 78.1 mt -59.31 -40.79 87.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 15.0 110.33 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 40.5 tp -57.13 -44.15 83.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.324 0.583 . . . . 15.0 110.229 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.83 -41.61 96.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.734 -0.667 . . . . 15.0 110.451 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.27 88.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 15.0 110.736 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.3 mt -57.81 -51.88 67.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.201 0.524 . . . . 15.0 110.395 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.7 p -63.69 -40.27 96.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.614 -0.721 . . . . 15.0 111.389 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.4 m -63.34 -43.24 98.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.66 0.267 . . . . 15.0 111.386 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.41 -39.36 93.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.42 -0.355 . . . . 15.0 111.091 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.423 -0.353 . . . . 15.0 110.939 179.12 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.535 0.385 0 N-CA-C 110.125 -0.324 . . . . 15.0 110.125 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.06 155.02 25.23 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.441 1.428 . . . . 15.0 111.921 -175.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -111.95 138.14 48.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.379 -0.373 . . . . 15.0 110.79 179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.0 m -134.56 144.46 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.435 0.636 . . . . 15.0 111.638 176.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.1 tp -105.05 137.28 43.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.203 -0.908 . . . . 15.0 110.553 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.8 mt -103.16 133.41 47.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.01 0.433 . . . . 15.0 110.679 -177.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 85.5 mtp -106.05 134.43 49.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.31 -0.859 . . . . 15.0 110.197 174.404 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -57.43 144.98 34.4 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.108 0.48 . . . . 15.0 110.772 -177.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.35 175.16 36.29 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.763 -0.935 . . . . 15.0 110.763 -178.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.01 -32.68 47.97 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.681 0.252 . . . . 15.0 111.681 -179.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.95 -179.5 39.9 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.042 -0.823 . . . . 15.0 111.042 -178.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.01 113.98 3.88 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.156 -0.778 . . . . 15.0 111.156 -178.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -56.62 -47.66 79.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.119 0.485 . . . . 15.0 110.498 -179.453 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.38 -40.52 97.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 15.0 110.904 -178.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -57.46 -54.41 47.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.113 0.482 . . . . 15.0 110.764 -176.174 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.8 tp -57.88 -43.09 85.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 15.0 110.598 -179.004 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.37 -45.5 84.35 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.695 -0.402 . . . . 15.0 111.101 -178.02 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -59.81 -40.58 88.9 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.772 -0.371 . . . . 15.0 110.658 -176.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.1 mmt85 -59.76 -51.43 69.77 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.299 -0.56 . . . . 15.0 111.358 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.61 -35.7 80.41 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.541 -0.464 . . . . 15.0 111.108 -176.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -64.19 -43.35 95.35 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.918 -0.313 . . . . 15.0 111.127 177.076 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.78 -30.63 66.3 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.008 -0.615 . . . . 15.0 112.066 -178.273 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -88.2 8.71 25.81 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.66 0.985 . . . . 15.0 113.66 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.73 17.62 56.24 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 121.233 -0.508 . . . . 15.0 113.245 175.391 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.0 t -101.12 140.25 20.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 117.745 0.772 . . . . 15.0 109.861 177.475 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -80.57 127.73 32.79 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.118 -0.697 . . . . 15.0 109.118 178.245 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.1 t -116.89 131.39 69.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.208 0.528 . . . . 15.0 111.025 -172.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -134.89 135.33 41.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.367 -0.833 . . . . 15.0 109.293 172.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -120.65 133.53 55.36 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.773 0.32 . . . . 15.0 110.7 -176.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.7 tp -117.01 141.5 28.47 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 116.14 -0.482 . . . . 15.0 110.004 -174.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -72.07 135.07 24.46 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.418 1.412 . . . . 15.0 111.699 170.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.7 mt -61.7 -10.0 7.61 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.943 0.72 . . . . 15.0 112.943 179.305 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -77.21 -10.87 59.68 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.191 0.811 . . . . 15.0 113.191 -177.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -62.7 148.96 90.29 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 118.512 0.596 . . . . 15.0 110.824 -177.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.1 159.03 37.68 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.574 1.516 . . . . 15.0 113.225 -174.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.04 152.43 5.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.729 -0.669 . . . . 15.0 111.061 -178.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.28 -35.69 4.24 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.487 -0.645 . . . . 15.0 111.487 -176.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -59.47 -39.01 82.29 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 117.094 0.447 . . . . 15.0 110.835 -177.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.3 tp -59.3 -48.55 81.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.068 0.461 . . . . 15.0 110.274 -177.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.1 tp -62.47 -43.01 99.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.091 -0.504 . . . . 15.0 111.091 -175.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.62 -45.97 90.39 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.787 -0.365 . . . . 15.0 110.948 -175.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -61.07 -40.98 95.74 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.71 -0.396 . . . . 15.0 110.55 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 84.8 t -59.54 -48.15 88.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 110.013 -0.365 . . . . 15.0 110.013 -177.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -68.59 -51.04 46.91 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.681 0.613 . . . . 15.0 112.098 -174.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.56 -44.26 82.77 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.789 0.292 . . . . 15.0 111.789 -173.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -82.92 -10.08 58.99 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.14 0.793 . . . . 15.0 113.14 -178.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 55.63 55.77 6.87 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.621 0.724 . . . . 15.0 110.112 -177.041 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.3 mt -66.01 144.89 56.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.611 -0.722 . . . . 15.0 111.493 -173.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -93.92 -39.58 10.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.226 -0.897 . . . . 15.0 110.971 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.02 165.75 31.27 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 120.04 -1.076 . . . . 15.0 113.663 -175.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.3 mt -128.77 142.7 50.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.578 -0.811 . . . . 15.0 109.445 178.604 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.8 t -120.93 130.53 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 120.757 0.313 . . . . 15.0 110.541 -179.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.9 m -130.4 155.64 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.2 -0.455 . . . . 15.0 110.17 172.129 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.8 t -131.18 12.09 5.07 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.716 0.636 . . . . 15.0 112.716 177.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 81.9 p -154.14 151.52 29.34 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.184 0.516 . . . . 15.0 111.577 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.48 -40.08 91.7 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.599 -1.0 . . . . 15.0 110.599 176.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -58.93 -42.03 88.74 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.897 -0.321 . . . . 15.0 110.6 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.48 -46.23 94.75 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.627 -0.989 . . . . 15.0 110.627 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.9 tp -57.54 -43.32 84.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.985 0.421 . . . . 15.0 110.474 -179.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.31 -42.25 98.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.474 . . . . 15.0 110.81 -179.501 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -59.05 -42.38 90.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.955 0.407 . . . . 15.0 110.412 178.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.2 tp -58.47 -44.16 89.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.125 0.488 . . . . 15.0 110.296 -179.032 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -61.75 -48.32 81.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.942 -0.572 . . . . 15.0 110.762 -177.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.41 -42.65 99.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.043 -0.526 . . . . 15.0 111.095 -176.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 92.1 mt -67.42 -35.3 78.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.37 -0.377 . . . . 15.0 111.489 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.9 -38.1 78.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.06 0.457 . . . . 15.0 110.665 177.142 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.43 -143.25 0.58 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 109.501 -0.555 . . . . 15.0 109.501 173.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.53 -19.5 48.75 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.377 0.989 . . . . 15.0 112.63 -174.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -91.91 11.03 26.35 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 113.362 0.875 . . . . 15.0 113.362 -175.179 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 60.4 t-105 -47.9 -46.07 62.83 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-O 118.501 -0.762 . . . . 15.0 112.548 177.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -44.67 -42.71 14.73 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 121.416 1.411 . . . . 15.0 113.271 177.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -76.96 -48.73 17.24 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.032 0.444 . . . . 15.0 110.626 -177.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 87.4 mt -59.73 -35.6 60.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.014 -0.539 . . . . 15.0 111.061 -177.162 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.0 -20.64 34.95 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 119.969 -0.35 . . . . 15.0 112.946 -176.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -64.08 -30.16 71.25 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.34 0.57 . . . . 15.0 112.347 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.8 mt -62.21 150.49 84.2 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 119.545 -0.264 . . . . 15.0 110.891 -174.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.34 123.12 8.49 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 121.419 1.413 . . . . 15.0 111.669 175.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.4 tp -102.46 123.7 46.7 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.906 -0.318 . . . . 15.0 110.581 176.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -87.84 125.2 34.33 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.382 -0.599 . . . . 15.0 109.382 175.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.96 147.82 42.1 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 119.429 -0.319 . . . . 15.0 110.186 176.09 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -79.13 -24.43 6.77 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.532 1.488 . . . . 15.0 113.52 -175.11 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.9 p -143.09 161.25 49.23 Favored Pre-proline 0 CA--C 1.531 0.235 0 C-N-CA 120.627 -0.429 . . . . 15.0 111.41 -172.296 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -54.98 -44.05 53.52 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.115 1.21 . . . . 15.0 111.78 176.135 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -57.5 -48.46 79.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.847 0.356 . . . . 15.0 110.613 -177.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 55.7 t -59.74 -39.96 81.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.942 0.401 . . . . 15.0 110.043 178.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.22 -41.67 79.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 15.0 110.337 178.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -60.51 -40.55 91.83 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.303 -0.408 . . . . 15.0 110.415 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 96.9 mmm -57.84 -44.53 86.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.562 0.696 . . . . 15.0 110.195 179.052 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.68 -40.69 95.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.566 -0.743 . . . . 15.0 110.77 -179.417 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -62.54 -42.93 99.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.348 -0.387 . . . . 15.0 111.097 -179.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.0 -36.01 78.36 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.869 -0.332 . . . . 15.0 111.5 -176.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.1 mt -66.32 -22.9 66.29 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.272 0.471 . . . . 15.0 112.272 176.539 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.21 13.33 19.7 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 119.378 -0.679 . . . . 15.0 113.051 -176.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.89 122.02 11.94 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.504 1.152 . . . . 15.0 109.872 -178.142 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -74.35 -31.71 62.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.509 -0.769 . . . . 15.0 111.642 -171.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -129.38 111.59 12.97 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.996 0.427 . . . . 15.0 110.154 175.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 43.8 t -114.66 131.25 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 15.0 109.861 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 85.1 mt -120.69 124.57 72.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.242 -0.435 . . . . 15.0 110.304 -176.008 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -94.3 118.48 31.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.395 -0.366 . . . . 15.0 110.302 176.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.4 p -96.26 -3.97 43.12 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.216 0.821 . . . . 15.0 113.216 -178.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -55.72 -39.55 71.24 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 118.246 0.475 . . . . 15.0 110.776 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -91.53 -35.03 7.09 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.569 -0.612 . . . . 15.0 111.569 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -82.32 132.29 35.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.841 0.353 . . . . 15.0 110.76 -179.135 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.6 p -77.91 167.04 22.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.096 -0.502 . . . . 15.0 110.572 179.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.64 -54.4 23.24 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 112.974 0.731 . . . . 15.0 112.974 179.045 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.09 -34.84 98.91 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 CA-C-N 120.213 1.112 . . . . 15.0 111.68 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.93 -43.0 95.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.07 0.462 . . . . 15.0 109.988 177.337 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.8 mt -59.4 -40.11 85.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 15.0 110.522 178.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 43.7 tp -56.9 -44.37 82.26 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.39 0.614 . . . . 15.0 110.169 178.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.9 -41.11 95.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.589 -0.732 . . . . 15.0 110.491 179.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.33 -41.21 93.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.335 -0.393 . . . . 15.0 110.743 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.1 mt -57.88 -50.87 71.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.122 0.487 . . . . 15.0 110.373 -179.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.3 p -64.55 -40.98 96.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.657 -0.701 . . . . 15.0 111.374 -175.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.0 m -61.94 -42.46 99.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.703 0.287 . . . . 15.0 111.297 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.82 -43.51 98.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.473 -0.33 . . . . 15.0 111.033 -178.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.732 0.301 . . . . 15.0 110.835 179.646 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.5 mtm . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.373 -0.603 . . . . 4.44 109.373 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -125.93 74.58 71.29 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.138 -0.483 . . . . 2.16 110.315 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.45 155.08 54.7 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.525 1.483 . . . . 0.5 112.026 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -105.4 136.85 44.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.403 -0.362 . . . . 1.86 110.559 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.7 m -134.34 145.18 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.57 0.7 . . . . 1.06 111.753 176.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.1 tp -106.03 135.28 47.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.874 -1.057 . . . . 1.03 110.193 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.7 mt -103.44 134.68 43.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.242 -0.436 . . . . 1.11 110.275 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 87.0 mtp -96.75 134.02 40.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.148 -0.478 . . . . 1.1 110.438 173.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -59.21 144.3 46.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.297 -0.411 . . . . 3.26 110.705 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.08 175.11 36.07 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.963 -0.855 . . . . 0.56 110.963 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.69 -33.26 54.81 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.579 0.215 . . . . 2.15 111.579 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.78 175.84 33.67 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.915 -0.874 . . . . 0.64 110.915 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.87 117.92 4.9 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.437 -0.665 . . . . 0.61 111.437 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -57.15 -41.72 79.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.84 0.352 . . . . 3.52 110.533 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -61.16 -41.65 97.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 1.91 111.034 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -62.14 -56.09 22.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.856 0.36 . . . . 4.03 111.225 -176.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.25 -42.74 95.95 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.698 -0.401 . . . . 2.32 110.85 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.41 -40.26 95.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.325 -0.398 . . . . 1.06 110.936 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.08 -42.31 94.33 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.918 -0.313 . . . . 1.91 110.502 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -59.88 -51.65 68.81 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 120.568 -0.453 . . . . 3.79 111.256 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.9 mt -62.65 -37.65 87.18 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.538 -0.465 . . . . 1.07 111.025 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -62.83 -43.08 99.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.646 0.26 . . . . 4.13 110.894 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.33 -30.69 68.24 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 121.063 -0.589 . . . . 0.3 111.924 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -88.12 10.44 19.27 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.513 0.931 . . . . 0.42 113.513 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.04 20.23 47.28 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 121.25 -0.5 . . . . 0.28 113.127 174.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -101.04 139.86 21.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 117.552 0.676 . . . . 1.05 110.191 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -81.9 129.15 34.67 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.108 -0.701 . . . . 0.36 109.108 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -119.02 132.2 69.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.289 0.566 . . . . 1.07 111.512 -173.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -137.58 133.58 34.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.13 -0.941 . . . . 1.12 109.271 170.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -115.54 138.26 51.23 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.861 0.362 . . . . 1.06 110.968 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.1 tp -119.13 132.03 24.12 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-O 118.632 -0.699 . . . . 1.09 109.608 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.05 138.77 31.55 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.202 1.268 . . . . 0.71 111.903 174.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 77.4 mt -60.1 -9.22 2.97 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.397 0.888 . . . . 1.35 113.397 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -77.07 -7.41 55.67 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.262 0.838 . . . . 1.2 113.262 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -63.31 148.71 92.87 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 118.555 0.616 . . . . 1.07 110.357 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -80.3 158.04 22.88 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.556 1.504 . . . . 0.34 113.191 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.12 151.5 4.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.866 -0.606 . . . . 1.04 111.277 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.31 -38.0 3.25 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.599 -0.6 . . . . 0.19 111.599 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -62.22 -37.27 84.72 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 120.595 -0.442 . . . . 1.77 111.09 -177.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.0 tp -58.84 -48.13 82.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.978 0.418 . . . . 1.09 110.211 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 19.8 tp -64.36 -45.19 88.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 1.16 111.141 -175.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.83 -44.25 97.21 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.623 -0.431 . . . . 1.05 110.774 -176.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 56.2 ttm-85 -61.13 -42.7 99.02 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.945 -0.302 . . . . 2.87 110.706 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 94.4 t -61.23 -45.3 98.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.814 -0.354 . . . . 1.08 110.198 -177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -67.94 -50.71 54.37 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.352 0.407 . . . . 4.35 111.919 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.04 -44.4 80.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.662 -0.245 . . . . 1.04 111.554 -174.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -78.34 -10.11 59.54 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.968 0.729 . . . . 1.88 112.968 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 54.18 55.86 7.69 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.561 0.696 . . . . 4.29 110.602 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 93.6 mt -66.35 141.63 57.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.729 -0.669 . . . . 1.14 111.402 -175.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -89.81 -39.77 12.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.251 -0.886 . . . . 0.31 110.611 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.7 159.67 28.09 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.219 -0.991 . . . . 0.23 113.194 -175.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.2 mt -126.27 140.64 52.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.64 -0.78 . . . . 1.06 109.611 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.3 t -119.85 131.02 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 121.126 -0.229 . . . . 1.05 110.635 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.3 m -119.41 131.16 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.25 0.547 . . . . 1.09 110.998 175.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.4 m -71.54 -33.01 68.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.338 -0.846 . . . . 1.73 111.725 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 72.6 p -157.56 169.92 23.59 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.354 0.597 . . . . 0.93 111.767 -173.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.57 -36.62 64.89 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.176 -0.769 . . . . 0.45 111.176 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -59.24 -46.08 89.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.937 0.369 . . . . 2.57 110.68 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.84 -44.29 97.19 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.439 -1.064 . . . . 0.29 110.439 177.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 30.4 tp -56.34 -44.24 79.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.15 0.5 . . . . 1.16 110.824 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.6 -43.23 99.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.065 -0.516 . . . . 0.45 110.546 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -58.71 -39.1 79.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.72 110.65 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.0 tp -57.32 -45.18 84.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.295 0.569 . . . . 1.12 110.192 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -60.47 -47.05 87.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.562 -0.744 . . . . 0.88 110.586 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -61.78 -43.55 98.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.078 -0.51 . . . . 1.6 111.094 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.74 -34.94 78.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.458 -0.337 . . . . 1.07 111.468 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.72 -39.11 79.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.052 0.453 . . . . 1.04 110.684 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.07 -143.74 0.59 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.617 -0.512 . . . . 1.08 109.617 174.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.7 -18.77 45.09 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.367 0.985 . . . . 1.08 112.659 -175.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -91.88 10.13 30.02 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.366 0.876 . . . . 1.09 113.366 -174.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -47.88 -46.62 63.5 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 118.554 -0.736 . . . . 0.22 112.565 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -44.73 -41.39 14.79 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.472 1.448 . . . . 0.27 113.261 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.2 mp0 -77.0 -48.75 17.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.941 0.4 . . . . 1.86 110.795 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 88.0 mt -59.04 -40.6 81.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.136 -0.484 . . . . 1.04 110.76 -176.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.95 -15.66 36.5 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 116.315 -0.402 . . . . 0.22 113.162 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 -64.94 -30.48 71.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.351 0.575 . . . . 3.0 112.032 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 27.3 mt -74.04 150.5 87.98 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 121.077 -0.249 . . . . 1.12 111.519 -173.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.83 126.25 17.01 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.611 1.541 . . . . 1.05 112.349 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.5 tp -104.89 127.34 52.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.345 -0.389 . . . . 1.1 110.578 175.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -92.07 125.29 36.69 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.669 -0.493 . . . . 0.19 109.669 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.8 m -116.78 145.67 35.99 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-O 119.35 -0.357 . . . . 1.02 110.145 176.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.17 -22.86 8.11 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.531 1.487 . . . . 0.36 113.634 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.0 p -143.64 158.38 56.96 Favored Pre-proline 0 C--N 1.331 -0.236 0 C-N-CA 120.693 -0.403 . . . . 0.76 111.25 -171.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.37 -44.09 51.93 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.309 1.339 . . . . 0.76 111.689 176.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -58.12 -47.42 83.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.856 0.36 . . . . 3.5 110.939 -177.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.2 t -60.12 -39.9 81.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.796 -0.362 . . . . 1.05 110.093 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.43 -41.85 81.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.966 0.413 . . . . 0.96 110.383 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.86 -40.43 92.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.439 . . . . 1.56 110.549 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.0 mmm -58.12 -44.96 88.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.412 0.625 . . . . 1.36 110.061 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.05 -41.16 97.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.695 -0.684 . . . . 1.04 110.792 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 75.9 ttt-85 -61.85 -44.76 96.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.333 -0.394 . . . . 3.66 110.824 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.58 -36.1 77.69 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.925 -0.31 . . . . 2.1 111.348 -177.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.2 mt -65.9 -23.9 66.73 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.241 0.46 . . . . 1.09 112.241 177.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.83 13.3 16.54 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 119.413 -0.659 . . . . 0.23 113.163 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.82 121.98 11.79 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.499 1.149 . . . . 1.03 109.917 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -69.31 -36.01 76.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.629 -0.714 . . . . 0.71 111.24 -171.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -131.59 113.91 14.2 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.024 0.44 . . . . 3.58 110.36 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.9 t -112.53 131.06 65.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.15 -0.477 . . . . 1.05 109.876 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 85.9 mt -119.27 123.33 71.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.856 -0.611 . . . . 1.09 110.026 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -94.93 118.28 31.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.406 -0.361 . . . . 1.13 110.248 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 32.0 p -96.11 -6.56 38.18 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.158 0.799 . . . . 0.97 113.158 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -55.32 -39.83 70.42 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 118.211 0.46 . . . . 4.21 110.812 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -93.72 -35.02 6.3 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.599 -0.6 . . . . 0.69 111.599 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -78.16 132.28 37.56 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.828 0.347 . . . . 1.17 110.632 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.2 m -74.86 162.83 28.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 1.4 110.659 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.76 -54.32 24.36 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 112.891 0.7 . . . . 1.07 112.891 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.94 -34.15 98.99 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 CA-C-N 119.987 1.031 . . . . 0.34 111.692 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.02 -43.07 95.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.037 0.446 . . . . 1.08 109.953 177.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.0 mt -59.19 -40.45 85.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 1.02 110.425 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 37.7 tp -56.98 -43.58 81.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.272 0.558 . . . . 1.06 110.183 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.58 -40.93 93.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.744 -0.662 . . . . 1.04 110.491 178.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.83 -42.19 93.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.328 -0.396 . . . . 1.05 110.684 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.5 mt -57.99 -50.21 74.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.177 0.513 . . . . 1.1 110.427 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.3 p -62.7 -40.89 98.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.798 -0.637 . . . . 1.06 111.231 -175.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.9 t -62.24 -45.15 94.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.766 0.317 . . . . 1.58 111.412 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.59 -38.61 88.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.449 -0.341 . . . . 1.01 111.179 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.66 -34.97 73.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.473 -0.33 . . . . 1.11 111.368 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 87.6 mt -57.43 -38.09 73.83 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.006 -0.277 . . . . 1.43 110.94 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -62.08 -35.04 77.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.596 -0.274 . . . . 2.4 111.376 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -56.98 -45.53 82.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.778 0.323 . . . . 4.77 110.813 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -57.44 -39.08 75.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 7.27 111.089 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -57.78 -43.11 85.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.422 -0.354 . . . . 8.24 111.183 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -54.81 -35.83 64.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.454 -0.339 . . . . 9.73 111.527 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -104.46 138.56 40.66 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.889 0.376 . . . . 10.51 110.773 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 118.048 -0.977 . . . . 12.12 110.494 -179.934 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.6 mtm . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.366 -0.605 . . . . 15.0 109.366 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -126.92 74.09 76.25 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 116.1 -0.5 . . . . 15.0 110.405 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.58 155.02 27.87 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.596 1.531 . . . . 15.0 112.065 -177.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -113.03 137.36 51.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.307 -0.406 . . . . 15.0 110.581 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.3 m -135.3 145.94 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.563 0.696 . . . . 15.0 111.709 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.0 tp -105.75 136.74 44.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.027 -0.988 . . . . 15.0 110.332 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.7 mt -104.52 133.86 47.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.972 0.415 . . . . 15.0 110.695 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 83.7 mtp -101.45 134.46 44.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.279 -0.873 . . . . 15.0 110.714 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -57.33 143.33 40.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.129 0.49 . . . . 15.0 110.772 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.86 175.09 29.14 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.852 -0.899 . . . . 15.0 110.852 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.81 -32.54 67.67 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.684 0.253 . . . . 15.0 111.684 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.34 -173.74 22.25 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.033 -0.827 . . . . 15.0 111.033 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.93 114.7 3.99 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.031 -0.828 . . . . 15.0 111.031 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -57.52 -44.84 85.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.273 0.558 . . . . 15.0 110.228 -176.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.99 -41.46 99.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.856 -0.611 . . . . 15.0 111.273 -177.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -60.01 -49.89 75.9 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.861 -0.335 . . . . 15.0 111.085 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.3 mt -57.64 -44.49 85.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.129 0.49 . . . . 15.0 110.43 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.43 -42.27 91.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 15.0 110.688 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -58.53 -41.51 85.67 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.031 -0.268 . . . . 15.0 110.475 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 69.0 mtm180 -59.31 -51.46 69.85 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.447 -0.501 . . . . 15.0 110.878 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.1 -37.57 83.2 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.519 -0.472 . . . . 15.0 110.988 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 40.2 mtp180 -64.21 -42.49 96.58 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.921 -0.312 . . . . 15.0 111.184 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.0 -30.67 67.04 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.007 -0.616 . . . . 15.0 111.967 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -88.14 8.87 24.87 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.6 0.963 . . . . 15.0 113.6 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.08 17.12 58.26 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 121.235 -0.507 . . . . 15.0 113.234 176.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.7 t -101.03 139.06 23.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 117.748 0.774 . . . . 15.0 109.95 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -78.65 134.64 37.13 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.346 -0.612 . . . . 15.0 109.346 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.7 t -119.24 131.55 71.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.345 0.593 . . . . 15.0 111.331 -173.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -131.59 122.81 26.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.174 -0.921 . . . . 15.0 109.216 170.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -107.88 129.98 55.04 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.904 0.383 . . . . 15.0 110.812 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.3 tp -120.64 113.31 33.42 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 118.892 -0.575 . . . . 15.0 110.672 -175.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.19 135.2 67.85 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.27 1.313 . . . . 15.0 112.372 172.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.1 mt -58.95 -11.87 3.88 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.28 0.844 . . . . 15.0 113.28 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -77.16 -6.22 52.1 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.417 0.895 . . . . 15.0 113.417 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -69.31 150.92 97.09 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 118.558 0.617 . . . . 15.0 110.771 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.63 151.29 32.25 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.616 1.544 . . . . 15.0 113.715 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.76 152.57 3.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.305 -0.861 . . . . 15.0 111.453 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.67 -38.14 3.21 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 115.72 -0.673 . . . . 15.0 111.871 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.3 -37.09 86.26 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 120.323 -0.551 . . . . 15.0 111.103 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.4 tp -58.75 -47.71 83.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.98 0.419 . . . . 15.0 110.168 -178.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 16.3 tp -62.65 -45.36 93.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.974 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.9 -45.04 95.46 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.577 -0.449 . . . . 15.0 110.871 -175.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -62.71 -40.05 95.94 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.768 -0.373 . . . . 15.0 111.07 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 91.4 t -61.78 -45.24 99.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.807 -0.357 . . . . 15.0 110.289 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -69.56 -47.51 63.42 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.205 0.446 . . . . 15.0 112.205 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.8 -44.27 77.72 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.977 -0.289 . . . . 15.0 111.609 -175.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -79.67 -10.11 59.74 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.053 0.76 . . . . 15.0 113.053 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 56.29 55.93 6.23 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.488 0.661 . . . . 15.0 109.989 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.29 145.18 53.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.836 -0.62 . . . . 15.0 111.302 -176.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -92.36 -40.54 10.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.323 -0.853 . . . . 15.0 111.061 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.63 161.87 28.6 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.012 -1.089 . . . . 15.0 113.651 -173.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.2 mt -126.08 144.06 50.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.494 -0.853 . . . . 15.0 109.934 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.7 t -120.87 129.91 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 O-C-N 122.353 -0.217 . . . . 15.0 110.712 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.5 m -124.72 141.43 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-O 121.042 0.449 . . . . 15.0 110.471 172.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.8 m -96.59 -14.16 22.4 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.901 0.704 . . . . 15.0 112.901 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.5 p -157.57 163.25 38.54 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 121.414 0.626 . . . . 15.0 111.914 -174.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.23 -37.3 72.25 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.98 -0.848 . . . . 15.0 110.98 176.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -58.99 -44.98 91.69 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 122.666 -0.314 . . . . 15.0 110.633 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.81 -43.54 97.84 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.476 -1.049 . . . . 15.0 110.476 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.8 tp -56.85 -45.1 82.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.145 0.498 . . . . 15.0 110.699 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.64 -43.53 98.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.086 -0.506 . . . . 15.0 110.644 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -59.08 -39.25 81.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.274 -0.421 . . . . 15.0 110.682 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.3 tp -57.63 -44.84 85.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.179 0.514 . . . . 15.0 110.061 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -61.09 -47.61 85.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.735 -0.666 . . . . 15.0 110.585 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.88 -43.13 99.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.108 -0.496 . . . . 15.0 111.159 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.92 -35.53 80.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.443 -0.344 . . . . 15.0 111.426 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.77 -37.91 80.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.029 0.442 . . . . 15.0 110.856 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.51 -144.19 0.55 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 109.51 -0.552 . . . . 15.0 109.51 174.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.53 -19.56 49.14 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.349 0.977 . . . . 15.0 112.575 -174.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -91.9 12.16 22.55 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.32 0.859 . . . . 15.0 113.32 -174.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 -47.79 -46.36 62.05 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 118.551 -0.737 . . . . 15.0 112.587 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -44.72 -41.43 14.76 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 121.417 1.412 . . . . 15.0 113.247 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -77.0 -48.72 17.16 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.544 -0.462 . . . . 15.0 110.836 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 93.0 mt -59.74 -40.45 82.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.451 . . . . 15.0 110.903 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.44 -16.4 35.72 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 116.401 -0.363 . . . . 15.0 113.11 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.1 mtp-105 -64.67 -30.33 71.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.336 0.568 . . . . 15.0 112.027 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 23.4 mt -76.03 150.54 83.46 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 121.028 -0.269 . . . . 15.0 111.58 -172.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -63.22 128.36 22.53 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.628 1.552 . . . . 15.0 112.39 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.9 tp -108.59 127.56 54.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.511 -0.313 . . . . 15.0 110.657 174.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -88.7 127.31 35.58 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.576 -0.527 . . . . 15.0 109.576 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.1 m -119.16 146.24 40.13 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 110.012 -0.366 . . . . 15.0 110.012 175.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.15 -22.58 8.36 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.608 1.538 . . . . 15.0 113.651 -174.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.7 p -143.47 158.2 57.87 Favored Pre-proline 0 CA--C 1.53 0.196 0 C-N-CA 120.645 -0.422 . . . . 15.0 111.263 -171.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.39 -44.0 52.66 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.32 1.347 . . . . 15.0 111.699 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 -58.37 -47.25 84.43 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.858 -0.337 . . . . 15.0 110.926 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.9 t -59.75 -40.43 82.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.923 0.392 . . . . 15.0 109.965 178.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.46 -42.75 83.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.002 0.43 . . . . 15.0 110.404 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.31 -40.4 90.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 15.0 110.61 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.0 mmm -58.14 -44.39 87.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.428 0.632 . . . . 15.0 110.159 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.49 -40.51 94.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.655 -0.702 . . . . 15.0 110.862 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -62.61 -42.9 99.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.346 -0.388 . . . . 15.0 111.028 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.36 -36.16 77.37 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.832 -0.347 . . . . 15.0 111.274 -177.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.99 -22.78 65.9 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.399 0.518 . . . . 15.0 112.399 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 107.99 13.24 20.35 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 119.373 -0.682 . . . . 15.0 113.128 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.76 122.0 11.8 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 118.494 1.147 . . . . 15.0 109.961 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -69.04 -36.43 77.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.573 -0.74 . . . . 15.0 111.141 -171.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -131.79 112.92 12.92 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.152 0.501 . . . . 15.0 110.536 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.0 t -112.19 130.66 65.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.033 -0.531 . . . . 15.0 109.84 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.6 mt -118.46 122.17 68.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.886 -0.597 . . . . 15.0 109.999 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -94.21 116.56 28.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.429 -0.35 . . . . 15.0 110.433 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.9 p -97.07 4.57 51.31 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.162 0.801 . . . . 15.0 113.162 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 36.2 tpt85 -55.94 -39.92 72.42 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 118.187 0.449 . . . . 15.0 110.648 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.15 -35.13 5.39 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.486 -0.646 . . . . 15.0 111.486 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.65 138.58 44.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.847 0.356 . . . . 15.0 110.549 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.7 p -87.04 165.38 15.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 15.0 110.621 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.69 -54.23 24.77 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 118.552 -0.737 . . . . 15.0 112.923 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.54 -35.98 97.38 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 CA-C-N 120.596 1.249 . . . . 15.0 111.414 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.77 95.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.017 0.437 . . . . 15.0 110.051 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.3 mt -59.23 -40.02 84.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 15.0 110.514 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 42.0 tp -57.08 -44.52 83.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.379 0.609 . . . . 15.0 110.084 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.74 -41.16 94.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.627 -0.715 . . . . 15.0 110.488 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.3 -41.36 93.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.314 -0.403 . . . . 15.0 110.78 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.6 mt -57.89 -50.53 73.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.122 0.487 . . . . 15.0 110.401 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.3 p -63.85 -40.39 96.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.715 -0.675 . . . . 15.0 111.381 -175.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.8 p -65.44 -39.42 92.06 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.025 -0.27 . . . . 15.0 111.398 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.28 96.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.508 -0.315 . . . . 15.0 111.088 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.46 -39.54 83.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.467 -0.333 . . . . 15.0 110.755 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.36 -38.56 90.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.415 -0.357 . . . . 15.0 110.878 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.64 -34.73 78.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.461 -0.336 . . . . 15.0 111.477 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -56.51 -40.7 75.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.664 0.269 . . . . 15.0 110.853 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -111.58 128.33 56.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.84 0.352 . . . . 15.0 110.655 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -58.13 -40.77 82.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.481 . . . . 15.0 110.656 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -115.45 131.07 57.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.27 -0.423 . . . . 15.0 110.623 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -60.87 -42.54 98.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 15.0 110.456 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.992 -1.004 . . . . 15.0 110.508 -179.894 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.4 mmm . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.15 -0.685 . . . . 15.0 109.15 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.01 78.56 70.1 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.124 -0.489 . . . . 15.0 110.28 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.41 152.99 7.93 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.433 1.422 . . . . 15.0 111.857 -176.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -115.63 139.24 50.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.326 -0.397 . . . . 15.0 110.802 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.2 m -133.76 145.97 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.466 0.65 . . . . 15.0 111.652 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.4 tp -105.07 136.5 44.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.048 -0.978 . . . . 15.0 110.375 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.2 mt -104.11 135.14 43.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.972 0.415 . . . . 15.0 110.624 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 96.6 mmm -89.34 134.12 34.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.458 -0.792 . . . . 15.0 110.149 174.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -57.64 141.39 48.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.958 0.408 . . . . 15.0 110.551 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.56 175.11 42.0 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.854 -0.898 . . . . 15.0 110.854 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -54.99 -35.22 64.12 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.205 -0.198 . . . . 15.0 111.217 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.23 162.87 7.45 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.861 -0.895 . . . . 15.0 110.861 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.87 123.56 6.34 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.151 -0.78 . . . . 15.0 111.151 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -56.66 -46.57 80.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.058 0.456 . . . . 15.0 110.422 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.32 -39.33 94.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.899 -0.591 . . . . 15.0 111.235 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -61.23 -56.01 25.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.927 0.394 . . . . 15.0 111.027 -175.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.6 mt -61.7 -41.99 98.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.018 0.437 . . . . 15.0 110.663 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.99 -36.28 79.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 15.0 111.182 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.23 -44.95 95.41 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.963 -0.295 . . . . 15.0 110.616 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -59.77 -51.65 68.86 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.084 -0.646 . . . . 15.0 111.252 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.47 -37.32 87.12 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.517 -0.473 . . . . 15.0 111.137 -176.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -64.02 -43.8 94.51 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.14 -0.224 . . . . 15.0 111.048 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.29 -30.63 68.0 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.043 -0.599 . . . . 15.0 111.923 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -88.14 9.9 21.15 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.515 0.932 . . . . 15.0 113.515 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.11 16.12 56.42 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 121.261 -0.495 . . . . 15.0 113.435 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -101.15 139.77 21.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 117.719 0.759 . . . . 15.0 109.98 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -84.93 133.61 34.28 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.483 -0.562 . . . . 15.0 109.483 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.4 t -115.12 131.45 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.09 0.471 . . . . 15.0 111.005 -174.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -133.78 128.76 35.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.568 -0.742 . . . . 15.0 109.33 171.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -111.38 134.64 52.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.799 0.333 . . . . 15.0 110.652 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.7 tp -112.83 129.95 23.96 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-O 118.492 -0.766 . . . . 15.0 109.732 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -72.08 139.64 33.06 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 CA-C-N 120.431 1.19 . . . . 15.0 111.676 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.2 mt -59.38 -9.35 2.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.631 0.974 . . . . 15.0 113.631 -176.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -77.09 -7.07 55.11 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.396 0.888 . . . . 15.0 113.396 -177.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -65.72 145.89 99.01 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 118.618 0.644 . . . . 15.0 110.633 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.74 159.01 21.66 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 121.629 1.552 . . . . 15.0 113.187 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.28 151.27 5.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.839 -0.618 . . . . 15.0 111.294 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.23 -38.09 3.22 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.71 -0.556 . . . . 15.0 111.71 -178.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -61.05 -36.75 80.4 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 120.595 -0.442 . . . . 15.0 111.213 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.9 tp -59.15 -47.03 86.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.962 0.411 . . . . 15.0 110.254 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.3 tp -62.39 -45.74 91.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 15.0 110.86 -176.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.58 -44.22 97.42 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.659 -0.416 . . . . 15.0 110.774 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.0 ttm-85 -60.74 -41.81 96.1 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.98 -0.288 . . . . 15.0 110.728 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.1 t -60.47 -46.18 95.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.73 -0.388 . . . . 15.0 110.11 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -69.83 -47.7 61.73 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.29 0.478 . . . . 15.0 112.29 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.28 -44.33 79.58 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.03 -0.268 . . . . 15.0 111.538 -174.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -80.34 -10.1 59.75 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.11 0.781 . . . . 15.0 113.11 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 94.2 mtm-85 56.22 55.81 6.38 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.553 0.692 . . . . 15.0 110.111 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 94.6 mt -72.77 146.35 46.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.631 -0.713 . . . . 15.0 111.467 -175.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -94.46 -40.49 9.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.357 -0.838 . . . . 15.0 110.915 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.78 165.53 29.22 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 119.878 -1.153 . . . . 15.0 113.695 -172.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.5 mt -127.89 143.16 51.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.576 -0.812 . . . . 15.0 109.983 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 49.0 t -123.06 133.69 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 110.077 -0.342 . . . . 15.0 110.077 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.9 m -119.24 126.92 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.185 0.517 . . . . 15.0 110.749 174.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.8 m -68.92 -32.73 72.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.476 -0.784 . . . . 15.0 111.686 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.5 p -155.19 166.28 34.06 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.411 0.624 . . . . 15.0 111.887 -173.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.88 -37.51 70.32 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.217 -0.753 . . . . 15.0 111.217 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -58.66 -46.16 87.78 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.742 -0.383 . . . . 15.0 110.72 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.95 -42.61 99.79 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.841 -0.904 . . . . 15.0 110.841 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.9 tp -57.32 -47.18 82.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.053 0.454 . . . . 15.0 110.594 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.77 -44.62 96.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.134 0.492 . . . . 15.0 110.594 -177.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -59.51 -40.11 86.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 15.0 110.616 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.5 tp -56.57 -42.78 79.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.18 0.514 . . . . 15.0 110.195 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -58.55 -46.48 86.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.804 -0.635 . . . . 15.0 110.249 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -60.97 -42.93 99.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.819 -0.628 . . . . 15.0 111.032 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.08 -34.94 78.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.374 -0.375 . . . . 15.0 111.474 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.31 -38.15 79.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.119 0.485 . . . . 15.0 110.677 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.51 -144.43 0.55 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 109.54 -0.541 . . . . 15.0 109.54 173.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.47 -19.57 48.79 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.289 0.95 . . . . 15.0 112.563 -174.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -91.86 10.86 26.94 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.336 0.865 . . . . 15.0 113.336 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -47.83 -47.07 63.42 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 118.544 -0.741 . . . . 15.0 112.536 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -44.78 -40.52 14.58 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 121.422 1.414 . . . . 15.0 113.216 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -76.96 -48.77 17.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.036 0.446 . . . . 15.0 110.735 -177.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 89.1 mt -59.46 -40.11 80.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.511 . . . . 15.0 110.752 -177.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.56 -14.71 36.7 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 116.31 -0.405 . . . . 15.0 113.345 -175.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -65.88 -29.79 70.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.399 0.6 . . . . 15.0 112.037 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.0 mt -74.87 150.02 85.87 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 120.919 -0.312 . . . . 15.0 111.291 -173.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.0 128.27 26.07 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.606 1.537 . . . . 15.0 112.249 176.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.3 tp -105.72 124.91 50.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.387 -0.369 . . . . 15.0 110.497 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -91.71 126.54 36.83 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.796 -0.446 . . . . 15.0 109.796 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.4 m -118.72 146.45 39.99 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-O 119.327 -0.368 . . . . 15.0 110.238 176.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -79.18 -23.49 7.56 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.561 1.507 . . . . 15.0 113.522 -176.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.2 p -143.26 162.78 41.01 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 120.572 -0.451 . . . . 15.0 111.517 -171.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -56.84 -43.97 49.43 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.153 1.236 . . . . 15.0 111.821 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -57.57 -48.15 80.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.882 0.372 . . . . 15.0 110.712 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.5 t -60.37 -39.4 80.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.813 -0.355 . . . . 15.0 110.118 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.31 -41.43 79.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.931 0.396 . . . . 15.0 110.373 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.18 -40.22 93.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.29 -0.414 . . . . 15.0 110.603 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.1 mmm -58.53 -44.53 89.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.378 0.609 . . . . 15.0 110.107 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.74 -42.48 99.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.714 -0.675 . . . . 15.0 110.853 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -61.92 -44.02 97.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 15.0 110.738 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -59.22 -36.16 74.92 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.947 -0.301 . . . . 15.0 111.302 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 77.0 mt -67.26 -23.95 65.74 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.351 0.5 . . . . 15.0 112.351 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.33 13.37 17.45 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 119.263 -0.743 . . . . 15.0 113.096 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.77 122.03 11.88 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 118.564 1.182 . . . . 15.0 109.897 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -68.84 -35.72 77.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.617 -0.719 . . . . 15.0 111.281 -171.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -130.19 113.94 15.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.907 0.384 . . . . 15.0 110.251 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.2 130.3 64.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 15.0 109.953 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 87.6 mt -120.2 120.66 63.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.936 -0.575 . . . . 15.0 110.007 -176.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -95.4 117.79 30.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.41 -0.359 . . . . 15.0 110.323 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.2 p -96.02 -1.49 48.77 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.211 0.819 . . . . 15.0 113.211 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -56.14 -40.28 73.56 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 118.215 0.461 . . . . 15.0 110.527 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.08 -34.98 5.21 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.415 -0.674 . . . . 15.0 111.415 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.46 144.89 53.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.851 0.358 . . . . 15.0 110.52 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.1 t -89.8 158.92 17.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.069 -0.514 . . . . 15.0 110.546 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.65 -54.34 23.73 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 112.992 0.738 . . . . 15.0 112.992 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.72 -35.06 98.95 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 CA-C-N 120.134 1.083 . . . . 15.0 111.78 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.99 -43.13 95.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.124 0.488 . . . . 15.0 109.982 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 78.5 mt -59.06 -40.53 85.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 15.0 110.43 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 38.9 tp -57.19 -43.68 82.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.231 0.538 . . . . 15.0 110.168 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.13 -40.86 91.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.747 -0.661 . . . . 15.0 110.458 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.96 -41.61 92.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.414 . . . . 15.0 110.73 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.5 mt -57.81 -51.11 70.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.195 0.522 . . . . 15.0 110.396 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.3 p -63.6 -39.77 95.23 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.608 -0.724 . . . . 15.0 111.385 -175.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.2 p -65.9 -40.04 91.17 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.921 -0.312 . . . . 15.0 111.453 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.09 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.511 -0.313 . . . . 15.0 111.078 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.27 -34.09 71.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.428 -0.351 . . . . 15.0 111.398 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 83.5 mt -56.68 -38.27 72.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.668 0.271 . . . . 15.0 111.005 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -62.8 -36.97 84.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.576 -0.284 . . . . 15.0 111.204 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -60.41 -41.73 94.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.858 0.361 . . . . 15.0 111.035 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -54.82 -38.26 67.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 15.0 111.389 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -110.7 127.83 55.47 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.891 0.377 . . . . 15.0 110.897 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -57.91 -39.66 78.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 15.0 110.905 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -114.24 144.08 43.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.289 -0.414 . . . . 15.0 110.55 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.912 -1.042 . . . . 15.0 110.718 -179.752 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.6 mtm . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.446 -0.576 . . . . 15.0 109.446 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -126.35 83.0 65.05 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.165 -0.471 . . . . 15.0 110.241 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.01 153.74 30.64 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.385 1.39 . . . . 15.0 111.83 -175.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -112.86 138.33 49.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.456 -0.338 . . . . 15.0 110.782 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.1 m -133.33 143.52 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 121.515 0.674 . . . . 15.0 111.521 176.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.6 tp -103.41 134.76 46.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.011 -0.995 . . . . 15.0 110.417 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.4 mt -99.04 135.0 35.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.024 0.44 . . . . 15.0 110.542 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 83.3 mtp -103.17 134.18 47.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.445 -0.798 . . . . 15.0 109.593 171.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -57.51 144.68 35.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.128 0.49 . . . . 15.0 110.984 -172.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.38 175.15 32.65 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.739 -0.944 . . . . 15.0 110.739 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -54.53 -33.42 59.97 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.517 0.191 . . . . 15.0 111.517 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.06 171.12 36.1 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.898 -0.881 . . . . 15.0 110.898 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.91 133.98 12.26 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.312 -0.715 . . . . 15.0 111.312 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -56.8 -46.04 81.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.086 0.469 . . . . 15.0 110.405 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.18 -41.14 99.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.679 -0.691 . . . . 15.0 111.329 -176.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -61.73 -56.07 23.49 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.746 -0.382 . . . . 15.0 111.224 -175.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.3 mt -61.94 -43.47 98.77 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.739 -0.384 . . . . 15.0 111.052 -176.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.17 -43.27 99.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.392 -0.367 . . . . 15.0 110.573 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -58.72 -41.85 87.34 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.977 -0.289 . . . . 15.0 110.395 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -58.76 -51.69 68.88 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.656 -0.418 . . . . 15.0 111.179 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.2 mt -62.74 -37.77 87.88 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.596 -0.442 . . . . 15.0 111.243 -177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -63.53 -42.4 98.43 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.853 -0.339 . . . . 15.0 111.214 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.43 -30.71 68.63 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.021 -0.609 . . . . 15.0 111.961 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -88.18 9.92 21.21 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.56 0.948 . . . . 15.0 113.56 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.4 16.26 57.42 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 121.18 -0.533 . . . . 15.0 113.436 175.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.1 t -101.1 140.24 20.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 117.803 0.802 . . . . 15.0 110.168 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -83.17 130.5 35.11 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.101 -0.703 . . . . 15.0 109.101 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.1 t -119.72 133.23 67.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.17 0.51 . . . . 15.0 111.191 -172.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -139.23 137.75 36.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.362 -0.836 . . . . 15.0 109.465 171.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -115.41 138.25 51.2 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.916 0.389 . . . . 15.0 111.035 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 tp -119.98 113.29 34.37 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-O 118.677 -0.678 . . . . 15.0 110.354 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.7 135.02 48.73 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 121.23 1.287 . . . . 15.0 112.304 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.42 -16.96 51.88 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.031 0.752 . . . . 15.0 113.031 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -77.14 -4.34 44.01 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.445 0.905 . . . . 15.0 113.445 -175.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -70.61 149.97 95.45 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 118.428 0.558 . . . . 15.0 110.816 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.31 147.14 52.49 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.6 1.533 . . . . 15.0 113.747 -174.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.9 152.55 3.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.429 -0.805 . . . . 15.0 111.291 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.78 -38.09 3.21 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.948 -0.569 . . . . 15.0 111.837 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -62.65 -36.88 84.28 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 120.346 -0.542 . . . . 15.0 111.092 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.2 tp -58.9 -46.9 86.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.915 0.388 . . . . 15.0 110.188 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 20.8 tp -62.25 -43.85 97.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 15.0 110.854 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.64 -45.88 92.16 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.635 -0.426 . . . . 15.0 110.853 -176.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -62.91 -40.03 96.33 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.874 -0.331 . . . . 15.0 111.165 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.4 t -60.56 -44.51 96.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.881 -0.415 . . . . 15.0 109.881 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -65.9 -51.82 55.38 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.369 0.418 . . . . 15.0 111.87 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.09 -44.37 80.18 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.028 -0.269 . . . . 15.0 111.629 -174.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -80.31 -10.04 59.75 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.168 0.803 . . . . 15.0 113.168 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 92.2 mtm-85 55.62 55.81 6.83 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.61 0.719 . . . . 15.0 110.406 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.0 146.23 53.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.656 -0.702 . . . . 15.0 110.965 -177.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -95.98 -40.7 9.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.695 -0.684 . . . . 15.0 110.906 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.7 164.83 28.81 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 119.945 -1.121 . . . . 15.0 113.589 -172.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.7 mt -126.79 145.16 50.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.456 -0.872 . . . . 15.0 109.919 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.1 t -121.0 129.14 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 110.437 -0.208 . . . . 15.0 110.437 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.7 m -126.99 139.24 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 120.955 0.407 . . . . 15.0 110.365 173.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.5 m -101.36 -4.8 26.32 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.055 0.761 . . . . 15.0 113.055 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.0 p -157.45 157.83 34.65 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-O 121.487 0.661 . . . . 15.0 111.977 -175.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.67 -37.75 78.31 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.048 -0.821 . . . . 15.0 111.048 177.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -57.03 -46.11 82.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.774 0.321 . . . . 15.0 110.716 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.69 -44.12 97.19 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.651 -0.98 . . . . 15.0 110.651 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.7 tp -56.01 -46.39 78.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.274 0.559 . . . . 15.0 110.717 -178.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -62.33 -42.9 99.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.911 -0.586 . . . . 15.0 110.874 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -58.89 -38.51 79.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.377 -0.374 . . . . 15.0 110.829 178.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.5 tp -57.58 -45.25 85.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.281 0.562 . . . . 15.0 110.086 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -61.45 -47.6 84.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.667 -0.697 . . . . 15.0 110.628 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -62.05 -43.46 98.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 15.0 111.281 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.1 mt -66.42 -35.63 80.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.382 -0.372 . . . . 15.0 111.379 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.28 -37.74 81.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.012 0.434 . . . . 15.0 110.884 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.72 -144.16 0.54 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.388 -0.597 . . . . 15.0 109.388 174.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.49 -18.64 41.66 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.319 0.963 . . . . 15.0 112.614 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -91.83 11.14 25.79 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.265 0.839 . . . . 15.0 113.265 -174.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -47.7 -46.83 61.87 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 118.6 -0.714 . . . . 15.0 112.592 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -44.64 -41.85 14.54 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.434 1.423 . . . . 15.0 113.22 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -76.99 -48.73 17.18 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.059 0.457 . . . . 15.0 110.807 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 95.2 mt -59.92 -40.03 81.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 15.0 110.855 -176.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.99 -15.74 29.7 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 119.916 -0.38 . . . . 15.0 112.966 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -64.82 -31.47 72.72 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 117.433 0.616 . . . . 15.0 111.884 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.7 mt -73.77 135.38 77.83 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 118.866 -0.587 . . . . 15.0 110.361 -175.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.01 134.18 60.57 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.39 1.393 . . . . 15.0 112.59 177.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.7 tp -107.66 130.18 54.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.974 -0.557 . . . . 15.0 110.65 176.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -89.19 123.9 33.86 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.27 -0.641 . . . . 15.0 109.27 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.7 m -114.53 146.61 36.28 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 119.378 -0.344 . . . . 15.0 110.237 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -79.14 -23.77 7.36 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.52 1.48 . . . . 15.0 113.574 -174.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.0 p -143.44 162.22 43.3 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 120.564 -0.455 . . . . 15.0 111.677 -171.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.0 -44.0 51.35 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.154 1.236 . . . . 15.0 111.791 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -57.95 -47.28 83.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.837 0.351 . . . . 15.0 110.838 -177.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.17 -41.17 85.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 15.0 110.047 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.82 -42.68 84.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.901 0.382 . . . . 15.0 110.411 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.33 -42.08 98.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 15.0 110.604 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 86.7 mtp -59.41 -43.81 92.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.198 0.523 . . . . 15.0 110.44 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.6 94.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.931 -0.577 . . . . 15.0 110.74 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -61.59 -44.44 97.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.336 -0.393 . . . . 15.0 110.674 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.43 -36.1 77.38 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.842 -0.343 . . . . 15.0 111.313 -177.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.7 mt -64.9 -24.12 67.43 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.206 0.447 . . . . 15.0 112.206 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.55 13.33 17.09 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 119.311 -0.716 . . . . 15.0 113.103 -176.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.91 121.98 11.84 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.573 1.187 . . . . 15.0 109.894 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -69.31 -35.18 75.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.659 -0.701 . . . . 15.0 111.267 -171.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -131.08 115.71 16.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.003 0.43 . . . . 15.0 110.182 177.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.9 t -114.69 130.1 69.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.281 -0.418 . . . . 15.0 110.027 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.7 mt -119.48 124.91 73.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.997 -0.547 . . . . 15.0 110.058 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -95.39 118.03 31.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.384 -0.371 . . . . 15.0 110.038 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.4 p -96.73 -0.38 48.3 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.219 0.822 . . . . 15.0 113.219 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -56.0 -40.08 72.81 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 118.186 0.448 . . . . 15.0 110.62 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.02 -35.02 5.21 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.507 -0.637 . . . . 15.0 111.507 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.58 142.32 50.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.815 0.341 . . . . 15.0 110.664 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.6 m -89.89 163.24 15.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.496 . . . . 15.0 110.505 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.78 -54.28 24.72 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 112.977 0.732 . . . . 15.0 112.977 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.23 -34.27 98.41 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 CA-C-N 120.068 1.06 . . . . 15.0 111.635 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.14 -43.14 95.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.058 0.456 . . . . 15.0 110.012 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 78.6 mt -59.38 -40.49 86.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 15.0 110.515 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 42.2 tp -56.88 -44.9 82.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.51 0.671 . . . . 15.0 110.166 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.04 92.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.526 -0.761 . . . . 15.0 110.708 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.57 -42.3 96.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.476 -0.329 . . . . 15.0 110.907 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.6 mt -57.92 -51.47 69.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.171 0.51 . . . . 15.0 110.388 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.7 p -63.5 -40.16 96.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.628 -0.714 . . . . 15.0 111.28 -175.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.0 t -63.18 -44.27 95.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.662 0.268 . . . . 15.0 111.385 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.03 85.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.473 -0.331 . . . . 15.0 110.955 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.39 73.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.496 -0.32 . . . . 15.0 111.277 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.7 mt -58.79 -37.53 76.54 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 121.122 -0.231 . . . . 15.0 111.165 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.85 -37.31 81.67 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 121.031 -0.267 . . . . 15.0 111.109 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -55.94 -37.26 68.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.574 -0.285 . . . . 15.0 111.221 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -105.05 134.62 47.84 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.76 0.314 . . . . 15.0 110.758 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -120.96 128.39 52.68 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.222 -0.445 . . . . 15.0 110.67 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -58.56 -39.31 79.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 15.0 110.926 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -56.4 -41.14 75.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.375 -0.375 . . . . 15.0 110.674 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 . . . . . 0 C--O 1.219 -0.543 0 CA-C-O 118.047 -0.977 . . . . 15.0 110.607 179.668 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.5 mtp . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.395 -0.594 . . . . 15.0 109.395 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -126.17 74.27 72.37 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.135 -0.484 . . . . 15.0 110.361 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -58.01 155.03 35.58 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.52 1.48 . . . . 15.0 112.035 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -110.61 139.88 45.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.518 -0.31 . . . . 15.0 110.741 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 m -135.75 142.31 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.556 0.693 . . . . 15.0 111.635 176.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.2 tp -105.0 133.8 49.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.94 -1.027 . . . . 15.0 110.169 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.9 mt -106.02 135.18 45.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.286 -0.415 . . . . 15.0 110.22 -177.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 83.7 mtp -94.37 134.05 37.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.157 -0.474 . . . . 15.0 110.537 175.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -62.79 145.87 53.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.043 0.449 . . . . 15.0 111.536 -174.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.96 175.2 42.85 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.638 -0.985 . . . . 15.0 110.638 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.91 -33.3 68.62 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.725 0.268 . . . . 15.0 111.725 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.95 164.35 3.6 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.165 -0.774 . . . . 15.0 111.165 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.99 104.77 2.81 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.92 -0.872 . . . . 15.0 110.92 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 -69.18 -32.52 71.89 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.794 0.294 . . . . 15.0 111.794 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.33 -45.64 87.71 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.595 -0.442 . . . . 15.0 110.366 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -65.9 -55.21 18.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.359 -0.382 . . . . 15.0 111.233 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.0 tt -56.76 -43.13 80.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.843 0.354 . . . . 15.0 110.959 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.47 -43.02 99.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.388 -0.369 . . . . 15.0 110.575 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.82 -41.02 85.84 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.808 -0.357 . . . . 15.0 110.566 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -60.97 -51.32 69.73 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 120.371 -0.532 . . . . 15.0 111.366 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 70.0 mt -61.15 -37.78 84.08 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.316 -0.554 . . . . 15.0 110.845 -178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -65.03 -41.41 95.27 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 120.694 -0.402 . . . . 15.0 111.356 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.88 -30.68 66.68 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.028 -0.606 . . . . 15.0 111.883 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -88.08 9.97 20.76 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.477 0.917 . . . . 15.0 113.477 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.24 17.09 58.07 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 121.333 -0.46 . . . . 15.0 113.263 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -101.04 139.56 22.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 117.807 0.804 . . . . 15.0 110.126 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -82.0 126.2 31.69 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.393 -0.595 . . . . 15.0 109.393 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.5 t -116.75 129.32 73.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.087 0.47 . . . . 15.0 110.933 -174.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -136.39 132.65 35.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.636 -0.711 . . . . 15.0 109.685 172.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -112.63 133.45 54.66 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.947 0.403 . . . . 15.0 110.789 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.1 tp -116.08 113.33 41.7 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 118.824 -0.607 . . . . 15.0 110.367 -176.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.65 135.81 68.42 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 121.362 1.374 . . . . 15.0 112.692 174.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 73.9 mt -59.48 -10.48 3.37 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.37 0.878 . . . . 15.0 113.37 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -77.16 -6.26 52.25 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.298 0.851 . . . . 15.0 113.298 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -71.78 148.72 92.57 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 118.588 0.631 . . . . 15.0 110.582 -178.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -74.6 152.08 42.46 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.604 1.536 . . . . 15.0 113.782 -174.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.73 152.52 3.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.373 -0.83 . . . . 15.0 111.292 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.31 -38.28 3.15 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.799 -0.637 . . . . 15.0 111.782 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.5 -36.03 82.85 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 117.343 0.571 . . . . 15.0 111.264 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.8 tp -58.74 -46.86 86.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.942 0.401 . . . . 15.0 110.135 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 16.6 tp -63.33 -44.45 94.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 15.0 110.875 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.56 -44.76 96.44 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.706 -0.398 . . . . 15.0 110.871 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 61.7 ttm-85 -60.88 -42.78 98.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.458 -0.337 . . . . 15.0 110.655 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.5 t -60.34 -45.37 96.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.777 -0.369 . . . . 15.0 110.174 -177.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -67.29 -51.78 48.63 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.485 0.491 . . . . 15.0 112.058 -176.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.64 -44.35 82.19 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.986 -0.286 . . . . 15.0 111.565 -174.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -79.83 -10.15 59.75 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.972 0.73 . . . . 15.0 112.972 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 54.78 55.95 7.26 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.595 0.712 . . . . 15.0 110.086 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 97.5 mt -65.09 144.91 56.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.744 -0.662 . . . . 15.0 111.314 -174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -92.84 -39.13 11.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.133 -0.94 . . . . 15.0 110.81 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.69 160.96 28.46 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 120.149 -1.024 . . . . 15.0 113.469 -175.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.1 mt -126.16 144.37 50.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.575 -0.812 . . . . 15.0 109.564 177.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.7 t -122.71 131.51 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 O-C-N 122.315 -0.24 . . . . 15.0 110.93 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.0 m -127.53 150.69 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.08 0.467 . . . . 15.0 110.37 171.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.5 t -107.5 -15.65 14.56 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.605 -0.725 . . . . 15.0 112.711 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.4 p -152.75 160.59 43.13 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.402 0.62 . . . . 15.0 111.917 -173.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.37 -37.78 75.8 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.016 -0.834 . . . . 15.0 111.016 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -57.19 -46.16 83.09 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 122.599 -0.353 . . . . 15.0 110.703 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.14 -45.62 95.68 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.621 -0.991 . . . . 15.0 110.621 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.0 tp -56.94 -44.61 82.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.103 0.478 . . . . 15.0 110.736 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.69 -43.44 98.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.481 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -59.04 -37.31 76.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.124 -0.489 . . . . 15.0 110.858 177.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.1 tp -57.5 -44.96 85.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.286 0.565 . . . . 15.0 110.121 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -60.66 -46.87 88.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.53 -0.759 . . . . 15.0 110.539 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -62.61 -43.96 97.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 15.0 111.347 -176.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.08 -35.07 79.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.476 -0.329 . . . . 15.0 111.266 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.3 -37.95 82.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.007 0.432 . . . . 15.0 110.858 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.37 -144.63 0.55 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.461 -0.57 . . . . 15.0 109.461 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.45 -19.13 45.28 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.29 0.95 . . . . 15.0 112.586 -174.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -91.88 11.76 23.84 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.295 0.85 . . . . 15.0 113.295 -174.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 59.0 t-105 -47.77 -46.85 62.7 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 118.564 -0.731 . . . . 15.0 112.519 177.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -44.66 -41.29 14.58 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 121.431 1.421 . . . . 15.0 113.287 177.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -76.96 -48.75 17.2 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.607 -0.437 . . . . 15.0 110.803 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.5 mt -58.91 -40.18 79.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.197 -0.456 . . . . 15.0 110.796 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.39 -16.99 37.77 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 116.291 -0.413 . . . . 15.0 113.254 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -66.58 -28.93 68.9 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.297 0.548 . . . . 15.0 112.17 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.2 mt -74.85 150.59 86.24 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 121.031 -0.268 . . . . 15.0 111.514 -172.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -63.8 126.52 17.57 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 121.626 1.551 . . . . 15.0 112.309 176.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.8 tp -105.7 127.25 52.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.508 -0.315 . . . . 15.0 110.824 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -89.45 127.13 35.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.589 -0.522 . . . . 15.0 109.589 175.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.5 m -118.53 146.76 40.47 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 110.08 -0.341 . . . . 15.0 110.08 175.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -79.1 -23.45 7.69 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.61 1.54 . . . . 15.0 113.457 -176.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.5 p -144.3 158.44 54.68 Favored Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 120.671 -0.412 . . . . 15.0 111.355 -172.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.07 -44.03 52.18 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.26 1.307 . . . . 15.0 111.737 176.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -57.65 -47.71 81.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.882 0.372 . . . . 15.0 110.929 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.3 t -59.65 -40.69 82.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.906 0.384 . . . . 15.0 109.983 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.55 -42.25 82.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.81 0.338 . . . . 15.0 110.444 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.41 -41.03 93.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.49 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.1 mmm -58.39 -43.95 88.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.401 0.619 . . . . 15.0 110.157 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.28 -40.62 94.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.733 -0.667 . . . . 15.0 110.795 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -62.53 -42.82 99.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.342 -0.39 . . . . 15.0 111.074 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.67 -36.11 77.92 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.897 -0.321 . . . . 15.0 111.33 -177.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.2 mt -67.95 -22.12 65.05 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.404 0.52 . . . . 15.0 112.404 177.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.99 13.39 18.15 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 119.315 -0.714 . . . . 15.0 113.217 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.77 121.98 11.76 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.579 1.189 . . . . 15.0 109.864 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -70.3 -35.37 73.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.55 -0.75 . . . . 15.0 111.275 -171.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -131.84 112.53 12.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.977 0.418 . . . . 15.0 110.486 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.2 t -112.0 130.69 65.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.135 -0.484 . . . . 15.0 109.883 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 84.3 mt -118.95 122.6 69.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.016 -0.538 . . . . 15.0 110.11 -176.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.57 117.07 29.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.457 -0.338 . . . . 15.0 110.431 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.3 p -97.02 6.12 49.18 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.168 0.803 . . . . 15.0 113.168 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 71.9 ttp85 -55.76 -39.37 71.11 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.169 0.441 . . . . 15.0 110.803 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.68 -35.09 5.27 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.6 -0.6 . . . . 15.0 111.6 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.26 139.07 54.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.969 0.414 . . . . 15.0 110.773 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.8 p -89.84 167.84 12.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.996 -0.547 . . . . 15.0 110.464 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.75 -54.2 25.22 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 113.028 0.751 . . . . 15.0 113.028 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.73 -36.6 98.54 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 CA-C-N 120.509 1.218 . . . . 15.0 111.447 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.55 -43.13 97.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.98 0.419 . . . . 15.0 110.183 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.5 mt -59.36 -40.8 87.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.198 -0.456 . . . . 15.0 110.398 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.9 tp -57.67 -44.7 85.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.323 0.583 . . . . 15.0 110.188 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.98 -40.71 94.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.666 -0.697 . . . . 15.0 110.595 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.85 -42.04 97.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.424 -0.353 . . . . 15.0 110.765 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.3 mt -57.87 -50.44 73.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.047 0.451 . . . . 15.0 110.44 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.7 p -65.02 -40.49 94.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.805 -0.634 . . . . 15.0 111.479 -175.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.9 p -64.37 -39.67 94.33 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.98 -0.288 . . . . 15.0 111.28 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.54 -43.27 94.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.634 -0.257 . . . . 15.0 111.037 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.56 -40.66 97.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.543 -0.299 . . . . 15.0 110.976 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 89.6 mt -66.94 -38.09 85.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.429 -0.351 . . . . 15.0 111.521 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -121.04 123.67 42.95 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.848 0.356 . . . . 15.0 111.165 -177.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -112.1 -29.12 7.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.013 -0.54 . . . . 15.0 111.889 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -53.97 -40.76 67.16 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.6 0.238 . . . . 15.0 111.388 -176.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -116.7 129.38 56.1 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.998 0.428 . . . . 15.0 110.836 -178.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -58.78 -38.61 78.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.85 -0.614 . . . . 15.0 110.989 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -110.54 140.61 44.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.404 -0.362 . . . . 15.0 110.665 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 117.995 -1.002 . . . . 15.0 110.66 179.822 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.389 -0.597 . . . . 15.0 109.389 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -125.5 79.16 67.54 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.132 -0.486 . . . . 15.0 110.194 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -54.09 152.37 24.62 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 121.481 1.454 . . . . 15.0 111.824 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -112.43 135.7 52.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.291 -0.413 . . . . 15.0 110.509 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.8 m -133.1 145.58 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.619 0.723 . . . . 15.0 111.859 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.9 tp -103.66 136.86 42.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.964 -1.016 . . . . 15.0 110.496 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.8 mt -100.79 133.87 42.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.033 0.444 . . . . 15.0 110.683 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 84.8 mtp -102.56 134.62 45.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.242 -0.89 . . . . 15.0 110.09 173.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -57.36 141.16 48.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.213 0.53 . . . . 15.0 110.572 -173.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.13 175.28 31.66 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.551 -1.02 . . . . 15.0 110.551 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.7 mp0 -58.0 -31.68 67.19 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.951 -0.3 . . . . 15.0 111.515 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.49 173.27 33.61 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.908 -0.877 . . . . 15.0 110.908 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.32 132.21 11.05 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.488 -0.645 . . . . 15.0 111.488 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -56.87 -44.08 81.86 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.127 0.489 . . . . 15.0 110.227 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.38 -43.42 97.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.767 -0.651 . . . . 15.0 111.024 -175.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -58.2 -55.93 28.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.012 0.434 . . . . 15.0 110.909 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.1 mt -61.35 -42.85 99.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 15.0 110.91 -175.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.12 -45.0 96.48 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.767 -0.373 . . . . 15.0 111.163 -177.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.23 -38.81 84.56 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.598 -0.441 . . . . 15.0 110.811 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -60.63 -51.51 69.1 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 119.973 -0.691 . . . . 15.0 110.918 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 79.9 mt -63.57 -38.02 89.52 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 120.451 -0.499 . . . . 15.0 111.252 -176.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -63.57 -42.47 98.33 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.91 -0.316 . . . . 15.0 111.266 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.71 -30.72 69.63 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 120.865 -0.684 . . . . 15.0 112.011 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -88.8 10.14 22.11 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.654 0.983 . . . . 15.0 113.654 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.8 17.25 56.89 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 121.251 -0.5 . . . . 15.0 113.295 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.1 t -101.02 141.02 18.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 117.712 0.756 . . . . 15.0 110.088 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -84.8 131.36 34.55 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.297 -0.631 . . . . 15.0 109.297 177.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.3 t -117.72 131.19 71.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.129 0.49 . . . . 15.0 111.121 -173.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -137.4 133.82 35.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.464 -0.789 . . . . 15.0 109.488 171.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -116.06 138.38 51.28 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.968 0.413 . . . . 15.0 111.194 -177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.0 tp -119.21 135.97 24.21 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 109.243 -0.651 . . . . 15.0 109.243 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.22 135.92 25.77 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.182 1.255 . . . . 15.0 111.759 173.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 84.1 mt -59.9 -9.31 2.84 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.41 0.893 . . . . 15.0 113.41 -177.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -77.14 -7.91 56.6 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.415 0.894 . . . . 15.0 113.415 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -64.57 146.55 98.18 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 118.606 0.639 . . . . 15.0 110.552 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.03 159.03 27.15 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.617 1.544 . . . . 15.0 113.221 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.44 150.97 4.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.779 -0.646 . . . . 15.0 111.52 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.2 -38.01 3.25 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.321 -0.712 . . . . 15.0 111.321 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -61.34 -37.82 84.67 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.58 -0.448 . . . . 15.0 111.017 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 28.4 tp -59.0 -46.83 87.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.981 0.42 . . . . 15.0 110.127 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.6 tp -62.51 -43.56 98.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.178 -0.465 . . . . 15.0 110.914 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.17 -45.96 91.06 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.724 -0.39 . . . . 15.0 110.95 -176.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -61.52 -41.5 97.41 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.812 -0.355 . . . . 15.0 110.707 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 94.5 t -61.24 -45.8 97.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.779 -0.368 . . . . 15.0 110.204 -177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -69.11 -49.03 60.76 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.293 0.479 . . . . 15.0 112.293 -175.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.48 -44.3 75.08 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.992 -0.283 . . . . 15.0 111.642 -174.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -78.96 -10.16 59.74 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.09 0.774 . . . . 15.0 113.09 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 55.78 55.83 6.69 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.601 0.715 . . . . 15.0 110.306 -177.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 94.2 mt -74.18 146.91 43.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.552 -0.749 . . . . 15.0 111.306 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -96.78 -40.71 8.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.677 -0.692 . . . . 15.0 110.807 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.63 165.45 28.77 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 119.798 -1.191 . . . . 15.0 113.644 -171.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.7 mt -127.04 144.59 50.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.545 -0.828 . . . . 15.0 110.279 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.5 t -120.22 129.35 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 110.372 -0.233 . . . . 15.0 110.372 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.2 m -126.65 144.53 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.141 0.496 . . . . 15.0 110.657 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.0 t -102.84 -13.27 17.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.493 -0.776 . . . . 15.0 112.747 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.8 p -153.34 159.1 42.4 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.456 0.646 . . . . 15.0 112.075 -173.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.6 -37.9 78.5 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.972 -0.851 . . . . 15.0 110.972 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -58.45 -44.62 89.28 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.848 -0.341 . . . . 15.0 110.635 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.4 -45.38 96.31 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.623 -0.991 . . . . 15.0 110.623 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 42.5 tp -56.4 -45.73 80.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.129 0.49 . . . . 15.0 110.778 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -62.0 -42.73 99.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.043 -0.526 . . . . 15.0 110.89 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -59.22 -39.68 83.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.373 -0.376 . . . . 15.0 110.716 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.6 tp -58.09 -45.02 87.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.166 0.508 . . . . 15.0 110.238 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -60.7 -47.55 85.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.744 -0.662 . . . . 15.0 110.648 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -62.0 -43.19 99.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.014 -0.539 . . . . 15.0 111.136 -176.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.08 -34.95 78.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.451 -0.341 . . . . 15.0 111.453 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.47 -38.94 82.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.953 0.406 . . . . 15.0 110.535 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 58.96 -142.53 0.64 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.626 -0.509 . . . . 15.0 109.626 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.75 -18.58 44.16 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.39 0.996 . . . . 15.0 112.695 -174.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -91.79 9.26 33.42 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.315 0.857 . . . . 15.0 113.315 -175.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -47.74 -46.57 61.84 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.633 -0.699 . . . . 15.0 112.61 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -44.55 -43.04 14.34 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.493 1.462 . . . . 15.0 113.287 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -76.96 -48.81 17.02 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 120.644 -0.422 . . . . 15.0 110.931 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 86.4 mt -59.33 -39.05 77.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.11 -0.496 . . . . 15.0 110.85 -176.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.78 -13.2 38.54 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 119.826 -0.43 . . . . 15.0 113.405 -175.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -70.5 -29.21 65.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 117.578 0.689 . . . . 15.0 112.304 178.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.2 mt -69.86 126.51 92.53 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 118.572 -0.728 . . . . 15.0 109.606 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.23 133.45 52.68 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.106 1.204 . . . . 15.0 112.333 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.8 tp -105.75 129.31 53.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.904 -0.589 . . . . 15.0 110.552 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -90.52 122.45 33.36 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.249 -0.648 . . . . 15.0 109.249 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.9 m -114.99 148.01 39.6 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 119.457 -0.306 . . . . 15.0 110.326 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.21 -24.54 6.59 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.529 1.486 . . . . 15.0 113.614 -174.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.9 p -142.43 161.36 50.45 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 120.594 -0.442 . . . . 15.0 111.58 -172.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -55.32 -44.07 52.44 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.208 1.272 . . . . 15.0 111.76 176.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -57.17 -47.9 80.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.855 0.36 . . . . 15.0 110.639 -177.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.5 t -60.0 -41.37 85.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.904 0.383 . . . . 15.0 109.992 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.94 -42.1 84.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.969 0.414 . . . . 15.0 110.486 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.24 -41.71 97.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.433 . . . . 15.0 110.44 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 86.5 mtp -58.92 -41.82 88.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.101 0.477 . . . . 15.0 110.379 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.69 -41.21 94.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 15.0 110.576 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 -61.74 -43.29 99.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 15.0 110.809 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.24 -36.1 76.98 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.879 -0.328 . . . . 15.0 111.256 -177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 77.5 mt -65.89 -24.41 66.85 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.256 0.465 . . . . 15.0 112.256 176.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 107.67 13.25 20.88 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 119.437 -0.646 . . . . 15.0 113.075 -175.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.94 123.82 17.12 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 118.416 1.108 . . . . 15.0 109.939 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -72.17 -33.5 67.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.843 -0.617 . . . . 15.0 111.425 -172.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 45.9 tpt85 -131.81 114.57 14.87 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.903 0.382 . . . . 15.0 110.404 176.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 40.5 t -114.67 131.62 66.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.822 0.344 . . . . 15.0 110.145 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 87.8 mt -119.7 125.93 74.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.172 -0.467 . . . . 15.0 110.191 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -94.2 118.3 31.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.36 -0.382 . . . . 15.0 110.134 174.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.1 p -94.25 -7.2 42.73 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.17 0.804 . . . . 15.0 113.17 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -55.82 -39.41 71.34 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 118.122 0.419 . . . . 15.0 110.781 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -96.27 -35.04 5.63 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.491 -0.644 . . . . 15.0 111.491 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.24 143.44 40.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.796 0.331 . . . . 15.0 110.478 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.6 m -89.43 163.42 15.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 15.0 110.526 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.72 -54.31 24.23 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 112.878 0.695 . . . . 15.0 112.878 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.6 -34.13 98.65 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 CA-C-N 120.195 1.106 . . . . 15.0 111.646 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.29 -42.96 96.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.107 0.48 . . . . 15.0 110.026 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.8 mt -59.32 -39.88 84.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 15.0 110.495 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 29.4 tp -56.87 -45.04 82.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.399 0.618 . . . . 15.0 110.111 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.98 -39.73 90.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.506 -0.77 . . . . 15.0 110.601 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.63 -42.87 97.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.604 -0.271 . . . . 15.0 110.844 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.8 mt -58.04 -50.36 73.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.119 0.485 . . . . 15.0 110.405 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 71.7 p -63.5 -40.39 96.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.807 -0.633 . . . . 15.0 111.368 -175.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.8 m -64.01 -42.75 97.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.662 0.267 . . . . 15.0 111.292 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.25 -39.01 88.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.474 -0.33 . . . . 15.0 110.998 -178.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.15 -35.73 74.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.545 -0.298 . . . . 15.0 111.213 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 84.7 mt -58.54 -38.05 76.97 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 121.001 -0.279 . . . . 15.0 110.947 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -100.2 128.93 46.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 15.0 110.215 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -93.12 -35.28 13.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.299 -0.409 . . . . 15.0 111.61 -177.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -122.61 131.18 53.7 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.977 0.418 . . . . 15.0 110.991 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -62.24 -32.05 72.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.782 -0.644 . . . . 15.0 111.794 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -51.92 -38.89 58.02 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 111.681 0.252 . . . . 15.0 111.681 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -56.0 -40.54 73.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.734 0.302 . . . . 15.0 110.891 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.039 -0.982 . . . . 15.0 110.487 179.448 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.6 mtp . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.427 -0.582 . . . . 15.0 109.427 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -126.66 81.77 68.09 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.107 -0.497 . . . . 15.0 110.406 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -56.13 155.05 25.47 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.389 1.393 . . . . 15.0 111.761 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -109.98 138.04 46.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.479 -0.328 . . . . 15.0 110.901 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.8 m -134.06 144.35 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.538 0.685 . . . . 15.0 111.614 175.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.8 tp -103.78 136.74 42.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.949 -1.023 . . . . 15.0 110.274 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.8 mt -101.6 133.8 43.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.137 0.494 . . . . 15.0 111.013 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 98.7 mmm -94.69 134.28 37.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.153 -0.93 . . . . 15.0 109.045 170.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -57.46 140.68 49.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.894 0.378 . . . . 15.0 110.562 -175.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.28 175.1 27.74 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.995 -0.842 . . . . 15.0 110.995 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -58.2 -33.18 69.0 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.546 0.202 . . . . 15.0 111.546 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.94 173.27 35.25 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.979 -0.848 . . . . 15.0 110.979 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.98 131.36 10.37 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.25 -0.74 . . . . 15.0 111.25 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -57.41 -43.76 84.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.082 0.468 . . . . 15.0 110.317 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.18 -42.58 99.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.815 -0.63 . . . . 15.0 111.344 -176.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -61.68 -55.94 25.09 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.804 -0.359 . . . . 15.0 111.292 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.3 mt -59.87 -43.62 94.62 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.662 -0.415 . . . . 15.0 111.021 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.7 -41.31 99.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.491 -0.322 . . . . 15.0 110.995 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -60.04 -41.5 92.43 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.949 -0.3 . . . . 15.0 110.458 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -60.91 -51.73 68.04 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.622 -0.431 . . . . 15.0 111.319 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 72.9 mt -63.63 -36.96 85.54 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.349 -0.54 . . . . 15.0 110.971 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -62.49 -41.87 99.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.648 0.261 . . . . 15.0 111.092 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.7 -30.62 69.41 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.068 -0.587 . . . . 15.0 111.932 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -88.09 10.96 17.46 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.535 0.939 . . . . 15.0 113.535 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.39 17.77 56.54 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 121.279 -0.486 . . . . 15.0 113.368 174.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -101.05 139.0 23.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 117.807 0.803 . . . . 15.0 110.217 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -83.28 130.75 35.09 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.207 -0.664 . . . . 15.0 109.207 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.69 133.94 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.137 0.494 . . . . 15.0 111.401 -172.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -140.21 138.12 34.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.543 -0.753 . . . . 15.0 109.64 171.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -115.81 141.65 47.82 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.825 0.345 . . . . 15.0 110.789 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.9 tp -117.83 113.42 37.98 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 118.814 -0.612 . . . . 15.0 110.585 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -49.67 135.0 34.39 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.208 1.272 . . . . 15.0 111.903 173.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.0 mt -62.87 -13.37 33.17 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.214 0.82 . . . . 15.0 113.214 -176.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -77.14 -5.32 48.6 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.3 0.852 . . . . 15.0 113.3 -177.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -61.25 149.93 81.2 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 118.484 0.584 . . . . 15.0 110.375 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -80.07 151.91 21.26 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.567 1.512 . . . . 15.0 112.891 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.39 150.7 6.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.066 -0.515 . . . . 15.0 111.173 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.08 -38.03 3.24 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.57 -0.612 . . . . 15.0 111.57 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -62.05 -37.98 87.02 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 117.081 0.44 . . . . 15.0 110.995 -177.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.2 tp -59.3 -47.46 85.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.922 0.392 . . . . 15.0 110.155 -178.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.4 tp -63.0 -44.5 95.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.204 -0.453 . . . . 15.0 110.973 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.65 -45.66 93.08 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.702 -0.399 . . . . 15.0 110.675 -176.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 47.2 ttt85 -61.01 -42.03 97.68 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.784 -0.367 . . . . 15.0 110.706 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.8 t -60.88 -45.04 98.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.811 -0.355 . . . . 15.0 110.322 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -68.79 -48.24 64.13 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.235 0.457 . . . . 15.0 112.235 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.03 -44.3 72.99 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.995 -0.282 . . . . 15.0 111.629 -175.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -78.41 -10.03 59.53 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.046 0.758 . . . . 15.0 113.046 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 55.93 55.84 6.57 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.593 0.711 . . . . 15.0 110.252 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.01 144.21 52.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.552 -0.749 . . . . 15.0 110.976 -176.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -90.8 -40.58 11.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.394 -0.821 . . . . 15.0 110.764 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -150.8 166.46 30.34 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 119.797 -1.192 . . . . 15.0 113.774 -173.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.0 mt -125.73 143.05 51.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.519 -0.84 . . . . 15.0 109.888 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.8 t -121.28 131.6 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 110.307 -0.257 . . . . 15.0 110.307 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.0 m -128.46 139.72 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.058 0.456 . . . . 15.0 110.469 173.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.9 t -102.03 -14.93 16.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.566 -0.743 . . . . 15.0 112.81 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 85.2 p -145.9 156.77 43.76 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.28 0.562 . . . . 15.0 111.771 -174.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.18 -39.7 90.41 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.873 -0.891 . . . . 15.0 110.873 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -59.33 -43.54 92.69 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.837 -0.345 . . . . 15.0 110.533 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.41 -46.29 94.13 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.544 -1.023 . . . . 15.0 110.544 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.16 -44.84 83.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.106 0.479 . . . . 15.0 110.685 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.82 -42.64 99.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.025 -0.534 . . . . 15.0 110.93 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -59.97 -40.78 90.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.781 0.324 . . . . 15.0 110.642 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.5 tp -58.15 -44.26 87.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.24 0.543 . . . . 15.0 110.17 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -60.82 -46.95 88.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.833 -0.621 . . . . 15.0 110.769 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.31 -42.63 98.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.083 -0.508 . . . . 15.0 111.123 -176.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 94.8 mt -65.47 -36.19 83.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.404 -0.362 . . . . 15.0 111.332 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.47 -38.08 79.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.145 0.498 . . . . 15.0 110.923 177.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.14 -143.85 0.58 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.627 -0.508 . . . . 15.0 109.627 174.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.54 -20.9 58.92 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.307 0.958 . . . . 15.0 112.694 -173.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -92.47 13.53 19.37 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.222 0.823 . . . . 15.0 113.222 -175.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 53.8 t-105 -47.74 -46.65 62.06 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-O 118.608 -0.711 . . . . 15.0 112.53 176.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -44.61 -40.39 13.92 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 121.475 1.45 . . . . 15.0 113.19 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -77.0 -48.79 16.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.034 0.445 . . . . 15.0 110.808 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.34 -39.08 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 15.0 110.876 -177.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.78 -14.3 29.23 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 119.849 -0.417 . . . . 15.0 113.083 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -65.13 -30.9 71.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 117.461 0.631 . . . . 15.0 111.785 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.3 mt -74.02 139.82 76.65 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 119.068 -0.491 . . . . 15.0 110.397 -175.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -58.9 134.26 59.03 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 121.433 1.422 . . . . 15.0 112.556 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.8 tp -108.87 129.2 55.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.075 -0.512 . . . . 15.0 110.745 176.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -91.1 125.83 36.0 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.54 -0.541 . . . . 15.0 109.54 175.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.7 m -117.1 149.16 43.8 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 119.513 -0.279 . . . . 15.0 110.377 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -79.15 -25.53 5.85 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.645 1.563 . . . . 15.0 113.597 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.6 p -142.7 162.21 45.34 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 120.635 -0.426 . . . . 15.0 111.542 -172.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -56.02 -43.9 52.21 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.11 1.207 . . . . 15.0 111.862 176.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 68.5 mtp85 -58.79 -46.58 87.22 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.868 -0.333 . . . . 15.0 110.871 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.01 -40.85 84.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.959 -0.385 . . . . 15.0 109.959 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.59 -42.04 82.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.886 0.374 . . . . 15.0 110.467 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.46 -41.37 97.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.281 -0.418 . . . . 15.0 110.555 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 86.9 mtp -59.91 -43.4 94.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.223 0.535 . . . . 15.0 110.442 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.48 -40.85 96.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.025 -0.534 . . . . 15.0 110.719 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -61.24 -44.25 97.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 15.0 110.324 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.8 -36.15 74.0 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.986 -0.286 . . . . 15.0 111.251 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.9 mt -65.24 -26.03 67.93 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.113 0.412 . . . . 15.0 112.113 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.67 13.26 16.99 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 119.391 -0.672 . . . . 15.0 113.13 -176.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.92 122.1 12.13 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 118.527 1.163 . . . . 15.0 109.884 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -68.23 -35.32 77.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.764 -0.653 . . . . 15.0 111.23 -171.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.3 tpt85 -131.79 117.45 18.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.907 0.384 . . . . 15.0 110.137 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.7 t -114.41 130.06 69.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.996 0.427 . . . . 15.0 110.091 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 87.0 mt -118.81 125.16 74.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.801 -0.636 . . . . 15.0 110.171 -177.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.82 118.07 31.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.388 -0.369 . . . . 15.0 110.08 175.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.9 p -92.91 -8.21 43.94 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.164 0.802 . . . . 15.0 113.164 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -55.14 -39.54 69.58 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.045 0.384 . . . . 15.0 110.914 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.07 -35.09 5.17 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.513 -0.635 . . . . 15.0 111.513 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.87 145.42 53.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.879 0.371 . . . . 15.0 110.691 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.6 t -89.8 152.01 21.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 15.0 110.406 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.67 -54.43 23.11 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 113.087 0.773 . . . . 15.0 113.087 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.83 -36.17 94.96 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 CA-C-N 120.098 1.071 . . . . 15.0 111.642 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.88 -42.0 92.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.035 0.445 . . . . 15.0 110.078 176.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.6 mt -59.02 -40.16 84.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.243 -0.435 . . . . 15.0 110.517 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.1 tp -57.17 -43.88 82.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.39 0.614 . . . . 15.0 110.146 178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.84 -40.88 90.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.679 -0.691 . . . . 15.0 110.393 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.73 -40.8 89.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.311 -0.404 . . . . 15.0 110.715 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.9 mt -57.82 -50.74 72.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.271 0.558 . . . . 15.0 110.494 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.5 p -63.57 -40.54 97.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.6 -0.727 . . . . 15.0 111.326 -175.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 86.5 p -65.74 -39.17 90.86 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.911 -0.316 . . . . 15.0 111.42 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.62 -39.31 94.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.497 -0.32 . . . . 15.0 111.068 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.94 -36.21 74.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.418 -0.356 . . . . 15.0 111.163 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 82.5 mt -59.13 -34.46 72.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.499 -0.319 . . . . 15.0 111.357 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -57.71 -34.56 69.59 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 121.298 -0.161 . . . . 15.0 111.418 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -53.92 -35.73 62.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.559 0.219 . . . . 15.0 111.421 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -101.64 140.44 35.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.91 0.386 . . . . 15.0 110.587 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -113.5 141.57 46.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.05 -0.523 . . . . 15.0 110.532 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -114.62 123.93 50.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.305 -0.407 . . . . 15.0 110.336 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -56.02 -40.63 73.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 15.0 110.987 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.982 -1.009 . . . . 15.0 110.615 -179.286 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.7 mtm . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.412 -0.588 . . . . 15.0 109.412 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -125.91 79.76 68.3 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.18 -0.464 . . . . 15.0 110.242 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -49.98 151.51 8.54 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.449 1.433 . . . . 15.0 111.937 -175.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -119.93 141.13 49.91 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.334 -0.394 . . . . 15.0 110.703 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.6 m -133.87 145.77 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.474 0.654 . . . . 15.0 111.781 175.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.4 tp -104.9 135.45 46.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.077 -0.965 . . . . 15.0 110.067 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.7 mt -103.04 135.09 42.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.026 0.441 . . . . 15.0 110.545 -177.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 96.7 mmm -88.21 134.12 33.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.422 -0.808 . . . . 15.0 110.123 174.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -57.81 140.72 51.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 15.0 110.583 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.36 175.07 42.52 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.949 -0.86 . . . . 15.0 110.949 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.61 -34.09 64.55 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.263 -0.175 . . . . 15.0 111.419 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.72 162.19 4.36 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.246 -0.742 . . . . 15.0 111.246 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.95 119.59 5.06 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.202 -0.759 . . . . 15.0 111.202 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -57.07 -43.79 82.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.097 0.475 . . . . 15.0 110.24 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.68 -41.71 98.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.861 -0.609 . . . . 15.0 111.146 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -58.84 -56.09 26.66 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.713 -0.395 . . . . 15.0 110.966 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.9 mt -61.53 -40.62 95.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.32 -0.4 . . . . 15.0 111.051 -176.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.41 -46.2 90.87 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.78 -0.368 . . . . 15.0 111.336 -177.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -60.29 -40.04 89.04 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.532 -0.467 . . . . 15.0 110.688 -177.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -60.57 -51.61 68.67 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 120.27 -0.572 . . . . 15.0 111.134 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.3 mt -66.31 -36.12 82.13 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.474 -0.49 . . . . 15.0 111.256 -176.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -61.66 -43.42 98.89 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 121.111 -0.236 . . . . 15.0 110.699 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.9 -30.7 70.26 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 120.844 -0.694 . . . . 15.0 112.018 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -88.21 8.59 26.41 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.647 0.98 . . . . 15.0 113.647 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.2 12.01 63.95 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 121.241 -0.505 . . . . 15.0 113.462 176.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.11 139.89 21.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 117.886 0.843 . . . . 15.0 110.044 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -86.26 137.44 32.61 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.699 -0.482 . . . . 15.0 109.699 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.6 t -116.78 131.13 70.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.186 0.517 . . . . 15.0 110.96 -174.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -134.81 130.2 35.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.587 -0.733 . . . . 15.0 109.446 171.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -112.01 135.69 52.32 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.896 0.379 . . . . 15.0 110.87 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.0 tp -116.15 113.35 41.53 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-O 118.751 -0.643 . . . . 15.0 110.398 -176.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.35 136.52 63.15 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.189 1.26 . . . . 15.0 112.445 175.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.4 mt -58.62 -10.96 2.56 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.339 0.866 . . . . 15.0 113.339 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -77.15 -5.81 50.52 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.321 0.859 . . . . 15.0 113.321 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -65.75 146.06 99.0 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 118.491 0.587 . . . . 15.0 110.482 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -80.75 157.13 21.25 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.602 1.535 . . . . 15.0 113.142 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.41 151.47 5.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.921 -0.582 . . . . 15.0 111.331 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.13 -38.03 3.24 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.527 -0.629 . . . . 15.0 111.527 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -62.45 -36.69 83.22 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.601 -0.44 . . . . 15.0 111.096 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.4 tp -59.11 -47.12 86.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.962 0.411 . . . . 15.0 110.196 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 19.4 tp -62.71 -45.2 93.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 15.0 110.868 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.68 -44.53 96.77 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.687 -0.405 . . . . 15.0 110.76 -176.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 58.9 ttm-85 -60.72 -42.56 97.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.503 -0.317 . . . . 15.0 110.773 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.9 t -60.46 -45.85 96.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.778 -0.369 . . . . 15.0 110.215 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 62.1 ttm-85 -67.45 -51.63 49.18 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 123.453 0.471 . . . . 15.0 112.005 -176.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.36 -44.31 79.32 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 121.05 -0.26 . . . . 15.0 111.698 -174.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -78.85 -10.18 59.71 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.065 0.765 . . . . 15.0 113.065 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 54.67 55.83 7.46 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.515 0.674 . . . . 15.0 110.568 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 97.8 mt -74.15 143.75 45.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.794 -0.639 . . . . 15.0 111.086 -176.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -90.2 -40.61 12.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.456 -0.793 . . . . 15.0 110.772 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.61 165.89 28.74 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 119.869 -1.158 . . . . 15.0 113.537 -171.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.1 mt -127.09 145.69 50.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.665 -0.768 . . . . 15.0 110.042 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.3 t -122.78 133.2 69.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 110.248 -0.279 . . . . 15.0 110.248 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.2 m -124.57 138.35 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 120.99 0.424 . . . . 15.0 110.609 174.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.1 p -90.05 -18.02 26.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.727 -0.67 . . . . 15.0 112.636 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 77.0 p -156.68 161.43 39.86 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 121.364 0.602 . . . . 15.0 111.719 -176.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.95 -37.25 69.73 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.193 -0.763 . . . . 15.0 111.193 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -59.17 -46.09 89.29 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.899 -0.32 . . . . 15.0 110.789 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.9 -42.78 98.36 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.808 -0.917 . . . . 15.0 110.808 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 28.8 tp -58.11 -47.33 83.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.987 0.423 . . . . 15.0 110.622 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.49 -43.61 98.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.181 -0.463 . . . . 15.0 110.644 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -59.09 -40.91 86.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.104 -0.498 . . . . 15.0 110.527 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.2 tp -56.76 -42.55 79.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.059 0.457 . . . . 15.0 110.194 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -58.74 -46.99 86.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.875 -0.602 . . . . 15.0 110.238 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -61.37 -43.2 99.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.794 -0.639 . . . . 15.0 111.098 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.83 -35.99 82.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.281 -0.418 . . . . 15.0 111.437 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.55 -38.49 81.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.063 0.458 . . . . 15.0 110.816 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.45 -143.56 0.57 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 109.454 -0.572 . . . . 15.0 109.454 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.48 -19.1 45.31 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.347 0.976 . . . . 15.0 112.66 -174.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -91.84 10.39 28.83 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.295 0.85 . . . . 15.0 113.295 -174.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 53.5 t-105 -47.75 -48.13 60.75 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 118.553 -0.737 . . . . 15.0 112.423 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -44.72 -40.37 14.26 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.47 1.447 . . . . 15.0 113.159 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -77.1 -48.6 17.33 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.936 0.398 . . . . 15.0 111.202 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 93.7 mt -59.11 -39.27 78.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 15.0 110.826 -177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.96 0.4 14.92 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 119.693 -0.504 . . . . 15.0 113.22 -175.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.3 mtm105 -90.58 -1.28 57.88 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.013 0.906 . . . . 15.0 112.975 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 23.3 mt -90.09 139.47 27.27 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-O 118.869 -0.586 . . . . 15.0 109.656 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.67 131.23 40.51 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.376 1.384 . . . . 15.0 111.759 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.3 tp -105.43 128.07 53.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.748 0.309 . . . . 15.0 110.9 177.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -92.84 127.13 38.23 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.696 -0.483 . . . . 15.0 109.696 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.8 m -123.15 151.58 62.18 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-O 119.567 -0.254 . . . . 15.0 110.67 177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.28 -19.63 10.31 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 121.514 1.476 . . . . 15.0 113.803 -175.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.0 p -148.83 162.47 29.38 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 120.391 -0.524 . . . . 15.0 111.841 -171.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.4 -43.96 47.0 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.2 1.267 . . . . 15.0 111.885 176.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -58.2 -46.75 85.27 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.808 -0.357 . . . . 15.0 110.71 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 50.2 t -60.95 -38.38 79.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.689 -0.404 . . . . 15.0 110.128 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.85 -41.71 78.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.042 0.449 . . . . 15.0 110.427 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -60.88 -40.09 91.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.154 -0.476 . . . . 15.0 110.616 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.1 mmm -58.34 -45.85 87.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.45 0.643 . . . . 15.0 110.173 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.11 98.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.733 -0.667 . . . . 15.0 111.112 -177.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 71.6 ttp85 -62.28 -44.2 97.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.186 -0.461 . . . . 15.0 110.708 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -59.33 -36.15 75.12 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.978 -0.289 . . . . 15.0 111.236 -177.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 81.5 mt -65.46 -25.24 67.42 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.098 0.407 . . . . 15.0 112.098 177.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 111.58 13.2 13.24 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 119.293 -0.726 . . . . 15.0 113.235 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.22 131.08 49.95 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.566 1.183 . . . . 15.0 109.666 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -62.24 -44.42 96.59 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.452 -0.573 . . . . 15.0 109.452 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 47.9 ttt85 -131.84 119.03 20.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.464 -0.789 . . . . 15.0 110.945 -173.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.8 t -114.43 128.78 71.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.829 -0.623 . . . . 15.0 109.503 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 93.2 mt -117.79 123.92 72.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.903 -0.59 . . . . 15.0 110.279 -175.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -94.36 118.22 31.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.364 -0.38 . . . . 15.0 110.22 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.7 p -91.33 -6.94 52.3 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.141 0.793 . . . . 15.0 113.141 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 47.0 tpt85 -55.51 -39.61 70.73 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 118.208 0.458 . . . . 15.0 110.723 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.33 -35.2 5.32 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.48 -0.648 . . . . 15.0 111.48 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.11 144.25 42.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.816 0.341 . . . . 15.0 110.55 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.1 m -89.72 161.8 15.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.04 0.448 . . . . 15.0 110.578 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.65 -54.27 24.25 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 112.976 0.732 . . . . 15.0 112.976 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.05 -34.84 98.9 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 CA-C-N 120.213 1.112 . . . . 15.0 111.601 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.63 94.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.061 0.457 . . . . 15.0 110.048 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.3 mt -59.05 -40.9 86.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.446 . . . . 15.0 110.411 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 40.7 tp -57.31 -44.46 84.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.383 0.611 . . . . 15.0 110.136 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.31 -39.74 88.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.583 -0.735 . . . . 15.0 110.677 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.88 -42.42 97.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.415 -0.357 . . . . 15.0 110.899 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.0 mt -57.88 -50.36 73.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.026 0.441 . . . . 15.0 110.428 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.8 p -65.38 -39.95 92.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.827 -0.624 . . . . 15.0 111.576 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.1 p -66.35 -38.42 87.57 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.999 -0.28 . . . . 15.0 111.28 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.63 -42.59 95.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.41 -0.359 . . . . 15.0 111.133 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.55 -41.66 97.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.756 0.313 . . . . 15.0 110.579 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 93.5 mt -64.07 -37.1 86.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 15.0 111.081 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.61 -34.99 71.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.564 -0.289 . . . . 15.0 111.466 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -56.9 -41.43 78.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.549 0.214 . . . . 15.0 111.08 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -112.12 134.24 53.79 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.808 0.337 . . . . 15.0 110.73 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -118.5 130.14 55.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.273 -0.421 . . . . 15.0 110.51 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -60.75 -41.1 94.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 15.0 110.63 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -111.82 138.9 47.8 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.263 -0.426 . . . . 15.0 110.464 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.054 -0.974 . . . . 15.0 110.488 179.964 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.6 mtm . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.395 -0.594 . . . . 15.0 109.395 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -125.79 78.12 69.58 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.091 -0.504 . . . . 15.0 110.238 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -50.99 154.53 7.15 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.486 1.457 . . . . 15.0 111.871 -176.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -116.43 140.39 49.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.448 -0.342 . . . . 15.0 110.831 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.2 m -135.4 143.78 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.638 0.732 . . . . 15.0 111.69 175.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 tp -104.72 134.34 48.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.855 -1.066 . . . . 15.0 110.262 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.9 mt -103.35 135.15 42.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 15.0 110.505 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 85.9 mtp -101.08 134.11 44.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.66 -0.7 . . . . 15.0 109.531 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -57.61 146.47 30.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.002 0.429 . . . . 15.0 110.81 -174.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.92 175.14 33.79 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.97 -0.852 . . . . 15.0 110.97 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.56 -32.62 67.31 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.602 0.223 . . . . 15.0 111.602 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.51 177.01 18.25 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.014 -0.835 . . . . 15.0 111.014 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.0 122.09 5.81 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.313 -0.715 . . . . 15.0 111.313 -178.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -57.17 -44.52 83.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.098 0.475 . . . . 15.0 110.27 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.96 -41.13 97.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.927 -0.579 . . . . 15.0 110.958 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -57.88 -55.98 27.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.981 0.42 . . . . 15.0 111.0 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.8 tp -60.54 -42.13 95.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 15.0 111.025 -176.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.06 -43.69 98.51 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.799 -0.36 . . . . 15.0 111.45 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -61.73 -39.46 91.64 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.704 -0.398 . . . . 15.0 110.818 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -61.01 -51.6 68.54 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.381 -0.527 . . . . 15.0 111.232 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 80.9 mt -64.26 -37.58 87.97 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.409 -0.516 . . . . 15.0 111.001 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -63.79 -43.8 95.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.59 0.233 . . . . 15.0 111.121 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.93 -30.66 66.81 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.03 -0.605 . . . . 15.0 111.961 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -88.03 9.33 22.81 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.57 0.952 . . . . 15.0 113.57 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.21 13.63 58.5 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 121.247 -0.501 . . . . 15.0 113.554 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.0 t -101.09 138.15 26.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 117.845 0.822 . . . . 15.0 110.061 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -79.51 132.42 36.32 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.194 -0.669 . . . . 15.0 109.194 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.6 t -116.36 131.17 69.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.194 0.521 . . . . 15.0 111.106 -173.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -137.73 130.8 30.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.413 -0.812 . . . . 15.0 109.377 170.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -114.15 135.11 54.39 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.87 0.366 . . . . 15.0 110.645 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 tp -112.99 136.04 21.7 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.946 -0.55 . . . . 15.0 110.027 -175.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -72.16 135.11 24.36 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.332 1.354 . . . . 15.0 111.976 172.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.4 mt -58.36 -11.94 3.3 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.33 0.863 . . . . 15.0 113.33 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -77.21 -6.64 53.78 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.392 0.886 . . . . 15.0 113.392 -176.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -68.55 150.9 97.52 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 118.524 0.602 . . . . 15.0 110.738 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -78.95 155.9 26.61 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.64 1.56 . . . . 15.0 113.102 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.11 151.99 4.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.763 -0.653 . . . . 15.0 111.226 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.44 -38.03 3.24 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.945 -0.57 . . . . 15.0 111.688 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.68 -38.86 86.35 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 117.172 0.486 . . . . 15.0 110.738 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.2 tp -60.46 -48.3 82.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.954 0.407 . . . . 15.0 110.4 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.3 tp -60.38 -42.38 95.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 15.0 110.772 -175.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.25 -46.24 89.72 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.664 -0.415 . . . . 15.0 110.909 -175.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 -61.1 -41.35 96.52 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.499 -0.48 . . . . 15.0 110.679 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.2 t -60.33 -46.08 95.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.748 -0.381 . . . . 15.0 110.202 -176.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -68.57 -51.32 44.03 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 123.421 0.45 . . . . 15.0 112.066 -175.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.29 -44.25 79.72 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.857 0.317 . . . . 15.0 111.857 -173.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -79.56 -10.07 59.73 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.08 0.77 . . . . 15.0 113.08 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 55.5 55.78 6.96 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.632 0.729 . . . . 15.0 110.219 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.0 mt -68.04 143.56 55.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.671 -0.695 . . . . 15.0 111.364 -174.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -91.16 -40.13 11.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.151 -0.931 . . . . 15.0 110.838 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.37 160.75 28.46 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.023 -1.084 . . . . 15.0 113.788 -174.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 71.3 mt -125.39 143.39 51.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.486 -0.857 . . . . 15.0 109.618 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.6 t -122.11 132.07 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 121.148 -0.221 . . . . 15.0 110.764 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.5 m -124.23 145.78 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.144 0.497 . . . . 15.0 110.524 172.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 t -98.1 -21.45 16.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.479 -0.782 . . . . 15.0 112.426 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 81.3 p -152.73 162.16 41.62 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.414 0.625 . . . . 15.0 111.801 -174.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.86 -37.08 68.36 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.118 -0.793 . . . . 15.0 111.118 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -58.98 -46.08 88.99 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.858 -0.337 . . . . 15.0 110.646 -177.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.56 -44.07 98.18 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.732 -0.947 . . . . 15.0 110.732 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.2 tp -57.04 -45.09 83.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.112 0.482 . . . . 15.0 110.672 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.72 -43.69 98.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 15.0 110.534 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -59.83 -38.1 81.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.706 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.5 tp -56.69 -44.9 81.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.388 0.613 . . . . 15.0 110.155 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -60.0 -46.87 88.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.495 -0.775 . . . . 15.0 110.584 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -61.51 -43.23 99.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.975 -0.557 . . . . 15.0 111.091 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.09 -34.99 78.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.449 -0.342 . . . . 15.0 111.468 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.46 -38.14 80.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.965 0.412 . . . . 15.0 110.69 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.2 -143.93 0.58 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 109.605 -0.517 . . . . 15.0 109.605 174.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.53 -18.87 44.08 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.336 0.971 . . . . 15.0 112.678 -174.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -91.86 10.8 27.17 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.282 0.845 . . . . 15.0 113.282 -175.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 60.0 t-105 -47.81 -46.56 62.65 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-O 118.588 -0.72 . . . . 15.0 112.556 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -44.74 -41.6 14.86 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.438 1.425 . . . . 15.0 113.267 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -77.03 -48.79 16.92 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.954 0.407 . . . . 15.0 110.819 -177.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 90.3 mt -59.57 -40.56 82.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 15.0 110.855 -176.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.68 -15.87 35.37 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 116.392 -0.367 . . . . 15.0 113.144 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -65.06 -29.93 70.85 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.355 0.578 . . . . 15.0 112.073 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.2 mt -75.7 150.51 84.21 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 121.018 -0.273 . . . . 15.0 111.648 -173.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.31 128.23 23.21 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.751 1.634 . . . . 15.0 112.481 176.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.9 tp -106.32 125.66 51.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.343 -0.389 . . . . 15.0 110.516 174.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -90.05 126.56 35.81 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.634 -0.506 . . . . 15.0 109.634 176.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.7 m -119.06 147.28 42.31 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 119.438 -0.315 . . . . 15.0 110.176 176.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.14 -24.27 6.91 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.601 1.534 . . . . 15.0 113.529 -175.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.3 p -142.98 162.54 42.98 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 120.602 -0.439 . . . . 15.0 111.52 -171.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.14 -44.07 50.26 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.184 1.256 . . . . 15.0 111.755 176.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 70.9 ttp85 -57.45 -48.39 79.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.833 0.349 . . . . 15.0 110.845 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.8 t -59.9 -40.07 81.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.99 -0.374 . . . . 15.0 109.99 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.42 -42.29 82.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.903 0.383 . . . . 15.0 110.371 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -60.47 -40.11 90.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 15.0 110.621 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.1 mmm -58.46 -43.68 88.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.364 0.602 . . . . 15.0 110.212 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.16 -42.4 98.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.8 -0.636 . . . . 15.0 110.883 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -62.87 -42.01 99.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 15.0 110.871 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -59.64 -36.19 75.89 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.909 -0.317 . . . . 15.0 111.3 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.9 mt -68.96 -21.43 64.18 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.569 0.581 . . . . 15.0 112.569 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 106.85 13.28 22.28 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 119.376 -0.68 . . . . 15.0 113.086 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.79 122.14 12.15 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.439 1.12 . . . . 15.0 109.989 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -68.13 -36.04 79.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.55 -0.75 . . . . 15.0 111.226 -171.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.7 ttm-85 -131.76 114.03 14.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.045 0.45 . . . . 15.0 110.575 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.0 t -112.39 130.58 65.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.175 -0.466 . . . . 15.0 109.873 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.5 mt -119.74 123.73 71.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.941 -0.572 . . . . 15.0 110.142 -176.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.27 118.47 31.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.381 -0.372 . . . . 15.0 110.193 176.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.5 p -96.04 -3.99 43.86 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.283 0.846 . . . . 15.0 113.283 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -56.02 -39.96 72.7 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 118.199 0.454 . . . . 15.0 110.698 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -92.06 -35.07 6.86 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.505 -0.638 . . . . 15.0 111.505 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.44 142.38 41.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.841 0.353 . . . . 15.0 110.704 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.2 m -89.82 164.07 14.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 15.0 110.327 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.61 -54.22 24.43 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-O 118.523 -0.751 . . . . 15.0 112.963 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.59 -36.18 97.74 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 CA-C-N 120.583 1.244 . . . . 15.0 111.346 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.21 -42.61 95.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.046 0.451 . . . . 15.0 110.165 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.0 mt -58.95 -40.66 85.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 15.0 110.44 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 29.2 tp -57.36 -44.35 84.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.31 0.576 . . . . 15.0 110.181 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.6 -40.99 93.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.656 -0.702 . . . . 15.0 110.556 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.23 92.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.356 -0.384 . . . . 15.0 110.805 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.1 mt -57.9 -51.39 69.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.284 0.564 . . . . 15.0 110.451 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.2 p -64.69 -40.27 95.09 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.585 -0.734 . . . . 15.0 111.38 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.3 p -64.6 -38.88 92.52 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.037 -0.265 . . . . 15.0 111.335 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.81 -42.72 99.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.747 0.308 . . . . 15.0 110.891 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.64 -39.45 88.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.375 -0.375 . . . . 15.0 110.769 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.8 -35.0 79.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.419 -0.355 . . . . 15.0 111.399 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -93.99 137.54 33.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.945 0.402 . . . . 15.0 111.148 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -160.03 -61.39 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.894 -0.593 . . . . 15.0 110.357 178.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -55.31 -38.89 69.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 15.0 111.074 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -57.13 -40.57 77.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.355 -0.384 . . . . 15.0 110.87 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -57.17 -45.51 83.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.34 -0.391 . . . . 15.0 110.829 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -56.65 -39.46 73.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.354 -0.384 . . . . 15.0 110.868 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.044 -0.979 . . . . 15.0 110.513 179.922 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.376 -0.602 . . . . 15.0 109.376 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.26 83.35 64.05 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.164 -0.471 . . . . 15.0 110.421 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.01 153.89 5.91 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.373 1.382 . . . . 15.0 111.918 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -109.98 138.38 46.44 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.552 -0.295 . . . . 15.0 110.866 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.4 m -135.96 144.16 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 121.612 0.72 . . . . 15.0 111.707 177.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.4 tp -104.55 135.84 45.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.936 -1.029 . . . . 15.0 110.233 177.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.3 mt -102.58 135.11 41.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.279 -0.419 . . . . 15.0 110.319 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 86.5 mtp -99.08 134.02 42.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.898 -0.592 . . . . 15.0 110.305 173.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -57.59 140.93 49.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.377 . . . . 15.0 110.641 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.55 175.18 31.26 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.826 -0.91 . . . . 15.0 110.826 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.42 -33.02 65.42 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.163 -0.215 . . . . 15.0 111.424 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.7 176.27 32.65 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.674 -0.97 . . . . 15.0 110.674 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.98 120.66 5.55 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.951 -0.642 . . . . 15.0 111.519 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -57.01 -41.39 78.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.803 0.335 . . . . 15.0 110.575 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -62.23 -41.93 98.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.426 . . . . 15.0 111.229 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -63.42 -55.88 20.76 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.793 -0.363 . . . . 15.0 111.345 -176.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.0 mt -59.55 -43.69 93.45 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.724 -0.39 . . . . 15.0 110.967 -176.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.55 -40.24 96.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 15.0 110.812 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.89 -41.92 92.67 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.962 -0.295 . . . . 15.0 110.505 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -60.0 -51.74 68.36 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.591 -0.443 . . . . 15.0 110.999 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 80.6 mt -62.46 -37.53 86.29 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.497 -0.481 . . . . 15.0 111.103 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -63.32 -44.26 95.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.554 0.216 . . . . 15.0 110.929 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.18 -30.58 67.55 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.019 -0.61 . . . . 15.0 111.92 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -88.09 10.08 20.44 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.556 0.947 . . . . 15.0 113.556 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.09 18.82 41.66 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 121.109 -0.567 . . . . 15.0 113.351 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.3 t -101.02 139.97 20.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 117.665 0.732 . . . . 15.0 110.19 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -82.22 126.0 31.58 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.865 -0.791 . . . . 15.0 108.865 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.3 t -116.02 130.93 69.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.314 0.578 . . . . 15.0 111.331 -171.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -137.23 133.56 35.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.274 -0.875 . . . . 15.0 109.439 170.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -114.08 135.85 53.57 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.92 0.391 . . . . 15.0 110.857 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 tp -116.16 113.3 41.51 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.632 -0.699 . . . . 15.0 110.194 -176.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.0 135.12 50.94 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.159 1.239 . . . . 15.0 112.09 174.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.65 -9.2 3.56 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.325 0.861 . . . . 15.0 113.325 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -77.15 -6.03 51.33 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.184 0.809 . . . . 15.0 113.184 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -64.62 150.11 94.49 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 118.512 0.596 . . . . 15.0 110.378 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -80.04 154.93 22.74 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.544 1.496 . . . . 15.0 113.27 -177.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.72 152.1 3.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.883 -0.599 . . . . 15.0 111.362 -178.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.23 -37.95 3.26 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.611 -0.596 . . . . 15.0 111.611 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -61.23 -36.52 80.17 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.607 -0.437 . . . . 15.0 111.184 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.4 tp -59.16 -48.83 80.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.965 0.412 . . . . 15.0 110.228 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 23.1 tp -62.73 -44.25 96.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 15.0 110.988 -175.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.08 -44.84 95.79 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.67 -0.412 . . . . 15.0 110.907 -176.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 60.0 ttm-85 -60.79 -41.87 96.46 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 121.01 -0.276 . . . . 15.0 110.713 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.4 t -60.68 -45.78 96.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.835 -0.346 . . . . 15.0 110.111 -177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -70.52 -46.86 62.83 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.1 0.408 . . . . 15.0 112.1 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.49 -44.44 82.62 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.047 -0.261 . . . . 15.0 111.442 -175.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -81.15 -10.16 59.69 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.124 0.787 . . . . 15.0 113.124 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 54.66 55.89 7.4 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.582 0.706 . . . . 15.0 110.483 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.4 mt -69.94 150.63 46.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.618 -0.719 . . . . 15.0 111.546 -175.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -95.25 -40.51 9.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.162 -0.926 . . . . 15.0 110.767 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -149.7 165.36 29.62 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 119.955 -1.117 . . . . 15.0 113.75 -174.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 70.7 mt -126.09 142.57 51.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.489 -0.856 . . . . 15.0 109.575 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.39 130.18 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.682 0.277 . . . . 15.0 110.777 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.7 m -128.1 155.68 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.02 0.438 . . . . 15.0 110.575 171.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.3 t -131.34 14.4 5.06 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.681 -0.691 . . . . 15.0 112.408 176.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.6 p -155.0 149.35 26.16 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.267 0.556 . . . . 15.0 111.548 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.89 -40.18 92.74 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.61 -0.996 . . . . 15.0 110.61 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -58.57 -41.4 85.57 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.916 -0.314 . . . . 15.0 110.473 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.91 -47.15 92.67 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.774 -0.93 . . . . 15.0 110.774 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.1 tp -57.06 -44.43 83.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.109 0.48 . . . . 15.0 110.653 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.78 -43.59 98.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.032 -0.531 . . . . 15.0 110.822 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -59.36 -38.93 81.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 15.0 110.767 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.2 tp -57.48 -44.81 85.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.247 0.546 . . . . 15.0 110.172 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -60.68 -47.15 87.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.675 -0.693 . . . . 15.0 110.468 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -61.97 -43.94 97.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 15.0 111.31 -176.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.57 -35.24 79.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.367 -0.379 . . . . 15.0 111.358 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.42 -38.78 81.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.939 0.4 . . . . 15.0 110.646 178.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.11 -143.72 0.59 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.58 -0.526 . . . . 15.0 109.58 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.47 -18.14 37.23 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.417 1.008 . . . . 15.0 112.654 -175.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -91.79 9.61 31.94 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.341 0.867 . . . . 15.0 113.341 -175.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 59.2 t-105 -47.85 -47.35 63.14 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-O 118.629 -0.701 . . . . 15.0 112.546 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -44.78 -40.76 14.77 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 121.482 1.455 . . . . 15.0 113.199 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -76.97 -48.79 17.07 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.044 0.45 . . . . 15.0 110.741 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 92.8 mt -59.59 -39.93 80.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.025 -0.534 . . . . 15.0 110.925 -176.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.51 -15.82 33.9 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 119.944 -0.364 . . . . 15.0 113.116 -176.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -65.87 -30.03 70.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.387 0.593 . . . . 15.0 112.016 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.7 mt -74.49 150.62 87.06 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 111.638 0.236 . . . . 15.0 111.638 -172.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.97 123.58 13.2 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.599 1.533 . . . . 15.0 112.026 176.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.8 tp -103.35 123.44 46.82 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.804 -0.358 . . . . 15.0 110.426 174.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -89.38 123.38 33.48 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.057 -0.72 . . . . 15.0 109.057 175.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.3 m -112.25 151.82 43.99 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 110.341 -0.244 . . . . 15.0 110.341 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.0 -28.65 3.76 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.414 1.409 . . . . 15.0 113.1 -175.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.4 p -144.39 167.91 13.8 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 120.656 -0.418 . . . . 15.0 111.537 -173.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -60.42 -44.0 30.42 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 121.228 1.286 . . . . 15.0 111.6 177.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -57.0 -47.99 79.52 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.88 -0.328 . . . . 15.0 110.777 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.55 -40.07 83.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.604 -0.438 . . . . 15.0 110.027 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.01 -41.71 79.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.928 0.394 . . . . 15.0 110.545 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.27 -41.32 96.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.218 -0.447 . . . . 15.0 110.529 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 87.3 mtp -59.57 -44.04 93.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.307 0.575 . . . . 15.0 110.384 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.5 -40.52 94.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.858 -0.61 . . . . 15.0 110.791 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -61.15 -45.04 96.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.278 -0.419 . . . . 15.0 110.435 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.68 -36.2 76.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.508 -0.315 . . . . 15.0 111.298 -177.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.82 -26.47 68.35 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.108 0.41 . . . . 15.0 112.108 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.21 13.16 10.14 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 119.281 -0.733 . . . . 15.0 113.177 -176.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.9 121.82 11.45 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.597 1.198 . . . . 15.0 109.691 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -71.61 -39.75 70.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.519 -0.764 . . . . 15.0 110.617 -171.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 52.8 ttp85 -132.09 113.9 13.9 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.453 0.644 . . . . 15.0 110.832 178.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.2 t -114.43 133.28 61.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.645 -0.707 . . . . 15.0 110.264 -176.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 87.6 mt -117.54 126.42 74.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.677 -0.692 . . . . 15.0 110.244 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -96.26 117.48 30.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.452 -0.34 . . . . 15.0 110.519 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 30.3 p -69.67 -20.32 63.57 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.574 0.583 . . . . 15.0 112.574 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -53.21 -36.97 61.57 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 122.113 -0.367 . . . . 15.0 111.508 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.27 -35.18 8.19 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 120.824 -0.703 . . . . 15.0 111.648 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -92.18 120.92 33.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.766 0.317 . . . . 15.0 111.121 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.9 m -70.44 165.85 21.65 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.433 -0.58 . . . . 15.0 109.433 174.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.55 -54.4 22.85 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 112.776 0.658 . . . . 15.0 112.776 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -57.49 -34.96 98.84 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 120.9 1.067 . . . . 15.0 111.4 176.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.14 -40.8 95.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.842 0.353 . . . . 15.0 110.365 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.2 mt -58.97 -41.79 88.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.015 0.435 . . . . 15.0 110.169 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.5 tp -57.23 -45.15 84.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.488 0.661 . . . . 15.0 110.169 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.46 91.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.505 -0.77 . . . . 15.0 110.817 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.97 -42.47 98.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.578 -0.283 . . . . 15.0 110.815 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.6 mt -57.94 -52.25 66.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.397 0.617 . . . . 15.0 110.463 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.7 p -66.32 -38.36 87.53 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.454 -0.794 . . . . 15.0 111.656 -174.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.3 p -67.65 -38.19 83.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.709 0.29 . . . . 15.0 111.322 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.7 -40.57 97.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.423 -0.353 . . . . 15.0 110.827 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.05 -38.86 80.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.395 -0.366 . . . . 15.0 110.797 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 86.8 mt -62.41 -37.78 87.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.41 -0.359 . . . . 15.0 110.95 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.55 143.66 56.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.766 0.317 . . . . 15.0 110.654 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -143.05 -57.96 0.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.295 -0.411 . . . . 15.0 110.666 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -55.42 -41.23 72.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 15.0 111.191 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -55.49 -39.15 70.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.464 -0.335 . . . . 15.0 111.173 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -54.75 -37.31 65.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.348 -0.387 . . . . 15.0 111.491 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -111.9 138.01 49.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.922 0.391 . . . . 15.0 110.916 -177.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 118.048 -0.977 . . . . 15.0 110.517 179.575 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.4 mtm . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.306 -0.628 . . . . 15.0 109.306 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.0 79.78 68.62 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.176 -0.466 . . . . 15.0 110.29 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -55.58 154.98 22.91 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 121.439 1.426 . . . . 15.0 111.696 -176.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -111.98 140.11 46.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.582 -0.281 . . . . 15.0 110.815 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.9 m -136.17 143.92 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.647 0.737 . . . . 15.0 111.818 175.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.1 tp -105.07 136.75 43.97 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.924 -1.034 . . . . 15.0 110.245 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.0 mt -104.61 135.14 43.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.096 0.474 . . . . 15.0 111.067 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 99.0 mmm -94.89 134.04 37.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.134 -0.939 . . . . 15.0 109.364 172.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -66.28 145.07 56.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.937 0.398 . . . . 15.0 110.554 -178.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -161.08 175.22 37.74 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.76 -0.936 . . . . 15.0 110.76 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -51.29 -31.2 20.58 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.847 0.314 . . . . 15.0 111.847 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.99 -174.02 1.74 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.938 -0.865 . . . . 15.0 110.938 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -108.4 109.58 2.9 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.49 -0.644 . . . . 15.0 111.49 -177.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.3 mtm-85 -55.2 -38.85 68.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.645 0.26 . . . . 15.0 111.035 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -59.87 -54.98 39.84 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.067 0.395 . . . . 15.0 112.067 -172.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -69.95 -45.09 68.18 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.274 -0.57 . . . . 15.0 111.435 -173.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.1 tp -58.12 -44.84 87.96 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 120.491 -0.484 . . . . 15.0 110.589 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.75 -42.5 99.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 15.0 110.44 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -57.96 -40.46 80.65 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.931 -0.308 . . . . 15.0 110.562 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -59.08 -51.64 69.19 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.959 0.409 . . . . 15.0 111.042 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.7 mt -59.81 -37.32 78.81 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.567 -0.453 . . . . 15.0 110.887 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -62.95 -41.97 99.68 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 121.107 -0.237 . . . . 15.0 111.119 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.25 -30.56 67.75 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 120.981 -0.628 . . . . 15.0 111.966 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -88.18 9.57 22.42 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.557 0.947 . . . . 15.0 113.557 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.32 15.42 58.78 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 121.23 -0.509 . . . . 15.0 113.393 175.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.9 t -101.04 137.84 27.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 117.917 0.858 . . . . 15.0 110.209 178.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -81.17 129.92 34.79 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.367 -0.605 . . . . 15.0 109.367 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.4 t -120.11 132.23 70.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.241 0.543 . . . . 15.0 111.192 -173.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -139.18 135.22 33.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.391 -0.822 . . . . 15.0 109.731 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -114.8 138.78 50.35 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.775 0.322 . . . . 15.0 110.553 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.0 tp -114.85 113.43 44.49 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 118.756 -0.64 . . . . 15.0 110.896 -173.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -49.88 135.07 35.89 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.158 1.238 . . . . 15.0 111.886 172.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.1 mt -66.79 -11.13 53.98 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.216 0.821 . . . . 15.0 113.216 -174.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -77.31 -9.4 58.8 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.169 0.803 . . . . 15.0 113.169 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -65.28 148.02 98.22 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 118.502 0.592 . . . . 15.0 110.544 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.34 148.74 43.93 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.565 1.51 . . . . 15.0 113.58 -174.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.93 152.52 3.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.465 -0.789 . . . . 15.0 111.228 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.2 -38.15 3.21 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.497 -0.641 . . . . 15.0 111.497 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -64.16 -36.38 83.86 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 120.426 -0.51 . . . . 15.0 111.12 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.5 tp -58.66 -45.97 88.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.896 0.379 . . . . 15.0 110.196 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 16.8 tp -63.49 -45.57 90.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 15.0 110.902 -177.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.78 99.25 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.784 -0.367 . . . . 15.0 110.859 -177.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -60.99 -44.14 97.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.428 -0.351 . . . . 15.0 110.511 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 67.3 t -61.5 -46.1 97.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.935 -0.306 . . . . 15.0 110.252 -177.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 70.7 ttp85 -68.53 -48.07 65.28 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.984 0.364 . . . . 15.0 111.984 -176.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.09 -44.47 84.28 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.1 -0.24 . . . . 15.0 111.512 -173.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -81.99 -10.01 59.38 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.249 0.833 . . . . 15.0 113.249 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 55.86 55.82 6.64 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.607 0.718 . . . . 15.0 110.336 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.5 mt -63.53 146.09 54.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.601 -0.727 . . . . 15.0 111.426 -174.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -87.72 -39.76 14.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.982 -1.008 . . . . 15.0 110.685 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.52 166.39 30.7 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.045 -1.074 . . . . 15.0 113.639 -174.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.1 mt -125.91 142.08 51.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.507 -0.846 . . . . 15.0 109.612 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.0 t -121.47 131.37 73.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.282 -0.266 . . . . 15.0 110.282 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.5 m -125.69 130.44 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.009 0.433 . . . . 15.0 110.216 172.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.7 p -92.81 -10.86 35.3 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.915 0.709 . . . . 15.0 112.915 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 82.8 p -152.52 157.6 41.33 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 121.271 0.558 . . . . 15.0 111.561 -176.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.78 -38.92 85.94 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.962 -0.855 . . . . 15.0 110.962 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -58.97 -43.93 91.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.777 0.322 . . . . 15.0 110.416 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.3 -44.84 97.09 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.784 -0.926 . . . . 15.0 110.784 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.9 tp -57.7 -44.61 85.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.095 0.474 . . . . 15.0 110.531 -178.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.26 -42.23 98.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.063 -0.517 . . . . 15.0 110.64 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -58.99 -39.91 83.23 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.834 -0.346 . . . . 15.0 110.628 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.5 tp -58.23 -44.83 88.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.181 0.515 . . . . 15.0 110.109 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -61.6 -47.22 86.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.697 -0.683 . . . . 15.0 110.787 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -61.91 -43.86 97.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 15.0 111.185 -176.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.3 mt -66.3 -34.98 79.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.351 -0.386 . . . . 15.0 111.387 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.0 -39.17 81.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.126 0.489 . . . . 15.0 110.581 177.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.16 -143.3 0.6 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 109.609 -0.515 . . . . 15.0 109.609 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.44 -19.09 44.88 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.391 0.996 . . . . 15.0 112.608 -175.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -91.91 10.44 28.78 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.297 0.851 . . . . 15.0 113.297 -175.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -47.81 -46.9 63.15 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-O 118.666 -0.683 . . . . 15.0 112.494 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -44.68 -40.43 14.15 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.483 1.455 . . . . 15.0 113.283 177.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -77.0 -48.73 17.17 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.691 -0.404 . . . . 15.0 110.803 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.5 mt -59.63 -39.73 80.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 15.0 110.83 -177.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.2 -16.44 34.08 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 116.334 -0.394 . . . . 15.0 113.124 -177.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -64.73 -30.3 71.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 117.365 0.582 . . . . 15.0 111.959 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 27.5 mt -76.45 150.59 82.51 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 120.903 -0.319 . . . . 15.0 111.312 -173.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.4 129.54 28.59 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.63 1.554 . . . . 15.0 112.473 176.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.0 tp -107.78 126.26 52.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.448 -0.342 . . . . 15.0 110.605 175.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -90.97 126.09 35.97 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.721 -0.474 . . . . 15.0 109.721 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.0 m -117.47 147.15 40.08 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 110.079 -0.341 . . . . 15.0 110.079 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.15 -23.25 7.81 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.639 1.56 . . . . 15.0 113.598 -174.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.5 p -143.51 158.15 57.8 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 120.737 -0.385 . . . . 15.0 111.33 -172.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.29 -43.95 53.03 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.238 1.292 . . . . 15.0 111.792 176.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -58.11 -47.37 83.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.779 0.323 . . . . 15.0 110.931 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.89 -40.24 82.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.75 -0.38 . . . . 15.0 110.036 178.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.36 -42.46 82.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.962 0.41 . . . . 15.0 110.422 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.09 -41.87 97.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.144 -0.48 . . . . 15.0 110.506 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 87.1 mtp -59.29 -43.88 92.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.227 0.537 . . . . 15.0 110.353 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.44 94.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.963 -0.562 . . . . 15.0 110.801 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -61.31 -44.36 97.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.298 -0.41 . . . . 15.0 110.629 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.17 -36.1 76.84 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.857 -0.337 . . . . 15.0 111.234 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.8 mt -64.3 -25.69 68.16 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.942 0.349 . . . . 15.0 111.942 176.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.43 13.25 15.26 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 119.314 -0.714 . . . . 15.0 113.095 -176.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.88 121.95 11.75 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 118.566 1.183 . . . . 15.0 109.888 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -69.5 -35.09 75.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.668 -0.696 . . . . 15.0 111.328 -171.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.1 tpt85 -131.79 114.5 14.79 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.957 0.408 . . . . 15.0 110.082 177.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.1 t -110.85 130.25 64.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.045 0.45 . . . . 15.0 109.851 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 85.2 mt -119.61 124.95 73.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.818 -0.628 . . . . 15.0 110.053 -176.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -95.33 117.32 30.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.435 -0.348 . . . . 15.0 110.302 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.9 p -97.05 -1.55 45.15 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.182 0.808 . . . . 15.0 113.182 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 46.9 tpt85 -55.67 -39.7 71.31 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.184 0.447 . . . . 15.0 110.665 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.01 -35.17 5.41 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.53 -0.628 . . . . 15.0 111.53 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.18 140.2 52.49 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.879 0.371 . . . . 15.0 110.651 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.9 p -86.12 163.75 17.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.065 -0.516 . . . . 15.0 110.508 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.71 -54.39 23.63 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 113.0 0.741 . . . . 15.0 113.0 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.29 -35.04 99.11 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 CA-C-N 120.163 1.094 . . . . 15.0 111.63 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.07 -43.4 95.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.091 0.472 . . . . 15.0 110.012 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 76.1 mt -59.36 -40.74 87.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 15.0 110.406 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 33.8 tp -57.2 -43.82 83.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.33 0.586 . . . . 15.0 110.229 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.52 -41.8 95.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.683 -0.69 . . . . 15.0 110.487 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.28 -40.38 90.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 15.0 110.761 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.0 mt -57.81 -51.8 68.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.267 0.556 . . . . 15.0 110.383 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.6 p -63.79 -40.06 95.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.59 -0.732 . . . . 15.0 111.324 -175.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.1 m -62.38 -44.31 96.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.676 0.274 . . . . 15.0 111.426 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.4 -38.25 88.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.432 -0.349 . . . . 15.0 111.156 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.85 -34.51 71.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.451 -0.34 . . . . 15.0 111.255 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 85.1 mt -56.9 -39.89 75.26 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.0 -0.28 . . . . 15.0 110.677 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -63.75 141.23 58.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.455 -0.339 . . . . 15.0 110.343 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -119.62 128.47 53.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.41 -0.359 . . . . 15.0 110.443 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -58.79 -41.46 86.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.169 -0.469 . . . . 15.0 110.636 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -59.27 -38.55 80.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 15.0 111.078 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -55.45 -39.83 70.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.449 -0.341 . . . . 15.0 111.179 -177.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -108.86 137.09 47.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.917 0.389 . . . . 15.0 110.721 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.03 -0.986 . . . . 15.0 110.578 179.933 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.341 -0.614 . . . . 15.0 109.341 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -126.95 80.97 70.54 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.097 -0.501 . . . . 15.0 110.34 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -49.87 152.31 7.3 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.387 1.391 . . . . 15.0 111.776 -176.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -117.77 137.88 52.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.354 -0.385 . . . . 15.0 110.385 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.7 m -134.77 146.04 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.501 0.667 . . . . 15.0 111.826 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.6 tp -104.37 135.55 45.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.048 -0.978 . . . . 15.0 110.318 178.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 55.0 mt -103.59 135.02 43.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.407 . . . . 15.0 110.439 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 88.3 mtp -100.15 134.06 43.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.731 -0.668 . . . . 15.0 110.332 174.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -58.24 141.69 50.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.376 -0.375 . . . . 15.0 110.624 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.0 175.14 34.57 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.045 -0.822 . . . . 15.0 111.045 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -54.98 -33.86 62.87 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.549 0.203 . . . . 15.0 111.549 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.9 -179.69 4.76 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.954 -0.859 . . . . 15.0 110.954 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.02 114.31 3.93 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.224 -0.75 . . . . 15.0 111.224 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -55.85 -47.23 77.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.323 0.583 . . . . 15.0 110.339 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.95 -41.38 97.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.739 -0.664 . . . . 15.0 110.839 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -56.51 -55.83 28.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.766 0.317 . . . . 15.0 111.18 -175.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.1 mp -59.99 -42.38 94.1 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.665 -0.414 . . . . 15.0 111.064 -176.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.63 -45.74 91.07 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.643 -0.423 . . . . 15.0 111.447 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.29 -40.99 92.4 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.769 -0.372 . . . . 15.0 110.527 -178.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -58.52 -51.51 69.59 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.589 -0.445 . . . . 15.0 111.126 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.8 mt -63.99 -38.2 90.22 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.436 -0.505 . . . . 15.0 111.262 -176.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -65.28 -40.45 93.9 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 120.521 -0.472 . . . . 15.0 111.254 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.03 -30.57 70.44 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.972 -0.632 . . . . 15.0 112.095 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -88.33 10.03 21.25 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.571 0.952 . . . . 15.0 113.571 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.54 16.41 60.28 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 121.286 -0.483 . . . . 15.0 113.265 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.7 t -101.08 138.85 23.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 117.824 0.812 . . . . 15.0 109.877 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -79.12 133.37 36.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.494 -0.558 . . . . 15.0 109.494 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.1 t -118.37 130.37 73.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.173 0.511 . . . . 15.0 111.117 -173.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -135.35 124.74 24.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.419 -0.809 . . . . 15.0 109.442 170.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -112.79 134.16 54.44 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.857 0.361 . . . . 15.0 110.833 -177.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.1 tp -114.3 139.44 23.83 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.042 -0.527 . . . . 15.0 109.937 -176.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -72.08 136.22 26.67 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 121.409 1.406 . . . . 15.0 111.822 171.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.8 mt -57.89 -12.73 3.42 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.368 0.877 . . . . 15.0 113.368 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -77.22 -5.05 47.79 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.467 0.914 . . . . 15.0 113.467 -175.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -68.06 145.59 97.76 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 118.559 0.618 . . . . 15.0 110.784 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.96 159.09 30.87 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.685 1.59 . . . . 15.0 113.479 -176.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.26 151.52 2.83 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.727 -0.669 . . . . 15.0 111.62 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.14 -36.98 3.58 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.397 -0.681 . . . . 15.0 111.397 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -60.02 -37.05 78.62 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.613 -0.435 . . . . 15.0 110.972 -178.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.3 tp -58.5 -47.13 85.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.022 0.439 . . . . 15.0 110.253 -177.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.1 tp -61.87 -44.68 96.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 15.0 110.745 -177.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.18 97.22 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.682 -0.407 . . . . 15.0 111.018 -176.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -60.96 -41.53 96.51 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.815 -0.354 . . . . 15.0 110.672 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.5 t -60.53 -47.31 93.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.809 -0.356 . . . . 15.0 110.262 -176.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -72.27 -47.65 48.53 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.461 0.541 . . . . 15.0 112.461 -175.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.69 -44.31 82.06 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.051 -0.26 . . . . 15.0 111.557 -174.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -81.78 -10.03 59.46 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.105 0.78 . . . . 15.0 113.105 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 56.64 55.87 6.02 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.593 0.711 . . . . 15.0 110.164 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 94.9 mt -77.9 142.53 38.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.667 -0.697 . . . . 15.0 111.364 -176.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -90.76 -40.65 11.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.55 -0.75 . . . . 15.0 110.64 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.66 167.01 28.72 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 119.908 -1.139 . . . . 15.0 113.396 -171.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 71.4 mt -126.96 146.91 50.15 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.889 -0.656 . . . . 15.0 110.312 -178.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.5 t -122.77 131.48 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.544 0.211 . . . . 15.0 110.495 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 m -124.85 146.99 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.125 0.488 . . . . 15.0 110.735 173.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 t -100.81 -15.98 17.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.535 -0.757 . . . . 15.0 112.835 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.0 p -156.31 161.28 40.21 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-O 121.437 0.637 . . . . 15.0 111.901 -175.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.18 -37.67 73.63 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.056 -0.818 . . . . 15.0 111.056 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -59.25 -44.53 92.37 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.932 -0.307 . . . . 15.0 110.709 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.29 -43.68 98.29 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.611 -0.996 . . . . 15.0 110.611 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 14.3 tp -57.05 -45.82 82.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.153 0.502 . . . . 15.0 110.596 -179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.35 -43.74 98.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.117 -0.492 . . . . 15.0 110.569 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -59.77 -38.91 83.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 15.0 110.647 178.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.4 tp -57.06 -44.32 82.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.124 0.488 . . . . 15.0 110.161 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -60.24 -47.61 85.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.809 -0.632 . . . . 15.0 110.459 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -61.85 -43.15 99.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.945 -0.571 . . . . 15.0 111.137 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.84 -35.3 79.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.443 -0.344 . . . . 15.0 111.49 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.44 -38.51 80.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.955 0.407 . . . . 15.0 110.75 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.28 -144.09 0.57 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 109.541 -0.54 . . . . 15.0 109.541 174.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.87 -18.56 45.43 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.357 0.981 . . . . 15.0 112.64 -174.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -91.95 10.45 28.84 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.327 0.862 . . . . 15.0 113.327 -175.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -47.74 -47.32 62.01 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 118.69 -0.672 . . . . 15.0 112.586 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -44.81 -40.11 14.35 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.458 1.439 . . . . 15.0 113.233 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -76.94 -48.77 17.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.023 0.439 . . . . 15.0 110.725 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 92.2 mt -59.25 -40.59 81.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 15.0 110.839 -177.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.41 -14.47 34.46 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-N 116.269 -0.423 . . . . 15.0 113.23 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -66.18 -29.8 70.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.415 0.607 . . . . 15.0 112.076 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.9 mt -74.72 145.11 81.3 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-O 119.252 -0.404 . . . . 15.0 110.953 -174.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -60.0 129.54 30.78 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.446 1.431 . . . . 15.0 111.756 174.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.1 tp -106.34 128.16 53.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.609 -0.269 . . . . 15.0 110.852 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -91.01 126.12 36.0 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.618 -0.512 . . . . 15.0 109.618 176.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.7 m -119.43 147.52 43.54 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 110.085 -0.339 . . . . 15.0 110.085 176.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.23 -23.23 7.73 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.471 1.447 . . . . 15.0 113.636 -174.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.9 p -143.36 161.11 49.11 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 120.62 -0.432 . . . . 15.0 111.563 -172.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -54.91 -44.11 52.88 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.2 1.267 . . . . 15.0 111.889 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -58.82 -46.75 86.9 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.895 -0.322 . . . . 15.0 110.973 -177.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.4 t -60.13 -40.3 83.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.737 -0.385 . . . . 15.0 110.066 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.61 -42.31 83.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.0 0.429 . . . . 15.0 110.469 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.92 -40.47 93.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.176 -0.466 . . . . 15.0 110.592 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.1 mmm -58.26 -44.99 88.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.447 0.641 . . . . 15.0 110.159 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.76 -40.64 95.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.642 -0.708 . . . . 15.0 110.825 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -61.64 -44.43 96.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.385 -0.37 . . . . 15.0 110.755 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -60.29 -36.19 77.28 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.872 -0.331 . . . . 15.0 111.262 -177.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 77.0 mt -66.0 -23.87 66.66 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.303 0.483 . . . . 15.0 112.303 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.69 13.28 16.88 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.399 -0.667 . . . . 15.0 113.177 -176.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.81 122.03 11.91 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.481 1.14 . . . . 15.0 109.905 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -67.62 -36.54 81.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.541 -0.754 . . . . 15.0 111.059 -171.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -131.82 117.88 19.13 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.923 0.392 . . . . 15.0 110.62 177.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.2 t -114.65 129.94 69.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.008 0.432 . . . . 15.0 109.952 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 90.5 mt -119.27 122.19 68.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.87 -0.604 . . . . 15.0 110.125 -177.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -92.53 117.7 30.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.483 -0.326 . . . . 15.0 110.166 175.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.8 p -95.69 -3.52 45.9 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.232 0.827 . . . . 15.0 113.232 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -55.88 -40.04 72.4 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.287 0.494 . . . . 15.0 110.699 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -95.59 -35.01 5.8 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.463 -0.655 . . . . 15.0 111.463 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.29 143.77 46.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.791 0.329 . . . . 15.0 110.466 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 65.1 m -89.77 160.75 16.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.228 -0.442 . . . . 15.0 110.567 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.67 -54.24 24.56 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.973 0.731 . . . . 15.0 112.973 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.62 -34.54 98.26 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 CA-C-N 120.318 1.149 . . . . 15.0 111.524 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.03 -42.66 94.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.065 0.46 . . . . 15.0 109.985 176.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 78.3 mt -59.04 -39.98 83.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 15.0 110.489 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 33.7 tp -56.85 -44.85 82.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.547 0.689 . . . . 15.0 110.144 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.4 -40.4 90.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.518 -0.765 . . . . 15.0 110.568 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.2 -42.49 95.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.319 -0.4 . . . . 15.0 110.782 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.1 mt -58.05 -49.16 77.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.031 0.443 . . . . 15.0 110.421 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.4 p -62.51 -40.71 97.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.897 -0.592 . . . . 15.0 111.274 -175.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.9 p -65.99 -39.88 90.72 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.969 -0.292 . . . . 15.0 111.349 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.25 -39.01 93.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.666 0.27 . . . . 15.0 111.117 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.93 -34.89 72.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.433 -0.349 . . . . 15.0 111.252 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 82.3 mt -56.8 -39.71 74.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.729 0.3 . . . . 15.0 110.731 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.47 -35.03 79.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.366 -0.379 . . . . 15.0 111.317 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -56.0 -39.66 72.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.625 0.25 . . . . 15.0 110.92 -178.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -110.56 131.64 54.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.858 0.361 . . . . 15.0 110.712 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -116.01 130.54 56.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.168 -0.469 . . . . 15.0 110.534 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -60.88 -42.78 98.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 15.0 110.539 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -55.52 -39.8 70.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 15.0 110.992 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 . . . . . 0 C--O 1.221 -0.411 0 CA-C-O 117.925 -1.036 . . . . 15.0 110.473 179.922 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.3 mmm . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.131 -0.692 . . . . 15.0 109.131 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -127.38 79.49 73.19 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 116.146 -0.479 . . . . 15.0 110.285 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.94 155.06 8.98 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.347 1.364 . . . . 15.0 111.734 -177.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -114.26 140.74 48.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.412 -0.358 . . . . 15.0 110.837 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.6 m -136.55 144.94 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.598 0.714 . . . . 15.0 111.568 176.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.8 tp -105.69 134.18 49.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.943 -1.026 . . . . 15.0 110.518 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.4 mt -100.79 135.12 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.315 -0.402 . . . . 15.0 110.291 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 82.4 mtp -101.75 132.62 47.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.1 -0.5 . . . . 15.0 110.098 171.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -57.74 147.1 28.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.217 0.532 . . . . 15.0 111.564 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.49 175.19 40.55 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.615 -0.994 . . . . 15.0 110.615 -178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -51.94 -32.61 33.79 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.748 0.277 . . . . 15.0 111.748 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.68 170.29 18.24 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.855 -0.898 . . . . 15.0 110.855 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.95 125.18 7.07 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.35 -0.7 . . . . 15.0 111.35 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -57.09 -46.46 82.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.961 0.41 . . . . 15.0 110.482 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -64.05 -40.83 97.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.974 -0.557 . . . . 15.0 111.318 -175.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -61.8 -55.98 24.33 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.775 -0.37 . . . . 15.0 111.427 -176.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.5 tp -61.07 -45.4 94.89 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.687 -0.405 . . . . 15.0 111.192 -175.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.2 -39.72 95.42 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.669 -0.412 . . . . 15.0 110.82 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -60.75 -41.6 95.72 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.905 -0.318 . . . . 15.0 110.576 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -59.65 -51.76 68.41 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 120.686 -0.406 . . . . 15.0 111.241 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.86 -36.99 85.74 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.478 -0.489 . . . . 15.0 111.062 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -63.54 -42.77 98.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.625 0.25 . . . . 15.0 111.088 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.21 -30.56 67.61 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.119 -0.563 . . . . 15.0 111.987 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -88.04 9.96 20.7 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.559 0.948 . . . . 15.0 113.559 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.26 15.04 56.52 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 121.22 -0.514 . . . . 15.0 113.494 173.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.7 t -101.06 136.18 33.9 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 117.972 0.886 . . . . 15.0 110.072 177.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -77.67 129.63 35.8 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.9 -0.778 . . . . 15.0 108.9 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.7 t -123.07 134.13 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.207 0.527 . . . . 15.0 111.468 -171.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -139.4 139.81 37.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.363 -0.835 . . . . 15.0 109.714 172.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -114.13 136.08 53.32 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.883 0.373 . . . . 15.0 110.891 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.8 tp -113.81 121.18 37.6 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-O 118.705 -0.664 . . . . 15.0 110.314 -175.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.25 135.03 67.83 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 CA-C-N 120.337 1.156 . . . . 15.0 112.223 173.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.9 mt -62.43 -16.72 56.67 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.973 0.731 . . . . 15.0 112.973 -178.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -77.18 -5.06 47.72 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.43 0.9 . . . . 15.0 113.43 -175.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -69.84 148.92 96.59 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 118.545 0.611 . . . . 15.0 110.837 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.43 149.69 50.74 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.573 1.515 . . . . 15.0 113.864 -173.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.23 152.58 4.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.258 -0.883 . . . . 15.0 111.265 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.62 -38.1 3.22 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 115.837 -0.619 . . . . 15.0 111.636 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -63.71 -36.61 84.42 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.392 -0.523 . . . . 15.0 111.16 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.9 tp -59.1 -47.01 86.83 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.86 -0.336 . . . . 15.0 110.174 -178.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 17.6 tp -63.35 -45.76 89.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 15.0 110.917 -176.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.6 -44.22 97.41 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.61 -0.436 . . . . 15.0 110.836 -176.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -62.24 -41.97 98.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.486 -0.325 . . . . 15.0 110.754 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 94.0 t -60.61 -45.18 97.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.946 -0.39 . . . . 15.0 109.946 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -67.83 -47.94 67.61 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.325 0.391 . . . . 15.0 111.687 -177.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.6 -44.48 86.44 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 121.042 -0.263 . . . . 15.0 111.685 -173.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -83.04 -10.01 58.96 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.323 0.86 . . . . 15.0 113.323 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 55.79 55.84 6.69 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.68 0.752 . . . . 15.0 110.333 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.11 144.95 56.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.62 -0.718 . . . . 15.0 111.36 -175.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -89.69 -40.52 12.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.067 -0.969 . . . . 15.0 110.694 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.97 161.14 28.52 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.045 -1.074 . . . . 15.0 113.553 -174.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.2 mt -126.0 140.94 52.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.428 -0.886 . . . . 15.0 109.568 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.3 t -120.69 130.06 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.696 0.284 . . . . 15.0 110.804 -178.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 m -123.56 138.81 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.007 0.432 . . . . 15.0 110.289 173.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.6 m -89.96 -23.89 21.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.729 -0.669 . . . . 15.0 112.413 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.9 p -154.15 165.51 36.01 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.447 0.641 . . . . 15.0 111.964 -173.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.99 -37.76 72.3 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.148 -0.781 . . . . 15.0 111.148 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -57.68 -46.12 84.7 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.736 -0.385 . . . . 15.0 110.632 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.59 -45.31 96.56 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.448 -1.061 . . . . 15.0 110.448 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 26.0 tp -56.5 -42.66 78.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.137 0.494 . . . . 15.0 110.762 -177.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.82 -43.28 99.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.504 . . . . 15.0 110.584 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -58.05 -39.91 79.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.379 -0.373 . . . . 15.0 110.559 177.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.5 tp -57.8 -45.47 86.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.164 0.507 . . . . 15.0 110.167 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -61.51 -47.68 84.5 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.635 -0.711 . . . . 15.0 110.638 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -61.72 -43.1 99.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.039 -0.528 . . . . 15.0 111.116 -176.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 94.2 mt -66.7 -35.53 80.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.325 -0.398 . . . . 15.0 111.453 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.71 -38.05 80.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.056 0.455 . . . . 15.0 110.781 177.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.4 -143.99 0.56 Allowed 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.527 -0.545 . . . . 15.0 109.527 174.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.67 -19.09 47.19 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.302 0.955 . . . . 15.0 112.652 -174.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -91.81 11.22 25.5 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.285 0.846 . . . . 15.0 113.285 -175.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -47.68 -46.7 61.45 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 118.595 -0.716 . . . . 15.0 112.606 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -44.76 -41.27 14.88 Favored 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 121.439 1.426 . . . . 15.0 113.166 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -76.88 -48.81 17.24 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.664 -0.414 . . . . 15.0 110.831 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 92.3 mt -59.88 -39.32 79.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.17 -0.468 . . . . 15.0 110.873 -176.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.28 -15.96 32.77 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 119.853 -0.415 . . . . 15.0 113.092 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.0 mtm105 -66.04 -30.29 70.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.42 0.61 . . . . 15.0 112.011 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.8 mt -73.6 150.59 88.99 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 121.171 -0.212 . . . . 15.0 111.463 -173.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.49 126.33 17.41 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 121.684 1.589 . . . . 15.0 112.322 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.4 tp -105.4 124.69 49.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.332 -0.395 . . . . 15.0 110.552 175.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -90.74 127.41 36.31 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.802 -0.444 . . . . 15.0 109.802 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 29.1 m -121.43 145.66 43.08 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 110.118 -0.327 . . . . 15.0 110.118 175.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.18 -22.3 8.54 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.727 1.618 . . . . 15.0 113.64 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 53.3 p -141.54 157.44 65.48 Favored Pre-proline 0 C--N 1.331 -0.233 0 C-N-CA 120.765 -0.374 . . . . 15.0 111.327 -169.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.24 -44.06 50.13 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.273 1.315 . . . . 15.0 112.338 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -61.3 -43.52 98.73 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 120.603 -0.439 . . . . 15.0 111.116 -177.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.3 t -59.63 -40.92 83.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.657 -0.498 . . . . 15.0 109.657 177.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.66 -41.74 82.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.901 0.381 . . . . 15.0 110.4 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.57 -40.41 91.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.246 -0.434 . . . . 15.0 110.597 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 96.9 mmm -58.3 -45.09 88.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.437 0.637 . . . . 15.0 110.132 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.62 -40.57 95.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.709 -0.678 . . . . 15.0 110.783 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -61.75 -44.2 97.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.315 -0.402 . . . . 15.0 110.765 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -60.31 -36.16 77.26 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.912 -0.315 . . . . 15.0 111.326 -177.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.2 mt -65.79 -23.83 66.79 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.199 0.444 . . . . 15.0 112.199 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.45 13.25 17.49 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-O 119.369 -0.684 . . . . 15.0 113.127 -176.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.87 122.59 13.28 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 118.49 1.145 . . . . 15.0 109.97 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -70.16 -36.17 74.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.667 -0.697 . . . . 15.0 111.188 -172.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 31.0 ttm105 -130.35 111.63 12.53 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.114 0.483 . . . . 15.0 110.382 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.1 130.87 63.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.989 -0.551 . . . . 15.0 109.817 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 85.8 mt -119.78 121.87 67.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.97 -0.559 . . . . 15.0 110.061 -176.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -95.75 116.51 28.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.39 -0.368 . . . . 15.0 110.24 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 28.3 p -97.09 1.29 49.85 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.23 0.826 . . . . 15.0 113.23 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -55.91 -39.89 72.27 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.26 0.482 . . . . 15.0 110.737 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -96.66 -35.17 5.5 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.523 -0.631 . . . . 15.0 111.523 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.6 143.52 53.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.864 0.364 . . . . 15.0 110.604 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.9 m -89.84 161.36 16.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 15.0 110.504 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.73 -54.19 25.22 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-O 118.522 -0.751 . . . . 15.0 112.97 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -56.52 -36.13 97.43 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 CA-C-N 120.559 1.235 . . . . 15.0 111.318 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.31 -42.67 96.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.045 0.45 . . . . 15.0 110.18 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.1 mt -59.28 -41.05 87.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 15.0 110.492 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.7 tp -57.39 -44.02 84.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.339 0.59 . . . . 15.0 110.14 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.63 93.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.617 -0.72 . . . . 15.0 110.542 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.67 89.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.389 -0.368 . . . . 15.0 110.763 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.2 mt -57.86 -52.5 65.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.391 0.615 . . . . 15.0 110.357 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.2 p -63.83 -40.28 96.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.536 -0.756 . . . . 15.0 111.354 -175.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.7 t -62.14 -45.03 95.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.686 0.279 . . . . 15.0 111.422 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.43 -39.4 90.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.509 -0.314 . . . . 15.0 110.99 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.15 -37.21 76.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.444 -0.344 . . . . 15.0 111.048 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 92.7 mt -60.93 -37.6 82.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.559 -0.291 . . . . 15.0 111.22 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.58 -39.21 79.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.733 0.301 . . . . 15.0 110.916 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -56.82 -36.45 69.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.383 -0.371 . . . . 15.0 111.307 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -55.58 -40.27 71.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.551 -0.295 . . . . 15.0 111.01 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -109.78 127.68 54.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.866 0.365 . . . . 15.0 110.634 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -57.92 -40.29 80.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.045 -0.525 . . . . 15.0 110.875 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -115.92 139.83 49.84 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.223 -0.444 . . . . 15.0 110.572 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 . . . . . 0 C--O 1.219 -0.528 0 CA-C-O 118.031 -0.985 . . . . 15.0 110.606 179.811 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.6 mtm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.471 -0.566 . . . . 15.0 109.471 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.9 p30 -125.84 76.49 70.8 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.133 -0.485 . . . . 15.0 110.307 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -54.41 155.03 17.47 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.434 1.422 . . . . 15.0 112.004 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -113.75 138.73 49.84 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.222 -0.445 . . . . 15.0 110.751 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.5 m -134.81 145.8 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 121.53 0.681 . . . . 15.0 111.943 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.8 tp -104.7 137.87 41.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.029 -0.987 . . . . 15.0 110.214 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.2 mt -103.07 135.1 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.082 0.467 . . . . 15.0 111.146 -177.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 97.9 mmm -95.5 125.91 40.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.106 -0.952 . . . . 15.0 108.905 169.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.0 mtm180 -59.59 147.67 36.31 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.487 -0.485 . . . . 15.0 110.689 -176.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.28 175.18 34.76 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.776 -0.929 . . . . 15.0 110.776 -178.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -51.59 -32.19 27.75 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.789 0.292 . . . . 15.0 111.789 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.81 173.76 16.78 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.855 -0.898 . . . . 15.0 110.855 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.99 126.38 7.66 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.351 -0.699 . . . . 15.0 111.351 -178.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -56.64 -47.43 79.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.193 0.52 . . . . 15.0 110.417 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.72 -40.99 98.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.642 -0.708 . . . . 15.0 111.202 -176.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -61.1 -55.99 26.12 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.722 -0.391 . . . . 15.0 111.393 -175.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.9 mt -62.19 -45.06 95.07 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.757 -0.377 . . . . 15.0 111.372 -175.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.44 -41.29 98.65 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.699 -0.4 . . . . 15.0 110.904 -177.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -59.87 -41.27 91.13 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.978 -0.289 . . . . 15.0 110.388 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 52.2 ttt85 -60.19 -51.64 68.7 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 120.764 -0.374 . . . . 15.0 111.305 -177.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.72 -36.72 83.92 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.374 -0.53 . . . . 15.0 110.94 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 46.0 tpt85 -61.36 -41.46 97.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.684 0.278 . . . . 15.0 110.399 177.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.83 -30.57 66.35 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.2 -0.524 . . . . 15.0 111.993 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -88.02 9.91 20.8 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.46 0.911 . . . . 15.0 113.46 178.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.1 18.71 58.88 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 121.314 -0.47 . . . . 15.0 113.054 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.1 t -101.06 138.75 24.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 117.77 0.785 . . . . 15.0 109.949 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -81.6 129.63 34.76 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.164 -0.68 . . . . 15.0 109.164 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.4 t -122.66 134.39 65.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.267 0.556 . . . . 15.0 111.418 -172.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -139.61 138.53 36.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.14 -0.936 . . . . 15.0 109.404 171.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -115.5 140.87 48.76 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.832 0.348 . . . . 15.0 110.833 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 33.9 tp -112.67 129.6 24.26 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-O 118.523 -0.751 . . . . 15.0 109.813 -175.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -65.73 134.98 39.85 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 CA-C-N 120.418 1.185 . . . . 15.0 111.38 174.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.8 mt -65.83 -9.19 26.6 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.294 0.85 . . . . 15.0 113.294 -175.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -77.29 -11.33 59.82 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.12 0.785 . . . . 15.0 113.12 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -63.15 148.5 92.8 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 118.416 0.553 . . . . 15.0 110.434 -176.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.89 157.5 31.09 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.523 1.482 . . . . 15.0 113.14 -177.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.44 151.25 5.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.84 -0.618 . . . . 15.0 111.177 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.91 -37.02 3.63 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.354 -0.698 . . . . 15.0 111.354 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.31 -37.78 81.64 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.592 -0.443 . . . . 15.0 110.985 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.4 tp -58.84 -47.31 85.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.028 0.442 . . . . 15.0 110.239 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.8 tp -62.79 -44.58 95.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.106 -0.497 . . . . 15.0 110.951 -176.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.9 -44.72 96.21 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.7 -0.4 . . . . 15.0 110.92 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 -61.61 -40.8 96.12 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.841 -0.344 . . . . 15.0 110.98 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 88.8 t -61.78 -45.74 98.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.829 -0.349 . . . . 15.0 110.375 -177.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -67.42 -50.82 57.73 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.312 0.382 . . . . 15.0 111.936 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.41 -44.35 79.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.674 0.273 . . . . 15.0 111.578 -174.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -78.28 -10.05 59.49 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.043 0.757 . . . . 15.0 113.043 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 56.32 55.9 6.23 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.539 0.685 . . . . 15.0 110.074 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 94.8 mt -69.87 144.73 52.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.846 -0.616 . . . . 15.0 111.381 -176.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -90.9 -40.52 11.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.188 -0.914 . . . . 15.0 110.499 176.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -152.52 168.93 31.64 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 120.129 -1.034 . . . . 15.0 113.216 -174.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 75.8 mt -124.69 141.41 52.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.851 -0.675 . . . . 15.0 110.108 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.5 t -120.25 130.42 74.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.022 -0.362 . . . . 15.0 110.022 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.6 m -122.6 129.39 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 121.047 0.451 . . . . 15.0 110.235 173.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.2 p -95.09 -3.59 47.81 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.931 0.715 . . . . 15.0 112.931 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 81.7 p -154.31 154.71 33.84 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.447 0.567 . . . . 15.0 111.545 -177.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.02 -39.83 90.27 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.887 -0.885 . . . . 15.0 110.887 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -59.19 -42.82 91.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.916 -0.314 . . . . 15.0 110.511 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.88 -44.97 96.6 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.859 -0.896 . . . . 15.0 110.859 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.3 tp -58.16 -47.82 82.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.091 0.472 . . . . 15.0 110.366 -177.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -61.23 -40.71 95.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.018 -0.537 . . . . 15.0 110.695 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -59.74 -40.29 87.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.441 -0.345 . . . . 15.0 110.629 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.1 tp -57.81 -44.16 86.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.235 0.541 . . . . 15.0 110.125 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -60.69 -47.14 87.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.791 -0.64 . . . . 15.0 110.623 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.54 -43.17 99.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.137 -0.483 . . . . 15.0 111.184 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.4 mt -67.04 -34.71 78.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.498 -0.319 . . . . 15.0 111.431 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.97 -39.07 80.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.068 0.461 . . . . 15.0 110.6 177.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 58.83 -143.15 0.62 Allowed 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.736 -0.468 . . . . 15.0 109.736 173.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.61 -19.98 52.79 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.337 0.971 . . . . 15.0 112.639 -174.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -91.88 10.81 27.19 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.265 0.839 . . . . 15.0 113.265 -175.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 56.7 t-105 -47.85 -46.61 63.14 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 118.563 -0.732 . . . . 15.0 112.547 177.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -44.66 -40.71 14.33 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.389 1.393 . . . . 15.0 113.288 177.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -76.96 -48.89 16.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.948 0.404 . . . . 15.0 110.698 -178.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 89.6 mt -59.25 -39.59 79.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 15.0 110.826 -177.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.56 -14.47 35.55 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.817 -0.435 . . . . 15.0 113.23 -176.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -64.96 -30.12 71.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.501 0.651 . . . . 15.0 111.907 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 23.4 mt -76.29 150.42 82.74 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 120.932 -0.307 . . . . 15.0 111.264 -174.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.34 128.97 29.29 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.624 1.55 . . . . 15.0 112.286 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 14.0 tp -107.07 124.54 49.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 15.0 110.533 175.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -92.59 121.95 34.53 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.356 -0.609 . . . . 15.0 109.356 174.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.5 m -107.0 147.38 34.99 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-O 119.345 -0.36 . . . . 15.0 110.207 177.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.18 -25.88 5.56 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.577 1.518 . . . . 15.0 113.404 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.9 p -145.26 163.44 32.26 Favored Pre-proline 0 CA--C 1.531 0.227 0 C-N-CA 120.636 -0.425 . . . . 15.0 111.46 -172.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.3 -44.01 47.07 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 121.13 1.22 . . . . 15.0 111.829 176.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -58.28 -46.74 85.49 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.81 -0.356 . . . . 15.0 110.817 -177.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.0 t -59.9 -41.04 84.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.882 -0.414 . . . . 15.0 109.882 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.87 -39.32 77.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.674 0.273 . . . . 15.0 110.707 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.88 -42.08 97.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.504 -0.316 . . . . 15.0 110.563 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 52.2 mtm -64.89 -42.94 94.36 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 119.871 -0.731 . . . . 15.0 110.129 176.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.5 -43.96 93.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.584 -0.28 . . . . 15.0 111.484 -171.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -67.02 -38.57 86.19 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.161 -0.616 . . . . 15.0 110.443 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -59.76 -35.16 74.04 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 120.653 -0.419 . . . . 15.0 111.246 176.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 67.2 mt -59.88 -29.11 68.1 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.877 -0.329 . . . . 15.0 111.378 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.27 13.08 20.28 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 119.431 -0.649 . . . . 15.0 112.821 -172.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.93 123.33 15.46 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.515 1.157 . . . . 15.0 109.862 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -70.46 -35.1 73.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.971 -0.558 . . . . 15.0 111.323 -172.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -131.62 113.98 14.27 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 110.052 -0.351 . . . . 15.0 110.052 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 45.6 t -109.44 129.79 63.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.036 0.446 . . . . 15.0 110.121 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 82.4 mt -120.92 125.66 74.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.745 -0.661 . . . . 15.0 109.978 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -94.44 114.5 26.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.212 -0.292 . . . . 15.0 110.212 175.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 28.6 p -78.36 -25.84 46.48 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 120.639 -0.424 . . . . 15.0 112.021 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -55.11 -38.17 67.8 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.646 0.26 . . . . 15.0 110.913 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.96 -35.15 7.83 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.597 -0.601 . . . . 15.0 111.597 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.36 127.02 36.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.373 . . . . 15.0 110.908 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.3 m -65.09 156.87 30.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.081 0.467 . . . . 15.0 110.787 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.68 -54.34 23.8 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 113.031 0.752 . . . . 15.0 113.031 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -56.2 -35.48 95.44 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 CA-C-N 120.367 1.167 . . . . 15.0 111.339 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.05 -41.33 92.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.955 0.407 . . . . 15.0 110.235 176.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 78.0 mt -58.94 -41.9 88.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.97 0.414 . . . . 15.0 110.329 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.61 -44.16 85.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.445 0.64 . . . . 15.0 110.131 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.4 -40.09 89.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.602 -0.726 . . . . 15.0 110.586 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.25 -41.03 92.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.41 -0.359 . . . . 15.0 110.785 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.4 mt -57.85 -51.01 71.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.152 0.501 . . . . 15.0 110.404 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.8 p -63.28 -41.27 98.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.68 -0.691 . . . . 15.0 111.252 -175.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.0 m -63.46 -43.22 97.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.662 0.267 . . . . 15.0 111.389 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.35 -39.03 91.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.478 -0.328 . . . . 15.0 111.05 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.73 -37.77 79.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.552 -0.295 . . . . 15.0 110.952 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 90.4 mt -59.91 -38.28 81.88 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.916 -0.314 . . . . 15.0 110.938 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -62.43 138.46 58.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.746 0.307 . . . . 15.0 110.426 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -132.4 131.63 42.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.372 -0.376 . . . . 15.0 110.735 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -60.85 -40.34 92.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 15.0 110.585 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -107.13 129.13 54.88 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.298 -0.41 . . . . 15.0 110.541 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -59.91 -40.7 89.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.026 -0.534 . . . . 15.0 110.759 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -107.23 136.78 46.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.472 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.938 -1.029 . . . . 15.0 110.598 -179.399 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.432 -0.581 . . . . 15.0 109.432 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -125.55 83.69 61.43 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 116.157 -0.474 . . . . 15.0 110.32 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -59.18 155.06 41.95 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.38 1.387 . . . . 15.0 111.942 -177.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -105.4 136.48 44.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.387 -0.369 . . . . 15.0 110.62 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.8 m -132.68 143.56 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 121.585 0.707 . . . . 15.0 111.587 177.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.8 tp -102.77 135.87 43.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.981 -1.009 . . . . 15.0 110.274 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.9 mt -102.04 134.76 41.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.981 0.42 . . . . 15.0 110.558 -178.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 85.6 mtp -103.52 134.27 47.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.441 -0.8 . . . . 15.0 109.943 173.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 -57.46 144.86 35.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.016 0.436 . . . . 15.0 110.833 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.2 175.24 33.24 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.658 -0.977 . . . . 15.0 110.658 -177.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -50.97 -32.07 19.84 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.88 0.326 . . . . 15.0 111.88 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.95 175.42 47.77 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.782 -0.927 . . . . 15.0 110.782 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.64 131.68 10.81 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.474 -0.65 . . . . 15.0 111.474 -178.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -56.56 -44.35 80.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.869 0.366 . . . . 15.0 110.616 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.83 -43.19 99.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.126 -0.488 . . . . 15.0 111.183 -176.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -62.49 -56.06 21.61 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.8 -0.36 . . . . 15.0 111.384 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.9 tt -61.7 -43.69 98.37 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.777 -0.369 . . . . 15.0 110.985 -175.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.38 -42.43 99.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.414 -0.357 . . . . 15.0 110.84 -177.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.78 -41.21 90.62 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.875 -0.33 . . . . 15.0 110.457 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -59.64 -51.72 68.61 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.565 -0.454 . . . . 15.0 111.34 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.5 mt -62.58 -37.5 86.43 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.436 -0.505 . . . . 15.0 110.933 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 46.9 tpt85 -63.03 -44.8 94.91 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 121.066 -0.254 . . . . 15.0 110.711 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.43 -30.57 68.4 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.955 -0.64 . . . . 15.0 111.894 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -88.11 9.24 23.34 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.626 0.973 . . . . 15.0 113.626 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.77 13.55 54.77 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 121.066 -0.588 . . . . 15.0 113.65 173.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.0 t -101.1 138.52 25.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 117.953 0.876 . . . . 15.0 110.021 177.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -79.33 131.88 36.27 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.348 -0.612 . . . . 15.0 109.348 178.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.9 t -117.68 130.79 72.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.198 0.523 . . . . 15.0 111.528 -171.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -139.33 133.03 30.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.32 -0.855 . . . . 15.0 109.388 170.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -112.66 137.39 51.01 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.9 0.381 . . . . 15.0 110.974 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 40.5 tp -118.9 113.45 35.91 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 118.618 -0.706 . . . . 15.0 109.969 -176.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -56.09 135.26 68.93 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.069 1.179 . . . . 15.0 112.318 177.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 77.3 mt -60.56 -9.21 3.48 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.298 0.851 . . . . 15.0 113.298 -178.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -77.15 -9.98 59.1 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.205 0.817 . . . . 15.0 113.205 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -62.53 147.2 92.8 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 118.338 0.517 . . . . 15.0 110.26 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.29 158.96 33.28 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.559 1.506 . . . . 15.0 113.252 -178.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.84 152.42 3.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.783 -0.644 . . . . 15.0 111.337 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.39 -36.3 3.88 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.489 -0.644 . . . . 15.0 111.489 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -60.01 -37.22 79.09 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.689 -0.404 . . . . 15.0 111.041 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.8 tp -58.65 -46.34 87.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.965 0.412 . . . . 15.0 110.168 -178.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.7 tp -61.78 -44.14 97.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.139 -0.482 . . . . 15.0 110.742 -177.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.01 -43.61 98.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.352 -0.386 . . . . 15.0 111.241 -176.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -61.28 -41.82 97.6 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.751 -0.38 . . . . 15.0 110.625 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.6 t -61.65 -47.03 95.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.88 -0.328 . . . . 15.0 110.491 -175.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -75.42 -43.5 49.57 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.492 0.553 . . . . 15.0 112.492 -174.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.59 -44.37 74.52 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.667 0.247 . . . . 15.0 111.667 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -82.74 -10.09 59.05 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.123 0.786 . . . . 15.0 113.123 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 58.36 55.88 4.73 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.563 0.697 . . . . 15.0 109.553 -177.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 94.1 mt -71.47 145.7 49.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.752 -0.658 . . . . 15.0 111.412 -174.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -95.41 -40.52 9.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.231 -0.895 . . . . 15.0 110.774 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -150.93 166.64 30.44 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 120.057 -1.068 . . . . 15.0 113.412 -173.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.5 mt -126.61 144.17 50.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.732 -0.734 . . . . 15.0 110.046 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.8 t -122.1 129.38 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 110.386 -0.227 . . . . 15.0 110.386 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.5 m -127.65 152.05 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.053 0.454 . . . . 15.0 110.456 172.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.9 m -123.47 7.92 8.97 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.744 -0.662 . . . . 15.0 112.77 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.9 p -155.62 151.69 27.81 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 118.514 0.597 . . . . 15.0 111.772 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.87 -39.75 92.08 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.633 -0.987 . . . . 15.0 110.633 176.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -58.25 -41.8 85.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.702 0.287 . . . . 15.0 110.382 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.82 -47.98 88.54 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.687 -0.965 . . . . 15.0 110.687 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.2 tp -57.13 -44.42 83.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.15 0.5 . . . . 15.0 110.705 -177.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.63 -42.37 98.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.063 -0.517 . . . . 15.0 110.823 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -59.47 -39.89 85.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.393 -0.367 . . . . 15.0 110.576 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.4 tp -58.12 -44.29 87.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.094 0.473 . . . . 15.0 110.274 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -60.67 -47.52 85.91 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.849 -0.614 . . . . 15.0 110.631 -178.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -62.13 -43.41 98.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.085 -0.507 . . . . 15.0 111.113 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.8 mt -66.42 -35.27 79.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.414 -0.357 . . . . 15.0 111.375 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.92 -38.75 79.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.032 0.444 . . . . 15.0 110.672 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.21 -143.54 0.59 Allowed 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 109.515 -0.55 . . . . 15.0 109.515 174.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.43 -19.04 44.38 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.342 0.973 . . . . 15.0 112.609 -175.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -91.88 10.5 28.48 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.299 0.852 . . . . 15.0 113.299 -174.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -47.76 -46.72 62.33 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 118.576 -0.726 . . . . 15.0 112.561 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -44.69 -41.99 14.72 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 121.481 1.454 . . . . 15.0 113.244 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -77.01 -48.69 17.23 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.949 0.405 . . . . 15.0 110.862 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.7 mt -59.01 -40.78 81.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.138 -0.483 . . . . 15.0 110.748 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.51 -16.1 35.05 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 119.896 -0.391 . . . . 15.0 113.048 -177.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -63.66 -30.64 71.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.425 0.612 . . . . 15.0 111.989 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.6 mt -74.89 149.02 85.24 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 120.979 -0.289 . . . . 15.0 111.265 -173.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.85 129.07 24.89 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.558 1.505 . . . . 15.0 112.517 176.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.4 tp -107.77 126.43 52.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 15.0 110.577 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -89.84 125.01 35.17 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.438 -0.579 . . . . 15.0 109.438 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.87 147.56 37.98 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-O 119.373 -0.346 . . . . 15.0 110.319 177.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -79.17 -23.94 7.17 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.574 1.516 . . . . 15.0 113.52 -175.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.7 p -144.4 158.23 54.73 Favored Pre-proline 0 CA--C 1.531 0.232 0 C-N-CA 120.664 -0.414 . . . . 15.0 111.321 -172.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.82 -44.04 51.34 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.255 1.304 . . . . 15.0 111.694 175.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -56.73 -48.56 77.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.847 0.356 . . . . 15.0 110.858 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.2 t -59.61 -40.66 82.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.836 0.351 . . . . 15.0 110.071 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.72 -42.29 83.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.012 0.434 . . . . 15.0 110.505 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.6 -41.67 97.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 15.0 110.658 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 87.1 mtp -59.82 -44.44 94.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.238 0.542 . . . . 15.0 110.432 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.35 -41.2 96.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.993 -0.548 . . . . 15.0 110.725 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 54.0 ttm-85 -61.19 -44.52 97.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.25 -0.432 . . . . 15.0 110.539 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -59.84 -36.26 76.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.527 -0.306 . . . . 15.0 111.397 -177.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 81.9 mt -65.39 -24.15 67.15 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.244 0.461 . . . . 15.0 112.244 177.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.85 13.2 14.41 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-O 119.444 -0.642 . . . . 15.0 113.158 -176.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.89 121.97 11.8 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.466 1.133 . . . . 15.0 109.893 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -70.5 -35.48 73.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.69 -0.686 . . . . 15.0 111.322 -171.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -131.07 112.83 13.24 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.975 0.417 . . . . 15.0 110.115 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.2 t -111.41 129.49 66.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.79 -0.448 . . . . 15.0 109.79 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 83.9 mt -119.53 125.49 74.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.967 -0.56 . . . . 15.0 110.222 -176.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -94.9 117.74 30.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.435 -0.348 . . . . 15.0 110.286 176.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.2 p -88.6 -18.69 27.5 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.574 0.583 . . . . 15.0 112.574 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 tpt85 -55.17 -38.9 68.92 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 122.229 -0.294 . . . . 15.0 110.766 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -93.16 -34.95 6.49 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.633 -0.587 . . . . 15.0 111.633 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -89.51 125.59 35.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.843 0.354 . . . . 15.0 110.705 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.7 m -64.64 158.63 23.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.159 0.504 . . . . 15.0 110.901 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.79 -54.24 25.06 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 113.011 0.745 . . . . 15.0 113.011 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -56.65 -34.84 96.68 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 CA-C-N 120.447 1.196 . . . . 15.0 111.451 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.74 93.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.029 0.442 . . . . 15.0 110.081 176.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 78.8 mt -58.95 -41.13 86.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.077 0.465 . . . . 15.0 110.454 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 30.6 tp -56.98 -44.34 82.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.546 0.689 . . . . 15.0 110.104 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.45 -40.14 90.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.508 -0.769 . . . . 15.0 110.551 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.83 -41.12 90.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.399 -0.364 . . . . 15.0 110.757 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.0 mt -57.89 -52.08 66.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.262 0.553 . . . . 15.0 110.305 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.9 p -63.53 -40.6 97.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.571 -0.741 . . . . 15.0 111.315 -175.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.3 m -62.73 -43.51 98.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.67 0.271 . . . . 15.0 111.443 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.34 -39.87 94.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.414 -0.357 . . . . 15.0 111.045 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.49 -36.94 79.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.48 -0.327 . . . . 15.0 111.164 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.21 -38.36 83.1 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.918 -0.313 . . . . 15.0 111.159 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.83 -37.75 88.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.554 -0.294 . . . . 15.0 111.257 -178.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -61.18 -42.84 99.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.751 0.31 . . . . 15.0 110.973 -178.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -54.74 -35.82 64.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.427 . . . . 15.0 111.492 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -102.38 126.22 49.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.911 0.386 . . . . 15.0 110.726 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -58.72 -38.98 79.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.893 -0.594 . . . . 15.0 110.985 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -106.86 139.01 41.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.328 -0.396 . . . . 15.0 110.483 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.015 -0.993 . . . . 15.0 110.625 -179.776 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.6 mtm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.371 -0.603 . . . . 15.0 109.371 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -126.31 82.48 65.73 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.074 -0.512 . . . . 15.0 110.329 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.7 155.04 28.4 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.393 1.395 . . . . 15.0 111.875 -176.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -111.68 138.13 48.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.795 0.331 . . . . 15.0 110.864 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.1 m -134.66 144.31 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.565 0.698 . . . . 15.0 111.572 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.2 tp -104.38 136.0 44.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.916 -1.038 . . . . 15.0 110.264 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.8 mt -103.53 135.1 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.123 0.487 . . . . 15.0 111.129 -176.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 98.5 mmm -95.3 133.65 38.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.109 -0.95 . . . . 15.0 109.21 171.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -63.91 143.74 57.62 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.76 -0.376 . . . . 15.0 110.479 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.24 175.13 34.02 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.924 -0.871 . . . . 15.0 110.924 -178.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -52.55 -32.45 40.87 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.742 0.275 . . . . 15.0 111.742 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.69 176.39 32.38 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.807 -0.917 . . . . 15.0 110.807 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.0 120.24 5.77 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.504 -0.638 . . . . 15.0 111.504 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -56.89 -41.8 78.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.794 0.331 . . . . 15.0 110.452 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.07 -40.63 98.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 15.0 111.134 -177.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -62.35 -56.0 22.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.984 0.421 . . . . 15.0 111.124 -176.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.3 mt -59.92 -44.82 94.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.942 0.401 . . . . 15.0 110.759 -176.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.53 -37.49 86.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 15.0 111.052 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.0 -42.89 99.32 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.955 -0.298 . . . . 15.0 110.598 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -61.53 -51.52 68.27 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.125 -0.63 . . . . 15.0 110.895 -178.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 84.6 mt -61.46 -37.99 85.6 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.632 -0.427 . . . . 15.0 110.931 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 57.5 ttt85 -63.63 -43.52 96.59 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.196 -0.202 . . . . 15.0 111.084 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.03 -30.6 67.05 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.967 -0.635 . . . . 15.0 111.915 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -88.2 10.1 20.63 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.481 0.919 . . . . 15.0 113.481 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.91 18.27 51.41 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 121.187 -0.53 . . . . 15.0 113.292 174.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.4 t -101.01 140.32 20.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 117.688 0.744 . . . . 15.0 110.131 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -84.78 130.38 34.69 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.475 -0.565 . . . . 15.0 109.475 178.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.2 t -119.97 133.76 65.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.205 0.526 . . . . 15.0 111.271 -173.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -139.08 132.72 30.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.443 -0.799 . . . . 15.0 109.611 171.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -113.01 137.64 51.1 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.89 0.376 . . . . 15.0 110.467 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.7 tp -114.92 113.49 44.28 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.683 -0.675 . . . . 15.0 110.824 -173.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -49.05 135.08 29.97 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.156 1.237 . . . . 15.0 111.881 174.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.2 mt -64.61 -13.36 53.11 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.15 0.796 . . . . 15.0 113.15 -174.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -77.23 -6.01 51.45 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.293 0.849 . . . . 15.0 113.293 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -60.0 151.04 67.24 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 118.559 0.618 . . . . 15.0 110.388 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.75 151.72 25.0 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.548 1.499 . . . . 15.0 113.044 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.53 152.29 5.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.925 -0.58 . . . . 15.0 111.162 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.84 -36.6 3.8 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.449 -0.66 . . . . 15.0 111.449 -177.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.44 -37.94 82.54 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.655 -0.418 . . . . 15.0 110.958 -177.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.9 tp -59.14 -46.32 88.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.952 0.406 . . . . 15.0 110.256 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.1 tp -61.97 -44.64 96.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 15.0 110.824 -176.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.89 -43.93 97.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.348 -0.387 . . . . 15.0 110.91 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.8 mtp85 -61.83 -41.77 98.2 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.811 -0.356 . . . . 15.0 110.888 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.5 t -59.4 -46.08 92.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.868 -0.419 . . . . 15.0 109.868 -177.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.2 tpt85 -71.55 -50.3 32.45 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 123.37 0.419 . . . . 15.0 112.024 -176.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.04 -44.44 92.48 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.089 0.403 . . . . 15.0 112.089 -171.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 mp0 -89.87 -5.61 56.65 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.429 0.899 . . . . 15.0 113.429 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 56.77 55.93 5.89 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.616 0.722 . . . . 15.0 110.167 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.23 140.44 58.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.525 -0.761 . . . . 15.0 111.058 -175.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -84.47 -40.64 17.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.491 -0.777 . . . . 15.0 110.671 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -154.04 168.04 32.36 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 119.872 -1.156 . . . . 15.0 113.773 -173.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.8 mt -123.65 143.51 50.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.502 -0.849 . . . . 15.0 109.671 177.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.9 t -122.66 132.76 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.143 -0.317 . . . . 15.0 110.143 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.2 m -126.47 142.41 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 121.057 0.456 . . . . 15.0 110.547 173.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.6 t -97.44 -19.95 18.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.622 -0.717 . . . . 15.0 112.439 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.2 p -151.27 161.65 42.32 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 121.333 0.587 . . . . 15.0 111.528 -174.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.45 -39.12 83.18 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.946 -0.862 . . . . 15.0 110.946 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -58.82 -44.62 90.91 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.876 -0.329 . . . . 15.0 110.653 -178.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.06 -44.48 97.23 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.545 -1.022 . . . . 15.0 110.545 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.1 tp -57.27 -43.03 82.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.115 0.483 . . . . 15.0 110.639 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.08 -42.73 99.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 15.0 110.692 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -58.95 -41.61 87.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.852 0.358 . . . . 15.0 110.543 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.8 tp -58.67 -43.94 90.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.125 0.488 . . . . 15.0 110.181 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -61.19 -47.32 86.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.955 -0.566 . . . . 15.0 110.725 -178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -61.22 -42.7 99.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 15.0 111.117 -177.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 92.7 mt -65.82 -36.32 83.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.341 -0.391 . . . . 15.0 111.374 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.32 -38.57 80.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.141 0.496 . . . . 15.0 110.85 178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.13 -143.15 0.61 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.648 -0.501 . . . . 15.0 109.648 174.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.52 -19.82 51.0 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.321 0.964 . . . . 15.0 112.734 -174.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -91.97 11.4 25.23 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.217 0.821 . . . . 15.0 113.217 -175.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -47.85 -46.7 63.25 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 118.584 -0.722 . . . . 15.0 112.593 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -44.7 -41.25 14.7 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.474 1.45 . . . . 15.0 113.224 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.5 mp0 -77.03 -48.77 17.0 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.943 0.402 . . . . 15.0 110.827 -178.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 90.8 mt -60.03 -40.52 83.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 15.0 110.902 -176.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.79 -13.72 26.66 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.915 -0.38 . . . . 15.0 113.156 -177.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -64.44 -31.46 72.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 117.359 0.579 . . . . 15.0 111.766 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.3 mt -72.99 141.84 82.11 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 119.204 -0.427 . . . . 15.0 110.456 -176.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -59.33 135.24 64.05 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.342 1.361 . . . . 15.0 112.434 177.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.9 tp -109.34 127.76 54.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 15.0 110.736 176.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -91.35 127.18 36.68 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.821 -0.437 . . . . 15.0 109.821 176.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.6 m -119.6 147.44 43.69 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 119.45 -0.309 . . . . 15.0 110.25 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.24 -24.23 6.83 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.597 1.531 . . . . 15.0 113.478 -175.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.2 p -142.58 158.51 60.06 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 120.71 -0.396 . . . . 15.0 111.27 -171.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.43 -44.05 52.33 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.285 1.323 . . . . 15.0 111.761 176.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -58.29 -47.43 83.67 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.773 -0.371 . . . . 15.0 110.924 -177.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.17 -39.65 81.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.788 -0.365 . . . . 15.0 110.096 178.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.25 -41.84 80.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.925 0.393 . . . . 15.0 110.404 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.75 -40.86 94.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.131 -0.486 . . . . 15.0 110.526 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.0 mmm -58.33 -45.17 88.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.456 0.646 . . . . 15.0 110.177 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.76 -40.32 94.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.704 -0.68 . . . . 15.0 110.937 -179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.0 ttt-85 -62.07 -44.63 96.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 15.0 110.792 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.76 -36.15 76.06 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.818 -0.353 . . . . 15.0 111.236 -177.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 76.4 mt -65.49 -25.6 67.55 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.088 0.403 . . . . 15.0 112.088 177.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.55 13.37 14.78 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 119.288 -0.729 . . . . 15.0 113.18 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.87 122.68 13.51 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 118.513 1.157 . . . . 15.0 110.002 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -67.52 -35.83 79.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.518 -0.764 . . . . 15.0 111.256 -171.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -131.82 117.67 18.85 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.954 0.407 . . . . 15.0 110.087 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.9 t -114.18 130.36 68.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.975 0.417 . . . . 15.0 109.989 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 89.9 mt -119.16 123.58 71.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.811 -0.631 . . . . 15.0 110.077 -177.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -94.7 117.44 30.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.376 -0.375 . . . . 15.0 110.086 175.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 30.8 p -95.42 -1.65 50.54 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.306 0.854 . . . . 15.0 113.306 -178.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -55.89 -39.88 72.2 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 118.191 0.451 . . . . 15.0 110.672 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -96.24 -35.06 5.63 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 111.511 -0.636 . . . . 15.0 111.511 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.7 143.23 53.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.829 0.347 . . . . 15.0 110.635 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 65.2 m -89.85 160.12 16.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 15.0 110.506 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.66 -54.41 23.21 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 112.945 0.72 . . . . 15.0 112.945 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.54 -34.53 98.88 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 CA-C-N 120.079 1.064 . . . . 15.0 111.708 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.01 96.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.028 0.442 . . . . 15.0 110.034 177.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.7 mt -59.42 -40.77 87.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 15.0 110.399 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 36.6 tp -57.26 -44.03 83.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.272 0.558 . . . . 15.0 110.164 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.18 -40.59 90.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.696 -0.683 . . . . 15.0 110.436 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.09 -40.13 88.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.377 -0.374 . . . . 15.0 110.811 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.6 mt -57.88 -51.4 69.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.174 0.512 . . . . 15.0 110.479 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.9 p -64.74 -41.56 95.84 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.637 -0.71 . . . . 15.0 111.384 -175.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.0 t -61.36 -43.87 98.14 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.051 -0.26 . . . . 15.0 111.26 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.18 -42.5 99.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.472 -0.331 . . . . 15.0 111.066 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.15 -39.56 95.04 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.975 -0.29 . . . . 15.0 111.209 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.0 mt -64.8 -39.35 93.46 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.775 0.287 . . . . 15.0 111.775 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -116.12 129.48 56.35 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.943 0.401 . . . . 15.0 110.866 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -60.74 -41.99 96.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.964 -0.562 . . . . 15.0 111.391 -178.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -116.23 140.17 49.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.97 0.414 . . . . 15.0 111.339 -176.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -89.74 -17.99 27.21 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.69 0.626 . . . . 15.0 112.69 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -54.69 -39.13 67.82 Favored 'General case' 0 C--O 1.231 0.09 0 O-C-N 122.172 -0.33 . . . . 15.0 111.148 -177.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -107.34 135.12 49.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.396 -0.366 . . . . 15.0 110.468 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.977 -1.011 . . . . 15.0 110.589 179.866 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.1 ttm . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.328 -0.619 . . . . 15.0 109.328 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -126.05 79.43 69.3 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.11 -0.496 . . . . 15.0 110.173 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.19 152.67 10.64 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.511 1.474 . . . . 15.0 112.214 -174.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -115.12 140.96 48.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.113 -0.494 . . . . 15.0 110.693 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 m -134.36 144.17 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.614 0.721 . . . . 15.0 111.519 176.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.8 tp -105.26 135.08 47.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.91 -1.041 . . . . 15.0 110.381 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.5 mt -99.8 133.02 44.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.034 0.445 . . . . 15.0 110.598 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 83.8 mtp -100.7 134.39 43.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.418 -0.81 . . . . 15.0 109.255 170.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -57.39 145.21 33.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.135 0.493 . . . . 15.0 111.222 -170.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.51 175.08 27.03 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.895 -0.882 . . . . 15.0 110.895 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.27 -32.29 71.04 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.817 0.303 . . . . 15.0 111.817 -178.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.96 -177.68 20.6 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.234 -0.746 . . . . 15.0 111.234 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.9 127.99 8.46 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.9 -0.88 . . . . 15.0 110.9 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 52.4 mmt-85 -60.02 -46.61 88.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.221 0.534 . . . . 15.0 109.648 -176.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.09 -40.01 96.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.59 -0.732 . . . . 15.0 111.235 -176.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -60.81 -55.96 26.86 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.758 -0.377 . . . . 15.0 111.258 -175.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.5 mt -61.91 -44.9 95.82 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.735 -0.386 . . . . 15.0 111.132 -176.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.7 95.48 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.657 -0.417 . . . . 15.0 110.894 -177.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -60.03 -41.52 92.43 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 121.008 -0.277 . . . . 15.0 110.442 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.4 ttt85 -59.96 -51.55 69.19 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.665 -0.414 . . . . 15.0 111.2 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 70.6 mt -60.79 -36.79 79.89 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.518 -0.473 . . . . 15.0 110.937 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 60.4 ttt85 -61.73 -43.16 99.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.693 0.283 . . . . 15.0 110.727 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.19 -30.56 67.55 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.053 -0.594 . . . . 15.0 111.855 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -88.1 9.93 20.95 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.521 0.934 . . . . 15.0 113.521 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.3 12.83 58.16 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 121.189 -0.529 . . . . 15.0 113.689 173.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.9 t -101.06 136.12 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 118.084 0.942 . . . . 15.0 110.115 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -78.04 132.22 37.67 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.076 -0.713 . . . . 15.0 109.076 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 31.3 t -121.09 133.79 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.247 0.546 . . . . 15.0 111.37 -172.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -140.59 142.11 35.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.285 -0.87 . . . . 15.0 109.648 170.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -115.31 138.6 50.79 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.949 0.404 . . . . 15.0 111.03 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.0 tp -119.07 113.34 35.66 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 118.586 -0.721 . . . . 15.0 109.863 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.19 135.2 59.14 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 121.06 1.173 . . . . 15.0 112.257 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 76.1 mt -60.85 -12.03 9.66 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.089 0.774 . . . . 15.0 113.089 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -77.15 -7.78 56.39 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.271 0.841 . . . . 15.0 113.271 -177.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -61.98 150.3 83.58 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 118.45 0.568 . . . . 15.0 110.478 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.93 154.25 25.9 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.555 1.503 . . . . 15.0 113.119 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.3 151.82 5.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.878 -0.601 . . . . 15.0 111.227 -178.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.98 -38.1 3.22 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.498 -0.641 . . . . 15.0 111.498 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.74 -37.96 86.17 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.64 -0.424 . . . . 15.0 110.974 -177.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.4 tp -59.05 -48.93 79.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.916 0.389 . . . . 15.0 110.209 -177.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.5 tp -64.34 -44.96 89.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.138 -0.483 . . . . 15.0 111.215 -175.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.78 -45.51 93.59 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.626 -0.43 . . . . 15.0 110.78 -175.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.3 ttt85 -62.23 -41.81 98.75 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.855 -0.338 . . . . 15.0 110.856 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.6 t -60.93 -43.81 96.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.753 -0.379 . . . . 15.0 110.176 -178.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -68.46 -48.66 63.94 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.117 0.414 . . . . 15.0 112.117 -176.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.58 -44.28 78.54 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.94 -0.304 . . . . 15.0 111.53 -175.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -79.47 -10.13 59.74 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.045 0.757 . . . . 15.0 113.045 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 54.84 55.86 7.34 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.607 0.717 . . . . 15.0 110.418 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 94.1 mt -66.73 148.15 52.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.689 -0.687 . . . . 15.0 111.584 -175.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -95.35 -40.6 9.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.29 -0.868 . . . . 15.0 110.826 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.67 160.32 28.27 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.009 -1.091 . . . . 15.0 113.443 -173.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.4 mt -126.61 141.55 51.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.505 -0.847 . . . . 15.0 109.838 178.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.47 131.22 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 121.143 -0.223 . . . . 15.0 110.702 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 m -123.08 145.56 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.158 0.504 . . . . 15.0 110.562 173.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.3 t -97.83 -20.28 17.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.467 -0.788 . . . . 15.0 112.536 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.8 p -155.93 164.44 38.48 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.442 0.639 . . . . 15.0 111.903 -174.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.91 -37.38 70.0 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.173 -0.771 . . . . 15.0 111.173 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -58.35 -45.72 87.63 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.863 -0.335 . . . . 15.0 110.674 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.17 -46.19 94.68 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.468 -1.053 . . . . 15.0 110.468 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 30.1 tp -56.16 -44.02 78.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.16 0.505 . . . . 15.0 110.831 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.76 -43.1 99.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.039 -0.528 . . . . 15.0 110.672 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -59.03 -39.97 83.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.39 -0.368 . . . . 15.0 110.639 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.9 tp -57.88 -44.56 86.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.189 0.518 . . . . 15.0 110.243 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -60.92 -47.51 86.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.713 -0.676 . . . . 15.0 110.62 -178.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -61.45 -42.99 99.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.014 -0.539 . . . . 15.0 111.053 -177.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.97 -35.91 81.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.352 -0.385 . . . . 15.0 111.405 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.0 -39.22 81.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.975 0.417 . . . . 15.0 110.597 178.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.09 -142.81 0.62 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.591 -0.522 . . . . 15.0 109.591 174.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.49 -19.29 46.81 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.384 0.993 . . . . 15.0 112.601 -174.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -91.82 10.46 28.48 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.355 0.872 . . . . 15.0 113.355 -175.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.9 t-105 -47.84 -46.36 62.62 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 118.598 -0.715 . . . . 15.0 112.665 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -44.73 -41.6 14.83 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 121.525 1.484 . . . . 15.0 113.182 177.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -76.93 -48.8 17.13 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 120.616 -0.434 . . . . 15.0 110.841 -178.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 89.8 mt -59.71 -40.17 81.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 15.0 110.808 -176.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.38 -16.65 36.27 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 119.948 -0.362 . . . . 15.0 113.126 -176.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 60.7 mtp85 -65.31 -30.17 71.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.423 0.611 . . . . 15.0 112.025 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.8 mt -73.52 150.51 89.13 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 111.533 0.197 . . . . 15.0 111.533 -172.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.4 126.35 17.52 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.67 1.58 . . . . 15.0 112.513 176.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.5 tp -105.53 125.75 51.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.473 174.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -89.89 125.89 35.51 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.497 -0.557 . . . . 15.0 109.497 175.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.4 m -116.82 146.07 36.94 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 119.335 -0.364 . . . . 15.0 110.181 176.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.21 -22.97 7.98 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.559 1.506 . . . . 15.0 113.582 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.5 p -144.32 161.77 42.98 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 120.649 -0.421 . . . . 15.0 111.575 -172.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -55.9 -44.01 51.52 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 121.165 1.243 . . . . 15.0 111.821 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -57.56 -47.79 81.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.842 0.353 . . . . 15.0 110.773 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.7 t -59.76 -40.63 83.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.988 -0.375 . . . . 15.0 109.988 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.64 -41.37 81.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.942 0.401 . . . . 15.0 110.484 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.13 -40.0 92.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.425 . . . . 15.0 110.718 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.0 mmm -58.63 -45.09 90.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.383 0.611 . . . . 15.0 110.073 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.73 -41.67 97.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.727 -0.669 . . . . 15.0 110.865 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -61.73 -44.7 96.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.262 -0.426 . . . . 15.0 110.591 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -59.7 -36.11 75.87 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.905 -0.318 . . . . 15.0 111.259 -177.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.97 -23.53 65.96 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.357 0.503 . . . . 15.0 112.357 177.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.7 13.27 16.89 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 119.368 -0.684 . . . . 15.0 113.05 -176.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.78 122.01 11.84 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 118.522 1.161 . . . . 15.0 109.952 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -70.32 -35.7 73.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.677 -0.692 . . . . 15.0 111.22 -172.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -130.87 112.67 13.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.073 0.463 . . . . 15.0 110.422 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.6 t -111.7 130.15 65.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.076 -0.511 . . . . 15.0 109.73 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.1 mt -118.95 122.83 70.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.901 -0.59 . . . . 15.0 110.01 -176.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.33 118.86 32.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.401 -0.363 . . . . 15.0 110.255 176.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.8 p -95.16 -9.63 32.89 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.074 0.768 . . . . 15.0 113.074 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -55.46 -39.79 70.81 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 118.161 0.437 . . . . 15.0 110.843 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -94.77 -35.16 5.96 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.475 -0.65 . . . . 15.0 111.475 178.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.75 145.99 44.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.789 0.328 . . . . 15.0 110.46 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.5 m -89.8 158.88 17.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 15.0 110.451 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.66 -54.24 24.53 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 113.093 0.775 . . . . 15.0 113.093 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -57.48 -35.15 98.88 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 CA-C-N 120.383 1.173 . . . . 15.0 111.5 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.62 95.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.065 0.46 . . . . 15.0 110.091 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.8 mt -59.12 -40.62 85.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 15.0 110.361 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.13 -43.8 82.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.386 0.612 . . . . 15.0 110.113 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.21 -40.58 90.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.7 -0.682 . . . . 15.0 110.495 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.21 -41.58 93.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.358 -0.383 . . . . 15.0 110.808 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.2 mt -57.87 -50.83 71.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.218 0.533 . . . . 15.0 110.408 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.9 p -63.18 -41.3 99.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.719 -0.673 . . . . 15.0 111.265 -175.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.4 m -63.25 -43.45 97.97 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.084 -0.246 . . . . 15.0 111.36 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.6 -38.49 87.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.529 -0.305 . . . . 15.0 111.087 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.17 -32.17 70.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.45 -0.341 . . . . 15.0 111.685 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 85.8 mt -55.6 -36.2 66.68 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 121.066 -0.253 . . . . 15.0 111.27 -178.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -56.7 139.13 51.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.964 0.412 . . . . 15.0 110.812 -178.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -136.47 126.72 26.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.923 -0.58 . . . . 15.0 110.113 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -138.05 90.21 2.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.854 0.359 . . . . 15.0 110.96 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -139.35 144.02 38.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 15.0 110.446 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -130.53 135.97 48.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.375 -0.375 . . . . 15.0 110.59 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -122.08 141.43 51.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.166 -0.47 . . . . 15.0 110.401 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.048 -0.977 . . . . 15.0 110.511 179.968 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.4 mmm . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.146 -0.687 . . . . 15.0 109.146 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -126.14 78.04 71.07 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 116.079 -0.509 . . . . 15.0 110.106 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -50.23 151.6 9.18 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.461 1.441 . . . . 15.0 112.101 -174.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -117.75 140.36 49.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.162 -0.472 . . . . 15.0 110.802 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.8 m -134.03 144.29 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.542 0.686 . . . . 15.0 111.68 176.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.9 tp -104.21 136.78 43.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.131 -0.941 . . . . 15.0 110.233 178.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.9 mt -105.78 135.06 45.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.216 0.531 . . . . 15.0 111.098 -176.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 98.0 mmm -94.43 134.06 37.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.003 -0.998 . . . . 15.0 109.319 171.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -57.55 143.91 39.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.883 0.373 . . . . 15.0 110.673 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.18 175.08 28.57 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.961 -0.856 . . . . 15.0 110.961 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -59.24 -32.27 69.83 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.676 0.25 . . . . 15.0 111.676 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.7 -177.72 24.35 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.934 -0.866 . . . . 15.0 110.934 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.85 119.02 4.89 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.178 -0.769 . . . . 15.0 111.178 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -57.92 -44.57 86.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.303 0.573 . . . . 15.0 110.025 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.47 -42.2 98.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.821 -0.627 . . . . 15.0 111.022 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -57.05 -54.42 46.94 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.959 0.409 . . . . 15.0 110.997 -176.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.8 mt -58.35 -41.67 85.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.391 -0.368 . . . . 15.0 110.696 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.72 -41.92 96.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.362 -0.381 . . . . 15.0 111.573 -178.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.07 -40.84 95.2 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.765 -0.374 . . . . 15.0 110.653 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -59.55 -51.59 69.18 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.437 -0.505 . . . . 15.0 111.054 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 78.6 mt -63.18 -37.02 85.58 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.61 -0.436 . . . . 15.0 111.069 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -61.53 -43.5 98.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.725 0.297 . . . . 15.0 110.552 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.39 -30.62 68.33 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.954 -0.641 . . . . 15.0 111.933 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -88.07 9.71 21.64 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.632 0.975 . . . . 15.0 113.632 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.91 14.44 59.37 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 121.205 -0.521 . . . . 15.0 113.482 174.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.0 t -101.12 138.32 25.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 117.904 0.852 . . . . 15.0 110.163 178.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -83.37 136.98 34.14 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.378 -0.601 . . . . 15.0 109.378 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.1 t -117.03 133.92 62.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.326 0.584 . . . . 15.0 111.516 -173.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -135.33 125.88 26.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.114 -0.948 . . . . 15.0 109.257 169.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -112.34 132.79 54.8 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.762 0.315 . . . . 15.0 110.362 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 tp -115.83 113.5 42.19 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 118.776 -0.63 . . . . 15.0 110.966 -172.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -51.14 135.1 44.86 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.008 1.138 . . . . 15.0 111.769 173.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.3 mt -63.3 -9.23 10.9 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.143 0.794 . . . . 15.0 113.143 -175.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -77.2 -8.79 58.15 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.306 0.854 . . . . 15.0 113.306 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -60.05 150.09 71.71 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 118.417 0.553 . . . . 15.0 110.463 -177.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -80.63 153.14 20.18 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.547 1.498 . . . . 15.0 113.108 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.64 151.33 6.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.924 -0.58 . . . . 15.0 111.221 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.44 -38.06 3.23 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.393 -0.683 . . . . 15.0 111.393 -177.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -61.48 -37.43 83.59 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.658 -0.417 . . . . 15.0 111.068 -177.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.5 tp -60.23 -47.3 86.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.874 0.368 . . . . 15.0 110.332 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 18.3 tp -62.34 -44.66 95.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.896 -176.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.94 -44.08 97.51 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.714 -0.395 . . . . 15.0 110.773 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -60.07 -43.31 95.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.485 -0.325 . . . . 15.0 110.496 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.7 t -61.23 -46.91 95.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.911 -0.316 . . . . 15.0 110.277 -177.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -67.99 -50.12 57.54 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.261 0.351 . . . . 15.0 111.843 -175.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.83 -44.48 77.12 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.727 0.269 . . . . 15.0 111.727 -173.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -78.73 -10.04 59.63 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.213 0.82 . . . . 15.0 113.213 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 56.43 55.83 6.21 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.6 0.714 . . . . 15.0 110.139 -177.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.5 mt -70.57 147.84 48.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.609 -0.723 . . . . 15.0 111.029 -176.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -95.69 -40.66 9.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.597 -0.729 . . . . 15.0 110.798 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -149.22 166.9 29.54 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 119.806 -1.187 . . . . 15.0 113.765 -171.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 74.8 mt -126.81 144.47 50.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.627 -0.786 . . . . 15.0 110.155 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.7 t -122.69 132.11 71.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 110.181 -0.303 . . . . 15.0 110.181 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 m -128.57 141.16 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 121.152 0.501 . . . . 15.0 110.565 173.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.6 t -99.33 -16.4 18.47 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.564 -0.744 . . . . 15.0 112.674 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 81.5 p -151.02 159.71 44.39 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.281 0.562 . . . . 15.0 111.684 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.5 -39.05 83.52 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.929 -0.868 . . . . 15.0 110.929 178.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -58.99 -44.49 91.62 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.801 -0.359 . . . . 15.0 110.636 -178.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.04 -44.62 97.09 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.559 -1.016 . . . . 15.0 110.559 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 31.8 tp -57.35 -43.08 83.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.063 0.459 . . . . 15.0 110.578 -179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.16 -42.44 98.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.116 -0.493 . . . . 15.0 110.734 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -59.34 -41.63 89.62 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.849 -0.34 . . . . 15.0 110.54 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.9 tp -58.39 -44.1 88.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.222 0.534 . . . . 15.0 110.237 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -61.61 -48.01 82.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.845 -0.616 . . . . 15.0 110.836 -178.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -61.27 -42.82 99.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.067 -0.515 . . . . 15.0 111.017 -176.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.31 -35.9 81.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.346 -0.388 . . . . 15.0 111.37 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.86 -39.36 81.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.059 0.457 . . . . 15.0 110.665 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 58.88 -142.18 0.66 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.68 -0.489 . . . . 15.0 109.68 174.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.66 -18.61 43.32 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.426 1.012 . . . . 15.0 112.62 -175.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -91.9 9.36 33.27 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.331 0.863 . . . . 15.0 113.331 -175.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -47.79 -46.94 63.02 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.63 -0.7 . . . . 15.0 112.532 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -44.72 -40.91 14.66 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 C-N-CA 121.357 1.372 . . . . 15.0 113.252 177.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -76.96 -48.78 17.11 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.996 0.427 . . . . 15.0 110.828 -178.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.8 mt -59.84 -40.36 82.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.928 -176.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.0 -13.49 34.39 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 119.877 -0.401 . . . . 15.0 113.197 -176.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 -64.98 -30.61 71.61 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.486 0.643 . . . . 15.0 111.839 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.7 mt -72.52 146.21 88.48 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 119.32 -0.372 . . . . 15.0 110.922 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -61.42 131.15 34.74 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.375 1.383 . . . . 15.0 111.909 175.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.3 tp -107.0 126.97 53.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.581 -0.281 . . . . 15.0 110.697 176.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -89.8 126.79 35.81 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.579 -0.526 . . . . 15.0 109.579 176.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.1 m -119.78 151.35 52.1 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-O 119.513 -0.28 . . . . 15.0 110.602 176.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.2 -22.83 8.1 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.549 1.499 . . . . 15.0 113.869 -176.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.5 p -147.82 162.73 30.39 Favored Pre-proline 0 CA--C 1.531 0.236 0 C-N-CA 120.388 -0.525 . . . . 15.0 111.802 -171.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.17 -44.12 49.69 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.26 1.307 . . . . 15.0 111.792 176.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -57.05 -48.12 79.3 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.849 0.357 . . . . 15.0 110.765 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.6 t -60.22 -39.1 79.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.799 -0.36 . . . . 15.0 110.094 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.92 -41.49 78.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.982 0.42 . . . . 15.0 110.459 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -61.08 -41.0 95.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 15.0 110.429 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.0 mmm -58.13 -45.43 87.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.589 0.709 . . . . 15.0 110.195 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.76 96.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.608 -0.724 . . . . 15.0 110.935 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -61.85 -44.38 96.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.363 -0.38 . . . . 15.0 110.836 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.3 -36.06 77.01 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.851 -0.34 . . . . 15.0 111.339 -177.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.8 mt -66.13 -23.93 66.58 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.289 0.477 . . . . 15.0 112.289 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.24 13.31 17.82 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 119.406 -0.663 . . . . 15.0 113.171 -176.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.01 122.38 12.89 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.551 1.175 . . . . 15.0 109.852 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -67.94 -36.52 80.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.597 -0.729 . . . . 15.0 111.123 -171.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 58.7 ttt85 -131.82 117.54 18.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.956 0.408 . . . . 15.0 110.567 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.55 130.13 69.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.925 0.393 . . . . 15.0 110.038 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 90.6 mt -119.68 124.16 72.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.902 -0.59 . . . . 15.0 110.299 -177.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -92.88 114.85 27.52 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.907 -0.405 . . . . 15.0 109.907 174.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.8 p -81.44 -13.95 57.64 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.95 0.722 . . . . 15.0 112.95 -178.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -54.74 -38.74 67.52 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 122.082 -0.386 . . . . 15.0 111.001 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.53 -35.01 8.13 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.644 -0.583 . . . . 15.0 111.644 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.98 122.38 34.44 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.83 0.348 . . . . 15.0 110.81 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 48.8 m -65.42 161.98 18.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.634 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.63 -54.2 24.71 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 118.49 -0.767 . . . . 15.0 113.033 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.38 -35.99 96.8 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 CA-C-N 120.564 1.237 . . . . 15.0 111.384 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.32 -42.11 94.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.027 0.441 . . . . 15.0 110.125 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.8 mt -59.0 -40.42 84.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.062 0.458 . . . . 15.0 110.57 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 39.8 tp -57.21 -44.52 83.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.408 0.623 . . . . 15.0 110.053 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.21 -39.57 87.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.587 -0.733 . . . . 15.0 110.538 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.48 -41.48 94.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.443 -0.344 . . . . 15.0 110.917 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.0 mt -57.9 -51.16 70.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.161 0.505 . . . . 15.0 110.443 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.6 p -63.61 -40.24 96.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.67 -0.695 . . . . 15.0 111.323 -175.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.9 p -66.34 -38.6 88.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.724 0.297 . . . . 15.0 111.336 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.3 96.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.495 -0.321 . . . . 15.0 110.82 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.9 -39.7 86.26 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.478 -0.328 . . . . 15.0 110.616 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 86.7 mt -62.6 -35.65 80.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.417 -0.356 . . . . 15.0 111.232 178.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -54.82 -35.91 64.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.551 0.215 . . . . 15.0 111.339 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -111.38 138.2 48.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.766 0.317 . . . . 15.0 110.416 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -118.54 133.07 56.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.26 -0.427 . . . . 15.0 110.448 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -113.87 130.44 56.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.2 -0.454 . . . . 15.0 110.581 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -60.46 -41.73 94.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 15.0 110.579 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -55.17 -39.33 69.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.143 -0.48 . . . . 15.0 111.037 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.009 -0.996 . . . . 15.0 110.581 179.929 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.3 mtp . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.308 -0.627 . . . . 15.0 109.308 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -128.08 78.42 75.37 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.234 -0.439 . . . . 15.0 110.126 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.1 150.27 10.62 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.504 1.469 . . . . 15.0 112.179 -174.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -117.0 140.71 49.16 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.22 -0.446 . . . . 15.0 110.858 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.7 m -134.28 144.62 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.567 0.698 . . . . 15.0 111.67 175.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.6 tp -104.27 137.51 42.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.078 -0.965 . . . . 15.0 110.326 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.5 mt -102.47 134.12 44.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.005 0.431 . . . . 15.0 111.025 -177.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 98.4 mmm -95.01 134.15 38.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.221 -0.9 . . . . 15.0 109.307 171.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -57.65 144.63 37.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.948 0.404 . . . . 15.0 110.678 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -161.68 175.15 38.25 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.801 -0.92 . . . . 15.0 110.801 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.94 -34.72 60.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.536 0.208 . . . . 15.0 111.486 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.81 162.94 29.83 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.9 -0.88 . . . . 15.0 110.9 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.93 130.92 10.1 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.232 -0.747 . . . . 15.0 111.232 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -57.13 -43.82 82.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.985 0.421 . . . . 15.0 110.359 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.23 -43.01 99.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.046 -0.525 . . . . 15.0 111.333 -176.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -61.52 -56.09 23.87 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.858 -0.337 . . . . 15.0 111.341 -176.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.4 mt -60.66 -43.45 97.6 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.708 -0.397 . . . . 15.0 111.031 -176.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.78 -39.4 94.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.389 -0.369 . . . . 15.0 110.92 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -60.76 -43.01 98.53 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.905 -0.318 . . . . 15.0 110.482 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -61.19 -51.57 68.43 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.421 -0.511 . . . . 15.0 110.943 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 69.2 mt -62.61 -36.97 84.48 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.515 -0.474 . . . . 15.0 110.999 -178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -63.05 -43.31 99.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.618 0.247 . . . . 15.0 111.045 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.96 -30.59 66.79 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.035 -0.602 . . . . 15.0 111.932 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -88.09 9.87 21.12 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.494 0.924 . . . . 15.0 113.494 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.27 14.69 58.48 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 121.258 -0.496 . . . . 15.0 113.501 174.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.0 t -101.1 139.07 23.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 117.857 0.828 . . . . 15.0 110.22 178.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -84.45 134.08 34.47 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.04 -0.726 . . . . 15.0 109.04 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.4 t -119.59 133.96 64.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.229 0.537 . . . . 15.0 111.353 -173.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -137.84 136.3 37.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.469 -0.787 . . . . 15.0 109.591 172.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -115.37 140.93 48.69 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.793 0.33 . . . . 15.0 110.827 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.1 tp -119.3 113.43 35.28 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-O 118.741 -0.647 . . . . 15.0 110.715 -175.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.17 135.08 63.36 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 121.168 1.246 . . . . 15.0 111.964 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 50.3 mt -62.53 -9.14 7.72 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.358 0.873 . . . . 15.0 113.358 -175.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -77.09 -9.5 58.78 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.18 0.807 . . . . 15.0 113.18 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -60.78 149.18 80.85 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 118.292 0.496 . . . . 15.0 110.251 -178.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.97 154.18 25.7 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.53 1.487 . . . . 15.0 112.968 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.23 150.77 5.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.955 -0.566 . . . . 15.0 111.163 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.95 -37.65 3.39 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.439 -0.664 . . . . 15.0 111.439 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.89 -36.9 80.41 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.594 -0.442 . . . . 15.0 111.103 -177.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.2 tp -58.97 -45.99 89.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.379 . . . . 15.0 110.201 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.2 tp -62.65 -45.35 93.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.209 -0.45 . . . . 15.0 110.803 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.74 -43.59 98.56 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.731 -0.388 . . . . 15.0 110.852 -176.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -60.52 -43.9 96.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.558 -0.292 . . . . 15.0 110.522 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.3 t -61.18 -46.38 96.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.774 -0.37 . . . . 15.0 110.214 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -68.41 -51.04 48.25 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.348 0.405 . . . . 15.0 112.025 -175.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.83 -44.37 81.26 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.736 0.273 . . . . 15.0 111.736 -173.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -79.37 -10.17 59.75 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.06 0.763 . . . . 15.0 113.06 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.7 mtp180 55.39 55.81 7.0 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.658 0.742 . . . . 15.0 110.273 -177.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.72 146.22 50.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.643 -0.708 . . . . 15.0 111.296 -174.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -93.45 -40.6 10.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.408 -0.814 . . . . 15.0 110.876 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.86 165.11 29.23 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 119.943 -1.122 . . . . 15.0 113.785 -173.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 74.2 mt -125.62 142.16 51.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.466 -0.867 . . . . 15.0 109.837 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.6 t -120.49 129.55 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 110.261 -0.274 . . . . 15.0 110.261 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.5 m -128.27 133.39 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.873 0.368 . . . . 15.0 110.095 172.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.5 p -99.38 -4.22 32.09 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.998 0.74 . . . . 15.0 112.998 177.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 82.7 p -152.46 154.92 36.49 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.366 0.603 . . . . 15.0 111.793 -176.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.03 -38.92 88.43 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.986 -0.846 . . . . 15.0 110.986 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -57.41 -46.14 83.83 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 122.63 -0.336 . . . . 15.0 110.638 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.32 -44.37 96.6 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.7 -0.96 . . . . 15.0 110.7 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 36.5 tp -57.19 -45.27 83.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.123 0.487 . . . . 15.0 110.597 -178.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.35 -42.13 98.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.029 -0.532 . . . . 15.0 110.818 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -60.06 -40.48 89.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.523 -0.308 . . . . 15.0 110.669 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.1 tp -58.42 -44.35 89.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.142 0.496 . . . . 15.0 110.149 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -60.96 -47.35 86.86 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.801 -0.636 . . . . 15.0 110.719 -178.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.43 -43.02 99.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.089 -0.505 . . . . 15.0 111.116 -176.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.3 mt -66.26 -35.44 80.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.354 -0.385 . . . . 15.0 111.375 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.03 -39.0 80.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.095 0.474 . . . . 15.0 110.672 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.02 -142.89 0.62 Allowed 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.691 -0.485 . . . . 15.0 109.691 174.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.56 -19.77 50.94 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.38 0.991 . . . . 15.0 112.697 -174.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -91.9 11.04 26.29 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.307 0.854 . . . . 15.0 113.307 -175.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 55.0 t-105 -47.83 -46.67 63.01 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-O 118.555 -0.736 . . . . 15.0 112.521 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -44.56 -41.09 14.22 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.498 1.465 . . . . 15.0 113.198 177.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -76.93 -48.83 17.05 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.944 0.402 . . . . 15.0 110.849 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.3 mt -59.92 -39.82 81.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 15.0 110.871 -176.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.21 -14.6 33.68 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 119.898 -0.39 . . . . 15.0 113.092 -176.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -64.15 -30.36 71.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.404 0.602 . . . . 15.0 111.963 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.0 mt -75.36 150.57 85.07 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 120.939 -0.305 . . . . 15.0 111.53 -173.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -61.98 128.35 23.94 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.675 1.584 . . . . 15.0 112.457 176.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.1 tp -107.64 126.31 52.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.313 -0.403 . . . . 15.0 110.474 174.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -90.52 125.65 35.67 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.599 -0.519 . . . . 15.0 109.599 176.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.1 m -116.99 147.78 40.83 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 110.154 -0.313 . . . . 15.0 110.154 176.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.24 -24.76 6.36 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.634 1.556 . . . . 15.0 113.538 -174.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.8 p -142.78 162.3 44.7 Favored Pre-proline 0 CA--C 1.531 0.213 0 C-N-CA 120.611 -0.436 . . . . 15.0 111.658 -171.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.0 -44.04 50.96 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.21 1.273 . . . . 15.0 111.841 176.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -58.25 -47.06 84.75 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.915 -0.314 . . . . 15.0 110.737 -177.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.6 t -60.2 -41.02 85.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 110.003 -0.369 . . . . 15.0 110.003 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.74 -42.35 83.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.925 0.393 . . . . 15.0 110.509 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -61.43 -41.8 97.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 15.0 110.563 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 87.1 mtp -59.17 -43.88 92.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.211 0.529 . . . . 15.0 110.268 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.52 94.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.889 -0.596 . . . . 15.0 110.792 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -61.24 -44.39 97.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.274 -0.421 . . . . 15.0 110.566 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.05 -36.15 76.69 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.868 -0.333 . . . . 15.0 111.244 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.1 mt -64.24 -25.94 68.28 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.019 0.378 . . . . 15.0 112.019 176.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.27 13.32 15.49 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 119.313 -0.715 . . . . 15.0 113.045 -176.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.97 122.4 12.91 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.521 1.16 . . . . 15.0 109.91 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -69.9 -35.95 75.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.705 -0.68 . . . . 15.0 111.223 -172.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -131.07 112.63 13.06 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.042 0.449 . . . . 15.0 110.398 178.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.0 t -111.0 130.23 64.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.183 -0.462 . . . . 15.0 109.901 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 84.6 mt -119.3 125.23 74.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.832 -0.622 . . . . 15.0 110.081 -177.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -95.33 118.12 31.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.401 -0.363 . . . . 15.0 110.261 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 32.0 p -95.76 -4.16 44.51 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.184 0.809 . . . . 15.0 113.184 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.1 tpt85 -55.6 -39.54 70.89 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.086 0.403 . . . . 15.0 110.712 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -95.79 -35.14 5.71 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.532 -0.627 . . . . 15.0 111.532 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.64 137.27 40.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.823 0.344 . . . . 15.0 110.68 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.2 p -83.87 164.49 19.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 15.0 110.665 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.72 -54.3 24.33 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 113.018 0.748 . . . . 15.0 113.018 179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.49 -36.0 97.19 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 CA-C-N 120.469 1.203 . . . . 15.0 111.394 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.47 -42.89 97.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.114 0.483 . . . . 15.0 110.103 178.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.3 mt -59.0 -41.2 87.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 15.0 110.414 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 34.3 tp -57.61 -44.55 85.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.37 0.605 . . . . 15.0 110.183 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.78 94.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.673 -0.694 . . . . 15.0 110.514 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.7 -41.08 94.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.416 -0.356 . . . . 15.0 110.811 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.4 mt -57.69 -51.76 68.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.233 0.539 . . . . 15.0 110.459 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.0 p -64.04 -40.57 96.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.647 -0.706 . . . . 15.0 111.33 -175.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.9 m -63.42 -42.86 98.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.732 0.301 . . . . 15.0 111.46 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.64 -39.27 93.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.446 -0.343 . . . . 15.0 111.049 -178.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.75 -36.81 77.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.555 -0.293 . . . . 15.0 111.14 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 89.5 mt -61.26 -37.84 84.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.679 -0.237 . . . . 15.0 111.194 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -105.44 128.31 53.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.804 0.335 . . . . 15.0 110.896 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -99.6 -34.47 10.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 15.0 111.307 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -120.75 129.37 53.59 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.879 0.371 . . . . 15.0 110.762 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -58.69 -38.57 78.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.006 -0.543 . . . . 15.0 111.006 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -53.38 -37.12 62.13 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.35 -0.387 . . . . 15.0 111.435 -177.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -112.37 137.53 50.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.834 0.35 . . . . 15.0 110.653 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.986 -1.007 . . . . 15.0 110.542 -179.939 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.4 mmm . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.212 -0.662 . . . . 15.0 109.212 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -125.71 81.54 65.09 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 116.193 -0.458 . . . . 15.0 110.179 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -56.42 152.87 37.39 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.393 1.395 . . . . 15.0 112.0 -175.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -110.78 139.0 46.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.383 -0.371 . . . . 15.0 110.687 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.2 m -135.72 142.74 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.596 0.713 . . . . 15.0 111.695 176.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.3 tp -104.77 135.35 46.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.863 -1.062 . . . . 15.0 110.129 178.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 57.5 mt -104.75 133.74 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.19 0.519 . . . . 15.0 110.888 -176.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 98.4 mmm -95.2 134.06 38.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.062 -0.972 . . . . 15.0 109.488 173.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -62.09 143.99 55.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.886 0.374 . . . . 15.0 110.677 -178.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.57 175.07 32.83 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.108 -0.797 . . . . 15.0 111.108 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.59 -33.31 66.08 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.576 0.214 . . . . 15.0 111.576 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.4 -178.28 4.6 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.963 -0.855 . . . . 15.0 110.963 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.04 112.6 3.67 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.05 -0.82 . . . . 15.0 111.05 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -56.83 -45.85 82.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.308 0.575 . . . . 15.0 110.146 -177.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.77 -44.31 93.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.694 -0.684 . . . . 15.0 111.122 -177.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -56.61 -53.83 53.06 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.805 -0.358 . . . . 15.0 111.281 -175.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.9 mp -59.88 -43.21 94.87 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 120.649 -0.42 . . . . 15.0 110.883 -177.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.89 -42.52 98.14 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.752 -0.379 . . . . 15.0 111.48 -177.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.21 -39.16 89.2 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.776 -0.37 . . . . 15.0 110.846 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -60.23 -51.49 69.34 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.273 -0.571 . . . . 15.0 111.133 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 80.3 mt -62.89 -38.68 91.87 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.499 -0.48 . . . . 15.0 111.008 -177.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -64.0 -43.64 95.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.574 0.226 . . . . 15.0 110.955 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.24 -30.56 67.7 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.032 -0.604 . . . . 15.0 112.026 -178.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -88.14 9.76 21.63 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.52 0.933 . . . . 15.0 113.52 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.68 16.45 52.05 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 121.12 -0.562 . . . . 15.0 113.444 173.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.06 138.84 23.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 117.784 0.792 . . . . 15.0 110.058 177.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -78.29 125.41 29.32 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.059 -0.719 . . . . 15.0 109.059 177.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.3 t -117.63 131.65 69.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.132 0.492 . . . . 15.0 111.03 -172.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -137.61 131.79 32.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.611 -0.722 . . . . 15.0 109.77 171.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -114.62 134.55 54.97 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.217 -0.29 . . . . 15.0 110.217 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.2 tp -111.34 140.26 22.79 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 119.162 -0.446 . . . . 15.0 110.373 -174.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -72.11 135.13 24.49 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.219 1.279 . . . . 15.0 111.11 170.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.0 mt -63.21 -9.25 10.5 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.122 0.786 . . . . 15.0 113.122 -175.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -77.27 -10.25 59.31 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.263 0.838 . . . . 15.0 113.263 -177.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -62.46 151.07 83.98 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 118.552 0.614 . . . . 15.0 110.855 -177.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -79.11 155.49 25.89 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.479 1.453 . . . . 15.0 113.1 -177.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.24 150.73 8.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.875 -0.602 . . . . 15.0 111.072 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.98 -36.28 4.21 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.514 -0.634 . . . . 15.0 111.514 -177.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -59.54 -40.05 85.94 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 120.498 -0.481 . . . . 15.0 110.697 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.7 tp -61.13 -47.97 83.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.963 0.411 . . . . 15.0 110.458 -177.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 19.0 tp -61.25 -43.44 98.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 15.0 110.888 -175.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.12 -46.01 90.92 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.782 -0.367 . . . . 15.0 110.84 -175.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 46.9 ttt85 -61.1 -41.87 97.47 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.635 -0.426 . . . . 15.0 110.567 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 94.4 t -58.78 -45.59 91.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.753 -0.379 . . . . 15.0 110.022 -177.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -70.59 -50.94 31.93 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.503 0.502 . . . . 15.0 112.275 -176.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.75 -44.4 86.03 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.067 0.395 . . . . 15.0 112.067 -172.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.6 mp0 -89.11 -7.03 56.56 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.391 0.886 . . . . 15.0 113.391 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.8 ttt-85 57.97 56.05 4.92 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.662 0.744 . . . . 15.0 109.829 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.9 mt -60.61 142.69 55.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.595 -0.73 . . . . 15.0 110.891 -175.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -90.56 -40.56 11.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.481 -0.781 . . . . 15.0 110.822 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -149.57 163.57 29.31 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.079 -1.058 . . . . 15.0 113.498 -174.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.4 mt -126.27 141.06 52.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.433 -0.883 . . . . 15.0 109.903 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.4 t -120.83 131.31 73.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 110.294 -0.262 . . . . 15.0 110.294 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.6 m -124.14 130.55 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.134 0.493 . . . . 15.0 110.374 172.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.6 m -87.17 -19.45 28.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.586 -0.734 . . . . 15.0 112.514 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.8 p -151.86 161.04 43.29 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.336 0.588 . . . . 15.0 111.509 -175.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.35 -39.17 82.24 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.992 -0.843 . . . . 15.0 110.992 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -57.93 -45.9 85.85 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.864 -0.334 . . . . 15.0 110.563 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.63 -43.96 97.27 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.734 -0.947 . . . . 15.0 110.734 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.2 tp -57.48 -43.99 84.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.023 0.439 . . . . 15.0 110.559 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.03 -42.17 97.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.077 -0.51 . . . . 15.0 110.641 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -59.51 -40.72 87.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.444 -0.344 . . . . 15.0 110.635 178.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.9 tp -58.61 -44.54 89.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.135 0.493 . . . . 15.0 110.114 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -61.29 -47.26 86.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.852 -0.613 . . . . 15.0 110.703 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -61.36 -42.93 99.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.086 -0.506 . . . . 15.0 111.102 -176.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.7 mt -66.94 -34.95 78.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.34 -0.391 . . . . 15.0 111.478 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.04 -39.49 82.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.076 0.465 . . . . 15.0 110.601 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 58.95 -142.79 0.63 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 109.662 -0.496 . . . . 15.0 109.662 174.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.53 -18.87 44.06 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.417 1.008 . . . . 15.0 112.631 -174.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -91.82 9.65 31.86 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.313 0.857 . . . . 15.0 113.313 -175.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -47.97 -46.62 64.38 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-O 118.559 -0.734 . . . . 15.0 112.521 177.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -44.7 -41.2 14.69 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.481 1.454 . . . . 15.0 113.218 177.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.5 mp0 -77.03 -48.76 17.01 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.688 -0.405 . . . . 15.0 110.755 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 89.8 mt -59.8 -40.2 81.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.279 -0.419 . . . . 15.0 110.858 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.73 -15.14 32.71 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 119.903 -0.387 . . . . 15.0 113.107 -177.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -64.25 -30.61 71.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.417 0.608 . . . . 15.0 111.977 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.5 mt -76.24 150.46 82.9 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 121.065 -0.254 . . . . 15.0 111.397 -173.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.92 128.13 25.68 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 121.695 1.597 . . . . 15.0 112.43 176.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.3 tp -106.68 125.58 51.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 15.0 110.425 174.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -91.56 125.63 36.36 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.607 -0.516 . . . . 15.0 109.607 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.2 m -116.85 148.06 41.3 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 110.114 -0.328 . . . . 15.0 110.114 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -79.12 -24.27 6.92 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.486 1.457 . . . . 15.0 113.592 -175.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.6 p -143.43 162.06 44.15 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 120.564 -0.454 . . . . 15.0 111.644 -172.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.85 -44.04 51.33 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.241 1.294 . . . . 15.0 111.741 176.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -57.62 -47.87 81.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.8 0.333 . . . . 15.0 110.827 -178.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 52.4 t -59.74 -40.64 83.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.767 -0.373 . . . . 15.0 110.03 178.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.46 -42.3 82.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.921 0.391 . . . . 15.0 110.488 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.24 -41.87 97.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.147 -0.479 . . . . 15.0 110.465 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 87.0 mtp -59.34 -43.68 92.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.349 0.595 . . . . 15.0 110.384 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.48 -40.07 93.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.916 -0.584 . . . . 15.0 110.77 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -61.23 -44.28 97.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.335 -0.393 . . . . 15.0 110.61 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.95 -36.17 76.51 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.936 -0.306 . . . . 15.0 111.224 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.0 mt -64.09 -25.73 68.23 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.086 0.402 . . . . 15.0 112.086 176.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.57 13.31 17.06 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 119.336 -0.702 . . . . 15.0 113.098 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.02 122.87 14.07 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.534 1.167 . . . . 15.0 109.92 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -69.91 -35.7 74.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.734 -0.666 . . . . 15.0 111.223 -172.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -130.71 113.31 13.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.938 0.399 . . . . 15.0 110.302 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.09 129.52 66.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.236 -0.438 . . . . 15.0 109.9 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.2 mt -120.11 125.72 74.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.81 -0.632 . . . . 15.0 110.163 -176.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -94.39 117.33 29.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.458 -0.337 . . . . 15.0 110.345 175.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 32.0 p -97.0 -1.53 45.33 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.299 0.852 . . . . 15.0 113.299 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -55.53 -39.57 70.72 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 118.182 0.446 . . . . 15.0 110.785 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -95.21 -35.02 5.88 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.53 -0.628 . . . . 15.0 111.53 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.51 138.89 47.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.802 0.334 . . . . 15.0 110.644 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.5 p -85.77 164.9 17.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.094 -0.503 . . . . 15.0 110.529 179.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.68 -54.33 23.94 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 113.0 0.741 . . . . 15.0 113.0 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.69 -34.59 99.02 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 CA-C-N 120.099 1.071 . . . . 15.0 111.718 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.27 -43.31 96.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.104 0.478 . . . . 15.0 109.989 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 78.1 mt -59.31 -40.79 87.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 15.0 110.33 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 40.5 tp -57.13 -44.15 83.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.324 0.583 . . . . 15.0 110.229 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.83 -41.61 96.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.734 -0.667 . . . . 15.0 110.451 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.27 88.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 15.0 110.736 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.3 mt -57.81 -51.88 67.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.201 0.524 . . . . 15.0 110.395 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.7 p -63.69 -40.27 96.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.614 -0.721 . . . . 15.0 111.389 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.4 m -63.34 -43.24 98.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.66 0.267 . . . . 15.0 111.386 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.41 -39.36 93.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.42 -0.355 . . . . 15.0 111.091 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.87 -37.9 77.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.423 -0.353 . . . . 15.0 110.939 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 86.5 mt -61.6 -37.06 82.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.459 -0.337 . . . . 15.0 111.17 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -59.36 -38.25 79.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.59 -0.277 . . . . 15.0 111.248 -177.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -57.96 -43.41 86.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.517 -0.31 . . . . 15.0 111.23 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -56.32 -41.82 76.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.371 -0.377 . . . . 15.0 111.204 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -56.76 -41.78 78.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.453 -0.34 . . . . 15.0 111.067 -178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -57.12 -45.14 83.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.804 0.335 . . . . 15.0 110.843 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -57.18 -40.0 76.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 15.0 110.85 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.062 -0.97 . . . . 15.0 110.532 179.996 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.4 mtp . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.256 -0.646 . . . . 15.0 109.256 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.94 81.26 70.69 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.213 -0.449 . . . . 15.0 110.125 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.06 155.02 25.23 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.441 1.428 . . . . 15.0 111.921 -175.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -111.95 138.14 48.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.379 -0.373 . . . . 15.0 110.79 179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.0 m -134.56 144.46 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.435 0.636 . . . . 15.0 111.638 176.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.1 tp -105.05 137.28 43.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.203 -0.908 . . . . 15.0 110.553 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.8 mt -103.16 133.41 47.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.01 0.433 . . . . 15.0 110.679 -177.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 85.5 mtp -106.05 134.43 49.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.31 -0.859 . . . . 15.0 110.197 174.404 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -57.43 144.98 34.4 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.108 0.48 . . . . 15.0 110.772 -177.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.35 175.16 36.29 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.763 -0.935 . . . . 15.0 110.763 -178.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.01 -32.68 47.97 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.681 0.252 . . . . 15.0 111.681 -179.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.95 -179.5 39.9 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.042 -0.823 . . . . 15.0 111.042 -178.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.01 113.98 3.88 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.156 -0.778 . . . . 15.0 111.156 -178.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -56.62 -47.66 79.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.119 0.485 . . . . 15.0 110.498 -179.453 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.38 -40.52 97.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 15.0 110.904 -178.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -57.46 -54.41 47.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.113 0.482 . . . . 15.0 110.764 -176.174 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.8 tp -57.88 -43.09 85.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 15.0 110.598 -179.004 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.37 -45.5 84.35 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.695 -0.402 . . . . 15.0 111.101 -178.02 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -59.81 -40.58 88.9 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.772 -0.371 . . . . 15.0 110.658 -176.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.1 mmt85 -59.76 -51.43 69.77 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.299 -0.56 . . . . 15.0 111.358 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.61 -35.7 80.41 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.541 -0.464 . . . . 15.0 111.108 -176.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -64.19 -43.35 95.35 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.918 -0.313 . . . . 15.0 111.127 177.076 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.78 -30.63 66.3 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.008 -0.615 . . . . 15.0 112.066 -178.273 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -88.2 8.71 25.81 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.66 0.985 . . . . 15.0 113.66 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.73 17.62 56.24 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 121.233 -0.508 . . . . 15.0 113.245 175.391 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.0 t -101.12 140.25 20.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 117.745 0.772 . . . . 15.0 109.861 177.475 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -80.57 127.73 32.79 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.118 -0.697 . . . . 15.0 109.118 178.245 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.1 t -116.89 131.39 69.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.208 0.528 . . . . 15.0 111.025 -172.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -134.89 135.33 41.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.367 -0.833 . . . . 15.0 109.293 172.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -120.65 133.53 55.36 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.773 0.32 . . . . 15.0 110.7 -176.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.7 tp -117.01 141.5 28.47 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 116.14 -0.482 . . . . 15.0 110.004 -174.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -72.07 135.07 24.46 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.418 1.412 . . . . 15.0 111.699 170.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.7 mt -61.7 -10.0 7.61 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.943 0.72 . . . . 15.0 112.943 179.305 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -77.21 -10.87 59.68 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.191 0.811 . . . . 15.0 113.191 -177.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -62.7 148.96 90.29 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 118.512 0.596 . . . . 15.0 110.824 -177.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.1 159.03 37.68 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.574 1.516 . . . . 15.0 113.225 -174.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.04 152.43 5.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.729 -0.669 . . . . 15.0 111.061 -178.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.28 -35.69 4.24 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.487 -0.645 . . . . 15.0 111.487 -176.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -59.47 -39.01 82.29 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 117.094 0.447 . . . . 15.0 110.835 -177.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.3 tp -59.3 -48.55 81.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.068 0.461 . . . . 15.0 110.274 -177.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.1 tp -62.47 -43.01 99.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.091 -0.504 . . . . 15.0 111.091 -175.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.62 -45.97 90.39 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.787 -0.365 . . . . 15.0 110.948 -175.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -61.07 -40.98 95.74 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.71 -0.396 . . . . 15.0 110.55 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 84.8 t -59.54 -48.15 88.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 110.013 -0.365 . . . . 15.0 110.013 -177.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -68.59 -51.04 46.91 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.681 0.613 . . . . 15.0 112.098 -174.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.56 -44.26 82.77 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.789 0.292 . . . . 15.0 111.789 -173.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -82.92 -10.08 58.99 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.14 0.793 . . . . 15.0 113.14 -178.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 55.63 55.77 6.87 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.621 0.724 . . . . 15.0 110.112 -177.041 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.3 mt -66.01 144.89 56.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.611 -0.722 . . . . 15.0 111.493 -173.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -93.92 -39.58 10.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.226 -0.897 . . . . 15.0 110.971 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.02 165.75 31.27 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 120.04 -1.076 . . . . 15.0 113.663 -175.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.3 mt -128.77 142.7 50.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.578 -0.811 . . . . 15.0 109.445 178.604 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 45.8 t -120.93 130.53 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 120.757 0.313 . . . . 15.0 110.541 -179.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.9 m -130.4 155.64 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.2 -0.455 . . . . 15.0 110.17 172.129 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.8 t -131.18 12.09 5.07 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.716 0.636 . . . . 15.0 112.716 177.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 81.9 p -154.14 151.52 29.34 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.184 0.516 . . . . 15.0 111.577 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.48 -40.08 91.7 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.599 -1.0 . . . . 15.0 110.599 176.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -58.93 -42.03 88.74 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.897 -0.321 . . . . 15.0 110.6 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.48 -46.23 94.75 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.627 -0.989 . . . . 15.0 110.627 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.9 tp -57.54 -43.32 84.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.985 0.421 . . . . 15.0 110.474 -179.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.31 -42.25 98.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.474 . . . . 15.0 110.81 -179.501 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -59.05 -42.38 90.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.955 0.407 . . . . 15.0 110.412 178.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.2 tp -58.47 -44.16 89.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.125 0.488 . . . . 15.0 110.296 -179.032 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -61.75 -48.32 81.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.942 -0.572 . . . . 15.0 110.762 -177.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.41 -42.65 99.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.043 -0.526 . . . . 15.0 111.095 -176.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 92.1 mt -67.42 -35.3 78.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.37 -0.377 . . . . 15.0 111.489 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.9 -38.1 78.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.06 0.457 . . . . 15.0 110.665 177.142 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.43 -143.25 0.58 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 109.501 -0.555 . . . . 15.0 109.501 173.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.53 -19.5 48.75 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.377 0.989 . . . . 15.0 112.63 -174.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -91.91 11.03 26.35 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 113.362 0.875 . . . . 15.0 113.362 -175.179 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 60.4 t-105 -47.9 -46.07 62.83 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-O 118.501 -0.762 . . . . 15.0 112.548 177.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -44.67 -42.71 14.73 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 121.416 1.411 . . . . 15.0 113.271 177.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -76.96 -48.73 17.24 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.032 0.444 . . . . 15.0 110.626 -177.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 87.4 mt -59.73 -35.6 60.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.014 -0.539 . . . . 15.0 111.061 -177.162 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.0 -20.64 34.95 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 119.969 -0.35 . . . . 15.0 112.946 -176.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -64.08 -30.16 71.25 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.34 0.57 . . . . 15.0 112.347 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.8 mt -62.21 150.49 84.2 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 119.545 -0.264 . . . . 15.0 110.891 -174.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.34 123.12 8.49 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 121.419 1.413 . . . . 15.0 111.669 175.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.4 tp -102.46 123.7 46.7 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.906 -0.318 . . . . 15.0 110.581 176.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -87.84 125.2 34.33 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.382 -0.599 . . . . 15.0 109.382 175.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.96 147.82 42.1 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 119.429 -0.319 . . . . 15.0 110.186 176.09 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -79.13 -24.43 6.77 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.532 1.488 . . . . 15.0 113.52 -175.11 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.9 p -143.09 161.25 49.23 Favored Pre-proline 0 CA--C 1.531 0.235 0 C-N-CA 120.627 -0.429 . . . . 15.0 111.41 -172.296 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -54.98 -44.05 53.52 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.115 1.21 . . . . 15.0 111.78 176.135 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -57.5 -48.46 79.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.847 0.356 . . . . 15.0 110.613 -177.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 55.7 t -59.74 -39.96 81.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.942 0.401 . . . . 15.0 110.043 178.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.22 -41.67 79.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 15.0 110.337 178.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -60.51 -40.55 91.83 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.303 -0.408 . . . . 15.0 110.415 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 96.9 mmm -57.84 -44.53 86.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.562 0.696 . . . . 15.0 110.195 179.052 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.68 -40.69 95.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.566 -0.743 . . . . 15.0 110.77 -179.417 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -62.54 -42.93 99.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.348 -0.387 . . . . 15.0 111.097 -179.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.0 -36.01 78.36 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.869 -0.332 . . . . 15.0 111.5 -176.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.1 mt -66.32 -22.9 66.29 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.272 0.471 . . . . 15.0 112.272 176.539 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.21 13.33 19.7 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 119.378 -0.679 . . . . 15.0 113.051 -176.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.89 122.02 11.94 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.504 1.152 . . . . 15.0 109.872 -178.142 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -74.35 -31.71 62.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.509 -0.769 . . . . 15.0 111.642 -171.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -129.38 111.59 12.97 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.996 0.427 . . . . 15.0 110.154 175.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 43.8 t -114.66 131.25 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 15.0 109.861 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 85.1 mt -120.69 124.57 72.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.242 -0.435 . . . . 15.0 110.304 -176.008 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -94.3 118.48 31.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.395 -0.366 . . . . 15.0 110.302 176.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.4 p -96.26 -3.97 43.12 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.216 0.821 . . . . 15.0 113.216 -178.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -55.72 -39.55 71.24 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 118.246 0.475 . . . . 15.0 110.776 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -91.53 -35.03 7.09 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.569 -0.612 . . . . 15.0 111.569 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -82.32 132.29 35.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.841 0.353 . . . . 15.0 110.76 -179.135 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.6 p -77.91 167.04 22.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.096 -0.502 . . . . 15.0 110.572 179.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.64 -54.4 23.24 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 112.974 0.731 . . . . 15.0 112.974 179.045 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.09 -34.84 98.91 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 CA-C-N 120.213 1.112 . . . . 15.0 111.68 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.93 -43.0 95.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.07 0.462 . . . . 15.0 109.988 177.337 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.8 mt -59.4 -40.11 85.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 15.0 110.522 178.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 43.7 tp -56.9 -44.37 82.26 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.39 0.614 . . . . 15.0 110.169 178.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.9 -41.11 95.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.589 -0.732 . . . . 15.0 110.491 179.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.33 -41.21 93.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.335 -0.393 . . . . 15.0 110.743 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.1 mt -57.88 -50.87 71.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.122 0.487 . . . . 15.0 110.373 -179.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.3 p -64.55 -40.98 96.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.657 -0.701 . . . . 15.0 111.374 -175.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.0 m -61.94 -42.46 99.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.703 0.287 . . . . 15.0 111.297 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.82 -43.51 98.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.473 -0.33 . . . . 15.0 111.033 -178.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.51 95.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.732 0.301 . . . . 15.0 110.835 179.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.7 -35.97 82.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.344 -0.389 . . . . 15.0 111.477 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -95.72 129.03 43.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.863 0.363 . . . . 15.0 110.591 -178.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -97.51 -28.39 13.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 15.0 112.091 -179.213 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -122.44 114.11 20.27 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.738 0.304 . . . . 15.0 110.671 -178.169 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -142.92 110.52 5.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 15.0 110.482 178.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -129.23 129.51 45.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.408 -0.36 . . . . 15.0 110.787 179.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -59.17 -40.66 86.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 15.0 110.664 178.139 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.99 -1.005 . . . . 15.0 110.504 -179.57 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 110.315 -0.254 . . . . 2.1600000000000001 110.315 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.45 155.08 54.7 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.525 1.483 . . . . 0.33000000000000002 112.026 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -105.4 136.85 44.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.403 -0.362 . . . . 1.24 110.559 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.469 HG21 HD13 ' A' ' 21' ' ' LEU . 13.7 m -134.34 145.18 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.57 0.7 . . . . 0.19 111.753 176.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.424 HD13 ' HD3' ' A' ' 43' ' ' ARG . 13.1 tp -106.03 135.28 47.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.874 -1.057 . . . . 0.19 110.193 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.549 HD11 ' CG1' ' A' ' 28' ' ' VAL . 47.7 mt -103.44 134.68 43.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.242 -0.436 . . . . 0.32000000000000001 110.275 -178.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.456 ' SD ' HG12 ' A' ' 54' ' ' VAL . 87.0 mtp -96.75 134.02 40.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.148 -0.478 . . . . 1.03 110.438 173.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -59.21 144.3 46.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.297 -0.411 . . . . 2.79 110.705 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.08 175.11 36.07 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.963 -0.855 . . . . 0.5 110.963 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.69 -33.26 54.81 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.579 0.215 . . . . 2.1499999999999999 111.579 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.78 175.84 33.67 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.915 -0.874 . . . . 0.56999999999999995 110.915 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.87 117.92 4.9 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.437 -0.665 . . . . 0.54000000000000004 111.437 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -57.15 -41.72 79.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.84 0.352 . . . . 2.9500000000000002 110.533 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -61.16 -41.65 97.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 1.9099999999999999 111.034 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -62.14 -56.09 22.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.856 0.36 . . . . 3.1600000000000001 111.225 -176.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.25 -42.74 95.95 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.698 -0.401 . . . . 1.76 110.85 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.492 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -62.41 -40.26 95.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.325 -0.398 . . . . 0.35999999999999999 110.936 -178.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.08 -42.31 94.33 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.918 -0.313 . . . . 1.9099999999999999 110.502 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -59.88 -51.65 68.81 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 120.568 -0.453 . . . . 3.2400000000000002 111.256 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.469 HD13 HG21 ' A' ' 5' ' ' VAL . 82.9 mt -62.65 -37.65 87.18 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.538 -0.465 . . . . 0.25 111.025 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -62.83 -43.08 99.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.646 0.26 . . . . 3.5099999999999998 110.894 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.33 -30.69 68.24 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 121.063 -0.589 . . . . 0.29999999999999999 111.924 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -88.12 10.44 19.27 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.513 0.931 . . . . 0.39000000000000001 113.513 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.04 20.23 47.28 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 121.25 -0.5 . . . . 0.25 113.127 174.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -101.04 139.86 21.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 117.552 0.676 . . . . 0.23000000000000001 110.191 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -81.9 129.15 34.67 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.108 -0.701 . . . . 0.34999999999999998 109.108 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.549 ' CG1' HD11 ' A' ' 7' ' ' ILE . 40.5 t -119.02 132.2 69.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.289 0.566 . . . . 0.29999999999999999 111.512 -173.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -137.58 133.58 34.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.13 -0.941 . . . . 1.1200000000000001 109.271 170.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -115.54 138.26 51.23 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.861 0.362 . . . . 0.57999999999999996 110.968 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.1 tp -119.13 132.03 24.12 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-O 118.632 -0.699 . . . . 0.42999999999999999 109.608 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.05 138.77 31.55 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.202 1.268 . . . . 0.46999999999999997 111.903 174.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.454 HD13 ' OD1' ' A' ' 62' ' ' ASN . 77.4 mt -60.1 -9.22 2.97 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.397 0.888 . . . . 0.67000000000000004 113.397 -177.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -77.07 -7.41 55.67 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.262 0.838 . . . . 1.2 113.262 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -63.31 148.71 92.87 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 118.555 0.616 . . . . 0.73999999999999999 110.357 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -80.3 158.04 22.88 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.556 1.504 . . . . 0.31 113.191 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.12 151.5 4.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.866 -0.606 . . . . 0.23999999999999999 111.277 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.31 -38.0 3.25 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.599 -0.6 . . . . 0.17999999999999999 111.599 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -62.22 -37.27 84.72 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 120.595 -0.442 . . . . 1.77 111.09 -177.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.557 ' O ' HG23 ' A' ' 44' ' ' VAL . 24.0 tp -58.84 -48.13 82.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.978 0.418 . . . . 0.33000000000000002 110.211 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.533 HD22 ' CG ' ' A' ' 70' ' ' ASP . 19.8 tp -64.36 -45.19 88.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.35999999999999999 111.141 -175.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.83 -44.25 97.21 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.623 -0.431 . . . . 0.25 110.774 -176.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.424 ' HD3' HD13 ' A' ' 6' ' ' LEU . 56.2 ttm-85 -61.13 -42.7 99.02 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.945 -0.302 . . . . 2.5699999999999998 110.706 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 40' ' ' LEU . 94.4 t -61.23 -45.3 98.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.814 -0.354 . . . . 0.28999999999999998 110.198 -177.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -67.94 -50.71 54.37 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.352 0.407 . . . . 3.6800000000000002 111.919 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.04 -44.4 80.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.662 -0.245 . . . . 0.40000000000000002 111.554 -174.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -78.34 -10.11 59.54 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.968 0.729 . . . . 1.8799999999999999 112.968 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 54.18 55.86 7.69 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.561 0.696 . . . . 3.6000000000000001 110.602 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.521 HD12 HG22 ' A' ' 44' ' ' VAL . 93.6 mt -66.35 141.63 57.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.729 -0.669 . . . . 0.28000000000000003 111.402 -175.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -89.81 -39.77 12.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.251 -0.886 . . . . 0.31 110.611 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.7 159.67 28.09 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.219 -0.991 . . . . 0.19 113.194 -175.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.2 mt -126.27 140.64 52.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.64 -0.78 . . . . 0.19 109.611 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.411 HG22 ' CD1' ' A' ' 80' ' ' PHE . 42.3 t -119.85 131.02 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 121.126 -0.229 . . . . 0.20999999999999999 110.635 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.456 HG12 ' SD ' ' A' ' 8' ' ' MET . 3.3 m -119.41 131.16 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.25 0.547 . . . . 0.23999999999999999 110.998 175.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.4 m -71.54 -33.01 68.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.338 -0.846 . . . . 1.4099999999999999 111.725 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 72.6 p -157.56 169.92 23.59 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.354 0.597 . . . . 0.48999999999999999 111.767 -173.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.57 -36.62 64.89 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.176 -0.769 . . . . 0.40000000000000002 111.176 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -59.24 -46.08 89.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.937 0.369 . . . . 2.1800000000000002 110.68 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.84 -44.29 97.19 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.439 -1.064 . . . . 0.28000000000000003 110.439 177.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.641 HD13 HD21 ' A' ' 79' ' ' LEU . 30.4 tp -56.34 -44.24 79.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.15 0.5 . . . . 0.34999999999999998 110.824 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.6 -43.23 99.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.065 -0.516 . . . . 0.45000000000000001 110.546 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.454 ' OD1' HD13 ' A' ' 33' ' ' LEU . 24.3 m120 -58.71 -39.1 79.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.71999999999999997 110.65 177.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.476 ' CD1' HD21 ' A' ' 40' ' ' LEU . 13.0 tp -57.32 -45.18 84.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.295 0.569 . . . . 0.34999999999999998 110.192 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -60.47 -47.05 87.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.562 -0.744 . . . . 0.28999999999999998 110.586 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -61.78 -43.55 98.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.078 -0.51 . . . . 1.25 111.094 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.74 -34.94 78.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.458 -0.337 . . . . 0.25 111.468 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.666 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -58.72 -39.11 79.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.052 0.453 . . . . 0.17000000000000001 110.684 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.07 -143.74 0.59 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.617 -0.512 . . . . 0.20999999999999999 109.617 174.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.7 -18.77 45.09 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.367 0.985 . . . . 0.25 112.659 -175.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.533 ' CG ' HD22 ' A' ' 41' ' ' LEU . 21.5 m-20 -91.88 10.13 30.02 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.366 0.876 . . . . 1.0900000000000001 113.366 -174.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -47.88 -46.62 63.5 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 118.554 -0.736 . . . . 0.20999999999999999 112.565 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -44.73 -41.39 14.79 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.472 1.448 . . . . 0.25 113.261 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.2 mp0 -77.0 -48.75 17.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.941 0.4 . . . . 1.8600000000000001 110.795 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.666 HD12 ' HB1' ' A' ' 67' ' ' ALA . 88.0 mt -59.04 -40.6 81.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.136 -0.484 . . . . 0.19 110.76 -176.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.95 -15.66 36.5 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 116.315 -0.402 . . . . 0.19 113.162 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 -64.94 -30.48 71.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.351 0.575 . . . . 2.4300000000000002 112.032 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 27.3 mt -74.04 150.5 87.98 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 121.077 -0.249 . . . . 0.39000000000000001 111.519 -173.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.83 126.25 17.01 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.611 1.541 . . . . 0.64000000000000001 112.349 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.641 HD21 HD13 ' A' ' 60' ' ' LEU . 23.5 tp -104.89 127.34 52.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.345 -0.389 . . . . 0.23999999999999999 110.578 175.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.411 ' CD1' HG22 ' A' ' 53' ' ' VAL . 70.5 m-85 -92.07 125.29 36.69 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.669 -0.493 . . . . 0.14999999999999999 109.669 176.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.705 HG21 ' HB2' ' A' ' 87' ' ' ALA . 26.8 m -116.78 145.67 35.99 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-O 119.35 -0.357 . . . . 0.19 110.145 176.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.17 -22.86 8.11 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.531 1.487 . . . . 0.33000000000000002 113.634 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.408 ' OG ' HG23 ' A' ' 86' ' ' VAL . 25.0 p -143.64 158.38 56.96 Favored Pre-proline 0 C--N 1.331 -0.236 0 C-N-CA 120.693 -0.403 . . . . 0.27000000000000002 111.25 -171.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.37 -44.09 51.93 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.309 1.339 . . . . 0.42999999999999999 111.689 176.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -58.12 -47.42 83.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.856 0.36 . . . . 2.9900000000000002 110.939 -177.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.408 HG23 ' OG ' ' A' ' 83' ' ' SER . 60.2 t -60.12 -39.9 81.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.796 -0.362 . . . . 0.23999999999999999 110.093 178.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.705 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.43 -41.85 81.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.966 0.413 . . . . 0.20000000000000001 110.383 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.86 -40.43 92.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.439 . . . . 1.5600000000000001 110.549 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.0 mmm -58.12 -44.96 88.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.412 0.625 . . . . 1.05 110.061 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.488 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -62.05 -41.16 97.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.695 -0.684 . . . . 0.20999999999999999 110.792 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 75.9 ttt-85 -61.85 -44.76 96.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.333 -0.394 . . . . 3.1200000000000001 110.824 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.58 -36.1 77.69 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.925 -0.31 . . . . 2.1000000000000001 111.348 -177.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.2 mt -65.9 -23.9 66.73 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.241 0.46 . . . . 0.28999999999999998 112.241 177.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.83 13.3 16.54 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 119.413 -0.659 . . . . 0.22 113.163 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.82 121.98 11.79 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.499 1.149 . . . . 0.19 109.917 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -69.31 -36.01 76.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.629 -0.714 . . . . 0.69999999999999996 111.24 -171.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -131.59 113.91 14.2 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.024 0.44 . . . . 2.8900000000000001 110.36 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.9 t -112.53 131.06 65.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.15 -0.477 . . . . 0.20000000000000001 109.876 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 85.9 mt -119.27 123.33 71.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.856 -0.611 . . . . 0.22 110.026 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -94.93 118.28 31.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.406 -0.361 . . . . 1.1299999999999999 110.248 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.516 ' HB2' HD11 ' A' ' 109' ' ' LEU . 32.0 p -96.11 -6.56 38.18 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.158 0.799 . . . . 0.34000000000000002 113.158 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -55.32 -39.83 70.42 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 118.211 0.46 . . . . 3.4700000000000002 110.812 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -93.72 -35.02 6.3 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.599 -0.6 . . . . 0.65000000000000002 111.599 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -78.16 132.28 37.56 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.828 0.347 . . . . 0.46000000000000002 110.632 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.2 m -74.86 162.83 28.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 1.21 110.659 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.76 -54.32 24.36 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 112.891 0.7 . . . . 0.34999999999999998 112.891 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.94 -34.15 98.99 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 CA-C-N 119.987 1.031 . . . . 0.31 111.692 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.02 -43.07 95.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.037 0.446 . . . . 0.27000000000000002 109.953 177.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.516 HD11 ' HB2' ' A' ' 101' ' ' CYS . 80.0 mt -59.19 -40.45 85.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.23999999999999999 110.425 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 37.7 tp -56.98 -43.58 81.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.272 0.558 . . . . 0.22 110.183 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.58 -40.93 93.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.744 -0.662 . . . . 0.25 110.491 178.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.83 -42.19 93.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.328 -0.396 . . . . 0.23999999999999999 110.684 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.5 mt -57.99 -50.21 74.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.177 0.513 . . . . 0.27000000000000002 110.427 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.3 p -62.7 -40.89 98.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.798 -0.637 . . . . 0.31 111.231 -175.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.9 t -62.24 -45.15 94.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.766 0.317 . . . . 1.25 111.412 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.59 -38.61 88.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.449 -0.341 . . . . 0.44 111.179 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.473 -0.33 . . . . 0.5 111.368 179.742 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.6 p30 . . . . . 0 CA--C 1.536 0.411 0 N-CA-C 110.405 -0.22 . . . . 15.0 110.405 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.58 155.02 27.87 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.596 1.531 . . . . 15.0 112.065 -177.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.427 ' CB ' HD23 ' A' ' 49' ' ' LEU . 60.0 mttp -113.03 137.36 51.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.307 -0.406 . . . . 15.0 110.581 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.622 HG21 HD13 ' A' ' 21' ' ' LEU . 15.3 m -135.3 145.94 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.563 0.696 . . . . 15.0 111.709 176.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.559 HD12 ' O ' ' A' ' 29' ' ' ASP . 14.0 tp -105.75 136.74 44.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.027 -0.988 . . . . 15.0 110.332 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.415 HD11 ' CG1' ' A' ' 28' ' ' VAL . 61.7 mt -104.52 133.86 47.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.972 0.415 . . . . 15.0 110.695 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.463 ' SD ' HD13 ' A' ' 63' ' ' LEU . 83.7 mtp -101.45 134.46 44.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.279 -0.873 . . . . 15.0 110.714 175.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -57.33 143.33 40.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.129 0.49 . . . . 15.0 110.772 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.86 175.09 29.14 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.852 -0.899 . . . . 15.0 110.852 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.81 -32.54 67.67 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.684 0.253 . . . . 15.0 111.684 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.34 -173.74 22.25 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.033 -0.827 . . . . 15.0 111.033 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.93 114.7 3.99 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.031 -0.828 . . . . 15.0 111.031 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -57.52 -44.84 85.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.273 0.558 . . . . 15.0 110.228 -176.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.99 -41.46 99.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.856 -0.611 . . . . 15.0 111.273 -177.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -60.01 -49.89 75.9 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.861 -0.335 . . . . 15.0 111.085 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.3 mt -57.64 -44.49 85.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.129 0.49 . . . . 15.0 110.43 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.486 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -59.43 -42.27 91.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 15.0 110.688 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -58.53 -41.51 85.67 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.031 -0.268 . . . . 15.0 110.475 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 69.0 mtm180 -59.31 -51.46 69.85 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.447 -0.501 . . . . 15.0 110.878 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.622 HD13 HG21 ' A' ' 5' ' ' VAL . 81.4 mt -61.1 -37.57 83.2 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.519 -0.472 . . . . 15.0 110.988 -177.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.445 ' HG3' HG21 ' A' ' 28' ' ' VAL . 40.2 mtp180 -64.21 -42.49 96.58 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.921 -0.312 . . . . 15.0 111.184 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.0 -30.67 67.04 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.007 -0.616 . . . . 15.0 111.967 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -88.14 8.87 24.87 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.6 0.963 . . . . 15.0 113.6 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.08 17.12 58.26 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 121.235 -0.507 . . . . 15.0 113.234 176.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.7 t -101.03 139.06 23.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 117.748 0.774 . . . . 15.0 109.95 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -78.65 134.64 37.13 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.346 -0.612 . . . . 15.0 109.346 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.486 HG11 ' HB1' ' A' ' 18' ' ' ALA . 48.7 t -119.24 131.55 71.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.345 0.593 . . . . 15.0 111.331 -173.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.559 ' O ' HD12 ' A' ' 6' ' ' LEU . 23.1 t70 -131.59 122.81 26.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.174 -0.921 . . . . 15.0 109.216 170.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -107.88 129.98 55.04 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.904 0.383 . . . . 15.0 110.812 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.3 tp -120.64 113.31 33.42 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 118.892 -0.575 . . . . 15.0 110.672 -175.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.19 135.2 67.85 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.27 1.313 . . . . 15.0 112.372 172.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.598 HD13 ' OD1' ' A' ' 62' ' ' ASN . 71.1 mt -58.95 -11.87 3.88 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.28 0.844 . . . . 15.0 113.28 -178.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -77.16 -6.22 52.1 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.417 0.895 . . . . 15.0 113.417 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -69.31 150.92 97.09 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 118.558 0.617 . . . . 15.0 110.771 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.63 151.29 32.25 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.616 1.544 . . . . 15.0 113.715 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.76 152.57 3.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.305 -0.861 . . . . 15.0 111.453 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.67 -38.14 3.21 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 115.72 -0.673 . . . . 15.0 111.871 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.3 -37.09 86.26 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 120.323 -0.551 . . . . 15.0 111.103 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.576 ' O ' HG23 ' A' ' 44' ' ' VAL . 24.4 tp -58.75 -47.71 83.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.98 0.419 . . . . 15.0 110.168 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.463 HD13 HD11 ' A' ' 74' ' ' ILE . 16.3 tp -62.65 -45.36 93.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.974 -176.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.9 -45.04 95.46 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.577 -0.449 . . . . 15.0 110.871 -175.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -62.71 -40.05 95.94 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.768 -0.373 . . . . 15.0 111.07 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 40' ' ' LEU . 91.4 t -61.78 -45.24 99.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.807 -0.357 . . . . 15.0 110.289 -178.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -69.56 -47.51 63.42 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.205 0.446 . . . . 15.0 112.205 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.8 -44.27 77.72 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.977 -0.289 . . . . 15.0 111.609 -175.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -79.67 -10.11 59.74 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.053 0.76 . . . . 15.0 113.053 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 56.29 55.93 6.23 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.488 0.661 . . . . 15.0 109.989 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 44' ' ' VAL . 95.7 mt -69.29 145.18 53.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.836 -0.62 . . . . 15.0 111.302 -176.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -92.36 -40.54 10.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.323 -0.853 . . . . 15.0 111.061 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.63 161.87 28.6 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.012 -1.089 . . . . 15.0 113.651 -173.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.2 mt -126.08 144.06 50.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.494 -0.853 . . . . 15.0 109.934 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.533 HG22 ' CD1' ' A' ' 80' ' ' PHE . 46.7 t -120.87 129.91 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 O-C-N 122.353 -0.217 . . . . 15.0 110.712 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.4 HG12 ' SD ' ' A' ' 8' ' ' MET . 10.5 m -124.72 141.43 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-O 121.042 0.449 . . . . 15.0 110.471 172.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.8 m -96.59 -14.16 22.4 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.901 0.704 . . . . 15.0 112.901 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.5 p -157.57 163.25 38.54 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 121.414 0.626 . . . . 15.0 111.914 -174.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.23 -37.3 72.25 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.98 -0.848 . . . . 15.0 110.98 176.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -58.99 -44.98 91.69 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 122.666 -0.314 . . . . 15.0 110.633 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.81 -43.54 97.84 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.476 -1.049 . . . . 15.0 110.476 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.505 HD21 ' HA ' ' A' ' 90' ' ' ALA . 20.8 tp -56.85 -45.1 82.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.145 0.498 . . . . 15.0 110.699 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.64 -43.53 98.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.086 -0.506 . . . . 15.0 110.644 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.598 ' OD1' HD13 ' A' ' 33' ' ' LEU . 27.3 m120 -59.08 -39.25 81.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.274 -0.421 . . . . 15.0 110.682 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.463 HD13 ' SD ' ' A' ' 8' ' ' MET . 12.3 tp -57.63 -44.84 85.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.179 0.514 . . . . 15.0 110.061 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -61.09 -47.61 85.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.735 -0.666 . . . . 15.0 110.585 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.88 -43.13 99.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.108 -0.496 . . . . 15.0 111.159 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.92 -35.53 80.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.443 -0.344 . . . . 15.0 111.426 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.657 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.77 -37.91 80.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.029 0.442 . . . . 15.0 110.856 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.51 -144.19 0.55 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 109.51 -0.552 . . . . 15.0 109.51 174.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.53 -19.56 49.14 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.349 0.977 . . . . 15.0 112.575 -174.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.429 ' CG ' HD22 ' A' ' 41' ' ' LEU . 23.3 m-20 -91.9 12.16 22.55 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.32 0.859 . . . . 15.0 113.32 -174.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 -47.79 -46.36 62.05 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 118.551 -0.737 . . . . 15.0 112.587 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -44.72 -41.43 14.76 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 121.417 1.412 . . . . 15.0 113.247 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -77.0 -48.72 17.16 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.544 -0.462 . . . . 15.0 110.836 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.657 HD12 ' HB1' ' A' ' 67' ' ' ALA . 93.0 mt -59.74 -40.45 82.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.451 . . . . 15.0 110.903 -176.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.44 -16.4 35.72 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 116.401 -0.363 . . . . 15.0 113.11 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.1 mtp-105 -64.67 -30.33 71.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.336 0.568 . . . . 15.0 112.027 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 23.4 mt -76.03 150.54 83.46 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 121.028 -0.269 . . . . 15.0 111.58 -172.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -63.22 128.36 22.53 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.628 1.552 . . . . 15.0 112.39 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.9 tp -108.59 127.56 54.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.511 -0.313 . . . . 15.0 110.657 174.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.533 ' CD1' HG22 ' A' ' 53' ' ' VAL . 80.1 m-85 -88.7 127.31 35.58 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.576 -0.527 . . . . 15.0 109.576 176.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.677 HG21 ' HB2' ' A' ' 87' ' ' ALA . 28.1 m -119.16 146.24 40.13 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 110.012 -0.366 . . . . 15.0 110.012 175.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.15 -22.58 8.36 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.608 1.538 . . . . 15.0 113.651 -174.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.417 ' OG ' HG23 ' A' ' 86' ' ' VAL . 24.7 p -143.47 158.2 57.87 Favored Pre-proline 0 CA--C 1.53 0.196 0 C-N-CA 120.645 -0.422 . . . . 15.0 111.263 -171.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.39 -44.0 52.66 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.32 1.347 . . . . 15.0 111.699 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 -58.37 -47.25 84.43 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.858 -0.337 . . . . 15.0 110.926 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.417 HG23 ' OG ' ' A' ' 83' ' ' SER . 60.9 t -59.75 -40.43 82.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.923 0.392 . . . . 15.0 109.965 178.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.677 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.46 -42.75 83.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.002 0.43 . . . . 15.0 110.404 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.31 -40.4 90.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 15.0 110.61 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.0 mmm -58.14 -44.39 87.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.428 0.632 . . . . 15.0 110.159 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.505 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.49 -40.51 94.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.655 -0.702 . . . . 15.0 110.862 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -62.61 -42.9 99.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.346 -0.388 . . . . 15.0 111.028 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.36 -36.16 77.37 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.832 -0.347 . . . . 15.0 111.274 -177.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.99 -22.78 65.9 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.399 0.518 . . . . 15.0 112.399 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 107.99 13.24 20.35 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 119.373 -0.682 . . . . 15.0 113.128 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.76 122.0 11.8 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 118.494 1.147 . . . . 15.0 109.961 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -69.04 -36.43 77.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.573 -0.74 . . . . 15.0 111.141 -171.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -131.79 112.92 12.92 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.152 0.501 . . . . 15.0 110.536 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.0 t -112.19 130.66 65.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.033 -0.531 . . . . 15.0 109.84 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.6 mt -118.46 122.17 68.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.886 -0.597 . . . . 15.0 109.999 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -94.21 116.56 28.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.429 -0.35 . . . . 15.0 110.433 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.9 p -97.07 4.57 51.31 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.162 0.801 . . . . 15.0 113.162 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 36.2 tpt85 -55.94 -39.92 72.42 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 118.187 0.449 . . . . 15.0 110.648 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.15 -35.13 5.39 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.486 -0.646 . . . . 15.0 111.486 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.65 138.58 44.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.847 0.356 . . . . 15.0 110.549 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.7 p -87.04 165.38 15.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 15.0 110.621 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.69 -54.23 24.77 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 118.552 -0.737 . . . . 15.0 112.923 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.54 -35.98 97.38 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 CA-C-N 120.596 1.249 . . . . 15.0 111.414 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.77 95.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.017 0.437 . . . . 15.0 110.051 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.3 mt -59.23 -40.02 84.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 15.0 110.514 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 42.0 tp -57.08 -44.52 83.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.379 0.609 . . . . 15.0 110.084 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.74 -41.16 94.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.627 -0.715 . . . . 15.0 110.488 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.3 -41.36 93.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.314 -0.403 . . . . 15.0 110.78 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.6 mt -57.89 -50.53 73.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.122 0.487 . . . . 15.0 110.401 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.3 p -63.85 -40.39 96.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.715 -0.675 . . . . 15.0 111.381 -175.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.8 p -65.44 -39.42 92.06 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.025 -0.27 . . . . 15.0 111.398 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.28 96.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.508 -0.315 . . . . 15.0 111.088 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.467 -0.333 . . . . 15.0 110.755 179.65 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.535 0.386 0 N-CA-C 110.28 -0.267 . . . . 15.0 110.28 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.41 152.99 7.93 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.433 1.422 . . . . 15.0 111.857 -176.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.443 ' HB2' HD23 ' A' ' 49' ' ' LEU . 94.1 mttt -115.63 139.24 50.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.326 -0.397 . . . . 15.0 110.802 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.2 m -133.76 145.97 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.466 0.65 . . . . 15.0 111.652 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.505 HD13 ' CD ' ' A' ' 43' ' ' ARG . 12.4 tp -105.07 136.5 44.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.048 -0.978 . . . . 15.0 110.375 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.494 HD11 ' CG1' ' A' ' 28' ' ' VAL . 58.2 mt -104.11 135.14 43.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.972 0.415 . . . . 15.0 110.624 -178.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.606 ' HE3' HD21 ' A' ' 33' ' ' LEU . 96.6 mmm -89.34 134.12 34.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.458 -0.792 . . . . 15.0 110.149 174.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -57.64 141.39 48.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.958 0.408 . . . . 15.0 110.551 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.56 175.11 42.0 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.854 -0.898 . . . . 15.0 110.854 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -54.99 -35.22 64.12 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.205 -0.198 . . . . 15.0 111.217 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.23 162.87 7.45 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.861 -0.895 . . . . 15.0 110.861 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.87 123.56 6.34 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.151 -0.78 . . . . 15.0 111.151 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -56.66 -46.57 80.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.058 0.456 . . . . 15.0 110.422 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.32 -39.33 94.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.899 -0.591 . . . . 15.0 111.235 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -61.23 -56.01 25.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.927 0.394 . . . . 15.0 111.027 -175.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.6 mt -61.7 -41.99 98.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.018 0.437 . . . . 15.0 110.663 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.504 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -60.99 -36.28 79.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 15.0 111.182 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.23 -44.95 95.41 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.963 -0.295 . . . . 15.0 110.616 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -59.77 -51.65 68.86 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.084 -0.646 . . . . 15.0 111.252 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.47 -37.32 87.12 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.517 -0.473 . . . . 15.0 111.137 -176.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -64.02 -43.8 94.51 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.14 -0.224 . . . . 15.0 111.048 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.29 -30.63 68.0 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.043 -0.599 . . . . 15.0 111.923 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -88.14 9.9 21.15 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.515 0.932 . . . . 15.0 113.515 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.11 16.12 56.42 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 121.261 -0.495 . . . . 15.0 113.435 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -101.15 139.77 21.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 117.719 0.759 . . . . 15.0 109.98 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -84.93 133.61 34.28 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.483 -0.562 . . . . 15.0 109.483 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.504 HG11 ' CB ' ' A' ' 18' ' ' ALA . 39.4 t -115.12 131.45 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.09 0.471 . . . . 15.0 111.005 -174.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -133.78 128.76 35.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.568 -0.742 . . . . 15.0 109.33 171.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -111.38 134.64 52.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.799 0.333 . . . . 15.0 110.652 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.7 tp -112.83 129.95 23.96 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-O 118.492 -0.766 . . . . 15.0 109.732 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -72.08 139.64 33.06 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 CA-C-N 120.431 1.19 . . . . 15.0 111.676 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.606 HD21 ' HE3' ' A' ' 8' ' ' MET . 18.2 mt -59.38 -9.35 2.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.631 0.974 . . . . 15.0 113.631 -176.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -77.09 -7.07 55.11 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.396 0.888 . . . . 15.0 113.396 -177.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -65.72 145.89 99.01 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 118.618 0.644 . . . . 15.0 110.633 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.74 159.01 21.66 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 121.629 1.552 . . . . 15.0 113.187 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.28 151.27 5.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.839 -0.618 . . . . 15.0 111.294 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.23 -38.09 3.22 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.71 -0.556 . . . . 15.0 111.71 -178.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -61.05 -36.75 80.4 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 120.595 -0.442 . . . . 15.0 111.213 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.57 ' O ' HG23 ' A' ' 44' ' ' VAL . 27.9 tp -59.15 -47.03 86.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.962 0.411 . . . . 15.0 110.254 -178.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.59 HD22 ' OD2' ' A' ' 70' ' ' ASP . 9.3 tp -62.39 -45.74 91.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 15.0 110.86 -176.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.58 -44.22 97.42 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.659 -0.416 . . . . 15.0 110.774 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.505 ' CD ' HD13 ' A' ' 6' ' ' LEU . 57.0 ttm-85 -60.74 -41.81 96.1 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.98 -0.288 . . . . 15.0 110.728 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.578 ' HA ' HD12 ' A' ' 49' ' ' LEU . 96.1 t -60.47 -46.18 95.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.73 -0.388 . . . . 15.0 110.11 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -69.83 -47.7 61.73 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.29 0.478 . . . . 15.0 112.29 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.28 -44.33 79.58 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.03 -0.268 . . . . 15.0 111.538 -174.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -80.34 -10.1 59.75 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.11 0.781 . . . . 15.0 113.11 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 94.2 mtm-85 56.22 55.81 6.38 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.553 0.692 . . . . 15.0 110.111 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.578 HD12 ' HA ' ' A' ' 44' ' ' VAL . 94.6 mt -72.77 146.35 46.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.631 -0.713 . . . . 15.0 111.467 -175.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -94.46 -40.49 9.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.357 -0.838 . . . . 15.0 110.915 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.78 165.53 29.22 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 119.878 -1.153 . . . . 15.0 113.695 -172.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.5 mt -127.89 143.16 51.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.576 -0.812 . . . . 15.0 109.983 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.502 HG22 ' CD1' ' A' ' 80' ' ' PHE . 49.0 t -123.06 133.69 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 110.077 -0.342 . . . . 15.0 110.077 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.434 HG12 ' HG3' ' A' ' 8' ' ' MET . 3.9 m -119.24 126.92 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.185 0.517 . . . . 15.0 110.749 174.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.8 m -68.92 -32.73 72.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.476 -0.784 . . . . 15.0 111.686 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.5 p -155.19 166.28 34.06 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.411 0.624 . . . . 15.0 111.887 -173.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.88 -37.51 70.32 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.217 -0.753 . . . . 15.0 111.217 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -58.66 -46.16 87.78 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.742 -0.383 . . . . 15.0 110.72 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.95 -42.61 99.79 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.841 -0.904 . . . . 15.0 110.841 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.615 HD13 HD21 ' A' ' 79' ' ' LEU . 34.9 tp -57.32 -47.18 82.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.053 0.454 . . . . 15.0 110.594 -178.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.77 -44.62 96.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.134 0.492 . . . . 15.0 110.594 -177.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.463 ' CB ' HD22 ' A' ' 33' ' ' LEU . 19.0 m120 -59.51 -40.11 86.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 15.0 110.616 178.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.5 tp -56.57 -42.78 79.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.18 0.514 . . . . 15.0 110.195 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -58.55 -46.48 86.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.804 -0.635 . . . . 15.0 110.249 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -60.97 -42.93 99.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.819 -0.628 . . . . 15.0 111.032 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.08 -34.94 78.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.374 -0.375 . . . . 15.0 111.474 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.678 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.31 -38.15 79.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.119 0.485 . . . . 15.0 110.677 177.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.51 -144.43 0.55 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 109.54 -0.541 . . . . 15.0 109.54 173.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.47 -19.57 48.79 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.289 0.95 . . . . 15.0 112.563 -174.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.59 ' OD2' HD22 ' A' ' 41' ' ' LEU . 76.6 m-20 -91.86 10.86 26.94 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.336 0.865 . . . . 15.0 113.336 -174.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -47.83 -47.07 63.42 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 118.544 -0.741 . . . . 15.0 112.536 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -44.78 -40.52 14.58 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 121.422 1.414 . . . . 15.0 113.216 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -76.96 -48.77 17.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.036 0.446 . . . . 15.0 110.735 -177.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.678 HD12 ' HB1' ' A' ' 67' ' ' ALA . 89.1 mt -59.46 -40.11 80.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.511 . . . . 15.0 110.752 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.56 -14.71 36.7 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 116.31 -0.405 . . . . 15.0 113.345 -175.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -65.88 -29.79 70.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.399 0.6 . . . . 15.0 112.037 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.0 mt -74.87 150.02 85.87 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 120.919 -0.312 . . . . 15.0 111.291 -173.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.0 128.27 26.07 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.606 1.537 . . . . 15.0 112.249 176.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.615 HD21 HD13 ' A' ' 60' ' ' LEU . 27.3 tp -105.72 124.91 50.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.387 -0.369 . . . . 15.0 110.497 174.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.502 ' CD1' HG22 ' A' ' 53' ' ' VAL . 69.2 m-85 -91.71 126.54 36.83 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.796 -0.446 . . . . 15.0 109.796 177.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.656 HG21 ' HB2' ' A' ' 87' ' ' ALA . 27.4 m -118.72 146.45 39.99 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-O 119.327 -0.368 . . . . 15.0 110.238 176.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -79.18 -23.49 7.56 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.561 1.507 . . . . 15.0 113.522 -176.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.2 p -143.26 162.78 41.01 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 120.572 -0.451 . . . . 15.0 111.517 -171.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -56.84 -43.97 49.43 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.153 1.236 . . . . 15.0 111.821 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -57.57 -48.15 80.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.882 0.372 . . . . 15.0 110.712 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.5 t -60.37 -39.4 80.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.813 -0.355 . . . . 15.0 110.118 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.656 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.31 -41.43 79.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.931 0.396 . . . . 15.0 110.373 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.18 -40.22 93.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.29 -0.414 . . . . 15.0 110.603 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.1 mmm -58.53 -44.53 89.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.378 0.609 . . . . 15.0 110.107 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.496 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.74 -42.48 99.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.714 -0.675 . . . . 15.0 110.853 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -61.92 -44.02 97.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 15.0 110.738 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -59.22 -36.16 74.92 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.947 -0.301 . . . . 15.0 111.302 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 77.0 mt -67.26 -23.95 65.74 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.351 0.5 . . . . 15.0 112.351 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.33 13.37 17.45 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 119.263 -0.743 . . . . 15.0 113.096 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.77 122.03 11.88 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 118.564 1.182 . . . . 15.0 109.897 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -68.84 -35.72 77.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.617 -0.719 . . . . 15.0 111.281 -171.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -130.19 113.94 15.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.907 0.384 . . . . 15.0 110.251 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.2 130.3 64.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 15.0 109.953 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 87.6 mt -120.2 120.66 63.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.936 -0.575 . . . . 15.0 110.007 -176.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -95.4 117.79 30.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.41 -0.359 . . . . 15.0 110.323 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.479 ' HA ' ' HB3' ' A' ' 104' ' ' ALA . 31.2 p -96.02 -1.49 48.77 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.211 0.819 . . . . 15.0 113.211 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -56.14 -40.28 73.56 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 118.215 0.461 . . . . 15.0 110.527 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.08 -34.98 5.21 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.415 -0.674 . . . . 15.0 111.415 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.479 ' HB3' ' HA ' ' A' ' 101' ' ' CYS . . . -69.46 144.89 53.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.851 0.358 . . . . 15.0 110.52 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.1 t -89.8 158.92 17.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.069 -0.514 . . . . 15.0 110.546 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.65 -54.34 23.73 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 112.992 0.738 . . . . 15.0 112.992 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.72 -35.06 98.95 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 CA-C-N 120.134 1.083 . . . . 15.0 111.78 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.99 -43.13 95.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.124 0.488 . . . . 15.0 109.982 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.416 HD11 ' HB2' ' A' ' 101' ' ' CYS . 78.5 mt -59.06 -40.53 85.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 15.0 110.43 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 38.9 tp -57.19 -43.68 82.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.231 0.538 . . . . 15.0 110.168 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.13 -40.86 91.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.747 -0.661 . . . . 15.0 110.458 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.96 -41.61 92.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.414 . . . . 15.0 110.73 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.5 mt -57.81 -51.11 70.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.195 0.522 . . . . 15.0 110.396 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.3 p -63.6 -39.77 95.23 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.608 -0.724 . . . . 15.0 111.385 -175.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.2 p -65.9 -40.04 91.17 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.921 -0.312 . . . . 15.0 111.453 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.09 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.511 -0.313 . . . . 15.0 111.078 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.428 -0.351 . . . . 15.0 111.398 179.321 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 CA--C 1.534 0.334 0 N-CA-C 110.241 -0.281 . . . . 15.0 110.241 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.01 153.74 30.64 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.385 1.39 . . . . 15.0 111.83 -175.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.444 ' CB ' HD23 ' A' ' 49' ' ' LEU . 60.3 mttp -112.86 138.33 49.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.456 -0.338 . . . . 15.0 110.782 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.567 HG21 HD13 ' A' ' 21' ' ' LEU . 15.1 m -133.33 143.52 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 121.515 0.674 . . . . 15.0 111.521 176.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.6 tp -103.41 134.76 46.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.011 -0.995 . . . . 15.0 110.417 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.617 HD11 ' CG1' ' A' ' 28' ' ' VAL . 52.4 mt -99.04 135.0 35.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.024 0.44 . . . . 15.0 110.542 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 83.3 mtp -103.17 134.18 47.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.445 -0.798 . . . . 15.0 109.593 171.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -57.51 144.68 35.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.128 0.49 . . . . 15.0 110.984 -172.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.38 175.15 32.65 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.739 -0.944 . . . . 15.0 110.739 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -54.53 -33.42 59.97 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.517 0.191 . . . . 15.0 111.517 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.06 171.12 36.1 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.898 -0.881 . . . . 15.0 110.898 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.91 133.98 12.26 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.312 -0.715 . . . . 15.0 111.312 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -56.8 -46.04 81.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.086 0.469 . . . . 15.0 110.405 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.18 -41.14 99.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.679 -0.691 . . . . 15.0 111.329 -176.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -61.73 -56.07 23.49 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.746 -0.382 . . . . 15.0 111.224 -175.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.3 mt -61.94 -43.47 98.77 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.739 -0.384 . . . . 15.0 111.052 -176.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.17 -43.27 99.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.392 -0.367 . . . . 15.0 110.573 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -58.72 -41.85 87.34 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.977 -0.289 . . . . 15.0 110.395 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -58.76 -51.69 68.88 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.656 -0.418 . . . . 15.0 111.179 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.567 HD13 HG21 ' A' ' 5' ' ' VAL . 77.2 mt -62.74 -37.77 87.88 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.596 -0.442 . . . . 15.0 111.243 -177.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -63.53 -42.4 98.43 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.853 -0.339 . . . . 15.0 111.214 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.43 -30.71 68.63 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.021 -0.609 . . . . 15.0 111.961 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -88.18 9.92 21.21 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.56 0.948 . . . . 15.0 113.56 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.4 16.26 57.42 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 121.18 -0.533 . . . . 15.0 113.436 175.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.1 t -101.1 140.24 20.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 117.803 0.802 . . . . 15.0 110.168 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -83.17 130.5 35.11 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.101 -0.703 . . . . 15.0 109.101 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.617 ' CG1' HD11 ' A' ' 7' ' ' ILE . 37.1 t -119.72 133.23 67.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.17 0.51 . . . . 15.0 111.191 -172.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -139.23 137.75 36.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.362 -0.836 . . . . 15.0 109.465 171.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.48 ' HB3' HD12 ' A' ' 7' ' ' ILE . 34.6 p90 -115.41 138.25 51.2 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.916 0.389 . . . . 15.0 111.035 -178.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 tp -119.98 113.29 34.37 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-O 118.677 -0.678 . . . . 15.0 110.354 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.7 135.02 48.73 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 121.23 1.287 . . . . 15.0 112.304 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.42 -16.96 51.88 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.031 0.752 . . . . 15.0 113.031 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -77.14 -4.34 44.01 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.445 0.905 . . . . 15.0 113.445 -175.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -70.61 149.97 95.45 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 118.428 0.558 . . . . 15.0 110.816 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.31 147.14 52.49 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.6 1.533 . . . . 15.0 113.747 -174.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.9 152.55 3.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.429 -0.805 . . . . 15.0 111.291 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.78 -38.09 3.21 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.948 -0.569 . . . . 15.0 111.837 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -62.65 -36.88 84.28 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 120.346 -0.542 . . . . 15.0 111.092 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.577 ' O ' HG23 ' A' ' 44' ' ' VAL . 27.2 tp -58.9 -46.9 86.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.915 0.388 . . . . 15.0 110.188 -178.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.512 HD22 ' CG ' ' A' ' 70' ' ' ASP . 20.8 tp -62.25 -43.85 97.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 15.0 110.854 -177.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.64 -45.88 92.16 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.635 -0.426 . . . . 15.0 110.853 -176.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -62.91 -40.03 96.33 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.874 -0.331 . . . . 15.0 111.165 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 40' ' ' LEU . 93.4 t -60.56 -44.51 96.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.881 -0.415 . . . . 15.0 109.881 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -65.9 -51.82 55.38 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.369 0.418 . . . . 15.0 111.87 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.09 -44.37 80.18 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.028 -0.269 . . . . 15.0 111.629 -174.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -80.31 -10.04 59.75 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.168 0.803 . . . . 15.0 113.168 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 92.2 mtm-85 55.62 55.81 6.83 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.61 0.719 . . . . 15.0 110.406 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.531 HD12 HG22 ' A' ' 44' ' ' VAL . 95.9 mt -68.0 146.23 53.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.656 -0.702 . . . . 15.0 110.965 -177.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -95.98 -40.7 9.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.695 -0.684 . . . . 15.0 110.906 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.7 164.83 28.81 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 119.945 -1.121 . . . . 15.0 113.589 -172.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.7 mt -126.79 145.16 50.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.456 -0.872 . . . . 15.0 109.919 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.525 HG22 ' CD1' ' A' ' 80' ' ' PHE . 47.1 t -121.0 129.14 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 110.437 -0.208 . . . . 15.0 110.437 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.7 m -126.99 139.24 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 120.955 0.407 . . . . 15.0 110.365 173.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.5 m -101.36 -4.8 26.32 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.055 0.761 . . . . 15.0 113.055 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.0 p -157.45 157.83 34.65 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-O 121.487 0.661 . . . . 15.0 111.977 -175.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.67 -37.75 78.31 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.048 -0.821 . . . . 15.0 111.048 177.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -57.03 -46.11 82.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.774 0.321 . . . . 15.0 110.716 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.69 -44.12 97.19 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.651 -0.98 . . . . 15.0 110.651 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.7 tp -56.01 -46.39 78.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.274 0.559 . . . . 15.0 110.717 -178.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -62.33 -42.9 99.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.911 -0.586 . . . . 15.0 110.874 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -58.89 -38.51 79.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.377 -0.374 . . . . 15.0 110.829 178.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.5 tp -57.58 -45.25 85.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.281 0.562 . . . . 15.0 110.086 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -61.45 -47.6 84.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.667 -0.697 . . . . 15.0 110.628 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -62.05 -43.46 98.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 15.0 111.281 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.1 mt -66.42 -35.63 80.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.382 -0.372 . . . . 15.0 111.379 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.661 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -60.28 -37.74 81.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.012 0.434 . . . . 15.0 110.884 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.72 -144.16 0.54 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.388 -0.597 . . . . 15.0 109.388 174.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.49 -18.64 41.66 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.319 0.963 . . . . 15.0 112.614 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.512 ' CG ' HD22 ' A' ' 41' ' ' LEU . 21.5 m-20 -91.83 11.14 25.79 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.265 0.839 . . . . 15.0 113.265 -174.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -47.7 -46.83 61.87 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 118.6 -0.714 . . . . 15.0 112.592 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -44.64 -41.85 14.54 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.434 1.423 . . . . 15.0 113.22 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -76.99 -48.73 17.18 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.059 0.457 . . . . 15.0 110.807 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.661 HD12 ' HB1' ' A' ' 67' ' ' ALA . 95.2 mt -59.92 -40.03 81.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 15.0 110.855 -176.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.99 -15.74 29.7 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 119.916 -0.38 . . . . 15.0 112.966 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -64.82 -31.47 72.72 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 117.433 0.616 . . . . 15.0 111.884 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.7 mt -73.77 135.38 77.83 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 118.866 -0.587 . . . . 15.0 110.361 -175.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.01 134.18 60.57 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.39 1.393 . . . . 15.0 112.59 177.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.7 tp -107.66 130.18 54.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.974 -0.557 . . . . 15.0 110.65 176.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.525 ' CD1' HG22 ' A' ' 53' ' ' VAL . 77.4 m-85 -89.19 123.9 33.86 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.27 -0.641 . . . . 15.0 109.27 175.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.699 HG21 ' HB2' ' A' ' 87' ' ' ALA . 25.7 m -114.53 146.61 36.28 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 119.378 -0.344 . . . . 15.0 110.237 177.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -79.14 -23.77 7.36 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.52 1.48 . . . . 15.0 113.574 -174.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.0 p -143.44 162.22 43.3 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 120.564 -0.455 . . . . 15.0 111.677 -171.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.0 -44.0 51.35 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.154 1.236 . . . . 15.0 111.791 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -57.95 -47.28 83.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.837 0.351 . . . . 15.0 110.838 -177.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.17 -41.17 85.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 15.0 110.047 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.699 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.82 -42.68 84.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.901 0.382 . . . . 15.0 110.411 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.33 -42.08 98.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 15.0 110.604 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 86.7 mtp -59.41 -43.81 92.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.198 0.523 . . . . 15.0 110.44 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.6 94.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.931 -0.577 . . . . 15.0 110.74 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -61.59 -44.44 97.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.336 -0.393 . . . . 15.0 110.674 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.43 -36.1 77.38 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.842 -0.343 . . . . 15.0 111.313 -177.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.7 mt -64.9 -24.12 67.43 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.206 0.447 . . . . 15.0 112.206 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.55 13.33 17.09 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 119.311 -0.716 . . . . 15.0 113.103 -176.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.91 121.98 11.84 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.573 1.187 . . . . 15.0 109.894 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -69.31 -35.18 75.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.659 -0.701 . . . . 15.0 111.267 -171.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -131.08 115.71 16.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.003 0.43 . . . . 15.0 110.182 177.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.9 t -114.69 130.1 69.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.281 -0.418 . . . . 15.0 110.027 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.7 mt -119.48 124.91 73.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.997 -0.547 . . . . 15.0 110.058 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -95.39 118.03 31.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.384 -0.371 . . . . 15.0 110.038 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.415 ' HA ' ' HB3' ' A' ' 104' ' ' ALA . 31.4 p -96.73 -0.38 48.3 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.219 0.822 . . . . 15.0 113.219 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -56.0 -40.08 72.81 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 118.186 0.448 . . . . 15.0 110.62 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.02 -35.02 5.21 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.507 -0.637 . . . . 15.0 111.507 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.415 ' HB3' ' HA ' ' A' ' 101' ' ' CYS . . . -71.58 142.32 50.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.815 0.341 . . . . 15.0 110.664 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.6 m -89.89 163.24 15.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.496 . . . . 15.0 110.505 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.78 -54.28 24.72 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 112.977 0.732 . . . . 15.0 112.977 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.23 -34.27 98.41 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 CA-C-N 120.068 1.06 . . . . 15.0 111.635 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.14 -43.14 95.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.058 0.456 . . . . 15.0 110.012 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 78.6 mt -59.38 -40.49 86.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 15.0 110.515 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 42.2 tp -56.88 -44.9 82.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.51 0.671 . . . . 15.0 110.166 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.04 92.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.526 -0.761 . . . . 15.0 110.708 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.57 -42.3 96.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.476 -0.329 . . . . 15.0 110.907 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.6 mt -57.92 -51.47 69.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.171 0.51 . . . . 15.0 110.388 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.7 p -63.5 -40.16 96.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.628 -0.714 . . . . 15.0 111.28 -175.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.0 t -63.18 -44.27 95.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.662 0.268 . . . . 15.0 111.385 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.03 85.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.473 -0.331 . . . . 15.0 110.955 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.496 -0.32 . . . . 15.0 111.277 178.419 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 CA--C 1.536 0.406 0 N-CA-C 110.361 -0.237 . . . . 15.0 110.361 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -58.01 155.03 35.58 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.52 1.48 . . . . 15.0 112.035 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -110.61 139.88 45.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.518 -0.31 . . . . 15.0 110.741 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.415 HG21 HD13 ' A' ' 21' ' ' LEU . 13.5 m -135.75 142.31 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.556 0.693 . . . . 15.0 111.635 176.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.2 tp -105.0 133.8 49.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.94 -1.027 . . . . 15.0 110.169 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.569 HD11 ' CG1' ' A' ' 28' ' ' VAL . 41.9 mt -106.02 135.18 45.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.286 -0.415 . . . . 15.0 110.22 -177.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.416 ' SD ' HD13 ' A' ' 63' ' ' LEU . 83.7 mtp -94.37 134.05 37.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.157 -0.474 . . . . 15.0 110.537 175.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -62.79 145.87 53.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.043 0.449 . . . . 15.0 111.536 -174.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.96 175.2 42.85 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.638 -0.985 . . . . 15.0 110.638 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.91 -33.3 68.62 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.725 0.268 . . . . 15.0 111.725 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.95 164.35 3.6 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.165 -0.774 . . . . 15.0 111.165 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.99 104.77 2.81 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.92 -0.872 . . . . 15.0 110.92 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.435 ' HD2' HG21 ' A' ' 7' ' ' ILE . 87.5 mmt-85 -69.18 -32.52 71.89 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.794 0.294 . . . . 15.0 111.794 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.33 -45.64 87.71 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.595 -0.442 . . . . 15.0 110.366 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -65.9 -55.21 18.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.359 -0.382 . . . . 15.0 111.233 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.476 HD23 ' C ' ' A' ' 17' ' ' LEU . 10.0 tt -56.76 -43.13 80.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.843 0.354 . . . . 15.0 110.959 -177.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.47 -43.02 99.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.388 -0.369 . . . . 15.0 110.575 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.82 -41.02 85.84 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.808 -0.357 . . . . 15.0 110.566 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -60.97 -51.32 69.73 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 120.371 -0.532 . . . . 15.0 111.366 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.415 HD13 HG21 ' A' ' 5' ' ' VAL . 70.0 mt -61.15 -37.78 84.08 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.316 -0.554 . . . . 15.0 110.845 -178.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -65.03 -41.41 95.27 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 120.694 -0.402 . . . . 15.0 111.356 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.88 -30.68 66.68 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.028 -0.606 . . . . 15.0 111.883 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -88.08 9.97 20.76 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.477 0.917 . . . . 15.0 113.477 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.24 17.09 58.07 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 121.333 -0.46 . . . . 15.0 113.263 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -101.04 139.56 22.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 117.807 0.804 . . . . 15.0 110.126 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -82.0 126.2 31.69 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.393 -0.595 . . . . 15.0 109.393 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.569 ' CG1' HD11 ' A' ' 7' ' ' ILE . 41.5 t -116.75 129.32 73.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.087 0.47 . . . . 15.0 110.933 -174.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -136.39 132.65 35.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.636 -0.711 . . . . 15.0 109.685 172.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -112.63 133.45 54.66 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.947 0.403 . . . . 15.0 110.789 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.1 tp -116.08 113.33 41.7 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 118.824 -0.607 . . . . 15.0 110.367 -176.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.65 135.81 68.42 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 121.362 1.374 . . . . 15.0 112.692 174.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.524 HD13 ' OD1' ' A' ' 62' ' ' ASN . 73.9 mt -59.48 -10.48 3.37 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.37 0.878 . . . . 15.0 113.37 -178.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -77.16 -6.26 52.25 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.298 0.851 . . . . 15.0 113.298 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -71.78 148.72 92.57 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 118.588 0.631 . . . . 15.0 110.582 -178.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -74.6 152.08 42.46 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.604 1.536 . . . . 15.0 113.782 -174.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.73 152.52 3.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.373 -0.83 . . . . 15.0 111.292 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.31 -38.28 3.15 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.799 -0.637 . . . . 15.0 111.782 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.5 -36.03 82.85 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 117.343 0.571 . . . . 15.0 111.264 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.563 ' O ' HG23 ' A' ' 44' ' ' VAL . 26.8 tp -58.74 -46.86 86.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.942 0.401 . . . . 15.0 110.135 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.472 HD22 ' CG ' ' A' ' 70' ' ' ASP . 16.6 tp -63.33 -44.45 94.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 15.0 110.875 -176.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.56 -44.76 96.44 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.706 -0.398 . . . . 15.0 110.871 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 61.7 ttm-85 -60.88 -42.78 98.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.458 -0.337 . . . . 15.0 110.655 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 40' ' ' LEU . 98.5 t -60.34 -45.37 96.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.777 -0.369 . . . . 15.0 110.174 -177.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -67.29 -51.78 48.63 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.485 0.491 . . . . 15.0 112.058 -176.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.64 -44.35 82.19 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.986 -0.286 . . . . 15.0 111.565 -174.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -79.83 -10.15 59.75 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.972 0.73 . . . . 15.0 112.972 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 54.78 55.95 7.26 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.595 0.712 . . . . 15.0 110.086 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.55 HD12 HG22 ' A' ' 44' ' ' VAL . 97.5 mt -65.09 144.91 56.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.744 -0.662 . . . . 15.0 111.314 -174.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -92.84 -39.13 11.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.133 -0.94 . . . . 15.0 110.81 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.69 160.96 28.46 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 120.149 -1.024 . . . . 15.0 113.469 -175.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.1 mt -126.16 144.37 50.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.575 -0.812 . . . . 15.0 109.564 177.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.49 HG22 ' HD1' ' A' ' 80' ' ' PHE . 44.7 t -122.71 131.51 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 O-C-N 122.315 -0.24 . . . . 15.0 110.93 -177.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.0 m -127.53 150.69 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.08 0.467 . . . . 15.0 110.37 171.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.5 t -107.5 -15.65 14.56 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.605 -0.725 . . . . 15.0 112.711 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.4 p -152.75 160.59 43.13 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.402 0.62 . . . . 15.0 111.917 -173.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.37 -37.78 75.8 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.016 -0.834 . . . . 15.0 111.016 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -57.19 -46.16 83.09 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 122.599 -0.353 . . . . 15.0 110.703 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.14 -45.62 95.68 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.621 -0.991 . . . . 15.0 110.621 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.57 HD21 ' HA ' ' A' ' 90' ' ' ALA . 21.0 tp -56.94 -44.61 82.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.103 0.478 . . . . 15.0 110.736 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.69 -43.44 98.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.481 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.524 ' OD1' HD13 ' A' ' 33' ' ' LEU . 28.9 m120 -59.04 -37.31 76.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.124 -0.489 . . . . 15.0 110.858 177.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.416 HD13 ' SD ' ' A' ' 8' ' ' MET . 12.1 tp -57.5 -44.96 85.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.286 0.565 . . . . 15.0 110.121 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -60.66 -46.87 88.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.53 -0.759 . . . . 15.0 110.539 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -62.61 -43.96 97.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 15.0 111.347 -176.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.08 -35.07 79.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.476 -0.329 . . . . 15.0 111.266 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.667 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -60.3 -37.95 82.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.007 0.432 . . . . 15.0 110.858 178.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.37 -144.63 0.55 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.461 -0.57 . . . . 15.0 109.461 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.45 -19.13 45.28 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.29 0.95 . . . . 15.0 112.586 -174.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.472 ' CG ' HD22 ' A' ' 41' ' ' LEU . 22.0 m-20 -91.88 11.76 23.84 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.295 0.85 . . . . 15.0 113.295 -174.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 59.0 t-105 -47.77 -46.85 62.7 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 118.564 -0.731 . . . . 15.0 112.519 177.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -44.66 -41.29 14.58 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 121.431 1.421 . . . . 15.0 113.287 177.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -76.96 -48.75 17.2 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.607 -0.437 . . . . 15.0 110.803 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.667 HD12 ' HB1' ' A' ' 67' ' ' ALA . 91.5 mt -58.91 -40.18 79.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.197 -0.456 . . . . 15.0 110.796 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.39 -16.99 37.77 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 116.291 -0.413 . . . . 15.0 113.254 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -66.58 -28.93 68.9 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.297 0.548 . . . . 15.0 112.17 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.2 mt -74.85 150.59 86.24 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 121.031 -0.268 . . . . 15.0 111.514 -172.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -63.8 126.52 17.57 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 121.626 1.551 . . . . 15.0 112.309 176.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.8 tp -105.7 127.25 52.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.508 -0.315 . . . . 15.0 110.824 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.49 ' HD1' HG22 ' A' ' 53' ' ' VAL . 69.6 m-85 -89.45 127.13 35.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.589 -0.522 . . . . 15.0 109.589 175.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.718 HG21 ' HB2' ' A' ' 87' ' ' ALA . 27.5 m -118.53 146.76 40.47 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 110.08 -0.341 . . . . 15.0 110.08 175.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.404 ' HD2' HG11 ' A' ' 86' ' ' VAL . 78.2 Cg_endo -79.1 -23.45 7.69 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.61 1.54 . . . . 15.0 113.457 -176.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.403 ' OG ' HG23 ' A' ' 86' ' ' VAL . 25.5 p -144.3 158.44 54.68 Favored Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 120.671 -0.412 . . . . 15.0 111.355 -172.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.07 -44.03 52.18 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.26 1.307 . . . . 15.0 111.737 176.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -57.65 -47.71 81.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.882 0.372 . . . . 15.0 110.929 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.404 HG11 ' HD2' ' A' ' 82' ' ' PRO . 60.3 t -59.65 -40.69 82.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.906 0.384 . . . . 15.0 109.983 178.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.718 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.55 -42.25 82.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.81 0.338 . . . . 15.0 110.444 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.41 -41.03 93.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.49 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.1 mmm -58.39 -43.95 88.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.401 0.619 . . . . 15.0 110.157 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.57 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.28 -40.62 94.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.733 -0.667 . . . . 15.0 110.795 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -62.53 -42.82 99.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.342 -0.39 . . . . 15.0 111.074 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.67 -36.11 77.92 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.897 -0.321 . . . . 15.0 111.33 -177.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.2 mt -67.95 -22.12 65.05 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.404 0.52 . . . . 15.0 112.404 177.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.99 13.39 18.15 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 119.315 -0.714 . . . . 15.0 113.217 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.77 121.98 11.76 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.579 1.189 . . . . 15.0 109.864 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -70.3 -35.37 73.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.55 -0.75 . . . . 15.0 111.275 -171.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -131.84 112.53 12.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.977 0.418 . . . . 15.0 110.486 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.2 t -112.0 130.69 65.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.135 -0.484 . . . . 15.0 109.883 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 84.3 mt -118.95 122.6 69.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.016 -0.538 . . . . 15.0 110.11 -176.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.57 117.07 29.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.457 -0.338 . . . . 15.0 110.431 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.3 p -97.02 6.12 49.18 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.168 0.803 . . . . 15.0 113.168 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 71.9 ttp85 -55.76 -39.37 71.11 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.169 0.441 . . . . 15.0 110.803 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.68 -35.09 5.27 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.6 -0.6 . . . . 15.0 111.6 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.26 139.07 54.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.969 0.414 . . . . 15.0 110.773 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.8 p -89.84 167.84 12.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.996 -0.547 . . . . 15.0 110.464 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.75 -54.2 25.22 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 113.028 0.751 . . . . 15.0 113.028 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.73 -36.6 98.54 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 CA-C-N 120.509 1.218 . . . . 15.0 111.447 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.55 -43.13 97.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.98 0.419 . . . . 15.0 110.183 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.5 mt -59.36 -40.8 87.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.198 -0.456 . . . . 15.0 110.398 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.9 tp -57.67 -44.7 85.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.323 0.583 . . . . 15.0 110.188 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.98 -40.71 94.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.666 -0.697 . . . . 15.0 110.595 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.85 -42.04 97.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.424 -0.353 . . . . 15.0 110.765 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.3 mt -57.87 -50.44 73.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.047 0.451 . . . . 15.0 110.44 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.7 p -65.02 -40.49 94.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.805 -0.634 . . . . 15.0 111.479 -175.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.9 p -64.37 -39.67 94.33 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.98 -0.288 . . . . 15.0 111.28 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.54 -43.27 94.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.634 -0.257 . . . . 15.0 111.037 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.543 -0.299 . . . . 15.0 110.976 179.757 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 CA--C 1.534 0.355 0 N-CA-C 110.194 -0.299 . . . . 15.0 110.194 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -54.09 152.37 24.62 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 121.481 1.454 . . . . 15.0 111.824 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -112.43 135.7 52.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.291 -0.413 . . . . 15.0 110.509 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.57 HG21 HD13 ' A' ' 21' ' ' LEU . 17.8 m -133.1 145.58 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.619 0.723 . . . . 15.0 111.859 177.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.9 tp -103.66 136.86 42.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.964 -1.016 . . . . 15.0 110.496 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.631 HD11 ' CG1' ' A' ' 28' ' ' VAL . 54.8 mt -100.79 133.87 42.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.033 0.444 . . . . 15.0 110.683 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.423 ' SD ' HD13 ' A' ' 63' ' ' LEU . 84.8 mtp -102.56 134.62 45.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.242 -0.89 . . . . 15.0 110.09 173.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -57.36 141.16 48.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.213 0.53 . . . . 15.0 110.572 -173.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.13 175.28 31.66 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.551 -1.02 . . . . 15.0 110.551 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.7 mp0 -58.0 -31.68 67.19 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.951 -0.3 . . . . 15.0 111.515 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.49 173.27 33.61 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.908 -0.877 . . . . 15.0 110.908 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.32 132.21 11.05 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.488 -0.645 . . . . 15.0 111.488 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -56.87 -44.08 81.86 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.127 0.489 . . . . 15.0 110.227 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.38 -43.42 97.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.767 -0.651 . . . . 15.0 111.024 -175.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -58.2 -55.93 28.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.012 0.434 . . . . 15.0 110.909 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.1 mt -61.35 -42.85 99.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 15.0 110.91 -175.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.12 -45.0 96.48 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.767 -0.373 . . . . 15.0 111.163 -177.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.23 -38.81 84.56 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.598 -0.441 . . . . 15.0 110.811 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -60.63 -51.51 69.1 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 119.973 -0.691 . . . . 15.0 110.918 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.57 HD13 HG21 ' A' ' 5' ' ' VAL . 79.9 mt -63.57 -38.02 89.52 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 120.451 -0.499 . . . . 15.0 111.252 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -63.57 -42.47 98.33 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.91 -0.316 . . . . 15.0 111.266 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.71 -30.72 69.63 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 120.865 -0.684 . . . . 15.0 112.011 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -88.8 10.14 22.11 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.654 0.983 . . . . 15.0 113.654 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.8 17.25 56.89 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 121.251 -0.5 . . . . 15.0 113.295 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.1 t -101.02 141.02 18.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 117.712 0.756 . . . . 15.0 110.088 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -84.8 131.36 34.55 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.297 -0.631 . . . . 15.0 109.297 177.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.631 ' CG1' HD11 ' A' ' 7' ' ' ILE . 40.3 t -117.72 131.19 71.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.129 0.49 . . . . 15.0 111.121 -173.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -137.4 133.82 35.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.464 -0.789 . . . . 15.0 109.488 171.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.552 ' HB3' HD12 ' A' ' 7' ' ' ILE . 42.1 p90 -116.06 138.38 51.28 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.968 0.413 . . . . 15.0 111.194 -177.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.0 tp -119.21 135.97 24.21 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 109.243 -0.651 . . . . 15.0 109.243 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.22 135.92 25.77 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.182 1.255 . . . . 15.0 111.759 173.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 84.1 mt -59.9 -9.31 2.84 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.41 0.893 . . . . 15.0 113.41 -177.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -77.14 -7.91 56.6 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.415 0.894 . . . . 15.0 113.415 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -64.57 146.55 98.18 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 118.606 0.639 . . . . 15.0 110.552 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.03 159.03 27.15 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.617 1.544 . . . . 15.0 113.221 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.44 150.97 4.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.779 -0.646 . . . . 15.0 111.52 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.2 -38.01 3.25 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.321 -0.712 . . . . 15.0 111.321 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -61.34 -37.82 84.67 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.58 -0.448 . . . . 15.0 111.017 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.573 ' O ' HG23 ' A' ' 44' ' ' VAL . 28.4 tp -59.0 -46.83 87.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.981 0.42 . . . . 15.0 110.127 -178.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.481 HD13 ' CB ' ' A' ' 70' ' ' ASP . 14.6 tp -62.51 -43.56 98.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.178 -0.465 . . . . 15.0 110.914 -177.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.17 -45.96 91.06 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.724 -0.39 . . . . 15.0 110.95 -176.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -61.52 -41.5 97.41 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.812 -0.355 . . . . 15.0 110.707 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 40' ' ' LEU . 94.5 t -61.24 -45.8 97.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.779 -0.368 . . . . 15.0 110.204 -177.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -69.11 -49.03 60.76 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.293 0.479 . . . . 15.0 112.293 -175.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.48 -44.3 75.08 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.992 -0.283 . . . . 15.0 111.642 -174.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -78.96 -10.16 59.74 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.09 0.774 . . . . 15.0 113.09 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 55.78 55.83 6.69 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.601 0.715 . . . . 15.0 110.306 -177.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.557 HD12 ' HA ' ' A' ' 44' ' ' VAL . 94.2 mt -74.18 146.91 43.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.552 -0.749 . . . . 15.0 111.306 -176.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -96.78 -40.71 8.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.677 -0.692 . . . . 15.0 110.807 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.63 165.45 28.77 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 119.798 -1.191 . . . . 15.0 113.644 -171.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.444 ' HB2' HD12 ' A' ' 79' ' ' LEU . 72.7 mt -127.04 144.59 50.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.545 -0.828 . . . . 15.0 110.279 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.521 HG22 ' CD1' ' A' ' 80' ' ' PHE . 47.5 t -120.22 129.35 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 110.372 -0.233 . . . . 15.0 110.372 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.2 m -126.65 144.53 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.141 0.496 . . . . 15.0 110.657 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.0 t -102.84 -13.27 17.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.493 -0.776 . . . . 15.0 112.747 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.8 p -153.34 159.1 42.4 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.456 0.646 . . . . 15.0 112.075 -173.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.6 -37.9 78.5 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.972 -0.851 . . . . 15.0 110.972 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -58.45 -44.62 89.28 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.848 -0.341 . . . . 15.0 110.635 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.4 -45.38 96.31 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.623 -0.991 . . . . 15.0 110.623 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.537 HD13 HD21 ' A' ' 79' ' ' LEU . 42.5 tp -56.4 -45.73 80.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.129 0.49 . . . . 15.0 110.778 -177.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -62.0 -42.73 99.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.043 -0.526 . . . . 15.0 110.89 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -59.22 -39.68 83.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.373 -0.376 . . . . 15.0 110.716 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.423 HD13 ' SD ' ' A' ' 8' ' ' MET . 13.6 tp -58.09 -45.02 87.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.166 0.508 . . . . 15.0 110.238 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -60.7 -47.55 85.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.744 -0.662 . . . . 15.0 110.648 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -62.0 -43.19 99.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.014 -0.539 . . . . 15.0 111.136 -176.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.08 -34.95 78.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.451 -0.341 . . . . 15.0 111.453 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.697 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.47 -38.94 82.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.953 0.406 . . . . 15.0 110.535 177.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 58.96 -142.53 0.64 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.626 -0.509 . . . . 15.0 109.626 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.75 -18.58 44.16 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.39 0.996 . . . . 15.0 112.695 -174.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.481 ' CB ' HD13 ' A' ' 41' ' ' LEU . 26.4 m-20 -91.79 9.26 33.42 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.315 0.857 . . . . 15.0 113.315 -175.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -47.74 -46.57 61.84 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.633 -0.699 . . . . 15.0 112.61 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -44.55 -43.04 14.34 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.493 1.462 . . . . 15.0 113.287 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -76.96 -48.81 17.02 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 120.644 -0.422 . . . . 15.0 110.931 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.697 HD12 ' HB1' ' A' ' 67' ' ' ALA . 86.4 mt -59.33 -39.05 77.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.11 -0.496 . . . . 15.0 110.85 -176.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.78 -13.2 38.54 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 119.826 -0.43 . . . . 15.0 113.405 -175.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -70.5 -29.21 65.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 117.578 0.689 . . . . 15.0 112.304 178.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.2 mt -69.86 126.51 92.53 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 118.572 -0.728 . . . . 15.0 109.606 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.23 133.45 52.68 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.106 1.204 . . . . 15.0 112.333 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.537 HD21 HD13 ' A' ' 60' ' ' LEU . 17.8 tp -105.75 129.31 53.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.904 -0.589 . . . . 15.0 110.552 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.521 ' CD1' HG22 ' A' ' 53' ' ' VAL . 77.5 m-85 -90.52 122.45 33.36 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.249 -0.648 . . . . 15.0 109.249 175.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.65 HG21 ' HB2' ' A' ' 87' ' ' ALA . 25.9 m -114.99 148.01 39.6 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 119.457 -0.306 . . . . 15.0 110.326 177.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.21 -24.54 6.59 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.529 1.486 . . . . 15.0 113.614 -174.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.9 p -142.43 161.36 50.45 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 120.594 -0.442 . . . . 15.0 111.58 -172.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -55.32 -44.07 52.44 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.208 1.272 . . . . 15.0 111.76 176.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -57.17 -47.9 80.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.855 0.36 . . . . 15.0 110.639 -177.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.5 t -60.0 -41.37 85.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.904 0.383 . . . . 15.0 109.992 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.65 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.94 -42.1 84.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.969 0.414 . . . . 15.0 110.486 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.24 -41.71 97.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.433 . . . . 15.0 110.44 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 86.5 mtp -58.92 -41.82 88.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.101 0.477 . . . . 15.0 110.379 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.69 -41.21 94.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 15.0 110.576 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 -61.74 -43.29 99.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 15.0 110.809 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.24 -36.1 76.98 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.879 -0.328 . . . . 15.0 111.256 -177.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 77.5 mt -65.89 -24.41 66.85 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.256 0.465 . . . . 15.0 112.256 176.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 107.67 13.25 20.88 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 119.437 -0.646 . . . . 15.0 113.075 -175.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.94 123.82 17.12 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 118.416 1.108 . . . . 15.0 109.939 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -72.17 -33.5 67.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.843 -0.617 . . . . 15.0 111.425 -172.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 45.9 tpt85 -131.81 114.57 14.87 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.903 0.382 . . . . 15.0 110.404 176.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 40.5 t -114.67 131.62 66.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.822 0.344 . . . . 15.0 110.145 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 87.8 mt -119.7 125.93 74.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.172 -0.467 . . . . 15.0 110.191 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -94.2 118.3 31.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.36 -0.382 . . . . 15.0 110.134 174.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.1 p -94.25 -7.2 42.73 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.17 0.804 . . . . 15.0 113.17 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -55.82 -39.41 71.34 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 118.122 0.419 . . . . 15.0 110.781 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -96.27 -35.04 5.63 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.491 -0.644 . . . . 15.0 111.491 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.24 143.44 40.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.796 0.331 . . . . 15.0 110.478 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.6 m -89.43 163.42 15.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 15.0 110.526 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.72 -54.31 24.23 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 112.878 0.695 . . . . 15.0 112.878 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.6 -34.13 98.65 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 CA-C-N 120.195 1.106 . . . . 15.0 111.646 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.29 -42.96 96.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.107 0.48 . . . . 15.0 110.026 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.8 mt -59.32 -39.88 84.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 15.0 110.495 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 29.4 tp -56.87 -45.04 82.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.399 0.618 . . . . 15.0 110.111 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.98 -39.73 90.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.506 -0.77 . . . . 15.0 110.601 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.63 -42.87 97.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.604 -0.271 . . . . 15.0 110.844 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.8 mt -58.04 -50.36 73.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.119 0.485 . . . . 15.0 110.405 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 71.7 p -63.5 -40.39 96.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.807 -0.633 . . . . 15.0 111.368 -175.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.8 m -64.01 -42.75 97.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.662 0.267 . . . . 15.0 111.292 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.25 -39.01 88.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.474 -0.33 . . . . 15.0 110.998 -178.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.545 -0.298 . . . . 15.0 111.213 178.666 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 110.406 -0.22 . . . . 15.0 110.406 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -56.13 155.05 25.47 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.389 1.393 . . . . 15.0 111.761 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.441 ' CB ' HD23 ' A' ' 49' ' ' LEU . 93.4 mttt -109.98 138.04 46.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.479 -0.328 . . . . 15.0 110.901 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.448 HG21 HD13 ' A' ' 21' ' ' LEU . 15.8 m -134.06 144.35 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.538 0.685 . . . . 15.0 111.614 175.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.8 tp -103.78 136.74 42.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.949 -1.023 . . . . 15.0 110.274 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.643 HD11 ' CG1' ' A' ' 28' ' ' VAL . 54.8 mt -101.6 133.8 43.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.137 0.494 . . . . 15.0 111.013 -177.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.549 ' HB2' HG12 ' A' ' 54' ' ' VAL . 98.7 mmm -94.69 134.28 37.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.153 -0.93 . . . . 15.0 109.045 170.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -57.46 140.68 49.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.894 0.378 . . . . 15.0 110.562 -175.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.28 175.1 27.74 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.995 -0.842 . . . . 15.0 110.995 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -58.2 -33.18 69.0 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.546 0.202 . . . . 15.0 111.546 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.94 173.27 35.25 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.979 -0.848 . . . . 15.0 110.979 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.98 131.36 10.37 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.25 -0.74 . . . . 15.0 111.25 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -57.41 -43.76 84.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.082 0.468 . . . . 15.0 110.317 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.18 -42.58 99.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.815 -0.63 . . . . 15.0 111.344 -176.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -61.68 -55.94 25.09 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.804 -0.359 . . . . 15.0 111.292 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.3 mt -59.87 -43.62 94.62 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.662 -0.415 . . . . 15.0 111.021 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.7 -41.31 99.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.491 -0.322 . . . . 15.0 110.995 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -60.04 -41.5 92.43 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.949 -0.3 . . . . 15.0 110.458 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -60.91 -51.73 68.04 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.622 -0.431 . . . . 15.0 111.319 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.448 HD13 HG21 ' A' ' 5' ' ' VAL . 72.9 mt -63.63 -36.96 85.54 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.349 -0.54 . . . . 15.0 110.971 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -62.49 -41.87 99.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.648 0.261 . . . . 15.0 111.092 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.7 -30.62 69.41 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.068 -0.587 . . . . 15.0 111.932 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -88.09 10.96 17.46 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.535 0.939 . . . . 15.0 113.535 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.39 17.77 56.54 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 121.279 -0.486 . . . . 15.0 113.368 174.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -101.05 139.0 23.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 117.807 0.803 . . . . 15.0 110.217 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -83.28 130.75 35.09 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.207 -0.664 . . . . 15.0 109.207 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.643 ' CG1' HD11 ' A' ' 7' ' ' ILE . 21.2 t -119.69 133.94 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.137 0.494 . . . . 15.0 111.401 -172.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -140.21 138.12 34.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.543 -0.753 . . . . 15.0 109.64 171.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.473 ' HB3' HD12 ' A' ' 7' ' ' ILE . 38.8 p90 -115.81 141.65 47.82 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.825 0.345 . . . . 15.0 110.789 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.9 tp -117.83 113.42 37.98 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 118.814 -0.612 . . . . 15.0 110.585 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -49.67 135.0 34.39 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.208 1.272 . . . . 15.0 111.903 173.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.655 HD13 ' OD1' ' A' ' 62' ' ' ASN . 46.0 mt -62.87 -13.37 33.17 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.214 0.82 . . . . 15.0 113.214 -176.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -77.14 -5.32 48.6 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.3 0.852 . . . . 15.0 113.3 -177.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -61.25 149.93 81.2 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 118.484 0.584 . . . . 15.0 110.375 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -80.07 151.91 21.26 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.567 1.512 . . . . 15.0 112.891 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.39 150.7 6.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.066 -0.515 . . . . 15.0 111.173 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.08 -38.03 3.24 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.57 -0.612 . . . . 15.0 111.57 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -62.05 -37.98 87.02 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 117.081 0.44 . . . . 15.0 110.995 -177.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.558 ' O ' HG23 ' A' ' 44' ' ' VAL . 21.2 tp -59.3 -47.46 85.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.922 0.392 . . . . 15.0 110.155 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.486 HD13 HD11 ' A' ' 74' ' ' ILE . 15.4 tp -63.0 -44.5 95.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.204 -0.453 . . . . 15.0 110.973 -176.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.65 -45.66 93.08 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.702 -0.399 . . . . 15.0 110.675 -176.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 47.2 ttt85 -61.01 -42.03 97.68 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.784 -0.367 . . . . 15.0 110.706 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 40' ' ' LEU . 96.8 t -60.88 -45.04 98.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.811 -0.355 . . . . 15.0 110.322 -177.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -68.79 -48.24 64.13 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.235 0.457 . . . . 15.0 112.235 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.03 -44.3 72.99 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.995 -0.282 . . . . 15.0 111.629 -175.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -78.41 -10.03 59.53 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.046 0.758 . . . . 15.0 113.046 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 55.93 55.84 6.57 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.593 0.711 . . . . 15.0 110.252 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 44' ' ' VAL . 96.2 mt -70.01 144.21 52.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.552 -0.749 . . . . 15.0 110.976 -176.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -90.8 -40.58 11.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.394 -0.821 . . . . 15.0 110.764 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -150.8 166.46 30.34 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 119.797 -1.192 . . . . 15.0 113.774 -173.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.0 mt -125.73 143.05 51.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.519 -0.84 . . . . 15.0 109.888 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.516 HG22 ' CD1' ' A' ' 80' ' ' PHE . 46.8 t -121.28 131.6 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 110.307 -0.257 . . . . 15.0 110.307 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.549 HG12 ' HB2' ' A' ' 8' ' ' MET . 7.0 m -128.46 139.72 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.058 0.456 . . . . 15.0 110.469 173.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.9 t -102.03 -14.93 16.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.566 -0.743 . . . . 15.0 112.81 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 85.2 p -145.9 156.77 43.76 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.28 0.562 . . . . 15.0 111.771 -174.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.18 -39.7 90.41 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.873 -0.891 . . . . 15.0 110.873 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -59.33 -43.54 92.69 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.837 -0.345 . . . . 15.0 110.533 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.41 -46.29 94.13 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.544 -1.023 . . . . 15.0 110.544 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.54 HD13 HD21 ' A' ' 79' ' ' LEU . 35.2 tp -57.16 -44.84 83.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.106 0.479 . . . . 15.0 110.685 -177.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.82 -42.64 99.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.025 -0.534 . . . . 15.0 110.93 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.655 ' OD1' HD13 ' A' ' 33' ' ' LEU . 30.9 m120 -59.97 -40.78 90.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.781 0.324 . . . . 15.0 110.642 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.425 ' CD1' HD21 ' A' ' 40' ' ' LEU . 13.5 tp -58.15 -44.26 87.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.24 0.543 . . . . 15.0 110.17 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -60.82 -46.95 88.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.833 -0.621 . . . . 15.0 110.769 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.31 -42.63 98.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.083 -0.508 . . . . 15.0 111.123 -176.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 94.8 mt -65.47 -36.19 83.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.404 -0.362 . . . . 15.0 111.332 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.675 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.47 -38.08 79.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.145 0.498 . . . . 15.0 110.923 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.14 -143.85 0.58 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.627 -0.508 . . . . 15.0 109.627 174.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.54 -20.9 58.92 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.307 0.958 . . . . 15.0 112.694 -173.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.472 ' OD2' HD22 ' A' ' 41' ' ' LEU . 77.6 m-20 -92.47 13.53 19.37 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.222 0.823 . . . . 15.0 113.222 -175.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 53.8 t-105 -47.74 -46.65 62.06 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-O 118.608 -0.711 . . . . 15.0 112.53 176.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -44.61 -40.39 13.92 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 121.475 1.45 . . . . 15.0 113.19 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -77.0 -48.79 16.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.034 0.445 . . . . 15.0 110.808 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.675 HD12 ' HB1' ' A' ' 67' ' ' ALA . 91.1 mt -60.34 -39.08 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 15.0 110.876 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.78 -14.3 29.23 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 119.849 -0.417 . . . . 15.0 113.083 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -65.13 -30.9 71.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 117.461 0.631 . . . . 15.0 111.785 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.3 mt -74.02 139.82 76.65 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 119.068 -0.491 . . . . 15.0 110.397 -175.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -58.9 134.26 59.03 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 121.433 1.422 . . . . 15.0 112.556 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.54 HD21 HD13 ' A' ' 60' ' ' LEU . 22.8 tp -108.87 129.2 55.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.075 -0.512 . . . . 15.0 110.745 176.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.516 ' CD1' HG22 ' A' ' 53' ' ' VAL . 84.3 m-85 -91.1 125.83 36.0 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.54 -0.541 . . . . 15.0 109.54 175.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.674 HG21 ' HB2' ' A' ' 87' ' ' ALA . 27.7 m -117.1 149.16 43.8 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 119.513 -0.279 . . . . 15.0 110.377 176.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.405 ' HD2' HG11 ' A' ' 86' ' ' VAL . 72.5 Cg_endo -79.15 -25.53 5.85 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.645 1.563 . . . . 15.0 113.597 -174.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.4 ' OG ' HG23 ' A' ' 86' ' ' VAL . 27.6 p -142.7 162.21 45.34 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 120.635 -0.426 . . . . 15.0 111.542 -172.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -56.02 -43.9 52.21 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.11 1.207 . . . . 15.0 111.862 176.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 68.5 mtp85 -58.79 -46.58 87.22 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.868 -0.333 . . . . 15.0 110.871 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.405 HG11 ' HD2' ' A' ' 82' ' ' PRO . 54.8 t -60.01 -40.85 84.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.959 -0.385 . . . . 15.0 109.959 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.674 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.59 -42.04 82.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.886 0.374 . . . . 15.0 110.467 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.46 -41.37 97.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.281 -0.418 . . . . 15.0 110.555 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 86.9 mtp -59.91 -43.4 94.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.223 0.535 . . . . 15.0 110.442 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.48 -40.85 96.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.025 -0.534 . . . . 15.0 110.719 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -61.24 -44.25 97.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 15.0 110.324 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.8 -36.15 74.0 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.986 -0.286 . . . . 15.0 111.251 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.9 mt -65.24 -26.03 67.93 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.113 0.412 . . . . 15.0 112.113 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.67 13.26 16.99 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 119.391 -0.672 . . . . 15.0 113.13 -176.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.92 122.1 12.13 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 118.527 1.163 . . . . 15.0 109.884 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -68.23 -35.32 77.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.764 -0.653 . . . . 15.0 111.23 -171.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.3 tpt85 -131.79 117.45 18.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.907 0.384 . . . . 15.0 110.137 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.7 t -114.41 130.06 69.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.996 0.427 . . . . 15.0 110.091 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 87.0 mt -118.81 125.16 74.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.801 -0.636 . . . . 15.0 110.171 -177.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.82 118.07 31.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.388 -0.369 . . . . 15.0 110.08 175.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 104' ' ' ALA . 31.9 p -92.91 -8.21 43.94 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.164 0.802 . . . . 15.0 113.164 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -55.14 -39.54 69.58 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.045 0.384 . . . . 15.0 110.914 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.07 -35.09 5.17 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.513 -0.635 . . . . 15.0 111.513 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' A' ' 101' ' ' CYS . . . -68.87 145.42 53.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.879 0.371 . . . . 15.0 110.691 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.437 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 20.6 t -89.8 152.01 21.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 15.0 110.406 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.67 -54.43 23.11 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 113.087 0.773 . . . . 15.0 113.087 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.83 -36.17 94.96 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 CA-C-N 120.098 1.071 . . . . 15.0 111.642 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 105' ' ' SER . . . -59.88 -42.0 92.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.035 0.445 . . . . 15.0 110.078 176.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.6 mt -59.02 -40.16 84.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.243 -0.435 . . . . 15.0 110.517 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.1 tp -57.17 -43.88 82.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.39 0.614 . . . . 15.0 110.146 178.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.84 -40.88 90.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.679 -0.691 . . . . 15.0 110.393 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.73 -40.8 89.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.311 -0.404 . . . . 15.0 110.715 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.9 mt -57.82 -50.74 72.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.271 0.558 . . . . 15.0 110.494 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.5 p -63.57 -40.54 97.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.6 -0.727 . . . . 15.0 111.326 -175.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 86.5 p -65.74 -39.17 90.86 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.911 -0.316 . . . . 15.0 111.42 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.62 -39.31 94.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.497 -0.32 . . . . 15.0 111.068 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.418 -0.356 . . . . 15.0 111.163 179.204 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 . . . . . 0 CA--C 1.534 0.355 0 N-CA-C 110.242 -0.281 . . . . 15.0 110.242 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -49.98 151.51 8.54 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.449 1.433 . . . . 15.0 111.937 -175.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.47 ' HB2' HD23 ' A' ' 49' ' ' LEU . 75.9 mttt -119.93 141.13 49.91 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.334 -0.394 . . . . 15.0 110.703 -178.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.474 HG21 HD13 ' A' ' 21' ' ' LEU . 22.6 m -133.87 145.77 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.474 0.654 . . . . 15.0 111.781 175.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.488 HD13 ' CD ' ' A' ' 43' ' ' ARG . 13.4 tp -104.9 135.45 46.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.077 -0.965 . . . . 15.0 110.067 178.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.51 HD11 ' CG1' ' A' ' 28' ' ' VAL . 58.7 mt -103.04 135.09 42.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.026 0.441 . . . . 15.0 110.545 -177.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.569 ' HE3' HD21 ' A' ' 33' ' ' LEU . 96.7 mmm -88.21 134.12 33.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.422 -0.808 . . . . 15.0 110.123 174.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -57.81 140.72 51.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 15.0 110.583 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.36 175.07 42.52 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.949 -0.86 . . . . 15.0 110.949 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.61 -34.09 64.55 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.263 -0.175 . . . . 15.0 111.419 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.72 162.19 4.36 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.246 -0.742 . . . . 15.0 111.246 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.95 119.59 5.06 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.202 -0.759 . . . . 15.0 111.202 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -57.07 -43.79 82.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.097 0.475 . . . . 15.0 110.24 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.68 -41.71 98.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.861 -0.609 . . . . 15.0 111.146 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -58.84 -56.09 26.66 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.713 -0.395 . . . . 15.0 110.966 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.9 mt -61.53 -40.62 95.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.32 -0.4 . . . . 15.0 111.051 -176.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.41 -46.2 90.87 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.78 -0.368 . . . . 15.0 111.336 -177.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -60.29 -40.04 89.04 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.532 -0.467 . . . . 15.0 110.688 -177.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -60.57 -51.61 68.67 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 120.27 -0.572 . . . . 15.0 111.134 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.474 HD13 HG21 ' A' ' 5' ' ' VAL . 82.3 mt -66.31 -36.12 82.13 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.474 -0.49 . . . . 15.0 111.256 -176.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -61.66 -43.42 98.89 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 121.111 -0.236 . . . . 15.0 110.699 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.9 -30.7 70.26 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 120.844 -0.694 . . . . 15.0 112.018 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -88.21 8.59 26.41 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.647 0.98 . . . . 15.0 113.647 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.2 12.01 63.95 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 121.241 -0.505 . . . . 15.0 113.462 176.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.11 139.89 21.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 117.886 0.843 . . . . 15.0 110.044 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -86.26 137.44 32.61 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.699 -0.482 . . . . 15.0 109.699 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.51 ' CG1' HD11 ' A' ' 7' ' ' ILE . 38.6 t -116.78 131.13 70.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.186 0.517 . . . . 15.0 110.96 -174.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -134.81 130.2 35.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.587 -0.733 . . . . 15.0 109.446 171.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -112.01 135.69 52.32 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.896 0.379 . . . . 15.0 110.87 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.0 tp -116.15 113.35 41.53 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-O 118.751 -0.643 . . . . 15.0 110.398 -176.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.35 136.52 63.15 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.189 1.26 . . . . 15.0 112.445 175.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.569 HD21 ' HE3' ' A' ' 8' ' ' MET . 13.4 mt -58.62 -10.96 2.56 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.339 0.866 . . . . 15.0 113.339 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -77.15 -5.81 50.52 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.321 0.859 . . . . 15.0 113.321 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -65.75 146.06 99.0 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 118.491 0.587 . . . . 15.0 110.482 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -80.75 157.13 21.25 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.602 1.535 . . . . 15.0 113.142 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.41 151.47 5.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.921 -0.582 . . . . 15.0 111.331 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.13 -38.03 3.24 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.527 -0.629 . . . . 15.0 111.527 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -62.45 -36.69 83.22 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.601 -0.44 . . . . 15.0 111.096 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.559 ' O ' HG23 ' A' ' 44' ' ' VAL . 27.4 tp -59.11 -47.12 86.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.962 0.411 . . . . 15.0 110.196 -178.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.5 HD13 ' CB ' ' A' ' 70' ' ' ASP . 19.4 tp -62.71 -45.2 93.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 15.0 110.868 -176.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.68 -44.53 96.77 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.687 -0.405 . . . . 15.0 110.76 -176.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.488 ' CD ' HD13 ' A' ' 6' ' ' LEU . 58.9 ttm-85 -60.72 -42.56 97.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.503 -0.317 . . . . 15.0 110.773 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 40' ' ' LEU . 97.9 t -60.46 -45.85 96.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.778 -0.369 . . . . 15.0 110.215 -177.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 62.1 ttm-85 -67.45 -51.63 49.18 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 123.453 0.471 . . . . 15.0 112.005 -176.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.36 -44.31 79.32 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 121.05 -0.26 . . . . 15.0 111.698 -174.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -78.85 -10.18 59.71 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.065 0.765 . . . . 15.0 113.065 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 54.67 55.83 7.46 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.515 0.674 . . . . 15.0 110.568 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.482 HD13 ' HB2' ' A' ' 6' ' ' LEU . 97.8 mt -74.15 143.75 45.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.794 -0.639 . . . . 15.0 111.086 -176.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.52 ' O ' HD22 ' A' ' 77' ' ' LEU . 9.4 m120 -90.2 -40.61 12.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.456 -0.793 . . . . 15.0 110.772 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.61 165.89 28.74 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 119.869 -1.158 . . . . 15.0 113.537 -171.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.1 mt -127.09 145.69 50.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.665 -0.768 . . . . 15.0 110.042 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.494 HG22 ' CD1' ' A' ' 80' ' ' PHE . 47.3 t -122.78 133.2 69.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 110.248 -0.279 . . . . 15.0 110.248 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.426 HG12 ' HG3' ' A' ' 8' ' ' MET . 10.2 m -124.57 138.35 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 120.99 0.424 . . . . 15.0 110.609 174.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.1 p -90.05 -18.02 26.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.727 -0.67 . . . . 15.0 112.636 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 77.0 p -156.68 161.43 39.86 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 121.364 0.602 . . . . 15.0 111.719 -176.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.95 -37.25 69.73 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.193 -0.763 . . . . 15.0 111.193 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -59.17 -46.09 89.29 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.899 -0.32 . . . . 15.0 110.789 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.9 -42.78 98.36 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.808 -0.917 . . . . 15.0 110.808 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.609 HD13 HD21 ' A' ' 79' ' ' LEU . 28.8 tp -58.11 -47.33 83.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.987 0.423 . . . . 15.0 110.622 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.49 -43.61 98.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.181 -0.463 . . . . 15.0 110.644 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.407 ' CB ' HD22 ' A' ' 33' ' ' LEU . 79.4 m-20 -59.09 -40.91 86.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.104 -0.498 . . . . 15.0 110.527 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.2 tp -56.76 -42.55 79.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.059 0.457 . . . . 15.0 110.194 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -58.74 -46.99 86.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.875 -0.602 . . . . 15.0 110.238 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -61.37 -43.2 99.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.794 -0.639 . . . . 15.0 111.098 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.83 -35.99 82.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.281 -0.418 . . . . 15.0 111.437 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.659 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.55 -38.49 81.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.063 0.458 . . . . 15.0 110.816 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.45 -143.56 0.57 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 109.454 -0.572 . . . . 15.0 109.454 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.48 -19.1 45.31 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.347 0.976 . . . . 15.0 112.66 -174.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.5 ' CB ' HD13 ' A' ' 41' ' ' LEU . 13.8 m-20 -91.84 10.39 28.83 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.295 0.85 . . . . 15.0 113.295 -174.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 53.5 t-105 -47.75 -48.13 60.75 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 118.553 -0.737 . . . . 15.0 112.423 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -44.72 -40.37 14.26 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.47 1.447 . . . . 15.0 113.159 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -77.1 -48.6 17.33 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.936 0.398 . . . . 15.0 111.202 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.659 HD12 ' HB1' ' A' ' 67' ' ' ALA . 93.7 mt -59.11 -39.27 78.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 15.0 110.826 -177.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.96 0.4 14.92 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 119.693 -0.504 . . . . 15.0 113.22 -175.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.3 mtm105 -90.58 -1.28 57.88 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.013 0.906 . . . . 15.0 112.975 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.52 HD22 ' O ' ' A' ' 50' ' ' ASN . 23.3 mt -90.09 139.47 27.27 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-O 118.869 -0.586 . . . . 15.0 109.656 172.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.67 131.23 40.51 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.376 1.384 . . . . 15.0 111.759 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.609 HD21 HD13 ' A' ' 60' ' ' LEU . 24.3 tp -105.43 128.07 53.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.748 0.309 . . . . 15.0 110.9 177.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.494 ' CD1' HG22 ' A' ' 53' ' ' VAL . 73.3 m-85 -92.84 127.13 38.23 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.696 -0.483 . . . . 15.0 109.696 176.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.448 HG21 ' HB2' ' A' ' 87' ' ' ALA . 32.8 m -123.15 151.58 62.18 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-O 119.567 -0.254 . . . . 15.0 110.67 177.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.28 -19.63 10.31 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 121.514 1.476 . . . . 15.0 113.803 -175.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.0 p -148.83 162.47 29.38 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 120.391 -0.524 . . . . 15.0 111.841 -171.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.4 -43.96 47.0 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.2 1.267 . . . . 15.0 111.885 176.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -58.2 -46.75 85.27 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.808 -0.357 . . . . 15.0 110.71 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 50.2 t -60.95 -38.38 79.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.689 -0.404 . . . . 15.0 110.128 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.448 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -56.85 -41.71 78.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.042 0.449 . . . . 15.0 110.427 177.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -60.88 -40.09 91.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.154 -0.476 . . . . 15.0 110.616 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.1 mmm -58.34 -45.85 87.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.45 0.643 . . . . 15.0 110.173 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.494 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -62.09 -42.11 98.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.733 -0.667 . . . . 15.0 111.112 -177.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 71.6 ttp85 -62.28 -44.2 97.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.186 -0.461 . . . . 15.0 110.708 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -59.33 -36.15 75.12 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.978 -0.289 . . . . 15.0 111.236 -177.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 81.5 mt -65.46 -25.24 67.42 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.098 0.407 . . . . 15.0 112.098 177.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 111.58 13.2 13.24 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 119.293 -0.726 . . . . 15.0 113.235 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.22 131.08 49.95 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.566 1.183 . . . . 15.0 109.666 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -62.24 -44.42 96.59 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.452 -0.573 . . . . 15.0 109.452 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 47.9 ttt85 -131.84 119.03 20.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.464 -0.789 . . . . 15.0 110.945 -173.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.8 t -114.43 128.78 71.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.829 -0.623 . . . . 15.0 109.503 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.448 ' O ' HG22 ' A' ' 81' ' ' VAL . 93.2 mt -117.79 123.92 72.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.903 -0.59 . . . . 15.0 110.279 -175.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -94.36 118.22 31.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.364 -0.38 . . . . 15.0 110.22 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.7 p -91.33 -6.94 52.3 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.141 0.793 . . . . 15.0 113.141 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 47.0 tpt85 -55.51 -39.61 70.73 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 118.208 0.458 . . . . 15.0 110.723 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.33 -35.2 5.32 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.48 -0.648 . . . . 15.0 111.48 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.11 144.25 42.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.816 0.341 . . . . 15.0 110.55 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.1 m -89.72 161.8 15.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.04 0.448 . . . . 15.0 110.578 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.65 -54.27 24.25 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 112.976 0.732 . . . . 15.0 112.976 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.05 -34.84 98.9 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 CA-C-N 120.213 1.112 . . . . 15.0 111.601 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.63 94.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.061 0.457 . . . . 15.0 110.048 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.3 mt -59.05 -40.9 86.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.446 . . . . 15.0 110.411 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 40.7 tp -57.31 -44.46 84.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.383 0.611 . . . . 15.0 110.136 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.31 -39.74 88.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.583 -0.735 . . . . 15.0 110.677 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.88 -42.42 97.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.415 -0.357 . . . . 15.0 110.899 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.0 mt -57.88 -50.36 73.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.026 0.441 . . . . 15.0 110.428 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.8 p -65.38 -39.95 92.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.827 -0.624 . . . . 15.0 111.576 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.1 p -66.35 -38.42 87.57 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.999 -0.28 . . . . 15.0 111.28 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.63 -42.59 95.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.41 -0.359 . . . . 15.0 111.133 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.249 0 CA-C-O 120.756 0.313 . . . . 15.0 110.579 179.856 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 . . . . . 0 CA--C 1.535 0.393 0 N-CA-C 110.238 -0.282 . . . . 15.0 110.238 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -50.99 154.53 7.15 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.486 1.457 . . . . 15.0 111.871 -176.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.5 ' HB2' HD23 ' A' ' 49' ' ' LEU . 93.8 mttt -116.43 140.39 49.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.448 -0.342 . . . . 15.0 110.831 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.577 HG21 HD13 ' A' ' 21' ' ' LEU . 12.2 m -135.4 143.78 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.638 0.732 . . . . 15.0 111.69 175.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 tp -104.72 134.34 48.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.855 -1.066 . . . . 15.0 110.262 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.562 HD11 ' CG1' ' A' ' 28' ' ' VAL . 48.9 mt -103.35 135.15 42.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 15.0 110.505 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.629 ' SD ' HD13 ' A' ' 63' ' ' LEU . 85.9 mtp -101.08 134.11 44.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.66 -0.7 . . . . 15.0 109.531 172.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -57.61 146.47 30.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.002 0.429 . . . . 15.0 110.81 -174.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.92 175.14 33.79 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.97 -0.852 . . . . 15.0 110.97 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.56 -32.62 67.31 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.602 0.223 . . . . 15.0 111.602 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.51 177.01 18.25 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.014 -0.835 . . . . 15.0 111.014 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.0 122.09 5.81 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.313 -0.715 . . . . 15.0 111.313 -178.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -57.17 -44.52 83.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.098 0.475 . . . . 15.0 110.27 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.96 -41.13 97.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.927 -0.579 . . . . 15.0 110.958 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -57.88 -55.98 27.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.981 0.42 . . . . 15.0 111.0 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.417 HD21 HG11 ' A' ' 53' ' ' VAL . 26.8 tp -60.54 -42.13 95.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 15.0 111.025 -176.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.06 -43.69 98.51 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.799 -0.36 . . . . 15.0 111.45 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -61.73 -39.46 91.64 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.704 -0.398 . . . . 15.0 110.818 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -61.01 -51.6 68.54 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.381 -0.527 . . . . 15.0 111.232 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.577 HD13 HG21 ' A' ' 5' ' ' VAL . 80.9 mt -64.26 -37.58 87.97 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.409 -0.516 . . . . 15.0 111.001 -177.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -63.79 -43.8 95.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.59 0.233 . . . . 15.0 111.121 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.93 -30.66 66.81 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.03 -0.605 . . . . 15.0 111.961 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -88.03 9.33 22.81 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.57 0.952 . . . . 15.0 113.57 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.21 13.63 58.5 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 121.247 -0.501 . . . . 15.0 113.554 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.0 t -101.09 138.15 26.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 117.845 0.822 . . . . 15.0 110.061 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -79.51 132.42 36.32 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.194 -0.669 . . . . 15.0 109.194 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.562 ' CG1' HD11 ' A' ' 7' ' ' ILE . 39.6 t -116.36 131.17 69.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.194 0.521 . . . . 15.0 111.106 -173.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -137.73 130.8 30.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.413 -0.812 . . . . 15.0 109.377 170.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.406 ' HB3' HD12 ' A' ' 7' ' ' ILE . 31.0 p90 -114.15 135.11 54.39 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.87 0.366 . . . . 15.0 110.645 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 tp -112.99 136.04 21.7 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.946 -0.55 . . . . 15.0 110.027 -175.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -72.16 135.11 24.36 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.332 1.354 . . . . 15.0 111.976 172.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.613 HD22 ' CB ' ' A' ' 62' ' ' ASN . 62.4 mt -58.36 -11.94 3.3 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.33 0.863 . . . . 15.0 113.33 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -77.21 -6.64 53.78 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.392 0.886 . . . . 15.0 113.392 -176.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -68.55 150.9 97.52 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 118.524 0.602 . . . . 15.0 110.738 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -78.95 155.9 26.61 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.64 1.56 . . . . 15.0 113.102 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.11 151.99 4.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.763 -0.653 . . . . 15.0 111.226 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.44 -38.03 3.24 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.945 -0.57 . . . . 15.0 111.688 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.68 -38.86 86.35 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 117.172 0.486 . . . . 15.0 110.738 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.531 ' O ' HG23 ' A' ' 44' ' ' VAL . 18.2 tp -60.46 -48.3 82.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.954 0.407 . . . . 15.0 110.4 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.435 HD22 ' CG ' ' A' ' 70' ' ' ASP . 21.3 tp -60.38 -42.38 95.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 15.0 110.772 -175.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.25 -46.24 89.72 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.664 -0.415 . . . . 15.0 110.909 -175.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 -61.1 -41.35 96.52 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.499 -0.48 . . . . 15.0 110.679 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 40' ' ' LEU . 82.2 t -60.33 -46.08 95.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.748 -0.381 . . . . 15.0 110.202 -176.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -68.57 -51.32 44.03 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 123.421 0.45 . . . . 15.0 112.066 -175.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.29 -44.25 79.72 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.857 0.317 . . . . 15.0 111.857 -173.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -79.56 -10.07 59.73 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.08 0.77 . . . . 15.0 113.08 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 55.5 55.78 6.96 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.632 0.729 . . . . 15.0 110.219 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.5 HD23 ' HB2' ' A' ' 4' ' ' LYS . 96.0 mt -68.04 143.56 55.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.671 -0.695 . . . . 15.0 111.364 -174.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -91.16 -40.13 11.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.151 -0.931 . . . . 15.0 110.838 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.37 160.75 28.46 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.023 -1.084 . . . . 15.0 113.788 -174.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 71.3 mt -125.39 143.39 51.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.486 -0.857 . . . . 15.0 109.618 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.53 HG22 ' CD1' ' A' ' 80' ' ' PHE . 45.6 t -122.11 132.07 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 121.148 -0.221 . . . . 15.0 110.764 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.405 HG12 ' SD ' ' A' ' 8' ' ' MET . 8.5 m -124.23 145.78 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.144 0.497 . . . . 15.0 110.524 172.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 t -98.1 -21.45 16.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.479 -0.782 . . . . 15.0 112.426 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 81.3 p -152.73 162.16 41.62 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.414 0.625 . . . . 15.0 111.801 -174.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.86 -37.08 68.36 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.118 -0.793 . . . . 15.0 111.118 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -58.98 -46.08 88.99 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.858 -0.337 . . . . 15.0 110.646 -177.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.56 -44.07 98.18 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.732 -0.947 . . . . 15.0 110.732 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.627 HD13 HD21 ' A' ' 79' ' ' LEU . 32.2 tp -57.04 -45.09 83.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.112 0.482 . . . . 15.0 110.672 -178.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.72 -43.69 98.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 15.0 110.534 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.613 ' CB ' HD22 ' A' ' 33' ' ' LEU . 22.8 m120 -59.83 -38.1 81.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.706 178.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.629 HD13 ' SD ' ' A' ' 8' ' ' MET . 9.5 tp -56.69 -44.9 81.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.388 0.613 . . . . 15.0 110.155 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -60.0 -46.87 88.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.495 -0.775 . . . . 15.0 110.584 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -61.51 -43.23 99.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.975 -0.557 . . . . 15.0 111.091 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.09 -34.99 78.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.449 -0.342 . . . . 15.0 111.468 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.668 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.46 -38.14 80.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.965 0.412 . . . . 15.0 110.69 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.2 -143.93 0.58 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 109.605 -0.517 . . . . 15.0 109.605 174.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.53 -18.87 44.08 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.336 0.971 . . . . 15.0 112.678 -174.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.435 ' CG ' HD22 ' A' ' 41' ' ' LEU . 23.3 m-20 -91.86 10.8 27.17 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.282 0.845 . . . . 15.0 113.282 -175.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 60.0 t-105 -47.81 -46.56 62.65 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-O 118.588 -0.72 . . . . 15.0 112.556 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -44.74 -41.6 14.86 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.438 1.425 . . . . 15.0 113.267 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -77.03 -48.79 16.92 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.954 0.407 . . . . 15.0 110.819 -177.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.668 HD12 ' HB1' ' A' ' 67' ' ' ALA . 90.3 mt -59.57 -40.56 82.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 15.0 110.855 -176.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.68 -15.87 35.37 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 116.392 -0.367 . . . . 15.0 113.144 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -65.06 -29.93 70.85 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.355 0.578 . . . . 15.0 112.073 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.2 mt -75.7 150.51 84.21 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 121.018 -0.273 . . . . 15.0 111.648 -173.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.31 128.23 23.21 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.751 1.634 . . . . 15.0 112.481 176.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.627 HD21 HD13 ' A' ' 60' ' ' LEU . 23.9 tp -106.32 125.66 51.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.343 -0.389 . . . . 15.0 110.516 174.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.53 ' CD1' HG22 ' A' ' 53' ' ' VAL . 69.3 m-85 -90.05 126.56 35.81 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.634 -0.506 . . . . 15.0 109.634 176.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.653 HG21 ' HB2' ' A' ' 87' ' ' ALA . 26.7 m -119.06 147.28 42.31 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 119.438 -0.315 . . . . 15.0 110.176 176.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.14 -24.27 6.91 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.601 1.534 . . . . 15.0 113.529 -175.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.3 p -142.98 162.54 42.98 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 120.602 -0.439 . . . . 15.0 111.52 -171.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.14 -44.07 50.26 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.184 1.256 . . . . 15.0 111.755 176.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 70.9 ttp85 -57.45 -48.39 79.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.833 0.349 . . . . 15.0 110.845 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.8 t -59.9 -40.07 81.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.99 -0.374 . . . . 15.0 109.99 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.653 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.42 -42.29 82.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.903 0.383 . . . . 15.0 110.371 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -60.47 -40.11 90.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 15.0 110.621 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.1 mmm -58.46 -43.68 88.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.364 0.602 . . . . 15.0 110.212 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.496 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.16 -42.4 98.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.8 -0.636 . . . . 15.0 110.883 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.455 ' HD2' HG21 ' A' ' 98' ' ' VAL . 28.9 mmm180 -62.87 -42.01 99.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 15.0 110.871 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -59.64 -36.19 75.89 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.909 -0.317 . . . . 15.0 111.3 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.9 mt -68.96 -21.43 64.18 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.569 0.581 . . . . 15.0 112.569 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 106.85 13.28 22.28 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 119.376 -0.68 . . . . 15.0 113.086 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.79 122.14 12.15 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.439 1.12 . . . . 15.0 109.989 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -68.13 -36.04 79.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.55 -0.75 . . . . 15.0 111.226 -171.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.7 ttm-85 -131.76 114.03 14.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.045 0.45 . . . . 15.0 110.575 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.455 HG21 ' HD2' ' A' ' 91' ' ' ARG . 47.0 t -112.39 130.58 65.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.175 -0.466 . . . . 15.0 109.873 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.5 mt -119.74 123.73 71.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.941 -0.572 . . . . 15.0 110.142 -176.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.27 118.47 31.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.381 -0.372 . . . . 15.0 110.193 176.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.5 p -96.04 -3.99 43.86 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.283 0.846 . . . . 15.0 113.283 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -56.02 -39.96 72.7 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 118.199 0.454 . . . . 15.0 110.698 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -92.06 -35.07 6.86 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.505 -0.638 . . . . 15.0 111.505 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.44 142.38 41.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.841 0.353 . . . . 15.0 110.704 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.2 m -89.82 164.07 14.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 15.0 110.327 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.61 -54.22 24.43 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-O 118.523 -0.751 . . . . 15.0 112.963 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.59 -36.18 97.74 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 CA-C-N 120.583 1.244 . . . . 15.0 111.346 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.21 -42.61 95.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.046 0.451 . . . . 15.0 110.165 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.0 mt -58.95 -40.66 85.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 15.0 110.44 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 29.2 tp -57.36 -44.35 84.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.31 0.576 . . . . 15.0 110.181 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.6 -40.99 93.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.656 -0.702 . . . . 15.0 110.556 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.23 92.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.356 -0.384 . . . . 15.0 110.805 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.1 mt -57.9 -51.39 69.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.284 0.564 . . . . 15.0 110.451 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.2 p -64.69 -40.27 95.09 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.585 -0.734 . . . . 15.0 111.38 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.3 p -64.6 -38.88 92.52 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.037 -0.265 . . . . 15.0 111.335 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.81 -42.72 99.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.747 0.308 . . . . 15.0 110.891 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.375 -0.375 . . . . 15.0 110.769 178.556 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.534 0.331 0 N-CA-C 110.421 -0.214 . . . . 15.0 110.421 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.01 153.89 5.91 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.373 1.382 . . . . 15.0 111.918 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -109.98 138.38 46.44 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.552 -0.295 . . . . 15.0 110.866 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.471 HG21 HD13 ' A' ' 21' ' ' LEU . 12.4 m -135.96 144.16 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 121.612 0.72 . . . . 15.0 111.707 177.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.408 HD13 ' CD ' ' A' ' 43' ' ' ARG . 12.4 tp -104.55 135.84 45.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.936 -1.029 . . . . 15.0 110.233 177.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.57 HD11 ' CG1' ' A' ' 28' ' ' VAL . 50.3 mt -102.58 135.11 41.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.279 -0.419 . . . . 15.0 110.319 -178.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.487 ' SD ' HD13 ' A' ' 63' ' ' LEU . 86.5 mtp -99.08 134.02 42.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.898 -0.592 . . . . 15.0 110.305 173.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -57.59 140.93 49.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.377 . . . . 15.0 110.641 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.55 175.18 31.26 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.826 -0.91 . . . . 15.0 110.826 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.42 -33.02 65.42 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.163 -0.215 . . . . 15.0 111.424 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.7 176.27 32.65 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.674 -0.97 . . . . 15.0 110.674 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.98 120.66 5.55 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.951 -0.642 . . . . 15.0 111.519 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -57.01 -41.39 78.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.803 0.335 . . . . 15.0 110.575 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -62.23 -41.93 98.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.426 . . . . 15.0 111.229 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -63.42 -55.88 20.76 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.793 -0.363 . . . . 15.0 111.345 -176.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.0 mt -59.55 -43.69 93.45 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.724 -0.39 . . . . 15.0 110.967 -176.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.503 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -62.55 -40.24 96.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 15.0 110.812 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.89 -41.92 92.67 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.962 -0.295 . . . . 15.0 110.505 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -60.0 -51.74 68.36 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.591 -0.443 . . . . 15.0 110.999 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.471 HD13 HG21 ' A' ' 5' ' ' VAL . 80.6 mt -62.46 -37.53 86.29 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.497 -0.481 . . . . 15.0 111.103 -178.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -63.32 -44.26 95.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.554 0.216 . . . . 15.0 110.929 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.18 -30.58 67.55 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.019 -0.61 . . . . 15.0 111.92 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -88.09 10.08 20.44 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.556 0.947 . . . . 15.0 113.556 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.09 18.82 41.66 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 121.109 -0.567 . . . . 15.0 113.351 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.3 t -101.02 139.97 20.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 117.665 0.732 . . . . 15.0 110.19 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -82.22 126.0 31.58 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.865 -0.791 . . . . 15.0 108.865 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.57 ' CG1' HD11 ' A' ' 7' ' ' ILE . 42.3 t -116.02 130.93 69.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.314 0.578 . . . . 15.0 111.331 -171.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -137.23 133.56 35.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.274 -0.875 . . . . 15.0 109.439 170.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.402 ' HB3' HD12 ' A' ' 7' ' ' ILE . 36.4 p90 -114.08 135.85 53.57 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.92 0.391 . . . . 15.0 110.857 -178.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 tp -116.16 113.3 41.51 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.632 -0.699 . . . . 15.0 110.194 -176.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.0 135.12 50.94 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.159 1.239 . . . . 15.0 112.09 174.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.65 -9.2 3.56 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.325 0.861 . . . . 15.0 113.325 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -77.15 -6.03 51.33 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.184 0.809 . . . . 15.0 113.184 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -64.62 150.11 94.49 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 118.512 0.596 . . . . 15.0 110.378 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -80.04 154.93 22.74 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.544 1.496 . . . . 15.0 113.27 -177.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.72 152.1 3.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.883 -0.599 . . . . 15.0 111.362 -178.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.23 -37.95 3.26 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.611 -0.596 . . . . 15.0 111.611 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -61.23 -36.52 80.17 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.607 -0.437 . . . . 15.0 111.184 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.558 ' O ' HG23 ' A' ' 44' ' ' VAL . 25.4 tp -59.16 -48.83 80.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.965 0.412 . . . . 15.0 110.228 -178.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.451 HD22 ' CG ' ' A' ' 70' ' ' ASP . 23.1 tp -62.73 -44.25 96.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 15.0 110.988 -175.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.08 -44.84 95.79 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.67 -0.412 . . . . 15.0 110.907 -176.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.408 ' CD ' HD13 ' A' ' 6' ' ' LEU . 60.0 ttm-85 -60.79 -41.87 96.46 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 121.01 -0.276 . . . . 15.0 110.713 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 40' ' ' LEU . 98.4 t -60.68 -45.78 96.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.835 -0.346 . . . . 15.0 110.111 -177.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -70.52 -46.86 62.83 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.1 0.408 . . . . 15.0 112.1 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.49 -44.44 82.62 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.047 -0.261 . . . . 15.0 111.442 -175.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -81.15 -10.16 59.69 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.124 0.787 . . . . 15.0 113.124 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 54.66 55.89 7.4 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.582 0.706 . . . . 15.0 110.483 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.4 mt -69.94 150.63 46.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.618 -0.719 . . . . 15.0 111.546 -175.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -95.25 -40.51 9.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.162 -0.926 . . . . 15.0 110.767 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -149.7 165.36 29.62 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 119.955 -1.117 . . . . 15.0 113.75 -174.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 70.7 mt -126.09 142.57 51.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.489 -0.856 . . . . 15.0 109.575 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.518 HG22 ' CD1' ' A' ' 80' ' ' PHE . 46.2 t -121.39 130.18 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.682 0.277 . . . . 15.0 110.777 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.7 m -128.1 155.68 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.02 0.438 . . . . 15.0 110.575 171.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.3 t -131.34 14.4 5.06 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.681 -0.691 . . . . 15.0 112.408 176.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.6 p -155.0 149.35 26.16 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.267 0.556 . . . . 15.0 111.548 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.89 -40.18 92.74 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.61 -0.996 . . . . 15.0 110.61 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -58.57 -41.4 85.57 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.916 -0.314 . . . . 15.0 110.473 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.91 -47.15 92.67 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.774 -0.93 . . . . 15.0 110.774 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.413 HD21 ' HA ' ' A' ' 90' ' ' ALA . 27.1 tp -57.06 -44.43 83.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.109 0.48 . . . . 15.0 110.653 -178.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.78 -43.59 98.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.032 -0.531 . . . . 15.0 110.822 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -59.36 -38.93 81.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 15.0 110.767 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.487 HD13 ' SD ' ' A' ' 8' ' ' MET . 13.2 tp -57.48 -44.81 85.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.247 0.546 . . . . 15.0 110.172 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -60.68 -47.15 87.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.675 -0.693 . . . . 15.0 110.468 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -61.97 -43.94 97.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 15.0 111.31 -176.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.57 -35.24 79.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.367 -0.379 . . . . 15.0 111.358 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.67 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.42 -38.78 81.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.939 0.4 . . . . 15.0 110.646 178.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.11 -143.72 0.59 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.58 -0.526 . . . . 15.0 109.58 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.47 -18.14 37.23 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.417 1.008 . . . . 15.0 112.654 -175.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.451 ' CG ' HD22 ' A' ' 41' ' ' LEU . 27.8 m-20 -91.79 9.61 31.94 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.341 0.867 . . . . 15.0 113.341 -175.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 59.2 t-105 -47.85 -47.35 63.14 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-O 118.629 -0.701 . . . . 15.0 112.546 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -44.78 -40.76 14.77 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 121.482 1.455 . . . . 15.0 113.199 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -76.97 -48.79 17.07 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.044 0.45 . . . . 15.0 110.741 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.67 HD12 ' HB1' ' A' ' 67' ' ' ALA . 92.8 mt -59.59 -39.93 80.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.025 -0.534 . . . . 15.0 110.925 -176.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.51 -15.82 33.9 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 119.944 -0.364 . . . . 15.0 113.116 -176.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -65.87 -30.03 70.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.387 0.593 . . . . 15.0 112.016 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.7 mt -74.49 150.62 87.06 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 111.638 0.236 . . . . 15.0 111.638 -172.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.97 123.58 13.2 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.599 1.533 . . . . 15.0 112.026 176.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.8 tp -103.35 123.44 46.82 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.804 -0.358 . . . . 15.0 110.426 174.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.518 ' CD1' HG22 ' A' ' 53' ' ' VAL . 76.5 m-85 -89.38 123.38 33.48 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.057 -0.72 . . . . 15.0 109.057 175.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.738 HG21 ' HB2' ' A' ' 87' ' ' ALA . 25.3 m -112.25 151.82 43.99 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 110.341 -0.244 . . . . 15.0 110.341 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.0 -28.65 3.76 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.414 1.409 . . . . 15.0 113.1 -175.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.4 p -144.39 167.91 13.8 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 120.656 -0.418 . . . . 15.0 111.537 -173.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -60.42 -44.0 30.42 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 121.228 1.286 . . . . 15.0 111.6 177.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -57.0 -47.99 79.52 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.88 -0.328 . . . . 15.0 110.777 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.55 -40.07 83.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.604 -0.438 . . . . 15.0 110.027 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.738 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.01 -41.71 79.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.928 0.394 . . . . 15.0 110.545 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.27 -41.32 96.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.218 -0.447 . . . . 15.0 110.529 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 87.3 mtp -59.57 -44.04 93.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.307 0.575 . . . . 15.0 110.384 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.413 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.5 -40.52 94.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.858 -0.61 . . . . 15.0 110.791 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -61.15 -45.04 96.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.278 -0.419 . . . . 15.0 110.435 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.68 -36.2 76.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.508 -0.315 . . . . 15.0 111.298 -177.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.82 -26.47 68.35 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.108 0.41 . . . . 15.0 112.108 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.21 13.16 10.14 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 119.281 -0.733 . . . . 15.0 113.177 -176.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.9 121.82 11.45 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.597 1.198 . . . . 15.0 109.691 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -71.61 -39.75 70.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.519 -0.764 . . . . 15.0 110.617 -171.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.47 ' NH2' ' HB1' ' A' ' 116' ' ' ALA . 52.8 ttp85 -132.09 113.9 13.9 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.453 0.644 . . . . 15.0 110.832 178.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.2 t -114.43 133.28 61.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.645 -0.707 . . . . 15.0 110.264 -176.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 87.6 mt -117.54 126.42 74.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.677 -0.692 . . . . 15.0 110.244 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -96.26 117.48 30.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.452 -0.34 . . . . 15.0 110.519 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 30.3 p -69.67 -20.32 63.57 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.574 0.583 . . . . 15.0 112.574 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -53.21 -36.97 61.57 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 122.113 -0.367 . . . . 15.0 111.508 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.27 -35.18 8.19 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 120.824 -0.703 . . . . 15.0 111.648 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -92.18 120.92 33.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.766 0.317 . . . . 15.0 111.121 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.485 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 49.9 m -70.44 165.85 21.65 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.433 -0.58 . . . . 15.0 109.433 174.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.55 -54.4 22.85 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 112.776 0.658 . . . . 15.0 112.776 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -57.49 -34.96 98.84 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 120.9 1.067 . . . . 15.0 111.4 176.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 105' ' ' SER . . . -61.14 -40.8 95.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.842 0.353 . . . . 15.0 110.365 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.2 mt -58.97 -41.79 88.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.015 0.435 . . . . 15.0 110.169 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.5 tp -57.23 -45.15 84.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.488 0.661 . . . . 15.0 110.169 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.46 91.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.505 -0.77 . . . . 15.0 110.817 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.97 -42.47 98.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.578 -0.283 . . . . 15.0 110.815 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.6 mt -57.94 -52.25 66.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.397 0.617 . . . . 15.0 110.463 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.7 p -66.32 -38.36 87.53 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.454 -0.794 . . . . 15.0 111.656 -174.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.3 p -67.65 -38.19 83.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.709 0.29 . . . . 15.0 111.322 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.47 ' HB1' ' NH2' ' A' ' 97' ' ' ARG . . . -62.7 -40.57 97.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.423 -0.353 . . . . 15.0 110.827 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.395 -0.366 . . . . 15.0 110.797 178.345 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 110.29 -0.263 . . . . 15.0 110.29 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.42 ' HG2' HG22 ' A' ' 26' ' ' VAL . 17.2 Cg_endo -55.58 154.98 22.91 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 121.439 1.426 . . . . 15.0 111.696 -176.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.462 ' HB2' HD23 ' A' ' 49' ' ' LEU . 97.9 mttt -111.98 140.11 46.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.582 -0.281 . . . . 15.0 110.815 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.443 HG21 HD13 ' A' ' 21' ' ' LEU . 15.9 m -136.17 143.92 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.647 0.737 . . . . 15.0 111.818 175.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.1 tp -105.07 136.75 43.97 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.924 -1.034 . . . . 15.0 110.245 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.633 HD11 ' CG1' ' A' ' 28' ' ' VAL . 51.0 mt -104.61 135.14 43.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.096 0.474 . . . . 15.0 111.067 -177.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.511 ' HB2' HG12 ' A' ' 54' ' ' VAL . 99.0 mmm -94.89 134.04 37.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.134 -0.939 . . . . 15.0 109.364 172.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -66.28 145.07 56.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.937 0.398 . . . . 15.0 110.554 -178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -161.08 175.22 37.74 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.76 -0.936 . . . . 15.0 110.76 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -51.29 -31.2 20.58 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.847 0.314 . . . . 15.0 111.847 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.99 -174.02 1.74 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.938 -0.865 . . . . 15.0 110.938 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -108.4 109.58 2.9 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.49 -0.644 . . . . 15.0 111.49 -177.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.3 mtm-85 -55.2 -38.85 68.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.645 0.26 . . . . 15.0 111.035 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -59.87 -54.98 39.84 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.067 0.395 . . . . 15.0 112.067 -172.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -69.95 -45.09 68.18 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.274 -0.57 . . . . 15.0 111.435 -173.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.1 tp -58.12 -44.84 87.96 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 120.491 -0.484 . . . . 15.0 110.589 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.412 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -62.75 -42.5 99.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 15.0 110.44 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -57.96 -40.46 80.65 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.931 -0.308 . . . . 15.0 110.562 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -59.08 -51.64 69.19 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.959 0.409 . . . . 15.0 111.042 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.443 HD13 HG21 ' A' ' 5' ' ' VAL . 77.7 mt -59.81 -37.32 78.81 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.567 -0.453 . . . . 15.0 110.887 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -62.95 -41.97 99.68 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 121.107 -0.237 . . . . 15.0 111.119 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.25 -30.56 67.75 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 120.981 -0.628 . . . . 15.0 111.966 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -88.18 9.57 22.42 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.557 0.947 . . . . 15.0 113.557 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.32 15.42 58.78 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 121.23 -0.509 . . . . 15.0 113.393 175.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.42 HG22 ' HG2' ' A' ' 3' ' ' PRO . 43.9 t -101.04 137.84 27.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 117.917 0.858 . . . . 15.0 110.209 178.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -81.17 129.92 34.79 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.367 -0.605 . . . . 15.0 109.367 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.633 ' CG1' HD11 ' A' ' 7' ' ' ILE . 42.4 t -120.11 132.23 70.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.241 0.543 . . . . 15.0 111.192 -173.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -139.18 135.22 33.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.391 -0.822 . . . . 15.0 109.731 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.432 ' HB3' HD12 ' A' ' 7' ' ' ILE . 32.0 p90 -114.8 138.78 50.35 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.775 0.322 . . . . 15.0 110.553 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.0 tp -114.85 113.43 44.49 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 118.756 -0.64 . . . . 15.0 110.896 -173.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -49.88 135.07 35.89 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.158 1.238 . . . . 15.0 111.886 172.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.669 HD13 ' OD1' ' A' ' 62' ' ' ASN . 58.1 mt -66.79 -11.13 53.98 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.216 0.821 . . . . 15.0 113.216 -174.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -77.31 -9.4 58.8 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.169 0.803 . . . . 15.0 113.169 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -65.28 148.02 98.22 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 118.502 0.592 . . . . 15.0 110.544 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.34 148.74 43.93 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.565 1.51 . . . . 15.0 113.58 -174.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.93 152.52 3.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.465 -0.789 . . . . 15.0 111.228 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.2 -38.15 3.21 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.497 -0.641 . . . . 15.0 111.497 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -64.16 -36.38 83.86 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 120.426 -0.51 . . . . 15.0 111.12 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.547 HD21 ' CD1' ' A' ' 63' ' ' LEU . 24.5 tp -58.66 -45.97 88.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.896 0.379 . . . . 15.0 110.196 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.497 HD22 ' CG ' ' A' ' 70' ' ' ASP . 16.8 tp -63.49 -45.57 90.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 15.0 110.902 -177.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.78 99.25 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.784 -0.367 . . . . 15.0 110.859 -177.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -60.99 -44.14 97.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.428 -0.351 . . . . 15.0 110.511 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 40' ' ' LEU . 67.3 t -61.5 -46.1 97.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.935 -0.306 . . . . 15.0 110.252 -177.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 70.7 ttp85 -68.53 -48.07 65.28 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.984 0.364 . . . . 15.0 111.984 -176.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.09 -44.47 84.28 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.1 -0.24 . . . . 15.0 111.512 -173.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -81.99 -10.01 59.38 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.249 0.833 . . . . 15.0 113.249 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 55.86 55.82 6.64 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.607 0.718 . . . . 15.0 110.336 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.484 HD12 HG22 ' A' ' 44' ' ' VAL . 95.5 mt -63.53 146.09 54.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.601 -0.727 . . . . 15.0 111.426 -174.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -87.72 -39.76 14.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.982 -1.008 . . . . 15.0 110.685 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.52 166.39 30.7 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.045 -1.074 . . . . 15.0 113.639 -174.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.1 mt -125.91 142.08 51.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.507 -0.846 . . . . 15.0 109.612 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.519 HG22 ' CD1' ' A' ' 80' ' ' PHE . 48.0 t -121.47 131.37 73.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.282 -0.266 . . . . 15.0 110.282 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.511 HG12 ' HB2' ' A' ' 8' ' ' MET . 6.5 m -125.69 130.44 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.009 0.433 . . . . 15.0 110.216 172.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.7 p -92.81 -10.86 35.3 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.915 0.709 . . . . 15.0 112.915 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 82.8 p -152.52 157.6 41.33 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 121.271 0.558 . . . . 15.0 111.561 -176.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.78 -38.92 85.94 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.962 -0.855 . . . . 15.0 110.962 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -58.97 -43.93 91.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.777 0.322 . . . . 15.0 110.416 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.3 -44.84 97.09 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.784 -0.926 . . . . 15.0 110.784 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.587 HD13 HD21 ' A' ' 79' ' ' LEU . 32.9 tp -57.7 -44.61 85.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.095 0.474 . . . . 15.0 110.531 -178.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.26 -42.23 98.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.063 -0.517 . . . . 15.0 110.64 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.669 ' OD1' HD13 ' A' ' 33' ' ' LEU . 28.0 m120 -58.99 -39.91 83.23 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.834 -0.346 . . . . 15.0 110.628 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.547 ' CD1' HD21 ' A' ' 40' ' ' LEU . 12.5 tp -58.23 -44.83 88.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.181 0.515 . . . . 15.0 110.109 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -61.6 -47.22 86.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.697 -0.683 . . . . 15.0 110.787 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -61.91 -43.86 97.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 15.0 111.185 -176.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.3 mt -66.3 -34.98 79.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.351 -0.386 . . . . 15.0 111.387 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.674 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.0 -39.17 81.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.126 0.489 . . . . 15.0 110.581 177.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.16 -143.3 0.6 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 109.609 -0.515 . . . . 15.0 109.609 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.44 -19.09 44.88 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.391 0.996 . . . . 15.0 112.608 -175.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.497 ' CG ' HD22 ' A' ' 41' ' ' LEU . 22.3 m-20 -91.91 10.44 28.78 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.297 0.851 . . . . 15.0 113.297 -175.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -47.81 -46.9 63.15 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-O 118.666 -0.683 . . . . 15.0 112.494 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -44.68 -40.43 14.15 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.483 1.455 . . . . 15.0 113.283 177.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -77.0 -48.73 17.17 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.691 -0.404 . . . . 15.0 110.803 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.674 HD12 ' HB1' ' A' ' 67' ' ' ALA . 91.5 mt -59.63 -39.73 80.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 15.0 110.83 -177.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.2 -16.44 34.08 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 116.334 -0.394 . . . . 15.0 113.124 -177.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -64.73 -30.3 71.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 117.365 0.582 . . . . 15.0 111.959 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 27.5 mt -76.45 150.59 82.51 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 120.903 -0.319 . . . . 15.0 111.312 -173.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.4 129.54 28.59 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.63 1.554 . . . . 15.0 112.473 176.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.587 HD21 HD13 ' A' ' 60' ' ' LEU . 24.0 tp -107.78 126.26 52.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.448 -0.342 . . . . 15.0 110.605 175.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.519 ' CD1' HG22 ' A' ' 53' ' ' VAL . 78.7 m-85 -90.97 126.09 35.97 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.721 -0.474 . . . . 15.0 109.721 176.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.676 HG21 ' HB2' ' A' ' 87' ' ' ALA . 29.0 m -117.47 147.15 40.08 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 110.079 -0.341 . . . . 15.0 110.079 176.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.15 -23.25 7.81 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.639 1.56 . . . . 15.0 113.598 -174.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.417 ' OG ' HG23 ' A' ' 86' ' ' VAL . 24.5 p -143.51 158.15 57.8 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 120.737 -0.385 . . . . 15.0 111.33 -172.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.29 -43.95 53.03 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.238 1.292 . . . . 15.0 111.792 176.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -58.11 -47.37 83.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.779 0.323 . . . . 15.0 110.931 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.417 HG23 ' OG ' ' A' ' 83' ' ' SER . 60.8 t -59.89 -40.24 82.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.75 -0.38 . . . . 15.0 110.036 178.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.676 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.36 -42.46 82.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.962 0.41 . . . . 15.0 110.422 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.09 -41.87 97.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.144 -0.48 . . . . 15.0 110.506 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 87.1 mtp -59.29 -43.88 92.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.227 0.537 . . . . 15.0 110.353 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.44 94.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.963 -0.562 . . . . 15.0 110.801 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -61.31 -44.36 97.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.298 -0.41 . . . . 15.0 110.629 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.17 -36.1 76.84 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.857 -0.337 . . . . 15.0 111.234 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.8 mt -64.3 -25.69 68.16 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.942 0.349 . . . . 15.0 111.942 176.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.43 13.25 15.26 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 119.314 -0.714 . . . . 15.0 113.095 -176.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.88 121.95 11.75 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 118.566 1.183 . . . . 15.0 109.888 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -69.5 -35.09 75.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.668 -0.696 . . . . 15.0 111.328 -171.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.1 tpt85 -131.79 114.5 14.79 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.957 0.408 . . . . 15.0 110.082 177.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.1 t -110.85 130.25 64.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.045 0.45 . . . . 15.0 109.851 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 85.2 mt -119.61 124.95 73.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.818 -0.628 . . . . 15.0 110.053 -176.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -95.33 117.32 30.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.435 -0.348 . . . . 15.0 110.302 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.9 p -97.05 -1.55 45.15 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.182 0.808 . . . . 15.0 113.182 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 46.9 tpt85 -55.67 -39.7 71.31 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.184 0.447 . . . . 15.0 110.665 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.01 -35.17 5.41 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.53 -0.628 . . . . 15.0 111.53 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.18 140.2 52.49 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.879 0.371 . . . . 15.0 110.651 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.9 p -86.12 163.75 17.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.065 -0.516 . . . . 15.0 110.508 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.71 -54.39 23.63 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 113.0 0.741 . . . . 15.0 113.0 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.29 -35.04 99.11 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 CA-C-N 120.163 1.094 . . . . 15.0 111.63 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.07 -43.4 95.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.091 0.472 . . . . 15.0 110.012 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 76.1 mt -59.36 -40.74 87.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 15.0 110.406 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 33.8 tp -57.2 -43.82 83.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.33 0.586 . . . . 15.0 110.229 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.52 -41.8 95.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.683 -0.69 . . . . 15.0 110.487 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.28 -40.38 90.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 15.0 110.761 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.0 mt -57.81 -51.8 68.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.267 0.556 . . . . 15.0 110.383 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.6 p -63.79 -40.06 95.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.59 -0.732 . . . . 15.0 111.324 -175.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.1 m -62.38 -44.31 96.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.676 0.274 . . . . 15.0 111.426 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.4 -38.25 88.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.432 -0.349 . . . . 15.0 111.156 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.451 -0.34 . . . . 15.0 111.255 179.315 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 CA--C 1.535 0.382 0 N-CA-C 110.34 -0.244 . . . . 15.0 110.34 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -49.87 152.31 7.3 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.387 1.391 . . . . 15.0 111.776 -176.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -117.77 137.88 52.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.354 -0.385 . . . . 15.0 110.385 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.613 HG21 HD13 ' A' ' 21' ' ' LEU . 15.7 m -134.77 146.04 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.501 0.667 . . . . 15.0 111.826 177.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.571 ' HB2' HD13 ' A' ' 49' ' ' LEU . 13.6 tp -104.37 135.55 45.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.048 -0.978 . . . . 15.0 110.318 178.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.486 HD11 ' CG1' ' A' ' 28' ' ' VAL . 55.0 mt -103.59 135.02 43.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.407 . . . . 15.0 110.439 -177.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.577 ' CE ' HD21 ' A' ' 33' ' ' LEU . 88.3 mtp -100.15 134.06 43.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.731 -0.668 . . . . 15.0 110.332 174.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -58.24 141.69 50.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.376 -0.375 . . . . 15.0 110.624 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.0 175.14 34.57 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.045 -0.822 . . . . 15.0 111.045 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -54.98 -33.86 62.87 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.549 0.203 . . . . 15.0 111.549 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.9 -179.69 4.76 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.954 -0.859 . . . . 15.0 110.954 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.02 114.31 3.93 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.224 -0.75 . . . . 15.0 111.224 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -55.85 -47.23 77.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.323 0.583 . . . . 15.0 110.339 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.95 -41.38 97.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.739 -0.664 . . . . 15.0 110.839 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -56.51 -55.83 28.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.766 0.317 . . . . 15.0 111.18 -175.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.461 ' H ' HD12 ' A' ' 17' ' ' LEU . 6.1 mp -59.99 -42.38 94.1 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.665 -0.414 . . . . 15.0 111.064 -176.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.63 -45.74 91.07 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.643 -0.423 . . . . 15.0 111.447 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.29 -40.99 92.4 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.769 -0.372 . . . . 15.0 110.527 -178.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -58.52 -51.51 69.59 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.589 -0.445 . . . . 15.0 111.126 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.613 HD13 HG21 ' A' ' 5' ' ' VAL . 76.8 mt -63.99 -38.2 90.22 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.436 -0.505 . . . . 15.0 111.262 -176.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -65.28 -40.45 93.9 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 120.521 -0.472 . . . . 15.0 111.254 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.03 -30.57 70.44 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.972 -0.632 . . . . 15.0 112.095 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -88.33 10.03 21.25 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.571 0.952 . . . . 15.0 113.571 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.54 16.41 60.28 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 121.286 -0.483 . . . . 15.0 113.265 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.7 t -101.08 138.85 23.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 117.824 0.812 . . . . 15.0 109.877 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -79.12 133.37 36.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.494 -0.558 . . . . 15.0 109.494 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.486 ' CG1' HD11 ' A' ' 7' ' ' ILE . 45.1 t -118.37 130.37 73.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.173 0.511 . . . . 15.0 111.117 -173.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.424 ' O ' HD12 ' A' ' 6' ' ' LEU . 22.8 t70 -135.35 124.74 24.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.419 -0.809 . . . . 15.0 109.442 170.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.416 ' HB3' HD12 ' A' ' 7' ' ' ILE . 15.2 p90 -112.79 134.16 54.44 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.857 0.361 . . . . 15.0 110.833 -177.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.1 tp -114.3 139.44 23.83 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.042 -0.527 . . . . 15.0 109.937 -176.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -72.08 136.22 26.67 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 121.409 1.406 . . . . 15.0 111.822 171.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.577 HD21 ' CE ' ' A' ' 8' ' ' MET . 19.8 mt -57.89 -12.73 3.42 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.368 0.877 . . . . 15.0 113.368 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -77.22 -5.05 47.79 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.467 0.914 . . . . 15.0 113.467 -175.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -68.06 145.59 97.76 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 118.559 0.618 . . . . 15.0 110.784 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.96 159.09 30.87 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.685 1.59 . . . . 15.0 113.479 -176.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.26 151.52 2.83 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.727 -0.669 . . . . 15.0 111.62 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.14 -36.98 3.58 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.397 -0.681 . . . . 15.0 111.397 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -60.02 -37.05 78.62 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.613 -0.435 . . . . 15.0 110.972 -178.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.567 ' O ' HG23 ' A' ' 44' ' ' VAL . 26.3 tp -58.5 -47.13 85.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.022 0.439 . . . . 15.0 110.253 -177.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.62 HD22 ' OD2' ' A' ' 70' ' ' ASP . 9.1 tp -61.87 -44.68 96.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 15.0 110.745 -177.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.18 97.22 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.682 -0.407 . . . . 15.0 111.018 -176.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -60.96 -41.53 96.51 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.815 -0.354 . . . . 15.0 110.672 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 40' ' ' LEU . 99.5 t -60.53 -47.31 93.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.809 -0.356 . . . . 15.0 110.262 -176.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -72.27 -47.65 48.53 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.461 0.541 . . . . 15.0 112.461 -175.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.69 -44.31 82.06 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.051 -0.26 . . . . 15.0 111.557 -174.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -81.78 -10.03 59.46 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.105 0.78 . . . . 15.0 113.105 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 56.64 55.87 6.02 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.593 0.711 . . . . 15.0 110.164 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.571 HD13 ' HB2' ' A' ' 6' ' ' LEU . 94.9 mt -77.9 142.53 38.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.667 -0.697 . . . . 15.0 111.364 -176.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.551 ' O ' HD22 ' A' ' 77' ' ' LEU . 9.3 m120 -90.76 -40.65 11.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.55 -0.75 . . . . 15.0 110.64 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.66 167.01 28.72 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 119.908 -1.139 . . . . 15.0 113.396 -171.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 71.4 mt -126.96 146.91 50.15 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.889 -0.656 . . . . 15.0 110.312 -178.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.538 HG22 ' CD1' ' A' ' 80' ' ' PHE . 47.5 t -122.77 131.48 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.544 0.211 . . . . 15.0 110.495 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 m -124.85 146.99 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.125 0.488 . . . . 15.0 110.735 173.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 t -100.81 -15.98 17.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.535 -0.757 . . . . 15.0 112.835 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.0 p -156.31 161.28 40.21 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-O 121.437 0.637 . . . . 15.0 111.901 -175.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.18 -37.67 73.63 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.056 -0.818 . . . . 15.0 111.056 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -59.25 -44.53 92.37 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.932 -0.307 . . . . 15.0 110.709 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.29 -43.68 98.29 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.611 -0.996 . . . . 15.0 110.611 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.546 HD21 ' HA ' ' A' ' 90' ' ' ALA . 14.3 tp -57.05 -45.82 82.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.153 0.502 . . . . 15.0 110.596 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.35 -43.74 98.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.117 -0.492 . . . . 15.0 110.569 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.573 ' CB ' HD22 ' A' ' 33' ' ' LEU . 18.9 m120 -59.77 -38.91 83.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 15.0 110.647 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.495 HD13 ' SD ' ' A' ' 8' ' ' MET . 14.4 tp -57.06 -44.32 82.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.124 0.488 . . . . 15.0 110.161 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -60.24 -47.61 85.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.809 -0.632 . . . . 15.0 110.459 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -61.85 -43.15 99.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.945 -0.571 . . . . 15.0 111.137 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.84 -35.3 79.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.443 -0.344 . . . . 15.0 111.49 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.68 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.44 -38.51 80.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.955 0.407 . . . . 15.0 110.75 178.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.28 -144.09 0.57 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 109.541 -0.54 . . . . 15.0 109.541 174.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.87 -18.56 45.43 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.357 0.981 . . . . 15.0 112.64 -174.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.62 ' OD2' HD22 ' A' ' 41' ' ' LEU . 77.7 m-20 -91.95 10.45 28.84 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.327 0.862 . . . . 15.0 113.327 -175.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -47.74 -47.32 62.01 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 118.69 -0.672 . . . . 15.0 112.586 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -44.81 -40.11 14.35 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.458 1.439 . . . . 15.0 113.233 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -76.94 -48.77 17.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.023 0.439 . . . . 15.0 110.725 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.68 HD12 ' HB1' ' A' ' 67' ' ' ALA . 92.2 mt -59.25 -40.59 81.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 15.0 110.839 -177.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.41 -14.47 34.46 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-N 116.269 -0.423 . . . . 15.0 113.23 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -66.18 -29.8 70.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.415 0.607 . . . . 15.0 112.076 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.551 HD22 ' O ' ' A' ' 50' ' ' ASN . 21.9 mt -74.72 145.11 81.3 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-O 119.252 -0.404 . . . . 15.0 110.953 -174.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -60.0 129.54 30.78 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.446 1.431 . . . . 15.0 111.756 174.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.1 tp -106.34 128.16 53.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.609 -0.269 . . . . 15.0 110.852 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.538 ' CD1' HG22 ' A' ' 53' ' ' VAL . 80.8 m-85 -91.01 126.12 36.0 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.618 -0.512 . . . . 15.0 109.618 176.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.667 HG21 ' HB2' ' A' ' 87' ' ' ALA . 28.7 m -119.43 147.52 43.54 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 110.085 -0.339 . . . . 15.0 110.085 176.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.23 -23.23 7.73 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.471 1.447 . . . . 15.0 113.636 -174.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.9 p -143.36 161.11 49.11 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 120.62 -0.432 . . . . 15.0 111.563 -172.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -54.91 -44.11 52.88 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.2 1.267 . . . . 15.0 111.889 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -58.82 -46.75 86.9 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.895 -0.322 . . . . 15.0 110.973 -177.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.4 t -60.13 -40.3 83.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.737 -0.385 . . . . 15.0 110.066 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.667 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.61 -42.31 83.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.0 0.429 . . . . 15.0 110.469 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.92 -40.47 93.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.176 -0.466 . . . . 15.0 110.592 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.1 mmm -58.26 -44.99 88.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.447 0.641 . . . . 15.0 110.159 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.546 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.76 -40.64 95.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.642 -0.708 . . . . 15.0 110.825 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -61.64 -44.43 96.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.385 -0.37 . . . . 15.0 110.755 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -60.29 -36.19 77.28 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.872 -0.331 . . . . 15.0 111.262 -177.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 77.0 mt -66.0 -23.87 66.66 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.303 0.483 . . . . 15.0 112.303 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.69 13.28 16.88 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.399 -0.667 . . . . 15.0 113.177 -176.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.81 122.03 11.91 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.481 1.14 . . . . 15.0 109.905 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -67.62 -36.54 81.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.541 -0.754 . . . . 15.0 111.059 -171.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -131.82 117.88 19.13 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.923 0.392 . . . . 15.0 110.62 177.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.2 t -114.65 129.94 69.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.008 0.432 . . . . 15.0 109.952 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 90.5 mt -119.27 122.19 68.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.87 -0.604 . . . . 15.0 110.125 -177.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -92.53 117.7 30.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.483 -0.326 . . . . 15.0 110.166 175.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 104' ' ' ALA . 31.8 p -95.69 -3.52 45.9 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.232 0.827 . . . . 15.0 113.232 -178.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -55.88 -40.04 72.4 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.287 0.494 . . . . 15.0 110.699 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -95.59 -35.01 5.8 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.463 -0.655 . . . . 15.0 111.463 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.416 ' HB3' ' HA ' ' A' ' 101' ' ' CYS . . . -73.29 143.77 46.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.791 0.329 . . . . 15.0 110.466 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 65.1 m -89.77 160.75 16.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.228 -0.442 . . . . 15.0 110.567 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.67 -54.24 24.56 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.973 0.731 . . . . 15.0 112.973 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.62 -34.54 98.26 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 CA-C-N 120.318 1.149 . . . . 15.0 111.524 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.03 -42.66 94.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.065 0.46 . . . . 15.0 109.985 176.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 78.3 mt -59.04 -39.98 83.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 15.0 110.489 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 33.7 tp -56.85 -44.85 82.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.547 0.689 . . . . 15.0 110.144 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.4 -40.4 90.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.518 -0.765 . . . . 15.0 110.568 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.2 -42.49 95.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.319 -0.4 . . . . 15.0 110.782 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.1 mt -58.05 -49.16 77.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.031 0.443 . . . . 15.0 110.421 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.4 p -62.51 -40.71 97.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.897 -0.592 . . . . 15.0 111.274 -175.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.9 p -65.99 -39.88 90.72 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.969 -0.292 . . . . 15.0 111.349 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.25 -39.01 93.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.666 0.27 . . . . 15.0 111.117 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.433 -0.349 . . . . 15.0 111.252 178.961 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 110.285 -0.265 . . . . 15.0 110.285 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.94 155.06 8.98 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.347 1.364 . . . . 15.0 111.734 -177.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.464 ' HB2' HD23 ' A' ' 49' ' ' LEU . 55.5 mttm -114.26 140.74 48.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.412 -0.358 . . . . 15.0 110.837 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.559 HG21 HD13 ' A' ' 21' ' ' LEU . 10.6 m -136.55 144.94 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.598 0.714 . . . . 15.0 111.568 176.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.8 tp -105.69 134.18 49.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.943 -1.026 . . . . 15.0 110.518 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.613 HD11 ' CG1' ' A' ' 28' ' ' VAL . 44.4 mt -100.79 135.12 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.315 -0.402 . . . . 15.0 110.291 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 82.4 mtp -101.75 132.62 47.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.1 -0.5 . . . . 15.0 110.098 171.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -57.74 147.1 28.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.217 0.532 . . . . 15.0 111.564 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.49 175.19 40.55 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.615 -0.994 . . . . 15.0 110.615 -178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -51.94 -32.61 33.79 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.748 0.277 . . . . 15.0 111.748 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.68 170.29 18.24 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.855 -0.898 . . . . 15.0 110.855 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.95 125.18 7.07 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.35 -0.7 . . . . 15.0 111.35 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -57.09 -46.46 82.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.961 0.41 . . . . 15.0 110.482 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -64.05 -40.83 97.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.974 -0.557 . . . . 15.0 111.318 -175.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -61.8 -55.98 24.33 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.775 -0.37 . . . . 15.0 111.427 -176.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.683 HD21 HG11 ' A' ' 53' ' ' VAL . 28.5 tp -61.07 -45.4 94.89 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.687 -0.405 . . . . 15.0 111.192 -175.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.2 -39.72 95.42 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.669 -0.412 . . . . 15.0 110.82 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -60.75 -41.6 95.72 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.905 -0.318 . . . . 15.0 110.576 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.445 ' HD3' ' HB2' ' A' ' 106' ' ' ALA . 38.2 ttm180 -59.65 -51.76 68.41 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 120.686 -0.406 . . . . 15.0 111.241 -178.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.559 HD13 HG21 ' A' ' 5' ' ' VAL . 88.2 mt -63.86 -36.99 85.74 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.478 -0.489 . . . . 15.0 111.062 -178.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -63.54 -42.77 98.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.625 0.25 . . . . 15.0 111.088 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.21 -30.56 67.61 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.119 -0.563 . . . . 15.0 111.987 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -88.04 9.96 20.7 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.559 0.948 . . . . 15.0 113.559 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.26 15.04 56.52 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 121.22 -0.514 . . . . 15.0 113.494 173.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.7 t -101.06 136.18 33.9 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 117.972 0.886 . . . . 15.0 110.072 177.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -77.67 129.63 35.8 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.9 -0.778 . . . . 15.0 108.9 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.613 ' CG1' HD11 ' A' ' 7' ' ' ILE . 22.7 t -123.07 134.13 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.207 0.527 . . . . 15.0 111.468 -171.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -139.4 139.81 37.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.363 -0.835 . . . . 15.0 109.714 172.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.425 ' HB3' HD12 ' A' ' 7' ' ' ILE . 27.8 p90 -114.13 136.08 53.32 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.883 0.373 . . . . 15.0 110.891 -178.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.8 tp -113.81 121.18 37.6 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-O 118.705 -0.664 . . . . 15.0 110.314 -175.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.25 135.03 67.83 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 CA-C-N 120.337 1.156 . . . . 15.0 112.223 173.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.424 HD13 ' OD1' ' A' ' 62' ' ' ASN . 74.9 mt -62.43 -16.72 56.67 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.973 0.731 . . . . 15.0 112.973 -178.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -77.18 -5.06 47.72 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.43 0.9 . . . . 15.0 113.43 -175.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -69.84 148.92 96.59 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 118.545 0.611 . . . . 15.0 110.837 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.43 149.69 50.74 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.573 1.515 . . . . 15.0 113.864 -173.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.23 152.58 4.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.258 -0.883 . . . . 15.0 111.265 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.62 -38.1 3.22 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 115.837 -0.619 . . . . 15.0 111.636 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -63.71 -36.61 84.42 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.392 -0.523 . . . . 15.0 111.16 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.571 ' O ' HG23 ' A' ' 44' ' ' VAL . 24.9 tp -59.1 -47.01 86.83 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.86 -0.336 . . . . 15.0 110.174 -178.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.488 HD13 HD11 ' A' ' 74' ' ' ILE . 17.6 tp -63.35 -45.76 89.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 15.0 110.917 -176.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.6 -44.22 97.41 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.61 -0.436 . . . . 15.0 110.836 -176.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -62.24 -41.97 98.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.486 -0.325 . . . . 15.0 110.754 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 40' ' ' LEU . 94.0 t -60.61 -45.18 97.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.946 -0.39 . . . . 15.0 109.946 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -67.83 -47.94 67.61 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.325 0.391 . . . . 15.0 111.687 -177.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.6 -44.48 86.44 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 121.042 -0.263 . . . . 15.0 111.685 -173.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -83.04 -10.01 58.96 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.323 0.86 . . . . 15.0 113.323 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 55.79 55.84 6.69 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.68 0.752 . . . . 15.0 110.333 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.506 HD12 HG22 ' A' ' 44' ' ' VAL . 96.0 mt -64.11 144.95 56.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.62 -0.718 . . . . 15.0 111.36 -175.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -89.69 -40.52 12.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.067 -0.969 . . . . 15.0 110.694 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.97 161.14 28.52 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.045 -1.074 . . . . 15.0 113.553 -174.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.2 mt -126.0 140.94 52.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.428 -0.886 . . . . 15.0 109.568 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.683 HG11 HD21 ' A' ' 17' ' ' LEU . 41.3 t -120.69 130.06 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.696 0.284 . . . . 15.0 110.804 -178.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 m -123.56 138.81 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.007 0.432 . . . . 15.0 110.289 173.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.6 m -89.96 -23.89 21.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.729 -0.669 . . . . 15.0 112.413 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.9 p -154.15 165.51 36.01 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.447 0.641 . . . . 15.0 111.964 -173.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.99 -37.76 72.3 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.148 -0.781 . . . . 15.0 111.148 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -57.68 -46.12 84.7 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.736 -0.385 . . . . 15.0 110.632 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.59 -45.31 96.56 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.448 -1.061 . . . . 15.0 110.448 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.578 HD13 HD21 ' A' ' 79' ' ' LEU . 26.0 tp -56.5 -42.66 78.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.137 0.494 . . . . 15.0 110.762 -177.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.82 -43.28 99.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.504 . . . . 15.0 110.584 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.424 ' OD1' HD13 ' A' ' 33' ' ' LEU . 29.6 m120 -58.05 -39.91 79.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.379 -0.373 . . . . 15.0 110.559 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.441 ' CD1' HD21 ' A' ' 40' ' ' LEU . 12.5 tp -57.8 -45.47 86.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.164 0.507 . . . . 15.0 110.167 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -61.51 -47.68 84.5 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.635 -0.711 . . . . 15.0 110.638 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -61.72 -43.1 99.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.039 -0.528 . . . . 15.0 111.116 -176.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 94.2 mt -66.7 -35.53 80.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.325 -0.398 . . . . 15.0 111.453 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.671 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.71 -38.05 80.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.056 0.455 . . . . 15.0 110.781 177.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.4 -143.99 0.56 Allowed 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.527 -0.545 . . . . 15.0 109.527 174.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.67 -19.09 47.19 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.302 0.955 . . . . 15.0 112.652 -174.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -91.81 11.22 25.5 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.285 0.846 . . . . 15.0 113.285 -175.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -47.68 -46.7 61.45 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 118.595 -0.716 . . . . 15.0 112.606 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -44.76 -41.27 14.88 Favored 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 121.439 1.426 . . . . 15.0 113.166 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -76.88 -48.81 17.24 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.664 -0.414 . . . . 15.0 110.831 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.671 HD12 ' HB1' ' A' ' 67' ' ' ALA . 92.3 mt -59.88 -39.32 79.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.17 -0.468 . . . . 15.0 110.873 -176.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.28 -15.96 32.77 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 119.853 -0.415 . . . . 15.0 113.092 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.0 mtm105 -66.04 -30.29 70.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.42 0.61 . . . . 15.0 112.011 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.8 mt -73.6 150.59 88.99 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 121.171 -0.212 . . . . 15.0 111.463 -173.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.49 126.33 17.41 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 121.684 1.589 . . . . 15.0 112.322 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.578 HD21 HD13 ' A' ' 60' ' ' LEU . 26.4 tp -105.4 124.69 49.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.332 -0.395 . . . . 15.0 110.552 175.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.412 ' CD1' HG22 ' A' ' 53' ' ' VAL . 79.4 m-85 -90.74 127.41 36.31 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.802 -0.444 . . . . 15.0 109.802 177.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.638 HG21 ' HB2' ' A' ' 87' ' ' ALA . 29.1 m -121.43 145.66 43.08 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 110.118 -0.327 . . . . 15.0 110.118 175.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.18 -22.3 8.54 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.727 1.618 . . . . 15.0 113.64 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.551 ' OG ' HG23 ' A' ' 86' ' ' VAL . 53.3 p -141.54 157.44 65.48 Favored Pre-proline 0 C--N 1.331 -0.233 0 C-N-CA 120.765 -0.374 . . . . 15.0 111.327 -169.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.24 -44.06 50.13 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.273 1.315 . . . . 15.0 112.338 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -61.3 -43.52 98.73 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 120.603 -0.439 . . . . 15.0 111.116 -177.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.551 HG23 ' OG ' ' A' ' 83' ' ' SER . 57.3 t -59.63 -40.92 83.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.657 -0.498 . . . . 15.0 109.657 177.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.638 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.66 -41.74 82.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.901 0.381 . . . . 15.0 110.4 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.57 -40.41 91.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.246 -0.434 . . . . 15.0 110.597 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 96.9 mmm -58.3 -45.09 88.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.437 0.637 . . . . 15.0 110.132 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.502 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.62 -40.57 95.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.709 -0.678 . . . . 15.0 110.783 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -61.75 -44.2 97.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.315 -0.402 . . . . 15.0 110.765 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -60.31 -36.16 77.26 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.912 -0.315 . . . . 15.0 111.326 -177.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.2 mt -65.79 -23.83 66.79 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.199 0.444 . . . . 15.0 112.199 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.45 13.25 17.49 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-O 119.369 -0.684 . . . . 15.0 113.127 -176.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.87 122.59 13.28 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 118.49 1.145 . . . . 15.0 109.97 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -70.16 -36.17 74.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.667 -0.697 . . . . 15.0 111.188 -172.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 31.0 ttm105 -130.35 111.63 12.53 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.114 0.483 . . . . 15.0 110.382 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.1 130.87 63.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.989 -0.551 . . . . 15.0 109.817 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 85.8 mt -119.78 121.87 67.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.97 -0.559 . . . . 15.0 110.061 -176.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -95.75 116.51 28.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.39 -0.368 . . . . 15.0 110.24 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 28.3 p -97.09 1.29 49.85 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.23 0.826 . . . . 15.0 113.23 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -55.91 -39.89 72.27 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.26 0.482 . . . . 15.0 110.737 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -96.66 -35.17 5.5 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.523 -0.631 . . . . 15.0 111.523 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.6 143.52 53.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.864 0.364 . . . . 15.0 110.604 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.9 m -89.84 161.36 16.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 15.0 110.504 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.445 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . . . -47.73 -54.19 25.22 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-O 118.522 -0.751 . . . . 15.0 112.97 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -56.52 -36.13 97.43 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 CA-C-N 120.559 1.235 . . . . 15.0 111.318 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.31 -42.67 96.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.045 0.45 . . . . 15.0 110.18 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.1 mt -59.28 -41.05 87.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 15.0 110.492 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.7 tp -57.39 -44.02 84.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.339 0.59 . . . . 15.0 110.14 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.63 93.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.617 -0.72 . . . . 15.0 110.542 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.67 89.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.389 -0.368 . . . . 15.0 110.763 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.2 mt -57.86 -52.5 65.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.391 0.615 . . . . 15.0 110.357 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.2 p -63.83 -40.28 96.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.536 -0.756 . . . . 15.0 111.354 -175.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.7 t -62.14 -45.03 95.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.686 0.279 . . . . 15.0 111.422 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.43 -39.4 90.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.509 -0.314 . . . . 15.0 110.99 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.444 -0.344 . . . . 15.0 111.048 178.914 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.9 p30 . . . . . 0 CA--C 1.536 0.406 0 N-CA-C 110.307 -0.257 . . . . 15.0 110.307 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -54.41 155.03 17.47 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.434 1.422 . . . . 15.0 112.004 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -113.75 138.73 49.84 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.222 -0.445 . . . . 15.0 110.751 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.472 HG21 HD13 ' A' ' 21' ' ' LEU . 17.5 m -134.81 145.8 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 121.53 0.681 . . . . 15.0 111.943 177.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.8 tp -104.7 137.87 41.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.029 -0.987 . . . . 15.0 110.214 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.627 HD11 ' CG1' ' A' ' 28' ' ' VAL . 53.2 mt -103.07 135.1 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.082 0.467 . . . . 15.0 111.146 -177.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.475 ' HB2' HG12 ' A' ' 54' ' ' VAL . 97.9 mmm -95.5 125.91 40.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.106 -0.952 . . . . 15.0 108.905 169.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.0 mtm180 -59.59 147.67 36.31 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.487 -0.485 . . . . 15.0 110.689 -176.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.28 175.18 34.76 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.776 -0.929 . . . . 15.0 110.776 -178.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -51.59 -32.19 27.75 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.789 0.292 . . . . 15.0 111.789 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.81 173.76 16.78 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.855 -0.898 . . . . 15.0 110.855 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.99 126.38 7.66 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.351 -0.699 . . . . 15.0 111.351 -178.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -56.64 -47.43 79.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.193 0.52 . . . . 15.0 110.417 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.72 -40.99 98.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.642 -0.708 . . . . 15.0 111.202 -176.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -61.1 -55.99 26.12 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.722 -0.391 . . . . 15.0 111.393 -175.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.9 mt -62.19 -45.06 95.07 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.757 -0.377 . . . . 15.0 111.372 -175.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.44 -41.29 98.65 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.699 -0.4 . . . . 15.0 110.904 -177.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -59.87 -41.27 91.13 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.978 -0.289 . . . . 15.0 110.388 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.525 ' HE ' ' HB2' ' A' ' 106' ' ' ALA . 52.2 ttt85 -60.19 -51.64 68.7 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 120.764 -0.374 . . . . 15.0 111.305 -177.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.472 HD13 HG21 ' A' ' 5' ' ' VAL . 86.9 mt -62.72 -36.72 83.92 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.374 -0.53 . . . . 15.0 110.94 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 46.0 tpt85 -61.36 -41.46 97.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.684 0.278 . . . . 15.0 110.399 177.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.83 -30.57 66.35 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.2 -0.524 . . . . 15.0 111.993 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -88.02 9.91 20.8 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.46 0.911 . . . . 15.0 113.46 178.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.1 18.71 58.88 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 121.314 -0.47 . . . . 15.0 113.054 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.1 t -101.06 138.75 24.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 117.77 0.785 . . . . 15.0 109.949 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -81.6 129.63 34.76 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.164 -0.68 . . . . 15.0 109.164 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.627 ' CG1' HD11 ' A' ' 7' ' ' ILE . 28.4 t -122.66 134.39 65.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.267 0.556 . . . . 15.0 111.418 -172.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -139.61 138.53 36.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.14 -0.936 . . . . 15.0 109.404 171.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.502 ' HB3' HD12 ' A' ' 7' ' ' ILE . 30.2 p90 -115.5 140.87 48.76 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.832 0.348 . . . . 15.0 110.833 -178.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 33.9 tp -112.67 129.6 24.26 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-O 118.523 -0.751 . . . . 15.0 109.813 -175.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -65.73 134.98 39.85 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 CA-C-N 120.418 1.185 . . . . 15.0 111.38 174.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.615 HD13 ' OD1' ' A' ' 62' ' ' ASN . 57.8 mt -65.83 -9.19 26.6 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.294 0.85 . . . . 15.0 113.294 -175.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -77.29 -11.33 59.82 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.12 0.785 . . . . 15.0 113.12 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -63.15 148.5 92.8 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 118.416 0.553 . . . . 15.0 110.434 -176.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.89 157.5 31.09 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.523 1.482 . . . . 15.0 113.14 -177.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.44 151.25 5.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.84 -0.618 . . . . 15.0 111.177 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.91 -37.02 3.63 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.354 -0.698 . . . . 15.0 111.354 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.31 -37.78 81.64 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.592 -0.443 . . . . 15.0 110.985 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.557 ' O ' HG23 ' A' ' 44' ' ' VAL . 22.4 tp -58.84 -47.31 85.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.028 0.442 . . . . 15.0 110.239 -177.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.541 HD22 ' OD2' ' A' ' 70' ' ' ASP . 10.8 tp -62.79 -44.58 95.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.106 -0.497 . . . . 15.0 110.951 -176.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.9 -44.72 96.21 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.7 -0.4 . . . . 15.0 110.92 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 -61.61 -40.8 96.12 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.841 -0.344 . . . . 15.0 110.98 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 40' ' ' LEU . 88.8 t -61.78 -45.74 98.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.829 -0.349 . . . . 15.0 110.375 -177.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -67.42 -50.82 57.73 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.312 0.382 . . . . 15.0 111.936 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.41 -44.35 79.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.674 0.273 . . . . 15.0 111.578 -174.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -78.28 -10.05 59.49 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.043 0.757 . . . . 15.0 113.043 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 56.32 55.9 6.23 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.539 0.685 . . . . 15.0 110.074 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.532 HD12 HG22 ' A' ' 44' ' ' VAL . 94.8 mt -69.87 144.73 52.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.846 -0.616 . . . . 15.0 111.381 -176.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -90.9 -40.52 11.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.188 -0.914 . . . . 15.0 110.499 176.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -152.52 168.93 31.64 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 120.129 -1.034 . . . . 15.0 113.216 -174.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 75.8 mt -124.69 141.41 52.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.851 -0.675 . . . . 15.0 110.108 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.55 HG22 ' CD1' ' A' ' 80' ' ' PHE . 48.5 t -120.25 130.42 74.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.022 -0.362 . . . . 15.0 110.022 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.475 HG12 ' HB2' ' A' ' 8' ' ' MET . 11.6 m -122.6 129.39 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 121.047 0.451 . . . . 15.0 110.235 173.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.2 p -95.09 -3.59 47.81 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.931 0.715 . . . . 15.0 112.931 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 81.7 p -154.31 154.71 33.84 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.447 0.567 . . . . 15.0 111.545 -177.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.02 -39.83 90.27 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.887 -0.885 . . . . 15.0 110.887 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -59.19 -42.82 91.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.916 -0.314 . . . . 15.0 110.511 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.88 -44.97 96.6 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.859 -0.896 . . . . 15.0 110.859 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.585 HD13 HD21 ' A' ' 79' ' ' LEU . 52.3 tp -58.16 -47.82 82.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.091 0.472 . . . . 15.0 110.366 -177.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -61.23 -40.71 95.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.018 -0.537 . . . . 15.0 110.695 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.615 ' OD1' HD13 ' A' ' 33' ' ' LEU . 23.8 m120 -59.74 -40.29 87.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.441 -0.345 . . . . 15.0 110.629 177.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.402 ' CD1' HD21 ' A' ' 40' ' ' LEU . 15.1 tp -57.81 -44.16 86.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.235 0.541 . . . . 15.0 110.125 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -60.69 -47.14 87.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.791 -0.64 . . . . 15.0 110.623 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.54 -43.17 99.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.137 -0.483 . . . . 15.0 111.184 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.4 mt -67.04 -34.71 78.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.498 -0.319 . . . . 15.0 111.431 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.682 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -58.97 -39.07 80.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.068 0.461 . . . . 15.0 110.6 177.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 58.83 -143.15 0.62 Allowed 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.736 -0.468 . . . . 15.0 109.736 173.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.61 -19.98 52.79 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.337 0.971 . . . . 15.0 112.639 -174.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.541 ' OD2' HD22 ' A' ' 41' ' ' LEU . 77.9 m-20 -91.88 10.81 27.19 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.265 0.839 . . . . 15.0 113.265 -175.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 56.7 t-105 -47.85 -46.61 63.14 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 118.563 -0.732 . . . . 15.0 112.547 177.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -44.66 -40.71 14.33 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.389 1.393 . . . . 15.0 113.288 177.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -76.96 -48.89 16.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.948 0.404 . . . . 15.0 110.698 -178.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.682 HD12 ' HB1' ' A' ' 67' ' ' ALA . 89.6 mt -59.25 -39.59 79.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 15.0 110.826 -177.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.56 -14.47 35.55 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.817 -0.435 . . . . 15.0 113.23 -176.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -64.96 -30.12 71.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.501 0.651 . . . . 15.0 111.907 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 23.4 mt -76.29 150.42 82.74 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 120.932 -0.307 . . . . 15.0 111.264 -174.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.34 128.97 29.29 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.624 1.55 . . . . 15.0 112.286 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.585 HD21 HD13 ' A' ' 60' ' ' LEU . 14.0 tp -107.07 124.54 49.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 15.0 110.533 175.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.55 ' CD1' HG22 ' A' ' 53' ' ' VAL . 86.3 m-85 -92.59 121.95 34.53 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.356 -0.609 . . . . 15.0 109.356 174.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.715 HG21 ' HB2' ' A' ' 87' ' ' ALA . 21.5 m -107.0 147.38 34.99 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-O 119.345 -0.36 . . . . 15.0 110.207 177.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.18 -25.88 5.56 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.577 1.518 . . . . 15.0 113.404 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.9 p -145.26 163.44 32.26 Favored Pre-proline 0 CA--C 1.531 0.227 0 C-N-CA 120.636 -0.425 . . . . 15.0 111.46 -172.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.3 -44.01 47.07 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 121.13 1.22 . . . . 15.0 111.829 176.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -58.28 -46.74 85.49 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.81 -0.356 . . . . 15.0 110.817 -177.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.0 t -59.9 -41.04 84.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.882 -0.414 . . . . 15.0 109.882 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.715 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.87 -39.32 77.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.674 0.273 . . . . 15.0 110.707 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.88 -42.08 97.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.504 -0.316 . . . . 15.0 110.563 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 52.2 mtm -64.89 -42.94 94.36 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 119.871 -0.731 . . . . 15.0 110.129 176.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.5 -43.96 93.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.584 -0.28 . . . . 15.0 111.484 -171.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -67.02 -38.57 86.19 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.161 -0.616 . . . . 15.0 110.443 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -59.76 -35.16 74.04 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 120.653 -0.419 . . . . 15.0 111.246 176.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 67.2 mt -59.88 -29.11 68.1 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.877 -0.329 . . . . 15.0 111.378 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.27 13.08 20.28 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 119.431 -0.649 . . . . 15.0 112.821 -172.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.93 123.33 15.46 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.515 1.157 . . . . 15.0 109.862 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -70.46 -35.1 73.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.971 -0.558 . . . . 15.0 111.323 -172.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -131.62 113.98 14.27 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 110.052 -0.351 . . . . 15.0 110.052 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 45.6 t -109.44 129.79 63.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.036 0.446 . . . . 15.0 110.121 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 82.4 mt -120.92 125.66 74.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.745 -0.661 . . . . 15.0 109.978 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -94.44 114.5 26.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.212 -0.292 . . . . 15.0 110.212 175.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 28.6 p -78.36 -25.84 46.48 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 120.639 -0.424 . . . . 15.0 112.021 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -55.11 -38.17 67.8 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.646 0.26 . . . . 15.0 110.913 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.96 -35.15 7.83 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.597 -0.601 . . . . 15.0 111.597 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.36 127.02 36.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.373 . . . . 15.0 110.908 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.427 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 50.3 m -65.09 156.87 30.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.081 0.467 . . . . 15.0 110.787 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.525 ' HB2' ' HE ' ' A' ' 20' ' ' ARG . . . -47.68 -54.34 23.8 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 113.031 0.752 . . . . 15.0 113.031 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -56.2 -35.48 95.44 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 CA-C-N 120.367 1.167 . . . . 15.0 111.339 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 105' ' ' SER . . . -60.05 -41.33 92.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.955 0.407 . . . . 15.0 110.235 176.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 78.0 mt -58.94 -41.9 88.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.97 0.414 . . . . 15.0 110.329 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.61 -44.16 85.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.445 0.64 . . . . 15.0 110.131 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.4 -40.09 89.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.602 -0.726 . . . . 15.0 110.586 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.25 -41.03 92.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.41 -0.359 . . . . 15.0 110.785 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.4 mt -57.85 -51.01 71.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.152 0.501 . . . . 15.0 110.404 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.8 p -63.28 -41.27 98.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.68 -0.691 . . . . 15.0 111.252 -175.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.0 m -63.46 -43.22 97.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.662 0.267 . . . . 15.0 111.389 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.35 -39.03 91.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.478 -0.328 . . . . 15.0 111.05 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.552 -0.295 . . . . 15.0 110.952 179.045 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 . . . . . 0 CA--C 1.534 0.327 0 N-CA-C 110.32 -0.252 . . . . 15.0 110.32 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -59.18 155.06 41.95 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.38 1.387 . . . . 15.0 111.942 -177.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -105.4 136.48 44.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.387 -0.369 . . . . 15.0 110.62 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.8 m -132.68 143.56 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 121.585 0.707 . . . . 15.0 111.587 177.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.446 HD11 ' HB2' ' A' ' 31' ' ' LEU . 13.8 tp -102.77 135.87 43.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.981 -1.009 . . . . 15.0 110.274 178.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.578 HD11 ' CG1' ' A' ' 28' ' ' VAL . 51.9 mt -102.04 134.76 41.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.981 0.42 . . . . 15.0 110.558 -178.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.44 ' HB2' HG12 ' A' ' 54' ' ' VAL . 85.6 mtp -103.52 134.27 47.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.441 -0.8 . . . . 15.0 109.943 173.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 -57.46 144.86 35.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.016 0.436 . . . . 15.0 110.833 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.2 175.24 33.24 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.658 -0.977 . . . . 15.0 110.658 -177.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -50.97 -32.07 19.84 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.88 0.326 . . . . 15.0 111.88 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.95 175.42 47.77 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.782 -0.927 . . . . 15.0 110.782 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.64 131.68 10.81 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.474 -0.65 . . . . 15.0 111.474 -178.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -56.56 -44.35 80.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.869 0.366 . . . . 15.0 110.616 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.83 -43.19 99.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.126 -0.488 . . . . 15.0 111.183 -176.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -62.49 -56.06 21.61 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.8 -0.36 . . . . 15.0 111.384 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.47 HD23 ' C ' ' A' ' 17' ' ' LEU . 8.9 tt -61.7 -43.69 98.37 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.777 -0.369 . . . . 15.0 110.985 -175.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.528 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -62.38 -42.43 99.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.414 -0.357 . . . . 15.0 110.84 -177.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.78 -41.21 90.62 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.875 -0.33 . . . . 15.0 110.457 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -59.64 -51.72 68.61 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.565 -0.454 . . . . 15.0 111.34 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.5 mt -62.58 -37.5 86.43 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.436 -0.505 . . . . 15.0 110.933 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 46.9 tpt85 -63.03 -44.8 94.91 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 121.066 -0.254 . . . . 15.0 110.711 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.43 -30.57 68.4 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.955 -0.64 . . . . 15.0 111.894 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -88.11 9.24 23.34 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.626 0.973 . . . . 15.0 113.626 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.77 13.55 54.77 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 121.066 -0.588 . . . . 15.0 113.65 173.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.0 t -101.1 138.52 25.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 117.953 0.876 . . . . 15.0 110.021 177.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -79.33 131.88 36.27 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.348 -0.612 . . . . 15.0 109.348 178.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.578 ' CG1' HD11 ' A' ' 7' ' ' ILE . 43.9 t -117.68 130.79 72.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.198 0.523 . . . . 15.0 111.528 -171.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -139.33 133.03 30.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.32 -0.855 . . . . 15.0 109.388 170.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -112.66 137.39 51.01 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.9 0.381 . . . . 15.0 110.974 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.446 ' HB2' HD11 ' A' ' 6' ' ' LEU . 40.5 tp -118.9 113.45 35.91 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 118.618 -0.706 . . . . 15.0 109.969 -176.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -56.09 135.26 68.93 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.069 1.179 . . . . 15.0 112.318 177.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 77.3 mt -60.56 -9.21 3.48 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.298 0.851 . . . . 15.0 113.298 -178.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -77.15 -9.98 59.1 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.205 0.817 . . . . 15.0 113.205 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -62.53 147.2 92.8 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 118.338 0.517 . . . . 15.0 110.26 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.29 158.96 33.28 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.559 1.506 . . . . 15.0 113.252 -178.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.84 152.42 3.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.783 -0.644 . . . . 15.0 111.337 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.39 -36.3 3.88 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.489 -0.644 . . . . 15.0 111.489 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -60.01 -37.22 79.09 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.689 -0.404 . . . . 15.0 111.041 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.576 ' O ' HG23 ' A' ' 44' ' ' VAL . 25.8 tp -58.65 -46.34 87.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.965 0.412 . . . . 15.0 110.168 -178.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.611 HD22 ' OD2' ' A' ' 70' ' ' ASP . 9.7 tp -61.78 -44.14 97.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.139 -0.482 . . . . 15.0 110.742 -177.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.01 -43.61 98.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.352 -0.386 . . . . 15.0 111.241 -176.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -61.28 -41.82 97.6 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.751 -0.38 . . . . 15.0 110.625 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.579 ' HA ' HD12 ' A' ' 49' ' ' LEU . 97.6 t -61.65 -47.03 95.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.88 -0.328 . . . . 15.0 110.491 -175.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -75.42 -43.5 49.57 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.492 0.553 . . . . 15.0 112.492 -174.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.59 -44.37 74.52 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.667 0.247 . . . . 15.0 111.667 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -82.74 -10.09 59.05 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.123 0.786 . . . . 15.0 113.123 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 58.36 55.88 4.73 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.563 0.697 . . . . 15.0 109.553 -177.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.579 HD12 ' HA ' ' A' ' 44' ' ' VAL . 94.1 mt -71.47 145.7 49.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.752 -0.658 . . . . 15.0 111.412 -174.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -95.41 -40.52 9.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.231 -0.895 . . . . 15.0 110.774 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -150.93 166.64 30.44 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 120.057 -1.068 . . . . 15.0 113.412 -173.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.5 mt -126.61 144.17 50.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.732 -0.734 . . . . 15.0 110.046 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.549 HG22 ' CD1' ' A' ' 80' ' ' PHE . 47.8 t -122.1 129.38 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 110.386 -0.227 . . . . 15.0 110.386 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.44 HG12 ' HB2' ' A' ' 8' ' ' MET . 15.5 m -127.65 152.05 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.053 0.454 . . . . 15.0 110.456 172.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.9 m -123.47 7.92 8.97 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.744 -0.662 . . . . 15.0 112.77 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.9 p -155.62 151.69 27.81 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 118.514 0.597 . . . . 15.0 111.772 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.87 -39.75 92.08 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.633 -0.987 . . . . 15.0 110.633 176.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -58.25 -41.8 85.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.702 0.287 . . . . 15.0 110.382 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.82 -47.98 88.54 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.687 -0.965 . . . . 15.0 110.687 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.614 HD13 HD21 ' A' ' 79' ' ' LEU . 34.2 tp -57.13 -44.42 83.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.15 0.5 . . . . 15.0 110.705 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.63 -42.37 98.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.063 -0.517 . . . . 15.0 110.823 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -59.47 -39.89 85.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.393 -0.367 . . . . 15.0 110.576 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.4 tp -58.12 -44.29 87.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.094 0.473 . . . . 15.0 110.274 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -60.67 -47.52 85.91 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.849 -0.614 . . . . 15.0 110.631 -178.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -62.13 -43.41 98.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.085 -0.507 . . . . 15.0 111.113 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.8 mt -66.42 -35.27 79.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.414 -0.357 . . . . 15.0 111.375 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.664 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -58.92 -38.75 79.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.032 0.444 . . . . 15.0 110.672 178.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.21 -143.54 0.59 Allowed 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 109.515 -0.55 . . . . 15.0 109.515 174.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.43 -19.04 44.38 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.342 0.973 . . . . 15.0 112.609 -175.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.611 ' OD2' HD22 ' A' ' 41' ' ' LEU . 79.2 m-20 -91.88 10.5 28.48 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.299 0.852 . . . . 15.0 113.299 -174.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -47.76 -46.72 62.33 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 118.576 -0.726 . . . . 15.0 112.561 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -44.69 -41.99 14.72 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 121.481 1.454 . . . . 15.0 113.244 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -77.01 -48.69 17.23 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.949 0.405 . . . . 15.0 110.862 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.664 HD12 ' HB1' ' A' ' 67' ' ' ALA . 91.7 mt -59.01 -40.78 81.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.138 -0.483 . . . . 15.0 110.748 -176.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.51 -16.1 35.05 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 119.896 -0.391 . . . . 15.0 113.048 -177.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -63.66 -30.64 71.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.425 0.612 . . . . 15.0 111.989 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.6 mt -74.89 149.02 85.24 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 120.979 -0.289 . . . . 15.0 111.265 -173.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.85 129.07 24.89 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.558 1.505 . . . . 15.0 112.517 176.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.614 HD21 HD13 ' A' ' 60' ' ' LEU . 22.4 tp -107.77 126.43 52.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 15.0 110.577 174.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.549 ' CD1' HG22 ' A' ' 53' ' ' VAL . 80.3 m-85 -89.84 125.01 35.17 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.438 -0.579 . . . . 15.0 109.438 175.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.741 HG21 ' HB2' ' A' ' 87' ' ' ALA . 27.6 m -113.87 147.56 37.98 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-O 119.373 -0.346 . . . . 15.0 110.319 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.418 ' HD2' HG11 ' A' ' 86' ' ' VAL . 90.1 Cg_endo -79.17 -23.94 7.17 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.574 1.516 . . . . 15.0 113.52 -175.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.7 p -144.4 158.23 54.73 Favored Pre-proline 0 CA--C 1.531 0.232 0 C-N-CA 120.664 -0.414 . . . . 15.0 111.321 -172.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.82 -44.04 51.34 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.255 1.304 . . . . 15.0 111.694 175.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -56.73 -48.56 77.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.847 0.356 . . . . 15.0 110.858 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.418 HG11 ' HD2' ' A' ' 82' ' ' PRO . 60.2 t -59.61 -40.66 82.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.836 0.351 . . . . 15.0 110.071 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.741 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.72 -42.29 83.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.012 0.434 . . . . 15.0 110.505 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.6 -41.67 97.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 15.0 110.658 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 87.1 mtp -59.82 -44.44 94.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.238 0.542 . . . . 15.0 110.432 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.434 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.35 -41.2 96.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.993 -0.548 . . . . 15.0 110.725 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 54.0 ttm-85 -61.19 -44.52 97.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.25 -0.432 . . . . 15.0 110.539 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -59.84 -36.26 76.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.527 -0.306 . . . . 15.0 111.397 -177.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 81.9 mt -65.39 -24.15 67.15 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.244 0.461 . . . . 15.0 112.244 177.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.85 13.2 14.41 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-O 119.444 -0.642 . . . . 15.0 113.158 -176.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.89 121.97 11.8 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.466 1.133 . . . . 15.0 109.893 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -70.5 -35.48 73.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.69 -0.686 . . . . 15.0 111.322 -171.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -131.07 112.83 13.24 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.975 0.417 . . . . 15.0 110.115 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.2 t -111.41 129.49 66.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.79 -0.448 . . . . 15.0 109.79 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 83.9 mt -119.53 125.49 74.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.967 -0.56 . . . . 15.0 110.222 -176.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -94.9 117.74 30.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.435 -0.348 . . . . 15.0 110.286 176.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.545 ' HB2' HD11 ' A' ' 109' ' ' LEU . 31.2 p -88.6 -18.69 27.5 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.574 0.583 . . . . 15.0 112.574 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 tpt85 -55.17 -38.9 68.92 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 122.229 -0.294 . . . . 15.0 110.766 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -93.16 -34.95 6.49 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.633 -0.587 . . . . 15.0 111.633 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -89.51 125.59 35.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.843 0.354 . . . . 15.0 110.705 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.409 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 47.7 m -64.64 158.63 23.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.159 0.504 . . . . 15.0 110.901 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.79 -54.24 25.06 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 113.011 0.745 . . . . 15.0 113.011 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -56.65 -34.84 96.68 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 CA-C-N 120.447 1.196 . . . . 15.0 111.451 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 105' ' ' SER . . . -60.22 -41.74 93.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.029 0.442 . . . . 15.0 110.081 176.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.545 HD11 ' HB2' ' A' ' 101' ' ' CYS . 78.8 mt -58.95 -41.13 86.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.077 0.465 . . . . 15.0 110.454 178.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 30.6 tp -56.98 -44.34 82.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.546 0.689 . . . . 15.0 110.104 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.45 -40.14 90.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.508 -0.769 . . . . 15.0 110.551 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.83 -41.12 90.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.399 -0.364 . . . . 15.0 110.757 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.0 mt -57.89 -52.08 66.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.262 0.553 . . . . 15.0 110.305 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.9 p -63.53 -40.6 97.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.571 -0.741 . . . . 15.0 111.315 -175.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.3 m -62.73 -43.51 98.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.67 0.271 . . . . 15.0 111.443 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.34 -39.87 94.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.414 -0.357 . . . . 15.0 111.045 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.48 -0.327 . . . . 15.0 111.164 179.978 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 . . . . . 0 CA--C 1.535 0.376 0 N-CA-C 110.329 -0.249 . . . . 15.0 110.329 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.7 155.04 28.4 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.393 1.395 . . . . 15.0 111.875 -176.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.421 ' CB ' HD23 ' A' ' 49' ' ' LEU . 96.1 mttt -111.68 138.13 48.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.795 0.331 . . . . 15.0 110.864 -178.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.426 HG21 HD13 ' A' ' 21' ' ' LEU . 15.1 m -134.66 144.31 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.565 0.698 . . . . 15.0 111.572 175.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.2 tp -104.38 136.0 44.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.916 -1.038 . . . . 15.0 110.264 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.614 HD11 ' CG1' ' A' ' 28' ' ' VAL . 50.8 mt -103.53 135.1 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.123 0.487 . . . . 15.0 111.129 -176.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.531 ' HB2' HG12 ' A' ' 54' ' ' VAL . 98.5 mmm -95.3 133.65 38.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.109 -0.95 . . . . 15.0 109.21 171.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.421 ' H ' HD21 ' A' ' 33' ' ' LEU . 55.9 ttp180 -63.91 143.74 57.62 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.76 -0.376 . . . . 15.0 110.479 -177.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.24 175.13 34.02 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.924 -0.871 . . . . 15.0 110.924 -178.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -52.55 -32.45 40.87 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.742 0.275 . . . . 15.0 111.742 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.69 176.39 32.38 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.807 -0.917 . . . . 15.0 110.807 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.0 120.24 5.77 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.504 -0.638 . . . . 15.0 111.504 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -56.89 -41.8 78.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.794 0.331 . . . . 15.0 110.452 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.07 -40.63 98.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 15.0 111.134 -177.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -62.35 -56.0 22.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.984 0.421 . . . . 15.0 111.124 -176.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.3 mt -59.92 -44.82 94.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.942 0.401 . . . . 15.0 110.759 -176.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.532 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -62.53 -37.49 86.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 15.0 111.052 -178.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.0 -42.89 99.32 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.955 -0.298 . . . . 15.0 110.598 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -61.53 -51.52 68.27 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.125 -0.63 . . . . 15.0 110.895 -178.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.426 HD13 HG21 ' A' ' 5' ' ' VAL . 84.6 mt -61.46 -37.99 85.6 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.632 -0.427 . . . . 15.0 110.931 -178.268 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 57.5 ttt85 -63.63 -43.52 96.59 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.196 -0.202 . . . . 15.0 111.084 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.03 -30.6 67.05 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.967 -0.635 . . . . 15.0 111.915 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -88.2 10.1 20.63 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.481 0.919 . . . . 15.0 113.481 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.91 18.27 51.41 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 121.187 -0.53 . . . . 15.0 113.292 174.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.4 t -101.01 140.32 20.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 117.688 0.744 . . . . 15.0 110.131 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -84.78 130.38 34.69 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.475 -0.565 . . . . 15.0 109.475 178.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.614 ' CG1' HD11 ' A' ' 7' ' ' ILE . 37.2 t -119.97 133.76 65.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.205 0.526 . . . . 15.0 111.271 -173.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -139.08 132.72 30.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.443 -0.799 . . . . 15.0 109.611 171.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.461 ' HB3' HD12 ' A' ' 7' ' ' ILE . 38.3 p90 -113.01 137.64 51.1 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.89 0.376 . . . . 15.0 110.467 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.7 tp -114.92 113.49 44.28 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.683 -0.675 . . . . 15.0 110.824 -173.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -49.05 135.08 29.97 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.156 1.237 . . . . 15.0 111.881 174.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.608 HD13 ' OD1' ' A' ' 62' ' ' ASN . 43.2 mt -64.61 -13.36 53.11 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.15 0.796 . . . . 15.0 113.15 -174.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -77.23 -6.01 51.45 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.293 0.849 . . . . 15.0 113.293 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -60.0 151.04 67.24 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 118.559 0.618 . . . . 15.0 110.388 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.75 151.72 25.0 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.548 1.499 . . . . 15.0 113.044 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.53 152.29 5.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.925 -0.58 . . . . 15.0 111.162 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.84 -36.6 3.8 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.449 -0.66 . . . . 15.0 111.449 -177.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.44 -37.94 82.54 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.655 -0.418 . . . . 15.0 110.958 -177.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.563 ' O ' HG23 ' A' ' 44' ' ' VAL . 23.9 tp -59.14 -46.32 88.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.952 0.406 . . . . 15.0 110.256 -178.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.614 HD22 ' OD2' ' A' ' 70' ' ' ASP . 12.1 tp -61.97 -44.64 96.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 15.0 110.824 -176.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.89 -43.93 97.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.348 -0.387 . . . . 15.0 110.91 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.8 mtp85 -61.83 -41.77 98.2 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.811 -0.356 . . . . 15.0 110.888 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 40' ' ' LEU . 96.5 t -59.4 -46.08 92.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.868 -0.419 . . . . 15.0 109.868 -177.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.2 tpt85 -71.55 -50.3 32.45 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 123.37 0.419 . . . . 15.0 112.024 -176.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.04 -44.44 92.48 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.089 0.403 . . . . 15.0 112.089 -171.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 mp0 -89.87 -5.61 56.65 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.429 0.899 . . . . 15.0 113.429 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 56.77 55.93 5.89 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.616 0.722 . . . . 15.0 110.167 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.51 HD12 ' HA ' ' A' ' 44' ' ' VAL . 94.5 mt -64.23 140.44 58.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.525 -0.761 . . . . 15.0 111.058 -175.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -84.47 -40.64 17.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.491 -0.777 . . . . 15.0 110.671 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -154.04 168.04 32.36 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 119.872 -1.156 . . . . 15.0 113.773 -173.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.8 mt -123.65 143.51 50.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.502 -0.849 . . . . 15.0 109.671 177.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.48 HG22 ' CD1' ' A' ' 80' ' ' PHE . 46.9 t -122.66 132.76 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.143 -0.317 . . . . 15.0 110.143 -179.268 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.531 HG12 ' HB2' ' A' ' 8' ' ' MET . 9.2 m -126.47 142.41 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 121.057 0.456 . . . . 15.0 110.547 173.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.6 t -97.44 -19.95 18.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.622 -0.717 . . . . 15.0 112.439 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.2 p -151.27 161.65 42.32 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 121.333 0.587 . . . . 15.0 111.528 -174.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.45 -39.12 83.18 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.946 -0.862 . . . . 15.0 110.946 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -58.82 -44.62 90.91 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.876 -0.329 . . . . 15.0 110.653 -178.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.06 -44.48 97.23 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.545 -1.022 . . . . 15.0 110.545 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.602 HD13 HD21 ' A' ' 79' ' ' LEU . 32.1 tp -57.27 -43.03 82.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.115 0.483 . . . . 15.0 110.639 -178.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.08 -42.73 99.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 15.0 110.692 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.608 ' OD1' HD13 ' A' ' 33' ' ' LEU . 26.1 m120 -58.95 -41.61 87.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.852 0.358 . . . . 15.0 110.543 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.8 tp -58.67 -43.94 90.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.125 0.488 . . . . 15.0 110.181 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -61.19 -47.32 86.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.955 -0.566 . . . . 15.0 110.725 -178.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -61.22 -42.7 99.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 15.0 111.117 -177.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 92.7 mt -65.82 -36.32 83.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.341 -0.391 . . . . 15.0 111.374 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.687 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.32 -38.57 80.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.141 0.496 . . . . 15.0 110.85 178.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.13 -143.15 0.61 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.648 -0.501 . . . . 15.0 109.648 174.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.52 -19.82 51.0 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.321 0.964 . . . . 15.0 112.734 -174.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.614 ' OD2' HD22 ' A' ' 41' ' ' LEU . 79.3 m-20 -91.97 11.4 25.23 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.217 0.821 . . . . 15.0 113.217 -175.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -47.85 -46.7 63.25 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 118.584 -0.722 . . . . 15.0 112.593 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -44.7 -41.25 14.7 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.474 1.45 . . . . 15.0 113.224 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.5 mp0 -77.03 -48.77 17.0 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.943 0.402 . . . . 15.0 110.827 -178.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.687 HD12 ' HB1' ' A' ' 67' ' ' ALA . 90.8 mt -60.03 -40.52 83.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 15.0 110.902 -176.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.79 -13.72 26.66 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.915 -0.38 . . . . 15.0 113.156 -177.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -64.44 -31.46 72.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 117.359 0.579 . . . . 15.0 111.766 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.3 mt -72.99 141.84 82.11 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 119.204 -0.427 . . . . 15.0 110.456 -176.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -59.33 135.24 64.05 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.342 1.361 . . . . 15.0 112.434 177.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.602 HD21 HD13 ' A' ' 60' ' ' LEU . 23.9 tp -109.34 127.76 54.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 15.0 110.736 176.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.48 ' CD1' HG22 ' A' ' 53' ' ' VAL . 85.9 m-85 -91.35 127.18 36.68 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.821 -0.437 . . . . 15.0 109.821 176.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.664 HG21 ' HB2' ' A' ' 87' ' ' ALA . 28.6 m -119.6 147.44 43.69 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 119.45 -0.309 . . . . 15.0 110.25 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.24 -24.23 6.83 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.597 1.531 . . . . 15.0 113.478 -175.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.402 ' OG ' HG23 ' A' ' 86' ' ' VAL . 25.2 p -142.58 158.51 60.06 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 120.71 -0.396 . . . . 15.0 111.27 -171.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.43 -44.05 52.33 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.285 1.323 . . . . 15.0 111.761 176.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -58.29 -47.43 83.67 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.773 -0.371 . . . . 15.0 110.924 -177.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.402 HG23 ' OG ' ' A' ' 83' ' ' SER . 61.1 t -60.17 -39.65 81.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.788 -0.365 . . . . 15.0 110.096 178.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.664 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.25 -41.84 80.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.925 0.393 . . . . 15.0 110.404 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.75 -40.86 94.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.131 -0.486 . . . . 15.0 110.526 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.0 mmm -58.33 -45.17 88.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.456 0.646 . . . . 15.0 110.177 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.492 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.76 -40.32 94.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.704 -0.68 . . . . 15.0 110.937 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.0 ttt-85 -62.07 -44.63 96.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 15.0 110.792 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.76 -36.15 76.06 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.818 -0.353 . . . . 15.0 111.236 -177.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 76.4 mt -65.49 -25.6 67.55 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.088 0.403 . . . . 15.0 112.088 177.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.55 13.37 14.78 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 119.288 -0.729 . . . . 15.0 113.18 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.87 122.68 13.51 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 118.513 1.157 . . . . 15.0 110.002 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -67.52 -35.83 79.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.518 -0.764 . . . . 15.0 111.256 -171.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -131.82 117.67 18.85 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.954 0.407 . . . . 15.0 110.087 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.9 t -114.18 130.36 68.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.975 0.417 . . . . 15.0 109.989 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 89.9 mt -119.16 123.58 71.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.811 -0.631 . . . . 15.0 110.077 -177.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -94.7 117.44 30.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.376 -0.375 . . . . 15.0 110.086 175.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 104' ' ' ALA . 30.8 p -95.42 -1.65 50.54 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.306 0.854 . . . . 15.0 113.306 -178.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -55.89 -39.88 72.2 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 118.191 0.451 . . . . 15.0 110.672 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -96.24 -35.06 5.63 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 111.511 -0.636 . . . . 15.0 111.511 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.407 ' HB3' ' HA ' ' A' ' 101' ' ' CYS . . . -69.7 143.23 53.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.829 0.347 . . . . 15.0 110.635 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 65.2 m -89.85 160.12 16.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 15.0 110.506 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.66 -54.41 23.21 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 112.945 0.72 . . . . 15.0 112.945 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.54 -34.53 98.88 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 CA-C-N 120.079 1.064 . . . . 15.0 111.708 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.01 96.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.028 0.442 . . . . 15.0 110.034 177.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.7 mt -59.42 -40.77 87.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 15.0 110.399 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 36.6 tp -57.26 -44.03 83.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.272 0.558 . . . . 15.0 110.164 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.18 -40.59 90.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.696 -0.683 . . . . 15.0 110.436 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.09 -40.13 88.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.377 -0.374 . . . . 15.0 110.811 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.6 mt -57.88 -51.4 69.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.174 0.512 . . . . 15.0 110.479 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.9 p -64.74 -41.56 95.84 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.637 -0.71 . . . . 15.0 111.384 -175.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.0 t -61.36 -43.87 98.14 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.051 -0.26 . . . . 15.0 111.26 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.18 -42.5 99.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.472 -0.331 . . . . 15.0 111.066 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 C-N-CA 120.975 -0.29 . . . . 15.0 111.209 -179.889 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 110.173 -0.306 . . . . 15.0 110.173 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.19 152.67 10.64 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.511 1.474 . . . . 15.0 112.214 -174.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -115.12 140.96 48.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.113 -0.494 . . . . 15.0 110.693 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 m -134.36 144.17 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.614 0.721 . . . . 15.0 111.519 176.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.8 tp -105.26 135.08 47.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.91 -1.041 . . . . 15.0 110.381 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.619 HD11 ' CG1' ' A' ' 28' ' ' VAL . 52.5 mt -99.8 133.02 44.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.034 0.445 . . . . 15.0 110.598 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.44 ' SD ' HD13 ' A' ' 63' ' ' LEU . 83.8 mtp -100.7 134.39 43.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.418 -0.81 . . . . 15.0 109.255 170.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -57.39 145.21 33.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.135 0.493 . . . . 15.0 111.222 -170.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.51 175.08 27.03 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.895 -0.882 . . . . 15.0 110.895 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.27 -32.29 71.04 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.817 0.303 . . . . 15.0 111.817 -178.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.96 -177.68 20.6 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.234 -0.746 . . . . 15.0 111.234 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.9 127.99 8.46 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.9 -0.88 . . . . 15.0 110.9 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 52.4 mmt-85 -60.02 -46.61 88.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.221 0.534 . . . . 15.0 109.648 -176.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.09 -40.01 96.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.59 -0.732 . . . . 15.0 111.235 -176.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -60.81 -55.96 26.86 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.758 -0.377 . . . . 15.0 111.258 -175.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.5 mt -61.91 -44.9 95.82 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.735 -0.386 . . . . 15.0 111.132 -176.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.473 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -63.09 -39.7 95.48 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.657 -0.417 . . . . 15.0 110.894 -177.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -60.03 -41.52 92.43 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 121.008 -0.277 . . . . 15.0 110.442 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.4 ttt85 -59.96 -51.55 69.19 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.665 -0.414 . . . . 15.0 111.2 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 70.6 mt -60.79 -36.79 79.89 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.518 -0.473 . . . . 15.0 110.937 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 60.4 ttt85 -61.73 -43.16 99.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.693 0.283 . . . . 15.0 110.727 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.19 -30.56 67.55 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.053 -0.594 . . . . 15.0 111.855 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -88.1 9.93 20.95 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.521 0.934 . . . . 15.0 113.521 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.3 12.83 58.16 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 121.189 -0.529 . . . . 15.0 113.689 173.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.9 t -101.06 136.12 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 118.084 0.942 . . . . 15.0 110.115 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -78.04 132.22 37.67 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.076 -0.713 . . . . 15.0 109.076 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.619 ' CG1' HD11 ' A' ' 7' ' ' ILE . 31.3 t -121.09 133.79 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.247 0.546 . . . . 15.0 111.37 -172.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -140.59 142.11 35.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.285 -0.87 . . . . 15.0 109.648 170.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -115.31 138.6 50.79 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.949 0.404 . . . . 15.0 111.03 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.0 tp -119.07 113.34 35.66 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 118.586 -0.721 . . . . 15.0 109.863 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.19 135.2 59.14 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 121.06 1.173 . . . . 15.0 112.257 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 76.1 mt -60.85 -12.03 9.66 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.089 0.774 . . . . 15.0 113.089 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -77.15 -7.78 56.39 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.271 0.841 . . . . 15.0 113.271 -177.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -61.98 150.3 83.58 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 118.45 0.568 . . . . 15.0 110.478 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.93 154.25 25.9 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.555 1.503 . . . . 15.0 113.119 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.3 151.82 5.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.878 -0.601 . . . . 15.0 111.227 -178.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.98 -38.1 3.22 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.498 -0.641 . . . . 15.0 111.498 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.74 -37.96 86.17 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.64 -0.424 . . . . 15.0 110.974 -177.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.613 ' O ' HG23 ' A' ' 44' ' ' VAL . 22.4 tp -59.05 -48.93 79.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.916 0.389 . . . . 15.0 110.209 -177.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.5 HD22 ' CG ' ' A' ' 70' ' ' ASP . 15.5 tp -64.34 -44.96 89.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.138 -0.483 . . . . 15.0 111.215 -175.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.78 -45.51 93.59 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.626 -0.43 . . . . 15.0 110.78 -175.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.3 ttt85 -62.23 -41.81 98.75 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.855 -0.338 . . . . 15.0 110.856 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 40' ' ' LEU . 96.6 t -60.93 -43.81 96.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.753 -0.379 . . . . 15.0 110.176 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -68.46 -48.66 63.94 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.117 0.414 . . . . 15.0 112.117 -176.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.58 -44.28 78.54 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.94 -0.304 . . . . 15.0 111.53 -175.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -79.47 -10.13 59.74 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.045 0.757 . . . . 15.0 113.045 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 54.84 55.86 7.34 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.607 0.717 . . . . 15.0 110.418 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.532 HD12 HG22 ' A' ' 44' ' ' VAL . 94.1 mt -66.73 148.15 52.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.689 -0.687 . . . . 15.0 111.584 -175.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -95.35 -40.6 9.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.29 -0.868 . . . . 15.0 110.826 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.67 160.32 28.27 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.009 -1.091 . . . . 15.0 113.443 -173.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.4 mt -126.61 141.55 51.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.505 -0.847 . . . . 15.0 109.838 178.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.519 HG22 ' CD1' ' A' ' 80' ' ' PHE . 46.9 t -120.47 131.22 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 121.143 -0.223 . . . . 15.0 110.702 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.403 HG12 ' SD ' ' A' ' 8' ' ' MET . 7.5 m -123.08 145.56 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.158 0.504 . . . . 15.0 110.562 173.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.3 t -97.83 -20.28 17.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.467 -0.788 . . . . 15.0 112.536 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.8 p -155.93 164.44 38.48 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.442 0.639 . . . . 15.0 111.903 -174.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.91 -37.38 70.0 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.173 -0.771 . . . . 15.0 111.173 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -58.35 -45.72 87.63 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.863 -0.335 . . . . 15.0 110.674 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.17 -46.19 94.68 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.468 -1.053 . . . . 15.0 110.468 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.621 HD13 HD21 ' A' ' 79' ' ' LEU . 30.1 tp -56.16 -44.02 78.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.16 0.505 . . . . 15.0 110.831 -177.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.76 -43.1 99.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.039 -0.528 . . . . 15.0 110.672 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -59.03 -39.97 83.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.39 -0.368 . . . . 15.0 110.639 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.44 HD13 ' SD ' ' A' ' 8' ' ' MET . 12.9 tp -57.88 -44.56 86.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.189 0.518 . . . . 15.0 110.243 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -60.92 -47.51 86.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.713 -0.676 . . . . 15.0 110.62 -178.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -61.45 -42.99 99.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.014 -0.539 . . . . 15.0 111.053 -177.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.97 -35.91 81.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.352 -0.385 . . . . 15.0 111.405 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.665 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.0 -39.22 81.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.975 0.417 . . . . 15.0 110.597 178.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.09 -142.81 0.62 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.591 -0.522 . . . . 15.0 109.591 174.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.49 -19.29 46.81 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.384 0.993 . . . . 15.0 112.601 -174.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.5 ' CG ' HD22 ' A' ' 41' ' ' LEU . 20.2 m-20 -91.82 10.46 28.48 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.355 0.872 . . . . 15.0 113.355 -175.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.9 t-105 -47.84 -46.36 62.62 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 118.598 -0.715 . . . . 15.0 112.665 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -44.73 -41.6 14.83 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 121.525 1.484 . . . . 15.0 113.182 177.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -76.93 -48.8 17.13 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 120.616 -0.434 . . . . 15.0 110.841 -178.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.665 HD12 ' HB1' ' A' ' 67' ' ' ALA . 89.8 mt -59.71 -40.17 81.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 15.0 110.808 -176.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.38 -16.65 36.27 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 119.948 -0.362 . . . . 15.0 113.126 -176.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 60.7 mtp85 -65.31 -30.17 71.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.423 0.611 . . . . 15.0 112.025 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.8 mt -73.52 150.51 89.13 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 111.533 0.197 . . . . 15.0 111.533 -172.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.4 126.35 17.52 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.67 1.58 . . . . 15.0 112.513 176.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.621 HD21 HD13 ' A' ' 60' ' ' LEU . 22.5 tp -105.53 125.75 51.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.473 174.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.519 ' CD1' HG22 ' A' ' 53' ' ' VAL . 76.3 m-85 -89.89 125.89 35.51 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.497 -0.557 . . . . 15.0 109.497 175.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.712 HG21 ' HB2' ' A' ' 87' ' ' ALA . 26.4 m -116.82 146.07 36.94 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 119.335 -0.364 . . . . 15.0 110.181 176.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.412 ' HD2' HG11 ' A' ' 86' ' ' VAL . 71.9 Cg_endo -79.21 -22.97 7.98 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.559 1.506 . . . . 15.0 113.582 -176.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.5 p -144.32 161.77 42.98 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 120.649 -0.421 . . . . 15.0 111.575 -172.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -55.9 -44.01 51.52 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 121.165 1.243 . . . . 15.0 111.821 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -57.56 -47.79 81.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.842 0.353 . . . . 15.0 110.773 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.412 HG11 ' HD2' ' A' ' 82' ' ' PRO . 61.7 t -59.76 -40.63 83.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.988 -0.375 . . . . 15.0 109.988 178.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.712 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.64 -41.37 81.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.942 0.401 . . . . 15.0 110.484 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.13 -40.0 92.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.425 . . . . 15.0 110.718 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.0 mmm -58.63 -45.09 90.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.383 0.611 . . . . 15.0 110.073 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.503 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.73 -41.67 97.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.727 -0.669 . . . . 15.0 110.865 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -61.73 -44.7 96.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.262 -0.426 . . . . 15.0 110.591 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -59.7 -36.11 75.87 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.905 -0.318 . . . . 15.0 111.259 -177.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.97 -23.53 65.96 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.357 0.503 . . . . 15.0 112.357 177.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.7 13.27 16.89 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 119.368 -0.684 . . . . 15.0 113.05 -176.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.78 122.01 11.84 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 118.522 1.161 . . . . 15.0 109.952 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -70.32 -35.7 73.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.677 -0.692 . . . . 15.0 111.22 -172.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -130.87 112.67 13.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.073 0.463 . . . . 15.0 110.422 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.6 t -111.7 130.15 65.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.076 -0.511 . . . . 15.0 109.73 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.1 mt -118.95 122.83 70.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.901 -0.59 . . . . 15.0 110.01 -176.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.33 118.86 32.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.401 -0.363 . . . . 15.0 110.255 176.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.8 p -95.16 -9.63 32.89 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.074 0.768 . . . . 15.0 113.074 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -55.46 -39.79 70.81 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 118.161 0.437 . . . . 15.0 110.843 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -94.77 -35.16 5.96 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.475 -0.65 . . . . 15.0 111.475 178.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.75 145.99 44.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.789 0.328 . . . . 15.0 110.46 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.5 m -89.8 158.88 17.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 15.0 110.451 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.66 -54.24 24.53 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 113.093 0.775 . . . . 15.0 113.093 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -57.48 -35.15 98.88 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 CA-C-N 120.383 1.173 . . . . 15.0 111.5 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.62 95.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.065 0.46 . . . . 15.0 110.091 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.8 mt -59.12 -40.62 85.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 15.0 110.361 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.13 -43.8 82.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.386 0.612 . . . . 15.0 110.113 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.21 -40.58 90.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.7 -0.682 . . . . 15.0 110.495 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.21 -41.58 93.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.358 -0.383 . . . . 15.0 110.808 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.2 mt -57.87 -50.83 71.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.218 0.533 . . . . 15.0 110.408 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.9 p -63.18 -41.3 99.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.719 -0.673 . . . . 15.0 111.265 -175.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.4 m -63.25 -43.45 97.97 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.084 -0.246 . . . . 15.0 111.36 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.6 -38.49 87.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.529 -0.305 . . . . 15.0 111.087 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.45 -0.341 . . . . 15.0 111.685 178.831 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 110.106 -0.331 . . . . 15.0 110.106 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -50.23 151.6 9.18 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.461 1.441 . . . . 15.0 112.101 -174.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.502 ' HB2' HD23 ' A' ' 49' ' ' LEU . 59.7 mttp -117.75 140.36 49.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.162 -0.472 . . . . 15.0 110.802 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.511 HG21 HD13 ' A' ' 21' ' ' LEU . 16.8 m -134.03 144.29 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.542 0.686 . . . . 15.0 111.68 176.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.9 tp -104.21 136.78 43.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.131 -0.941 . . . . 15.0 110.233 178.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.461 HD11 ' CG1' ' A' ' 28' ' ' VAL . 59.9 mt -105.78 135.06 45.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.216 0.531 . . . . 15.0 111.098 -176.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.48 ' HB2' HG12 ' A' ' 54' ' ' VAL . 98.0 mmm -94.43 134.06 37.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.003 -0.998 . . . . 15.0 109.319 171.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -57.55 143.91 39.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.883 0.373 . . . . 15.0 110.673 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.18 175.08 28.57 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.961 -0.856 . . . . 15.0 110.961 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -59.24 -32.27 69.83 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.676 0.25 . . . . 15.0 111.676 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.7 -177.72 24.35 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.934 -0.866 . . . . 15.0 110.934 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.85 119.02 4.89 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.178 -0.769 . . . . 15.0 111.178 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -57.92 -44.57 86.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.303 0.573 . . . . 15.0 110.025 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.47 -42.2 98.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.821 -0.627 . . . . 15.0 111.022 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -57.05 -54.42 46.94 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.959 0.409 . . . . 15.0 110.997 -176.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.8 mt -58.35 -41.67 85.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.391 -0.368 . . . . 15.0 110.696 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.475 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -60.72 -41.92 96.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.362 -0.381 . . . . 15.0 111.573 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.07 -40.84 95.2 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.765 -0.374 . . . . 15.0 110.653 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -59.55 -51.59 69.18 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.437 -0.505 . . . . 15.0 111.054 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.511 HD13 HG21 ' A' ' 5' ' ' VAL . 78.6 mt -63.18 -37.02 85.58 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.61 -0.436 . . . . 15.0 111.069 -178.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -61.53 -43.5 98.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.725 0.297 . . . . 15.0 110.552 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.39 -30.62 68.33 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.954 -0.641 . . . . 15.0 111.933 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.434 ' HB3' HD22 ' A' ' 110' ' ' LEU . 25.2 mt-30 -88.07 9.71 21.64 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.632 0.975 . . . . 15.0 113.632 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.91 14.44 59.37 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 121.205 -0.521 . . . . 15.0 113.482 174.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.0 t -101.12 138.32 25.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 117.904 0.852 . . . . 15.0 110.163 178.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -83.37 136.98 34.14 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.378 -0.601 . . . . 15.0 109.378 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.475 HG11 ' CB ' ' A' ' 18' ' ' ALA . 44.1 t -117.03 133.92 62.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.326 0.584 . . . . 15.0 111.516 -173.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -135.33 125.88 26.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.114 -0.948 . . . . 15.0 109.257 169.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -112.34 132.79 54.8 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.762 0.315 . . . . 15.0 110.362 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 tp -115.83 113.5 42.19 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 118.776 -0.63 . . . . 15.0 110.966 -172.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -51.14 135.1 44.86 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.008 1.138 . . . . 15.0 111.769 173.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.522 HD13 ' OD1' ' A' ' 62' ' ' ASN . 51.3 mt -63.3 -9.23 10.9 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.143 0.794 . . . . 15.0 113.143 -175.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -77.2 -8.79 58.15 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.306 0.854 . . . . 15.0 113.306 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -60.05 150.09 71.71 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 118.417 0.553 . . . . 15.0 110.463 -177.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -80.63 153.14 20.18 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.547 1.498 . . . . 15.0 113.108 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.64 151.33 6.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.924 -0.58 . . . . 15.0 111.221 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.44 -38.06 3.23 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.393 -0.683 . . . . 15.0 111.393 -177.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -61.48 -37.43 83.59 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.658 -0.417 . . . . 15.0 111.068 -177.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.532 ' O ' HG23 ' A' ' 44' ' ' VAL . 24.5 tp -60.23 -47.3 86.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.874 0.368 . . . . 15.0 110.332 -178.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.511 HD22 ' CG ' ' A' ' 70' ' ' ASP . 18.3 tp -62.34 -44.66 95.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.896 -176.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.94 -44.08 97.51 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.714 -0.395 . . . . 15.0 110.773 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -60.07 -43.31 95.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.485 -0.325 . . . . 15.0 110.496 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 40' ' ' LEU . 78.7 t -61.23 -46.91 95.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.911 -0.316 . . . . 15.0 110.277 -177.015 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -67.99 -50.12 57.54 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.261 0.351 . . . . 15.0 111.843 -175.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.83 -44.48 77.12 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.727 0.269 . . . . 15.0 111.727 -173.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -78.73 -10.04 59.63 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.213 0.82 . . . . 15.0 113.213 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 56.43 55.83 6.21 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.6 0.714 . . . . 15.0 110.139 -177.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 44' ' ' VAL . 96.5 mt -70.57 147.84 48.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.609 -0.723 . . . . 15.0 111.029 -176.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -95.69 -40.66 9.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.597 -0.729 . . . . 15.0 110.798 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -149.22 166.9 29.54 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 119.806 -1.187 . . . . 15.0 113.765 -171.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 74.8 mt -126.81 144.47 50.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.627 -0.786 . . . . 15.0 110.155 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.516 HG22 ' CD1' ' A' ' 80' ' ' PHE . 47.7 t -122.69 132.11 71.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 110.181 -0.303 . . . . 15.0 110.181 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.48 HG12 ' HB2' ' A' ' 8' ' ' MET . 7.6 m -128.57 141.16 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 121.152 0.501 . . . . 15.0 110.565 173.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.6 t -99.33 -16.4 18.47 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.564 -0.744 . . . . 15.0 112.674 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 81.5 p -151.02 159.71 44.39 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.281 0.562 . . . . 15.0 111.684 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.5 -39.05 83.52 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.929 -0.868 . . . . 15.0 110.929 178.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -58.99 -44.49 91.62 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.801 -0.359 . . . . 15.0 110.636 -178.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.04 -44.62 97.09 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.559 -1.016 . . . . 15.0 110.559 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.614 HD13 HD21 ' A' ' 79' ' ' LEU . 31.8 tp -57.35 -43.08 83.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.063 0.459 . . . . 15.0 110.578 -179.106 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.16 -42.44 98.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.116 -0.493 . . . . 15.0 110.734 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.522 ' OD1' HD13 ' A' ' 33' ' ' LEU . 26.2 m120 -59.34 -41.63 89.62 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.849 -0.34 . . . . 15.0 110.54 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.436 ' CD1' HD21 ' A' ' 40' ' ' LEU . 13.9 tp -58.39 -44.1 88.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.222 0.534 . . . . 15.0 110.237 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -61.61 -48.01 82.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.845 -0.616 . . . . 15.0 110.836 -178.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -61.27 -42.82 99.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.067 -0.515 . . . . 15.0 111.017 -176.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.31 -35.9 81.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.346 -0.388 . . . . 15.0 111.37 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.679 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -58.86 -39.36 81.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.059 0.457 . . . . 15.0 110.665 177.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 58.88 -142.18 0.66 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.68 -0.489 . . . . 15.0 109.68 174.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.66 -18.61 43.32 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.426 1.012 . . . . 15.0 112.62 -175.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.511 ' CG ' HD22 ' A' ' 41' ' ' LEU . 15.7 m-20 -91.9 9.36 33.27 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.331 0.863 . . . . 15.0 113.331 -175.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -47.79 -46.94 63.02 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.63 -0.7 . . . . 15.0 112.532 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -44.72 -40.91 14.66 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 C-N-CA 121.357 1.372 . . . . 15.0 113.252 177.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -76.96 -48.78 17.11 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.996 0.427 . . . . 15.0 110.828 -178.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.679 HD12 ' HB1' ' A' ' 67' ' ' ALA . 91.8 mt -59.84 -40.36 82.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.928 -176.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.0 -13.49 34.39 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 119.877 -0.401 . . . . 15.0 113.197 -176.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 -64.98 -30.61 71.61 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.486 0.643 . . . . 15.0 111.839 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.7 mt -72.52 146.21 88.48 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 119.32 -0.372 . . . . 15.0 110.922 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -61.42 131.15 34.74 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.375 1.383 . . . . 15.0 111.909 175.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.614 HD21 HD13 ' A' ' 60' ' ' LEU . 27.3 tp -107.0 126.97 53.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.581 -0.281 . . . . 15.0 110.697 176.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.516 ' CD1' HG22 ' A' ' 53' ' ' VAL . 83.6 m-85 -89.8 126.79 35.81 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.579 -0.526 . . . . 15.0 109.579 176.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' A' ' 87' ' ' ALA . 30.1 m -119.78 151.35 52.1 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-O 119.513 -0.28 . . . . 15.0 110.602 176.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.412 ' HD2' HG11 ' A' ' 86' ' ' VAL . 72.2 Cg_endo -79.2 -22.83 8.1 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.549 1.499 . . . . 15.0 113.869 -176.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.5 p -147.82 162.73 30.39 Favored Pre-proline 0 CA--C 1.531 0.236 0 C-N-CA 120.388 -0.525 . . . . 15.0 111.802 -171.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.17 -44.12 49.69 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.26 1.307 . . . . 15.0 111.792 176.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -57.05 -48.12 79.3 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.849 0.357 . . . . 15.0 110.765 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.412 HG11 ' HD2' ' A' ' 82' ' ' PRO . 56.6 t -60.22 -39.1 79.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.799 -0.36 . . . . 15.0 110.094 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.469 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -56.92 -41.49 78.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.982 0.42 . . . . 15.0 110.459 178.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -61.08 -41.0 95.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 15.0 110.429 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.0 mmm -58.13 -45.43 87.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.589 0.709 . . . . 15.0 110.195 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.476 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -62.06 -40.76 96.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.608 -0.724 . . . . 15.0 110.935 -178.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -61.85 -44.38 96.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.363 -0.38 . . . . 15.0 110.836 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.3 -36.06 77.01 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.851 -0.34 . . . . 15.0 111.339 -177.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.8 mt -66.13 -23.93 66.58 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.289 0.477 . . . . 15.0 112.289 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.24 13.31 17.82 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 119.406 -0.663 . . . . 15.0 113.171 -176.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.01 122.38 12.89 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.551 1.175 . . . . 15.0 109.852 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -67.94 -36.52 80.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.597 -0.729 . . . . 15.0 111.123 -171.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 58.7 ttt85 -131.82 117.54 18.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.956 0.408 . . . . 15.0 110.567 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.55 130.13 69.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.925 0.393 . . . . 15.0 110.038 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 90.6 mt -119.68 124.16 72.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.902 -0.59 . . . . 15.0 110.299 -177.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -92.88 114.85 27.52 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.907 -0.405 . . . . 15.0 109.907 174.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.483 ' HB2' HD11 ' A' ' 109' ' ' LEU . 31.8 p -81.44 -13.95 57.64 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.95 0.722 . . . . 15.0 112.95 -178.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -54.74 -38.74 67.52 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 122.082 -0.386 . . . . 15.0 111.001 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.53 -35.01 8.13 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.644 -0.583 . . . . 15.0 111.644 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.98 122.38 34.44 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.83 0.348 . . . . 15.0 110.81 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 48.8 m -65.42 161.98 18.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.634 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.63 -54.2 24.71 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 118.49 -0.767 . . . . 15.0 113.033 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.38 -35.99 96.8 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 CA-C-N 120.564 1.237 . . . . 15.0 111.384 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.32 -42.11 94.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.027 0.441 . . . . 15.0 110.125 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' A' ' 101' ' ' CYS . 82.8 mt -59.0 -40.42 84.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.062 0.458 . . . . 15.0 110.57 178.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.434 HD22 ' HB3' ' A' ' 24' ' ' GLN . 39.8 tp -57.21 -44.52 83.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.408 0.623 . . . . 15.0 110.053 178.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.21 -39.57 87.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.587 -0.733 . . . . 15.0 110.538 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.48 -41.48 94.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.443 -0.344 . . . . 15.0 110.917 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.0 mt -57.9 -51.16 70.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.161 0.505 . . . . 15.0 110.443 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.6 p -63.61 -40.24 96.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.67 -0.695 . . . . 15.0 111.323 -175.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.9 p -66.34 -38.6 88.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.724 0.297 . . . . 15.0 111.336 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.3 96.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.495 -0.321 . . . . 15.0 110.82 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.478 -0.328 . . . . 15.0 110.616 177.892 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 . . . . . 0 CA--C 1.535 0.379 0 N-CA-C 110.126 -0.324 . . . . 15.0 110.126 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.1 150.27 10.62 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.504 1.469 . . . . 15.0 112.179 -174.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.497 ' HB2' HD23 ' A' ' 49' ' ' LEU . 61.3 mttp -117.0 140.71 49.16 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.22 -0.446 . . . . 15.0 110.858 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.512 HG21 HD13 ' A' ' 21' ' ' LEU . 15.7 m -134.28 144.62 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.567 0.698 . . . . 15.0 111.67 175.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.6 tp -104.27 137.51 42.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.078 -0.965 . . . . 15.0 110.326 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.617 HD11 ' CG1' ' A' ' 28' ' ' VAL . 52.5 mt -102.47 134.12 44.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.005 0.431 . . . . 15.0 111.025 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.532 ' HB2' HG12 ' A' ' 54' ' ' VAL . 98.4 mmm -95.01 134.15 38.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.221 -0.9 . . . . 15.0 109.307 171.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -57.65 144.63 37.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.948 0.404 . . . . 15.0 110.678 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -161.68 175.15 38.25 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.801 -0.92 . . . . 15.0 110.801 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.94 -34.72 60.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.536 0.208 . . . . 15.0 111.486 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.81 162.94 29.83 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.9 -0.88 . . . . 15.0 110.9 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.93 130.92 10.1 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.232 -0.747 . . . . 15.0 111.232 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -57.13 -43.82 82.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.985 0.421 . . . . 15.0 110.359 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.23 -43.01 99.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.046 -0.525 . . . . 15.0 111.333 -176.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -61.52 -56.09 23.87 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.858 -0.337 . . . . 15.0 111.341 -176.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.4 mt -60.66 -43.45 97.6 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.708 -0.397 . . . . 15.0 111.031 -176.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.78 -39.4 94.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.389 -0.369 . . . . 15.0 110.92 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -60.76 -43.01 98.53 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.905 -0.318 . . . . 15.0 110.482 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.487 ' NH2' ' HB3' ' A' ' 106' ' ' ALA . 15.6 tpt180 -61.19 -51.57 68.43 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.421 -0.511 . . . . 15.0 110.943 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.512 HD13 HG21 ' A' ' 5' ' ' VAL . 69.2 mt -62.61 -36.97 84.48 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.515 -0.474 . . . . 15.0 110.999 -178.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -63.05 -43.31 99.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.618 0.247 . . . . 15.0 111.045 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.96 -30.59 66.79 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.035 -0.602 . . . . 15.0 111.932 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.408 ' HB3' HD22 ' A' ' 110' ' ' LEU . 25.1 mt-30 -88.09 9.87 21.12 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.494 0.924 . . . . 15.0 113.494 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.27 14.69 58.48 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 121.258 -0.496 . . . . 15.0 113.501 174.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.0 t -101.1 139.07 23.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 117.857 0.828 . . . . 15.0 110.22 178.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -84.45 134.08 34.47 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.04 -0.726 . . . . 15.0 109.04 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.617 ' CG1' HD11 ' A' ' 7' ' ' ILE . 22.4 t -119.59 133.96 64.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.229 0.537 . . . . 15.0 111.353 -173.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -137.84 136.3 37.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.469 -0.787 . . . . 15.0 109.591 172.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.443 ' HB3' HD12 ' A' ' 7' ' ' ILE . 33.7 p90 -115.37 140.93 48.69 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.793 0.33 . . . . 15.0 110.827 -178.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.1 tp -119.3 113.43 35.28 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-O 118.741 -0.647 . . . . 15.0 110.715 -175.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.17 135.08 63.36 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 121.168 1.246 . . . . 15.0 111.964 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.681 HD13 ' OD1' ' A' ' 62' ' ' ASN . 50.3 mt -62.53 -9.14 7.72 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.358 0.873 . . . . 15.0 113.358 -175.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -77.09 -9.5 58.78 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.18 0.807 . . . . 15.0 113.18 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -60.78 149.18 80.85 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 118.292 0.496 . . . . 15.0 110.251 -178.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.97 154.18 25.7 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.53 1.487 . . . . 15.0 112.968 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.23 150.77 5.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.955 -0.566 . . . . 15.0 111.163 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.95 -37.65 3.39 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.439 -0.664 . . . . 15.0 111.439 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.89 -36.9 80.41 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.594 -0.442 . . . . 15.0 111.103 -177.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 44' ' ' VAL . 23.2 tp -58.97 -45.99 89.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.379 . . . . 15.0 110.201 -178.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.612 HD22 ' OD1' ' A' ' 70' ' ' ASP . 10.2 tp -62.65 -45.35 93.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.209 -0.45 . . . . 15.0 110.803 -177.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.74 -43.59 98.56 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.731 -0.388 . . . . 15.0 110.852 -176.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -60.52 -43.9 96.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.558 -0.292 . . . . 15.0 110.522 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.563 ' HA ' HD12 ' A' ' 49' ' ' LEU . 78.3 t -61.18 -46.38 96.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.774 -0.37 . . . . 15.0 110.214 -176.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -68.41 -51.04 48.25 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.348 0.405 . . . . 15.0 112.025 -175.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.83 -44.37 81.26 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.736 0.273 . . . . 15.0 111.736 -173.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -79.37 -10.17 59.75 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.06 0.763 . . . . 15.0 113.06 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.7 mtp180 55.39 55.81 7.0 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.658 0.742 . . . . 15.0 110.273 -177.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.563 HD12 ' HA ' ' A' ' 44' ' ' VAL . 94.8 mt -70.72 146.22 50.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.643 -0.708 . . . . 15.0 111.296 -174.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -93.45 -40.6 10.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.408 -0.814 . . . . 15.0 110.876 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.86 165.11 29.23 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 119.943 -1.122 . . . . 15.0 113.785 -173.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 74.2 mt -125.62 142.16 51.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.466 -0.867 . . . . 15.0 109.837 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.526 HG22 ' CD1' ' A' ' 80' ' ' PHE . 47.6 t -120.49 129.55 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 110.261 -0.274 . . . . 15.0 110.261 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.532 HG12 ' HB2' ' A' ' 8' ' ' MET . 10.5 m -128.27 133.39 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.873 0.368 . . . . 15.0 110.095 172.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.5 p -99.38 -4.22 32.09 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.998 0.74 . . . . 15.0 112.998 177.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 82.7 p -152.46 154.92 36.49 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.366 0.603 . . . . 15.0 111.793 -176.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.03 -38.92 88.43 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.986 -0.846 . . . . 15.0 110.986 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -57.41 -46.14 83.83 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 122.63 -0.336 . . . . 15.0 110.638 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.32 -44.37 96.6 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.7 -0.96 . . . . 15.0 110.7 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.628 HD13 HD21 ' A' ' 79' ' ' LEU . 36.5 tp -57.19 -45.27 83.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.123 0.487 . . . . 15.0 110.597 -178.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.35 -42.13 98.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.029 -0.532 . . . . 15.0 110.818 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.681 ' OD1' HD13 ' A' ' 33' ' ' LEU . 32.7 m120 -60.06 -40.48 89.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.523 -0.308 . . . . 15.0 110.669 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.1 tp -58.42 -44.35 89.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.142 0.496 . . . . 15.0 110.149 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -60.96 -47.35 86.86 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.801 -0.636 . . . . 15.0 110.719 -178.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.43 -43.02 99.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.089 -0.505 . . . . 15.0 111.116 -176.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.3 mt -66.26 -35.44 80.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.354 -0.385 . . . . 15.0 111.375 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.676 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.03 -39.0 80.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.095 0.474 . . . . 15.0 110.672 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.02 -142.89 0.62 Allowed 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.691 -0.485 . . . . 15.0 109.691 174.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.56 -19.77 50.94 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.38 0.991 . . . . 15.0 112.697 -174.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.612 ' OD1' HD22 ' A' ' 41' ' ' LEU . 78.4 m-20 -91.9 11.04 26.29 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.307 0.854 . . . . 15.0 113.307 -175.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 55.0 t-105 -47.83 -46.67 63.01 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-O 118.555 -0.736 . . . . 15.0 112.521 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -44.56 -41.09 14.22 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.498 1.465 . . . . 15.0 113.198 177.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -76.93 -48.83 17.05 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.944 0.402 . . . . 15.0 110.849 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.676 HD12 ' HB1' ' A' ' 67' ' ' ALA . 91.3 mt -59.92 -39.82 81.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 15.0 110.871 -176.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.21 -14.6 33.68 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 119.898 -0.39 . . . . 15.0 113.092 -176.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -64.15 -30.36 71.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.404 0.602 . . . . 15.0 111.963 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.0 mt -75.36 150.57 85.07 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 120.939 -0.305 . . . . 15.0 111.53 -173.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -61.98 128.35 23.94 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.675 1.584 . . . . 15.0 112.457 176.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.628 HD21 HD13 ' A' ' 60' ' ' LEU . 22.1 tp -107.64 126.31 52.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.313 -0.403 . . . . 15.0 110.474 174.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.526 ' CD1' HG22 ' A' ' 53' ' ' VAL . 75.7 m-85 -90.52 125.65 35.67 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.599 -0.519 . . . . 15.0 109.599 176.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.661 HG21 ' HB2' ' A' ' 87' ' ' ALA . 26.1 m -116.99 147.78 40.83 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 110.154 -0.313 . . . . 15.0 110.154 176.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.24 -24.76 6.36 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.634 1.556 . . . . 15.0 113.538 -174.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.8 p -142.78 162.3 44.7 Favored Pre-proline 0 CA--C 1.531 0.213 0 C-N-CA 120.611 -0.436 . . . . 15.0 111.658 -171.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.0 -44.04 50.96 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.21 1.273 . . . . 15.0 111.841 176.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -58.25 -47.06 84.75 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.915 -0.314 . . . . 15.0 110.737 -177.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.6 t -60.2 -41.02 85.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 110.003 -0.369 . . . . 15.0 110.003 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.661 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.74 -42.35 83.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.925 0.393 . . . . 15.0 110.509 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -61.43 -41.8 97.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 15.0 110.563 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 87.1 mtp -59.17 -43.88 92.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.211 0.529 . . . . 15.0 110.268 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.52 94.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.889 -0.596 . . . . 15.0 110.792 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -61.24 -44.39 97.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.274 -0.421 . . . . 15.0 110.566 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.05 -36.15 76.69 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.868 -0.333 . . . . 15.0 111.244 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.1 mt -64.24 -25.94 68.28 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.019 0.378 . . . . 15.0 112.019 176.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.27 13.32 15.49 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 119.313 -0.715 . . . . 15.0 113.045 -176.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.97 122.4 12.91 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.521 1.16 . . . . 15.0 109.91 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -69.9 -35.95 75.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.705 -0.68 . . . . 15.0 111.223 -172.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -131.07 112.63 13.06 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.042 0.449 . . . . 15.0 110.398 178.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.0 t -111.0 130.23 64.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.183 -0.462 . . . . 15.0 109.901 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 84.6 mt -119.3 125.23 74.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.832 -0.622 . . . . 15.0 110.081 -177.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -95.33 118.12 31.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.401 -0.363 . . . . 15.0 110.261 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 32.0 p -95.76 -4.16 44.51 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.184 0.809 . . . . 15.0 113.184 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.1 tpt85 -55.6 -39.54 70.89 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.086 0.403 . . . . 15.0 110.712 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -95.79 -35.14 5.71 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.532 -0.627 . . . . 15.0 111.532 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.64 137.27 40.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.823 0.344 . . . . 15.0 110.68 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.2 p -83.87 164.49 19.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 15.0 110.665 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.487 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . . . -47.72 -54.3 24.33 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 113.018 0.748 . . . . 15.0 113.018 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.49 -36.0 97.19 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 CA-C-N 120.469 1.203 . . . . 15.0 111.394 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.47 -42.89 97.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.114 0.483 . . . . 15.0 110.103 178.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.3 mt -59.0 -41.2 87.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 15.0 110.414 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.408 HD22 ' HB3' ' A' ' 24' ' ' GLN . 34.3 tp -57.61 -44.55 85.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.37 0.605 . . . . 15.0 110.183 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.78 94.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.673 -0.694 . . . . 15.0 110.514 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.7 -41.08 94.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.416 -0.356 . . . . 15.0 110.811 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.4 mt -57.69 -51.76 68.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.233 0.539 . . . . 15.0 110.459 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.0 p -64.04 -40.57 96.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.647 -0.706 . . . . 15.0 111.33 -175.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.9 m -63.42 -42.86 98.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.732 0.301 . . . . 15.0 111.46 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.64 -39.27 93.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.446 -0.343 . . . . 15.0 111.049 -178.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.555 -0.293 . . . . 15.0 111.14 179.519 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 . . . . . 0 CA--C 1.535 0.394 0 N-CA-C 110.179 -0.304 . . . . 15.0 110.179 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -56.42 152.87 37.39 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.393 1.395 . . . . 15.0 112.0 -175.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -110.78 139.0 46.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.383 -0.371 . . . . 15.0 110.687 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.497 HG21 HD13 ' A' ' 21' ' ' LEU . 13.2 m -135.72 142.74 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.596 0.713 . . . . 15.0 111.695 176.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.497 HD13 ' HD3' ' A' ' 43' ' ' ARG . 18.3 tp -104.77 135.35 46.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.863 -1.062 . . . . 15.0 110.129 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.576 HD11 ' CG1' ' A' ' 28' ' ' VAL . 57.5 mt -104.75 133.74 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.19 0.519 . . . . 15.0 110.888 -176.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 98.4 mmm -95.2 134.06 38.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.062 -0.972 . . . . 15.0 109.488 173.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -62.09 143.99 55.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.886 0.374 . . . . 15.0 110.677 -178.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.57 175.07 32.83 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.108 -0.797 . . . . 15.0 111.108 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.59 -33.31 66.08 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.576 0.214 . . . . 15.0 111.576 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.4 -178.28 4.6 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.963 -0.855 . . . . 15.0 110.963 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.04 112.6 3.67 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.05 -0.82 . . . . 15.0 111.05 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -56.83 -45.85 82.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.308 0.575 . . . . 15.0 110.146 -177.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.77 -44.31 93.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.694 -0.684 . . . . 15.0 111.122 -177.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -56.61 -53.83 53.06 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.805 -0.358 . . . . 15.0 111.281 -175.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.448 ' H ' HD12 ' A' ' 17' ' ' LEU . 5.9 mp -59.88 -43.21 94.87 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 120.649 -0.42 . . . . 15.0 110.883 -177.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.89 -42.52 98.14 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.752 -0.379 . . . . 15.0 111.48 -177.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.21 -39.16 89.2 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.776 -0.37 . . . . 15.0 110.846 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -60.23 -51.49 69.34 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.273 -0.571 . . . . 15.0 111.133 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.497 HD13 HG21 ' A' ' 5' ' ' VAL . 80.3 mt -62.89 -38.68 91.87 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.499 -0.48 . . . . 15.0 111.008 -177.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -64.0 -43.64 95.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.574 0.226 . . . . 15.0 110.955 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.24 -30.56 67.7 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.032 -0.604 . . . . 15.0 112.026 -178.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -88.14 9.76 21.63 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.52 0.933 . . . . 15.0 113.52 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.68 16.45 52.05 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 121.12 -0.562 . . . . 15.0 113.444 173.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.06 138.84 23.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 117.784 0.792 . . . . 15.0 110.058 177.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -78.29 125.41 29.32 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.059 -0.719 . . . . 15.0 109.059 177.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.576 ' CG1' HD11 ' A' ' 7' ' ' ILE . 41.3 t -117.63 131.65 69.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.132 0.492 . . . . 15.0 111.03 -172.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -137.61 131.79 32.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.611 -0.722 . . . . 15.0 109.77 171.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.402 ' HB3' HD12 ' A' ' 7' ' ' ILE . 11.2 p90 -114.62 134.55 54.97 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.217 -0.29 . . . . 15.0 110.217 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.2 tp -111.34 140.26 22.79 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 119.162 -0.446 . . . . 15.0 110.373 -174.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -72.11 135.13 24.49 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.219 1.279 . . . . 15.0 111.11 170.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.601 HD13 ' OD1' ' A' ' 62' ' ' ASN . 53.0 mt -63.21 -9.25 10.5 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.122 0.786 . . . . 15.0 113.122 -175.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -77.27 -10.25 59.31 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.263 0.838 . . . . 15.0 113.263 -177.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -62.46 151.07 83.98 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 118.552 0.614 . . . . 15.0 110.855 -177.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -79.11 155.49 25.89 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.479 1.453 . . . . 15.0 113.1 -177.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.24 150.73 8.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.875 -0.602 . . . . 15.0 111.072 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.98 -36.28 4.21 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.514 -0.634 . . . . 15.0 111.514 -177.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -59.54 -40.05 85.94 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 120.498 -0.481 . . . . 15.0 110.697 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.574 ' O ' HG23 ' A' ' 44' ' ' VAL . 23.7 tp -61.13 -47.97 83.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.963 0.411 . . . . 15.0 110.458 -177.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.485 HD13 ' CB ' ' A' ' 70' ' ' ASP . 19.0 tp -61.25 -43.44 98.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 15.0 110.888 -175.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.12 -46.01 90.92 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.782 -0.367 . . . . 15.0 110.84 -175.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.497 ' HD3' HD13 ' A' ' 6' ' ' LEU . 46.9 ttt85 -61.1 -41.87 97.47 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.635 -0.426 . . . . 15.0 110.567 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 40' ' ' LEU . 94.4 t -58.78 -45.59 91.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.753 -0.379 . . . . 15.0 110.022 -177.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -70.59 -50.94 31.93 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.503 0.502 . . . . 15.0 112.275 -176.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.75 -44.4 86.03 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.067 0.395 . . . . 15.0 112.067 -172.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.6 mp0 -89.11 -7.03 56.56 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.391 0.886 . . . . 15.0 113.391 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.8 ttt-85 57.97 56.05 4.92 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.662 0.744 . . . . 15.0 109.829 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.456 HD12 HG22 ' A' ' 44' ' ' VAL . 95.9 mt -60.61 142.69 55.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.595 -0.73 . . . . 15.0 110.891 -175.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -90.56 -40.56 11.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.481 -0.781 . . . . 15.0 110.822 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -149.57 163.57 29.31 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.079 -1.058 . . . . 15.0 113.498 -174.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.4 mt -126.27 141.06 52.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.433 -0.883 . . . . 15.0 109.903 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.555 HG22 ' CD1' ' A' ' 80' ' ' PHE . 47.4 t -120.83 131.31 73.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 110.294 -0.262 . . . . 15.0 110.294 -179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.6 m -124.14 130.55 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.134 0.493 . . . . 15.0 110.374 172.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.6 m -87.17 -19.45 28.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.586 -0.734 . . . . 15.0 112.514 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.8 p -151.86 161.04 43.29 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.336 0.588 . . . . 15.0 111.509 -175.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.35 -39.17 82.24 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.992 -0.843 . . . . 15.0 110.992 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -57.93 -45.9 85.85 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.864 -0.334 . . . . 15.0 110.563 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.63 -43.96 97.27 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.734 -0.947 . . . . 15.0 110.734 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.607 HD13 HD21 ' A' ' 79' ' ' LEU . 40.2 tp -57.48 -43.99 84.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.023 0.439 . . . . 15.0 110.559 -178.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.03 -42.17 97.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.077 -0.51 . . . . 15.0 110.641 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.601 ' OD1' HD13 ' A' ' 33' ' ' LEU . 25.9 m120 -59.51 -40.72 87.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.444 -0.344 . . . . 15.0 110.635 178.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.9 tp -58.61 -44.54 89.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.135 0.493 . . . . 15.0 110.114 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -61.29 -47.26 86.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.852 -0.613 . . . . 15.0 110.703 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -61.36 -42.93 99.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.086 -0.506 . . . . 15.0 111.102 -176.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.7 mt -66.94 -34.95 78.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.34 -0.391 . . . . 15.0 111.478 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.676 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.04 -39.49 82.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.076 0.465 . . . . 15.0 110.601 177.247 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 58.95 -142.79 0.63 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 109.662 -0.496 . . . . 15.0 109.662 174.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.53 -18.87 44.06 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.417 1.008 . . . . 15.0 112.631 -174.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.485 ' CB ' HD13 ' A' ' 41' ' ' LEU . 16.6 m-20 -91.82 9.65 31.86 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.313 0.857 . . . . 15.0 113.313 -175.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -47.97 -46.62 64.38 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-O 118.559 -0.734 . . . . 15.0 112.521 177.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -44.7 -41.2 14.69 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.481 1.454 . . . . 15.0 113.218 177.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.5 mp0 -77.03 -48.76 17.01 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.688 -0.405 . . . . 15.0 110.755 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.676 HD12 ' HB1' ' A' ' 67' ' ' ALA . 89.8 mt -59.8 -40.2 81.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.279 -0.419 . . . . 15.0 110.858 -176.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.73 -15.14 32.71 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 119.903 -0.387 . . . . 15.0 113.107 -177.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -64.25 -30.61 71.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.417 0.608 . . . . 15.0 111.977 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.5 mt -76.24 150.46 82.9 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 121.065 -0.254 . . . . 15.0 111.397 -173.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.92 128.13 25.68 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 121.695 1.597 . . . . 15.0 112.43 176.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.607 HD21 HD13 ' A' ' 60' ' ' LEU . 22.3 tp -106.68 125.58 51.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 15.0 110.425 174.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.555 ' CD1' HG22 ' A' ' 53' ' ' VAL . 84.2 m-85 -91.56 125.63 36.36 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.607 -0.516 . . . . 15.0 109.607 176.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.695 HG21 ' HB2' ' A' ' 87' ' ' ALA . 28.2 m -116.85 148.06 41.3 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 110.114 -0.328 . . . . 15.0 110.114 176.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.413 ' HD2' HG11 ' A' ' 86' ' ' VAL . 74.9 Cg_endo -79.12 -24.27 6.92 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.486 1.457 . . . . 15.0 113.592 -175.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.4 ' OG ' HG23 ' A' ' 86' ' ' VAL . 27.6 p -143.43 162.06 44.15 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 120.564 -0.454 . . . . 15.0 111.644 -172.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.85 -44.04 51.33 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.241 1.294 . . . . 15.0 111.741 176.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -57.62 -47.87 81.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.8 0.333 . . . . 15.0 110.827 -178.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.413 HG11 ' HD2' ' A' ' 82' ' ' PRO . 52.4 t -59.74 -40.64 83.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.767 -0.373 . . . . 15.0 110.03 178.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.695 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.46 -42.3 82.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.921 0.391 . . . . 15.0 110.488 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.24 -41.87 97.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.147 -0.479 . . . . 15.0 110.465 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 87.0 mtp -59.34 -43.68 92.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.349 0.595 . . . . 15.0 110.384 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.48 -40.07 93.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.916 -0.584 . . . . 15.0 110.77 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -61.23 -44.28 97.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.335 -0.393 . . . . 15.0 110.61 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.95 -36.17 76.51 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.936 -0.306 . . . . 15.0 111.224 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.0 mt -64.09 -25.73 68.23 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.086 0.402 . . . . 15.0 112.086 176.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.57 13.31 17.06 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 119.336 -0.702 . . . . 15.0 113.098 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.02 122.87 14.07 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.534 1.167 . . . . 15.0 109.92 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -69.91 -35.7 74.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.734 -0.666 . . . . 15.0 111.223 -172.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -130.71 113.31 13.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.938 0.399 . . . . 15.0 110.302 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.09 129.52 66.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.236 -0.438 . . . . 15.0 109.9 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.2 mt -120.11 125.72 74.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.81 -0.632 . . . . 15.0 110.163 -176.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -94.39 117.33 29.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.458 -0.337 . . . . 15.0 110.345 175.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 32.0 p -97.0 -1.53 45.33 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.299 0.852 . . . . 15.0 113.299 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -55.53 -39.57 70.72 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 118.182 0.446 . . . . 15.0 110.785 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -95.21 -35.02 5.88 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.53 -0.628 . . . . 15.0 111.53 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.51 138.89 47.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.802 0.334 . . . . 15.0 110.644 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.5 p -85.77 164.9 17.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.094 -0.503 . . . . 15.0 110.529 179.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.68 -54.33 23.94 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 113.0 0.741 . . . . 15.0 113.0 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.69 -34.59 99.02 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 CA-C-N 120.099 1.071 . . . . 15.0 111.718 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.27 -43.31 96.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.104 0.478 . . . . 15.0 109.989 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 78.1 mt -59.31 -40.79 87.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 15.0 110.33 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 40.5 tp -57.13 -44.15 83.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.324 0.583 . . . . 15.0 110.229 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.83 -41.61 96.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.734 -0.667 . . . . 15.0 110.451 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.27 88.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 15.0 110.736 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.3 mt -57.81 -51.88 67.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.201 0.524 . . . . 15.0 110.395 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.7 p -63.69 -40.27 96.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.614 -0.721 . . . . 15.0 111.389 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.4 m -63.34 -43.24 98.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.66 0.267 . . . . 15.0 111.386 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.41 -39.36 93.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.42 -0.355 . . . . 15.0 111.091 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.423 -0.353 . . . . 15.0 110.939 179.12 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.535 0.385 0 N-CA-C 110.125 -0.324 . . . . 15.0 110.125 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.06 155.02 25.23 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.441 1.428 . . . . 15.0 111.921 -175.974 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -111.95 138.14 48.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.379 -0.373 . . . . 15.0 110.79 179.721 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.51 HG21 HD13 ' A' ' 21' ' ' LEU . 15.0 m -134.56 144.46 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.435 0.636 . . . . 15.0 111.638 176.449 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.1 tp -105.05 137.28 43.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.203 -0.908 . . . . 15.0 110.553 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.608 HD11 ' CG1' ' A' ' 28' ' ' VAL . 54.8 mt -103.16 133.41 47.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.01 0.433 . . . . 15.0 110.679 -177.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.572 ' HB2' HG12 ' A' ' 54' ' ' VAL . 85.5 mtp -106.05 134.43 49.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.31 -0.859 . . . . 15.0 110.197 174.404 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -57.43 144.98 34.4 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.108 0.48 . . . . 15.0 110.772 -177.622 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.35 175.16 36.29 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.763 -0.935 . . . . 15.0 110.763 -178.001 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.01 -32.68 47.97 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.681 0.252 . . . . 15.0 111.681 -179.287 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.95 -179.5 39.9 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.042 -0.823 . . . . 15.0 111.042 -178.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.01 113.98 3.88 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.156 -0.778 . . . . 15.0 111.156 -178.516 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -56.62 -47.66 79.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.119 0.485 . . . . 15.0 110.498 -179.453 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.38 -40.52 97.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 15.0 110.904 -178.646 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -57.46 -54.41 47.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.113 0.482 . . . . 15.0 110.764 -176.174 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.889 HD21 HG11 ' A' ' 53' ' ' VAL . 15.8 tp -57.88 -43.09 85.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 15.0 110.598 -179.004 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.37 -45.5 84.35 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.695 -0.402 . . . . 15.0 111.101 -178.02 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -59.81 -40.58 88.9 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.772 -0.371 . . . . 15.0 110.658 -176.835 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.1 mmt85 -59.76 -51.43 69.77 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.299 -0.56 . . . . 15.0 111.358 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.51 HD13 HG21 ' A' ' 5' ' ' VAL . 86.2 mt -62.61 -35.7 80.41 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.541 -0.464 . . . . 15.0 111.108 -176.442 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -64.19 -43.35 95.35 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.918 -0.313 . . . . 15.0 111.127 177.076 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.78 -30.63 66.3 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.008 -0.615 . . . . 15.0 112.066 -178.273 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -88.2 8.71 25.81 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.66 0.985 . . . . 15.0 113.66 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.73 17.62 56.24 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 121.233 -0.508 . . . . 15.0 113.245 175.391 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.0 t -101.12 140.25 20.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 117.745 0.772 . . . . 15.0 109.861 177.475 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -80.57 127.73 32.79 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.118 -0.697 . . . . 15.0 109.118 178.245 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.608 ' CG1' HD11 ' A' ' 7' ' ' ILE . 43.1 t -116.89 131.39 69.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.208 0.528 . . . . 15.0 111.025 -172.902 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -134.89 135.33 41.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.367 -0.833 . . . . 15.0 109.293 172.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.566 ' HB3' HD12 ' A' ' 7' ' ' ILE . 9.1 p90 -120.65 133.53 55.36 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.773 0.32 . . . . 15.0 110.7 -176.515 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.7 tp -117.01 141.5 28.47 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 116.14 -0.482 . . . . 15.0 110.004 -174.339 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -72.07 135.07 24.46 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.418 1.412 . . . . 15.0 111.699 170.149 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.423 HD13 ' OD1' ' A' ' 62' ' ' ASN . 74.7 mt -61.7 -10.0 7.61 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.943 0.72 . . . . 15.0 112.943 179.305 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -77.21 -10.87 59.68 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.191 0.811 . . . . 15.0 113.191 -177.209 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -62.7 148.96 90.29 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 118.512 0.596 . . . . 15.0 110.824 -177.885 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.1 159.03 37.68 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.574 1.516 . . . . 15.0 113.225 -174.927 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.04 152.43 5.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.729 -0.669 . . . . 15.0 111.061 -178.759 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.28 -35.69 4.24 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.487 -0.645 . . . . 15.0 111.487 -176.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -59.47 -39.01 82.29 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 117.094 0.447 . . . . 15.0 110.835 -177.617 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.589 ' O ' HG23 ' A' ' 44' ' ' VAL . 22.3 tp -59.3 -48.55 81.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.068 0.461 . . . . 15.0 110.274 -177.731 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.606 HD22 ' OD1' ' A' ' 70' ' ' ASP . 10.1 tp -62.47 -43.01 99.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.091 -0.504 . . . . 15.0 111.091 -175.921 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.62 -45.97 90.39 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.787 -0.365 . . . . 15.0 110.948 -175.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -61.07 -40.98 95.74 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.71 -0.396 . . . . 15.0 110.55 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 40' ' ' LEU . 84.8 t -59.54 -48.15 88.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 110.013 -0.365 . . . . 15.0 110.013 -177.694 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -68.59 -51.04 46.91 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.681 0.613 . . . . 15.0 112.098 -174.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.56 -44.26 82.77 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.789 0.292 . . . . 15.0 111.789 -173.403 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -82.92 -10.08 58.99 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.14 0.793 . . . . 15.0 113.14 -178.643 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 55.63 55.77 6.87 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.621 0.724 . . . . 15.0 110.112 -177.041 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 44' ' ' VAL . 95.3 mt -66.01 144.89 56.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.611 -0.722 . . . . 15.0 111.493 -173.564 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -93.92 -39.58 10.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.226 -0.897 . . . . 15.0 110.971 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.02 165.75 31.27 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 120.04 -1.076 . . . . 15.0 113.663 -175.808 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.3 mt -128.77 142.7 50.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.578 -0.811 . . . . 15.0 109.445 178.604 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.889 HG11 HD21 ' A' ' 17' ' ' LEU . 45.8 t -120.93 130.53 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 120.757 0.313 . . . . 15.0 110.541 -179.504 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.572 HG12 ' HB2' ' A' ' 8' ' ' MET . 13.9 m -130.4 155.64 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.2 -0.455 . . . . 15.0 110.17 172.129 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.8 t -131.18 12.09 5.07 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.716 0.636 . . . . 15.0 112.716 177.926 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 81.9 p -154.14 151.52 29.34 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.184 0.516 . . . . 15.0 111.577 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.48 -40.08 91.7 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.599 -1.0 . . . . 15.0 110.599 176.755 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -58.93 -42.03 88.74 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.897 -0.321 . . . . 15.0 110.6 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.48 -46.23 94.75 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.627 -0.989 . . . . 15.0 110.627 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.413 HD13 HD21 ' A' ' 79' ' ' LEU . 29.9 tp -57.54 -43.32 84.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.985 0.421 . . . . 15.0 110.474 -179.246 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.31 -42.25 98.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.474 . . . . 15.0 110.81 -179.501 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.423 ' OD1' HD13 ' A' ' 33' ' ' LEU . 28.5 m120 -59.05 -42.38 90.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.955 0.407 . . . . 15.0 110.412 178.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.2 tp -58.47 -44.16 89.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.125 0.488 . . . . 15.0 110.296 -179.032 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -61.75 -48.32 81.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.942 -0.572 . . . . 15.0 110.762 -177.734 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.41 -42.65 99.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.043 -0.526 . . . . 15.0 111.095 -176.747 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 92.1 mt -67.42 -35.3 78.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.37 -0.377 . . . . 15.0 111.489 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.694 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -58.9 -38.1 78.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.06 0.457 . . . . 15.0 110.665 177.142 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.43 -143.25 0.58 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 109.501 -0.555 . . . . 15.0 109.501 173.655 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.53 -19.5 48.75 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.377 0.989 . . . . 15.0 112.63 -174.721 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.606 ' OD1' HD22 ' A' ' 41' ' ' LEU . 79.4 m-20 -91.91 11.03 26.35 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 113.362 0.875 . . . . 15.0 113.362 -175.179 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 60.4 t-105 -47.9 -46.07 62.83 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-O 118.501 -0.762 . . . . 15.0 112.548 177.917 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -44.67 -42.71 14.73 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 121.416 1.411 . . . . 15.0 113.271 177.063 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -76.96 -48.73 17.24 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.032 0.444 . . . . 15.0 110.626 -177.915 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.694 HD12 ' HB1' ' A' ' 67' ' ' ALA . 87.4 mt -59.73 -35.6 60.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.014 -0.539 . . . . 15.0 111.061 -177.162 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.0 -20.64 34.95 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 119.969 -0.35 . . . . 15.0 112.946 -176.772 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -64.08 -30.16 71.25 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.34 0.57 . . . . 15.0 112.347 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.8 mt -62.21 150.49 84.2 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 119.545 -0.264 . . . . 15.0 110.891 -174.491 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.453 ' HB2' HD12 ' A' ' 99' ' ' ILE . 59.0 Cg_endo -73.34 123.12 8.49 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 121.419 1.413 . . . . 15.0 111.669 175.764 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.413 HD21 HD13 ' A' ' 60' ' ' LEU . 26.4 tp -102.46 123.7 46.7 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.906 -0.318 . . . . 15.0 110.581 176.847 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.625 ' CD1' HG22 ' A' ' 53' ' ' VAL . 76.4 m-85 -87.84 125.2 34.33 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.382 -0.599 . . . . 15.0 109.382 175.606 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.663 HG21 ' HB2' ' A' ' 87' ' ' ALA . 27.0 m -117.96 147.82 42.1 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 119.429 -0.319 . . . . 15.0 110.186 176.09 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.405 ' HD2' HG11 ' A' ' 86' ' ' VAL . 94.6 Cg_endo -79.13 -24.43 6.77 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.532 1.488 . . . . 15.0 113.52 -175.11 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.9 p -143.09 161.25 49.23 Favored Pre-proline 0 CA--C 1.531 0.235 0 C-N-CA 120.627 -0.429 . . . . 15.0 111.41 -172.296 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -54.98 -44.05 53.52 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.115 1.21 . . . . 15.0 111.78 176.135 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -57.5 -48.46 79.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.847 0.356 . . . . 15.0 110.613 -177.696 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.405 HG11 ' HD2' ' A' ' 82' ' ' PRO . 55.7 t -59.74 -39.96 81.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.942 0.401 . . . . 15.0 110.043 178.517 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.663 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.22 -41.67 79.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 15.0 110.337 178.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -60.51 -40.55 91.83 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.303 -0.408 . . . . 15.0 110.415 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 96.9 mmm -57.84 -44.53 86.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.562 0.696 . . . . 15.0 110.195 179.052 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.68 -40.69 95.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.566 -0.743 . . . . 15.0 110.77 -179.417 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.445 ' HD3' HG21 ' A' ' 98' ' ' VAL . 29.9 mmt180 -62.54 -42.93 99.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.348 -0.387 . . . . 15.0 111.097 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.0 -36.01 78.36 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.869 -0.332 . . . . 15.0 111.5 -176.629 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.1 mt -66.32 -22.9 66.29 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.272 0.471 . . . . 15.0 112.272 176.539 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.21 13.33 19.7 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 119.378 -0.679 . . . . 15.0 113.051 -176.063 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.89 122.02 11.94 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.504 1.152 . . . . 15.0 109.872 -178.142 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -74.35 -31.71 62.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.509 -0.769 . . . . 15.0 111.642 -171.948 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -129.38 111.59 12.97 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.996 0.427 . . . . 15.0 110.154 175.922 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.445 HG21 ' HD3' ' A' ' 91' ' ' ARG . 43.8 t -114.66 131.25 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 15.0 109.861 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.453 HD12 ' HB2' ' A' ' 78' ' ' PRO . 85.1 mt -120.69 124.57 72.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.242 -0.435 . . . . 15.0 110.304 -176.008 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -94.3 118.48 31.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.395 -0.366 . . . . 15.0 110.302 176.381 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.4 p -96.26 -3.97 43.12 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.216 0.821 . . . . 15.0 113.216 -178.837 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -55.72 -39.55 71.24 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 118.246 0.475 . . . . 15.0 110.776 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -91.53 -35.03 7.09 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.569 -0.612 . . . . 15.0 111.569 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -82.32 132.29 35.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.841 0.353 . . . . 15.0 110.76 -179.135 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.6 p -77.91 167.04 22.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.096 -0.502 . . . . 15.0 110.572 179.126 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.64 -54.4 23.24 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 112.974 0.731 . . . . 15.0 112.974 179.045 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.09 -34.84 98.91 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 CA-C-N 120.213 1.112 . . . . 15.0 111.68 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.93 -43.0 95.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.07 0.462 . . . . 15.0 109.988 177.337 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.8 mt -59.4 -40.11 85.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 15.0 110.522 178.695 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 43.7 tp -56.9 -44.37 82.26 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.39 0.614 . . . . 15.0 110.169 178.515 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.9 -41.11 95.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.589 -0.732 . . . . 15.0 110.491 179.395 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.33 -41.21 93.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.335 -0.393 . . . . 15.0 110.743 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.1 mt -57.88 -50.87 71.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.122 0.487 . . . . 15.0 110.373 -179.163 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.3 p -64.55 -40.98 96.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.657 -0.701 . . . . 15.0 111.374 -175.779 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.0 m -61.94 -42.46 99.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.703 0.287 . . . . 15.0 111.297 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.82 -43.51 98.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.473 -0.33 . . . . 15.0 111.033 -178.51 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.732 0.301 . . . . 15.0 110.835 179.646 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.5 mtm . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.373 -0.603 . . . . 3.9100000000000001 109.373 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -125.93 74.58 71.29 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.138 -0.483 . . . . 2.1600000000000001 110.315 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.45 155.08 54.7 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.525 1.483 . . . . 0.33000000000000002 112.026 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -105.4 136.85 44.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.403 -0.362 . . . . 1.24 110.559 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.469 HG21 HD13 ' A' ' 21' ' ' LEU . 13.7 m -134.34 145.18 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.57 0.7 . . . . 0.19 111.753 176.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.424 HD13 ' HD3' ' A' ' 43' ' ' ARG . 13.1 tp -106.03 135.28 47.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.874 -1.057 . . . . 0.19 110.193 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.549 HD11 ' CG1' ' A' ' 28' ' ' VAL . 47.7 mt -103.44 134.68 43.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.242 -0.436 . . . . 0.32000000000000001 110.275 -178.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.456 ' SD ' HG12 ' A' ' 54' ' ' VAL . 87.0 mtp -96.75 134.02 40.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.148 -0.478 . . . . 1.03 110.438 173.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -59.21 144.3 46.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.297 -0.411 . . . . 2.79 110.705 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.08 175.11 36.07 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.963 -0.855 . . . . 0.5 110.963 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.69 -33.26 54.81 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.579 0.215 . . . . 2.1499999999999999 111.579 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.78 175.84 33.67 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.915 -0.874 . . . . 0.56999999999999995 110.915 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.87 117.92 4.9 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.437 -0.665 . . . . 0.54000000000000004 111.437 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -57.15 -41.72 79.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.84 0.352 . . . . 2.9500000000000002 110.533 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -61.16 -41.65 97.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 1.9099999999999999 111.034 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -62.14 -56.09 22.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.856 0.36 . . . . 3.1600000000000001 111.225 -176.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.25 -42.74 95.95 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.698 -0.401 . . . . 1.76 110.85 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.492 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -62.41 -40.26 95.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.325 -0.398 . . . . 0.35999999999999999 110.936 -178.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.08 -42.31 94.33 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.918 -0.313 . . . . 1.9099999999999999 110.502 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -59.88 -51.65 68.81 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 120.568 -0.453 . . . . 3.2400000000000002 111.256 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.469 HD13 HG21 ' A' ' 5' ' ' VAL . 82.9 mt -62.65 -37.65 87.18 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.538 -0.465 . . . . 0.25 111.025 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -62.83 -43.08 99.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.646 0.26 . . . . 3.5099999999999998 110.894 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.33 -30.69 68.24 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 121.063 -0.589 . . . . 0.29999999999999999 111.924 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -88.12 10.44 19.27 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.513 0.931 . . . . 0.39000000000000001 113.513 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.04 20.23 47.28 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 121.25 -0.5 . . . . 0.25 113.127 174.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -101.04 139.86 21.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 117.552 0.676 . . . . 0.23000000000000001 110.191 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -81.9 129.15 34.67 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.108 -0.701 . . . . 0.34999999999999998 109.108 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.549 ' CG1' HD11 ' A' ' 7' ' ' ILE . 40.5 t -119.02 132.2 69.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.289 0.566 . . . . 0.29999999999999999 111.512 -173.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -137.58 133.58 34.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.13 -0.941 . . . . 1.1200000000000001 109.271 170.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -115.54 138.26 51.23 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.861 0.362 . . . . 0.57999999999999996 110.968 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.1 tp -119.13 132.03 24.12 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-O 118.632 -0.699 . . . . 0.42999999999999999 109.608 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.05 138.77 31.55 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.202 1.268 . . . . 0.46999999999999997 111.903 174.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.454 HD13 ' OD1' ' A' ' 62' ' ' ASN . 77.4 mt -60.1 -9.22 2.97 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.397 0.888 . . . . 0.67000000000000004 113.397 -177.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -77.07 -7.41 55.67 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.262 0.838 . . . . 1.2 113.262 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -63.31 148.71 92.87 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 118.555 0.616 . . . . 0.73999999999999999 110.357 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -80.3 158.04 22.88 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.556 1.504 . . . . 0.31 113.191 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.12 151.5 4.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.866 -0.606 . . . . 0.23999999999999999 111.277 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.31 -38.0 3.25 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.599 -0.6 . . . . 0.17999999999999999 111.599 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -62.22 -37.27 84.72 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 120.595 -0.442 . . . . 1.77 111.09 -177.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.557 ' O ' HG23 ' A' ' 44' ' ' VAL . 24.0 tp -58.84 -48.13 82.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.978 0.418 . . . . 0.33000000000000002 110.211 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.533 HD22 ' CG ' ' A' ' 70' ' ' ASP . 19.8 tp -64.36 -45.19 88.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.35999999999999999 111.141 -175.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.83 -44.25 97.21 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.623 -0.431 . . . . 0.25 110.774 -176.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.424 ' HD3' HD13 ' A' ' 6' ' ' LEU . 56.2 ttm-85 -61.13 -42.7 99.02 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.945 -0.302 . . . . 2.5699999999999998 110.706 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 40' ' ' LEU . 94.4 t -61.23 -45.3 98.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.814 -0.354 . . . . 0.28999999999999998 110.198 -177.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -67.94 -50.71 54.37 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.352 0.407 . . . . 3.6800000000000002 111.919 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.04 -44.4 80.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.662 -0.245 . . . . 0.40000000000000002 111.554 -174.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -78.34 -10.11 59.54 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.968 0.729 . . . . 1.8799999999999999 112.968 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 54.18 55.86 7.69 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.561 0.696 . . . . 3.6000000000000001 110.602 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.521 HD12 HG22 ' A' ' 44' ' ' VAL . 93.6 mt -66.35 141.63 57.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.729 -0.669 . . . . 0.28000000000000003 111.402 -175.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -89.81 -39.77 12.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.251 -0.886 . . . . 0.31 110.611 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.7 159.67 28.09 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.219 -0.991 . . . . 0.19 113.194 -175.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.2 mt -126.27 140.64 52.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.64 -0.78 . . . . 0.19 109.611 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.411 HG22 ' CD1' ' A' ' 80' ' ' PHE . 42.3 t -119.85 131.02 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 121.126 -0.229 . . . . 0.20999999999999999 110.635 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.456 HG12 ' SD ' ' A' ' 8' ' ' MET . 3.3 m -119.41 131.16 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.25 0.547 . . . . 0.23999999999999999 110.998 175.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.4 m -71.54 -33.01 68.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.338 -0.846 . . . . 1.4099999999999999 111.725 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 72.6 p -157.56 169.92 23.59 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.354 0.597 . . . . 0.48999999999999999 111.767 -173.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.57 -36.62 64.89 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.176 -0.769 . . . . 0.40000000000000002 111.176 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -59.24 -46.08 89.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.937 0.369 . . . . 2.1800000000000002 110.68 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.84 -44.29 97.19 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.439 -1.064 . . . . 0.28000000000000003 110.439 177.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.641 HD13 HD21 ' A' ' 79' ' ' LEU . 30.4 tp -56.34 -44.24 79.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.15 0.5 . . . . 0.34999999999999998 110.824 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.6 -43.23 99.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.065 -0.516 . . . . 0.45000000000000001 110.546 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.454 ' OD1' HD13 ' A' ' 33' ' ' LEU . 24.3 m120 -58.71 -39.1 79.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.71999999999999997 110.65 177.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.476 ' CD1' HD21 ' A' ' 40' ' ' LEU . 13.0 tp -57.32 -45.18 84.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.295 0.569 . . . . 0.34999999999999998 110.192 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -60.47 -47.05 87.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.562 -0.744 . . . . 0.28999999999999998 110.586 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -61.78 -43.55 98.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.078 -0.51 . . . . 1.25 111.094 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.74 -34.94 78.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.458 -0.337 . . . . 0.25 111.468 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.666 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -58.72 -39.11 79.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.052 0.453 . . . . 0.17000000000000001 110.684 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.07 -143.74 0.59 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.617 -0.512 . . . . 0.20999999999999999 109.617 174.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.7 -18.77 45.09 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.367 0.985 . . . . 0.25 112.659 -175.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.533 ' CG ' HD22 ' A' ' 41' ' ' LEU . 21.5 m-20 -91.88 10.13 30.02 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.366 0.876 . . . . 1.0900000000000001 113.366 -174.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -47.88 -46.62 63.5 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 118.554 -0.736 . . . . 0.20999999999999999 112.565 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -44.73 -41.39 14.79 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.472 1.448 . . . . 0.25 113.261 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.2 mp0 -77.0 -48.75 17.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.941 0.4 . . . . 1.8600000000000001 110.795 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.666 HD12 ' HB1' ' A' ' 67' ' ' ALA . 88.0 mt -59.04 -40.6 81.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.136 -0.484 . . . . 0.19 110.76 -176.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.95 -15.66 36.5 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 116.315 -0.402 . . . . 0.19 113.162 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 -64.94 -30.48 71.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.351 0.575 . . . . 2.4300000000000002 112.032 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 27.3 mt -74.04 150.5 87.98 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 121.077 -0.249 . . . . 0.39000000000000001 111.519 -173.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.83 126.25 17.01 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.611 1.541 . . . . 0.64000000000000001 112.349 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.641 HD21 HD13 ' A' ' 60' ' ' LEU . 23.5 tp -104.89 127.34 52.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.345 -0.389 . . . . 0.23999999999999999 110.578 175.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.411 ' CD1' HG22 ' A' ' 53' ' ' VAL . 70.5 m-85 -92.07 125.29 36.69 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.669 -0.493 . . . . 0.14999999999999999 109.669 176.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.705 HG21 ' HB2' ' A' ' 87' ' ' ALA . 26.8 m -116.78 145.67 35.99 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-O 119.35 -0.357 . . . . 0.19 110.145 176.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.17 -22.86 8.11 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.531 1.487 . . . . 0.33000000000000002 113.634 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.408 ' OG ' HG23 ' A' ' 86' ' ' VAL . 25.0 p -143.64 158.38 56.96 Favored Pre-proline 0 C--N 1.331 -0.236 0 C-N-CA 120.693 -0.403 . . . . 0.27000000000000002 111.25 -171.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.37 -44.09 51.93 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.309 1.339 . . . . 0.42999999999999999 111.689 176.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -58.12 -47.42 83.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.856 0.36 . . . . 2.9900000000000002 110.939 -177.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.408 HG23 ' OG ' ' A' ' 83' ' ' SER . 60.2 t -60.12 -39.9 81.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.796 -0.362 . . . . 0.23999999999999999 110.093 178.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.705 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.43 -41.85 81.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.966 0.413 . . . . 0.20000000000000001 110.383 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.86 -40.43 92.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.439 . . . . 1.5600000000000001 110.549 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.0 mmm -58.12 -44.96 88.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.412 0.625 . . . . 1.05 110.061 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.488 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -62.05 -41.16 97.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.695 -0.684 . . . . 0.20999999999999999 110.792 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 75.9 ttt-85 -61.85 -44.76 96.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.333 -0.394 . . . . 3.1200000000000001 110.824 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.58 -36.1 77.69 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.925 -0.31 . . . . 2.1000000000000001 111.348 -177.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.2 mt -65.9 -23.9 66.73 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.241 0.46 . . . . 0.28999999999999998 112.241 177.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.83 13.3 16.54 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 119.413 -0.659 . . . . 0.22 113.163 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.82 121.98 11.79 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.499 1.149 . . . . 0.19 109.917 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -69.31 -36.01 76.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.629 -0.714 . . . . 0.69999999999999996 111.24 -171.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -131.59 113.91 14.2 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.024 0.44 . . . . 2.8900000000000001 110.36 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.9 t -112.53 131.06 65.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.15 -0.477 . . . . 0.20000000000000001 109.876 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 85.9 mt -119.27 123.33 71.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.856 -0.611 . . . . 0.22 110.026 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -94.93 118.28 31.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.406 -0.361 . . . . 1.1299999999999999 110.248 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.516 ' HB2' HD11 ' A' ' 109' ' ' LEU . 32.0 p -96.11 -6.56 38.18 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.158 0.799 . . . . 0.34000000000000002 113.158 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -55.32 -39.83 70.42 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 118.211 0.46 . . . . 3.4700000000000002 110.812 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -93.72 -35.02 6.3 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.599 -0.6 . . . . 0.65000000000000002 111.599 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -78.16 132.28 37.56 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.828 0.347 . . . . 0.46000000000000002 110.632 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.2 m -74.86 162.83 28.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 1.21 110.659 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.76 -54.32 24.36 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 112.891 0.7 . . . . 0.34999999999999998 112.891 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.94 -34.15 98.99 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 CA-C-N 119.987 1.031 . . . . 0.31 111.692 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.02 -43.07 95.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.037 0.446 . . . . 0.27000000000000002 109.953 177.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.516 HD11 ' HB2' ' A' ' 101' ' ' CYS . 80.0 mt -59.19 -40.45 85.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.23999999999999999 110.425 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 37.7 tp -56.98 -43.58 81.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.272 0.558 . . . . 0.22 110.183 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.58 -40.93 93.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.744 -0.662 . . . . 0.25 110.491 178.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.83 -42.19 93.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.328 -0.396 . . . . 0.23999999999999999 110.684 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.5 mt -57.99 -50.21 74.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.177 0.513 . . . . 0.27000000000000002 110.427 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.3 p -62.7 -40.89 98.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.798 -0.637 . . . . 0.31 111.231 -175.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.9 t -62.24 -45.15 94.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.766 0.317 . . . . 1.25 111.412 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.59 -38.61 88.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.449 -0.341 . . . . 0.44 111.179 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.66 -34.97 73.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.473 -0.33 . . . . 0.5 111.368 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 87.6 mt -57.43 -38.09 73.83 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.006 -0.277 . . . . 0.83999999999999997 110.94 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -62.08 -35.04 77.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.596 -0.274 . . . . 2.3999999999999999 111.376 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -56.98 -45.53 82.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.778 0.323 . . . . 3.8999999999999999 110.813 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -57.44 -39.08 75.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 6.6299999999999999 111.089 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -57.78 -43.11 85.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.422 -0.354 . . . . 7.6100000000000003 111.183 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -54.81 -35.83 64.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.454 -0.339 . . . . 9.7300000000000004 111.527 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -104.46 138.56 40.66 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.889 0.376 . . . . 9.9100000000000001 110.773 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 118.048 -0.977 . . . . 11.52 110.494 -179.934 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.6 mtm . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.366 -0.605 . . . . 15.0 109.366 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -126.92 74.09 76.25 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 116.1 -0.5 . . . . 15.0 110.405 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.58 155.02 27.87 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.596 1.531 . . . . 15.0 112.065 -177.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.427 ' CB ' HD23 ' A' ' 49' ' ' LEU . 60.0 mttp -113.03 137.36 51.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.307 -0.406 . . . . 15.0 110.581 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.622 HG21 HD13 ' A' ' 21' ' ' LEU . 15.3 m -135.3 145.94 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.563 0.696 . . . . 15.0 111.709 176.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.559 HD12 ' O ' ' A' ' 29' ' ' ASP . 14.0 tp -105.75 136.74 44.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.027 -0.988 . . . . 15.0 110.332 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.415 HD11 ' CG1' ' A' ' 28' ' ' VAL . 61.7 mt -104.52 133.86 47.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.972 0.415 . . . . 15.0 110.695 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.463 ' SD ' HD13 ' A' ' 63' ' ' LEU . 83.7 mtp -101.45 134.46 44.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.279 -0.873 . . . . 15.0 110.714 175.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -57.33 143.33 40.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.129 0.49 . . . . 15.0 110.772 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.86 175.09 29.14 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.852 -0.899 . . . . 15.0 110.852 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.81 -32.54 67.67 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.684 0.253 . . . . 15.0 111.684 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.34 -173.74 22.25 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.033 -0.827 . . . . 15.0 111.033 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.93 114.7 3.99 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.031 -0.828 . . . . 15.0 111.031 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -57.52 -44.84 85.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.273 0.558 . . . . 15.0 110.228 -176.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.99 -41.46 99.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.856 -0.611 . . . . 15.0 111.273 -177.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -60.01 -49.89 75.9 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.861 -0.335 . . . . 15.0 111.085 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.3 mt -57.64 -44.49 85.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.129 0.49 . . . . 15.0 110.43 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.486 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -59.43 -42.27 91.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 15.0 110.688 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -58.53 -41.51 85.67 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.031 -0.268 . . . . 15.0 110.475 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 69.0 mtm180 -59.31 -51.46 69.85 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.447 -0.501 . . . . 15.0 110.878 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.622 HD13 HG21 ' A' ' 5' ' ' VAL . 81.4 mt -61.1 -37.57 83.2 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.519 -0.472 . . . . 15.0 110.988 -177.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.445 ' HG3' HG21 ' A' ' 28' ' ' VAL . 40.2 mtp180 -64.21 -42.49 96.58 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.921 -0.312 . . . . 15.0 111.184 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.0 -30.67 67.04 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.007 -0.616 . . . . 15.0 111.967 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -88.14 8.87 24.87 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.6 0.963 . . . . 15.0 113.6 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.08 17.12 58.26 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 121.235 -0.507 . . . . 15.0 113.234 176.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.7 t -101.03 139.06 23.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 117.748 0.774 . . . . 15.0 109.95 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -78.65 134.64 37.13 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.346 -0.612 . . . . 15.0 109.346 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.486 HG11 ' HB1' ' A' ' 18' ' ' ALA . 48.7 t -119.24 131.55 71.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.345 0.593 . . . . 15.0 111.331 -173.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.559 ' O ' HD12 ' A' ' 6' ' ' LEU . 23.1 t70 -131.59 122.81 26.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.174 -0.921 . . . . 15.0 109.216 170.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -107.88 129.98 55.04 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.904 0.383 . . . . 15.0 110.812 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.3 tp -120.64 113.31 33.42 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 118.892 -0.575 . . . . 15.0 110.672 -175.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.19 135.2 67.85 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.27 1.313 . . . . 15.0 112.372 172.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.598 HD13 ' OD1' ' A' ' 62' ' ' ASN . 71.1 mt -58.95 -11.87 3.88 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.28 0.844 . . . . 15.0 113.28 -178.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -77.16 -6.22 52.1 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.417 0.895 . . . . 15.0 113.417 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -69.31 150.92 97.09 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 118.558 0.617 . . . . 15.0 110.771 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.63 151.29 32.25 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.616 1.544 . . . . 15.0 113.715 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.76 152.57 3.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.305 -0.861 . . . . 15.0 111.453 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.67 -38.14 3.21 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 115.72 -0.673 . . . . 15.0 111.871 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.3 -37.09 86.26 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 120.323 -0.551 . . . . 15.0 111.103 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.576 ' O ' HG23 ' A' ' 44' ' ' VAL . 24.4 tp -58.75 -47.71 83.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.98 0.419 . . . . 15.0 110.168 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.463 HD13 HD11 ' A' ' 74' ' ' ILE . 16.3 tp -62.65 -45.36 93.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.974 -176.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.9 -45.04 95.46 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.577 -0.449 . . . . 15.0 110.871 -175.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -62.71 -40.05 95.94 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.768 -0.373 . . . . 15.0 111.07 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 40' ' ' LEU . 91.4 t -61.78 -45.24 99.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.807 -0.357 . . . . 15.0 110.289 -178.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -69.56 -47.51 63.42 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.205 0.446 . . . . 15.0 112.205 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.8 -44.27 77.72 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.977 -0.289 . . . . 15.0 111.609 -175.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -79.67 -10.11 59.74 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.053 0.76 . . . . 15.0 113.053 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 56.29 55.93 6.23 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.488 0.661 . . . . 15.0 109.989 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 44' ' ' VAL . 95.7 mt -69.29 145.18 53.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.836 -0.62 . . . . 15.0 111.302 -176.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -92.36 -40.54 10.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.323 -0.853 . . . . 15.0 111.061 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.63 161.87 28.6 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.012 -1.089 . . . . 15.0 113.651 -173.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.2 mt -126.08 144.06 50.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.494 -0.853 . . . . 15.0 109.934 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.533 HG22 ' CD1' ' A' ' 80' ' ' PHE . 46.7 t -120.87 129.91 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 O-C-N 122.353 -0.217 . . . . 15.0 110.712 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.4 HG12 ' SD ' ' A' ' 8' ' ' MET . 10.5 m -124.72 141.43 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-O 121.042 0.449 . . . . 15.0 110.471 172.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.8 m -96.59 -14.16 22.4 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.901 0.704 . . . . 15.0 112.901 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.5 p -157.57 163.25 38.54 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 121.414 0.626 . . . . 15.0 111.914 -174.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.23 -37.3 72.25 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.98 -0.848 . . . . 15.0 110.98 176.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -58.99 -44.98 91.69 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 122.666 -0.314 . . . . 15.0 110.633 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.81 -43.54 97.84 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.476 -1.049 . . . . 15.0 110.476 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.505 HD21 ' HA ' ' A' ' 90' ' ' ALA . 20.8 tp -56.85 -45.1 82.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.145 0.498 . . . . 15.0 110.699 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.64 -43.53 98.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.086 -0.506 . . . . 15.0 110.644 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.598 ' OD1' HD13 ' A' ' 33' ' ' LEU . 27.3 m120 -59.08 -39.25 81.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.274 -0.421 . . . . 15.0 110.682 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.463 HD13 ' SD ' ' A' ' 8' ' ' MET . 12.3 tp -57.63 -44.84 85.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.179 0.514 . . . . 15.0 110.061 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -61.09 -47.61 85.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.735 -0.666 . . . . 15.0 110.585 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.88 -43.13 99.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.108 -0.496 . . . . 15.0 111.159 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.92 -35.53 80.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.443 -0.344 . . . . 15.0 111.426 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.657 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.77 -37.91 80.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.029 0.442 . . . . 15.0 110.856 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.51 -144.19 0.55 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 109.51 -0.552 . . . . 15.0 109.51 174.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.53 -19.56 49.14 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.349 0.977 . . . . 15.0 112.575 -174.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.429 ' CG ' HD22 ' A' ' 41' ' ' LEU . 23.3 m-20 -91.9 12.16 22.55 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.32 0.859 . . . . 15.0 113.32 -174.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 -47.79 -46.36 62.05 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 118.551 -0.737 . . . . 15.0 112.587 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -44.72 -41.43 14.76 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 121.417 1.412 . . . . 15.0 113.247 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -77.0 -48.72 17.16 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.544 -0.462 . . . . 15.0 110.836 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.657 HD12 ' HB1' ' A' ' 67' ' ' ALA . 93.0 mt -59.74 -40.45 82.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.451 . . . . 15.0 110.903 -176.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.44 -16.4 35.72 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 116.401 -0.363 . . . . 15.0 113.11 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.1 mtp-105 -64.67 -30.33 71.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.336 0.568 . . . . 15.0 112.027 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 23.4 mt -76.03 150.54 83.46 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 121.028 -0.269 . . . . 15.0 111.58 -172.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -63.22 128.36 22.53 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.628 1.552 . . . . 15.0 112.39 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.9 tp -108.59 127.56 54.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.511 -0.313 . . . . 15.0 110.657 174.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.533 ' CD1' HG22 ' A' ' 53' ' ' VAL . 80.1 m-85 -88.7 127.31 35.58 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.576 -0.527 . . . . 15.0 109.576 176.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.677 HG21 ' HB2' ' A' ' 87' ' ' ALA . 28.1 m -119.16 146.24 40.13 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 110.012 -0.366 . . . . 15.0 110.012 175.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.15 -22.58 8.36 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.608 1.538 . . . . 15.0 113.651 -174.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.417 ' OG ' HG23 ' A' ' 86' ' ' VAL . 24.7 p -143.47 158.2 57.87 Favored Pre-proline 0 CA--C 1.53 0.196 0 C-N-CA 120.645 -0.422 . . . . 15.0 111.263 -171.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.39 -44.0 52.66 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.32 1.347 . . . . 15.0 111.699 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 -58.37 -47.25 84.43 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.858 -0.337 . . . . 15.0 110.926 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.417 HG23 ' OG ' ' A' ' 83' ' ' SER . 60.9 t -59.75 -40.43 82.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.923 0.392 . . . . 15.0 109.965 178.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.677 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.46 -42.75 83.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.002 0.43 . . . . 15.0 110.404 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.31 -40.4 90.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 15.0 110.61 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.0 mmm -58.14 -44.39 87.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.428 0.632 . . . . 15.0 110.159 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.505 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.49 -40.51 94.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.655 -0.702 . . . . 15.0 110.862 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -62.61 -42.9 99.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.346 -0.388 . . . . 15.0 111.028 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.36 -36.16 77.37 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.832 -0.347 . . . . 15.0 111.274 -177.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.99 -22.78 65.9 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.399 0.518 . . . . 15.0 112.399 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 107.99 13.24 20.35 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 119.373 -0.682 . . . . 15.0 113.128 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.76 122.0 11.8 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 118.494 1.147 . . . . 15.0 109.961 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -69.04 -36.43 77.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.573 -0.74 . . . . 15.0 111.141 -171.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -131.79 112.92 12.92 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.152 0.501 . . . . 15.0 110.536 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.0 t -112.19 130.66 65.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.033 -0.531 . . . . 15.0 109.84 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.6 mt -118.46 122.17 68.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.886 -0.597 . . . . 15.0 109.999 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -94.21 116.56 28.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.429 -0.35 . . . . 15.0 110.433 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.9 p -97.07 4.57 51.31 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.162 0.801 . . . . 15.0 113.162 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 36.2 tpt85 -55.94 -39.92 72.42 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 118.187 0.449 . . . . 15.0 110.648 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.15 -35.13 5.39 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.486 -0.646 . . . . 15.0 111.486 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.65 138.58 44.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.847 0.356 . . . . 15.0 110.549 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.7 p -87.04 165.38 15.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 15.0 110.621 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.69 -54.23 24.77 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 118.552 -0.737 . . . . 15.0 112.923 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.54 -35.98 97.38 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 CA-C-N 120.596 1.249 . . . . 15.0 111.414 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.77 95.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.017 0.437 . . . . 15.0 110.051 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.3 mt -59.23 -40.02 84.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 15.0 110.514 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 42.0 tp -57.08 -44.52 83.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.379 0.609 . . . . 15.0 110.084 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.74 -41.16 94.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.627 -0.715 . . . . 15.0 110.488 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.3 -41.36 93.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.314 -0.403 . . . . 15.0 110.78 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.6 mt -57.89 -50.53 73.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.122 0.487 . . . . 15.0 110.401 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.3 p -63.85 -40.39 96.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.715 -0.675 . . . . 15.0 111.381 -175.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.8 p -65.44 -39.42 92.06 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.025 -0.27 . . . . 15.0 111.398 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.28 96.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.508 -0.315 . . . . 15.0 111.088 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.46 -39.54 83.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.467 -0.333 . . . . 15.0 110.755 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.36 -38.56 90.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.415 -0.357 . . . . 15.0 110.878 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.64 -34.73 78.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.461 -0.336 . . . . 15.0 111.477 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -56.51 -40.7 75.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.664 0.269 . . . . 15.0 110.853 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -111.58 128.33 56.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.84 0.352 . . . . 15.0 110.655 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -58.13 -40.77 82.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.481 . . . . 15.0 110.656 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -115.45 131.07 57.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.27 -0.423 . . . . 15.0 110.623 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -60.87 -42.54 98.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 15.0 110.456 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.992 -1.004 . . . . 15.0 110.508 -179.894 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.4 mmm . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.15 -0.685 . . . . 15.0 109.15 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.01 78.56 70.1 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.124 -0.489 . . . . 15.0 110.28 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.41 152.99 7.93 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.433 1.422 . . . . 15.0 111.857 -176.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.443 ' HB2' HD23 ' A' ' 49' ' ' LEU . 94.1 mttt -115.63 139.24 50.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.326 -0.397 . . . . 15.0 110.802 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.2 m -133.76 145.97 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.466 0.65 . . . . 15.0 111.652 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.505 HD13 ' CD ' ' A' ' 43' ' ' ARG . 12.4 tp -105.07 136.5 44.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.048 -0.978 . . . . 15.0 110.375 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.494 HD11 ' CG1' ' A' ' 28' ' ' VAL . 58.2 mt -104.11 135.14 43.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.972 0.415 . . . . 15.0 110.624 -178.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.606 ' HE3' HD21 ' A' ' 33' ' ' LEU . 96.6 mmm -89.34 134.12 34.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.458 -0.792 . . . . 15.0 110.149 174.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -57.64 141.39 48.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.958 0.408 . . . . 15.0 110.551 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.56 175.11 42.0 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.854 -0.898 . . . . 15.0 110.854 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -54.99 -35.22 64.12 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.205 -0.198 . . . . 15.0 111.217 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.23 162.87 7.45 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.861 -0.895 . . . . 15.0 110.861 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.87 123.56 6.34 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.151 -0.78 . . . . 15.0 111.151 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -56.66 -46.57 80.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.058 0.456 . . . . 15.0 110.422 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.32 -39.33 94.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.899 -0.591 . . . . 15.0 111.235 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -61.23 -56.01 25.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.927 0.394 . . . . 15.0 111.027 -175.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.6 mt -61.7 -41.99 98.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.018 0.437 . . . . 15.0 110.663 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.504 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -60.99 -36.28 79.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 15.0 111.182 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.23 -44.95 95.41 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.963 -0.295 . . . . 15.0 110.616 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -59.77 -51.65 68.86 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.084 -0.646 . . . . 15.0 111.252 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.47 -37.32 87.12 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.517 -0.473 . . . . 15.0 111.137 -176.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -64.02 -43.8 94.51 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.14 -0.224 . . . . 15.0 111.048 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.29 -30.63 68.0 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.043 -0.599 . . . . 15.0 111.923 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -88.14 9.9 21.15 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.515 0.932 . . . . 15.0 113.515 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.11 16.12 56.42 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 121.261 -0.495 . . . . 15.0 113.435 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -101.15 139.77 21.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 117.719 0.759 . . . . 15.0 109.98 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -84.93 133.61 34.28 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.483 -0.562 . . . . 15.0 109.483 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.504 HG11 ' CB ' ' A' ' 18' ' ' ALA . 39.4 t -115.12 131.45 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.09 0.471 . . . . 15.0 111.005 -174.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -133.78 128.76 35.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.568 -0.742 . . . . 15.0 109.33 171.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -111.38 134.64 52.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.799 0.333 . . . . 15.0 110.652 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.7 tp -112.83 129.95 23.96 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-O 118.492 -0.766 . . . . 15.0 109.732 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -72.08 139.64 33.06 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 CA-C-N 120.431 1.19 . . . . 15.0 111.676 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.606 HD21 ' HE3' ' A' ' 8' ' ' MET . 18.2 mt -59.38 -9.35 2.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.631 0.974 . . . . 15.0 113.631 -176.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -77.09 -7.07 55.11 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.396 0.888 . . . . 15.0 113.396 -177.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -65.72 145.89 99.01 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 118.618 0.644 . . . . 15.0 110.633 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.74 159.01 21.66 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 121.629 1.552 . . . . 15.0 113.187 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.28 151.27 5.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.839 -0.618 . . . . 15.0 111.294 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.23 -38.09 3.22 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.71 -0.556 . . . . 15.0 111.71 -178.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -61.05 -36.75 80.4 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 120.595 -0.442 . . . . 15.0 111.213 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.57 ' O ' HG23 ' A' ' 44' ' ' VAL . 27.9 tp -59.15 -47.03 86.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.962 0.411 . . . . 15.0 110.254 -178.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.59 HD22 ' OD2' ' A' ' 70' ' ' ASP . 9.3 tp -62.39 -45.74 91.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 15.0 110.86 -176.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.58 -44.22 97.42 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.659 -0.416 . . . . 15.0 110.774 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.505 ' CD ' HD13 ' A' ' 6' ' ' LEU . 57.0 ttm-85 -60.74 -41.81 96.1 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.98 -0.288 . . . . 15.0 110.728 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.578 ' HA ' HD12 ' A' ' 49' ' ' LEU . 96.1 t -60.47 -46.18 95.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.73 -0.388 . . . . 15.0 110.11 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -69.83 -47.7 61.73 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.29 0.478 . . . . 15.0 112.29 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.28 -44.33 79.58 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.03 -0.268 . . . . 15.0 111.538 -174.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -80.34 -10.1 59.75 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.11 0.781 . . . . 15.0 113.11 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 94.2 mtm-85 56.22 55.81 6.38 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.553 0.692 . . . . 15.0 110.111 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.578 HD12 ' HA ' ' A' ' 44' ' ' VAL . 94.6 mt -72.77 146.35 46.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.631 -0.713 . . . . 15.0 111.467 -175.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -94.46 -40.49 9.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.357 -0.838 . . . . 15.0 110.915 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.78 165.53 29.22 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 119.878 -1.153 . . . . 15.0 113.695 -172.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.5 mt -127.89 143.16 51.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.576 -0.812 . . . . 15.0 109.983 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.502 HG22 ' CD1' ' A' ' 80' ' ' PHE . 49.0 t -123.06 133.69 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 110.077 -0.342 . . . . 15.0 110.077 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.434 HG12 ' HG3' ' A' ' 8' ' ' MET . 3.9 m -119.24 126.92 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.185 0.517 . . . . 15.0 110.749 174.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.8 m -68.92 -32.73 72.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.476 -0.784 . . . . 15.0 111.686 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.5 p -155.19 166.28 34.06 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.411 0.624 . . . . 15.0 111.887 -173.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.88 -37.51 70.32 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.217 -0.753 . . . . 15.0 111.217 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -58.66 -46.16 87.78 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.742 -0.383 . . . . 15.0 110.72 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.95 -42.61 99.79 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.841 -0.904 . . . . 15.0 110.841 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.615 HD13 HD21 ' A' ' 79' ' ' LEU . 34.9 tp -57.32 -47.18 82.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.053 0.454 . . . . 15.0 110.594 -178.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.77 -44.62 96.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.134 0.492 . . . . 15.0 110.594 -177.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.463 ' CB ' HD22 ' A' ' 33' ' ' LEU . 19.0 m120 -59.51 -40.11 86.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 15.0 110.616 178.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.5 tp -56.57 -42.78 79.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.18 0.514 . . . . 15.0 110.195 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -58.55 -46.48 86.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.804 -0.635 . . . . 15.0 110.249 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -60.97 -42.93 99.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.819 -0.628 . . . . 15.0 111.032 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.08 -34.94 78.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.374 -0.375 . . . . 15.0 111.474 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.678 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.31 -38.15 79.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.119 0.485 . . . . 15.0 110.677 177.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.51 -144.43 0.55 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 109.54 -0.541 . . . . 15.0 109.54 173.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.47 -19.57 48.79 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.289 0.95 . . . . 15.0 112.563 -174.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.59 ' OD2' HD22 ' A' ' 41' ' ' LEU . 76.6 m-20 -91.86 10.86 26.94 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.336 0.865 . . . . 15.0 113.336 -174.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -47.83 -47.07 63.42 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 118.544 -0.741 . . . . 15.0 112.536 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -44.78 -40.52 14.58 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 121.422 1.414 . . . . 15.0 113.216 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -76.96 -48.77 17.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.036 0.446 . . . . 15.0 110.735 -177.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.678 HD12 ' HB1' ' A' ' 67' ' ' ALA . 89.1 mt -59.46 -40.11 80.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.511 . . . . 15.0 110.752 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.56 -14.71 36.7 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 116.31 -0.405 . . . . 15.0 113.345 -175.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -65.88 -29.79 70.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.399 0.6 . . . . 15.0 112.037 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.0 mt -74.87 150.02 85.87 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 120.919 -0.312 . . . . 15.0 111.291 -173.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.0 128.27 26.07 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.606 1.537 . . . . 15.0 112.249 176.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.615 HD21 HD13 ' A' ' 60' ' ' LEU . 27.3 tp -105.72 124.91 50.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.387 -0.369 . . . . 15.0 110.497 174.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.502 ' CD1' HG22 ' A' ' 53' ' ' VAL . 69.2 m-85 -91.71 126.54 36.83 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.796 -0.446 . . . . 15.0 109.796 177.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.656 HG21 ' HB2' ' A' ' 87' ' ' ALA . 27.4 m -118.72 146.45 39.99 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-O 119.327 -0.368 . . . . 15.0 110.238 176.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -79.18 -23.49 7.56 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.561 1.507 . . . . 15.0 113.522 -176.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.2 p -143.26 162.78 41.01 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 120.572 -0.451 . . . . 15.0 111.517 -171.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -56.84 -43.97 49.43 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.153 1.236 . . . . 15.0 111.821 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -57.57 -48.15 80.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.882 0.372 . . . . 15.0 110.712 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.5 t -60.37 -39.4 80.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.813 -0.355 . . . . 15.0 110.118 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.656 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.31 -41.43 79.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.931 0.396 . . . . 15.0 110.373 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.18 -40.22 93.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.29 -0.414 . . . . 15.0 110.603 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.1 mmm -58.53 -44.53 89.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.378 0.609 . . . . 15.0 110.107 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.496 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.74 -42.48 99.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.714 -0.675 . . . . 15.0 110.853 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -61.92 -44.02 97.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 15.0 110.738 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -59.22 -36.16 74.92 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.947 -0.301 . . . . 15.0 111.302 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 77.0 mt -67.26 -23.95 65.74 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.351 0.5 . . . . 15.0 112.351 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.33 13.37 17.45 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 119.263 -0.743 . . . . 15.0 113.096 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.77 122.03 11.88 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 118.564 1.182 . . . . 15.0 109.897 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -68.84 -35.72 77.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.617 -0.719 . . . . 15.0 111.281 -171.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -130.19 113.94 15.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.907 0.384 . . . . 15.0 110.251 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.2 130.3 64.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 15.0 109.953 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 87.6 mt -120.2 120.66 63.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.936 -0.575 . . . . 15.0 110.007 -176.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -95.4 117.79 30.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.41 -0.359 . . . . 15.0 110.323 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.479 ' HA ' ' HB3' ' A' ' 104' ' ' ALA . 31.2 p -96.02 -1.49 48.77 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.211 0.819 . . . . 15.0 113.211 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -56.14 -40.28 73.56 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 118.215 0.461 . . . . 15.0 110.527 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.08 -34.98 5.21 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.415 -0.674 . . . . 15.0 111.415 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.479 ' HB3' ' HA ' ' A' ' 101' ' ' CYS . . . -69.46 144.89 53.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.851 0.358 . . . . 15.0 110.52 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.1 t -89.8 158.92 17.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.069 -0.514 . . . . 15.0 110.546 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.65 -54.34 23.73 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 112.992 0.738 . . . . 15.0 112.992 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.72 -35.06 98.95 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 CA-C-N 120.134 1.083 . . . . 15.0 111.78 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.99 -43.13 95.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.124 0.488 . . . . 15.0 109.982 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.416 HD11 ' HB2' ' A' ' 101' ' ' CYS . 78.5 mt -59.06 -40.53 85.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 15.0 110.43 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 38.9 tp -57.19 -43.68 82.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.231 0.538 . . . . 15.0 110.168 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.13 -40.86 91.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.747 -0.661 . . . . 15.0 110.458 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.96 -41.61 92.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.414 . . . . 15.0 110.73 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.5 mt -57.81 -51.11 70.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.195 0.522 . . . . 15.0 110.396 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.3 p -63.6 -39.77 95.23 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.608 -0.724 . . . . 15.0 111.385 -175.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.2 p -65.9 -40.04 91.17 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.921 -0.312 . . . . 15.0 111.453 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.09 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.511 -0.313 . . . . 15.0 111.078 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.27 -34.09 71.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.428 -0.351 . . . . 15.0 111.398 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 83.5 mt -56.68 -38.27 72.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.668 0.271 . . . . 15.0 111.005 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -62.8 -36.97 84.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.576 -0.284 . . . . 15.0 111.204 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -60.41 -41.73 94.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.858 0.361 . . . . 15.0 111.035 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -54.82 -38.26 67.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 15.0 111.389 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -110.7 127.83 55.47 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.891 0.377 . . . . 15.0 110.897 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -57.91 -39.66 78.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 15.0 110.905 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -114.24 144.08 43.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.289 -0.414 . . . . 15.0 110.55 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.912 -1.042 . . . . 15.0 110.718 -179.752 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.6 mtm . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.446 -0.576 . . . . 15.0 109.446 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -126.35 83.0 65.05 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.165 -0.471 . . . . 15.0 110.241 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.01 153.74 30.64 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.385 1.39 . . . . 15.0 111.83 -175.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.444 ' CB ' HD23 ' A' ' 49' ' ' LEU . 60.3 mttp -112.86 138.33 49.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.456 -0.338 . . . . 15.0 110.782 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.567 HG21 HD13 ' A' ' 21' ' ' LEU . 15.1 m -133.33 143.52 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 121.515 0.674 . . . . 15.0 111.521 176.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.6 tp -103.41 134.76 46.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.011 -0.995 . . . . 15.0 110.417 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.617 HD11 ' CG1' ' A' ' 28' ' ' VAL . 52.4 mt -99.04 135.0 35.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.024 0.44 . . . . 15.0 110.542 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 83.3 mtp -103.17 134.18 47.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.445 -0.798 . . . . 15.0 109.593 171.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -57.51 144.68 35.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.128 0.49 . . . . 15.0 110.984 -172.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.38 175.15 32.65 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.739 -0.944 . . . . 15.0 110.739 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -54.53 -33.42 59.97 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.517 0.191 . . . . 15.0 111.517 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.06 171.12 36.1 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.898 -0.881 . . . . 15.0 110.898 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.91 133.98 12.26 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.312 -0.715 . . . . 15.0 111.312 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -56.8 -46.04 81.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.086 0.469 . . . . 15.0 110.405 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.18 -41.14 99.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.679 -0.691 . . . . 15.0 111.329 -176.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -61.73 -56.07 23.49 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.746 -0.382 . . . . 15.0 111.224 -175.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.3 mt -61.94 -43.47 98.77 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.739 -0.384 . . . . 15.0 111.052 -176.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.17 -43.27 99.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.392 -0.367 . . . . 15.0 110.573 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -58.72 -41.85 87.34 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.977 -0.289 . . . . 15.0 110.395 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -58.76 -51.69 68.88 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.656 -0.418 . . . . 15.0 111.179 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.567 HD13 HG21 ' A' ' 5' ' ' VAL . 77.2 mt -62.74 -37.77 87.88 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.596 -0.442 . . . . 15.0 111.243 -177.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -63.53 -42.4 98.43 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.853 -0.339 . . . . 15.0 111.214 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.43 -30.71 68.63 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.021 -0.609 . . . . 15.0 111.961 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -88.18 9.92 21.21 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.56 0.948 . . . . 15.0 113.56 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.4 16.26 57.42 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 121.18 -0.533 . . . . 15.0 113.436 175.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.1 t -101.1 140.24 20.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 117.803 0.802 . . . . 15.0 110.168 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -83.17 130.5 35.11 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.101 -0.703 . . . . 15.0 109.101 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.617 ' CG1' HD11 ' A' ' 7' ' ' ILE . 37.1 t -119.72 133.23 67.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.17 0.51 . . . . 15.0 111.191 -172.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -139.23 137.75 36.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.362 -0.836 . . . . 15.0 109.465 171.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.48 ' HB3' HD12 ' A' ' 7' ' ' ILE . 34.6 p90 -115.41 138.25 51.2 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.916 0.389 . . . . 15.0 111.035 -178.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 tp -119.98 113.29 34.37 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-O 118.677 -0.678 . . . . 15.0 110.354 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.7 135.02 48.73 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 121.23 1.287 . . . . 15.0 112.304 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.42 -16.96 51.88 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.031 0.752 . . . . 15.0 113.031 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -77.14 -4.34 44.01 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.445 0.905 . . . . 15.0 113.445 -175.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -70.61 149.97 95.45 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 118.428 0.558 . . . . 15.0 110.816 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.31 147.14 52.49 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.6 1.533 . . . . 15.0 113.747 -174.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.9 152.55 3.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.429 -0.805 . . . . 15.0 111.291 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.78 -38.09 3.21 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.948 -0.569 . . . . 15.0 111.837 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -62.65 -36.88 84.28 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 120.346 -0.542 . . . . 15.0 111.092 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.577 ' O ' HG23 ' A' ' 44' ' ' VAL . 27.2 tp -58.9 -46.9 86.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.915 0.388 . . . . 15.0 110.188 -178.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.512 HD22 ' CG ' ' A' ' 70' ' ' ASP . 20.8 tp -62.25 -43.85 97.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 15.0 110.854 -177.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.64 -45.88 92.16 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.635 -0.426 . . . . 15.0 110.853 -176.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -62.91 -40.03 96.33 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.874 -0.331 . . . . 15.0 111.165 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 40' ' ' LEU . 93.4 t -60.56 -44.51 96.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.881 -0.415 . . . . 15.0 109.881 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -65.9 -51.82 55.38 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.369 0.418 . . . . 15.0 111.87 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.09 -44.37 80.18 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.028 -0.269 . . . . 15.0 111.629 -174.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -80.31 -10.04 59.75 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.168 0.803 . . . . 15.0 113.168 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 92.2 mtm-85 55.62 55.81 6.83 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.61 0.719 . . . . 15.0 110.406 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.531 HD12 HG22 ' A' ' 44' ' ' VAL . 95.9 mt -68.0 146.23 53.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.656 -0.702 . . . . 15.0 110.965 -177.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -95.98 -40.7 9.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.695 -0.684 . . . . 15.0 110.906 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.7 164.83 28.81 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 119.945 -1.121 . . . . 15.0 113.589 -172.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.7 mt -126.79 145.16 50.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.456 -0.872 . . . . 15.0 109.919 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.525 HG22 ' CD1' ' A' ' 80' ' ' PHE . 47.1 t -121.0 129.14 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 110.437 -0.208 . . . . 15.0 110.437 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.7 m -126.99 139.24 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 120.955 0.407 . . . . 15.0 110.365 173.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.5 m -101.36 -4.8 26.32 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.055 0.761 . . . . 15.0 113.055 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.0 p -157.45 157.83 34.65 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-O 121.487 0.661 . . . . 15.0 111.977 -175.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.67 -37.75 78.31 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.048 -0.821 . . . . 15.0 111.048 177.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -57.03 -46.11 82.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.774 0.321 . . . . 15.0 110.716 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.69 -44.12 97.19 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.651 -0.98 . . . . 15.0 110.651 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.7 tp -56.01 -46.39 78.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.274 0.559 . . . . 15.0 110.717 -178.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -62.33 -42.9 99.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.911 -0.586 . . . . 15.0 110.874 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -58.89 -38.51 79.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.377 -0.374 . . . . 15.0 110.829 178.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.5 tp -57.58 -45.25 85.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.281 0.562 . . . . 15.0 110.086 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -61.45 -47.6 84.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.667 -0.697 . . . . 15.0 110.628 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -62.05 -43.46 98.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 15.0 111.281 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.1 mt -66.42 -35.63 80.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.382 -0.372 . . . . 15.0 111.379 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.661 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -60.28 -37.74 81.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.012 0.434 . . . . 15.0 110.884 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.72 -144.16 0.54 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.388 -0.597 . . . . 15.0 109.388 174.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.49 -18.64 41.66 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.319 0.963 . . . . 15.0 112.614 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.512 ' CG ' HD22 ' A' ' 41' ' ' LEU . 21.5 m-20 -91.83 11.14 25.79 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.265 0.839 . . . . 15.0 113.265 -174.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -47.7 -46.83 61.87 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 118.6 -0.714 . . . . 15.0 112.592 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -44.64 -41.85 14.54 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.434 1.423 . . . . 15.0 113.22 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -76.99 -48.73 17.18 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.059 0.457 . . . . 15.0 110.807 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.661 HD12 ' HB1' ' A' ' 67' ' ' ALA . 95.2 mt -59.92 -40.03 81.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 15.0 110.855 -176.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.99 -15.74 29.7 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 119.916 -0.38 . . . . 15.0 112.966 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -64.82 -31.47 72.72 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 117.433 0.616 . . . . 15.0 111.884 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.7 mt -73.77 135.38 77.83 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 118.866 -0.587 . . . . 15.0 110.361 -175.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.01 134.18 60.57 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.39 1.393 . . . . 15.0 112.59 177.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.7 tp -107.66 130.18 54.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.974 -0.557 . . . . 15.0 110.65 176.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.525 ' CD1' HG22 ' A' ' 53' ' ' VAL . 77.4 m-85 -89.19 123.9 33.86 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.27 -0.641 . . . . 15.0 109.27 175.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.699 HG21 ' HB2' ' A' ' 87' ' ' ALA . 25.7 m -114.53 146.61 36.28 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 119.378 -0.344 . . . . 15.0 110.237 177.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -79.14 -23.77 7.36 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.52 1.48 . . . . 15.0 113.574 -174.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.0 p -143.44 162.22 43.3 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 120.564 -0.455 . . . . 15.0 111.677 -171.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.0 -44.0 51.35 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.154 1.236 . . . . 15.0 111.791 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -57.95 -47.28 83.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.837 0.351 . . . . 15.0 110.838 -177.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.17 -41.17 85.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 15.0 110.047 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.699 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.82 -42.68 84.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.901 0.382 . . . . 15.0 110.411 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.33 -42.08 98.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 15.0 110.604 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 86.7 mtp -59.41 -43.81 92.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.198 0.523 . . . . 15.0 110.44 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.6 94.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.931 -0.577 . . . . 15.0 110.74 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -61.59 -44.44 97.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.336 -0.393 . . . . 15.0 110.674 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.43 -36.1 77.38 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.842 -0.343 . . . . 15.0 111.313 -177.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.7 mt -64.9 -24.12 67.43 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.206 0.447 . . . . 15.0 112.206 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.55 13.33 17.09 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 119.311 -0.716 . . . . 15.0 113.103 -176.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.91 121.98 11.84 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.573 1.187 . . . . 15.0 109.894 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -69.31 -35.18 75.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.659 -0.701 . . . . 15.0 111.267 -171.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -131.08 115.71 16.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.003 0.43 . . . . 15.0 110.182 177.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.9 t -114.69 130.1 69.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.281 -0.418 . . . . 15.0 110.027 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.7 mt -119.48 124.91 73.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.997 -0.547 . . . . 15.0 110.058 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -95.39 118.03 31.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.384 -0.371 . . . . 15.0 110.038 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.415 ' HA ' ' HB3' ' A' ' 104' ' ' ALA . 31.4 p -96.73 -0.38 48.3 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.219 0.822 . . . . 15.0 113.219 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -56.0 -40.08 72.81 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 118.186 0.448 . . . . 15.0 110.62 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.02 -35.02 5.21 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.507 -0.637 . . . . 15.0 111.507 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.415 ' HB3' ' HA ' ' A' ' 101' ' ' CYS . . . -71.58 142.32 50.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.815 0.341 . . . . 15.0 110.664 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.6 m -89.89 163.24 15.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.496 . . . . 15.0 110.505 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.78 -54.28 24.72 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 112.977 0.732 . . . . 15.0 112.977 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.23 -34.27 98.41 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 CA-C-N 120.068 1.06 . . . . 15.0 111.635 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.14 -43.14 95.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.058 0.456 . . . . 15.0 110.012 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 78.6 mt -59.38 -40.49 86.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 15.0 110.515 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 42.2 tp -56.88 -44.9 82.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.51 0.671 . . . . 15.0 110.166 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.04 92.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.526 -0.761 . . . . 15.0 110.708 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.57 -42.3 96.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.476 -0.329 . . . . 15.0 110.907 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.6 mt -57.92 -51.47 69.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.171 0.51 . . . . 15.0 110.388 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.7 p -63.5 -40.16 96.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.628 -0.714 . . . . 15.0 111.28 -175.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.0 t -63.18 -44.27 95.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.662 0.268 . . . . 15.0 111.385 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.03 85.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.473 -0.331 . . . . 15.0 110.955 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.39 73.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.496 -0.32 . . . . 15.0 111.277 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.7 mt -58.79 -37.53 76.54 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 121.122 -0.231 . . . . 15.0 111.165 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.85 -37.31 81.67 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 121.031 -0.267 . . . . 15.0 111.109 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -55.94 -37.26 68.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.574 -0.285 . . . . 15.0 111.221 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -105.05 134.62 47.84 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.76 0.314 . . . . 15.0 110.758 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -120.96 128.39 52.68 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.222 -0.445 . . . . 15.0 110.67 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -58.56 -39.31 79.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 15.0 110.926 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -56.4 -41.14 75.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.375 -0.375 . . . . 15.0 110.674 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 . . . . . 0 C--O 1.219 -0.543 0 CA-C-O 118.047 -0.977 . . . . 15.0 110.607 179.668 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.5 mtp . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.395 -0.594 . . . . 15.0 109.395 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -126.17 74.27 72.37 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.135 -0.484 . . . . 15.0 110.361 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -58.01 155.03 35.58 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.52 1.48 . . . . 15.0 112.035 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -110.61 139.88 45.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.518 -0.31 . . . . 15.0 110.741 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.415 HG21 HD13 ' A' ' 21' ' ' LEU . 13.5 m -135.75 142.31 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.556 0.693 . . . . 15.0 111.635 176.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.2 tp -105.0 133.8 49.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.94 -1.027 . . . . 15.0 110.169 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.569 HD11 ' CG1' ' A' ' 28' ' ' VAL . 41.9 mt -106.02 135.18 45.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.286 -0.415 . . . . 15.0 110.22 -177.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.416 ' SD ' HD13 ' A' ' 63' ' ' LEU . 83.7 mtp -94.37 134.05 37.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.157 -0.474 . . . . 15.0 110.537 175.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -62.79 145.87 53.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.043 0.449 . . . . 15.0 111.536 -174.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.96 175.2 42.85 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.638 -0.985 . . . . 15.0 110.638 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.91 -33.3 68.62 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.725 0.268 . . . . 15.0 111.725 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.95 164.35 3.6 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.165 -0.774 . . . . 15.0 111.165 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.99 104.77 2.81 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.92 -0.872 . . . . 15.0 110.92 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.435 ' HD2' HG21 ' A' ' 7' ' ' ILE . 87.5 mmt-85 -69.18 -32.52 71.89 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.794 0.294 . . . . 15.0 111.794 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.33 -45.64 87.71 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.595 -0.442 . . . . 15.0 110.366 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -65.9 -55.21 18.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.359 -0.382 . . . . 15.0 111.233 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.476 HD23 ' C ' ' A' ' 17' ' ' LEU . 10.0 tt -56.76 -43.13 80.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.843 0.354 . . . . 15.0 110.959 -177.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.47 -43.02 99.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.388 -0.369 . . . . 15.0 110.575 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.82 -41.02 85.84 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.808 -0.357 . . . . 15.0 110.566 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -60.97 -51.32 69.73 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 120.371 -0.532 . . . . 15.0 111.366 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.415 HD13 HG21 ' A' ' 5' ' ' VAL . 70.0 mt -61.15 -37.78 84.08 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.316 -0.554 . . . . 15.0 110.845 -178.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -65.03 -41.41 95.27 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 120.694 -0.402 . . . . 15.0 111.356 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.88 -30.68 66.68 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.028 -0.606 . . . . 15.0 111.883 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -88.08 9.97 20.76 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.477 0.917 . . . . 15.0 113.477 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.24 17.09 58.07 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 121.333 -0.46 . . . . 15.0 113.263 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -101.04 139.56 22.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 117.807 0.804 . . . . 15.0 110.126 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -82.0 126.2 31.69 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.393 -0.595 . . . . 15.0 109.393 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.569 ' CG1' HD11 ' A' ' 7' ' ' ILE . 41.5 t -116.75 129.32 73.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.087 0.47 . . . . 15.0 110.933 -174.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -136.39 132.65 35.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.636 -0.711 . . . . 15.0 109.685 172.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -112.63 133.45 54.66 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.947 0.403 . . . . 15.0 110.789 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.1 tp -116.08 113.33 41.7 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 118.824 -0.607 . . . . 15.0 110.367 -176.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.65 135.81 68.42 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 121.362 1.374 . . . . 15.0 112.692 174.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.524 HD13 ' OD1' ' A' ' 62' ' ' ASN . 73.9 mt -59.48 -10.48 3.37 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.37 0.878 . . . . 15.0 113.37 -178.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -77.16 -6.26 52.25 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.298 0.851 . . . . 15.0 113.298 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -71.78 148.72 92.57 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 118.588 0.631 . . . . 15.0 110.582 -178.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -74.6 152.08 42.46 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.604 1.536 . . . . 15.0 113.782 -174.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.73 152.52 3.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.373 -0.83 . . . . 15.0 111.292 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.31 -38.28 3.15 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.799 -0.637 . . . . 15.0 111.782 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.5 -36.03 82.85 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 117.343 0.571 . . . . 15.0 111.264 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.563 ' O ' HG23 ' A' ' 44' ' ' VAL . 26.8 tp -58.74 -46.86 86.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.942 0.401 . . . . 15.0 110.135 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.472 HD22 ' CG ' ' A' ' 70' ' ' ASP . 16.6 tp -63.33 -44.45 94.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 15.0 110.875 -176.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.56 -44.76 96.44 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.706 -0.398 . . . . 15.0 110.871 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 61.7 ttm-85 -60.88 -42.78 98.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.458 -0.337 . . . . 15.0 110.655 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 40' ' ' LEU . 98.5 t -60.34 -45.37 96.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.777 -0.369 . . . . 15.0 110.174 -177.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -67.29 -51.78 48.63 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.485 0.491 . . . . 15.0 112.058 -176.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.64 -44.35 82.19 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.986 -0.286 . . . . 15.0 111.565 -174.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -79.83 -10.15 59.75 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.972 0.73 . . . . 15.0 112.972 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 54.78 55.95 7.26 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.595 0.712 . . . . 15.0 110.086 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.55 HD12 HG22 ' A' ' 44' ' ' VAL . 97.5 mt -65.09 144.91 56.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.744 -0.662 . . . . 15.0 111.314 -174.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -92.84 -39.13 11.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.133 -0.94 . . . . 15.0 110.81 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.69 160.96 28.46 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 120.149 -1.024 . . . . 15.0 113.469 -175.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.1 mt -126.16 144.37 50.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.575 -0.812 . . . . 15.0 109.564 177.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.49 HG22 ' HD1' ' A' ' 80' ' ' PHE . 44.7 t -122.71 131.51 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 O-C-N 122.315 -0.24 . . . . 15.0 110.93 -177.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.0 m -127.53 150.69 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.08 0.467 . . . . 15.0 110.37 171.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.5 t -107.5 -15.65 14.56 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.605 -0.725 . . . . 15.0 112.711 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.4 p -152.75 160.59 43.13 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.402 0.62 . . . . 15.0 111.917 -173.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.37 -37.78 75.8 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.016 -0.834 . . . . 15.0 111.016 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -57.19 -46.16 83.09 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 122.599 -0.353 . . . . 15.0 110.703 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.14 -45.62 95.68 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.621 -0.991 . . . . 15.0 110.621 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.57 HD21 ' HA ' ' A' ' 90' ' ' ALA . 21.0 tp -56.94 -44.61 82.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.103 0.478 . . . . 15.0 110.736 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.69 -43.44 98.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.481 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.524 ' OD1' HD13 ' A' ' 33' ' ' LEU . 28.9 m120 -59.04 -37.31 76.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.124 -0.489 . . . . 15.0 110.858 177.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.416 HD13 ' SD ' ' A' ' 8' ' ' MET . 12.1 tp -57.5 -44.96 85.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.286 0.565 . . . . 15.0 110.121 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -60.66 -46.87 88.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.53 -0.759 . . . . 15.0 110.539 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -62.61 -43.96 97.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 15.0 111.347 -176.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.08 -35.07 79.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.476 -0.329 . . . . 15.0 111.266 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.667 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -60.3 -37.95 82.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.007 0.432 . . . . 15.0 110.858 178.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.37 -144.63 0.55 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.461 -0.57 . . . . 15.0 109.461 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.45 -19.13 45.28 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.29 0.95 . . . . 15.0 112.586 -174.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.472 ' CG ' HD22 ' A' ' 41' ' ' LEU . 22.0 m-20 -91.88 11.76 23.84 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.295 0.85 . . . . 15.0 113.295 -174.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 59.0 t-105 -47.77 -46.85 62.7 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 118.564 -0.731 . . . . 15.0 112.519 177.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -44.66 -41.29 14.58 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 121.431 1.421 . . . . 15.0 113.287 177.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -76.96 -48.75 17.2 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.607 -0.437 . . . . 15.0 110.803 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.667 HD12 ' HB1' ' A' ' 67' ' ' ALA . 91.5 mt -58.91 -40.18 79.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.197 -0.456 . . . . 15.0 110.796 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.39 -16.99 37.77 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 116.291 -0.413 . . . . 15.0 113.254 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -66.58 -28.93 68.9 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.297 0.548 . . . . 15.0 112.17 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.2 mt -74.85 150.59 86.24 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 121.031 -0.268 . . . . 15.0 111.514 -172.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -63.8 126.52 17.57 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 121.626 1.551 . . . . 15.0 112.309 176.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.8 tp -105.7 127.25 52.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.508 -0.315 . . . . 15.0 110.824 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.49 ' HD1' HG22 ' A' ' 53' ' ' VAL . 69.6 m-85 -89.45 127.13 35.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.589 -0.522 . . . . 15.0 109.589 175.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.718 HG21 ' HB2' ' A' ' 87' ' ' ALA . 27.5 m -118.53 146.76 40.47 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 110.08 -0.341 . . . . 15.0 110.08 175.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.404 ' HD2' HG11 ' A' ' 86' ' ' VAL . 78.2 Cg_endo -79.1 -23.45 7.69 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.61 1.54 . . . . 15.0 113.457 -176.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.403 ' OG ' HG23 ' A' ' 86' ' ' VAL . 25.5 p -144.3 158.44 54.68 Favored Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 120.671 -0.412 . . . . 15.0 111.355 -172.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.07 -44.03 52.18 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.26 1.307 . . . . 15.0 111.737 176.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -57.65 -47.71 81.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.882 0.372 . . . . 15.0 110.929 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.404 HG11 ' HD2' ' A' ' 82' ' ' PRO . 60.3 t -59.65 -40.69 82.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.906 0.384 . . . . 15.0 109.983 178.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.718 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.55 -42.25 82.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.81 0.338 . . . . 15.0 110.444 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.41 -41.03 93.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.49 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.1 mmm -58.39 -43.95 88.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.401 0.619 . . . . 15.0 110.157 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.57 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.28 -40.62 94.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.733 -0.667 . . . . 15.0 110.795 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -62.53 -42.82 99.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.342 -0.39 . . . . 15.0 111.074 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.67 -36.11 77.92 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.897 -0.321 . . . . 15.0 111.33 -177.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.2 mt -67.95 -22.12 65.05 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.404 0.52 . . . . 15.0 112.404 177.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.99 13.39 18.15 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 119.315 -0.714 . . . . 15.0 113.217 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.77 121.98 11.76 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.579 1.189 . . . . 15.0 109.864 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -70.3 -35.37 73.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.55 -0.75 . . . . 15.0 111.275 -171.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -131.84 112.53 12.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.977 0.418 . . . . 15.0 110.486 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.2 t -112.0 130.69 65.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.135 -0.484 . . . . 15.0 109.883 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 84.3 mt -118.95 122.6 69.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.016 -0.538 . . . . 15.0 110.11 -176.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.57 117.07 29.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.457 -0.338 . . . . 15.0 110.431 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.3 p -97.02 6.12 49.18 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.168 0.803 . . . . 15.0 113.168 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 71.9 ttp85 -55.76 -39.37 71.11 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.169 0.441 . . . . 15.0 110.803 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.68 -35.09 5.27 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.6 -0.6 . . . . 15.0 111.6 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.26 139.07 54.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.969 0.414 . . . . 15.0 110.773 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.8 p -89.84 167.84 12.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.996 -0.547 . . . . 15.0 110.464 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.75 -54.2 25.22 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 113.028 0.751 . . . . 15.0 113.028 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.73 -36.6 98.54 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 CA-C-N 120.509 1.218 . . . . 15.0 111.447 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.55 -43.13 97.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.98 0.419 . . . . 15.0 110.183 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.5 mt -59.36 -40.8 87.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.198 -0.456 . . . . 15.0 110.398 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.9 tp -57.67 -44.7 85.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.323 0.583 . . . . 15.0 110.188 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.98 -40.71 94.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.666 -0.697 . . . . 15.0 110.595 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.85 -42.04 97.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.424 -0.353 . . . . 15.0 110.765 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.3 mt -57.87 -50.44 73.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.047 0.451 . . . . 15.0 110.44 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.7 p -65.02 -40.49 94.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.805 -0.634 . . . . 15.0 111.479 -175.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.9 p -64.37 -39.67 94.33 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.98 -0.288 . . . . 15.0 111.28 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.54 -43.27 94.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.634 -0.257 . . . . 15.0 111.037 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.56 -40.66 97.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.543 -0.299 . . . . 15.0 110.976 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 89.6 mt -66.94 -38.09 85.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.429 -0.351 . . . . 15.0 111.521 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -121.04 123.67 42.95 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.848 0.356 . . . . 15.0 111.165 -177.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -112.1 -29.12 7.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.013 -0.54 . . . . 15.0 111.889 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -53.97 -40.76 67.16 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.6 0.238 . . . . 15.0 111.388 -176.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -116.7 129.38 56.1 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.998 0.428 . . . . 15.0 110.836 -178.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -58.78 -38.61 78.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.85 -0.614 . . . . 15.0 110.989 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -110.54 140.61 44.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.404 -0.362 . . . . 15.0 110.665 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 117.995 -1.002 . . . . 15.0 110.66 179.822 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.389 -0.597 . . . . 15.0 109.389 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -125.5 79.16 67.54 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.132 -0.486 . . . . 15.0 110.194 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -54.09 152.37 24.62 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 121.481 1.454 . . . . 15.0 111.824 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -112.43 135.7 52.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.291 -0.413 . . . . 15.0 110.509 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.57 HG21 HD13 ' A' ' 21' ' ' LEU . 17.8 m -133.1 145.58 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.619 0.723 . . . . 15.0 111.859 177.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.9 tp -103.66 136.86 42.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.964 -1.016 . . . . 15.0 110.496 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.631 HD11 ' CG1' ' A' ' 28' ' ' VAL . 54.8 mt -100.79 133.87 42.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.033 0.444 . . . . 15.0 110.683 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.423 ' SD ' HD13 ' A' ' 63' ' ' LEU . 84.8 mtp -102.56 134.62 45.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.242 -0.89 . . . . 15.0 110.09 173.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -57.36 141.16 48.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.213 0.53 . . . . 15.0 110.572 -173.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.13 175.28 31.66 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.551 -1.02 . . . . 15.0 110.551 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.7 mp0 -58.0 -31.68 67.19 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.951 -0.3 . . . . 15.0 111.515 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.49 173.27 33.61 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.908 -0.877 . . . . 15.0 110.908 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.32 132.21 11.05 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.488 -0.645 . . . . 15.0 111.488 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -56.87 -44.08 81.86 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.127 0.489 . . . . 15.0 110.227 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.38 -43.42 97.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.767 -0.651 . . . . 15.0 111.024 -175.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -58.2 -55.93 28.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.012 0.434 . . . . 15.0 110.909 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.1 mt -61.35 -42.85 99.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 15.0 110.91 -175.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.12 -45.0 96.48 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.767 -0.373 . . . . 15.0 111.163 -177.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.23 -38.81 84.56 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.598 -0.441 . . . . 15.0 110.811 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -60.63 -51.51 69.1 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 119.973 -0.691 . . . . 15.0 110.918 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.57 HD13 HG21 ' A' ' 5' ' ' VAL . 79.9 mt -63.57 -38.02 89.52 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 120.451 -0.499 . . . . 15.0 111.252 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -63.57 -42.47 98.33 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.91 -0.316 . . . . 15.0 111.266 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.71 -30.72 69.63 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 120.865 -0.684 . . . . 15.0 112.011 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -88.8 10.14 22.11 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.654 0.983 . . . . 15.0 113.654 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.8 17.25 56.89 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 121.251 -0.5 . . . . 15.0 113.295 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.1 t -101.02 141.02 18.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 117.712 0.756 . . . . 15.0 110.088 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -84.8 131.36 34.55 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.297 -0.631 . . . . 15.0 109.297 177.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.631 ' CG1' HD11 ' A' ' 7' ' ' ILE . 40.3 t -117.72 131.19 71.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.129 0.49 . . . . 15.0 111.121 -173.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -137.4 133.82 35.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.464 -0.789 . . . . 15.0 109.488 171.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.552 ' HB3' HD12 ' A' ' 7' ' ' ILE . 42.1 p90 -116.06 138.38 51.28 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.968 0.413 . . . . 15.0 111.194 -177.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.0 tp -119.21 135.97 24.21 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 109.243 -0.651 . . . . 15.0 109.243 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.22 135.92 25.77 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.182 1.255 . . . . 15.0 111.759 173.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 84.1 mt -59.9 -9.31 2.84 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.41 0.893 . . . . 15.0 113.41 -177.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -77.14 -7.91 56.6 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.415 0.894 . . . . 15.0 113.415 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -64.57 146.55 98.18 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 118.606 0.639 . . . . 15.0 110.552 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.03 159.03 27.15 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.617 1.544 . . . . 15.0 113.221 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.44 150.97 4.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.779 -0.646 . . . . 15.0 111.52 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.2 -38.01 3.25 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.321 -0.712 . . . . 15.0 111.321 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -61.34 -37.82 84.67 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.58 -0.448 . . . . 15.0 111.017 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.573 ' O ' HG23 ' A' ' 44' ' ' VAL . 28.4 tp -59.0 -46.83 87.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.981 0.42 . . . . 15.0 110.127 -178.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.481 HD13 ' CB ' ' A' ' 70' ' ' ASP . 14.6 tp -62.51 -43.56 98.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.178 -0.465 . . . . 15.0 110.914 -177.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.17 -45.96 91.06 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.724 -0.39 . . . . 15.0 110.95 -176.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -61.52 -41.5 97.41 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.812 -0.355 . . . . 15.0 110.707 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 40' ' ' LEU . 94.5 t -61.24 -45.8 97.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.779 -0.368 . . . . 15.0 110.204 -177.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -69.11 -49.03 60.76 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.293 0.479 . . . . 15.0 112.293 -175.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.48 -44.3 75.08 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.992 -0.283 . . . . 15.0 111.642 -174.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -78.96 -10.16 59.74 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.09 0.774 . . . . 15.0 113.09 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 55.78 55.83 6.69 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.601 0.715 . . . . 15.0 110.306 -177.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.557 HD12 ' HA ' ' A' ' 44' ' ' VAL . 94.2 mt -74.18 146.91 43.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.552 -0.749 . . . . 15.0 111.306 -176.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -96.78 -40.71 8.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.677 -0.692 . . . . 15.0 110.807 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.63 165.45 28.77 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 119.798 -1.191 . . . . 15.0 113.644 -171.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.444 ' HB2' HD12 ' A' ' 79' ' ' LEU . 72.7 mt -127.04 144.59 50.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.545 -0.828 . . . . 15.0 110.279 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.521 HG22 ' CD1' ' A' ' 80' ' ' PHE . 47.5 t -120.22 129.35 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 110.372 -0.233 . . . . 15.0 110.372 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.2 m -126.65 144.53 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.141 0.496 . . . . 15.0 110.657 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.0 t -102.84 -13.27 17.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.493 -0.776 . . . . 15.0 112.747 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.8 p -153.34 159.1 42.4 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.456 0.646 . . . . 15.0 112.075 -173.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.6 -37.9 78.5 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.972 -0.851 . . . . 15.0 110.972 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -58.45 -44.62 89.28 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.848 -0.341 . . . . 15.0 110.635 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.4 -45.38 96.31 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.623 -0.991 . . . . 15.0 110.623 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.537 HD13 HD21 ' A' ' 79' ' ' LEU . 42.5 tp -56.4 -45.73 80.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.129 0.49 . . . . 15.0 110.778 -177.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -62.0 -42.73 99.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.043 -0.526 . . . . 15.0 110.89 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -59.22 -39.68 83.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.373 -0.376 . . . . 15.0 110.716 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.423 HD13 ' SD ' ' A' ' 8' ' ' MET . 13.6 tp -58.09 -45.02 87.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.166 0.508 . . . . 15.0 110.238 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -60.7 -47.55 85.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.744 -0.662 . . . . 15.0 110.648 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -62.0 -43.19 99.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.014 -0.539 . . . . 15.0 111.136 -176.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.08 -34.95 78.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.451 -0.341 . . . . 15.0 111.453 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.697 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.47 -38.94 82.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.953 0.406 . . . . 15.0 110.535 177.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 58.96 -142.53 0.64 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.626 -0.509 . . . . 15.0 109.626 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.75 -18.58 44.16 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.39 0.996 . . . . 15.0 112.695 -174.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.481 ' CB ' HD13 ' A' ' 41' ' ' LEU . 26.4 m-20 -91.79 9.26 33.42 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.315 0.857 . . . . 15.0 113.315 -175.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -47.74 -46.57 61.84 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.633 -0.699 . . . . 15.0 112.61 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -44.55 -43.04 14.34 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.493 1.462 . . . . 15.0 113.287 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -76.96 -48.81 17.02 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 120.644 -0.422 . . . . 15.0 110.931 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.697 HD12 ' HB1' ' A' ' 67' ' ' ALA . 86.4 mt -59.33 -39.05 77.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.11 -0.496 . . . . 15.0 110.85 -176.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.78 -13.2 38.54 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 119.826 -0.43 . . . . 15.0 113.405 -175.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -70.5 -29.21 65.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 117.578 0.689 . . . . 15.0 112.304 178.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.2 mt -69.86 126.51 92.53 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 118.572 -0.728 . . . . 15.0 109.606 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.23 133.45 52.68 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.106 1.204 . . . . 15.0 112.333 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.537 HD21 HD13 ' A' ' 60' ' ' LEU . 17.8 tp -105.75 129.31 53.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.904 -0.589 . . . . 15.0 110.552 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.521 ' CD1' HG22 ' A' ' 53' ' ' VAL . 77.5 m-85 -90.52 122.45 33.36 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.249 -0.648 . . . . 15.0 109.249 175.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.65 HG21 ' HB2' ' A' ' 87' ' ' ALA . 25.9 m -114.99 148.01 39.6 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 119.457 -0.306 . . . . 15.0 110.326 177.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.21 -24.54 6.59 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.529 1.486 . . . . 15.0 113.614 -174.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.9 p -142.43 161.36 50.45 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 120.594 -0.442 . . . . 15.0 111.58 -172.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -55.32 -44.07 52.44 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.208 1.272 . . . . 15.0 111.76 176.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -57.17 -47.9 80.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.855 0.36 . . . . 15.0 110.639 -177.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.5 t -60.0 -41.37 85.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.904 0.383 . . . . 15.0 109.992 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.65 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.94 -42.1 84.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.969 0.414 . . . . 15.0 110.486 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.24 -41.71 97.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.433 . . . . 15.0 110.44 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 86.5 mtp -58.92 -41.82 88.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.101 0.477 . . . . 15.0 110.379 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.69 -41.21 94.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 15.0 110.576 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 -61.74 -43.29 99.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 15.0 110.809 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.24 -36.1 76.98 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.879 -0.328 . . . . 15.0 111.256 -177.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 77.5 mt -65.89 -24.41 66.85 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.256 0.465 . . . . 15.0 112.256 176.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 107.67 13.25 20.88 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 119.437 -0.646 . . . . 15.0 113.075 -175.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.94 123.82 17.12 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 118.416 1.108 . . . . 15.0 109.939 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -72.17 -33.5 67.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.843 -0.617 . . . . 15.0 111.425 -172.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 45.9 tpt85 -131.81 114.57 14.87 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.903 0.382 . . . . 15.0 110.404 176.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 40.5 t -114.67 131.62 66.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.822 0.344 . . . . 15.0 110.145 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 87.8 mt -119.7 125.93 74.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.172 -0.467 . . . . 15.0 110.191 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -94.2 118.3 31.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.36 -0.382 . . . . 15.0 110.134 174.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.1 p -94.25 -7.2 42.73 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.17 0.804 . . . . 15.0 113.17 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -55.82 -39.41 71.34 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 118.122 0.419 . . . . 15.0 110.781 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -96.27 -35.04 5.63 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.491 -0.644 . . . . 15.0 111.491 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.24 143.44 40.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.796 0.331 . . . . 15.0 110.478 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.6 m -89.43 163.42 15.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 15.0 110.526 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.72 -54.31 24.23 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 112.878 0.695 . . . . 15.0 112.878 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.6 -34.13 98.65 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 CA-C-N 120.195 1.106 . . . . 15.0 111.646 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.29 -42.96 96.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.107 0.48 . . . . 15.0 110.026 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.8 mt -59.32 -39.88 84.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 15.0 110.495 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 29.4 tp -56.87 -45.04 82.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.399 0.618 . . . . 15.0 110.111 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.98 -39.73 90.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.506 -0.77 . . . . 15.0 110.601 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.63 -42.87 97.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.604 -0.271 . . . . 15.0 110.844 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.8 mt -58.04 -50.36 73.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.119 0.485 . . . . 15.0 110.405 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 71.7 p -63.5 -40.39 96.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.807 -0.633 . . . . 15.0 111.368 -175.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.8 m -64.01 -42.75 97.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.662 0.267 . . . . 15.0 111.292 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.25 -39.01 88.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.474 -0.33 . . . . 15.0 110.998 -178.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.15 -35.73 74.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.545 -0.298 . . . . 15.0 111.213 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 84.7 mt -58.54 -38.05 76.97 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 121.001 -0.279 . . . . 15.0 110.947 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -100.2 128.93 46.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 15.0 110.215 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -93.12 -35.28 13.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.299 -0.409 . . . . 15.0 111.61 -177.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -122.61 131.18 53.7 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.977 0.418 . . . . 15.0 110.991 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -62.24 -32.05 72.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.782 -0.644 . . . . 15.0 111.794 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -51.92 -38.89 58.02 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 111.681 0.252 . . . . 15.0 111.681 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -56.0 -40.54 73.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.734 0.302 . . . . 15.0 110.891 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.039 -0.982 . . . . 15.0 110.487 179.448 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.6 mtp . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.427 -0.582 . . . . 15.0 109.427 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -126.66 81.77 68.09 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.107 -0.497 . . . . 15.0 110.406 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -56.13 155.05 25.47 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.389 1.393 . . . . 15.0 111.761 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.441 ' CB ' HD23 ' A' ' 49' ' ' LEU . 93.4 mttt -109.98 138.04 46.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.479 -0.328 . . . . 15.0 110.901 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.448 HG21 HD13 ' A' ' 21' ' ' LEU . 15.8 m -134.06 144.35 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.538 0.685 . . . . 15.0 111.614 175.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.8 tp -103.78 136.74 42.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.949 -1.023 . . . . 15.0 110.274 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.643 HD11 ' CG1' ' A' ' 28' ' ' VAL . 54.8 mt -101.6 133.8 43.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.137 0.494 . . . . 15.0 111.013 -177.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.549 ' HB2' HG12 ' A' ' 54' ' ' VAL . 98.7 mmm -94.69 134.28 37.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.153 -0.93 . . . . 15.0 109.045 170.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -57.46 140.68 49.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.894 0.378 . . . . 15.0 110.562 -175.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.28 175.1 27.74 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.995 -0.842 . . . . 15.0 110.995 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -58.2 -33.18 69.0 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.546 0.202 . . . . 15.0 111.546 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.94 173.27 35.25 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.979 -0.848 . . . . 15.0 110.979 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.98 131.36 10.37 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.25 -0.74 . . . . 15.0 111.25 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -57.41 -43.76 84.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.082 0.468 . . . . 15.0 110.317 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.18 -42.58 99.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.815 -0.63 . . . . 15.0 111.344 -176.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -61.68 -55.94 25.09 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.804 -0.359 . . . . 15.0 111.292 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.3 mt -59.87 -43.62 94.62 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.662 -0.415 . . . . 15.0 111.021 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.7 -41.31 99.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.491 -0.322 . . . . 15.0 110.995 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -60.04 -41.5 92.43 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.949 -0.3 . . . . 15.0 110.458 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -60.91 -51.73 68.04 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.622 -0.431 . . . . 15.0 111.319 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.448 HD13 HG21 ' A' ' 5' ' ' VAL . 72.9 mt -63.63 -36.96 85.54 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.349 -0.54 . . . . 15.0 110.971 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -62.49 -41.87 99.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.648 0.261 . . . . 15.0 111.092 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.7 -30.62 69.41 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.068 -0.587 . . . . 15.0 111.932 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -88.09 10.96 17.46 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.535 0.939 . . . . 15.0 113.535 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.39 17.77 56.54 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 121.279 -0.486 . . . . 15.0 113.368 174.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -101.05 139.0 23.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 117.807 0.803 . . . . 15.0 110.217 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -83.28 130.75 35.09 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.207 -0.664 . . . . 15.0 109.207 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.643 ' CG1' HD11 ' A' ' 7' ' ' ILE . 21.2 t -119.69 133.94 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.137 0.494 . . . . 15.0 111.401 -172.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -140.21 138.12 34.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.543 -0.753 . . . . 15.0 109.64 171.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.473 ' HB3' HD12 ' A' ' 7' ' ' ILE . 38.8 p90 -115.81 141.65 47.82 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.825 0.345 . . . . 15.0 110.789 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.9 tp -117.83 113.42 37.98 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 118.814 -0.612 . . . . 15.0 110.585 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -49.67 135.0 34.39 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.208 1.272 . . . . 15.0 111.903 173.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.655 HD13 ' OD1' ' A' ' 62' ' ' ASN . 46.0 mt -62.87 -13.37 33.17 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.214 0.82 . . . . 15.0 113.214 -176.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -77.14 -5.32 48.6 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.3 0.852 . . . . 15.0 113.3 -177.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -61.25 149.93 81.2 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 118.484 0.584 . . . . 15.0 110.375 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -80.07 151.91 21.26 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.567 1.512 . . . . 15.0 112.891 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.39 150.7 6.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.066 -0.515 . . . . 15.0 111.173 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.08 -38.03 3.24 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.57 -0.612 . . . . 15.0 111.57 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -62.05 -37.98 87.02 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 117.081 0.44 . . . . 15.0 110.995 -177.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.558 ' O ' HG23 ' A' ' 44' ' ' VAL . 21.2 tp -59.3 -47.46 85.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.922 0.392 . . . . 15.0 110.155 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.486 HD13 HD11 ' A' ' 74' ' ' ILE . 15.4 tp -63.0 -44.5 95.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.204 -0.453 . . . . 15.0 110.973 -176.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.65 -45.66 93.08 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.702 -0.399 . . . . 15.0 110.675 -176.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 47.2 ttt85 -61.01 -42.03 97.68 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.784 -0.367 . . . . 15.0 110.706 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 40' ' ' LEU . 96.8 t -60.88 -45.04 98.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.811 -0.355 . . . . 15.0 110.322 -177.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -68.79 -48.24 64.13 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.235 0.457 . . . . 15.0 112.235 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.03 -44.3 72.99 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.995 -0.282 . . . . 15.0 111.629 -175.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -78.41 -10.03 59.53 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.046 0.758 . . . . 15.0 113.046 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 55.93 55.84 6.57 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.593 0.711 . . . . 15.0 110.252 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 44' ' ' VAL . 96.2 mt -70.01 144.21 52.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.552 -0.749 . . . . 15.0 110.976 -176.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -90.8 -40.58 11.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.394 -0.821 . . . . 15.0 110.764 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -150.8 166.46 30.34 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 119.797 -1.192 . . . . 15.0 113.774 -173.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.0 mt -125.73 143.05 51.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.519 -0.84 . . . . 15.0 109.888 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.516 HG22 ' CD1' ' A' ' 80' ' ' PHE . 46.8 t -121.28 131.6 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 110.307 -0.257 . . . . 15.0 110.307 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.549 HG12 ' HB2' ' A' ' 8' ' ' MET . 7.0 m -128.46 139.72 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.058 0.456 . . . . 15.0 110.469 173.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.9 t -102.03 -14.93 16.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.566 -0.743 . . . . 15.0 112.81 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 85.2 p -145.9 156.77 43.76 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.28 0.562 . . . . 15.0 111.771 -174.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.18 -39.7 90.41 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.873 -0.891 . . . . 15.0 110.873 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -59.33 -43.54 92.69 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.837 -0.345 . . . . 15.0 110.533 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.41 -46.29 94.13 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.544 -1.023 . . . . 15.0 110.544 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.54 HD13 HD21 ' A' ' 79' ' ' LEU . 35.2 tp -57.16 -44.84 83.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.106 0.479 . . . . 15.0 110.685 -177.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.82 -42.64 99.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.025 -0.534 . . . . 15.0 110.93 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.655 ' OD1' HD13 ' A' ' 33' ' ' LEU . 30.9 m120 -59.97 -40.78 90.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.781 0.324 . . . . 15.0 110.642 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.425 ' CD1' HD21 ' A' ' 40' ' ' LEU . 13.5 tp -58.15 -44.26 87.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.24 0.543 . . . . 15.0 110.17 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -60.82 -46.95 88.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.833 -0.621 . . . . 15.0 110.769 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.31 -42.63 98.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.083 -0.508 . . . . 15.0 111.123 -176.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 94.8 mt -65.47 -36.19 83.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.404 -0.362 . . . . 15.0 111.332 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.675 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.47 -38.08 79.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.145 0.498 . . . . 15.0 110.923 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.14 -143.85 0.58 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.627 -0.508 . . . . 15.0 109.627 174.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.54 -20.9 58.92 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.307 0.958 . . . . 15.0 112.694 -173.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.472 ' OD2' HD22 ' A' ' 41' ' ' LEU . 77.6 m-20 -92.47 13.53 19.37 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.222 0.823 . . . . 15.0 113.222 -175.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 53.8 t-105 -47.74 -46.65 62.06 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-O 118.608 -0.711 . . . . 15.0 112.53 176.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -44.61 -40.39 13.92 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 121.475 1.45 . . . . 15.0 113.19 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -77.0 -48.79 16.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.034 0.445 . . . . 15.0 110.808 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.675 HD12 ' HB1' ' A' ' 67' ' ' ALA . 91.1 mt -60.34 -39.08 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 15.0 110.876 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.78 -14.3 29.23 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 119.849 -0.417 . . . . 15.0 113.083 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -65.13 -30.9 71.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 117.461 0.631 . . . . 15.0 111.785 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.3 mt -74.02 139.82 76.65 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 119.068 -0.491 . . . . 15.0 110.397 -175.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -58.9 134.26 59.03 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 121.433 1.422 . . . . 15.0 112.556 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.54 HD21 HD13 ' A' ' 60' ' ' LEU . 22.8 tp -108.87 129.2 55.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.075 -0.512 . . . . 15.0 110.745 176.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.516 ' CD1' HG22 ' A' ' 53' ' ' VAL . 84.3 m-85 -91.1 125.83 36.0 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.54 -0.541 . . . . 15.0 109.54 175.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.674 HG21 ' HB2' ' A' ' 87' ' ' ALA . 27.7 m -117.1 149.16 43.8 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 119.513 -0.279 . . . . 15.0 110.377 176.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.405 ' HD2' HG11 ' A' ' 86' ' ' VAL . 72.5 Cg_endo -79.15 -25.53 5.85 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.645 1.563 . . . . 15.0 113.597 -174.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.4 ' OG ' HG23 ' A' ' 86' ' ' VAL . 27.6 p -142.7 162.21 45.34 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 120.635 -0.426 . . . . 15.0 111.542 -172.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -56.02 -43.9 52.21 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.11 1.207 . . . . 15.0 111.862 176.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 68.5 mtp85 -58.79 -46.58 87.22 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.868 -0.333 . . . . 15.0 110.871 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.405 HG11 ' HD2' ' A' ' 82' ' ' PRO . 54.8 t -60.01 -40.85 84.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.959 -0.385 . . . . 15.0 109.959 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.674 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.59 -42.04 82.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.886 0.374 . . . . 15.0 110.467 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.46 -41.37 97.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.281 -0.418 . . . . 15.0 110.555 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 86.9 mtp -59.91 -43.4 94.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.223 0.535 . . . . 15.0 110.442 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.48 -40.85 96.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.025 -0.534 . . . . 15.0 110.719 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -61.24 -44.25 97.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 15.0 110.324 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.8 -36.15 74.0 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.986 -0.286 . . . . 15.0 111.251 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.9 mt -65.24 -26.03 67.93 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.113 0.412 . . . . 15.0 112.113 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.67 13.26 16.99 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 119.391 -0.672 . . . . 15.0 113.13 -176.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.92 122.1 12.13 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 118.527 1.163 . . . . 15.0 109.884 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -68.23 -35.32 77.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.764 -0.653 . . . . 15.0 111.23 -171.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.3 tpt85 -131.79 117.45 18.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.907 0.384 . . . . 15.0 110.137 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.7 t -114.41 130.06 69.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.996 0.427 . . . . 15.0 110.091 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 87.0 mt -118.81 125.16 74.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.801 -0.636 . . . . 15.0 110.171 -177.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.82 118.07 31.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.388 -0.369 . . . . 15.0 110.08 175.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 104' ' ' ALA . 31.9 p -92.91 -8.21 43.94 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.164 0.802 . . . . 15.0 113.164 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -55.14 -39.54 69.58 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.045 0.384 . . . . 15.0 110.914 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.07 -35.09 5.17 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.513 -0.635 . . . . 15.0 111.513 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' A' ' 101' ' ' CYS . . . -68.87 145.42 53.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.879 0.371 . . . . 15.0 110.691 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.437 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 20.6 t -89.8 152.01 21.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 15.0 110.406 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.67 -54.43 23.11 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 113.087 0.773 . . . . 15.0 113.087 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.83 -36.17 94.96 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 CA-C-N 120.098 1.071 . . . . 15.0 111.642 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 105' ' ' SER . . . -59.88 -42.0 92.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.035 0.445 . . . . 15.0 110.078 176.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.6 mt -59.02 -40.16 84.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.243 -0.435 . . . . 15.0 110.517 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.1 tp -57.17 -43.88 82.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.39 0.614 . . . . 15.0 110.146 178.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.84 -40.88 90.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.679 -0.691 . . . . 15.0 110.393 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.73 -40.8 89.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.311 -0.404 . . . . 15.0 110.715 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.9 mt -57.82 -50.74 72.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.271 0.558 . . . . 15.0 110.494 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.5 p -63.57 -40.54 97.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.6 -0.727 . . . . 15.0 111.326 -175.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 86.5 p -65.74 -39.17 90.86 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.911 -0.316 . . . . 15.0 111.42 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.62 -39.31 94.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.497 -0.32 . . . . 15.0 111.068 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.94 -36.21 74.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.418 -0.356 . . . . 15.0 111.163 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 82.5 mt -59.13 -34.46 72.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.499 -0.319 . . . . 15.0 111.357 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -57.71 -34.56 69.59 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 121.298 -0.161 . . . . 15.0 111.418 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -53.92 -35.73 62.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.559 0.219 . . . . 15.0 111.421 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -101.64 140.44 35.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.91 0.386 . . . . 15.0 110.587 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -113.5 141.57 46.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.05 -0.523 . . . . 15.0 110.532 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -114.62 123.93 50.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.305 -0.407 . . . . 15.0 110.336 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -56.02 -40.63 73.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 15.0 110.987 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.982 -1.009 . . . . 15.0 110.615 -179.286 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.7 mtm . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.412 -0.588 . . . . 15.0 109.412 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -125.91 79.76 68.3 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.18 -0.464 . . . . 15.0 110.242 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -49.98 151.51 8.54 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.449 1.433 . . . . 15.0 111.937 -175.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.47 ' HB2' HD23 ' A' ' 49' ' ' LEU . 75.9 mttt -119.93 141.13 49.91 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.334 -0.394 . . . . 15.0 110.703 -178.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.474 HG21 HD13 ' A' ' 21' ' ' LEU . 22.6 m -133.87 145.77 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.474 0.654 . . . . 15.0 111.781 175.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.488 HD13 ' CD ' ' A' ' 43' ' ' ARG . 13.4 tp -104.9 135.45 46.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.077 -0.965 . . . . 15.0 110.067 178.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.51 HD11 ' CG1' ' A' ' 28' ' ' VAL . 58.7 mt -103.04 135.09 42.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.026 0.441 . . . . 15.0 110.545 -177.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.569 ' HE3' HD21 ' A' ' 33' ' ' LEU . 96.7 mmm -88.21 134.12 33.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.422 -0.808 . . . . 15.0 110.123 174.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -57.81 140.72 51.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 15.0 110.583 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.36 175.07 42.52 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.949 -0.86 . . . . 15.0 110.949 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.61 -34.09 64.55 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.263 -0.175 . . . . 15.0 111.419 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.72 162.19 4.36 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.246 -0.742 . . . . 15.0 111.246 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.95 119.59 5.06 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.202 -0.759 . . . . 15.0 111.202 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -57.07 -43.79 82.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.097 0.475 . . . . 15.0 110.24 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.68 -41.71 98.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.861 -0.609 . . . . 15.0 111.146 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -58.84 -56.09 26.66 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.713 -0.395 . . . . 15.0 110.966 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.9 mt -61.53 -40.62 95.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.32 -0.4 . . . . 15.0 111.051 -176.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.41 -46.2 90.87 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.78 -0.368 . . . . 15.0 111.336 -177.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -60.29 -40.04 89.04 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.532 -0.467 . . . . 15.0 110.688 -177.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -60.57 -51.61 68.67 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 120.27 -0.572 . . . . 15.0 111.134 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.474 HD13 HG21 ' A' ' 5' ' ' VAL . 82.3 mt -66.31 -36.12 82.13 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.474 -0.49 . . . . 15.0 111.256 -176.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -61.66 -43.42 98.89 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 121.111 -0.236 . . . . 15.0 110.699 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.9 -30.7 70.26 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 120.844 -0.694 . . . . 15.0 112.018 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -88.21 8.59 26.41 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.647 0.98 . . . . 15.0 113.647 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.2 12.01 63.95 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 121.241 -0.505 . . . . 15.0 113.462 176.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.11 139.89 21.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 117.886 0.843 . . . . 15.0 110.044 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -86.26 137.44 32.61 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.699 -0.482 . . . . 15.0 109.699 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.51 ' CG1' HD11 ' A' ' 7' ' ' ILE . 38.6 t -116.78 131.13 70.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.186 0.517 . . . . 15.0 110.96 -174.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -134.81 130.2 35.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.587 -0.733 . . . . 15.0 109.446 171.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -112.01 135.69 52.32 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.896 0.379 . . . . 15.0 110.87 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.0 tp -116.15 113.35 41.53 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-O 118.751 -0.643 . . . . 15.0 110.398 -176.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.35 136.52 63.15 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.189 1.26 . . . . 15.0 112.445 175.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.569 HD21 ' HE3' ' A' ' 8' ' ' MET . 13.4 mt -58.62 -10.96 2.56 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.339 0.866 . . . . 15.0 113.339 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -77.15 -5.81 50.52 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.321 0.859 . . . . 15.0 113.321 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -65.75 146.06 99.0 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 118.491 0.587 . . . . 15.0 110.482 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -80.75 157.13 21.25 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.602 1.535 . . . . 15.0 113.142 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.41 151.47 5.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.921 -0.582 . . . . 15.0 111.331 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.13 -38.03 3.24 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.527 -0.629 . . . . 15.0 111.527 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -62.45 -36.69 83.22 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.601 -0.44 . . . . 15.0 111.096 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.559 ' O ' HG23 ' A' ' 44' ' ' VAL . 27.4 tp -59.11 -47.12 86.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.962 0.411 . . . . 15.0 110.196 -178.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.5 HD13 ' CB ' ' A' ' 70' ' ' ASP . 19.4 tp -62.71 -45.2 93.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 15.0 110.868 -176.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.68 -44.53 96.77 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.687 -0.405 . . . . 15.0 110.76 -176.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.488 ' CD ' HD13 ' A' ' 6' ' ' LEU . 58.9 ttm-85 -60.72 -42.56 97.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.503 -0.317 . . . . 15.0 110.773 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 40' ' ' LEU . 97.9 t -60.46 -45.85 96.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.778 -0.369 . . . . 15.0 110.215 -177.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 62.1 ttm-85 -67.45 -51.63 49.18 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 123.453 0.471 . . . . 15.0 112.005 -176.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.36 -44.31 79.32 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 121.05 -0.26 . . . . 15.0 111.698 -174.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -78.85 -10.18 59.71 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.065 0.765 . . . . 15.0 113.065 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 54.67 55.83 7.46 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.515 0.674 . . . . 15.0 110.568 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.482 HD13 ' HB2' ' A' ' 6' ' ' LEU . 97.8 mt -74.15 143.75 45.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.794 -0.639 . . . . 15.0 111.086 -176.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.52 ' O ' HD22 ' A' ' 77' ' ' LEU . 9.4 m120 -90.2 -40.61 12.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.456 -0.793 . . . . 15.0 110.772 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.61 165.89 28.74 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 119.869 -1.158 . . . . 15.0 113.537 -171.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.1 mt -127.09 145.69 50.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.665 -0.768 . . . . 15.0 110.042 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.494 HG22 ' CD1' ' A' ' 80' ' ' PHE . 47.3 t -122.78 133.2 69.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 110.248 -0.279 . . . . 15.0 110.248 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.426 HG12 ' HG3' ' A' ' 8' ' ' MET . 10.2 m -124.57 138.35 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 120.99 0.424 . . . . 15.0 110.609 174.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.1 p -90.05 -18.02 26.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.727 -0.67 . . . . 15.0 112.636 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 77.0 p -156.68 161.43 39.86 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 121.364 0.602 . . . . 15.0 111.719 -176.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.95 -37.25 69.73 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.193 -0.763 . . . . 15.0 111.193 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -59.17 -46.09 89.29 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.899 -0.32 . . . . 15.0 110.789 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.9 -42.78 98.36 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.808 -0.917 . . . . 15.0 110.808 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.609 HD13 HD21 ' A' ' 79' ' ' LEU . 28.8 tp -58.11 -47.33 83.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.987 0.423 . . . . 15.0 110.622 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.49 -43.61 98.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.181 -0.463 . . . . 15.0 110.644 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.407 ' CB ' HD22 ' A' ' 33' ' ' LEU . 79.4 m-20 -59.09 -40.91 86.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.104 -0.498 . . . . 15.0 110.527 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.2 tp -56.76 -42.55 79.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.059 0.457 . . . . 15.0 110.194 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -58.74 -46.99 86.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.875 -0.602 . . . . 15.0 110.238 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -61.37 -43.2 99.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.794 -0.639 . . . . 15.0 111.098 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.83 -35.99 82.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.281 -0.418 . . . . 15.0 111.437 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.659 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.55 -38.49 81.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.063 0.458 . . . . 15.0 110.816 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.45 -143.56 0.57 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 109.454 -0.572 . . . . 15.0 109.454 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.48 -19.1 45.31 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.347 0.976 . . . . 15.0 112.66 -174.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.5 ' CB ' HD13 ' A' ' 41' ' ' LEU . 13.8 m-20 -91.84 10.39 28.83 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.295 0.85 . . . . 15.0 113.295 -174.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 53.5 t-105 -47.75 -48.13 60.75 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 118.553 -0.737 . . . . 15.0 112.423 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -44.72 -40.37 14.26 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.47 1.447 . . . . 15.0 113.159 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -77.1 -48.6 17.33 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.936 0.398 . . . . 15.0 111.202 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.659 HD12 ' HB1' ' A' ' 67' ' ' ALA . 93.7 mt -59.11 -39.27 78.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 15.0 110.826 -177.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.96 0.4 14.92 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 119.693 -0.504 . . . . 15.0 113.22 -175.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.3 mtm105 -90.58 -1.28 57.88 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.013 0.906 . . . . 15.0 112.975 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.52 HD22 ' O ' ' A' ' 50' ' ' ASN . 23.3 mt -90.09 139.47 27.27 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-O 118.869 -0.586 . . . . 15.0 109.656 172.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.67 131.23 40.51 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.376 1.384 . . . . 15.0 111.759 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.609 HD21 HD13 ' A' ' 60' ' ' LEU . 24.3 tp -105.43 128.07 53.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.748 0.309 . . . . 15.0 110.9 177.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.494 ' CD1' HG22 ' A' ' 53' ' ' VAL . 73.3 m-85 -92.84 127.13 38.23 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.696 -0.483 . . . . 15.0 109.696 176.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.448 HG21 ' HB2' ' A' ' 87' ' ' ALA . 32.8 m -123.15 151.58 62.18 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-O 119.567 -0.254 . . . . 15.0 110.67 177.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.28 -19.63 10.31 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 121.514 1.476 . . . . 15.0 113.803 -175.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.0 p -148.83 162.47 29.38 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 120.391 -0.524 . . . . 15.0 111.841 -171.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.4 -43.96 47.0 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.2 1.267 . . . . 15.0 111.885 176.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -58.2 -46.75 85.27 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.808 -0.357 . . . . 15.0 110.71 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 50.2 t -60.95 -38.38 79.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.689 -0.404 . . . . 15.0 110.128 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.448 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -56.85 -41.71 78.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.042 0.449 . . . . 15.0 110.427 177.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -60.88 -40.09 91.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.154 -0.476 . . . . 15.0 110.616 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.1 mmm -58.34 -45.85 87.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.45 0.643 . . . . 15.0 110.173 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.494 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -62.09 -42.11 98.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.733 -0.667 . . . . 15.0 111.112 -177.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 71.6 ttp85 -62.28 -44.2 97.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.186 -0.461 . . . . 15.0 110.708 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -59.33 -36.15 75.12 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.978 -0.289 . . . . 15.0 111.236 -177.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 81.5 mt -65.46 -25.24 67.42 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.098 0.407 . . . . 15.0 112.098 177.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 111.58 13.2 13.24 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 119.293 -0.726 . . . . 15.0 113.235 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.22 131.08 49.95 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.566 1.183 . . . . 15.0 109.666 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -62.24 -44.42 96.59 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.452 -0.573 . . . . 15.0 109.452 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 47.9 ttt85 -131.84 119.03 20.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.464 -0.789 . . . . 15.0 110.945 -173.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.8 t -114.43 128.78 71.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.829 -0.623 . . . . 15.0 109.503 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.448 ' O ' HG22 ' A' ' 81' ' ' VAL . 93.2 mt -117.79 123.92 72.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.903 -0.59 . . . . 15.0 110.279 -175.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -94.36 118.22 31.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.364 -0.38 . . . . 15.0 110.22 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.7 p -91.33 -6.94 52.3 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.141 0.793 . . . . 15.0 113.141 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 47.0 tpt85 -55.51 -39.61 70.73 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 118.208 0.458 . . . . 15.0 110.723 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.33 -35.2 5.32 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.48 -0.648 . . . . 15.0 111.48 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.11 144.25 42.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.816 0.341 . . . . 15.0 110.55 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.1 m -89.72 161.8 15.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.04 0.448 . . . . 15.0 110.578 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.65 -54.27 24.25 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 112.976 0.732 . . . . 15.0 112.976 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.05 -34.84 98.9 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 CA-C-N 120.213 1.112 . . . . 15.0 111.601 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.63 94.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.061 0.457 . . . . 15.0 110.048 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.3 mt -59.05 -40.9 86.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.446 . . . . 15.0 110.411 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 40.7 tp -57.31 -44.46 84.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.383 0.611 . . . . 15.0 110.136 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.31 -39.74 88.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.583 -0.735 . . . . 15.0 110.677 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.88 -42.42 97.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.415 -0.357 . . . . 15.0 110.899 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.0 mt -57.88 -50.36 73.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.026 0.441 . . . . 15.0 110.428 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.8 p -65.38 -39.95 92.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.827 -0.624 . . . . 15.0 111.576 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.1 p -66.35 -38.42 87.57 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.999 -0.28 . . . . 15.0 111.28 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.63 -42.59 95.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.41 -0.359 . . . . 15.0 111.133 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.55 -41.66 97.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.756 0.313 . . . . 15.0 110.579 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 93.5 mt -64.07 -37.1 86.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 15.0 111.081 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.61 -34.99 71.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.564 -0.289 . . . . 15.0 111.466 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -56.9 -41.43 78.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.549 0.214 . . . . 15.0 111.08 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -112.12 134.24 53.79 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.808 0.337 . . . . 15.0 110.73 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -118.5 130.14 55.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.273 -0.421 . . . . 15.0 110.51 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -60.75 -41.1 94.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 15.0 110.63 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -111.82 138.9 47.8 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.263 -0.426 . . . . 15.0 110.464 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.054 -0.974 . . . . 15.0 110.488 179.964 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.6 mtm . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.395 -0.594 . . . . 15.0 109.395 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -125.79 78.12 69.58 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.091 -0.504 . . . . 15.0 110.238 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -50.99 154.53 7.15 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.486 1.457 . . . . 15.0 111.871 -176.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.5 ' HB2' HD23 ' A' ' 49' ' ' LEU . 93.8 mttt -116.43 140.39 49.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.448 -0.342 . . . . 15.0 110.831 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.577 HG21 HD13 ' A' ' 21' ' ' LEU . 12.2 m -135.4 143.78 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.638 0.732 . . . . 15.0 111.69 175.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 tp -104.72 134.34 48.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.855 -1.066 . . . . 15.0 110.262 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.562 HD11 ' CG1' ' A' ' 28' ' ' VAL . 48.9 mt -103.35 135.15 42.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 15.0 110.505 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.629 ' SD ' HD13 ' A' ' 63' ' ' LEU . 85.9 mtp -101.08 134.11 44.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.66 -0.7 . . . . 15.0 109.531 172.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -57.61 146.47 30.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.002 0.429 . . . . 15.0 110.81 -174.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.92 175.14 33.79 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.97 -0.852 . . . . 15.0 110.97 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.56 -32.62 67.31 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.602 0.223 . . . . 15.0 111.602 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.51 177.01 18.25 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.014 -0.835 . . . . 15.0 111.014 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.0 122.09 5.81 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.313 -0.715 . . . . 15.0 111.313 -178.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -57.17 -44.52 83.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.098 0.475 . . . . 15.0 110.27 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.96 -41.13 97.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.927 -0.579 . . . . 15.0 110.958 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -57.88 -55.98 27.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.981 0.42 . . . . 15.0 111.0 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.417 HD21 HG11 ' A' ' 53' ' ' VAL . 26.8 tp -60.54 -42.13 95.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 15.0 111.025 -176.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.06 -43.69 98.51 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.799 -0.36 . . . . 15.0 111.45 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -61.73 -39.46 91.64 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.704 -0.398 . . . . 15.0 110.818 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -61.01 -51.6 68.54 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.381 -0.527 . . . . 15.0 111.232 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.577 HD13 HG21 ' A' ' 5' ' ' VAL . 80.9 mt -64.26 -37.58 87.97 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.409 -0.516 . . . . 15.0 111.001 -177.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -63.79 -43.8 95.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.59 0.233 . . . . 15.0 111.121 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.93 -30.66 66.81 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.03 -0.605 . . . . 15.0 111.961 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -88.03 9.33 22.81 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.57 0.952 . . . . 15.0 113.57 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.21 13.63 58.5 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 121.247 -0.501 . . . . 15.0 113.554 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.0 t -101.09 138.15 26.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 117.845 0.822 . . . . 15.0 110.061 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -79.51 132.42 36.32 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.194 -0.669 . . . . 15.0 109.194 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.562 ' CG1' HD11 ' A' ' 7' ' ' ILE . 39.6 t -116.36 131.17 69.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.194 0.521 . . . . 15.0 111.106 -173.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -137.73 130.8 30.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.413 -0.812 . . . . 15.0 109.377 170.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.406 ' HB3' HD12 ' A' ' 7' ' ' ILE . 31.0 p90 -114.15 135.11 54.39 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.87 0.366 . . . . 15.0 110.645 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 tp -112.99 136.04 21.7 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.946 -0.55 . . . . 15.0 110.027 -175.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -72.16 135.11 24.36 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.332 1.354 . . . . 15.0 111.976 172.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.613 HD22 ' CB ' ' A' ' 62' ' ' ASN . 62.4 mt -58.36 -11.94 3.3 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.33 0.863 . . . . 15.0 113.33 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -77.21 -6.64 53.78 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.392 0.886 . . . . 15.0 113.392 -176.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -68.55 150.9 97.52 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 118.524 0.602 . . . . 15.0 110.738 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -78.95 155.9 26.61 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.64 1.56 . . . . 15.0 113.102 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.11 151.99 4.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.763 -0.653 . . . . 15.0 111.226 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.44 -38.03 3.24 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.945 -0.57 . . . . 15.0 111.688 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.68 -38.86 86.35 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 117.172 0.486 . . . . 15.0 110.738 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.531 ' O ' HG23 ' A' ' 44' ' ' VAL . 18.2 tp -60.46 -48.3 82.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.954 0.407 . . . . 15.0 110.4 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.435 HD22 ' CG ' ' A' ' 70' ' ' ASP . 21.3 tp -60.38 -42.38 95.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 15.0 110.772 -175.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.25 -46.24 89.72 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.664 -0.415 . . . . 15.0 110.909 -175.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 -61.1 -41.35 96.52 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.499 -0.48 . . . . 15.0 110.679 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 40' ' ' LEU . 82.2 t -60.33 -46.08 95.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.748 -0.381 . . . . 15.0 110.202 -176.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -68.57 -51.32 44.03 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 123.421 0.45 . . . . 15.0 112.066 -175.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.29 -44.25 79.72 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.857 0.317 . . . . 15.0 111.857 -173.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -79.56 -10.07 59.73 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.08 0.77 . . . . 15.0 113.08 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 55.5 55.78 6.96 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.632 0.729 . . . . 15.0 110.219 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.5 HD23 ' HB2' ' A' ' 4' ' ' LYS . 96.0 mt -68.04 143.56 55.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.671 -0.695 . . . . 15.0 111.364 -174.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -91.16 -40.13 11.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.151 -0.931 . . . . 15.0 110.838 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.37 160.75 28.46 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.023 -1.084 . . . . 15.0 113.788 -174.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 71.3 mt -125.39 143.39 51.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.486 -0.857 . . . . 15.0 109.618 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.53 HG22 ' CD1' ' A' ' 80' ' ' PHE . 45.6 t -122.11 132.07 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 121.148 -0.221 . . . . 15.0 110.764 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.405 HG12 ' SD ' ' A' ' 8' ' ' MET . 8.5 m -124.23 145.78 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.144 0.497 . . . . 15.0 110.524 172.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 t -98.1 -21.45 16.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.479 -0.782 . . . . 15.0 112.426 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 81.3 p -152.73 162.16 41.62 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.414 0.625 . . . . 15.0 111.801 -174.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.86 -37.08 68.36 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.118 -0.793 . . . . 15.0 111.118 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -58.98 -46.08 88.99 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.858 -0.337 . . . . 15.0 110.646 -177.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.56 -44.07 98.18 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.732 -0.947 . . . . 15.0 110.732 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.627 HD13 HD21 ' A' ' 79' ' ' LEU . 32.2 tp -57.04 -45.09 83.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.112 0.482 . . . . 15.0 110.672 -178.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.72 -43.69 98.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 15.0 110.534 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.613 ' CB ' HD22 ' A' ' 33' ' ' LEU . 22.8 m120 -59.83 -38.1 81.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.706 178.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.629 HD13 ' SD ' ' A' ' 8' ' ' MET . 9.5 tp -56.69 -44.9 81.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.388 0.613 . . . . 15.0 110.155 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -60.0 -46.87 88.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.495 -0.775 . . . . 15.0 110.584 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -61.51 -43.23 99.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.975 -0.557 . . . . 15.0 111.091 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.09 -34.99 78.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.449 -0.342 . . . . 15.0 111.468 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.668 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.46 -38.14 80.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.965 0.412 . . . . 15.0 110.69 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.2 -143.93 0.58 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 109.605 -0.517 . . . . 15.0 109.605 174.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.53 -18.87 44.08 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.336 0.971 . . . . 15.0 112.678 -174.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.435 ' CG ' HD22 ' A' ' 41' ' ' LEU . 23.3 m-20 -91.86 10.8 27.17 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.282 0.845 . . . . 15.0 113.282 -175.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 60.0 t-105 -47.81 -46.56 62.65 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-O 118.588 -0.72 . . . . 15.0 112.556 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -44.74 -41.6 14.86 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.438 1.425 . . . . 15.0 113.267 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -77.03 -48.79 16.92 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.954 0.407 . . . . 15.0 110.819 -177.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.668 HD12 ' HB1' ' A' ' 67' ' ' ALA . 90.3 mt -59.57 -40.56 82.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 15.0 110.855 -176.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.68 -15.87 35.37 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 116.392 -0.367 . . . . 15.0 113.144 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -65.06 -29.93 70.85 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.355 0.578 . . . . 15.0 112.073 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.2 mt -75.7 150.51 84.21 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 121.018 -0.273 . . . . 15.0 111.648 -173.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.31 128.23 23.21 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.751 1.634 . . . . 15.0 112.481 176.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.627 HD21 HD13 ' A' ' 60' ' ' LEU . 23.9 tp -106.32 125.66 51.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.343 -0.389 . . . . 15.0 110.516 174.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.53 ' CD1' HG22 ' A' ' 53' ' ' VAL . 69.3 m-85 -90.05 126.56 35.81 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.634 -0.506 . . . . 15.0 109.634 176.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.653 HG21 ' HB2' ' A' ' 87' ' ' ALA . 26.7 m -119.06 147.28 42.31 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 119.438 -0.315 . . . . 15.0 110.176 176.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.14 -24.27 6.91 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.601 1.534 . . . . 15.0 113.529 -175.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.3 p -142.98 162.54 42.98 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 120.602 -0.439 . . . . 15.0 111.52 -171.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.14 -44.07 50.26 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.184 1.256 . . . . 15.0 111.755 176.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 70.9 ttp85 -57.45 -48.39 79.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.833 0.349 . . . . 15.0 110.845 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.8 t -59.9 -40.07 81.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.99 -0.374 . . . . 15.0 109.99 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.653 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.42 -42.29 82.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.903 0.383 . . . . 15.0 110.371 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -60.47 -40.11 90.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 15.0 110.621 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.1 mmm -58.46 -43.68 88.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.364 0.602 . . . . 15.0 110.212 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.496 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.16 -42.4 98.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.8 -0.636 . . . . 15.0 110.883 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.455 ' HD2' HG21 ' A' ' 98' ' ' VAL . 28.9 mmm180 -62.87 -42.01 99.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 15.0 110.871 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -59.64 -36.19 75.89 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.909 -0.317 . . . . 15.0 111.3 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.9 mt -68.96 -21.43 64.18 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.569 0.581 . . . . 15.0 112.569 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 106.85 13.28 22.28 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 119.376 -0.68 . . . . 15.0 113.086 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.79 122.14 12.15 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.439 1.12 . . . . 15.0 109.989 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -68.13 -36.04 79.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.55 -0.75 . . . . 15.0 111.226 -171.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.7 ttm-85 -131.76 114.03 14.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.045 0.45 . . . . 15.0 110.575 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.455 HG21 ' HD2' ' A' ' 91' ' ' ARG . 47.0 t -112.39 130.58 65.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.175 -0.466 . . . . 15.0 109.873 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.5 mt -119.74 123.73 71.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.941 -0.572 . . . . 15.0 110.142 -176.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.27 118.47 31.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.381 -0.372 . . . . 15.0 110.193 176.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.5 p -96.04 -3.99 43.86 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.283 0.846 . . . . 15.0 113.283 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -56.02 -39.96 72.7 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 118.199 0.454 . . . . 15.0 110.698 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -92.06 -35.07 6.86 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.505 -0.638 . . . . 15.0 111.505 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.44 142.38 41.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.841 0.353 . . . . 15.0 110.704 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.2 m -89.82 164.07 14.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 15.0 110.327 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.61 -54.22 24.43 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-O 118.523 -0.751 . . . . 15.0 112.963 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.59 -36.18 97.74 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 CA-C-N 120.583 1.244 . . . . 15.0 111.346 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.21 -42.61 95.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.046 0.451 . . . . 15.0 110.165 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.0 mt -58.95 -40.66 85.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 15.0 110.44 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 29.2 tp -57.36 -44.35 84.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.31 0.576 . . . . 15.0 110.181 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.6 -40.99 93.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.656 -0.702 . . . . 15.0 110.556 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.23 92.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.356 -0.384 . . . . 15.0 110.805 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.1 mt -57.9 -51.39 69.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.284 0.564 . . . . 15.0 110.451 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.2 p -64.69 -40.27 95.09 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.585 -0.734 . . . . 15.0 111.38 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.3 p -64.6 -38.88 92.52 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.037 -0.265 . . . . 15.0 111.335 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.81 -42.72 99.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.747 0.308 . . . . 15.0 110.891 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.64 -39.45 88.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.375 -0.375 . . . . 15.0 110.769 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.8 -35.0 79.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.419 -0.355 . . . . 15.0 111.399 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -93.99 137.54 33.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.945 0.402 . . . . 15.0 111.148 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -160.03 -61.39 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.894 -0.593 . . . . 15.0 110.357 178.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -55.31 -38.89 69.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 15.0 111.074 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -57.13 -40.57 77.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.355 -0.384 . . . . 15.0 110.87 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -57.17 -45.51 83.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.34 -0.391 . . . . 15.0 110.829 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -56.65 -39.46 73.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.354 -0.384 . . . . 15.0 110.868 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.044 -0.979 . . . . 15.0 110.513 179.922 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.376 -0.602 . . . . 15.0 109.376 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.26 83.35 64.05 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.164 -0.471 . . . . 15.0 110.421 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.01 153.89 5.91 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.373 1.382 . . . . 15.0 111.918 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -109.98 138.38 46.44 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.552 -0.295 . . . . 15.0 110.866 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.471 HG21 HD13 ' A' ' 21' ' ' LEU . 12.4 m -135.96 144.16 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 121.612 0.72 . . . . 15.0 111.707 177.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.408 HD13 ' CD ' ' A' ' 43' ' ' ARG . 12.4 tp -104.55 135.84 45.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.936 -1.029 . . . . 15.0 110.233 177.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.57 HD11 ' CG1' ' A' ' 28' ' ' VAL . 50.3 mt -102.58 135.11 41.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.279 -0.419 . . . . 15.0 110.319 -178.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.487 ' SD ' HD13 ' A' ' 63' ' ' LEU . 86.5 mtp -99.08 134.02 42.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.898 -0.592 . . . . 15.0 110.305 173.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -57.59 140.93 49.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.377 . . . . 15.0 110.641 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.55 175.18 31.26 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.826 -0.91 . . . . 15.0 110.826 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.42 -33.02 65.42 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.163 -0.215 . . . . 15.0 111.424 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.7 176.27 32.65 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.674 -0.97 . . . . 15.0 110.674 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.98 120.66 5.55 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.951 -0.642 . . . . 15.0 111.519 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -57.01 -41.39 78.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.803 0.335 . . . . 15.0 110.575 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -62.23 -41.93 98.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.426 . . . . 15.0 111.229 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -63.42 -55.88 20.76 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.793 -0.363 . . . . 15.0 111.345 -176.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.0 mt -59.55 -43.69 93.45 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.724 -0.39 . . . . 15.0 110.967 -176.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.503 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -62.55 -40.24 96.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 15.0 110.812 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.89 -41.92 92.67 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.962 -0.295 . . . . 15.0 110.505 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -60.0 -51.74 68.36 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.591 -0.443 . . . . 15.0 110.999 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.471 HD13 HG21 ' A' ' 5' ' ' VAL . 80.6 mt -62.46 -37.53 86.29 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.497 -0.481 . . . . 15.0 111.103 -178.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -63.32 -44.26 95.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.554 0.216 . . . . 15.0 110.929 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.18 -30.58 67.55 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.019 -0.61 . . . . 15.0 111.92 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -88.09 10.08 20.44 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.556 0.947 . . . . 15.0 113.556 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.09 18.82 41.66 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 121.109 -0.567 . . . . 15.0 113.351 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.3 t -101.02 139.97 20.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 117.665 0.732 . . . . 15.0 110.19 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -82.22 126.0 31.58 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.865 -0.791 . . . . 15.0 108.865 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.57 ' CG1' HD11 ' A' ' 7' ' ' ILE . 42.3 t -116.02 130.93 69.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.314 0.578 . . . . 15.0 111.331 -171.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -137.23 133.56 35.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.274 -0.875 . . . . 15.0 109.439 170.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.402 ' HB3' HD12 ' A' ' 7' ' ' ILE . 36.4 p90 -114.08 135.85 53.57 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.92 0.391 . . . . 15.0 110.857 -178.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 tp -116.16 113.3 41.51 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.632 -0.699 . . . . 15.0 110.194 -176.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.0 135.12 50.94 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.159 1.239 . . . . 15.0 112.09 174.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.65 -9.2 3.56 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.325 0.861 . . . . 15.0 113.325 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -77.15 -6.03 51.33 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.184 0.809 . . . . 15.0 113.184 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -64.62 150.11 94.49 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 118.512 0.596 . . . . 15.0 110.378 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -80.04 154.93 22.74 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.544 1.496 . . . . 15.0 113.27 -177.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.72 152.1 3.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.883 -0.599 . . . . 15.0 111.362 -178.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.23 -37.95 3.26 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.611 -0.596 . . . . 15.0 111.611 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -61.23 -36.52 80.17 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.607 -0.437 . . . . 15.0 111.184 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.558 ' O ' HG23 ' A' ' 44' ' ' VAL . 25.4 tp -59.16 -48.83 80.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.965 0.412 . . . . 15.0 110.228 -178.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.451 HD22 ' CG ' ' A' ' 70' ' ' ASP . 23.1 tp -62.73 -44.25 96.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 15.0 110.988 -175.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.08 -44.84 95.79 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.67 -0.412 . . . . 15.0 110.907 -176.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.408 ' CD ' HD13 ' A' ' 6' ' ' LEU . 60.0 ttm-85 -60.79 -41.87 96.46 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 121.01 -0.276 . . . . 15.0 110.713 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 40' ' ' LEU . 98.4 t -60.68 -45.78 96.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.835 -0.346 . . . . 15.0 110.111 -177.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -70.52 -46.86 62.83 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.1 0.408 . . . . 15.0 112.1 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.49 -44.44 82.62 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.047 -0.261 . . . . 15.0 111.442 -175.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -81.15 -10.16 59.69 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.124 0.787 . . . . 15.0 113.124 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 54.66 55.89 7.4 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.582 0.706 . . . . 15.0 110.483 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.4 mt -69.94 150.63 46.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.618 -0.719 . . . . 15.0 111.546 -175.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -95.25 -40.51 9.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.162 -0.926 . . . . 15.0 110.767 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -149.7 165.36 29.62 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 119.955 -1.117 . . . . 15.0 113.75 -174.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 70.7 mt -126.09 142.57 51.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.489 -0.856 . . . . 15.0 109.575 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.518 HG22 ' CD1' ' A' ' 80' ' ' PHE . 46.2 t -121.39 130.18 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.682 0.277 . . . . 15.0 110.777 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.7 m -128.1 155.68 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.02 0.438 . . . . 15.0 110.575 171.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.3 t -131.34 14.4 5.06 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.681 -0.691 . . . . 15.0 112.408 176.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.6 p -155.0 149.35 26.16 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.267 0.556 . . . . 15.0 111.548 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.89 -40.18 92.74 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.61 -0.996 . . . . 15.0 110.61 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -58.57 -41.4 85.57 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.916 -0.314 . . . . 15.0 110.473 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.91 -47.15 92.67 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.774 -0.93 . . . . 15.0 110.774 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.413 HD21 ' HA ' ' A' ' 90' ' ' ALA . 27.1 tp -57.06 -44.43 83.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.109 0.48 . . . . 15.0 110.653 -178.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.78 -43.59 98.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.032 -0.531 . . . . 15.0 110.822 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -59.36 -38.93 81.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 15.0 110.767 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.487 HD13 ' SD ' ' A' ' 8' ' ' MET . 13.2 tp -57.48 -44.81 85.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.247 0.546 . . . . 15.0 110.172 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -60.68 -47.15 87.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.675 -0.693 . . . . 15.0 110.468 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -61.97 -43.94 97.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 15.0 111.31 -176.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.57 -35.24 79.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.367 -0.379 . . . . 15.0 111.358 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.67 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.42 -38.78 81.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.939 0.4 . . . . 15.0 110.646 178.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.11 -143.72 0.59 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.58 -0.526 . . . . 15.0 109.58 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.47 -18.14 37.23 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.417 1.008 . . . . 15.0 112.654 -175.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.451 ' CG ' HD22 ' A' ' 41' ' ' LEU . 27.8 m-20 -91.79 9.61 31.94 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.341 0.867 . . . . 15.0 113.341 -175.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 59.2 t-105 -47.85 -47.35 63.14 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-O 118.629 -0.701 . . . . 15.0 112.546 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -44.78 -40.76 14.77 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 121.482 1.455 . . . . 15.0 113.199 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -76.97 -48.79 17.07 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.044 0.45 . . . . 15.0 110.741 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.67 HD12 ' HB1' ' A' ' 67' ' ' ALA . 92.8 mt -59.59 -39.93 80.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.025 -0.534 . . . . 15.0 110.925 -176.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.51 -15.82 33.9 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 119.944 -0.364 . . . . 15.0 113.116 -176.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -65.87 -30.03 70.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.387 0.593 . . . . 15.0 112.016 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.7 mt -74.49 150.62 87.06 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 111.638 0.236 . . . . 15.0 111.638 -172.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.97 123.58 13.2 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.599 1.533 . . . . 15.0 112.026 176.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.8 tp -103.35 123.44 46.82 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.804 -0.358 . . . . 15.0 110.426 174.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.518 ' CD1' HG22 ' A' ' 53' ' ' VAL . 76.5 m-85 -89.38 123.38 33.48 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.057 -0.72 . . . . 15.0 109.057 175.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.738 HG21 ' HB2' ' A' ' 87' ' ' ALA . 25.3 m -112.25 151.82 43.99 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 110.341 -0.244 . . . . 15.0 110.341 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.0 -28.65 3.76 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.414 1.409 . . . . 15.0 113.1 -175.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.4 p -144.39 167.91 13.8 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 120.656 -0.418 . . . . 15.0 111.537 -173.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -60.42 -44.0 30.42 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 121.228 1.286 . . . . 15.0 111.6 177.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -57.0 -47.99 79.52 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.88 -0.328 . . . . 15.0 110.777 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.55 -40.07 83.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.604 -0.438 . . . . 15.0 110.027 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.738 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.01 -41.71 79.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.928 0.394 . . . . 15.0 110.545 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.27 -41.32 96.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.218 -0.447 . . . . 15.0 110.529 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 87.3 mtp -59.57 -44.04 93.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.307 0.575 . . . . 15.0 110.384 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.413 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.5 -40.52 94.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.858 -0.61 . . . . 15.0 110.791 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -61.15 -45.04 96.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.278 -0.419 . . . . 15.0 110.435 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.68 -36.2 76.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.508 -0.315 . . . . 15.0 111.298 -177.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.82 -26.47 68.35 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.108 0.41 . . . . 15.0 112.108 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.21 13.16 10.14 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 119.281 -0.733 . . . . 15.0 113.177 -176.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.9 121.82 11.45 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.597 1.198 . . . . 15.0 109.691 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -71.61 -39.75 70.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.519 -0.764 . . . . 15.0 110.617 -171.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.47 ' NH2' ' HB1' ' A' ' 116' ' ' ALA . 52.8 ttp85 -132.09 113.9 13.9 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.453 0.644 . . . . 15.0 110.832 178.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.2 t -114.43 133.28 61.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.645 -0.707 . . . . 15.0 110.264 -176.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 87.6 mt -117.54 126.42 74.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.677 -0.692 . . . . 15.0 110.244 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -96.26 117.48 30.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.452 -0.34 . . . . 15.0 110.519 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 30.3 p -69.67 -20.32 63.57 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.574 0.583 . . . . 15.0 112.574 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -53.21 -36.97 61.57 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 122.113 -0.367 . . . . 15.0 111.508 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.27 -35.18 8.19 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 120.824 -0.703 . . . . 15.0 111.648 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -92.18 120.92 33.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.766 0.317 . . . . 15.0 111.121 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.485 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 49.9 m -70.44 165.85 21.65 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.433 -0.58 . . . . 15.0 109.433 174.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.55 -54.4 22.85 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 112.776 0.658 . . . . 15.0 112.776 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -57.49 -34.96 98.84 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 120.9 1.067 . . . . 15.0 111.4 176.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 105' ' ' SER . . . -61.14 -40.8 95.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.842 0.353 . . . . 15.0 110.365 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.2 mt -58.97 -41.79 88.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.015 0.435 . . . . 15.0 110.169 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.5 tp -57.23 -45.15 84.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.488 0.661 . . . . 15.0 110.169 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.46 91.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.505 -0.77 . . . . 15.0 110.817 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.97 -42.47 98.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.578 -0.283 . . . . 15.0 110.815 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.6 mt -57.94 -52.25 66.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.397 0.617 . . . . 15.0 110.463 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.7 p -66.32 -38.36 87.53 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.454 -0.794 . . . . 15.0 111.656 -174.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.3 p -67.65 -38.19 83.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.709 0.29 . . . . 15.0 111.322 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.47 ' HB1' ' NH2' ' A' ' 97' ' ' ARG . . . -62.7 -40.57 97.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.423 -0.353 . . . . 15.0 110.827 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.05 -38.86 80.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.395 -0.366 . . . . 15.0 110.797 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 86.8 mt -62.41 -37.78 87.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.41 -0.359 . . . . 15.0 110.95 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.55 143.66 56.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.766 0.317 . . . . 15.0 110.654 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -143.05 -57.96 0.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.295 -0.411 . . . . 15.0 110.666 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -55.42 -41.23 72.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 15.0 111.191 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -55.49 -39.15 70.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.464 -0.335 . . . . 15.0 111.173 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -54.75 -37.31 65.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.348 -0.387 . . . . 15.0 111.491 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -111.9 138.01 49.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.922 0.391 . . . . 15.0 110.916 -177.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 118.048 -0.977 . . . . 15.0 110.517 179.575 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.4 mtm . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.306 -0.628 . . . . 15.0 109.306 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.0 79.78 68.62 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.176 -0.466 . . . . 15.0 110.29 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.42 ' HG2' HG22 ' A' ' 26' ' ' VAL . 17.2 Cg_endo -55.58 154.98 22.91 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 121.439 1.426 . . . . 15.0 111.696 -176.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.462 ' HB2' HD23 ' A' ' 49' ' ' LEU . 97.9 mttt -111.98 140.11 46.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.582 -0.281 . . . . 15.0 110.815 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.443 HG21 HD13 ' A' ' 21' ' ' LEU . 15.9 m -136.17 143.92 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.647 0.737 . . . . 15.0 111.818 175.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.1 tp -105.07 136.75 43.97 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.924 -1.034 . . . . 15.0 110.245 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.633 HD11 ' CG1' ' A' ' 28' ' ' VAL . 51.0 mt -104.61 135.14 43.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.096 0.474 . . . . 15.0 111.067 -177.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.511 ' HB2' HG12 ' A' ' 54' ' ' VAL . 99.0 mmm -94.89 134.04 37.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.134 -0.939 . . . . 15.0 109.364 172.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -66.28 145.07 56.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.937 0.398 . . . . 15.0 110.554 -178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -161.08 175.22 37.74 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.76 -0.936 . . . . 15.0 110.76 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -51.29 -31.2 20.58 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.847 0.314 . . . . 15.0 111.847 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.99 -174.02 1.74 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.938 -0.865 . . . . 15.0 110.938 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -108.4 109.58 2.9 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.49 -0.644 . . . . 15.0 111.49 -177.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.3 mtm-85 -55.2 -38.85 68.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.645 0.26 . . . . 15.0 111.035 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -59.87 -54.98 39.84 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.067 0.395 . . . . 15.0 112.067 -172.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -69.95 -45.09 68.18 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.274 -0.57 . . . . 15.0 111.435 -173.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.1 tp -58.12 -44.84 87.96 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 120.491 -0.484 . . . . 15.0 110.589 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.412 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -62.75 -42.5 99.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 15.0 110.44 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -57.96 -40.46 80.65 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.931 -0.308 . . . . 15.0 110.562 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -59.08 -51.64 69.19 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.959 0.409 . . . . 15.0 111.042 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.443 HD13 HG21 ' A' ' 5' ' ' VAL . 77.7 mt -59.81 -37.32 78.81 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.567 -0.453 . . . . 15.0 110.887 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -62.95 -41.97 99.68 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 121.107 -0.237 . . . . 15.0 111.119 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.25 -30.56 67.75 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 120.981 -0.628 . . . . 15.0 111.966 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -88.18 9.57 22.42 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.557 0.947 . . . . 15.0 113.557 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.32 15.42 58.78 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 121.23 -0.509 . . . . 15.0 113.393 175.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.42 HG22 ' HG2' ' A' ' 3' ' ' PRO . 43.9 t -101.04 137.84 27.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 117.917 0.858 . . . . 15.0 110.209 178.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -81.17 129.92 34.79 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.367 -0.605 . . . . 15.0 109.367 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.633 ' CG1' HD11 ' A' ' 7' ' ' ILE . 42.4 t -120.11 132.23 70.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.241 0.543 . . . . 15.0 111.192 -173.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -139.18 135.22 33.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.391 -0.822 . . . . 15.0 109.731 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.432 ' HB3' HD12 ' A' ' 7' ' ' ILE . 32.0 p90 -114.8 138.78 50.35 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.775 0.322 . . . . 15.0 110.553 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.0 tp -114.85 113.43 44.49 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 118.756 -0.64 . . . . 15.0 110.896 -173.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -49.88 135.07 35.89 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.158 1.238 . . . . 15.0 111.886 172.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.669 HD13 ' OD1' ' A' ' 62' ' ' ASN . 58.1 mt -66.79 -11.13 53.98 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.216 0.821 . . . . 15.0 113.216 -174.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -77.31 -9.4 58.8 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.169 0.803 . . . . 15.0 113.169 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -65.28 148.02 98.22 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 118.502 0.592 . . . . 15.0 110.544 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.34 148.74 43.93 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.565 1.51 . . . . 15.0 113.58 -174.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.93 152.52 3.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.465 -0.789 . . . . 15.0 111.228 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.2 -38.15 3.21 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.497 -0.641 . . . . 15.0 111.497 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -64.16 -36.38 83.86 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 120.426 -0.51 . . . . 15.0 111.12 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.547 HD21 ' CD1' ' A' ' 63' ' ' LEU . 24.5 tp -58.66 -45.97 88.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.896 0.379 . . . . 15.0 110.196 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.497 HD22 ' CG ' ' A' ' 70' ' ' ASP . 16.8 tp -63.49 -45.57 90.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 15.0 110.902 -177.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.78 99.25 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.784 -0.367 . . . . 15.0 110.859 -177.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -60.99 -44.14 97.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.428 -0.351 . . . . 15.0 110.511 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 40' ' ' LEU . 67.3 t -61.5 -46.1 97.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.935 -0.306 . . . . 15.0 110.252 -177.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 70.7 ttp85 -68.53 -48.07 65.28 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.984 0.364 . . . . 15.0 111.984 -176.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.09 -44.47 84.28 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.1 -0.24 . . . . 15.0 111.512 -173.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -81.99 -10.01 59.38 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.249 0.833 . . . . 15.0 113.249 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 55.86 55.82 6.64 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.607 0.718 . . . . 15.0 110.336 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.484 HD12 HG22 ' A' ' 44' ' ' VAL . 95.5 mt -63.53 146.09 54.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.601 -0.727 . . . . 15.0 111.426 -174.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -87.72 -39.76 14.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.982 -1.008 . . . . 15.0 110.685 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.52 166.39 30.7 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.045 -1.074 . . . . 15.0 113.639 -174.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.1 mt -125.91 142.08 51.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.507 -0.846 . . . . 15.0 109.612 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.519 HG22 ' CD1' ' A' ' 80' ' ' PHE . 48.0 t -121.47 131.37 73.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.282 -0.266 . . . . 15.0 110.282 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.511 HG12 ' HB2' ' A' ' 8' ' ' MET . 6.5 m -125.69 130.44 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.009 0.433 . . . . 15.0 110.216 172.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.7 p -92.81 -10.86 35.3 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.915 0.709 . . . . 15.0 112.915 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 82.8 p -152.52 157.6 41.33 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 121.271 0.558 . . . . 15.0 111.561 -176.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.78 -38.92 85.94 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.962 -0.855 . . . . 15.0 110.962 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -58.97 -43.93 91.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.777 0.322 . . . . 15.0 110.416 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.3 -44.84 97.09 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.784 -0.926 . . . . 15.0 110.784 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.587 HD13 HD21 ' A' ' 79' ' ' LEU . 32.9 tp -57.7 -44.61 85.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.095 0.474 . . . . 15.0 110.531 -178.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.26 -42.23 98.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.063 -0.517 . . . . 15.0 110.64 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.669 ' OD1' HD13 ' A' ' 33' ' ' LEU . 28.0 m120 -58.99 -39.91 83.23 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.834 -0.346 . . . . 15.0 110.628 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.547 ' CD1' HD21 ' A' ' 40' ' ' LEU . 12.5 tp -58.23 -44.83 88.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.181 0.515 . . . . 15.0 110.109 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -61.6 -47.22 86.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.697 -0.683 . . . . 15.0 110.787 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -61.91 -43.86 97.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 15.0 111.185 -176.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.3 mt -66.3 -34.98 79.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.351 -0.386 . . . . 15.0 111.387 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.674 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.0 -39.17 81.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.126 0.489 . . . . 15.0 110.581 177.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.16 -143.3 0.6 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 109.609 -0.515 . . . . 15.0 109.609 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.44 -19.09 44.88 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.391 0.996 . . . . 15.0 112.608 -175.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.497 ' CG ' HD22 ' A' ' 41' ' ' LEU . 22.3 m-20 -91.91 10.44 28.78 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.297 0.851 . . . . 15.0 113.297 -175.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -47.81 -46.9 63.15 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-O 118.666 -0.683 . . . . 15.0 112.494 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -44.68 -40.43 14.15 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.483 1.455 . . . . 15.0 113.283 177.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -77.0 -48.73 17.17 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.691 -0.404 . . . . 15.0 110.803 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.674 HD12 ' HB1' ' A' ' 67' ' ' ALA . 91.5 mt -59.63 -39.73 80.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 15.0 110.83 -177.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.2 -16.44 34.08 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 116.334 -0.394 . . . . 15.0 113.124 -177.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -64.73 -30.3 71.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 117.365 0.582 . . . . 15.0 111.959 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 27.5 mt -76.45 150.59 82.51 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 120.903 -0.319 . . . . 15.0 111.312 -173.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.4 129.54 28.59 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.63 1.554 . . . . 15.0 112.473 176.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.587 HD21 HD13 ' A' ' 60' ' ' LEU . 24.0 tp -107.78 126.26 52.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.448 -0.342 . . . . 15.0 110.605 175.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.519 ' CD1' HG22 ' A' ' 53' ' ' VAL . 78.7 m-85 -90.97 126.09 35.97 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.721 -0.474 . . . . 15.0 109.721 176.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.676 HG21 ' HB2' ' A' ' 87' ' ' ALA . 29.0 m -117.47 147.15 40.08 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 110.079 -0.341 . . . . 15.0 110.079 176.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.15 -23.25 7.81 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.639 1.56 . . . . 15.0 113.598 -174.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.417 ' OG ' HG23 ' A' ' 86' ' ' VAL . 24.5 p -143.51 158.15 57.8 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 120.737 -0.385 . . . . 15.0 111.33 -172.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.29 -43.95 53.03 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.238 1.292 . . . . 15.0 111.792 176.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -58.11 -47.37 83.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.779 0.323 . . . . 15.0 110.931 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.417 HG23 ' OG ' ' A' ' 83' ' ' SER . 60.8 t -59.89 -40.24 82.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.75 -0.38 . . . . 15.0 110.036 178.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.676 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.36 -42.46 82.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.962 0.41 . . . . 15.0 110.422 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.09 -41.87 97.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.144 -0.48 . . . . 15.0 110.506 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 87.1 mtp -59.29 -43.88 92.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.227 0.537 . . . . 15.0 110.353 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.44 94.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.963 -0.562 . . . . 15.0 110.801 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -61.31 -44.36 97.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.298 -0.41 . . . . 15.0 110.629 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.17 -36.1 76.84 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.857 -0.337 . . . . 15.0 111.234 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.8 mt -64.3 -25.69 68.16 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.942 0.349 . . . . 15.0 111.942 176.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.43 13.25 15.26 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 119.314 -0.714 . . . . 15.0 113.095 -176.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.88 121.95 11.75 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 118.566 1.183 . . . . 15.0 109.888 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -69.5 -35.09 75.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.668 -0.696 . . . . 15.0 111.328 -171.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.1 tpt85 -131.79 114.5 14.79 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.957 0.408 . . . . 15.0 110.082 177.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.1 t -110.85 130.25 64.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.045 0.45 . . . . 15.0 109.851 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 85.2 mt -119.61 124.95 73.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.818 -0.628 . . . . 15.0 110.053 -176.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -95.33 117.32 30.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.435 -0.348 . . . . 15.0 110.302 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.9 p -97.05 -1.55 45.15 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.182 0.808 . . . . 15.0 113.182 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 46.9 tpt85 -55.67 -39.7 71.31 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.184 0.447 . . . . 15.0 110.665 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.01 -35.17 5.41 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.53 -0.628 . . . . 15.0 111.53 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.18 140.2 52.49 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.879 0.371 . . . . 15.0 110.651 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.9 p -86.12 163.75 17.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.065 -0.516 . . . . 15.0 110.508 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.71 -54.39 23.63 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 113.0 0.741 . . . . 15.0 113.0 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.29 -35.04 99.11 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 CA-C-N 120.163 1.094 . . . . 15.0 111.63 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.07 -43.4 95.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.091 0.472 . . . . 15.0 110.012 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 76.1 mt -59.36 -40.74 87.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 15.0 110.406 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 33.8 tp -57.2 -43.82 83.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.33 0.586 . . . . 15.0 110.229 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.52 -41.8 95.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.683 -0.69 . . . . 15.0 110.487 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.28 -40.38 90.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 15.0 110.761 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.0 mt -57.81 -51.8 68.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.267 0.556 . . . . 15.0 110.383 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.6 p -63.79 -40.06 95.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.59 -0.732 . . . . 15.0 111.324 -175.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.1 m -62.38 -44.31 96.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.676 0.274 . . . . 15.0 111.426 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.4 -38.25 88.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.432 -0.349 . . . . 15.0 111.156 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.85 -34.51 71.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.451 -0.34 . . . . 15.0 111.255 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 85.1 mt -56.9 -39.89 75.26 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.0 -0.28 . . . . 15.0 110.677 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -63.75 141.23 58.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.455 -0.339 . . . . 15.0 110.343 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -119.62 128.47 53.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.41 -0.359 . . . . 15.0 110.443 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -58.79 -41.46 86.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.169 -0.469 . . . . 15.0 110.636 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -59.27 -38.55 80.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 15.0 111.078 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -55.45 -39.83 70.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.449 -0.341 . . . . 15.0 111.179 -177.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -108.86 137.09 47.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.917 0.389 . . . . 15.0 110.721 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.03 -0.986 . . . . 15.0 110.578 179.933 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.341 -0.614 . . . . 15.0 109.341 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -126.95 80.97 70.54 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.097 -0.501 . . . . 15.0 110.34 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -49.87 152.31 7.3 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.387 1.391 . . . . 15.0 111.776 -176.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -117.77 137.88 52.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.354 -0.385 . . . . 15.0 110.385 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.613 HG21 HD13 ' A' ' 21' ' ' LEU . 15.7 m -134.77 146.04 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.501 0.667 . . . . 15.0 111.826 177.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.571 ' HB2' HD13 ' A' ' 49' ' ' LEU . 13.6 tp -104.37 135.55 45.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.048 -0.978 . . . . 15.0 110.318 178.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.486 HD11 ' CG1' ' A' ' 28' ' ' VAL . 55.0 mt -103.59 135.02 43.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.407 . . . . 15.0 110.439 -177.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.577 ' CE ' HD21 ' A' ' 33' ' ' LEU . 88.3 mtp -100.15 134.06 43.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.731 -0.668 . . . . 15.0 110.332 174.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -58.24 141.69 50.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.376 -0.375 . . . . 15.0 110.624 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.0 175.14 34.57 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.045 -0.822 . . . . 15.0 111.045 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -54.98 -33.86 62.87 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.549 0.203 . . . . 15.0 111.549 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.9 -179.69 4.76 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.954 -0.859 . . . . 15.0 110.954 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.02 114.31 3.93 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.224 -0.75 . . . . 15.0 111.224 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -55.85 -47.23 77.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.323 0.583 . . . . 15.0 110.339 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.95 -41.38 97.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.739 -0.664 . . . . 15.0 110.839 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -56.51 -55.83 28.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.766 0.317 . . . . 15.0 111.18 -175.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.461 ' H ' HD12 ' A' ' 17' ' ' LEU . 6.1 mp -59.99 -42.38 94.1 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.665 -0.414 . . . . 15.0 111.064 -176.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.63 -45.74 91.07 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.643 -0.423 . . . . 15.0 111.447 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.29 -40.99 92.4 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.769 -0.372 . . . . 15.0 110.527 -178.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -58.52 -51.51 69.59 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.589 -0.445 . . . . 15.0 111.126 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.613 HD13 HG21 ' A' ' 5' ' ' VAL . 76.8 mt -63.99 -38.2 90.22 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.436 -0.505 . . . . 15.0 111.262 -176.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -65.28 -40.45 93.9 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 120.521 -0.472 . . . . 15.0 111.254 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.03 -30.57 70.44 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.972 -0.632 . . . . 15.0 112.095 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -88.33 10.03 21.25 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.571 0.952 . . . . 15.0 113.571 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.54 16.41 60.28 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 121.286 -0.483 . . . . 15.0 113.265 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.7 t -101.08 138.85 23.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 117.824 0.812 . . . . 15.0 109.877 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -79.12 133.37 36.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.494 -0.558 . . . . 15.0 109.494 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.486 ' CG1' HD11 ' A' ' 7' ' ' ILE . 45.1 t -118.37 130.37 73.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.173 0.511 . . . . 15.0 111.117 -173.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.424 ' O ' HD12 ' A' ' 6' ' ' LEU . 22.8 t70 -135.35 124.74 24.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.419 -0.809 . . . . 15.0 109.442 170.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.416 ' HB3' HD12 ' A' ' 7' ' ' ILE . 15.2 p90 -112.79 134.16 54.44 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.857 0.361 . . . . 15.0 110.833 -177.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.1 tp -114.3 139.44 23.83 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.042 -0.527 . . . . 15.0 109.937 -176.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -72.08 136.22 26.67 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 121.409 1.406 . . . . 15.0 111.822 171.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.577 HD21 ' CE ' ' A' ' 8' ' ' MET . 19.8 mt -57.89 -12.73 3.42 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.368 0.877 . . . . 15.0 113.368 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -77.22 -5.05 47.79 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.467 0.914 . . . . 15.0 113.467 -175.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -68.06 145.59 97.76 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 118.559 0.618 . . . . 15.0 110.784 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.96 159.09 30.87 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.685 1.59 . . . . 15.0 113.479 -176.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.26 151.52 2.83 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.727 -0.669 . . . . 15.0 111.62 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.14 -36.98 3.58 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.397 -0.681 . . . . 15.0 111.397 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -60.02 -37.05 78.62 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.613 -0.435 . . . . 15.0 110.972 -178.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.567 ' O ' HG23 ' A' ' 44' ' ' VAL . 26.3 tp -58.5 -47.13 85.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.022 0.439 . . . . 15.0 110.253 -177.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.62 HD22 ' OD2' ' A' ' 70' ' ' ASP . 9.1 tp -61.87 -44.68 96.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 15.0 110.745 -177.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.18 97.22 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.682 -0.407 . . . . 15.0 111.018 -176.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -60.96 -41.53 96.51 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.815 -0.354 . . . . 15.0 110.672 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 40' ' ' LEU . 99.5 t -60.53 -47.31 93.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.809 -0.356 . . . . 15.0 110.262 -176.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -72.27 -47.65 48.53 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.461 0.541 . . . . 15.0 112.461 -175.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.69 -44.31 82.06 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.051 -0.26 . . . . 15.0 111.557 -174.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -81.78 -10.03 59.46 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.105 0.78 . . . . 15.0 113.105 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 56.64 55.87 6.02 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.593 0.711 . . . . 15.0 110.164 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.571 HD13 ' HB2' ' A' ' 6' ' ' LEU . 94.9 mt -77.9 142.53 38.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.667 -0.697 . . . . 15.0 111.364 -176.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.551 ' O ' HD22 ' A' ' 77' ' ' LEU . 9.3 m120 -90.76 -40.65 11.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.55 -0.75 . . . . 15.0 110.64 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.66 167.01 28.72 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 119.908 -1.139 . . . . 15.0 113.396 -171.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 71.4 mt -126.96 146.91 50.15 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.889 -0.656 . . . . 15.0 110.312 -178.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.538 HG22 ' CD1' ' A' ' 80' ' ' PHE . 47.5 t -122.77 131.48 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.544 0.211 . . . . 15.0 110.495 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 m -124.85 146.99 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.125 0.488 . . . . 15.0 110.735 173.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 t -100.81 -15.98 17.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.535 -0.757 . . . . 15.0 112.835 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.0 p -156.31 161.28 40.21 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-O 121.437 0.637 . . . . 15.0 111.901 -175.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.18 -37.67 73.63 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.056 -0.818 . . . . 15.0 111.056 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -59.25 -44.53 92.37 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.932 -0.307 . . . . 15.0 110.709 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.29 -43.68 98.29 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.611 -0.996 . . . . 15.0 110.611 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.546 HD21 ' HA ' ' A' ' 90' ' ' ALA . 14.3 tp -57.05 -45.82 82.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.153 0.502 . . . . 15.0 110.596 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.35 -43.74 98.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.117 -0.492 . . . . 15.0 110.569 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.573 ' CB ' HD22 ' A' ' 33' ' ' LEU . 18.9 m120 -59.77 -38.91 83.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 15.0 110.647 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.495 HD13 ' SD ' ' A' ' 8' ' ' MET . 14.4 tp -57.06 -44.32 82.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.124 0.488 . . . . 15.0 110.161 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -60.24 -47.61 85.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.809 -0.632 . . . . 15.0 110.459 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -61.85 -43.15 99.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.945 -0.571 . . . . 15.0 111.137 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.84 -35.3 79.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.443 -0.344 . . . . 15.0 111.49 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.68 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.44 -38.51 80.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.955 0.407 . . . . 15.0 110.75 178.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.28 -144.09 0.57 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 109.541 -0.54 . . . . 15.0 109.541 174.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.87 -18.56 45.43 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.357 0.981 . . . . 15.0 112.64 -174.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.62 ' OD2' HD22 ' A' ' 41' ' ' LEU . 77.7 m-20 -91.95 10.45 28.84 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.327 0.862 . . . . 15.0 113.327 -175.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -47.74 -47.32 62.01 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 118.69 -0.672 . . . . 15.0 112.586 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -44.81 -40.11 14.35 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.458 1.439 . . . . 15.0 113.233 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -76.94 -48.77 17.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.023 0.439 . . . . 15.0 110.725 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.68 HD12 ' HB1' ' A' ' 67' ' ' ALA . 92.2 mt -59.25 -40.59 81.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 15.0 110.839 -177.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.41 -14.47 34.46 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-N 116.269 -0.423 . . . . 15.0 113.23 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -66.18 -29.8 70.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.415 0.607 . . . . 15.0 112.076 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.551 HD22 ' O ' ' A' ' 50' ' ' ASN . 21.9 mt -74.72 145.11 81.3 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-O 119.252 -0.404 . . . . 15.0 110.953 -174.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -60.0 129.54 30.78 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.446 1.431 . . . . 15.0 111.756 174.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.1 tp -106.34 128.16 53.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.609 -0.269 . . . . 15.0 110.852 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.538 ' CD1' HG22 ' A' ' 53' ' ' VAL . 80.8 m-85 -91.01 126.12 36.0 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.618 -0.512 . . . . 15.0 109.618 176.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.667 HG21 ' HB2' ' A' ' 87' ' ' ALA . 28.7 m -119.43 147.52 43.54 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 110.085 -0.339 . . . . 15.0 110.085 176.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.23 -23.23 7.73 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.471 1.447 . . . . 15.0 113.636 -174.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.9 p -143.36 161.11 49.11 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 120.62 -0.432 . . . . 15.0 111.563 -172.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -54.91 -44.11 52.88 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.2 1.267 . . . . 15.0 111.889 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -58.82 -46.75 86.9 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.895 -0.322 . . . . 15.0 110.973 -177.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.4 t -60.13 -40.3 83.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.737 -0.385 . . . . 15.0 110.066 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.667 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.61 -42.31 83.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.0 0.429 . . . . 15.0 110.469 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.92 -40.47 93.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.176 -0.466 . . . . 15.0 110.592 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.1 mmm -58.26 -44.99 88.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.447 0.641 . . . . 15.0 110.159 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.546 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.76 -40.64 95.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.642 -0.708 . . . . 15.0 110.825 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -61.64 -44.43 96.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.385 -0.37 . . . . 15.0 110.755 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -60.29 -36.19 77.28 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.872 -0.331 . . . . 15.0 111.262 -177.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 77.0 mt -66.0 -23.87 66.66 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.303 0.483 . . . . 15.0 112.303 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.69 13.28 16.88 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.399 -0.667 . . . . 15.0 113.177 -176.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.81 122.03 11.91 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.481 1.14 . . . . 15.0 109.905 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -67.62 -36.54 81.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.541 -0.754 . . . . 15.0 111.059 -171.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -131.82 117.88 19.13 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.923 0.392 . . . . 15.0 110.62 177.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.2 t -114.65 129.94 69.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.008 0.432 . . . . 15.0 109.952 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 90.5 mt -119.27 122.19 68.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.87 -0.604 . . . . 15.0 110.125 -177.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -92.53 117.7 30.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.483 -0.326 . . . . 15.0 110.166 175.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 104' ' ' ALA . 31.8 p -95.69 -3.52 45.9 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.232 0.827 . . . . 15.0 113.232 -178.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -55.88 -40.04 72.4 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.287 0.494 . . . . 15.0 110.699 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -95.59 -35.01 5.8 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.463 -0.655 . . . . 15.0 111.463 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.416 ' HB3' ' HA ' ' A' ' 101' ' ' CYS . . . -73.29 143.77 46.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.791 0.329 . . . . 15.0 110.466 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 65.1 m -89.77 160.75 16.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.228 -0.442 . . . . 15.0 110.567 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.67 -54.24 24.56 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.973 0.731 . . . . 15.0 112.973 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.62 -34.54 98.26 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 CA-C-N 120.318 1.149 . . . . 15.0 111.524 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.03 -42.66 94.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.065 0.46 . . . . 15.0 109.985 176.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 78.3 mt -59.04 -39.98 83.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 15.0 110.489 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 33.7 tp -56.85 -44.85 82.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.547 0.689 . . . . 15.0 110.144 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.4 -40.4 90.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.518 -0.765 . . . . 15.0 110.568 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.2 -42.49 95.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.319 -0.4 . . . . 15.0 110.782 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.1 mt -58.05 -49.16 77.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.031 0.443 . . . . 15.0 110.421 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.4 p -62.51 -40.71 97.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.897 -0.592 . . . . 15.0 111.274 -175.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.9 p -65.99 -39.88 90.72 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.969 -0.292 . . . . 15.0 111.349 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.25 -39.01 93.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.666 0.27 . . . . 15.0 111.117 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.93 -34.89 72.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.433 -0.349 . . . . 15.0 111.252 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 82.3 mt -56.8 -39.71 74.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.729 0.3 . . . . 15.0 110.731 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.47 -35.03 79.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.366 -0.379 . . . . 15.0 111.317 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -56.0 -39.66 72.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.625 0.25 . . . . 15.0 110.92 -178.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -110.56 131.64 54.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.858 0.361 . . . . 15.0 110.712 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -116.01 130.54 56.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.168 -0.469 . . . . 15.0 110.534 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -60.88 -42.78 98.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 15.0 110.539 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -55.52 -39.8 70.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 15.0 110.992 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 . . . . . 0 C--O 1.221 -0.411 0 CA-C-O 117.925 -1.036 . . . . 15.0 110.473 179.922 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.3 mmm . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.131 -0.692 . . . . 15.0 109.131 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -127.38 79.49 73.19 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 116.146 -0.479 . . . . 15.0 110.285 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.94 155.06 8.98 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.347 1.364 . . . . 15.0 111.734 -177.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.464 ' HB2' HD23 ' A' ' 49' ' ' LEU . 55.5 mttm -114.26 140.74 48.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.412 -0.358 . . . . 15.0 110.837 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.559 HG21 HD13 ' A' ' 21' ' ' LEU . 10.6 m -136.55 144.94 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.598 0.714 . . . . 15.0 111.568 176.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.8 tp -105.69 134.18 49.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.943 -1.026 . . . . 15.0 110.518 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.613 HD11 ' CG1' ' A' ' 28' ' ' VAL . 44.4 mt -100.79 135.12 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.315 -0.402 . . . . 15.0 110.291 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 82.4 mtp -101.75 132.62 47.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.1 -0.5 . . . . 15.0 110.098 171.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -57.74 147.1 28.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.217 0.532 . . . . 15.0 111.564 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.49 175.19 40.55 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.615 -0.994 . . . . 15.0 110.615 -178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -51.94 -32.61 33.79 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.748 0.277 . . . . 15.0 111.748 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.68 170.29 18.24 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.855 -0.898 . . . . 15.0 110.855 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.95 125.18 7.07 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.35 -0.7 . . . . 15.0 111.35 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -57.09 -46.46 82.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.961 0.41 . . . . 15.0 110.482 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -64.05 -40.83 97.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.974 -0.557 . . . . 15.0 111.318 -175.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -61.8 -55.98 24.33 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.775 -0.37 . . . . 15.0 111.427 -176.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.683 HD21 HG11 ' A' ' 53' ' ' VAL . 28.5 tp -61.07 -45.4 94.89 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.687 -0.405 . . . . 15.0 111.192 -175.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.2 -39.72 95.42 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.669 -0.412 . . . . 15.0 110.82 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -60.75 -41.6 95.72 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.905 -0.318 . . . . 15.0 110.576 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.445 ' HD3' ' HB2' ' A' ' 106' ' ' ALA . 38.2 ttm180 -59.65 -51.76 68.41 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 120.686 -0.406 . . . . 15.0 111.241 -178.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.559 HD13 HG21 ' A' ' 5' ' ' VAL . 88.2 mt -63.86 -36.99 85.74 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.478 -0.489 . . . . 15.0 111.062 -178.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -63.54 -42.77 98.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.625 0.25 . . . . 15.0 111.088 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.21 -30.56 67.61 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.119 -0.563 . . . . 15.0 111.987 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -88.04 9.96 20.7 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.559 0.948 . . . . 15.0 113.559 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.26 15.04 56.52 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 121.22 -0.514 . . . . 15.0 113.494 173.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.7 t -101.06 136.18 33.9 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 117.972 0.886 . . . . 15.0 110.072 177.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -77.67 129.63 35.8 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.9 -0.778 . . . . 15.0 108.9 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.613 ' CG1' HD11 ' A' ' 7' ' ' ILE . 22.7 t -123.07 134.13 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.207 0.527 . . . . 15.0 111.468 -171.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -139.4 139.81 37.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.363 -0.835 . . . . 15.0 109.714 172.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.425 ' HB3' HD12 ' A' ' 7' ' ' ILE . 27.8 p90 -114.13 136.08 53.32 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.883 0.373 . . . . 15.0 110.891 -178.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.8 tp -113.81 121.18 37.6 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-O 118.705 -0.664 . . . . 15.0 110.314 -175.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.25 135.03 67.83 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 CA-C-N 120.337 1.156 . . . . 15.0 112.223 173.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.424 HD13 ' OD1' ' A' ' 62' ' ' ASN . 74.9 mt -62.43 -16.72 56.67 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.973 0.731 . . . . 15.0 112.973 -178.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -77.18 -5.06 47.72 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.43 0.9 . . . . 15.0 113.43 -175.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -69.84 148.92 96.59 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 118.545 0.611 . . . . 15.0 110.837 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.43 149.69 50.74 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.573 1.515 . . . . 15.0 113.864 -173.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.23 152.58 4.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.258 -0.883 . . . . 15.0 111.265 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.62 -38.1 3.22 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 115.837 -0.619 . . . . 15.0 111.636 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -63.71 -36.61 84.42 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.392 -0.523 . . . . 15.0 111.16 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.571 ' O ' HG23 ' A' ' 44' ' ' VAL . 24.9 tp -59.1 -47.01 86.83 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.86 -0.336 . . . . 15.0 110.174 -178.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.488 HD13 HD11 ' A' ' 74' ' ' ILE . 17.6 tp -63.35 -45.76 89.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 15.0 110.917 -176.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.6 -44.22 97.41 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.61 -0.436 . . . . 15.0 110.836 -176.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -62.24 -41.97 98.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.486 -0.325 . . . . 15.0 110.754 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 40' ' ' LEU . 94.0 t -60.61 -45.18 97.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.946 -0.39 . . . . 15.0 109.946 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -67.83 -47.94 67.61 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.325 0.391 . . . . 15.0 111.687 -177.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.6 -44.48 86.44 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 121.042 -0.263 . . . . 15.0 111.685 -173.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -83.04 -10.01 58.96 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.323 0.86 . . . . 15.0 113.323 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 55.79 55.84 6.69 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.68 0.752 . . . . 15.0 110.333 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.506 HD12 HG22 ' A' ' 44' ' ' VAL . 96.0 mt -64.11 144.95 56.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.62 -0.718 . . . . 15.0 111.36 -175.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -89.69 -40.52 12.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.067 -0.969 . . . . 15.0 110.694 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.97 161.14 28.52 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.045 -1.074 . . . . 15.0 113.553 -174.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.2 mt -126.0 140.94 52.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.428 -0.886 . . . . 15.0 109.568 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.683 HG11 HD21 ' A' ' 17' ' ' LEU . 41.3 t -120.69 130.06 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.696 0.284 . . . . 15.0 110.804 -178.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 m -123.56 138.81 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.007 0.432 . . . . 15.0 110.289 173.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.6 m -89.96 -23.89 21.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.729 -0.669 . . . . 15.0 112.413 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.9 p -154.15 165.51 36.01 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.447 0.641 . . . . 15.0 111.964 -173.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.99 -37.76 72.3 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.148 -0.781 . . . . 15.0 111.148 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -57.68 -46.12 84.7 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.736 -0.385 . . . . 15.0 110.632 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.59 -45.31 96.56 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.448 -1.061 . . . . 15.0 110.448 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.578 HD13 HD21 ' A' ' 79' ' ' LEU . 26.0 tp -56.5 -42.66 78.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.137 0.494 . . . . 15.0 110.762 -177.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.82 -43.28 99.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.504 . . . . 15.0 110.584 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.424 ' OD1' HD13 ' A' ' 33' ' ' LEU . 29.6 m120 -58.05 -39.91 79.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.379 -0.373 . . . . 15.0 110.559 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.441 ' CD1' HD21 ' A' ' 40' ' ' LEU . 12.5 tp -57.8 -45.47 86.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.164 0.507 . . . . 15.0 110.167 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -61.51 -47.68 84.5 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.635 -0.711 . . . . 15.0 110.638 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -61.72 -43.1 99.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.039 -0.528 . . . . 15.0 111.116 -176.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 94.2 mt -66.7 -35.53 80.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.325 -0.398 . . . . 15.0 111.453 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.671 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.71 -38.05 80.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.056 0.455 . . . . 15.0 110.781 177.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.4 -143.99 0.56 Allowed 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.527 -0.545 . . . . 15.0 109.527 174.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.67 -19.09 47.19 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.302 0.955 . . . . 15.0 112.652 -174.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -91.81 11.22 25.5 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.285 0.846 . . . . 15.0 113.285 -175.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -47.68 -46.7 61.45 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 118.595 -0.716 . . . . 15.0 112.606 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -44.76 -41.27 14.88 Favored 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 121.439 1.426 . . . . 15.0 113.166 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -76.88 -48.81 17.24 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.664 -0.414 . . . . 15.0 110.831 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.671 HD12 ' HB1' ' A' ' 67' ' ' ALA . 92.3 mt -59.88 -39.32 79.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.17 -0.468 . . . . 15.0 110.873 -176.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.28 -15.96 32.77 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 119.853 -0.415 . . . . 15.0 113.092 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.0 mtm105 -66.04 -30.29 70.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.42 0.61 . . . . 15.0 112.011 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.8 mt -73.6 150.59 88.99 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 121.171 -0.212 . . . . 15.0 111.463 -173.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.49 126.33 17.41 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 121.684 1.589 . . . . 15.0 112.322 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.578 HD21 HD13 ' A' ' 60' ' ' LEU . 26.4 tp -105.4 124.69 49.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.332 -0.395 . . . . 15.0 110.552 175.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.412 ' CD1' HG22 ' A' ' 53' ' ' VAL . 79.4 m-85 -90.74 127.41 36.31 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.802 -0.444 . . . . 15.0 109.802 177.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.638 HG21 ' HB2' ' A' ' 87' ' ' ALA . 29.1 m -121.43 145.66 43.08 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 110.118 -0.327 . . . . 15.0 110.118 175.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.18 -22.3 8.54 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.727 1.618 . . . . 15.0 113.64 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.551 ' OG ' HG23 ' A' ' 86' ' ' VAL . 53.3 p -141.54 157.44 65.48 Favored Pre-proline 0 C--N 1.331 -0.233 0 C-N-CA 120.765 -0.374 . . . . 15.0 111.327 -169.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.24 -44.06 50.13 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.273 1.315 . . . . 15.0 112.338 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -61.3 -43.52 98.73 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 120.603 -0.439 . . . . 15.0 111.116 -177.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.551 HG23 ' OG ' ' A' ' 83' ' ' SER . 57.3 t -59.63 -40.92 83.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.657 -0.498 . . . . 15.0 109.657 177.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.638 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.66 -41.74 82.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.901 0.381 . . . . 15.0 110.4 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.57 -40.41 91.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.246 -0.434 . . . . 15.0 110.597 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 96.9 mmm -58.3 -45.09 88.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.437 0.637 . . . . 15.0 110.132 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.502 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.62 -40.57 95.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.709 -0.678 . . . . 15.0 110.783 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -61.75 -44.2 97.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.315 -0.402 . . . . 15.0 110.765 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -60.31 -36.16 77.26 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.912 -0.315 . . . . 15.0 111.326 -177.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.2 mt -65.79 -23.83 66.79 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.199 0.444 . . . . 15.0 112.199 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.45 13.25 17.49 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-O 119.369 -0.684 . . . . 15.0 113.127 -176.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.87 122.59 13.28 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 118.49 1.145 . . . . 15.0 109.97 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -70.16 -36.17 74.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.667 -0.697 . . . . 15.0 111.188 -172.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 31.0 ttm105 -130.35 111.63 12.53 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.114 0.483 . . . . 15.0 110.382 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.1 130.87 63.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.989 -0.551 . . . . 15.0 109.817 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 85.8 mt -119.78 121.87 67.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.97 -0.559 . . . . 15.0 110.061 -176.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -95.75 116.51 28.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.39 -0.368 . . . . 15.0 110.24 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 28.3 p -97.09 1.29 49.85 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.23 0.826 . . . . 15.0 113.23 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -55.91 -39.89 72.27 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.26 0.482 . . . . 15.0 110.737 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -96.66 -35.17 5.5 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.523 -0.631 . . . . 15.0 111.523 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.6 143.52 53.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.864 0.364 . . . . 15.0 110.604 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.9 m -89.84 161.36 16.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 15.0 110.504 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.445 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . . . -47.73 -54.19 25.22 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-O 118.522 -0.751 . . . . 15.0 112.97 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -56.52 -36.13 97.43 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 CA-C-N 120.559 1.235 . . . . 15.0 111.318 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.31 -42.67 96.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.045 0.45 . . . . 15.0 110.18 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.1 mt -59.28 -41.05 87.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 15.0 110.492 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.7 tp -57.39 -44.02 84.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.339 0.59 . . . . 15.0 110.14 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.63 93.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.617 -0.72 . . . . 15.0 110.542 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.67 89.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.389 -0.368 . . . . 15.0 110.763 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.2 mt -57.86 -52.5 65.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.391 0.615 . . . . 15.0 110.357 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.2 p -63.83 -40.28 96.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.536 -0.756 . . . . 15.0 111.354 -175.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.7 t -62.14 -45.03 95.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.686 0.279 . . . . 15.0 111.422 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.43 -39.4 90.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.509 -0.314 . . . . 15.0 110.99 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.15 -37.21 76.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.444 -0.344 . . . . 15.0 111.048 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 92.7 mt -60.93 -37.6 82.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.559 -0.291 . . . . 15.0 111.22 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.58 -39.21 79.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.733 0.301 . . . . 15.0 110.916 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -56.82 -36.45 69.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.383 -0.371 . . . . 15.0 111.307 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -55.58 -40.27 71.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.551 -0.295 . . . . 15.0 111.01 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -109.78 127.68 54.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.866 0.365 . . . . 15.0 110.634 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -57.92 -40.29 80.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.045 -0.525 . . . . 15.0 110.875 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -115.92 139.83 49.84 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.223 -0.444 . . . . 15.0 110.572 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 . . . . . 0 C--O 1.219 -0.528 0 CA-C-O 118.031 -0.985 . . . . 15.0 110.606 179.811 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.6 mtm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.471 -0.566 . . . . 15.0 109.471 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.9 p30 -125.84 76.49 70.8 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.133 -0.485 . . . . 15.0 110.307 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -54.41 155.03 17.47 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.434 1.422 . . . . 15.0 112.004 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -113.75 138.73 49.84 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.222 -0.445 . . . . 15.0 110.751 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.472 HG21 HD13 ' A' ' 21' ' ' LEU . 17.5 m -134.81 145.8 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 121.53 0.681 . . . . 15.0 111.943 177.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.8 tp -104.7 137.87 41.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.029 -0.987 . . . . 15.0 110.214 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.627 HD11 ' CG1' ' A' ' 28' ' ' VAL . 53.2 mt -103.07 135.1 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.082 0.467 . . . . 15.0 111.146 -177.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.475 ' HB2' HG12 ' A' ' 54' ' ' VAL . 97.9 mmm -95.5 125.91 40.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.106 -0.952 . . . . 15.0 108.905 169.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.0 mtm180 -59.59 147.67 36.31 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.487 -0.485 . . . . 15.0 110.689 -176.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.28 175.18 34.76 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.776 -0.929 . . . . 15.0 110.776 -178.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -51.59 -32.19 27.75 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.789 0.292 . . . . 15.0 111.789 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.81 173.76 16.78 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.855 -0.898 . . . . 15.0 110.855 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.99 126.38 7.66 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.351 -0.699 . . . . 15.0 111.351 -178.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -56.64 -47.43 79.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.193 0.52 . . . . 15.0 110.417 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.72 -40.99 98.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.642 -0.708 . . . . 15.0 111.202 -176.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -61.1 -55.99 26.12 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.722 -0.391 . . . . 15.0 111.393 -175.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.9 mt -62.19 -45.06 95.07 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.757 -0.377 . . . . 15.0 111.372 -175.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.44 -41.29 98.65 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.699 -0.4 . . . . 15.0 110.904 -177.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -59.87 -41.27 91.13 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.978 -0.289 . . . . 15.0 110.388 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.525 ' HE ' ' HB2' ' A' ' 106' ' ' ALA . 52.2 ttt85 -60.19 -51.64 68.7 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 120.764 -0.374 . . . . 15.0 111.305 -177.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.472 HD13 HG21 ' A' ' 5' ' ' VAL . 86.9 mt -62.72 -36.72 83.92 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.374 -0.53 . . . . 15.0 110.94 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 46.0 tpt85 -61.36 -41.46 97.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.684 0.278 . . . . 15.0 110.399 177.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.83 -30.57 66.35 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.2 -0.524 . . . . 15.0 111.993 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -88.02 9.91 20.8 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.46 0.911 . . . . 15.0 113.46 178.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.1 18.71 58.88 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 121.314 -0.47 . . . . 15.0 113.054 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.1 t -101.06 138.75 24.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 117.77 0.785 . . . . 15.0 109.949 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -81.6 129.63 34.76 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.164 -0.68 . . . . 15.0 109.164 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.627 ' CG1' HD11 ' A' ' 7' ' ' ILE . 28.4 t -122.66 134.39 65.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.267 0.556 . . . . 15.0 111.418 -172.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -139.61 138.53 36.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.14 -0.936 . . . . 15.0 109.404 171.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.502 ' HB3' HD12 ' A' ' 7' ' ' ILE . 30.2 p90 -115.5 140.87 48.76 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.832 0.348 . . . . 15.0 110.833 -178.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 33.9 tp -112.67 129.6 24.26 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-O 118.523 -0.751 . . . . 15.0 109.813 -175.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -65.73 134.98 39.85 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 CA-C-N 120.418 1.185 . . . . 15.0 111.38 174.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.615 HD13 ' OD1' ' A' ' 62' ' ' ASN . 57.8 mt -65.83 -9.19 26.6 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.294 0.85 . . . . 15.0 113.294 -175.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -77.29 -11.33 59.82 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.12 0.785 . . . . 15.0 113.12 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -63.15 148.5 92.8 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 118.416 0.553 . . . . 15.0 110.434 -176.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.89 157.5 31.09 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.523 1.482 . . . . 15.0 113.14 -177.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.44 151.25 5.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.84 -0.618 . . . . 15.0 111.177 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.91 -37.02 3.63 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.354 -0.698 . . . . 15.0 111.354 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.31 -37.78 81.64 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.592 -0.443 . . . . 15.0 110.985 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.557 ' O ' HG23 ' A' ' 44' ' ' VAL . 22.4 tp -58.84 -47.31 85.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.028 0.442 . . . . 15.0 110.239 -177.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.541 HD22 ' OD2' ' A' ' 70' ' ' ASP . 10.8 tp -62.79 -44.58 95.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.106 -0.497 . . . . 15.0 110.951 -176.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.9 -44.72 96.21 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.7 -0.4 . . . . 15.0 110.92 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 -61.61 -40.8 96.12 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.841 -0.344 . . . . 15.0 110.98 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 40' ' ' LEU . 88.8 t -61.78 -45.74 98.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.829 -0.349 . . . . 15.0 110.375 -177.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -67.42 -50.82 57.73 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.312 0.382 . . . . 15.0 111.936 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.41 -44.35 79.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.674 0.273 . . . . 15.0 111.578 -174.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -78.28 -10.05 59.49 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.043 0.757 . . . . 15.0 113.043 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 56.32 55.9 6.23 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.539 0.685 . . . . 15.0 110.074 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.532 HD12 HG22 ' A' ' 44' ' ' VAL . 94.8 mt -69.87 144.73 52.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.846 -0.616 . . . . 15.0 111.381 -176.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -90.9 -40.52 11.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.188 -0.914 . . . . 15.0 110.499 176.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -152.52 168.93 31.64 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 120.129 -1.034 . . . . 15.0 113.216 -174.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 75.8 mt -124.69 141.41 52.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.851 -0.675 . . . . 15.0 110.108 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.55 HG22 ' CD1' ' A' ' 80' ' ' PHE . 48.5 t -120.25 130.42 74.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.022 -0.362 . . . . 15.0 110.022 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.475 HG12 ' HB2' ' A' ' 8' ' ' MET . 11.6 m -122.6 129.39 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 121.047 0.451 . . . . 15.0 110.235 173.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.2 p -95.09 -3.59 47.81 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.931 0.715 . . . . 15.0 112.931 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 81.7 p -154.31 154.71 33.84 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.447 0.567 . . . . 15.0 111.545 -177.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.02 -39.83 90.27 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.887 -0.885 . . . . 15.0 110.887 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -59.19 -42.82 91.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.916 -0.314 . . . . 15.0 110.511 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.88 -44.97 96.6 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.859 -0.896 . . . . 15.0 110.859 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.585 HD13 HD21 ' A' ' 79' ' ' LEU . 52.3 tp -58.16 -47.82 82.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.091 0.472 . . . . 15.0 110.366 -177.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -61.23 -40.71 95.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.018 -0.537 . . . . 15.0 110.695 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.615 ' OD1' HD13 ' A' ' 33' ' ' LEU . 23.8 m120 -59.74 -40.29 87.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.441 -0.345 . . . . 15.0 110.629 177.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.402 ' CD1' HD21 ' A' ' 40' ' ' LEU . 15.1 tp -57.81 -44.16 86.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.235 0.541 . . . . 15.0 110.125 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -60.69 -47.14 87.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.791 -0.64 . . . . 15.0 110.623 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.54 -43.17 99.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.137 -0.483 . . . . 15.0 111.184 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.4 mt -67.04 -34.71 78.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.498 -0.319 . . . . 15.0 111.431 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.682 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -58.97 -39.07 80.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.068 0.461 . . . . 15.0 110.6 177.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 58.83 -143.15 0.62 Allowed 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.736 -0.468 . . . . 15.0 109.736 173.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.61 -19.98 52.79 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.337 0.971 . . . . 15.0 112.639 -174.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.541 ' OD2' HD22 ' A' ' 41' ' ' LEU . 77.9 m-20 -91.88 10.81 27.19 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.265 0.839 . . . . 15.0 113.265 -175.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 56.7 t-105 -47.85 -46.61 63.14 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 118.563 -0.732 . . . . 15.0 112.547 177.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -44.66 -40.71 14.33 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.389 1.393 . . . . 15.0 113.288 177.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -76.96 -48.89 16.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.948 0.404 . . . . 15.0 110.698 -178.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.682 HD12 ' HB1' ' A' ' 67' ' ' ALA . 89.6 mt -59.25 -39.59 79.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 15.0 110.826 -177.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.56 -14.47 35.55 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.817 -0.435 . . . . 15.0 113.23 -176.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -64.96 -30.12 71.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.501 0.651 . . . . 15.0 111.907 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 23.4 mt -76.29 150.42 82.74 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 120.932 -0.307 . . . . 15.0 111.264 -174.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.34 128.97 29.29 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.624 1.55 . . . . 15.0 112.286 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.585 HD21 HD13 ' A' ' 60' ' ' LEU . 14.0 tp -107.07 124.54 49.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 15.0 110.533 175.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.55 ' CD1' HG22 ' A' ' 53' ' ' VAL . 86.3 m-85 -92.59 121.95 34.53 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.356 -0.609 . . . . 15.0 109.356 174.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.715 HG21 ' HB2' ' A' ' 87' ' ' ALA . 21.5 m -107.0 147.38 34.99 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-O 119.345 -0.36 . . . . 15.0 110.207 177.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.18 -25.88 5.56 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.577 1.518 . . . . 15.0 113.404 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.9 p -145.26 163.44 32.26 Favored Pre-proline 0 CA--C 1.531 0.227 0 C-N-CA 120.636 -0.425 . . . . 15.0 111.46 -172.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.3 -44.01 47.07 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 121.13 1.22 . . . . 15.0 111.829 176.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -58.28 -46.74 85.49 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.81 -0.356 . . . . 15.0 110.817 -177.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.0 t -59.9 -41.04 84.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.882 -0.414 . . . . 15.0 109.882 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.715 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.87 -39.32 77.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.674 0.273 . . . . 15.0 110.707 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.88 -42.08 97.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.504 -0.316 . . . . 15.0 110.563 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 52.2 mtm -64.89 -42.94 94.36 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 119.871 -0.731 . . . . 15.0 110.129 176.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.5 -43.96 93.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.584 -0.28 . . . . 15.0 111.484 -171.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -67.02 -38.57 86.19 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.161 -0.616 . . . . 15.0 110.443 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -59.76 -35.16 74.04 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 120.653 -0.419 . . . . 15.0 111.246 176.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 67.2 mt -59.88 -29.11 68.1 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.877 -0.329 . . . . 15.0 111.378 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.27 13.08 20.28 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 119.431 -0.649 . . . . 15.0 112.821 -172.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.93 123.33 15.46 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.515 1.157 . . . . 15.0 109.862 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -70.46 -35.1 73.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.971 -0.558 . . . . 15.0 111.323 -172.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -131.62 113.98 14.27 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 110.052 -0.351 . . . . 15.0 110.052 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 45.6 t -109.44 129.79 63.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.036 0.446 . . . . 15.0 110.121 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 82.4 mt -120.92 125.66 74.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.745 -0.661 . . . . 15.0 109.978 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -94.44 114.5 26.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.212 -0.292 . . . . 15.0 110.212 175.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 28.6 p -78.36 -25.84 46.48 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 120.639 -0.424 . . . . 15.0 112.021 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -55.11 -38.17 67.8 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.646 0.26 . . . . 15.0 110.913 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.96 -35.15 7.83 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.597 -0.601 . . . . 15.0 111.597 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.36 127.02 36.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.373 . . . . 15.0 110.908 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.427 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 50.3 m -65.09 156.87 30.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.081 0.467 . . . . 15.0 110.787 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.525 ' HB2' ' HE ' ' A' ' 20' ' ' ARG . . . -47.68 -54.34 23.8 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 113.031 0.752 . . . . 15.0 113.031 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -56.2 -35.48 95.44 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 CA-C-N 120.367 1.167 . . . . 15.0 111.339 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 105' ' ' SER . . . -60.05 -41.33 92.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.955 0.407 . . . . 15.0 110.235 176.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 78.0 mt -58.94 -41.9 88.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.97 0.414 . . . . 15.0 110.329 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.61 -44.16 85.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.445 0.64 . . . . 15.0 110.131 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.4 -40.09 89.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.602 -0.726 . . . . 15.0 110.586 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.25 -41.03 92.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.41 -0.359 . . . . 15.0 110.785 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.4 mt -57.85 -51.01 71.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.152 0.501 . . . . 15.0 110.404 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.8 p -63.28 -41.27 98.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.68 -0.691 . . . . 15.0 111.252 -175.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.0 m -63.46 -43.22 97.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.662 0.267 . . . . 15.0 111.389 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.35 -39.03 91.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.478 -0.328 . . . . 15.0 111.05 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.73 -37.77 79.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.552 -0.295 . . . . 15.0 110.952 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 90.4 mt -59.91 -38.28 81.88 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.916 -0.314 . . . . 15.0 110.938 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -62.43 138.46 58.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.746 0.307 . . . . 15.0 110.426 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -132.4 131.63 42.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.372 -0.376 . . . . 15.0 110.735 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -60.85 -40.34 92.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 15.0 110.585 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -107.13 129.13 54.88 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.298 -0.41 . . . . 15.0 110.541 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -59.91 -40.7 89.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.026 -0.534 . . . . 15.0 110.759 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -107.23 136.78 46.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.472 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.938 -1.029 . . . . 15.0 110.598 -179.399 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.432 -0.581 . . . . 15.0 109.432 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -125.55 83.69 61.43 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 116.157 -0.474 . . . . 15.0 110.32 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -59.18 155.06 41.95 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.38 1.387 . . . . 15.0 111.942 -177.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -105.4 136.48 44.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.387 -0.369 . . . . 15.0 110.62 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.8 m -132.68 143.56 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 121.585 0.707 . . . . 15.0 111.587 177.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.446 HD11 ' HB2' ' A' ' 31' ' ' LEU . 13.8 tp -102.77 135.87 43.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.981 -1.009 . . . . 15.0 110.274 178.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.578 HD11 ' CG1' ' A' ' 28' ' ' VAL . 51.9 mt -102.04 134.76 41.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.981 0.42 . . . . 15.0 110.558 -178.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.44 ' HB2' HG12 ' A' ' 54' ' ' VAL . 85.6 mtp -103.52 134.27 47.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.441 -0.8 . . . . 15.0 109.943 173.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 -57.46 144.86 35.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.016 0.436 . . . . 15.0 110.833 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.2 175.24 33.24 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.658 -0.977 . . . . 15.0 110.658 -177.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -50.97 -32.07 19.84 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.88 0.326 . . . . 15.0 111.88 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.95 175.42 47.77 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.782 -0.927 . . . . 15.0 110.782 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.64 131.68 10.81 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.474 -0.65 . . . . 15.0 111.474 -178.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -56.56 -44.35 80.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.869 0.366 . . . . 15.0 110.616 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.83 -43.19 99.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.126 -0.488 . . . . 15.0 111.183 -176.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -62.49 -56.06 21.61 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.8 -0.36 . . . . 15.0 111.384 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.47 HD23 ' C ' ' A' ' 17' ' ' LEU . 8.9 tt -61.7 -43.69 98.37 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.777 -0.369 . . . . 15.0 110.985 -175.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.528 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -62.38 -42.43 99.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.414 -0.357 . . . . 15.0 110.84 -177.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.78 -41.21 90.62 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.875 -0.33 . . . . 15.0 110.457 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -59.64 -51.72 68.61 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.565 -0.454 . . . . 15.0 111.34 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.5 mt -62.58 -37.5 86.43 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.436 -0.505 . . . . 15.0 110.933 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 46.9 tpt85 -63.03 -44.8 94.91 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 121.066 -0.254 . . . . 15.0 110.711 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.43 -30.57 68.4 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.955 -0.64 . . . . 15.0 111.894 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -88.11 9.24 23.34 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.626 0.973 . . . . 15.0 113.626 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.77 13.55 54.77 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 121.066 -0.588 . . . . 15.0 113.65 173.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.0 t -101.1 138.52 25.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 117.953 0.876 . . . . 15.0 110.021 177.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -79.33 131.88 36.27 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.348 -0.612 . . . . 15.0 109.348 178.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.578 ' CG1' HD11 ' A' ' 7' ' ' ILE . 43.9 t -117.68 130.79 72.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.198 0.523 . . . . 15.0 111.528 -171.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -139.33 133.03 30.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.32 -0.855 . . . . 15.0 109.388 170.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -112.66 137.39 51.01 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.9 0.381 . . . . 15.0 110.974 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.446 ' HB2' HD11 ' A' ' 6' ' ' LEU . 40.5 tp -118.9 113.45 35.91 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 118.618 -0.706 . . . . 15.0 109.969 -176.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -56.09 135.26 68.93 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.069 1.179 . . . . 15.0 112.318 177.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 77.3 mt -60.56 -9.21 3.48 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.298 0.851 . . . . 15.0 113.298 -178.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -77.15 -9.98 59.1 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.205 0.817 . . . . 15.0 113.205 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -62.53 147.2 92.8 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 118.338 0.517 . . . . 15.0 110.26 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.29 158.96 33.28 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.559 1.506 . . . . 15.0 113.252 -178.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.84 152.42 3.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.783 -0.644 . . . . 15.0 111.337 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.39 -36.3 3.88 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.489 -0.644 . . . . 15.0 111.489 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -60.01 -37.22 79.09 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.689 -0.404 . . . . 15.0 111.041 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.576 ' O ' HG23 ' A' ' 44' ' ' VAL . 25.8 tp -58.65 -46.34 87.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.965 0.412 . . . . 15.0 110.168 -178.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.611 HD22 ' OD2' ' A' ' 70' ' ' ASP . 9.7 tp -61.78 -44.14 97.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.139 -0.482 . . . . 15.0 110.742 -177.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.01 -43.61 98.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.352 -0.386 . . . . 15.0 111.241 -176.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -61.28 -41.82 97.6 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.751 -0.38 . . . . 15.0 110.625 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.579 ' HA ' HD12 ' A' ' 49' ' ' LEU . 97.6 t -61.65 -47.03 95.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.88 -0.328 . . . . 15.0 110.491 -175.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -75.42 -43.5 49.57 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.492 0.553 . . . . 15.0 112.492 -174.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.59 -44.37 74.52 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.667 0.247 . . . . 15.0 111.667 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -82.74 -10.09 59.05 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.123 0.786 . . . . 15.0 113.123 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 58.36 55.88 4.73 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.563 0.697 . . . . 15.0 109.553 -177.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.579 HD12 ' HA ' ' A' ' 44' ' ' VAL . 94.1 mt -71.47 145.7 49.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.752 -0.658 . . . . 15.0 111.412 -174.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -95.41 -40.52 9.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.231 -0.895 . . . . 15.0 110.774 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -150.93 166.64 30.44 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 120.057 -1.068 . . . . 15.0 113.412 -173.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.5 mt -126.61 144.17 50.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.732 -0.734 . . . . 15.0 110.046 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.549 HG22 ' CD1' ' A' ' 80' ' ' PHE . 47.8 t -122.1 129.38 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 110.386 -0.227 . . . . 15.0 110.386 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.44 HG12 ' HB2' ' A' ' 8' ' ' MET . 15.5 m -127.65 152.05 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.053 0.454 . . . . 15.0 110.456 172.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.9 m -123.47 7.92 8.97 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.744 -0.662 . . . . 15.0 112.77 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.9 p -155.62 151.69 27.81 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 118.514 0.597 . . . . 15.0 111.772 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.87 -39.75 92.08 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.633 -0.987 . . . . 15.0 110.633 176.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -58.25 -41.8 85.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.702 0.287 . . . . 15.0 110.382 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.82 -47.98 88.54 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.687 -0.965 . . . . 15.0 110.687 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.614 HD13 HD21 ' A' ' 79' ' ' LEU . 34.2 tp -57.13 -44.42 83.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.15 0.5 . . . . 15.0 110.705 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.63 -42.37 98.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.063 -0.517 . . . . 15.0 110.823 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -59.47 -39.89 85.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.393 -0.367 . . . . 15.0 110.576 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.4 tp -58.12 -44.29 87.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.094 0.473 . . . . 15.0 110.274 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -60.67 -47.52 85.91 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.849 -0.614 . . . . 15.0 110.631 -178.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -62.13 -43.41 98.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.085 -0.507 . . . . 15.0 111.113 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.8 mt -66.42 -35.27 79.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.414 -0.357 . . . . 15.0 111.375 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.664 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -58.92 -38.75 79.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.032 0.444 . . . . 15.0 110.672 178.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.21 -143.54 0.59 Allowed 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 109.515 -0.55 . . . . 15.0 109.515 174.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.43 -19.04 44.38 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.342 0.973 . . . . 15.0 112.609 -175.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.611 ' OD2' HD22 ' A' ' 41' ' ' LEU . 79.2 m-20 -91.88 10.5 28.48 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.299 0.852 . . . . 15.0 113.299 -174.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -47.76 -46.72 62.33 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 118.576 -0.726 . . . . 15.0 112.561 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -44.69 -41.99 14.72 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 121.481 1.454 . . . . 15.0 113.244 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -77.01 -48.69 17.23 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.949 0.405 . . . . 15.0 110.862 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.664 HD12 ' HB1' ' A' ' 67' ' ' ALA . 91.7 mt -59.01 -40.78 81.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.138 -0.483 . . . . 15.0 110.748 -176.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.51 -16.1 35.05 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 119.896 -0.391 . . . . 15.0 113.048 -177.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -63.66 -30.64 71.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.425 0.612 . . . . 15.0 111.989 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.6 mt -74.89 149.02 85.24 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 120.979 -0.289 . . . . 15.0 111.265 -173.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.85 129.07 24.89 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.558 1.505 . . . . 15.0 112.517 176.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.614 HD21 HD13 ' A' ' 60' ' ' LEU . 22.4 tp -107.77 126.43 52.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 15.0 110.577 174.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.549 ' CD1' HG22 ' A' ' 53' ' ' VAL . 80.3 m-85 -89.84 125.01 35.17 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.438 -0.579 . . . . 15.0 109.438 175.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.741 HG21 ' HB2' ' A' ' 87' ' ' ALA . 27.6 m -113.87 147.56 37.98 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-O 119.373 -0.346 . . . . 15.0 110.319 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.418 ' HD2' HG11 ' A' ' 86' ' ' VAL . 90.1 Cg_endo -79.17 -23.94 7.17 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.574 1.516 . . . . 15.0 113.52 -175.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.7 p -144.4 158.23 54.73 Favored Pre-proline 0 CA--C 1.531 0.232 0 C-N-CA 120.664 -0.414 . . . . 15.0 111.321 -172.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.82 -44.04 51.34 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.255 1.304 . . . . 15.0 111.694 175.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -56.73 -48.56 77.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.847 0.356 . . . . 15.0 110.858 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.418 HG11 ' HD2' ' A' ' 82' ' ' PRO . 60.2 t -59.61 -40.66 82.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.836 0.351 . . . . 15.0 110.071 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.741 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.72 -42.29 83.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.012 0.434 . . . . 15.0 110.505 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.6 -41.67 97.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 15.0 110.658 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 87.1 mtp -59.82 -44.44 94.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.238 0.542 . . . . 15.0 110.432 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.434 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.35 -41.2 96.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.993 -0.548 . . . . 15.0 110.725 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 54.0 ttm-85 -61.19 -44.52 97.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.25 -0.432 . . . . 15.0 110.539 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -59.84 -36.26 76.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.527 -0.306 . . . . 15.0 111.397 -177.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 81.9 mt -65.39 -24.15 67.15 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.244 0.461 . . . . 15.0 112.244 177.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.85 13.2 14.41 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-O 119.444 -0.642 . . . . 15.0 113.158 -176.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.89 121.97 11.8 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.466 1.133 . . . . 15.0 109.893 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -70.5 -35.48 73.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.69 -0.686 . . . . 15.0 111.322 -171.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -131.07 112.83 13.24 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.975 0.417 . . . . 15.0 110.115 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.2 t -111.41 129.49 66.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.79 -0.448 . . . . 15.0 109.79 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 83.9 mt -119.53 125.49 74.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.967 -0.56 . . . . 15.0 110.222 -176.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -94.9 117.74 30.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.435 -0.348 . . . . 15.0 110.286 176.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.545 ' HB2' HD11 ' A' ' 109' ' ' LEU . 31.2 p -88.6 -18.69 27.5 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.574 0.583 . . . . 15.0 112.574 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 tpt85 -55.17 -38.9 68.92 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 122.229 -0.294 . . . . 15.0 110.766 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -93.16 -34.95 6.49 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.633 -0.587 . . . . 15.0 111.633 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -89.51 125.59 35.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.843 0.354 . . . . 15.0 110.705 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.409 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 47.7 m -64.64 158.63 23.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.159 0.504 . . . . 15.0 110.901 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.79 -54.24 25.06 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 113.011 0.745 . . . . 15.0 113.011 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -56.65 -34.84 96.68 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 CA-C-N 120.447 1.196 . . . . 15.0 111.451 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 105' ' ' SER . . . -60.22 -41.74 93.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.029 0.442 . . . . 15.0 110.081 176.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.545 HD11 ' HB2' ' A' ' 101' ' ' CYS . 78.8 mt -58.95 -41.13 86.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.077 0.465 . . . . 15.0 110.454 178.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 30.6 tp -56.98 -44.34 82.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.546 0.689 . . . . 15.0 110.104 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.45 -40.14 90.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.508 -0.769 . . . . 15.0 110.551 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.83 -41.12 90.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.399 -0.364 . . . . 15.0 110.757 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.0 mt -57.89 -52.08 66.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.262 0.553 . . . . 15.0 110.305 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.9 p -63.53 -40.6 97.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.571 -0.741 . . . . 15.0 111.315 -175.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.3 m -62.73 -43.51 98.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.67 0.271 . . . . 15.0 111.443 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.34 -39.87 94.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.414 -0.357 . . . . 15.0 111.045 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.49 -36.94 79.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.48 -0.327 . . . . 15.0 111.164 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.21 -38.36 83.1 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.918 -0.313 . . . . 15.0 111.159 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.83 -37.75 88.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.554 -0.294 . . . . 15.0 111.257 -178.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -61.18 -42.84 99.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.751 0.31 . . . . 15.0 110.973 -178.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -54.74 -35.82 64.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.427 . . . . 15.0 111.492 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -102.38 126.22 49.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.911 0.386 . . . . 15.0 110.726 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -58.72 -38.98 79.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.893 -0.594 . . . . 15.0 110.985 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -106.86 139.01 41.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.328 -0.396 . . . . 15.0 110.483 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.015 -0.993 . . . . 15.0 110.625 -179.776 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.6 mtm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.371 -0.603 . . . . 15.0 109.371 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -126.31 82.48 65.73 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.074 -0.512 . . . . 15.0 110.329 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.7 155.04 28.4 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.393 1.395 . . . . 15.0 111.875 -176.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.421 ' CB ' HD23 ' A' ' 49' ' ' LEU . 96.1 mttt -111.68 138.13 48.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.795 0.331 . . . . 15.0 110.864 -178.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.426 HG21 HD13 ' A' ' 21' ' ' LEU . 15.1 m -134.66 144.31 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.565 0.698 . . . . 15.0 111.572 175.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.2 tp -104.38 136.0 44.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.916 -1.038 . . . . 15.0 110.264 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.614 HD11 ' CG1' ' A' ' 28' ' ' VAL . 50.8 mt -103.53 135.1 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.123 0.487 . . . . 15.0 111.129 -176.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.531 ' HB2' HG12 ' A' ' 54' ' ' VAL . 98.5 mmm -95.3 133.65 38.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.109 -0.95 . . . . 15.0 109.21 171.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.421 ' H ' HD21 ' A' ' 33' ' ' LEU . 55.9 ttp180 -63.91 143.74 57.62 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.76 -0.376 . . . . 15.0 110.479 -177.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.24 175.13 34.02 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.924 -0.871 . . . . 15.0 110.924 -178.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -52.55 -32.45 40.87 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.742 0.275 . . . . 15.0 111.742 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.69 176.39 32.38 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.807 -0.917 . . . . 15.0 110.807 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.0 120.24 5.77 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.504 -0.638 . . . . 15.0 111.504 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -56.89 -41.8 78.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.794 0.331 . . . . 15.0 110.452 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.07 -40.63 98.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 15.0 111.134 -177.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -62.35 -56.0 22.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.984 0.421 . . . . 15.0 111.124 -176.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.3 mt -59.92 -44.82 94.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.942 0.401 . . . . 15.0 110.759 -176.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.532 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -62.53 -37.49 86.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 15.0 111.052 -178.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.0 -42.89 99.32 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.955 -0.298 . . . . 15.0 110.598 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -61.53 -51.52 68.27 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.125 -0.63 . . . . 15.0 110.895 -178.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.426 HD13 HG21 ' A' ' 5' ' ' VAL . 84.6 mt -61.46 -37.99 85.6 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.632 -0.427 . . . . 15.0 110.931 -178.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 57.5 ttt85 -63.63 -43.52 96.59 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.196 -0.202 . . . . 15.0 111.084 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.03 -30.6 67.05 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.967 -0.635 . . . . 15.0 111.915 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -88.2 10.1 20.63 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.481 0.919 . . . . 15.0 113.481 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.91 18.27 51.41 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 121.187 -0.53 . . . . 15.0 113.292 174.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.4 t -101.01 140.32 20.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 117.688 0.744 . . . . 15.0 110.131 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -84.78 130.38 34.69 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.475 -0.565 . . . . 15.0 109.475 178.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.614 ' CG1' HD11 ' A' ' 7' ' ' ILE . 37.2 t -119.97 133.76 65.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.205 0.526 . . . . 15.0 111.271 -173.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -139.08 132.72 30.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.443 -0.799 . . . . 15.0 109.611 171.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.461 ' HB3' HD12 ' A' ' 7' ' ' ILE . 38.3 p90 -113.01 137.64 51.1 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.89 0.376 . . . . 15.0 110.467 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.7 tp -114.92 113.49 44.28 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.683 -0.675 . . . . 15.0 110.824 -173.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -49.05 135.08 29.97 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.156 1.237 . . . . 15.0 111.881 174.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.608 HD13 ' OD1' ' A' ' 62' ' ' ASN . 43.2 mt -64.61 -13.36 53.11 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.15 0.796 . . . . 15.0 113.15 -174.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -77.23 -6.01 51.45 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.293 0.849 . . . . 15.0 113.293 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -60.0 151.04 67.24 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 118.559 0.618 . . . . 15.0 110.388 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.75 151.72 25.0 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.548 1.499 . . . . 15.0 113.044 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.53 152.29 5.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.925 -0.58 . . . . 15.0 111.162 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.84 -36.6 3.8 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.449 -0.66 . . . . 15.0 111.449 -177.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.44 -37.94 82.54 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.655 -0.418 . . . . 15.0 110.958 -177.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.563 ' O ' HG23 ' A' ' 44' ' ' VAL . 23.9 tp -59.14 -46.32 88.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.952 0.406 . . . . 15.0 110.256 -178.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.614 HD22 ' OD2' ' A' ' 70' ' ' ASP . 12.1 tp -61.97 -44.64 96.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 15.0 110.824 -176.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.89 -43.93 97.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.348 -0.387 . . . . 15.0 110.91 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.8 mtp85 -61.83 -41.77 98.2 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.811 -0.356 . . . . 15.0 110.888 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 40' ' ' LEU . 96.5 t -59.4 -46.08 92.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.868 -0.419 . . . . 15.0 109.868 -177.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.2 tpt85 -71.55 -50.3 32.45 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 123.37 0.419 . . . . 15.0 112.024 -176.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.04 -44.44 92.48 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.089 0.403 . . . . 15.0 112.089 -171.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 mp0 -89.87 -5.61 56.65 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.429 0.899 . . . . 15.0 113.429 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 56.77 55.93 5.89 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.616 0.722 . . . . 15.0 110.167 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.51 HD12 ' HA ' ' A' ' 44' ' ' VAL . 94.5 mt -64.23 140.44 58.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.525 -0.761 . . . . 15.0 111.058 -175.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -84.47 -40.64 17.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.491 -0.777 . . . . 15.0 110.671 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -154.04 168.04 32.36 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 119.872 -1.156 . . . . 15.0 113.773 -173.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.8 mt -123.65 143.51 50.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.502 -0.849 . . . . 15.0 109.671 177.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.48 HG22 ' CD1' ' A' ' 80' ' ' PHE . 46.9 t -122.66 132.76 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.143 -0.317 . . . . 15.0 110.143 -179.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.531 HG12 ' HB2' ' A' ' 8' ' ' MET . 9.2 m -126.47 142.41 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 121.057 0.456 . . . . 15.0 110.547 173.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.6 t -97.44 -19.95 18.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.622 -0.717 . . . . 15.0 112.439 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.2 p -151.27 161.65 42.32 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 121.333 0.587 . . . . 15.0 111.528 -174.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.45 -39.12 83.18 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.946 -0.862 . . . . 15.0 110.946 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -58.82 -44.62 90.91 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.876 -0.329 . . . . 15.0 110.653 -178.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.06 -44.48 97.23 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.545 -1.022 . . . . 15.0 110.545 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.602 HD13 HD21 ' A' ' 79' ' ' LEU . 32.1 tp -57.27 -43.03 82.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.115 0.483 . . . . 15.0 110.639 -178.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.08 -42.73 99.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 15.0 110.692 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.608 ' OD1' HD13 ' A' ' 33' ' ' LEU . 26.1 m120 -58.95 -41.61 87.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.852 0.358 . . . . 15.0 110.543 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.8 tp -58.67 -43.94 90.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.125 0.488 . . . . 15.0 110.181 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -61.19 -47.32 86.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.955 -0.566 . . . . 15.0 110.725 -178.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -61.22 -42.7 99.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 15.0 111.117 -177.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 92.7 mt -65.82 -36.32 83.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.341 -0.391 . . . . 15.0 111.374 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.687 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.32 -38.57 80.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.141 0.496 . . . . 15.0 110.85 178.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.13 -143.15 0.61 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.648 -0.501 . . . . 15.0 109.648 174.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.52 -19.82 51.0 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.321 0.964 . . . . 15.0 112.734 -174.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.614 ' OD2' HD22 ' A' ' 41' ' ' LEU . 79.3 m-20 -91.97 11.4 25.23 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.217 0.821 . . . . 15.0 113.217 -175.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -47.85 -46.7 63.25 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 118.584 -0.722 . . . . 15.0 112.593 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -44.7 -41.25 14.7 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.474 1.45 . . . . 15.0 113.224 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.5 mp0 -77.03 -48.77 17.0 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.943 0.402 . . . . 15.0 110.827 -178.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.687 HD12 ' HB1' ' A' ' 67' ' ' ALA . 90.8 mt -60.03 -40.52 83.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 15.0 110.902 -176.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.79 -13.72 26.66 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.915 -0.38 . . . . 15.0 113.156 -177.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -64.44 -31.46 72.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 117.359 0.579 . . . . 15.0 111.766 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.3 mt -72.99 141.84 82.11 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 119.204 -0.427 . . . . 15.0 110.456 -176.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -59.33 135.24 64.05 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.342 1.361 . . . . 15.0 112.434 177.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.602 HD21 HD13 ' A' ' 60' ' ' LEU . 23.9 tp -109.34 127.76 54.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 15.0 110.736 176.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.48 ' CD1' HG22 ' A' ' 53' ' ' VAL . 85.9 m-85 -91.35 127.18 36.68 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.821 -0.437 . . . . 15.0 109.821 176.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.664 HG21 ' HB2' ' A' ' 87' ' ' ALA . 28.6 m -119.6 147.44 43.69 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 119.45 -0.309 . . . . 15.0 110.25 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.24 -24.23 6.83 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.597 1.531 . . . . 15.0 113.478 -175.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.402 ' OG ' HG23 ' A' ' 86' ' ' VAL . 25.2 p -142.58 158.51 60.06 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 120.71 -0.396 . . . . 15.0 111.27 -171.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.43 -44.05 52.33 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.285 1.323 . . . . 15.0 111.761 176.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -58.29 -47.43 83.67 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.773 -0.371 . . . . 15.0 110.924 -177.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.402 HG23 ' OG ' ' A' ' 83' ' ' SER . 61.1 t -60.17 -39.65 81.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.788 -0.365 . . . . 15.0 110.096 178.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.664 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.25 -41.84 80.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.925 0.393 . . . . 15.0 110.404 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.75 -40.86 94.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.131 -0.486 . . . . 15.0 110.526 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.0 mmm -58.33 -45.17 88.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.456 0.646 . . . . 15.0 110.177 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.492 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.76 -40.32 94.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.704 -0.68 . . . . 15.0 110.937 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.0 ttt-85 -62.07 -44.63 96.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 15.0 110.792 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.76 -36.15 76.06 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.818 -0.353 . . . . 15.0 111.236 -177.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 76.4 mt -65.49 -25.6 67.55 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.088 0.403 . . . . 15.0 112.088 177.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.55 13.37 14.78 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 119.288 -0.729 . . . . 15.0 113.18 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.87 122.68 13.51 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 118.513 1.157 . . . . 15.0 110.002 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -67.52 -35.83 79.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.518 -0.764 . . . . 15.0 111.256 -171.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -131.82 117.67 18.85 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.954 0.407 . . . . 15.0 110.087 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.9 t -114.18 130.36 68.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.975 0.417 . . . . 15.0 109.989 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 89.9 mt -119.16 123.58 71.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.811 -0.631 . . . . 15.0 110.077 -177.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -94.7 117.44 30.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.376 -0.375 . . . . 15.0 110.086 175.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 104' ' ' ALA . 30.8 p -95.42 -1.65 50.54 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.306 0.854 . . . . 15.0 113.306 -178.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -55.89 -39.88 72.2 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 118.191 0.451 . . . . 15.0 110.672 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -96.24 -35.06 5.63 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 111.511 -0.636 . . . . 15.0 111.511 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.407 ' HB3' ' HA ' ' A' ' 101' ' ' CYS . . . -69.7 143.23 53.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.829 0.347 . . . . 15.0 110.635 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 65.2 m -89.85 160.12 16.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 15.0 110.506 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.66 -54.41 23.21 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 112.945 0.72 . . . . 15.0 112.945 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.54 -34.53 98.88 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 CA-C-N 120.079 1.064 . . . . 15.0 111.708 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.01 96.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.028 0.442 . . . . 15.0 110.034 177.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.7 mt -59.42 -40.77 87.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 15.0 110.399 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 36.6 tp -57.26 -44.03 83.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.272 0.558 . . . . 15.0 110.164 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.18 -40.59 90.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.696 -0.683 . . . . 15.0 110.436 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.09 -40.13 88.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.377 -0.374 . . . . 15.0 110.811 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.6 mt -57.88 -51.4 69.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.174 0.512 . . . . 15.0 110.479 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.9 p -64.74 -41.56 95.84 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.637 -0.71 . . . . 15.0 111.384 -175.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.0 t -61.36 -43.87 98.14 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.051 -0.26 . . . . 15.0 111.26 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.18 -42.5 99.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.472 -0.331 . . . . 15.0 111.066 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.15 -39.56 95.04 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.975 -0.29 . . . . 15.0 111.209 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.0 mt -64.8 -39.35 93.46 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.775 0.287 . . . . 15.0 111.775 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -116.12 129.48 56.35 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.943 0.401 . . . . 15.0 110.866 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -60.74 -41.99 96.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.964 -0.562 . . . . 15.0 111.391 -178.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 56.5 m80 -116.23 140.17 49.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.97 0.414 . . . . 15.0 111.339 -176.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -89.74 -17.99 27.21 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.69 0.626 . . . . 15.0 112.69 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -54.69 -39.13 67.82 Favored 'General case' 0 C--O 1.231 0.09 0 O-C-N 122.172 -0.33 . . . . 15.0 111.148 -177.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -107.34 135.12 49.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.396 -0.366 . . . . 15.0 110.468 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.977 -1.011 . . . . 15.0 110.589 179.866 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.1 ttm . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.328 -0.619 . . . . 15.0 109.328 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -126.05 79.43 69.3 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.11 -0.496 . . . . 15.0 110.173 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.19 152.67 10.64 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.511 1.474 . . . . 15.0 112.214 -174.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -115.12 140.96 48.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.113 -0.494 . . . . 15.0 110.693 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 m -134.36 144.17 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.614 0.721 . . . . 15.0 111.519 176.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.8 tp -105.26 135.08 47.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.91 -1.041 . . . . 15.0 110.381 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.619 HD11 ' CG1' ' A' ' 28' ' ' VAL . 52.5 mt -99.8 133.02 44.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.034 0.445 . . . . 15.0 110.598 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.44 ' SD ' HD13 ' A' ' 63' ' ' LEU . 83.8 mtp -100.7 134.39 43.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.418 -0.81 . . . . 15.0 109.255 170.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -57.39 145.21 33.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.135 0.493 . . . . 15.0 111.222 -170.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.51 175.08 27.03 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.895 -0.882 . . . . 15.0 110.895 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.27 -32.29 71.04 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.817 0.303 . . . . 15.0 111.817 -178.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.96 -177.68 20.6 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.234 -0.746 . . . . 15.0 111.234 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.9 127.99 8.46 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.9 -0.88 . . . . 15.0 110.9 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 52.4 mmt-85 -60.02 -46.61 88.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.221 0.534 . . . . 15.0 109.648 -176.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.09 -40.01 96.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.59 -0.732 . . . . 15.0 111.235 -176.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -60.81 -55.96 26.86 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.758 -0.377 . . . . 15.0 111.258 -175.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.5 mt -61.91 -44.9 95.82 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.735 -0.386 . . . . 15.0 111.132 -176.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.473 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -63.09 -39.7 95.48 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.657 -0.417 . . . . 15.0 110.894 -177.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -60.03 -41.52 92.43 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 121.008 -0.277 . . . . 15.0 110.442 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.4 ttt85 -59.96 -51.55 69.19 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.665 -0.414 . . . . 15.0 111.2 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 70.6 mt -60.79 -36.79 79.89 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.518 -0.473 . . . . 15.0 110.937 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 60.4 ttt85 -61.73 -43.16 99.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.693 0.283 . . . . 15.0 110.727 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.19 -30.56 67.55 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.053 -0.594 . . . . 15.0 111.855 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -88.1 9.93 20.95 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.521 0.934 . . . . 15.0 113.521 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.3 12.83 58.16 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 121.189 -0.529 . . . . 15.0 113.689 173.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.9 t -101.06 136.12 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 118.084 0.942 . . . . 15.0 110.115 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -78.04 132.22 37.67 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.076 -0.713 . . . . 15.0 109.076 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.619 ' CG1' HD11 ' A' ' 7' ' ' ILE . 31.3 t -121.09 133.79 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.247 0.546 . . . . 15.0 111.37 -172.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -140.59 142.11 35.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.285 -0.87 . . . . 15.0 109.648 170.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -115.31 138.6 50.79 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.949 0.404 . . . . 15.0 111.03 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.0 tp -119.07 113.34 35.66 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 118.586 -0.721 . . . . 15.0 109.863 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.19 135.2 59.14 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 121.06 1.173 . . . . 15.0 112.257 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 76.1 mt -60.85 -12.03 9.66 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.089 0.774 . . . . 15.0 113.089 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -77.15 -7.78 56.39 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.271 0.841 . . . . 15.0 113.271 -177.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -61.98 150.3 83.58 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 118.45 0.568 . . . . 15.0 110.478 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.93 154.25 25.9 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.555 1.503 . . . . 15.0 113.119 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.3 151.82 5.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.878 -0.601 . . . . 15.0 111.227 -178.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.98 -38.1 3.22 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.498 -0.641 . . . . 15.0 111.498 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.74 -37.96 86.17 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.64 -0.424 . . . . 15.0 110.974 -177.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.613 ' O ' HG23 ' A' ' 44' ' ' VAL . 22.4 tp -59.05 -48.93 79.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.916 0.389 . . . . 15.0 110.209 -177.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.5 HD22 ' CG ' ' A' ' 70' ' ' ASP . 15.5 tp -64.34 -44.96 89.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.138 -0.483 . . . . 15.0 111.215 -175.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.78 -45.51 93.59 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.626 -0.43 . . . . 15.0 110.78 -175.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.3 ttt85 -62.23 -41.81 98.75 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.855 -0.338 . . . . 15.0 110.856 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 40' ' ' LEU . 96.6 t -60.93 -43.81 96.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.753 -0.379 . . . . 15.0 110.176 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -68.46 -48.66 63.94 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.117 0.414 . . . . 15.0 112.117 -176.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.58 -44.28 78.54 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.94 -0.304 . . . . 15.0 111.53 -175.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -79.47 -10.13 59.74 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.045 0.757 . . . . 15.0 113.045 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 54.84 55.86 7.34 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.607 0.717 . . . . 15.0 110.418 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.532 HD12 HG22 ' A' ' 44' ' ' VAL . 94.1 mt -66.73 148.15 52.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.689 -0.687 . . . . 15.0 111.584 -175.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -95.35 -40.6 9.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.29 -0.868 . . . . 15.0 110.826 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.67 160.32 28.27 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.009 -1.091 . . . . 15.0 113.443 -173.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.4 mt -126.61 141.55 51.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.505 -0.847 . . . . 15.0 109.838 178.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.519 HG22 ' CD1' ' A' ' 80' ' ' PHE . 46.9 t -120.47 131.22 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 121.143 -0.223 . . . . 15.0 110.702 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.403 HG12 ' SD ' ' A' ' 8' ' ' MET . 7.5 m -123.08 145.56 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.158 0.504 . . . . 15.0 110.562 173.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.3 t -97.83 -20.28 17.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.467 -0.788 . . . . 15.0 112.536 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.8 p -155.93 164.44 38.48 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.442 0.639 . . . . 15.0 111.903 -174.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.91 -37.38 70.0 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.173 -0.771 . . . . 15.0 111.173 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -58.35 -45.72 87.63 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.863 -0.335 . . . . 15.0 110.674 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.17 -46.19 94.68 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.468 -1.053 . . . . 15.0 110.468 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.621 HD13 HD21 ' A' ' 79' ' ' LEU . 30.1 tp -56.16 -44.02 78.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.16 0.505 . . . . 15.0 110.831 -177.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.76 -43.1 99.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.039 -0.528 . . . . 15.0 110.672 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -59.03 -39.97 83.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.39 -0.368 . . . . 15.0 110.639 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.44 HD13 ' SD ' ' A' ' 8' ' ' MET . 12.9 tp -57.88 -44.56 86.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.189 0.518 . . . . 15.0 110.243 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -60.92 -47.51 86.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.713 -0.676 . . . . 15.0 110.62 -178.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -61.45 -42.99 99.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.014 -0.539 . . . . 15.0 111.053 -177.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.97 -35.91 81.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.352 -0.385 . . . . 15.0 111.405 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.665 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.0 -39.22 81.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.975 0.417 . . . . 15.0 110.597 178.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.09 -142.81 0.62 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.591 -0.522 . . . . 15.0 109.591 174.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.49 -19.29 46.81 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.384 0.993 . . . . 15.0 112.601 -174.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.5 ' CG ' HD22 ' A' ' 41' ' ' LEU . 20.2 m-20 -91.82 10.46 28.48 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.355 0.872 . . . . 15.0 113.355 -175.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.9 t-105 -47.84 -46.36 62.62 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 118.598 -0.715 . . . . 15.0 112.665 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -44.73 -41.6 14.83 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 121.525 1.484 . . . . 15.0 113.182 177.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -76.93 -48.8 17.13 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 120.616 -0.434 . . . . 15.0 110.841 -178.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.665 HD12 ' HB1' ' A' ' 67' ' ' ALA . 89.8 mt -59.71 -40.17 81.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 15.0 110.808 -176.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.38 -16.65 36.27 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 119.948 -0.362 . . . . 15.0 113.126 -176.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 60.7 mtp85 -65.31 -30.17 71.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.423 0.611 . . . . 15.0 112.025 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.8 mt -73.52 150.51 89.13 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 111.533 0.197 . . . . 15.0 111.533 -172.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.4 126.35 17.52 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.67 1.58 . . . . 15.0 112.513 176.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.621 HD21 HD13 ' A' ' 60' ' ' LEU . 22.5 tp -105.53 125.75 51.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.473 174.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.519 ' CD1' HG22 ' A' ' 53' ' ' VAL . 76.3 m-85 -89.89 125.89 35.51 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.497 -0.557 . . . . 15.0 109.497 175.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.712 HG21 ' HB2' ' A' ' 87' ' ' ALA . 26.4 m -116.82 146.07 36.94 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 119.335 -0.364 . . . . 15.0 110.181 176.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.412 ' HD2' HG11 ' A' ' 86' ' ' VAL . 71.9 Cg_endo -79.21 -22.97 7.98 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.559 1.506 . . . . 15.0 113.582 -176.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.5 p -144.32 161.77 42.98 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 120.649 -0.421 . . . . 15.0 111.575 -172.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -55.9 -44.01 51.52 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 121.165 1.243 . . . . 15.0 111.821 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -57.56 -47.79 81.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.842 0.353 . . . . 15.0 110.773 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.412 HG11 ' HD2' ' A' ' 82' ' ' PRO . 61.7 t -59.76 -40.63 83.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.988 -0.375 . . . . 15.0 109.988 178.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.712 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.64 -41.37 81.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.942 0.401 . . . . 15.0 110.484 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.13 -40.0 92.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.425 . . . . 15.0 110.718 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.0 mmm -58.63 -45.09 90.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.383 0.611 . . . . 15.0 110.073 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.503 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.73 -41.67 97.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.727 -0.669 . . . . 15.0 110.865 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -61.73 -44.7 96.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.262 -0.426 . . . . 15.0 110.591 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -59.7 -36.11 75.87 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.905 -0.318 . . . . 15.0 111.259 -177.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.97 -23.53 65.96 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.357 0.503 . . . . 15.0 112.357 177.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.7 13.27 16.89 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 119.368 -0.684 . . . . 15.0 113.05 -176.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.78 122.01 11.84 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 118.522 1.161 . . . . 15.0 109.952 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -70.32 -35.7 73.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.677 -0.692 . . . . 15.0 111.22 -172.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -130.87 112.67 13.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.073 0.463 . . . . 15.0 110.422 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.6 t -111.7 130.15 65.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.076 -0.511 . . . . 15.0 109.73 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.1 mt -118.95 122.83 70.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.901 -0.59 . . . . 15.0 110.01 -176.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.33 118.86 32.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.401 -0.363 . . . . 15.0 110.255 176.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.8 p -95.16 -9.63 32.89 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.074 0.768 . . . . 15.0 113.074 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -55.46 -39.79 70.81 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 118.161 0.437 . . . . 15.0 110.843 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -94.77 -35.16 5.96 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.475 -0.65 . . . . 15.0 111.475 178.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.75 145.99 44.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.789 0.328 . . . . 15.0 110.46 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.5 m -89.8 158.88 17.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 15.0 110.451 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.66 -54.24 24.53 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 113.093 0.775 . . . . 15.0 113.093 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -57.48 -35.15 98.88 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 CA-C-N 120.383 1.173 . . . . 15.0 111.5 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.62 95.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.065 0.46 . . . . 15.0 110.091 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.8 mt -59.12 -40.62 85.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 15.0 110.361 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.13 -43.8 82.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.386 0.612 . . . . 15.0 110.113 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.21 -40.58 90.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.7 -0.682 . . . . 15.0 110.495 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.21 -41.58 93.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.358 -0.383 . . . . 15.0 110.808 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.2 mt -57.87 -50.83 71.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.218 0.533 . . . . 15.0 110.408 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.9 p -63.18 -41.3 99.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.719 -0.673 . . . . 15.0 111.265 -175.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.4 m -63.25 -43.45 97.97 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.084 -0.246 . . . . 15.0 111.36 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.6 -38.49 87.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.529 -0.305 . . . . 15.0 111.087 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.17 -32.17 70.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.45 -0.341 . . . . 15.0 111.685 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 85.8 mt -55.6 -36.2 66.68 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 121.066 -0.253 . . . . 15.0 111.27 -178.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -56.7 139.13 51.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.964 0.412 . . . . 15.0 110.812 -178.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -136.47 126.72 26.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.923 -0.58 . . . . 15.0 110.113 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -138.05 90.21 2.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.854 0.359 . . . . 15.0 110.96 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -139.35 144.02 38.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 15.0 110.446 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -130.53 135.97 48.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.375 -0.375 . . . . 15.0 110.59 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -122.08 141.43 51.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.166 -0.47 . . . . 15.0 110.401 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.048 -0.977 . . . . 15.0 110.511 179.968 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.4 mmm . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.146 -0.687 . . . . 15.0 109.146 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -126.14 78.04 71.07 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 116.079 -0.509 . . . . 15.0 110.106 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -50.23 151.6 9.18 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.461 1.441 . . . . 15.0 112.101 -174.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.502 ' HB2' HD23 ' A' ' 49' ' ' LEU . 59.7 mttp -117.75 140.36 49.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.162 -0.472 . . . . 15.0 110.802 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.511 HG21 HD13 ' A' ' 21' ' ' LEU . 16.8 m -134.03 144.29 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.542 0.686 . . . . 15.0 111.68 176.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.9 tp -104.21 136.78 43.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.131 -0.941 . . . . 15.0 110.233 178.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.461 HD11 ' CG1' ' A' ' 28' ' ' VAL . 59.9 mt -105.78 135.06 45.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.216 0.531 . . . . 15.0 111.098 -176.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.48 ' HB2' HG12 ' A' ' 54' ' ' VAL . 98.0 mmm -94.43 134.06 37.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.003 -0.998 . . . . 15.0 109.319 171.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -57.55 143.91 39.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.883 0.373 . . . . 15.0 110.673 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.18 175.08 28.57 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.961 -0.856 . . . . 15.0 110.961 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -59.24 -32.27 69.83 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.676 0.25 . . . . 15.0 111.676 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.7 -177.72 24.35 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.934 -0.866 . . . . 15.0 110.934 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.85 119.02 4.89 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.178 -0.769 . . . . 15.0 111.178 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -57.92 -44.57 86.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.303 0.573 . . . . 15.0 110.025 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.47 -42.2 98.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.821 -0.627 . . . . 15.0 111.022 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -57.05 -54.42 46.94 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.959 0.409 . . . . 15.0 110.997 -176.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.8 mt -58.35 -41.67 85.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.391 -0.368 . . . . 15.0 110.696 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.475 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -60.72 -41.92 96.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.362 -0.381 . . . . 15.0 111.573 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.07 -40.84 95.2 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.765 -0.374 . . . . 15.0 110.653 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -59.55 -51.59 69.18 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.437 -0.505 . . . . 15.0 111.054 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.511 HD13 HG21 ' A' ' 5' ' ' VAL . 78.6 mt -63.18 -37.02 85.58 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.61 -0.436 . . . . 15.0 111.069 -178.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -61.53 -43.5 98.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.725 0.297 . . . . 15.0 110.552 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.39 -30.62 68.33 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.954 -0.641 . . . . 15.0 111.933 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.434 ' HB3' HD22 ' A' ' 110' ' ' LEU . 25.2 mt-30 -88.07 9.71 21.64 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.632 0.975 . . . . 15.0 113.632 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.91 14.44 59.37 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 121.205 -0.521 . . . . 15.0 113.482 174.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.0 t -101.12 138.32 25.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 117.904 0.852 . . . . 15.0 110.163 178.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -83.37 136.98 34.14 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.378 -0.601 . . . . 15.0 109.378 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.475 HG11 ' CB ' ' A' ' 18' ' ' ALA . 44.1 t -117.03 133.92 62.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.326 0.584 . . . . 15.0 111.516 -173.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -135.33 125.88 26.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.114 -0.948 . . . . 15.0 109.257 169.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -112.34 132.79 54.8 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.762 0.315 . . . . 15.0 110.362 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 tp -115.83 113.5 42.19 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 118.776 -0.63 . . . . 15.0 110.966 -172.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -51.14 135.1 44.86 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.008 1.138 . . . . 15.0 111.769 173.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.522 HD13 ' OD1' ' A' ' 62' ' ' ASN . 51.3 mt -63.3 -9.23 10.9 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.143 0.794 . . . . 15.0 113.143 -175.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -77.2 -8.79 58.15 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.306 0.854 . . . . 15.0 113.306 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -60.05 150.09 71.71 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 118.417 0.553 . . . . 15.0 110.463 -177.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -80.63 153.14 20.18 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.547 1.498 . . . . 15.0 113.108 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.64 151.33 6.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.924 -0.58 . . . . 15.0 111.221 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.44 -38.06 3.23 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.393 -0.683 . . . . 15.0 111.393 -177.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -61.48 -37.43 83.59 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.658 -0.417 . . . . 15.0 111.068 -177.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.532 ' O ' HG23 ' A' ' 44' ' ' VAL . 24.5 tp -60.23 -47.3 86.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.874 0.368 . . . . 15.0 110.332 -178.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.511 HD22 ' CG ' ' A' ' 70' ' ' ASP . 18.3 tp -62.34 -44.66 95.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.896 -176.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.94 -44.08 97.51 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.714 -0.395 . . . . 15.0 110.773 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -60.07 -43.31 95.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.485 -0.325 . . . . 15.0 110.496 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 40' ' ' LEU . 78.7 t -61.23 -46.91 95.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.911 -0.316 . . . . 15.0 110.277 -177.015 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -67.99 -50.12 57.54 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.261 0.351 . . . . 15.0 111.843 -175.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.83 -44.48 77.12 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.727 0.269 . . . . 15.0 111.727 -173.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -78.73 -10.04 59.63 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.213 0.82 . . . . 15.0 113.213 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 56.43 55.83 6.21 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.6 0.714 . . . . 15.0 110.139 -177.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 44' ' ' VAL . 96.5 mt -70.57 147.84 48.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.609 -0.723 . . . . 15.0 111.029 -176.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -95.69 -40.66 9.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.597 -0.729 . . . . 15.0 110.798 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -149.22 166.9 29.54 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 119.806 -1.187 . . . . 15.0 113.765 -171.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 74.8 mt -126.81 144.47 50.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.627 -0.786 . . . . 15.0 110.155 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.516 HG22 ' CD1' ' A' ' 80' ' ' PHE . 47.7 t -122.69 132.11 71.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 110.181 -0.303 . . . . 15.0 110.181 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.48 HG12 ' HB2' ' A' ' 8' ' ' MET . 7.6 m -128.57 141.16 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 121.152 0.501 . . . . 15.0 110.565 173.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.6 t -99.33 -16.4 18.47 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.564 -0.744 . . . . 15.0 112.674 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 81.5 p -151.02 159.71 44.39 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.281 0.562 . . . . 15.0 111.684 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.5 -39.05 83.52 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.929 -0.868 . . . . 15.0 110.929 178.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -58.99 -44.49 91.62 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.801 -0.359 . . . . 15.0 110.636 -178.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.04 -44.62 97.09 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.559 -1.016 . . . . 15.0 110.559 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.614 HD13 HD21 ' A' ' 79' ' ' LEU . 31.8 tp -57.35 -43.08 83.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.063 0.459 . . . . 15.0 110.578 -179.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.16 -42.44 98.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.116 -0.493 . . . . 15.0 110.734 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.522 ' OD1' HD13 ' A' ' 33' ' ' LEU . 26.2 m120 -59.34 -41.63 89.62 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.849 -0.34 . . . . 15.0 110.54 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.436 ' CD1' HD21 ' A' ' 40' ' ' LEU . 13.9 tp -58.39 -44.1 88.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.222 0.534 . . . . 15.0 110.237 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -61.61 -48.01 82.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.845 -0.616 . . . . 15.0 110.836 -178.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -61.27 -42.82 99.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.067 -0.515 . . . . 15.0 111.017 -176.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.31 -35.9 81.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.346 -0.388 . . . . 15.0 111.37 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.679 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -58.86 -39.36 81.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.059 0.457 . . . . 15.0 110.665 177.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 58.88 -142.18 0.66 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.68 -0.489 . . . . 15.0 109.68 174.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.66 -18.61 43.32 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.426 1.012 . . . . 15.0 112.62 -175.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.511 ' CG ' HD22 ' A' ' 41' ' ' LEU . 15.7 m-20 -91.9 9.36 33.27 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.331 0.863 . . . . 15.0 113.331 -175.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -47.79 -46.94 63.02 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.63 -0.7 . . . . 15.0 112.532 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -44.72 -40.91 14.66 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 C-N-CA 121.357 1.372 . . . . 15.0 113.252 177.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -76.96 -48.78 17.11 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.996 0.427 . . . . 15.0 110.828 -178.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.679 HD12 ' HB1' ' A' ' 67' ' ' ALA . 91.8 mt -59.84 -40.36 82.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.928 -176.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.0 -13.49 34.39 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 119.877 -0.401 . . . . 15.0 113.197 -176.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 -64.98 -30.61 71.61 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.486 0.643 . . . . 15.0 111.839 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.7 mt -72.52 146.21 88.48 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 119.32 -0.372 . . . . 15.0 110.922 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -61.42 131.15 34.74 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.375 1.383 . . . . 15.0 111.909 175.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.614 HD21 HD13 ' A' ' 60' ' ' LEU . 27.3 tp -107.0 126.97 53.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.581 -0.281 . . . . 15.0 110.697 176.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.516 ' CD1' HG22 ' A' ' 53' ' ' VAL . 83.6 m-85 -89.8 126.79 35.81 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.579 -0.526 . . . . 15.0 109.579 176.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' A' ' 87' ' ' ALA . 30.1 m -119.78 151.35 52.1 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-O 119.513 -0.28 . . . . 15.0 110.602 176.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.412 ' HD2' HG11 ' A' ' 86' ' ' VAL . 72.2 Cg_endo -79.2 -22.83 8.1 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.549 1.499 . . . . 15.0 113.869 -176.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.5 p -147.82 162.73 30.39 Favored Pre-proline 0 CA--C 1.531 0.236 0 C-N-CA 120.388 -0.525 . . . . 15.0 111.802 -171.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.17 -44.12 49.69 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.26 1.307 . . . . 15.0 111.792 176.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -57.05 -48.12 79.3 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.849 0.357 . . . . 15.0 110.765 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.412 HG11 ' HD2' ' A' ' 82' ' ' PRO . 56.6 t -60.22 -39.1 79.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.799 -0.36 . . . . 15.0 110.094 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.469 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -56.92 -41.49 78.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.982 0.42 . . . . 15.0 110.459 178.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -61.08 -41.0 95.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 15.0 110.429 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.0 mmm -58.13 -45.43 87.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.589 0.709 . . . . 15.0 110.195 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.476 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -62.06 -40.76 96.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.608 -0.724 . . . . 15.0 110.935 -178.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -61.85 -44.38 96.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.363 -0.38 . . . . 15.0 110.836 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.3 -36.06 77.01 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.851 -0.34 . . . . 15.0 111.339 -177.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.8 mt -66.13 -23.93 66.58 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.289 0.477 . . . . 15.0 112.289 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.24 13.31 17.82 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 119.406 -0.663 . . . . 15.0 113.171 -176.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.01 122.38 12.89 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.551 1.175 . . . . 15.0 109.852 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -67.94 -36.52 80.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.597 -0.729 . . . . 15.0 111.123 -171.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 58.7 ttt85 -131.82 117.54 18.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.956 0.408 . . . . 15.0 110.567 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.55 130.13 69.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.925 0.393 . . . . 15.0 110.038 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 90.6 mt -119.68 124.16 72.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.902 -0.59 . . . . 15.0 110.299 -177.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -92.88 114.85 27.52 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.907 -0.405 . . . . 15.0 109.907 174.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.483 ' HB2' HD11 ' A' ' 109' ' ' LEU . 31.8 p -81.44 -13.95 57.64 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.95 0.722 . . . . 15.0 112.95 -178.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -54.74 -38.74 67.52 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 122.082 -0.386 . . . . 15.0 111.001 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.53 -35.01 8.13 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.644 -0.583 . . . . 15.0 111.644 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.98 122.38 34.44 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.83 0.348 . . . . 15.0 110.81 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 48.8 m -65.42 161.98 18.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.634 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.63 -54.2 24.71 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 118.49 -0.767 . . . . 15.0 113.033 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.38 -35.99 96.8 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 CA-C-N 120.564 1.237 . . . . 15.0 111.384 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.32 -42.11 94.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.027 0.441 . . . . 15.0 110.125 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' A' ' 101' ' ' CYS . 82.8 mt -59.0 -40.42 84.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.062 0.458 . . . . 15.0 110.57 178.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.434 HD22 ' HB3' ' A' ' 24' ' ' GLN . 39.8 tp -57.21 -44.52 83.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.408 0.623 . . . . 15.0 110.053 178.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.21 -39.57 87.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.587 -0.733 . . . . 15.0 110.538 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.48 -41.48 94.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.443 -0.344 . . . . 15.0 110.917 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.0 mt -57.9 -51.16 70.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.161 0.505 . . . . 15.0 110.443 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.6 p -63.61 -40.24 96.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.67 -0.695 . . . . 15.0 111.323 -175.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.9 p -66.34 -38.6 88.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.724 0.297 . . . . 15.0 111.336 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.3 96.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.495 -0.321 . . . . 15.0 110.82 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.9 -39.7 86.26 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.478 -0.328 . . . . 15.0 110.616 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 86.7 mt -62.6 -35.65 80.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.417 -0.356 . . . . 15.0 111.232 178.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -54.82 -35.91 64.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.551 0.215 . . . . 15.0 111.339 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -111.38 138.2 48.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.766 0.317 . . . . 15.0 110.416 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -118.54 133.07 56.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.26 -0.427 . . . . 15.0 110.448 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -113.87 130.44 56.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.2 -0.454 . . . . 15.0 110.581 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -60.46 -41.73 94.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 15.0 110.579 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -55.17 -39.33 69.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.143 -0.48 . . . . 15.0 111.037 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.009 -0.996 . . . . 15.0 110.581 179.929 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.3 mtp . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.308 -0.627 . . . . 15.0 109.308 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -128.08 78.42 75.37 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.234 -0.439 . . . . 15.0 110.126 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.1 150.27 10.62 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.504 1.469 . . . . 15.0 112.179 -174.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.497 ' HB2' HD23 ' A' ' 49' ' ' LEU . 61.3 mttp -117.0 140.71 49.16 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.22 -0.446 . . . . 15.0 110.858 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.512 HG21 HD13 ' A' ' 21' ' ' LEU . 15.7 m -134.28 144.62 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.567 0.698 . . . . 15.0 111.67 175.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.6 tp -104.27 137.51 42.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.078 -0.965 . . . . 15.0 110.326 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.617 HD11 ' CG1' ' A' ' 28' ' ' VAL . 52.5 mt -102.47 134.12 44.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.005 0.431 . . . . 15.0 111.025 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.532 ' HB2' HG12 ' A' ' 54' ' ' VAL . 98.4 mmm -95.01 134.15 38.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.221 -0.9 . . . . 15.0 109.307 171.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -57.65 144.63 37.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.948 0.404 . . . . 15.0 110.678 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -161.68 175.15 38.25 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.801 -0.92 . . . . 15.0 110.801 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.94 -34.72 60.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.536 0.208 . . . . 15.0 111.486 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.81 162.94 29.83 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.9 -0.88 . . . . 15.0 110.9 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.93 130.92 10.1 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.232 -0.747 . . . . 15.0 111.232 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -57.13 -43.82 82.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.985 0.421 . . . . 15.0 110.359 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.23 -43.01 99.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.046 -0.525 . . . . 15.0 111.333 -176.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -61.52 -56.09 23.87 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.858 -0.337 . . . . 15.0 111.341 -176.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.4 mt -60.66 -43.45 97.6 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.708 -0.397 . . . . 15.0 111.031 -176.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.78 -39.4 94.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.389 -0.369 . . . . 15.0 110.92 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -60.76 -43.01 98.53 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.905 -0.318 . . . . 15.0 110.482 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.487 ' NH2' ' HB3' ' A' ' 106' ' ' ALA . 15.6 tpt180 -61.19 -51.57 68.43 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.421 -0.511 . . . . 15.0 110.943 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.512 HD13 HG21 ' A' ' 5' ' ' VAL . 69.2 mt -62.61 -36.97 84.48 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.515 -0.474 . . . . 15.0 110.999 -178.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -63.05 -43.31 99.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.618 0.247 . . . . 15.0 111.045 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.96 -30.59 66.79 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.035 -0.602 . . . . 15.0 111.932 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.408 ' HB3' HD22 ' A' ' 110' ' ' LEU . 25.1 mt-30 -88.09 9.87 21.12 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.494 0.924 . . . . 15.0 113.494 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.27 14.69 58.48 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 121.258 -0.496 . . . . 15.0 113.501 174.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.0 t -101.1 139.07 23.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 117.857 0.828 . . . . 15.0 110.22 178.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -84.45 134.08 34.47 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.04 -0.726 . . . . 15.0 109.04 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.617 ' CG1' HD11 ' A' ' 7' ' ' ILE . 22.4 t -119.59 133.96 64.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.229 0.537 . . . . 15.0 111.353 -173.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -137.84 136.3 37.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.469 -0.787 . . . . 15.0 109.591 172.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.443 ' HB3' HD12 ' A' ' 7' ' ' ILE . 33.7 p90 -115.37 140.93 48.69 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.793 0.33 . . . . 15.0 110.827 -178.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.1 tp -119.3 113.43 35.28 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-O 118.741 -0.647 . . . . 15.0 110.715 -175.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.17 135.08 63.36 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 121.168 1.246 . . . . 15.0 111.964 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.681 HD13 ' OD1' ' A' ' 62' ' ' ASN . 50.3 mt -62.53 -9.14 7.72 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.358 0.873 . . . . 15.0 113.358 -175.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -77.09 -9.5 58.78 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.18 0.807 . . . . 15.0 113.18 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -60.78 149.18 80.85 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 118.292 0.496 . . . . 15.0 110.251 -178.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.97 154.18 25.7 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.53 1.487 . . . . 15.0 112.968 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.23 150.77 5.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.955 -0.566 . . . . 15.0 111.163 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.95 -37.65 3.39 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.439 -0.664 . . . . 15.0 111.439 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.89 -36.9 80.41 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.594 -0.442 . . . . 15.0 111.103 -177.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 44' ' ' VAL . 23.2 tp -58.97 -45.99 89.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.379 . . . . 15.0 110.201 -178.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.612 HD22 ' OD1' ' A' ' 70' ' ' ASP . 10.2 tp -62.65 -45.35 93.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.209 -0.45 . . . . 15.0 110.803 -177.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.74 -43.59 98.56 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.731 -0.388 . . . . 15.0 110.852 -176.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -60.52 -43.9 96.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.558 -0.292 . . . . 15.0 110.522 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.563 ' HA ' HD12 ' A' ' 49' ' ' LEU . 78.3 t -61.18 -46.38 96.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.774 -0.37 . . . . 15.0 110.214 -176.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -68.41 -51.04 48.25 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.348 0.405 . . . . 15.0 112.025 -175.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.83 -44.37 81.26 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.736 0.273 . . . . 15.0 111.736 -173.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -79.37 -10.17 59.75 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.06 0.763 . . . . 15.0 113.06 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.7 mtp180 55.39 55.81 7.0 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.658 0.742 . . . . 15.0 110.273 -177.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.563 HD12 ' HA ' ' A' ' 44' ' ' VAL . 94.8 mt -70.72 146.22 50.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.643 -0.708 . . . . 15.0 111.296 -174.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -93.45 -40.6 10.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.408 -0.814 . . . . 15.0 110.876 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.86 165.11 29.23 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 119.943 -1.122 . . . . 15.0 113.785 -173.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 74.2 mt -125.62 142.16 51.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.466 -0.867 . . . . 15.0 109.837 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.526 HG22 ' CD1' ' A' ' 80' ' ' PHE . 47.6 t -120.49 129.55 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 110.261 -0.274 . . . . 15.0 110.261 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.532 HG12 ' HB2' ' A' ' 8' ' ' MET . 10.5 m -128.27 133.39 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.873 0.368 . . . . 15.0 110.095 172.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.5 p -99.38 -4.22 32.09 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.998 0.74 . . . . 15.0 112.998 177.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 82.7 p -152.46 154.92 36.49 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.366 0.603 . . . . 15.0 111.793 -176.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.03 -38.92 88.43 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.986 -0.846 . . . . 15.0 110.986 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -57.41 -46.14 83.83 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 122.63 -0.336 . . . . 15.0 110.638 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.32 -44.37 96.6 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.7 -0.96 . . . . 15.0 110.7 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.628 HD13 HD21 ' A' ' 79' ' ' LEU . 36.5 tp -57.19 -45.27 83.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.123 0.487 . . . . 15.0 110.597 -178.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.35 -42.13 98.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.029 -0.532 . . . . 15.0 110.818 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.681 ' OD1' HD13 ' A' ' 33' ' ' LEU . 32.7 m120 -60.06 -40.48 89.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.523 -0.308 . . . . 15.0 110.669 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.1 tp -58.42 -44.35 89.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.142 0.496 . . . . 15.0 110.149 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -60.96 -47.35 86.86 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.801 -0.636 . . . . 15.0 110.719 -178.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.43 -43.02 99.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.089 -0.505 . . . . 15.0 111.116 -176.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.3 mt -66.26 -35.44 80.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.354 -0.385 . . . . 15.0 111.375 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.676 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.03 -39.0 80.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.095 0.474 . . . . 15.0 110.672 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.02 -142.89 0.62 Allowed 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.691 -0.485 . . . . 15.0 109.691 174.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.56 -19.77 50.94 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.38 0.991 . . . . 15.0 112.697 -174.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.612 ' OD1' HD22 ' A' ' 41' ' ' LEU . 78.4 m-20 -91.9 11.04 26.29 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.307 0.854 . . . . 15.0 113.307 -175.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 55.0 t-105 -47.83 -46.67 63.01 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-O 118.555 -0.736 . . . . 15.0 112.521 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -44.56 -41.09 14.22 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.498 1.465 . . . . 15.0 113.198 177.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -76.93 -48.83 17.05 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.944 0.402 . . . . 15.0 110.849 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.676 HD12 ' HB1' ' A' ' 67' ' ' ALA . 91.3 mt -59.92 -39.82 81.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 15.0 110.871 -176.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.21 -14.6 33.68 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 119.898 -0.39 . . . . 15.0 113.092 -176.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -64.15 -30.36 71.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.404 0.602 . . . . 15.0 111.963 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.0 mt -75.36 150.57 85.07 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 120.939 -0.305 . . . . 15.0 111.53 -173.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -61.98 128.35 23.94 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.675 1.584 . . . . 15.0 112.457 176.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.628 HD21 HD13 ' A' ' 60' ' ' LEU . 22.1 tp -107.64 126.31 52.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.313 -0.403 . . . . 15.0 110.474 174.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.526 ' CD1' HG22 ' A' ' 53' ' ' VAL . 75.7 m-85 -90.52 125.65 35.67 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.599 -0.519 . . . . 15.0 109.599 176.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.661 HG21 ' HB2' ' A' ' 87' ' ' ALA . 26.1 m -116.99 147.78 40.83 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 110.154 -0.313 . . . . 15.0 110.154 176.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.24 -24.76 6.36 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.634 1.556 . . . . 15.0 113.538 -174.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.8 p -142.78 162.3 44.7 Favored Pre-proline 0 CA--C 1.531 0.213 0 C-N-CA 120.611 -0.436 . . . . 15.0 111.658 -171.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.0 -44.04 50.96 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.21 1.273 . . . . 15.0 111.841 176.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -58.25 -47.06 84.75 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.915 -0.314 . . . . 15.0 110.737 -177.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.6 t -60.2 -41.02 85.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 110.003 -0.369 . . . . 15.0 110.003 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.661 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.74 -42.35 83.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.925 0.393 . . . . 15.0 110.509 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -61.43 -41.8 97.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 15.0 110.563 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 87.1 mtp -59.17 -43.88 92.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.211 0.529 . . . . 15.0 110.268 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.52 94.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.889 -0.596 . . . . 15.0 110.792 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -61.24 -44.39 97.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.274 -0.421 . . . . 15.0 110.566 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.05 -36.15 76.69 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.868 -0.333 . . . . 15.0 111.244 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.1 mt -64.24 -25.94 68.28 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.019 0.378 . . . . 15.0 112.019 176.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.27 13.32 15.49 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 119.313 -0.715 . . . . 15.0 113.045 -176.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.97 122.4 12.91 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.521 1.16 . . . . 15.0 109.91 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -69.9 -35.95 75.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.705 -0.68 . . . . 15.0 111.223 -172.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -131.07 112.63 13.06 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.042 0.449 . . . . 15.0 110.398 178.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.0 t -111.0 130.23 64.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.183 -0.462 . . . . 15.0 109.901 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 84.6 mt -119.3 125.23 74.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.832 -0.622 . . . . 15.0 110.081 -177.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -95.33 118.12 31.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.401 -0.363 . . . . 15.0 110.261 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 32.0 p -95.76 -4.16 44.51 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.184 0.809 . . . . 15.0 113.184 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.1 tpt85 -55.6 -39.54 70.89 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.086 0.403 . . . . 15.0 110.712 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -95.79 -35.14 5.71 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.532 -0.627 . . . . 15.0 111.532 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.64 137.27 40.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.823 0.344 . . . . 15.0 110.68 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.2 p -83.87 164.49 19.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 15.0 110.665 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.487 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . . . -47.72 -54.3 24.33 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 113.018 0.748 . . . . 15.0 113.018 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.49 -36.0 97.19 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 CA-C-N 120.469 1.203 . . . . 15.0 111.394 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.47 -42.89 97.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.114 0.483 . . . . 15.0 110.103 178.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.3 mt -59.0 -41.2 87.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 15.0 110.414 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.408 HD22 ' HB3' ' A' ' 24' ' ' GLN . 34.3 tp -57.61 -44.55 85.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.37 0.605 . . . . 15.0 110.183 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.78 94.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.673 -0.694 . . . . 15.0 110.514 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.7 -41.08 94.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.416 -0.356 . . . . 15.0 110.811 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.4 mt -57.69 -51.76 68.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.233 0.539 . . . . 15.0 110.459 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.0 p -64.04 -40.57 96.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.647 -0.706 . . . . 15.0 111.33 -175.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.9 m -63.42 -42.86 98.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.732 0.301 . . . . 15.0 111.46 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.64 -39.27 93.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.446 -0.343 . . . . 15.0 111.049 -178.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.75 -36.81 77.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.555 -0.293 . . . . 15.0 111.14 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 89.5 mt -61.26 -37.84 84.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.679 -0.237 . . . . 15.0 111.194 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -105.44 128.31 53.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.804 0.335 . . . . 15.0 110.896 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -99.6 -34.47 10.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 15.0 111.307 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -120.75 129.37 53.59 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.879 0.371 . . . . 15.0 110.762 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -58.69 -38.57 78.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.006 -0.543 . . . . 15.0 111.006 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -53.38 -37.12 62.13 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.35 -0.387 . . . . 15.0 111.435 -177.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -112.37 137.53 50.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.834 0.35 . . . . 15.0 110.653 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.986 -1.007 . . . . 15.0 110.542 -179.939 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.4 mmm . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.212 -0.662 . . . . 15.0 109.212 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -125.71 81.54 65.09 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 116.193 -0.458 . . . . 15.0 110.179 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -56.42 152.87 37.39 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.393 1.395 . . . . 15.0 112.0 -175.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -110.78 139.0 46.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.383 -0.371 . . . . 15.0 110.687 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.497 HG21 HD13 ' A' ' 21' ' ' LEU . 13.2 m -135.72 142.74 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.596 0.713 . . . . 15.0 111.695 176.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.497 HD13 ' HD3' ' A' ' 43' ' ' ARG . 18.3 tp -104.77 135.35 46.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.863 -1.062 . . . . 15.0 110.129 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.576 HD11 ' CG1' ' A' ' 28' ' ' VAL . 57.5 mt -104.75 133.74 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.19 0.519 . . . . 15.0 110.888 -176.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 98.4 mmm -95.2 134.06 38.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.062 -0.972 . . . . 15.0 109.488 173.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -62.09 143.99 55.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.886 0.374 . . . . 15.0 110.677 -178.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.57 175.07 32.83 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.108 -0.797 . . . . 15.0 111.108 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.59 -33.31 66.08 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.576 0.214 . . . . 15.0 111.576 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.4 -178.28 4.6 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.963 -0.855 . . . . 15.0 110.963 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.04 112.6 3.67 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.05 -0.82 . . . . 15.0 111.05 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -56.83 -45.85 82.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.308 0.575 . . . . 15.0 110.146 -177.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.77 -44.31 93.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.694 -0.684 . . . . 15.0 111.122 -177.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -56.61 -53.83 53.06 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.805 -0.358 . . . . 15.0 111.281 -175.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.448 ' H ' HD12 ' A' ' 17' ' ' LEU . 5.9 mp -59.88 -43.21 94.87 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 120.649 -0.42 . . . . 15.0 110.883 -177.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.89 -42.52 98.14 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.752 -0.379 . . . . 15.0 111.48 -177.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.21 -39.16 89.2 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.776 -0.37 . . . . 15.0 110.846 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -60.23 -51.49 69.34 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.273 -0.571 . . . . 15.0 111.133 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.497 HD13 HG21 ' A' ' 5' ' ' VAL . 80.3 mt -62.89 -38.68 91.87 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.499 -0.48 . . . . 15.0 111.008 -177.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -64.0 -43.64 95.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.574 0.226 . . . . 15.0 110.955 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.24 -30.56 67.7 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.032 -0.604 . . . . 15.0 112.026 -178.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -88.14 9.76 21.63 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.52 0.933 . . . . 15.0 113.52 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.68 16.45 52.05 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 121.12 -0.562 . . . . 15.0 113.444 173.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.06 138.84 23.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 117.784 0.792 . . . . 15.0 110.058 177.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -78.29 125.41 29.32 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.059 -0.719 . . . . 15.0 109.059 177.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.576 ' CG1' HD11 ' A' ' 7' ' ' ILE . 41.3 t -117.63 131.65 69.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.132 0.492 . . . . 15.0 111.03 -172.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -137.61 131.79 32.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.611 -0.722 . . . . 15.0 109.77 171.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.402 ' HB3' HD12 ' A' ' 7' ' ' ILE . 11.2 p90 -114.62 134.55 54.97 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.217 -0.29 . . . . 15.0 110.217 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.2 tp -111.34 140.26 22.79 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 119.162 -0.446 . . . . 15.0 110.373 -174.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -72.11 135.13 24.49 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.219 1.279 . . . . 15.0 111.11 170.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.601 HD13 ' OD1' ' A' ' 62' ' ' ASN . 53.0 mt -63.21 -9.25 10.5 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.122 0.786 . . . . 15.0 113.122 -175.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -77.27 -10.25 59.31 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.263 0.838 . . . . 15.0 113.263 -177.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -62.46 151.07 83.98 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 118.552 0.614 . . . . 15.0 110.855 -177.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -79.11 155.49 25.89 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.479 1.453 . . . . 15.0 113.1 -177.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.24 150.73 8.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.875 -0.602 . . . . 15.0 111.072 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.98 -36.28 4.21 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.514 -0.634 . . . . 15.0 111.514 -177.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -59.54 -40.05 85.94 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 120.498 -0.481 . . . . 15.0 110.697 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.574 ' O ' HG23 ' A' ' 44' ' ' VAL . 23.7 tp -61.13 -47.97 83.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.963 0.411 . . . . 15.0 110.458 -177.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.485 HD13 ' CB ' ' A' ' 70' ' ' ASP . 19.0 tp -61.25 -43.44 98.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 15.0 110.888 -175.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.12 -46.01 90.92 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.782 -0.367 . . . . 15.0 110.84 -175.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.497 ' HD3' HD13 ' A' ' 6' ' ' LEU . 46.9 ttt85 -61.1 -41.87 97.47 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.635 -0.426 . . . . 15.0 110.567 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 40' ' ' LEU . 94.4 t -58.78 -45.59 91.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.753 -0.379 . . . . 15.0 110.022 -177.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -70.59 -50.94 31.93 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.503 0.502 . . . . 15.0 112.275 -176.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.75 -44.4 86.03 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.067 0.395 . . . . 15.0 112.067 -172.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.6 mp0 -89.11 -7.03 56.56 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.391 0.886 . . . . 15.0 113.391 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.8 ttt-85 57.97 56.05 4.92 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.662 0.744 . . . . 15.0 109.829 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.456 HD12 HG22 ' A' ' 44' ' ' VAL . 95.9 mt -60.61 142.69 55.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.595 -0.73 . . . . 15.0 110.891 -175.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -90.56 -40.56 11.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.481 -0.781 . . . . 15.0 110.822 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -149.57 163.57 29.31 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.079 -1.058 . . . . 15.0 113.498 -174.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.4 mt -126.27 141.06 52.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.433 -0.883 . . . . 15.0 109.903 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.555 HG22 ' CD1' ' A' ' 80' ' ' PHE . 47.4 t -120.83 131.31 73.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 110.294 -0.262 . . . . 15.0 110.294 -179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.6 m -124.14 130.55 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.134 0.493 . . . . 15.0 110.374 172.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.6 m -87.17 -19.45 28.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.586 -0.734 . . . . 15.0 112.514 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.8 p -151.86 161.04 43.29 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.336 0.588 . . . . 15.0 111.509 -175.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.35 -39.17 82.24 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.992 -0.843 . . . . 15.0 110.992 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -57.93 -45.9 85.85 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.864 -0.334 . . . . 15.0 110.563 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.63 -43.96 97.27 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.734 -0.947 . . . . 15.0 110.734 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.607 HD13 HD21 ' A' ' 79' ' ' LEU . 40.2 tp -57.48 -43.99 84.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.023 0.439 . . . . 15.0 110.559 -178.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.03 -42.17 97.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.077 -0.51 . . . . 15.0 110.641 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.601 ' OD1' HD13 ' A' ' 33' ' ' LEU . 25.9 m120 -59.51 -40.72 87.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.444 -0.344 . . . . 15.0 110.635 178.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.9 tp -58.61 -44.54 89.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.135 0.493 . . . . 15.0 110.114 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -61.29 -47.26 86.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.852 -0.613 . . . . 15.0 110.703 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -61.36 -42.93 99.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.086 -0.506 . . . . 15.0 111.102 -176.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.7 mt -66.94 -34.95 78.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.34 -0.391 . . . . 15.0 111.478 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.676 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.04 -39.49 82.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.076 0.465 . . . . 15.0 110.601 177.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 58.95 -142.79 0.63 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 109.662 -0.496 . . . . 15.0 109.662 174.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.53 -18.87 44.06 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.417 1.008 . . . . 15.0 112.631 -174.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.485 ' CB ' HD13 ' A' ' 41' ' ' LEU . 16.6 m-20 -91.82 9.65 31.86 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.313 0.857 . . . . 15.0 113.313 -175.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -47.97 -46.62 64.38 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-O 118.559 -0.734 . . . . 15.0 112.521 177.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -44.7 -41.2 14.69 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.481 1.454 . . . . 15.0 113.218 177.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.5 mp0 -77.03 -48.76 17.01 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.688 -0.405 . . . . 15.0 110.755 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.676 HD12 ' HB1' ' A' ' 67' ' ' ALA . 89.8 mt -59.8 -40.2 81.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.279 -0.419 . . . . 15.0 110.858 -176.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.73 -15.14 32.71 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 119.903 -0.387 . . . . 15.0 113.107 -177.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -64.25 -30.61 71.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.417 0.608 . . . . 15.0 111.977 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.5 mt -76.24 150.46 82.9 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 121.065 -0.254 . . . . 15.0 111.397 -173.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.92 128.13 25.68 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 121.695 1.597 . . . . 15.0 112.43 176.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.607 HD21 HD13 ' A' ' 60' ' ' LEU . 22.3 tp -106.68 125.58 51.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 15.0 110.425 174.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.555 ' CD1' HG22 ' A' ' 53' ' ' VAL . 84.2 m-85 -91.56 125.63 36.36 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.607 -0.516 . . . . 15.0 109.607 176.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.695 HG21 ' HB2' ' A' ' 87' ' ' ALA . 28.2 m -116.85 148.06 41.3 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 110.114 -0.328 . . . . 15.0 110.114 176.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.413 ' HD2' HG11 ' A' ' 86' ' ' VAL . 74.9 Cg_endo -79.12 -24.27 6.92 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.486 1.457 . . . . 15.0 113.592 -175.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.4 ' OG ' HG23 ' A' ' 86' ' ' VAL . 27.6 p -143.43 162.06 44.15 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 120.564 -0.454 . . . . 15.0 111.644 -172.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.85 -44.04 51.33 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.241 1.294 . . . . 15.0 111.741 176.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -57.62 -47.87 81.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.8 0.333 . . . . 15.0 110.827 -178.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.413 HG11 ' HD2' ' A' ' 82' ' ' PRO . 52.4 t -59.74 -40.64 83.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.767 -0.373 . . . . 15.0 110.03 178.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.695 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.46 -42.3 82.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.921 0.391 . . . . 15.0 110.488 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.24 -41.87 97.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.147 -0.479 . . . . 15.0 110.465 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 87.0 mtp -59.34 -43.68 92.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.349 0.595 . . . . 15.0 110.384 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.48 -40.07 93.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.916 -0.584 . . . . 15.0 110.77 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -61.23 -44.28 97.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.335 -0.393 . . . . 15.0 110.61 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.95 -36.17 76.51 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.936 -0.306 . . . . 15.0 111.224 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.0 mt -64.09 -25.73 68.23 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.086 0.402 . . . . 15.0 112.086 176.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.57 13.31 17.06 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 119.336 -0.702 . . . . 15.0 113.098 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.02 122.87 14.07 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.534 1.167 . . . . 15.0 109.92 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -69.91 -35.7 74.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.734 -0.666 . . . . 15.0 111.223 -172.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -130.71 113.31 13.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.938 0.399 . . . . 15.0 110.302 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.09 129.52 66.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.236 -0.438 . . . . 15.0 109.9 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.2 mt -120.11 125.72 74.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.81 -0.632 . . . . 15.0 110.163 -176.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -94.39 117.33 29.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.458 -0.337 . . . . 15.0 110.345 175.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 32.0 p -97.0 -1.53 45.33 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.299 0.852 . . . . 15.0 113.299 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -55.53 -39.57 70.72 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 118.182 0.446 . . . . 15.0 110.785 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -95.21 -35.02 5.88 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.53 -0.628 . . . . 15.0 111.53 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.51 138.89 47.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.802 0.334 . . . . 15.0 110.644 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.5 p -85.77 164.9 17.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.094 -0.503 . . . . 15.0 110.529 179.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.68 -54.33 23.94 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 113.0 0.741 . . . . 15.0 113.0 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.69 -34.59 99.02 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 CA-C-N 120.099 1.071 . . . . 15.0 111.718 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.27 -43.31 96.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.104 0.478 . . . . 15.0 109.989 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 78.1 mt -59.31 -40.79 87.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 15.0 110.33 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 40.5 tp -57.13 -44.15 83.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.324 0.583 . . . . 15.0 110.229 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.83 -41.61 96.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.734 -0.667 . . . . 15.0 110.451 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.27 88.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 15.0 110.736 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.3 mt -57.81 -51.88 67.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.201 0.524 . . . . 15.0 110.395 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.7 p -63.69 -40.27 96.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.614 -0.721 . . . . 15.0 111.389 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.4 m -63.34 -43.24 98.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.66 0.267 . . . . 15.0 111.386 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.41 -39.36 93.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.42 -0.355 . . . . 15.0 111.091 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.87 -37.9 77.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.423 -0.353 . . . . 15.0 110.939 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 86.5 mt -61.6 -37.06 82.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.459 -0.337 . . . . 15.0 111.17 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -59.36 -38.25 79.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.59 -0.277 . . . . 15.0 111.248 -177.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -57.96 -43.41 86.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.517 -0.31 . . . . 15.0 111.23 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -56.32 -41.82 76.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.371 -0.377 . . . . 15.0 111.204 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -56.76 -41.78 78.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.453 -0.34 . . . . 15.0 111.067 -178.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -57.12 -45.14 83.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.804 0.335 . . . . 15.0 110.843 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -57.18 -40.0 76.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 15.0 110.85 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.062 -0.97 . . . . 15.0 110.532 179.996 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.4 mtp . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.256 -0.646 . . . . 15.0 109.256 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.94 81.26 70.69 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.213 -0.449 . . . . 15.0 110.125 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.06 155.02 25.23 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.441 1.428 . . . . 15.0 111.921 -175.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -111.95 138.14 48.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.379 -0.373 . . . . 15.0 110.79 179.721 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.51 HG21 HD13 ' A' ' 21' ' ' LEU . 15.0 m -134.56 144.46 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.435 0.636 . . . . 15.0 111.638 176.449 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.1 tp -105.05 137.28 43.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.203 -0.908 . . . . 15.0 110.553 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.608 HD11 ' CG1' ' A' ' 28' ' ' VAL . 54.8 mt -103.16 133.41 47.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.01 0.433 . . . . 15.0 110.679 -177.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.572 ' HB2' HG12 ' A' ' 54' ' ' VAL . 85.5 mtp -106.05 134.43 49.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.31 -0.859 . . . . 15.0 110.197 174.404 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -57.43 144.98 34.4 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.108 0.48 . . . . 15.0 110.772 -177.622 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.35 175.16 36.29 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.763 -0.935 . . . . 15.0 110.763 -178.001 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.01 -32.68 47.97 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.681 0.252 . . . . 15.0 111.681 -179.287 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.95 -179.5 39.9 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.042 -0.823 . . . . 15.0 111.042 -178.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.01 113.98 3.88 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.156 -0.778 . . . . 15.0 111.156 -178.516 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -56.62 -47.66 79.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.119 0.485 . . . . 15.0 110.498 -179.453 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.38 -40.52 97.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 15.0 110.904 -178.646 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -57.46 -54.41 47.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.113 0.482 . . . . 15.0 110.764 -176.174 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.889 HD21 HG11 ' A' ' 53' ' ' VAL . 15.8 tp -57.88 -43.09 85.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 15.0 110.598 -179.004 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.37 -45.5 84.35 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.695 -0.402 . . . . 15.0 111.101 -178.02 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -59.81 -40.58 88.9 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.772 -0.371 . . . . 15.0 110.658 -176.835 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.1 mmt85 -59.76 -51.43 69.77 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.299 -0.56 . . . . 15.0 111.358 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.51 HD13 HG21 ' A' ' 5' ' ' VAL . 86.2 mt -62.61 -35.7 80.41 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.541 -0.464 . . . . 15.0 111.108 -176.442 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -64.19 -43.35 95.35 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.918 -0.313 . . . . 15.0 111.127 177.076 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.78 -30.63 66.3 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.008 -0.615 . . . . 15.0 112.066 -178.273 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -88.2 8.71 25.81 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.66 0.985 . . . . 15.0 113.66 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.73 17.62 56.24 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 121.233 -0.508 . . . . 15.0 113.245 175.391 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.0 t -101.12 140.25 20.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 117.745 0.772 . . . . 15.0 109.861 177.475 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -80.57 127.73 32.79 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.118 -0.697 . . . . 15.0 109.118 178.245 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.608 ' CG1' HD11 ' A' ' 7' ' ' ILE . 43.1 t -116.89 131.39 69.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.208 0.528 . . . . 15.0 111.025 -172.902 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -134.89 135.33 41.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.367 -0.833 . . . . 15.0 109.293 172.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.566 ' HB3' HD12 ' A' ' 7' ' ' ILE . 9.1 p90 -120.65 133.53 55.36 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.773 0.32 . . . . 15.0 110.7 -176.515 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.7 tp -117.01 141.5 28.47 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 116.14 -0.482 . . . . 15.0 110.004 -174.339 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -72.07 135.07 24.46 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.418 1.412 . . . . 15.0 111.699 170.149 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.423 HD13 ' OD1' ' A' ' 62' ' ' ASN . 74.7 mt -61.7 -10.0 7.61 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.943 0.72 . . . . 15.0 112.943 179.305 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -77.21 -10.87 59.68 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.191 0.811 . . . . 15.0 113.191 -177.209 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -62.7 148.96 90.29 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 118.512 0.596 . . . . 15.0 110.824 -177.885 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.1 159.03 37.68 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.574 1.516 . . . . 15.0 113.225 -174.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.04 152.43 5.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.729 -0.669 . . . . 15.0 111.061 -178.759 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.28 -35.69 4.24 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.487 -0.645 . . . . 15.0 111.487 -176.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -59.47 -39.01 82.29 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 117.094 0.447 . . . . 15.0 110.835 -177.617 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.589 ' O ' HG23 ' A' ' 44' ' ' VAL . 22.3 tp -59.3 -48.55 81.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.068 0.461 . . . . 15.0 110.274 -177.731 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.606 HD22 ' OD1' ' A' ' 70' ' ' ASP . 10.1 tp -62.47 -43.01 99.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.091 -0.504 . . . . 15.0 111.091 -175.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.62 -45.97 90.39 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.787 -0.365 . . . . 15.0 110.948 -175.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -61.07 -40.98 95.74 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.71 -0.396 . . . . 15.0 110.55 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 40' ' ' LEU . 84.8 t -59.54 -48.15 88.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 110.013 -0.365 . . . . 15.0 110.013 -177.694 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -68.59 -51.04 46.91 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.681 0.613 . . . . 15.0 112.098 -174.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.56 -44.26 82.77 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.789 0.292 . . . . 15.0 111.789 -173.403 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -82.92 -10.08 58.99 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.14 0.793 . . . . 15.0 113.14 -178.643 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 55.63 55.77 6.87 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.621 0.724 . . . . 15.0 110.112 -177.041 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 44' ' ' VAL . 95.3 mt -66.01 144.89 56.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.611 -0.722 . . . . 15.0 111.493 -173.564 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -93.92 -39.58 10.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.226 -0.897 . . . . 15.0 110.971 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.02 165.75 31.27 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 120.04 -1.076 . . . . 15.0 113.663 -175.808 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.3 mt -128.77 142.7 50.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.578 -0.811 . . . . 15.0 109.445 178.604 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.889 HG11 HD21 ' A' ' 17' ' ' LEU . 45.8 t -120.93 130.53 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 120.757 0.313 . . . . 15.0 110.541 -179.504 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.572 HG12 ' HB2' ' A' ' 8' ' ' MET . 13.9 m -130.4 155.64 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.2 -0.455 . . . . 15.0 110.17 172.129 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.8 t -131.18 12.09 5.07 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.716 0.636 . . . . 15.0 112.716 177.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 81.9 p -154.14 151.52 29.34 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.184 0.516 . . . . 15.0 111.577 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.48 -40.08 91.7 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.599 -1.0 . . . . 15.0 110.599 176.755 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -58.93 -42.03 88.74 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.897 -0.321 . . . . 15.0 110.6 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.48 -46.23 94.75 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.627 -0.989 . . . . 15.0 110.627 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.413 HD13 HD21 ' A' ' 79' ' ' LEU . 29.9 tp -57.54 -43.32 84.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.985 0.421 . . . . 15.0 110.474 -179.246 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.31 -42.25 98.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.474 . . . . 15.0 110.81 -179.501 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.423 ' OD1' HD13 ' A' ' 33' ' ' LEU . 28.5 m120 -59.05 -42.38 90.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.955 0.407 . . . . 15.0 110.412 178.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.2 tp -58.47 -44.16 89.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.125 0.488 . . . . 15.0 110.296 -179.032 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -61.75 -48.32 81.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.942 -0.572 . . . . 15.0 110.762 -177.734 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.41 -42.65 99.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.043 -0.526 . . . . 15.0 111.095 -176.747 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 92.1 mt -67.42 -35.3 78.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.37 -0.377 . . . . 15.0 111.489 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.694 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -58.9 -38.1 78.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.06 0.457 . . . . 15.0 110.665 177.142 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.43 -143.25 0.58 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 109.501 -0.555 . . . . 15.0 109.501 173.655 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.53 -19.5 48.75 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.377 0.989 . . . . 15.0 112.63 -174.721 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.606 ' OD1' HD22 ' A' ' 41' ' ' LEU . 79.4 m-20 -91.91 11.03 26.35 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 113.362 0.875 . . . . 15.0 113.362 -175.179 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 60.4 t-105 -47.9 -46.07 62.83 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-O 118.501 -0.762 . . . . 15.0 112.548 177.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -44.67 -42.71 14.73 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 121.416 1.411 . . . . 15.0 113.271 177.063 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -76.96 -48.73 17.24 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.032 0.444 . . . . 15.0 110.626 -177.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.694 HD12 ' HB1' ' A' ' 67' ' ' ALA . 87.4 mt -59.73 -35.6 60.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.014 -0.539 . . . . 15.0 111.061 -177.162 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.0 -20.64 34.95 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 119.969 -0.35 . . . . 15.0 112.946 -176.772 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -64.08 -30.16 71.25 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.34 0.57 . . . . 15.0 112.347 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.8 mt -62.21 150.49 84.2 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 119.545 -0.264 . . . . 15.0 110.891 -174.491 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.453 ' HB2' HD12 ' A' ' 99' ' ' ILE . 59.0 Cg_endo -73.34 123.12 8.49 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 121.419 1.413 . . . . 15.0 111.669 175.764 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.413 HD21 HD13 ' A' ' 60' ' ' LEU . 26.4 tp -102.46 123.7 46.7 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.906 -0.318 . . . . 15.0 110.581 176.847 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.625 ' CD1' HG22 ' A' ' 53' ' ' VAL . 76.4 m-85 -87.84 125.2 34.33 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.382 -0.599 . . . . 15.0 109.382 175.606 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.663 HG21 ' HB2' ' A' ' 87' ' ' ALA . 27.0 m -117.96 147.82 42.1 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 119.429 -0.319 . . . . 15.0 110.186 176.09 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.405 ' HD2' HG11 ' A' ' 86' ' ' VAL . 94.6 Cg_endo -79.13 -24.43 6.77 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.532 1.488 . . . . 15.0 113.52 -175.11 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.9 p -143.09 161.25 49.23 Favored Pre-proline 0 CA--C 1.531 0.235 0 C-N-CA 120.627 -0.429 . . . . 15.0 111.41 -172.296 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -54.98 -44.05 53.52 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.115 1.21 . . . . 15.0 111.78 176.135 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -57.5 -48.46 79.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.847 0.356 . . . . 15.0 110.613 -177.696 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.405 HG11 ' HD2' ' A' ' 82' ' ' PRO . 55.7 t -59.74 -39.96 81.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.942 0.401 . . . . 15.0 110.043 178.517 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.663 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.22 -41.67 79.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 15.0 110.337 178.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -60.51 -40.55 91.83 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.303 -0.408 . . . . 15.0 110.415 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 96.9 mmm -57.84 -44.53 86.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.562 0.696 . . . . 15.0 110.195 179.052 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.68 -40.69 95.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.566 -0.743 . . . . 15.0 110.77 -179.417 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.445 ' HD3' HG21 ' A' ' 98' ' ' VAL . 29.9 mmt180 -62.54 -42.93 99.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.348 -0.387 . . . . 15.0 111.097 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.0 -36.01 78.36 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.869 -0.332 . . . . 15.0 111.5 -176.629 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.1 mt -66.32 -22.9 66.29 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.272 0.471 . . . . 15.0 112.272 176.539 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.21 13.33 19.7 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 119.378 -0.679 . . . . 15.0 113.051 -176.063 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.89 122.02 11.94 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.504 1.152 . . . . 15.0 109.872 -178.142 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -74.35 -31.71 62.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.509 -0.769 . . . . 15.0 111.642 -171.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -129.38 111.59 12.97 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.996 0.427 . . . . 15.0 110.154 175.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.445 HG21 ' HD3' ' A' ' 91' ' ' ARG . 43.8 t -114.66 131.25 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 15.0 109.861 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.453 HD12 ' HB2' ' A' ' 78' ' ' PRO . 85.1 mt -120.69 124.57 72.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.242 -0.435 . . . . 15.0 110.304 -176.008 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -94.3 118.48 31.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.395 -0.366 . . . . 15.0 110.302 176.381 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.4 p -96.26 -3.97 43.12 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.216 0.821 . . . . 15.0 113.216 -178.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -55.72 -39.55 71.24 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 118.246 0.475 . . . . 15.0 110.776 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -91.53 -35.03 7.09 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.569 -0.612 . . . . 15.0 111.569 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -82.32 132.29 35.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.841 0.353 . . . . 15.0 110.76 -179.135 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.6 p -77.91 167.04 22.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.096 -0.502 . . . . 15.0 110.572 179.126 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.64 -54.4 23.24 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 112.974 0.731 . . . . 15.0 112.974 179.045 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.09 -34.84 98.91 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 CA-C-N 120.213 1.112 . . . . 15.0 111.68 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.93 -43.0 95.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.07 0.462 . . . . 15.0 109.988 177.337 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.8 mt -59.4 -40.11 85.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 15.0 110.522 178.695 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 43.7 tp -56.9 -44.37 82.26 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.39 0.614 . . . . 15.0 110.169 178.515 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.9 -41.11 95.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.589 -0.732 . . . . 15.0 110.491 179.395 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.33 -41.21 93.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.335 -0.393 . . . . 15.0 110.743 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.1 mt -57.88 -50.87 71.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.122 0.487 . . . . 15.0 110.373 -179.163 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.3 p -64.55 -40.98 96.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.657 -0.701 . . . . 15.0 111.374 -175.779 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.0 m -61.94 -42.46 99.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.703 0.287 . . . . 15.0 111.297 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.82 -43.51 98.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.473 -0.33 . . . . 15.0 111.033 -178.51 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.51 95.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.732 0.301 . . . . 15.0 110.835 179.646 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.7 -35.97 82.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.344 -0.389 . . . . 15.0 111.477 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -95.72 129.03 43.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.863 0.363 . . . . 15.0 110.591 -178.409 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -97.51 -28.39 13.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 15.0 112.091 -179.213 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -122.44 114.11 20.27 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.738 0.304 . . . . 15.0 110.671 -178.169 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -142.92 110.52 5.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 15.0 110.482 178.403 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -129.23 129.51 45.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.408 -0.36 . . . . 15.0 110.787 179.577 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -59.17 -40.66 86.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 15.0 110.664 178.139 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.99 -1.005 . . . . 15.0 110.504 -179.57 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 110.315 -0.254 . . . . 2.16 110.315 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.45 155.08 54.7 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.525 1.483 . . . . 0.33 112.026 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -105.4 136.85 44.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.403 -0.362 . . . . 1.24 110.559 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.469 HG21 HD13 ' A' ' 21' ' ' LEU . 13.7 m -134.34 145.18 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.57 0.7 . . . . 0.19 111.753 176.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.424 HD13 ' HD3' ' A' ' 43' ' ' ARG . 13.1 tp -106.03 135.28 47.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.874 -1.057 . . . . 0.19 110.193 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.549 HD11 ' CG1' ' A' ' 28' ' ' VAL . 47.7 mt -103.44 134.68 43.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.242 -0.436 . . . . 0.32 110.275 -178.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.456 ' SD ' HG12 ' A' ' 54' ' ' VAL . 87.0 mtp -96.75 134.02 40.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.148 -0.478 . . . . 1.03 110.438 173.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -59.21 144.3 46.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.297 -0.411 . . . . 2.79 110.705 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.08 175.11 36.07 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.963 -0.855 . . . . 0.5 110.963 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.69 -33.26 54.81 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.579 0.215 . . . . 2.15 111.579 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.78 175.84 33.67 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.915 -0.874 . . . . 0.57 110.915 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.87 117.92 4.9 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.437 -0.665 . . . . 0.54 111.437 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -57.15 -41.72 79.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.84 0.352 . . . . 2.95 110.533 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -61.16 -41.65 97.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 1.91 111.034 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -62.14 -56.09 22.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.856 0.36 . . . . 3.16 111.225 -176.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.25 -42.74 95.95 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.698 -0.401 . . . . 1.76 110.85 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.492 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -62.41 -40.26 95.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.325 -0.398 . . . . 0.36 110.936 -178.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.08 -42.31 94.33 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.918 -0.313 . . . . 1.91 110.502 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -59.88 -51.65 68.81 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 120.568 -0.453 . . . . 3.24 111.256 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.469 HD13 HG21 ' A' ' 5' ' ' VAL . 82.9 mt -62.65 -37.65 87.18 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.538 -0.465 . . . . 0.25 111.025 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -62.83 -43.08 99.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.646 0.26 . . . . 3.51 110.894 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.33 -30.69 68.24 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 121.063 -0.589 . . . . 0.3 111.924 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -88.12 10.44 19.27 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.513 0.931 . . . . 0.39 113.513 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.04 20.23 47.28 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 121.25 -0.5 . . . . 0.25 113.127 174.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -101.04 139.86 21.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 117.552 0.676 . . . . 0.23 110.191 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -81.9 129.15 34.67 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.108 -0.701 . . . . 0.35 109.108 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.549 ' CG1' HD11 ' A' ' 7' ' ' ILE . 40.5 t -119.02 132.2 69.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.289 0.566 . . . . 0.3 111.512 -173.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -137.58 133.58 34.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.13 -0.941 . . . . 1.12 109.271 170.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -115.54 138.26 51.23 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.861 0.362 . . . . 0.58 110.968 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.1 tp -119.13 132.03 24.12 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-O 118.632 -0.699 . . . . 0.43 109.608 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.05 138.77 31.55 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.202 1.268 . . . . 0.47 111.903 174.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.684 HD13 HD22 ' A' ' 62' ' ' ASN . 77.4 mt -60.1 -9.22 2.97 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.397 0.888 . . . . 0.67 113.397 -177.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -77.07 -7.41 55.67 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.262 0.838 . . . . 1.2 113.262 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -63.31 148.71 92.87 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 118.555 0.616 . . . . 0.74 110.357 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -80.3 158.04 22.88 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.556 1.504 . . . . 0.31 113.191 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.12 151.5 4.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.866 -0.606 . . . . 0.24 111.277 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.31 -38.0 3.25 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.599 -0.6 . . . . 0.18 111.599 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -62.22 -37.27 84.72 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 120.595 -0.442 . . . . 1.77 111.09 -177.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.557 ' O ' HG23 ' A' ' 44' ' ' VAL . 24.0 tp -58.84 -48.13 82.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.978 0.418 . . . . 0.33 110.211 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.533 HD22 ' CG ' ' A' ' 70' ' ' ASP . 19.8 tp -64.36 -45.19 88.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.36 111.141 -175.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.83 -44.25 97.21 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.623 -0.431 . . . . 0.25 110.774 -176.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.424 ' HD3' HD13 ' A' ' 6' ' ' LEU . 56.2 ttm-85 -61.13 -42.7 99.02 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.945 -0.302 . . . . 2.57 110.706 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 40' ' ' LEU . 94.4 t -61.23 -45.3 98.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.814 -0.354 . . . . 0.29 110.198 -177.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -67.94 -50.71 54.37 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.352 0.407 . . . . 3.68 111.919 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.04 -44.4 80.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.662 -0.245 . . . . 0.4 111.554 -174.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -78.34 -10.11 59.54 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.968 0.729 . . . . 1.88 112.968 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 54.18 55.86 7.69 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.561 0.696 . . . . 3.6 110.602 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.521 HD12 HG22 ' A' ' 44' ' ' VAL . 93.6 mt -66.35 141.63 57.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.729 -0.669 . . . . 0.28 111.402 -175.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -89.81 -39.77 12.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.251 -0.886 . . . . 0.31 110.611 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.7 159.67 28.09 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.219 -0.991 . . . . 0.19 113.194 -175.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.2 mt -126.27 140.64 52.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.64 -0.78 . . . . 0.19 109.611 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.411 HG22 ' CD1' ' A' ' 80' ' ' PHE . 42.3 t -119.85 131.02 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 121.126 -0.229 . . . . 0.21 110.635 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.456 HG12 ' SD ' ' A' ' 8' ' ' MET . 3.3 m -119.41 131.16 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.25 0.547 . . . . 0.24 110.998 175.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.4 m -71.54 -33.01 68.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.338 -0.846 . . . . 1.41 111.725 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 72.6 p -157.56 169.92 23.59 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.354 0.597 . . . . 0.49 111.767 -173.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.57 -36.62 64.89 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.176 -0.769 . . . . 0.4 111.176 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -59.24 -46.08 89.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.937 0.369 . . . . 2.18 110.68 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.84 -44.29 97.19 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.439 -1.064 . . . . 0.28 110.439 177.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.641 HD13 HD21 ' A' ' 79' ' ' LEU . 30.4 tp -56.34 -44.24 79.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.15 0.5 . . . . 0.35 110.824 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.6 -43.23 99.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.065 -0.516 . . . . 0.45 110.546 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.684 HD22 HD13 ' A' ' 33' ' ' LEU . 84.4 m-20 -58.71 -39.1 79.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.72 110.65 177.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.476 ' CD1' HD21 ' A' ' 40' ' ' LEU . 13.0 tp -57.32 -45.18 84.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.295 0.569 . . . . 0.35 110.192 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -60.47 -47.05 87.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.562 -0.744 . . . . 0.29 110.586 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -61.78 -43.55 98.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.078 -0.51 . . . . 1.25 111.094 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.74 -34.94 78.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.458 -0.337 . . . . 0.25 111.468 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.666 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -58.72 -39.11 79.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.052 0.453 . . . . 0.17 110.684 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.07 -143.74 0.59 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.617 -0.512 . . . . 0.21 109.617 174.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.7 -18.77 45.09 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.367 0.985 . . . . 0.25 112.659 -175.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.533 ' CG ' HD22 ' A' ' 41' ' ' LEU . 21.5 m-20 -91.88 10.13 30.02 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.366 0.876 . . . . 1.09 113.366 -174.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -47.88 -46.62 63.5 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 118.554 -0.736 . . . . 0.21 112.565 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -44.73 -41.39 14.79 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.472 1.448 . . . . 0.25 113.261 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.2 mp0 -77.0 -48.75 17.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.941 0.4 . . . . 1.86 110.795 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.666 HD12 ' HB1' ' A' ' 67' ' ' ALA . 88.0 mt -59.04 -40.6 81.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.136 -0.484 . . . . 0.19 110.76 -176.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.95 -15.66 36.5 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 116.315 -0.402 . . . . 0.19 113.162 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 -64.94 -30.48 71.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.351 0.575 . . . . 2.43 112.032 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 27.3 mt -74.04 150.5 87.98 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 121.077 -0.249 . . . . 0.39 111.519 -173.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.83 126.25 17.01 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.611 1.541 . . . . 0.64 112.349 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.641 HD21 HD13 ' A' ' 60' ' ' LEU . 23.5 tp -104.89 127.34 52.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.345 -0.389 . . . . 0.24 110.578 175.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.411 ' CD1' HG22 ' A' ' 53' ' ' VAL . 70.5 m-85 -92.07 125.29 36.69 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.669 -0.493 . . . . 0.15 109.669 176.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.705 HG21 ' HB2' ' A' ' 87' ' ' ALA . 26.8 m -116.78 145.67 35.99 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-O 119.35 -0.357 . . . . 0.19 110.145 176.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.17 -22.86 8.11 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.531 1.487 . . . . 0.33 113.634 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.408 ' OG ' HG23 ' A' ' 86' ' ' VAL . 25.0 p -143.64 158.38 56.96 Favored Pre-proline 0 C--N 1.331 -0.236 0 C-N-CA 120.693 -0.403 . . . . 0.27 111.25 -171.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.37 -44.09 51.93 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.309 1.339 . . . . 0.43 111.689 176.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -58.12 -47.42 83.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.856 0.36 . . . . 2.99 110.939 -177.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.408 HG23 ' OG ' ' A' ' 83' ' ' SER . 60.2 t -60.12 -39.9 81.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.796 -0.362 . . . . 0.24 110.093 178.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.705 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.43 -41.85 81.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.966 0.413 . . . . 0.2 110.383 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.86 -40.43 92.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.439 . . . . 1.56 110.549 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.0 mmm -58.12 -44.96 88.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.412 0.625 . . . . 1.05 110.061 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.488 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -62.05 -41.16 97.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.695 -0.684 . . . . 0.21 110.792 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 75.9 ttt-85 -61.85 -44.76 96.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.333 -0.394 . . . . 3.12 110.824 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.58 -36.1 77.69 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.925 -0.31 . . . . 2.1 111.348 -177.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.2 mt -65.9 -23.9 66.73 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.241 0.46 . . . . 0.29 112.241 177.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.83 13.3 16.54 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 119.413 -0.659 . . . . 0.22 113.163 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.82 121.98 11.79 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.499 1.149 . . . . 0.19 109.917 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -69.31 -36.01 76.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.629 -0.714 . . . . 0.7 111.24 -171.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -131.59 113.91 14.2 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.024 0.44 . . . . 2.89 110.36 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.9 t -112.53 131.06 65.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.15 -0.477 . . . . 0.2 109.876 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 85.9 mt -119.27 123.33 71.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.856 -0.611 . . . . 0.22 110.026 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -94.93 118.28 31.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.406 -0.361 . . . . 1.13 110.248 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.516 ' HB2' HD11 ' A' ' 109' ' ' LEU . 32.0 p -96.11 -6.56 38.18 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.158 0.799 . . . . 0.34 113.158 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -55.32 -39.83 70.42 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 118.211 0.46 . . . . 3.47 110.812 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -93.72 -35.02 6.3 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.599 -0.6 . . . . 0.65 111.599 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -78.16 132.28 37.56 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.828 0.347 . . . . 0.46 110.632 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.2 m -74.86 162.83 28.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 1.21 110.659 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.76 -54.32 24.36 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 112.891 0.7 . . . . 0.35 112.891 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.94 -34.15 98.99 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 CA-C-N 119.987 1.031 . . . . 0.31 111.692 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.02 -43.07 95.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.037 0.446 . . . . 0.27 109.953 177.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.516 HD11 ' HB2' ' A' ' 101' ' ' CYS . 80.0 mt -59.19 -40.45 85.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.24 110.425 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 37.7 tp -56.98 -43.58 81.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.272 0.558 . . . . 0.22 110.183 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.58 -40.93 93.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.744 -0.662 . . . . 0.25 110.491 178.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.83 -42.19 93.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.328 -0.396 . . . . 0.24 110.684 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.5 mt -57.99 -50.21 74.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.177 0.513 . . . . 0.27 110.427 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.3 p -62.7 -40.89 98.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.798 -0.637 . . . . 0.31 111.231 -175.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.9 t -62.24 -45.15 94.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.766 0.317 . . . . 1.25 111.412 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.59 -38.61 88.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.449 -0.341 . . . . 0.44 111.179 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.473 -0.33 . . . . 0.5 111.368 179.742 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.6 p30 . . . . . 0 CA--C 1.536 0.411 0 N-CA-C 110.405 -0.22 . . . . 15.0 110.405 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.58 155.02 27.87 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.596 1.531 . . . . 15.0 112.065 -177.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.427 ' CB ' HD23 ' A' ' 49' ' ' LEU . 60.0 mttp -113.03 137.36 51.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.307 -0.406 . . . . 15.0 110.581 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.622 HG21 HD13 ' A' ' 21' ' ' LEU . 15.3 m -135.3 145.94 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.563 0.696 . . . . 15.0 111.709 176.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.559 HD12 ' O ' ' A' ' 29' ' ' ASP . 14.0 tp -105.75 136.74 44.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.027 -0.988 . . . . 15.0 110.332 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.415 HD11 ' CG1' ' A' ' 28' ' ' VAL . 61.7 mt -104.52 133.86 47.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.972 0.415 . . . . 15.0 110.695 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.463 ' SD ' HD13 ' A' ' 63' ' ' LEU . 83.7 mtp -101.45 134.46 44.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.279 -0.873 . . . . 15.0 110.714 175.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -57.33 143.33 40.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.129 0.49 . . . . 15.0 110.772 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.86 175.09 29.14 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.852 -0.899 . . . . 15.0 110.852 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.81 -32.54 67.67 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.684 0.253 . . . . 15.0 111.684 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.34 -173.74 22.25 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.033 -0.827 . . . . 15.0 111.033 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.93 114.7 3.99 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.031 -0.828 . . . . 15.0 111.031 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -57.52 -44.84 85.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.273 0.558 . . . . 15.0 110.228 -176.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.99 -41.46 99.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.856 -0.611 . . . . 15.0 111.273 -177.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -60.01 -49.89 75.9 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.861 -0.335 . . . . 15.0 111.085 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.3 mt -57.64 -44.49 85.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.129 0.49 . . . . 15.0 110.43 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.486 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -59.43 -42.27 91.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 15.0 110.688 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -58.53 -41.51 85.67 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.031 -0.268 . . . . 15.0 110.475 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 69.0 mtm180 -59.31 -51.46 69.85 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.447 -0.501 . . . . 15.0 110.878 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.622 HD13 HG21 ' A' ' 5' ' ' VAL . 81.4 mt -61.1 -37.57 83.2 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.519 -0.472 . . . . 15.0 110.988 -177.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.445 ' HG3' HG21 ' A' ' 28' ' ' VAL . 40.2 mtp180 -64.21 -42.49 96.58 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.921 -0.312 . . . . 15.0 111.184 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.0 -30.67 67.04 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.007 -0.616 . . . . 15.0 111.967 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -88.14 8.87 24.87 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.6 0.963 . . . . 15.0 113.6 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.08 17.12 58.26 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 121.235 -0.507 . . . . 15.0 113.234 176.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.7 t -101.03 139.06 23.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 117.748 0.774 . . . . 15.0 109.95 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -78.65 134.64 37.13 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.346 -0.612 . . . . 15.0 109.346 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.486 HG11 ' HB1' ' A' ' 18' ' ' ALA . 48.7 t -119.24 131.55 71.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.345 0.593 . . . . 15.0 111.331 -173.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.559 ' O ' HD12 ' A' ' 6' ' ' LEU . 23.1 t70 -131.59 122.81 26.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.174 -0.921 . . . . 15.0 109.216 170.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -107.88 129.98 55.04 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.904 0.383 . . . . 15.0 110.812 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.3 tp -120.64 113.31 33.42 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 118.892 -0.575 . . . . 15.0 110.672 -175.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.19 135.2 67.85 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.27 1.313 . . . . 15.0 112.372 172.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.757 HD13 HD22 ' A' ' 62' ' ' ASN . 71.1 mt -58.95 -11.87 3.88 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.28 0.844 . . . . 15.0 113.28 -178.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -77.16 -6.22 52.1 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.417 0.895 . . . . 15.0 113.417 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -69.31 150.92 97.09 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 118.558 0.617 . . . . 15.0 110.771 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.63 151.29 32.25 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.616 1.544 . . . . 15.0 113.715 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.76 152.57 3.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.305 -0.861 . . . . 15.0 111.453 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.67 -38.14 3.21 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 115.72 -0.673 . . . . 15.0 111.871 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.3 -37.09 86.26 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 120.323 -0.551 . . . . 15.0 111.103 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.576 ' O ' HG23 ' A' ' 44' ' ' VAL . 24.4 tp -58.75 -47.71 83.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.98 0.419 . . . . 15.0 110.168 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.463 HD13 HD11 ' A' ' 74' ' ' ILE . 16.3 tp -62.65 -45.36 93.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.974 -176.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.9 -45.04 95.46 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.577 -0.449 . . . . 15.0 110.871 -175.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -62.71 -40.05 95.94 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.768 -0.373 . . . . 15.0 111.07 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 40' ' ' LEU . 91.4 t -61.78 -45.24 99.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.807 -0.357 . . . . 15.0 110.289 -178.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -69.56 -47.51 63.42 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.205 0.446 . . . . 15.0 112.205 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.8 -44.27 77.72 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.977 -0.289 . . . . 15.0 111.609 -175.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -79.67 -10.11 59.74 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.053 0.76 . . . . 15.0 113.053 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 56.29 55.93 6.23 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.488 0.661 . . . . 15.0 109.989 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 44' ' ' VAL . 95.7 mt -69.29 145.18 53.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.836 -0.62 . . . . 15.0 111.302 -176.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -92.36 -40.54 10.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.323 -0.853 . . . . 15.0 111.061 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.63 161.87 28.6 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.012 -1.089 . . . . 15.0 113.651 -173.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.2 mt -126.08 144.06 50.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.494 -0.853 . . . . 15.0 109.934 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.533 HG22 ' CD1' ' A' ' 80' ' ' PHE . 46.7 t -120.87 129.91 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 O-C-N 122.353 -0.217 . . . . 15.0 110.712 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.4 HG12 ' SD ' ' A' ' 8' ' ' MET . 10.5 m -124.72 141.43 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-O 121.042 0.449 . . . . 15.0 110.471 172.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.8 m -96.59 -14.16 22.4 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.901 0.704 . . . . 15.0 112.901 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.5 p -157.57 163.25 38.54 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 121.414 0.626 . . . . 15.0 111.914 -174.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.23 -37.3 72.25 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.98 -0.848 . . . . 15.0 110.98 176.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -58.99 -44.98 91.69 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 122.666 -0.314 . . . . 15.0 110.633 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.81 -43.54 97.84 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.476 -1.049 . . . . 15.0 110.476 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.505 HD21 ' HA ' ' A' ' 90' ' ' ALA . 20.8 tp -56.85 -45.1 82.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.145 0.498 . . . . 15.0 110.699 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.64 -43.53 98.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.086 -0.506 . . . . 15.0 110.644 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.757 HD22 HD13 ' A' ' 33' ' ' LEU . 84.0 m-20 -59.08 -39.25 81.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.274 -0.421 . . . . 15.0 110.682 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.463 HD13 ' SD ' ' A' ' 8' ' ' MET . 12.3 tp -57.63 -44.84 85.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.179 0.514 . . . . 15.0 110.061 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -61.09 -47.61 85.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.735 -0.666 . . . . 15.0 110.585 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.88 -43.13 99.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.108 -0.496 . . . . 15.0 111.159 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.92 -35.53 80.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.443 -0.344 . . . . 15.0 111.426 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.657 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.77 -37.91 80.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.029 0.442 . . . . 15.0 110.856 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.51 -144.19 0.55 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 109.51 -0.552 . . . . 15.0 109.51 174.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.53 -19.56 49.14 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.349 0.977 . . . . 15.0 112.575 -174.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.429 ' CG ' HD22 ' A' ' 41' ' ' LEU . 23.3 m-20 -91.9 12.16 22.55 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.32 0.859 . . . . 15.0 113.32 -174.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 -47.79 -46.36 62.05 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 118.551 -0.737 . . . . 15.0 112.587 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -44.72 -41.43 14.76 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 121.417 1.412 . . . . 15.0 113.247 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -77.0 -48.72 17.16 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.544 -0.462 . . . . 15.0 110.836 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.657 HD12 ' HB1' ' A' ' 67' ' ' ALA . 93.0 mt -59.74 -40.45 82.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.451 . . . . 15.0 110.903 -176.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.44 -16.4 35.72 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 116.401 -0.363 . . . . 15.0 113.11 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.1 mtp-105 -64.67 -30.33 71.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.336 0.568 . . . . 15.0 112.027 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 23.4 mt -76.03 150.54 83.46 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 121.028 -0.269 . . . . 15.0 111.58 -172.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -63.22 128.36 22.53 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.628 1.552 . . . . 15.0 112.39 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.9 tp -108.59 127.56 54.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.511 -0.313 . . . . 15.0 110.657 174.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.533 ' CD1' HG22 ' A' ' 53' ' ' VAL . 80.1 m-85 -88.7 127.31 35.58 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.576 -0.527 . . . . 15.0 109.576 176.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.677 HG21 ' HB2' ' A' ' 87' ' ' ALA . 28.1 m -119.16 146.24 40.13 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 110.012 -0.366 . . . . 15.0 110.012 175.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.15 -22.58 8.36 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.608 1.538 . . . . 15.0 113.651 -174.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.417 ' OG ' HG23 ' A' ' 86' ' ' VAL . 24.7 p -143.47 158.2 57.87 Favored Pre-proline 0 CA--C 1.53 0.196 0 C-N-CA 120.645 -0.422 . . . . 15.0 111.263 -171.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.39 -44.0 52.66 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.32 1.347 . . . . 15.0 111.699 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 -58.37 -47.25 84.43 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.858 -0.337 . . . . 15.0 110.926 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.417 HG23 ' OG ' ' A' ' 83' ' ' SER . 60.9 t -59.75 -40.43 82.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.923 0.392 . . . . 15.0 109.965 178.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.677 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.46 -42.75 83.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.002 0.43 . . . . 15.0 110.404 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.31 -40.4 90.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 15.0 110.61 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.0 mmm -58.14 -44.39 87.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.428 0.632 . . . . 15.0 110.159 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.505 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.49 -40.51 94.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.655 -0.702 . . . . 15.0 110.862 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -62.61 -42.9 99.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.346 -0.388 . . . . 15.0 111.028 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.36 -36.16 77.37 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.832 -0.347 . . . . 15.0 111.274 -177.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.99 -22.78 65.9 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.399 0.518 . . . . 15.0 112.399 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 107.99 13.24 20.35 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 119.373 -0.682 . . . . 15.0 113.128 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.76 122.0 11.8 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 118.494 1.147 . . . . 15.0 109.961 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -69.04 -36.43 77.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.573 -0.74 . . . . 15.0 111.141 -171.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -131.79 112.92 12.92 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.152 0.501 . . . . 15.0 110.536 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.0 t -112.19 130.66 65.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.033 -0.531 . . . . 15.0 109.84 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.6 mt -118.46 122.17 68.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.886 -0.597 . . . . 15.0 109.999 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -94.21 116.56 28.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.429 -0.35 . . . . 15.0 110.433 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.9 p -97.07 4.57 51.31 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.162 0.801 . . . . 15.0 113.162 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 36.2 tpt85 -55.94 -39.92 72.42 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 118.187 0.449 . . . . 15.0 110.648 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.15 -35.13 5.39 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.486 -0.646 . . . . 15.0 111.486 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.65 138.58 44.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.847 0.356 . . . . 15.0 110.549 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.7 p -87.04 165.38 15.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 15.0 110.621 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.69 -54.23 24.77 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 118.552 -0.737 . . . . 15.0 112.923 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.54 -35.98 97.38 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 CA-C-N 120.596 1.249 . . . . 15.0 111.414 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.77 95.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.017 0.437 . . . . 15.0 110.051 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.3 mt -59.23 -40.02 84.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 15.0 110.514 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 42.0 tp -57.08 -44.52 83.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.379 0.609 . . . . 15.0 110.084 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.74 -41.16 94.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.627 -0.715 . . . . 15.0 110.488 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.3 -41.36 93.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.314 -0.403 . . . . 15.0 110.78 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.6 mt -57.89 -50.53 73.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.122 0.487 . . . . 15.0 110.401 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.3 p -63.85 -40.39 96.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.715 -0.675 . . . . 15.0 111.381 -175.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.8 p -65.44 -39.42 92.06 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.025 -0.27 . . . . 15.0 111.398 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.28 96.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.508 -0.315 . . . . 15.0 111.088 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.467 -0.333 . . . . 15.0 110.755 179.65 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.535 0.386 0 N-CA-C 110.28 -0.267 . . . . 15.0 110.28 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.41 152.99 7.93 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.433 1.422 . . . . 15.0 111.857 -176.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.443 ' HB2' HD23 ' A' ' 49' ' ' LEU . 94.1 mttt -115.63 139.24 50.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.326 -0.397 . . . . 15.0 110.802 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.2 m -133.76 145.97 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.466 0.65 . . . . 15.0 111.652 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.505 HD13 ' CD ' ' A' ' 43' ' ' ARG . 12.4 tp -105.07 136.5 44.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.048 -0.978 . . . . 15.0 110.375 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.494 HD11 ' CG1' ' A' ' 28' ' ' VAL . 58.2 mt -104.11 135.14 43.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.972 0.415 . . . . 15.0 110.624 -178.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.606 ' HE3' HD21 ' A' ' 33' ' ' LEU . 96.6 mmm -89.34 134.12 34.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.458 -0.792 . . . . 15.0 110.149 174.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -57.64 141.39 48.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.958 0.408 . . . . 15.0 110.551 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.56 175.11 42.0 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.854 -0.898 . . . . 15.0 110.854 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -54.99 -35.22 64.12 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.205 -0.198 . . . . 15.0 111.217 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.23 162.87 7.45 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.861 -0.895 . . . . 15.0 110.861 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.87 123.56 6.34 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.151 -0.78 . . . . 15.0 111.151 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -56.66 -46.57 80.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.058 0.456 . . . . 15.0 110.422 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.32 -39.33 94.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.899 -0.591 . . . . 15.0 111.235 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -61.23 -56.01 25.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.927 0.394 . . . . 15.0 111.027 -175.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.6 mt -61.7 -41.99 98.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.018 0.437 . . . . 15.0 110.663 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.504 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -60.99 -36.28 79.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 15.0 111.182 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.23 -44.95 95.41 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.963 -0.295 . . . . 15.0 110.616 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -59.77 -51.65 68.86 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.084 -0.646 . . . . 15.0 111.252 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.47 -37.32 87.12 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.517 -0.473 . . . . 15.0 111.137 -176.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -64.02 -43.8 94.51 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.14 -0.224 . . . . 15.0 111.048 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.29 -30.63 68.0 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.043 -0.599 . . . . 15.0 111.923 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -88.14 9.9 21.15 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.515 0.932 . . . . 15.0 113.515 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.11 16.12 56.42 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 121.261 -0.495 . . . . 15.0 113.435 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -101.15 139.77 21.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 117.719 0.759 . . . . 15.0 109.98 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -84.93 133.61 34.28 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.483 -0.562 . . . . 15.0 109.483 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.504 HG11 ' CB ' ' A' ' 18' ' ' ALA . 39.4 t -115.12 131.45 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.09 0.471 . . . . 15.0 111.005 -174.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -133.78 128.76 35.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.568 -0.742 . . . . 15.0 109.33 171.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -111.38 134.64 52.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.799 0.333 . . . . 15.0 110.652 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.7 tp -112.83 129.95 23.96 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-O 118.492 -0.766 . . . . 15.0 109.732 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -72.08 139.64 33.06 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 CA-C-N 120.431 1.19 . . . . 15.0 111.676 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.606 HD21 ' HE3' ' A' ' 8' ' ' MET . 18.2 mt -59.38 -9.35 2.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.631 0.974 . . . . 15.0 113.631 -176.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -77.09 -7.07 55.11 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.396 0.888 . . . . 15.0 113.396 -177.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -65.72 145.89 99.01 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 118.618 0.644 . . . . 15.0 110.633 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.74 159.01 21.66 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 121.629 1.552 . . . . 15.0 113.187 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.28 151.27 5.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.839 -0.618 . . . . 15.0 111.294 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.23 -38.09 3.22 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.71 -0.556 . . . . 15.0 111.71 -178.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -61.05 -36.75 80.4 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 120.595 -0.442 . . . . 15.0 111.213 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.57 ' O ' HG23 ' A' ' 44' ' ' VAL . 27.9 tp -59.15 -47.03 86.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.962 0.411 . . . . 15.0 110.254 -178.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.59 HD22 ' OD2' ' A' ' 70' ' ' ASP . 9.3 tp -62.39 -45.74 91.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 15.0 110.86 -176.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.58 -44.22 97.42 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.659 -0.416 . . . . 15.0 110.774 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.505 ' CD ' HD13 ' A' ' 6' ' ' LEU . 57.0 ttm-85 -60.74 -41.81 96.1 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.98 -0.288 . . . . 15.0 110.728 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.578 ' HA ' HD12 ' A' ' 49' ' ' LEU . 96.1 t -60.47 -46.18 95.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.73 -0.388 . . . . 15.0 110.11 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -69.83 -47.7 61.73 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.29 0.478 . . . . 15.0 112.29 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.28 -44.33 79.58 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.03 -0.268 . . . . 15.0 111.538 -174.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -80.34 -10.1 59.75 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.11 0.781 . . . . 15.0 113.11 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 94.2 mtm-85 56.22 55.81 6.38 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.553 0.692 . . . . 15.0 110.111 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.578 HD12 ' HA ' ' A' ' 44' ' ' VAL . 94.6 mt -72.77 146.35 46.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.631 -0.713 . . . . 15.0 111.467 -175.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -94.46 -40.49 9.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.357 -0.838 . . . . 15.0 110.915 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.78 165.53 29.22 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 119.878 -1.153 . . . . 15.0 113.695 -172.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.5 mt -127.89 143.16 51.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.576 -0.812 . . . . 15.0 109.983 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.502 HG22 ' CD1' ' A' ' 80' ' ' PHE . 49.0 t -123.06 133.69 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 110.077 -0.342 . . . . 15.0 110.077 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.434 HG12 ' HG3' ' A' ' 8' ' ' MET . 3.9 m -119.24 126.92 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.185 0.517 . . . . 15.0 110.749 174.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.8 m -68.92 -32.73 72.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.476 -0.784 . . . . 15.0 111.686 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.5 p -155.19 166.28 34.06 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.411 0.624 . . . . 15.0 111.887 -173.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.88 -37.51 70.32 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.217 -0.753 . . . . 15.0 111.217 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -58.66 -46.16 87.78 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.742 -0.383 . . . . 15.0 110.72 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.95 -42.61 99.79 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.841 -0.904 . . . . 15.0 110.841 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.615 HD13 HD21 ' A' ' 79' ' ' LEU . 34.9 tp -57.32 -47.18 82.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.053 0.454 . . . . 15.0 110.594 -178.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.77 -44.62 96.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.134 0.492 . . . . 15.0 110.594 -177.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.463 ' CB ' HD22 ' A' ' 33' ' ' LEU . 78.0 m-20 -59.51 -40.11 86.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 15.0 110.616 178.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.5 tp -56.57 -42.78 79.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.18 0.514 . . . . 15.0 110.195 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -58.55 -46.48 86.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.804 -0.635 . . . . 15.0 110.249 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -60.97 -42.93 99.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.819 -0.628 . . . . 15.0 111.032 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.08 -34.94 78.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.374 -0.375 . . . . 15.0 111.474 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.678 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.31 -38.15 79.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.119 0.485 . . . . 15.0 110.677 177.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.51 -144.43 0.55 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 109.54 -0.541 . . . . 15.0 109.54 173.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.47 -19.57 48.79 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.289 0.95 . . . . 15.0 112.563 -174.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.59 ' OD2' HD22 ' A' ' 41' ' ' LEU . 76.6 m-20 -91.86 10.86 26.94 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.336 0.865 . . . . 15.0 113.336 -174.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -47.83 -47.07 63.42 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 118.544 -0.741 . . . . 15.0 112.536 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -44.78 -40.52 14.58 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 121.422 1.414 . . . . 15.0 113.216 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -76.96 -48.77 17.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.036 0.446 . . . . 15.0 110.735 -177.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.678 HD12 ' HB1' ' A' ' 67' ' ' ALA . 89.1 mt -59.46 -40.11 80.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.511 . . . . 15.0 110.752 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.56 -14.71 36.7 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 116.31 -0.405 . . . . 15.0 113.345 -175.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -65.88 -29.79 70.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.399 0.6 . . . . 15.0 112.037 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.0 mt -74.87 150.02 85.87 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 120.919 -0.312 . . . . 15.0 111.291 -173.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.0 128.27 26.07 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.606 1.537 . . . . 15.0 112.249 176.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.615 HD21 HD13 ' A' ' 60' ' ' LEU . 27.3 tp -105.72 124.91 50.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.387 -0.369 . . . . 15.0 110.497 174.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.502 ' CD1' HG22 ' A' ' 53' ' ' VAL . 69.2 m-85 -91.71 126.54 36.83 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.796 -0.446 . . . . 15.0 109.796 177.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.656 HG21 ' HB2' ' A' ' 87' ' ' ALA . 27.4 m -118.72 146.45 39.99 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-O 119.327 -0.368 . . . . 15.0 110.238 176.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -79.18 -23.49 7.56 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.561 1.507 . . . . 15.0 113.522 -176.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.2 p -143.26 162.78 41.01 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 120.572 -0.451 . . . . 15.0 111.517 -171.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -56.84 -43.97 49.43 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.153 1.236 . . . . 15.0 111.821 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -57.57 -48.15 80.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.882 0.372 . . . . 15.0 110.712 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.5 t -60.37 -39.4 80.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.813 -0.355 . . . . 15.0 110.118 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.656 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.31 -41.43 79.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.931 0.396 . . . . 15.0 110.373 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.18 -40.22 93.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.29 -0.414 . . . . 15.0 110.603 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.1 mmm -58.53 -44.53 89.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.378 0.609 . . . . 15.0 110.107 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.496 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.74 -42.48 99.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.714 -0.675 . . . . 15.0 110.853 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -61.92 -44.02 97.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 15.0 110.738 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -59.22 -36.16 74.92 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.947 -0.301 . . . . 15.0 111.302 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 77.0 mt -67.26 -23.95 65.74 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.351 0.5 . . . . 15.0 112.351 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.33 13.37 17.45 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 119.263 -0.743 . . . . 15.0 113.096 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.77 122.03 11.88 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 118.564 1.182 . . . . 15.0 109.897 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -68.84 -35.72 77.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.617 -0.719 . . . . 15.0 111.281 -171.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -130.19 113.94 15.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.907 0.384 . . . . 15.0 110.251 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.2 130.3 64.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 15.0 109.953 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 87.6 mt -120.2 120.66 63.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.936 -0.575 . . . . 15.0 110.007 -176.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -95.4 117.79 30.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.41 -0.359 . . . . 15.0 110.323 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.479 ' HA ' ' HB3' ' A' ' 104' ' ' ALA . 31.2 p -96.02 -1.49 48.77 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.211 0.819 . . . . 15.0 113.211 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -56.14 -40.28 73.56 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 118.215 0.461 . . . . 15.0 110.527 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.08 -34.98 5.21 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.415 -0.674 . . . . 15.0 111.415 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.479 ' HB3' ' HA ' ' A' ' 101' ' ' CYS . . . -69.46 144.89 53.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.851 0.358 . . . . 15.0 110.52 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.1 t -89.8 158.92 17.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.069 -0.514 . . . . 15.0 110.546 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.65 -54.34 23.73 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 112.992 0.738 . . . . 15.0 112.992 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.72 -35.06 98.95 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 CA-C-N 120.134 1.083 . . . . 15.0 111.78 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.99 -43.13 95.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.124 0.488 . . . . 15.0 109.982 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.416 HD11 ' HB2' ' A' ' 101' ' ' CYS . 78.5 mt -59.06 -40.53 85.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 15.0 110.43 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 38.9 tp -57.19 -43.68 82.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.231 0.538 . . . . 15.0 110.168 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.13 -40.86 91.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.747 -0.661 . . . . 15.0 110.458 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.96 -41.61 92.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.414 . . . . 15.0 110.73 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.5 mt -57.81 -51.11 70.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.195 0.522 . . . . 15.0 110.396 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.3 p -63.6 -39.77 95.23 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.608 -0.724 . . . . 15.0 111.385 -175.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.2 p -65.9 -40.04 91.17 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.921 -0.312 . . . . 15.0 111.453 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.09 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.511 -0.313 . . . . 15.0 111.078 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.428 -0.351 . . . . 15.0 111.398 179.321 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 CA--C 1.534 0.334 0 N-CA-C 110.241 -0.281 . . . . 15.0 110.241 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.01 153.74 30.64 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.385 1.39 . . . . 15.0 111.83 -175.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.444 ' CB ' HD23 ' A' ' 49' ' ' LEU . 60.3 mttp -112.86 138.33 49.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.456 -0.338 . . . . 15.0 110.782 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.567 HG21 HD13 ' A' ' 21' ' ' LEU . 15.1 m -133.33 143.52 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 121.515 0.674 . . . . 15.0 111.521 176.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.6 tp -103.41 134.76 46.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.011 -0.995 . . . . 15.0 110.417 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.617 HD11 ' CG1' ' A' ' 28' ' ' VAL . 52.4 mt -99.04 135.0 35.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.024 0.44 . . . . 15.0 110.542 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 83.3 mtp -103.17 134.18 47.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.445 -0.798 . . . . 15.0 109.593 171.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -57.51 144.68 35.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.128 0.49 . . . . 15.0 110.984 -172.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.38 175.15 32.65 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.739 -0.944 . . . . 15.0 110.739 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -54.53 -33.42 59.97 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.517 0.191 . . . . 15.0 111.517 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.06 171.12 36.1 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.898 -0.881 . . . . 15.0 110.898 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.91 133.98 12.26 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.312 -0.715 . . . . 15.0 111.312 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -56.8 -46.04 81.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.086 0.469 . . . . 15.0 110.405 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.18 -41.14 99.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.679 -0.691 . . . . 15.0 111.329 -176.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -61.73 -56.07 23.49 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.746 -0.382 . . . . 15.0 111.224 -175.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.3 mt -61.94 -43.47 98.77 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.739 -0.384 . . . . 15.0 111.052 -176.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.17 -43.27 99.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.392 -0.367 . . . . 15.0 110.573 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -58.72 -41.85 87.34 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.977 -0.289 . . . . 15.0 110.395 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -58.76 -51.69 68.88 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.656 -0.418 . . . . 15.0 111.179 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.567 HD13 HG21 ' A' ' 5' ' ' VAL . 77.2 mt -62.74 -37.77 87.88 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.596 -0.442 . . . . 15.0 111.243 -177.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -63.53 -42.4 98.43 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.853 -0.339 . . . . 15.0 111.214 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.43 -30.71 68.63 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.021 -0.609 . . . . 15.0 111.961 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -88.18 9.92 21.21 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.56 0.948 . . . . 15.0 113.56 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.4 16.26 57.42 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 121.18 -0.533 . . . . 15.0 113.436 175.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.1 t -101.1 140.24 20.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 117.803 0.802 . . . . 15.0 110.168 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -83.17 130.5 35.11 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.101 -0.703 . . . . 15.0 109.101 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.617 ' CG1' HD11 ' A' ' 7' ' ' ILE . 37.1 t -119.72 133.23 67.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.17 0.51 . . . . 15.0 111.191 -172.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -139.23 137.75 36.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.362 -0.836 . . . . 15.0 109.465 171.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.48 ' HB3' HD12 ' A' ' 7' ' ' ILE . 34.6 p90 -115.41 138.25 51.2 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.916 0.389 . . . . 15.0 111.035 -178.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 tp -119.98 113.29 34.37 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-O 118.677 -0.678 . . . . 15.0 110.354 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.7 135.02 48.73 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 121.23 1.287 . . . . 15.0 112.304 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.557 HD13 HD22 ' A' ' 62' ' ' ASN . 72.7 mt -61.42 -16.96 51.88 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.031 0.752 . . . . 15.0 113.031 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -77.14 -4.34 44.01 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.445 0.905 . . . . 15.0 113.445 -175.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -70.61 149.97 95.45 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 118.428 0.558 . . . . 15.0 110.816 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.31 147.14 52.49 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.6 1.533 . . . . 15.0 113.747 -174.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.9 152.55 3.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.429 -0.805 . . . . 15.0 111.291 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.78 -38.09 3.21 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.948 -0.569 . . . . 15.0 111.837 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -62.65 -36.88 84.28 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 120.346 -0.542 . . . . 15.0 111.092 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.577 ' O ' HG23 ' A' ' 44' ' ' VAL . 27.2 tp -58.9 -46.9 86.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.915 0.388 . . . . 15.0 110.188 -178.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.512 HD22 ' CG ' ' A' ' 70' ' ' ASP . 20.8 tp -62.25 -43.85 97.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 15.0 110.854 -177.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.64 -45.88 92.16 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.635 -0.426 . . . . 15.0 110.853 -176.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -62.91 -40.03 96.33 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.874 -0.331 . . . . 15.0 111.165 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 40' ' ' LEU . 93.4 t -60.56 -44.51 96.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.881 -0.415 . . . . 15.0 109.881 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -65.9 -51.82 55.38 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.369 0.418 . . . . 15.0 111.87 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.09 -44.37 80.18 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.028 -0.269 . . . . 15.0 111.629 -174.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -80.31 -10.04 59.75 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.168 0.803 . . . . 15.0 113.168 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 92.2 mtm-85 55.62 55.81 6.83 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.61 0.719 . . . . 15.0 110.406 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.531 HD12 HG22 ' A' ' 44' ' ' VAL . 95.9 mt -68.0 146.23 53.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.656 -0.702 . . . . 15.0 110.965 -177.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -95.98 -40.7 9.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.695 -0.684 . . . . 15.0 110.906 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.7 164.83 28.81 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 119.945 -1.121 . . . . 15.0 113.589 -172.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.7 mt -126.79 145.16 50.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.456 -0.872 . . . . 15.0 109.919 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.525 HG22 ' CD1' ' A' ' 80' ' ' PHE . 47.1 t -121.0 129.14 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 110.437 -0.208 . . . . 15.0 110.437 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.7 m -126.99 139.24 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 120.955 0.407 . . . . 15.0 110.365 173.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.5 m -101.36 -4.8 26.32 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.055 0.761 . . . . 15.0 113.055 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.0 p -157.45 157.83 34.65 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-O 121.487 0.661 . . . . 15.0 111.977 -175.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.67 -37.75 78.31 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.048 -0.821 . . . . 15.0 111.048 177.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -57.03 -46.11 82.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.774 0.321 . . . . 15.0 110.716 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.69 -44.12 97.19 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.651 -0.98 . . . . 15.0 110.651 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.7 tp -56.01 -46.39 78.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.274 0.559 . . . . 15.0 110.717 -178.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -62.33 -42.9 99.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.911 -0.586 . . . . 15.0 110.874 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.557 HD22 HD13 ' A' ' 33' ' ' LEU . 85.3 m-20 -58.89 -38.51 79.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.377 -0.374 . . . . 15.0 110.829 178.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.5 tp -57.58 -45.25 85.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.281 0.562 . . . . 15.0 110.086 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -61.45 -47.6 84.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.667 -0.697 . . . . 15.0 110.628 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -62.05 -43.46 98.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 15.0 111.281 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.1 mt -66.42 -35.63 80.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.382 -0.372 . . . . 15.0 111.379 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.661 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -60.28 -37.74 81.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.012 0.434 . . . . 15.0 110.884 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.72 -144.16 0.54 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.388 -0.597 . . . . 15.0 109.388 174.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.49 -18.64 41.66 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.319 0.963 . . . . 15.0 112.614 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.512 ' CG ' HD22 ' A' ' 41' ' ' LEU . 21.5 m-20 -91.83 11.14 25.79 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.265 0.839 . . . . 15.0 113.265 -174.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -47.7 -46.83 61.87 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 118.6 -0.714 . . . . 15.0 112.592 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -44.64 -41.85 14.54 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.434 1.423 . . . . 15.0 113.22 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -76.99 -48.73 17.18 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.059 0.457 . . . . 15.0 110.807 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.661 HD12 ' HB1' ' A' ' 67' ' ' ALA . 95.2 mt -59.92 -40.03 81.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 15.0 110.855 -176.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.99 -15.74 29.7 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 119.916 -0.38 . . . . 15.0 112.966 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -64.82 -31.47 72.72 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 117.433 0.616 . . . . 15.0 111.884 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.7 mt -73.77 135.38 77.83 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 118.866 -0.587 . . . . 15.0 110.361 -175.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.01 134.18 60.57 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.39 1.393 . . . . 15.0 112.59 177.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.7 tp -107.66 130.18 54.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.974 -0.557 . . . . 15.0 110.65 176.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.525 ' CD1' HG22 ' A' ' 53' ' ' VAL . 77.4 m-85 -89.19 123.9 33.86 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.27 -0.641 . . . . 15.0 109.27 175.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.699 HG21 ' HB2' ' A' ' 87' ' ' ALA . 25.7 m -114.53 146.61 36.28 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 119.378 -0.344 . . . . 15.0 110.237 177.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -79.14 -23.77 7.36 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.52 1.48 . . . . 15.0 113.574 -174.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.0 p -143.44 162.22 43.3 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 120.564 -0.455 . . . . 15.0 111.677 -171.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.0 -44.0 51.35 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.154 1.236 . . . . 15.0 111.791 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -57.95 -47.28 83.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.837 0.351 . . . . 15.0 110.838 -177.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.17 -41.17 85.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 15.0 110.047 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.699 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.82 -42.68 84.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.901 0.382 . . . . 15.0 110.411 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.33 -42.08 98.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 15.0 110.604 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 86.7 mtp -59.41 -43.81 92.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.198 0.523 . . . . 15.0 110.44 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.6 94.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.931 -0.577 . . . . 15.0 110.74 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -61.59 -44.44 97.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.336 -0.393 . . . . 15.0 110.674 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.43 -36.1 77.38 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.842 -0.343 . . . . 15.0 111.313 -177.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.7 mt -64.9 -24.12 67.43 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.206 0.447 . . . . 15.0 112.206 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.55 13.33 17.09 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 119.311 -0.716 . . . . 15.0 113.103 -176.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.91 121.98 11.84 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.573 1.187 . . . . 15.0 109.894 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -69.31 -35.18 75.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.659 -0.701 . . . . 15.0 111.267 -171.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -131.08 115.71 16.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.003 0.43 . . . . 15.0 110.182 177.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.9 t -114.69 130.1 69.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.281 -0.418 . . . . 15.0 110.027 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.7 mt -119.48 124.91 73.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.997 -0.547 . . . . 15.0 110.058 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -95.39 118.03 31.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.384 -0.371 . . . . 15.0 110.038 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.415 ' HA ' ' HB3' ' A' ' 104' ' ' ALA . 31.4 p -96.73 -0.38 48.3 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.219 0.822 . . . . 15.0 113.219 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -56.0 -40.08 72.81 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 118.186 0.448 . . . . 15.0 110.62 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.02 -35.02 5.21 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.507 -0.637 . . . . 15.0 111.507 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.415 ' HB3' ' HA ' ' A' ' 101' ' ' CYS . . . -71.58 142.32 50.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.815 0.341 . . . . 15.0 110.664 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.6 m -89.89 163.24 15.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.496 . . . . 15.0 110.505 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.78 -54.28 24.72 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 112.977 0.732 . . . . 15.0 112.977 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.23 -34.27 98.41 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 CA-C-N 120.068 1.06 . . . . 15.0 111.635 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.14 -43.14 95.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.058 0.456 . . . . 15.0 110.012 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 78.6 mt -59.38 -40.49 86.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 15.0 110.515 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 42.2 tp -56.88 -44.9 82.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.51 0.671 . . . . 15.0 110.166 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.04 92.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.526 -0.761 . . . . 15.0 110.708 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.57 -42.3 96.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.476 -0.329 . . . . 15.0 110.907 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.6 mt -57.92 -51.47 69.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.171 0.51 . . . . 15.0 110.388 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.7 p -63.5 -40.16 96.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.628 -0.714 . . . . 15.0 111.28 -175.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.0 t -63.18 -44.27 95.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.662 0.268 . . . . 15.0 111.385 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.03 85.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.473 -0.331 . . . . 15.0 110.955 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.496 -0.32 . . . . 15.0 111.277 178.419 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 CA--C 1.536 0.406 0 N-CA-C 110.361 -0.237 . . . . 15.0 110.361 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -58.01 155.03 35.58 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.52 1.48 . . . . 15.0 112.035 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -110.61 139.88 45.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.518 -0.31 . . . . 15.0 110.741 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.415 HG21 HD13 ' A' ' 21' ' ' LEU . 13.5 m -135.75 142.31 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.556 0.693 . . . . 15.0 111.635 176.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.2 tp -105.0 133.8 49.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.94 -1.027 . . . . 15.0 110.169 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.569 HD11 ' CG1' ' A' ' 28' ' ' VAL . 41.9 mt -106.02 135.18 45.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.286 -0.415 . . . . 15.0 110.22 -177.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.416 ' SD ' HD13 ' A' ' 63' ' ' LEU . 83.7 mtp -94.37 134.05 37.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.157 -0.474 . . . . 15.0 110.537 175.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -62.79 145.87 53.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.043 0.449 . . . . 15.0 111.536 -174.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.96 175.2 42.85 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.638 -0.985 . . . . 15.0 110.638 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.91 -33.3 68.62 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.725 0.268 . . . . 15.0 111.725 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.95 164.35 3.6 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.165 -0.774 . . . . 15.0 111.165 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.99 104.77 2.81 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.92 -0.872 . . . . 15.0 110.92 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.435 ' HD2' HG21 ' A' ' 7' ' ' ILE . 87.5 mmt-85 -69.18 -32.52 71.89 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.794 0.294 . . . . 15.0 111.794 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.33 -45.64 87.71 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.595 -0.442 . . . . 15.0 110.366 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -65.9 -55.21 18.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.359 -0.382 . . . . 15.0 111.233 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.476 ' C ' HD23 ' A' ' 17' ' ' LEU . 10.0 tt -56.76 -43.13 80.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.843 0.354 . . . . 15.0 110.959 -177.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.47 -43.02 99.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.388 -0.369 . . . . 15.0 110.575 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.82 -41.02 85.84 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.808 -0.357 . . . . 15.0 110.566 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -60.97 -51.32 69.73 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 120.371 -0.532 . . . . 15.0 111.366 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.415 HD13 HG21 ' A' ' 5' ' ' VAL . 70.0 mt -61.15 -37.78 84.08 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.316 -0.554 . . . . 15.0 110.845 -178.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -65.03 -41.41 95.27 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 120.694 -0.402 . . . . 15.0 111.356 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.88 -30.68 66.68 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.028 -0.606 . . . . 15.0 111.883 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -88.08 9.97 20.76 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.477 0.917 . . . . 15.0 113.477 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.24 17.09 58.07 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 121.333 -0.46 . . . . 15.0 113.263 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -101.04 139.56 22.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 117.807 0.804 . . . . 15.0 110.126 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -82.0 126.2 31.69 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.393 -0.595 . . . . 15.0 109.393 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.569 ' CG1' HD11 ' A' ' 7' ' ' ILE . 41.5 t -116.75 129.32 73.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.087 0.47 . . . . 15.0 110.933 -174.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -136.39 132.65 35.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.636 -0.711 . . . . 15.0 109.685 172.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -112.63 133.45 54.66 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.947 0.403 . . . . 15.0 110.789 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.1 tp -116.08 113.33 41.7 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 118.824 -0.607 . . . . 15.0 110.367 -176.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.65 135.81 68.42 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 121.362 1.374 . . . . 15.0 112.692 174.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.674 HD13 ' ND2' ' A' ' 62' ' ' ASN . 73.9 mt -59.48 -10.48 3.37 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.37 0.878 . . . . 15.0 113.37 -178.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -77.16 -6.26 52.25 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.298 0.851 . . . . 15.0 113.298 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -71.78 148.72 92.57 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 118.588 0.631 . . . . 15.0 110.582 -178.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -74.6 152.08 42.46 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.604 1.536 . . . . 15.0 113.782 -174.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.73 152.52 3.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.373 -0.83 . . . . 15.0 111.292 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.31 -38.28 3.15 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.799 -0.637 . . . . 15.0 111.782 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.5 -36.03 82.85 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 117.343 0.571 . . . . 15.0 111.264 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.563 ' O ' HG23 ' A' ' 44' ' ' VAL . 26.8 tp -58.74 -46.86 86.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.942 0.401 . . . . 15.0 110.135 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.472 HD22 ' CG ' ' A' ' 70' ' ' ASP . 16.6 tp -63.33 -44.45 94.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 15.0 110.875 -176.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.56 -44.76 96.44 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.706 -0.398 . . . . 15.0 110.871 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 61.7 ttm-85 -60.88 -42.78 98.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.458 -0.337 . . . . 15.0 110.655 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 40' ' ' LEU . 98.5 t -60.34 -45.37 96.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.777 -0.369 . . . . 15.0 110.174 -177.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -67.29 -51.78 48.63 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.485 0.491 . . . . 15.0 112.058 -176.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.64 -44.35 82.19 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.986 -0.286 . . . . 15.0 111.565 -174.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -79.83 -10.15 59.75 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.972 0.73 . . . . 15.0 112.972 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 54.78 55.95 7.26 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.595 0.712 . . . . 15.0 110.086 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.55 HD12 HG22 ' A' ' 44' ' ' VAL . 97.5 mt -65.09 144.91 56.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.744 -0.662 . . . . 15.0 111.314 -174.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -92.84 -39.13 11.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.133 -0.94 . . . . 15.0 110.81 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.69 160.96 28.46 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 120.149 -1.024 . . . . 15.0 113.469 -175.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.1 mt -126.16 144.37 50.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.575 -0.812 . . . . 15.0 109.564 177.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.49 HG22 ' HD1' ' A' ' 80' ' ' PHE . 44.7 t -122.71 131.51 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 O-C-N 122.315 -0.24 . . . . 15.0 110.93 -177.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.0 m -127.53 150.69 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.08 0.467 . . . . 15.0 110.37 171.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.5 t -107.5 -15.65 14.56 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.605 -0.725 . . . . 15.0 112.711 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.4 p -152.75 160.59 43.13 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.402 0.62 . . . . 15.0 111.917 -173.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.37 -37.78 75.8 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.016 -0.834 . . . . 15.0 111.016 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -57.19 -46.16 83.09 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 122.599 -0.353 . . . . 15.0 110.703 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.14 -45.62 95.68 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.621 -0.991 . . . . 15.0 110.621 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.57 HD21 ' HA ' ' A' ' 90' ' ' ALA . 21.0 tp -56.94 -44.61 82.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.103 0.478 . . . . 15.0 110.736 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.69 -43.44 98.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.481 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.674 ' ND2' HD13 ' A' ' 33' ' ' LEU . 84.5 m-20 -59.04 -37.31 76.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.124 -0.489 . . . . 15.0 110.858 177.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.416 HD13 ' SD ' ' A' ' 8' ' ' MET . 12.1 tp -57.5 -44.96 85.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.286 0.565 . . . . 15.0 110.121 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -60.66 -46.87 88.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.53 -0.759 . . . . 15.0 110.539 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -62.61 -43.96 97.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 15.0 111.347 -176.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.08 -35.07 79.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.476 -0.329 . . . . 15.0 111.266 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.667 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -60.3 -37.95 82.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.007 0.432 . . . . 15.0 110.858 178.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.37 -144.63 0.55 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.461 -0.57 . . . . 15.0 109.461 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.45 -19.13 45.28 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.29 0.95 . . . . 15.0 112.586 -174.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.472 ' CG ' HD22 ' A' ' 41' ' ' LEU . 22.0 m-20 -91.88 11.76 23.84 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.295 0.85 . . . . 15.0 113.295 -174.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 59.0 t-105 -47.77 -46.85 62.7 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 118.564 -0.731 . . . . 15.0 112.519 177.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -44.66 -41.29 14.58 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 121.431 1.421 . . . . 15.0 113.287 177.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -76.96 -48.75 17.2 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.607 -0.437 . . . . 15.0 110.803 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.667 HD12 ' HB1' ' A' ' 67' ' ' ALA . 91.5 mt -58.91 -40.18 79.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.197 -0.456 . . . . 15.0 110.796 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.39 -16.99 37.77 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 116.291 -0.413 . . . . 15.0 113.254 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -66.58 -28.93 68.9 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.297 0.548 . . . . 15.0 112.17 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.2 mt -74.85 150.59 86.24 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 121.031 -0.268 . . . . 15.0 111.514 -172.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -63.8 126.52 17.57 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 121.626 1.551 . . . . 15.0 112.309 176.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.8 tp -105.7 127.25 52.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.508 -0.315 . . . . 15.0 110.824 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.49 ' HD1' HG22 ' A' ' 53' ' ' VAL . 69.6 m-85 -89.45 127.13 35.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.589 -0.522 . . . . 15.0 109.589 175.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.718 HG21 ' HB2' ' A' ' 87' ' ' ALA . 27.5 m -118.53 146.76 40.47 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 110.08 -0.341 . . . . 15.0 110.08 175.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.404 ' HD2' HG11 ' A' ' 86' ' ' VAL . 78.2 Cg_endo -79.1 -23.45 7.69 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.61 1.54 . . . . 15.0 113.457 -176.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.403 ' OG ' HG23 ' A' ' 86' ' ' VAL . 25.5 p -144.3 158.44 54.68 Favored Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 120.671 -0.412 . . . . 15.0 111.355 -172.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.07 -44.03 52.18 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.26 1.307 . . . . 15.0 111.737 176.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -57.65 -47.71 81.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.882 0.372 . . . . 15.0 110.929 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.404 HG11 ' HD2' ' A' ' 82' ' ' PRO . 60.3 t -59.65 -40.69 82.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.906 0.384 . . . . 15.0 109.983 178.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.718 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.55 -42.25 82.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.81 0.338 . . . . 15.0 110.444 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.41 -41.03 93.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.49 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.1 mmm -58.39 -43.95 88.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.401 0.619 . . . . 15.0 110.157 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.57 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.28 -40.62 94.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.733 -0.667 . . . . 15.0 110.795 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -62.53 -42.82 99.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.342 -0.39 . . . . 15.0 111.074 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.67 -36.11 77.92 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.897 -0.321 . . . . 15.0 111.33 -177.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.2 mt -67.95 -22.12 65.05 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.404 0.52 . . . . 15.0 112.404 177.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.99 13.39 18.15 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 119.315 -0.714 . . . . 15.0 113.217 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.77 121.98 11.76 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.579 1.189 . . . . 15.0 109.864 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -70.3 -35.37 73.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.55 -0.75 . . . . 15.0 111.275 -171.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -131.84 112.53 12.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.977 0.418 . . . . 15.0 110.486 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.2 t -112.0 130.69 65.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.135 -0.484 . . . . 15.0 109.883 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 84.3 mt -118.95 122.6 69.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.016 -0.538 . . . . 15.0 110.11 -176.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.57 117.07 29.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.457 -0.338 . . . . 15.0 110.431 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.3 p -97.02 6.12 49.18 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.168 0.803 . . . . 15.0 113.168 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 71.9 ttp85 -55.76 -39.37 71.11 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.169 0.441 . . . . 15.0 110.803 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.68 -35.09 5.27 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.6 -0.6 . . . . 15.0 111.6 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.26 139.07 54.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.969 0.414 . . . . 15.0 110.773 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.8 p -89.84 167.84 12.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.996 -0.547 . . . . 15.0 110.464 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.75 -54.2 25.22 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 113.028 0.751 . . . . 15.0 113.028 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.73 -36.6 98.54 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 CA-C-N 120.509 1.218 . . . . 15.0 111.447 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.55 -43.13 97.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.98 0.419 . . . . 15.0 110.183 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.5 mt -59.36 -40.8 87.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.198 -0.456 . . . . 15.0 110.398 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.9 tp -57.67 -44.7 85.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.323 0.583 . . . . 15.0 110.188 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.98 -40.71 94.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.666 -0.697 . . . . 15.0 110.595 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.85 -42.04 97.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.424 -0.353 . . . . 15.0 110.765 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.3 mt -57.87 -50.44 73.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.047 0.451 . . . . 15.0 110.44 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.7 p -65.02 -40.49 94.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.805 -0.634 . . . . 15.0 111.479 -175.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.9 p -64.37 -39.67 94.33 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.98 -0.288 . . . . 15.0 111.28 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.54 -43.27 94.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.634 -0.257 . . . . 15.0 111.037 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.543 -0.299 . . . . 15.0 110.976 179.757 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 CA--C 1.534 0.355 0 N-CA-C 110.194 -0.299 . . . . 15.0 110.194 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -54.09 152.37 24.62 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 121.481 1.454 . . . . 15.0 111.824 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -112.43 135.7 52.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.291 -0.413 . . . . 15.0 110.509 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.57 HG21 HD13 ' A' ' 21' ' ' LEU . 17.8 m -133.1 145.58 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.619 0.723 . . . . 15.0 111.859 177.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.9 tp -103.66 136.86 42.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.964 -1.016 . . . . 15.0 110.496 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.631 HD11 ' CG1' ' A' ' 28' ' ' VAL . 54.8 mt -100.79 133.87 42.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.033 0.444 . . . . 15.0 110.683 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.423 ' SD ' HD13 ' A' ' 63' ' ' LEU . 84.8 mtp -102.56 134.62 45.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.242 -0.89 . . . . 15.0 110.09 173.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -57.36 141.16 48.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.213 0.53 . . . . 15.0 110.572 -173.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.13 175.28 31.66 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.551 -1.02 . . . . 15.0 110.551 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.7 mp0 -58.0 -31.68 67.19 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.951 -0.3 . . . . 15.0 111.515 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.49 173.27 33.61 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.908 -0.877 . . . . 15.0 110.908 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.32 132.21 11.05 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.488 -0.645 . . . . 15.0 111.488 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -56.87 -44.08 81.86 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.127 0.489 . . . . 15.0 110.227 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.38 -43.42 97.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.767 -0.651 . . . . 15.0 111.024 -175.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -58.2 -55.93 28.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.012 0.434 . . . . 15.0 110.909 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.1 mt -61.35 -42.85 99.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 15.0 110.91 -175.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.12 -45.0 96.48 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.767 -0.373 . . . . 15.0 111.163 -177.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.23 -38.81 84.56 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.598 -0.441 . . . . 15.0 110.811 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -60.63 -51.51 69.1 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 119.973 -0.691 . . . . 15.0 110.918 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.57 HD13 HG21 ' A' ' 5' ' ' VAL . 79.9 mt -63.57 -38.02 89.52 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 120.451 -0.499 . . . . 15.0 111.252 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -63.57 -42.47 98.33 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.91 -0.316 . . . . 15.0 111.266 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.71 -30.72 69.63 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 120.865 -0.684 . . . . 15.0 112.011 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -88.8 10.14 22.11 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.654 0.983 . . . . 15.0 113.654 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.8 17.25 56.89 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 121.251 -0.5 . . . . 15.0 113.295 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.1 t -101.02 141.02 18.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 117.712 0.756 . . . . 15.0 110.088 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -84.8 131.36 34.55 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.297 -0.631 . . . . 15.0 109.297 177.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.631 ' CG1' HD11 ' A' ' 7' ' ' ILE . 40.3 t -117.72 131.19 71.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.129 0.49 . . . . 15.0 111.121 -173.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -137.4 133.82 35.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.464 -0.789 . . . . 15.0 109.488 171.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.552 ' HB3' HD12 ' A' ' 7' ' ' ILE . 42.1 p90 -116.06 138.38 51.28 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.968 0.413 . . . . 15.0 111.194 -177.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.0 tp -119.21 135.97 24.21 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 109.243 -0.651 . . . . 15.0 109.243 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.22 135.92 25.77 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.182 1.255 . . . . 15.0 111.759 173.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.555 HD13 HD22 ' A' ' 62' ' ' ASN . 84.1 mt -59.9 -9.31 2.84 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.41 0.893 . . . . 15.0 113.41 -177.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -77.14 -7.91 56.6 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.415 0.894 . . . . 15.0 113.415 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -64.57 146.55 98.18 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 118.606 0.639 . . . . 15.0 110.552 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.03 159.03 27.15 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.617 1.544 . . . . 15.0 113.221 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.44 150.97 4.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.779 -0.646 . . . . 15.0 111.52 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.2 -38.01 3.25 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.321 -0.712 . . . . 15.0 111.321 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -61.34 -37.82 84.67 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.58 -0.448 . . . . 15.0 111.017 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.573 ' O ' HG23 ' A' ' 44' ' ' VAL . 28.4 tp -59.0 -46.83 87.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.981 0.42 . . . . 15.0 110.127 -178.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.481 HD13 ' CB ' ' A' ' 70' ' ' ASP . 14.6 tp -62.51 -43.56 98.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.178 -0.465 . . . . 15.0 110.914 -177.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.17 -45.96 91.06 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.724 -0.39 . . . . 15.0 110.95 -176.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -61.52 -41.5 97.41 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.812 -0.355 . . . . 15.0 110.707 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 40' ' ' LEU . 94.5 t -61.24 -45.8 97.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.779 -0.368 . . . . 15.0 110.204 -177.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -69.11 -49.03 60.76 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.293 0.479 . . . . 15.0 112.293 -175.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.48 -44.3 75.08 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.992 -0.283 . . . . 15.0 111.642 -174.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -78.96 -10.16 59.74 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.09 0.774 . . . . 15.0 113.09 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 55.78 55.83 6.69 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.601 0.715 . . . . 15.0 110.306 -177.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.557 HD12 ' HA ' ' A' ' 44' ' ' VAL . 94.2 mt -74.18 146.91 43.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.552 -0.749 . . . . 15.0 111.306 -176.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -96.78 -40.71 8.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.677 -0.692 . . . . 15.0 110.807 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.63 165.45 28.77 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 119.798 -1.191 . . . . 15.0 113.644 -171.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.444 ' HB2' HD12 ' A' ' 79' ' ' LEU . 72.7 mt -127.04 144.59 50.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.545 -0.828 . . . . 15.0 110.279 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.521 HG22 ' CD1' ' A' ' 80' ' ' PHE . 47.5 t -120.22 129.35 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 110.372 -0.233 . . . . 15.0 110.372 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.2 m -126.65 144.53 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.141 0.496 . . . . 15.0 110.657 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.0 t -102.84 -13.27 17.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.493 -0.776 . . . . 15.0 112.747 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.8 p -153.34 159.1 42.4 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.456 0.646 . . . . 15.0 112.075 -173.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.6 -37.9 78.5 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.972 -0.851 . . . . 15.0 110.972 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -58.45 -44.62 89.28 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.848 -0.341 . . . . 15.0 110.635 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.4 -45.38 96.31 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.623 -0.991 . . . . 15.0 110.623 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.537 HD13 HD21 ' A' ' 79' ' ' LEU . 42.5 tp -56.4 -45.73 80.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.129 0.49 . . . . 15.0 110.778 -177.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -62.0 -42.73 99.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.043 -0.526 . . . . 15.0 110.89 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.555 HD22 HD13 ' A' ' 33' ' ' LEU . 83.3 m-20 -59.22 -39.68 83.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.373 -0.376 . . . . 15.0 110.716 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.423 HD13 ' SD ' ' A' ' 8' ' ' MET . 13.6 tp -58.09 -45.02 87.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.166 0.508 . . . . 15.0 110.238 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -60.7 -47.55 85.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.744 -0.662 . . . . 15.0 110.648 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -62.0 -43.19 99.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.014 -0.539 . . . . 15.0 111.136 -176.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.08 -34.95 78.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.451 -0.341 . . . . 15.0 111.453 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.697 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.47 -38.94 82.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.953 0.406 . . . . 15.0 110.535 177.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 58.96 -142.53 0.64 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.626 -0.509 . . . . 15.0 109.626 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.75 -18.58 44.16 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.39 0.996 . . . . 15.0 112.695 -174.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.481 ' CB ' HD13 ' A' ' 41' ' ' LEU . 26.4 m-20 -91.79 9.26 33.42 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.315 0.857 . . . . 15.0 113.315 -175.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -47.74 -46.57 61.84 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.633 -0.699 . . . . 15.0 112.61 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -44.55 -43.04 14.34 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.493 1.462 . . . . 15.0 113.287 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -76.96 -48.81 17.02 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 120.644 -0.422 . . . . 15.0 110.931 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.697 HD12 ' HB1' ' A' ' 67' ' ' ALA . 86.4 mt -59.33 -39.05 77.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.11 -0.496 . . . . 15.0 110.85 -176.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.78 -13.2 38.54 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 119.826 -0.43 . . . . 15.0 113.405 -175.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -70.5 -29.21 65.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 117.578 0.689 . . . . 15.0 112.304 178.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.2 mt -69.86 126.51 92.53 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 118.572 -0.728 . . . . 15.0 109.606 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.23 133.45 52.68 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.106 1.204 . . . . 15.0 112.333 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.537 HD21 HD13 ' A' ' 60' ' ' LEU . 17.8 tp -105.75 129.31 53.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.904 -0.589 . . . . 15.0 110.552 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.521 ' CD1' HG22 ' A' ' 53' ' ' VAL . 77.5 m-85 -90.52 122.45 33.36 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.249 -0.648 . . . . 15.0 109.249 175.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.65 HG21 ' HB2' ' A' ' 87' ' ' ALA . 25.9 m -114.99 148.01 39.6 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 119.457 -0.306 . . . . 15.0 110.326 177.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.21 -24.54 6.59 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.529 1.486 . . . . 15.0 113.614 -174.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.9 p -142.43 161.36 50.45 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 120.594 -0.442 . . . . 15.0 111.58 -172.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -55.32 -44.07 52.44 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.208 1.272 . . . . 15.0 111.76 176.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -57.17 -47.9 80.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.855 0.36 . . . . 15.0 110.639 -177.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.5 t -60.0 -41.37 85.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.904 0.383 . . . . 15.0 109.992 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.65 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.94 -42.1 84.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.969 0.414 . . . . 15.0 110.486 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.24 -41.71 97.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.433 . . . . 15.0 110.44 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 86.5 mtp -58.92 -41.82 88.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.101 0.477 . . . . 15.0 110.379 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.69 -41.21 94.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 15.0 110.576 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 -61.74 -43.29 99.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 15.0 110.809 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.24 -36.1 76.98 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.879 -0.328 . . . . 15.0 111.256 -177.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 77.5 mt -65.89 -24.41 66.85 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.256 0.465 . . . . 15.0 112.256 176.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 107.67 13.25 20.88 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 119.437 -0.646 . . . . 15.0 113.075 -175.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.94 123.82 17.12 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 118.416 1.108 . . . . 15.0 109.939 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -72.17 -33.5 67.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.843 -0.617 . . . . 15.0 111.425 -172.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 45.9 tpt85 -131.81 114.57 14.87 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.903 0.382 . . . . 15.0 110.404 176.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 40.5 t -114.67 131.62 66.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.822 0.344 . . . . 15.0 110.145 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 87.8 mt -119.7 125.93 74.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.172 -0.467 . . . . 15.0 110.191 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -94.2 118.3 31.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.36 -0.382 . . . . 15.0 110.134 174.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.1 p -94.25 -7.2 42.73 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.17 0.804 . . . . 15.0 113.17 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -55.82 -39.41 71.34 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 118.122 0.419 . . . . 15.0 110.781 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -96.27 -35.04 5.63 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.491 -0.644 . . . . 15.0 111.491 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.24 143.44 40.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.796 0.331 . . . . 15.0 110.478 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.6 m -89.43 163.42 15.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 15.0 110.526 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.72 -54.31 24.23 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 112.878 0.695 . . . . 15.0 112.878 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.6 -34.13 98.65 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 CA-C-N 120.195 1.106 . . . . 15.0 111.646 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.29 -42.96 96.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.107 0.48 . . . . 15.0 110.026 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.8 mt -59.32 -39.88 84.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 15.0 110.495 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 29.4 tp -56.87 -45.04 82.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.399 0.618 . . . . 15.0 110.111 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.98 -39.73 90.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.506 -0.77 . . . . 15.0 110.601 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.63 -42.87 97.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.604 -0.271 . . . . 15.0 110.844 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.8 mt -58.04 -50.36 73.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.119 0.485 . . . . 15.0 110.405 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 71.7 p -63.5 -40.39 96.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.807 -0.633 . . . . 15.0 111.368 -175.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.8 m -64.01 -42.75 97.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.662 0.267 . . . . 15.0 111.292 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.25 -39.01 88.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.474 -0.33 . . . . 15.0 110.998 -178.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.545 -0.298 . . . . 15.0 111.213 178.666 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 110.406 -0.22 . . . . 15.0 110.406 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -56.13 155.05 25.47 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.389 1.393 . . . . 15.0 111.761 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.441 ' CB ' HD23 ' A' ' 49' ' ' LEU . 93.4 mttt -109.98 138.04 46.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.479 -0.328 . . . . 15.0 110.901 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.448 HG21 HD13 ' A' ' 21' ' ' LEU . 15.8 m -134.06 144.35 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.538 0.685 . . . . 15.0 111.614 175.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.8 tp -103.78 136.74 42.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.949 -1.023 . . . . 15.0 110.274 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.643 HD11 ' CG1' ' A' ' 28' ' ' VAL . 54.8 mt -101.6 133.8 43.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.137 0.494 . . . . 15.0 111.013 -177.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.549 ' HB2' HG12 ' A' ' 54' ' ' VAL . 98.7 mmm -94.69 134.28 37.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.153 -0.93 . . . . 15.0 109.045 170.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -57.46 140.68 49.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.894 0.378 . . . . 15.0 110.562 -175.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.28 175.1 27.74 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.995 -0.842 . . . . 15.0 110.995 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -58.2 -33.18 69.0 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.546 0.202 . . . . 15.0 111.546 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.94 173.27 35.25 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.979 -0.848 . . . . 15.0 110.979 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.98 131.36 10.37 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.25 -0.74 . . . . 15.0 111.25 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -57.41 -43.76 84.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.082 0.468 . . . . 15.0 110.317 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.18 -42.58 99.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.815 -0.63 . . . . 15.0 111.344 -176.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -61.68 -55.94 25.09 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.804 -0.359 . . . . 15.0 111.292 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.3 mt -59.87 -43.62 94.62 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.662 -0.415 . . . . 15.0 111.021 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.7 -41.31 99.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.491 -0.322 . . . . 15.0 110.995 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -60.04 -41.5 92.43 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.949 -0.3 . . . . 15.0 110.458 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -60.91 -51.73 68.04 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.622 -0.431 . . . . 15.0 111.319 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.448 HD13 HG21 ' A' ' 5' ' ' VAL . 72.9 mt -63.63 -36.96 85.54 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.349 -0.54 . . . . 15.0 110.971 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -62.49 -41.87 99.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.648 0.261 . . . . 15.0 111.092 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.7 -30.62 69.41 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.068 -0.587 . . . . 15.0 111.932 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -88.09 10.96 17.46 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.535 0.939 . . . . 15.0 113.535 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.39 17.77 56.54 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 121.279 -0.486 . . . . 15.0 113.368 174.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -101.05 139.0 23.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 117.807 0.803 . . . . 15.0 110.217 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -83.28 130.75 35.09 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.207 -0.664 . . . . 15.0 109.207 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.643 ' CG1' HD11 ' A' ' 7' ' ' ILE . 21.2 t -119.69 133.94 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.137 0.494 . . . . 15.0 111.401 -172.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -140.21 138.12 34.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.543 -0.753 . . . . 15.0 109.64 171.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.473 ' HB3' HD12 ' A' ' 7' ' ' ILE . 38.8 p90 -115.81 141.65 47.82 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.825 0.345 . . . . 15.0 110.789 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.9 tp -117.83 113.42 37.98 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 118.814 -0.612 . . . . 15.0 110.585 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -49.67 135.0 34.39 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.208 1.272 . . . . 15.0 111.903 173.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.793 HD13 ' ND2' ' A' ' 62' ' ' ASN . 46.0 mt -62.87 -13.37 33.17 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.214 0.82 . . . . 15.0 113.214 -176.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -77.14 -5.32 48.6 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.3 0.852 . . . . 15.0 113.3 -177.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -61.25 149.93 81.2 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 118.484 0.584 . . . . 15.0 110.375 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -80.07 151.91 21.26 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.567 1.512 . . . . 15.0 112.891 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.39 150.7 6.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.066 -0.515 . . . . 15.0 111.173 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.08 -38.03 3.24 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.57 -0.612 . . . . 15.0 111.57 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -62.05 -37.98 87.02 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 117.081 0.44 . . . . 15.0 110.995 -177.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.558 ' O ' HG23 ' A' ' 44' ' ' VAL . 21.2 tp -59.3 -47.46 85.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.922 0.392 . . . . 15.0 110.155 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.486 HD13 HD11 ' A' ' 74' ' ' ILE . 15.4 tp -63.0 -44.5 95.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.204 -0.453 . . . . 15.0 110.973 -176.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.65 -45.66 93.08 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.702 -0.399 . . . . 15.0 110.675 -176.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 47.2 ttt85 -61.01 -42.03 97.68 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.784 -0.367 . . . . 15.0 110.706 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 40' ' ' LEU . 96.8 t -60.88 -45.04 98.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.811 -0.355 . . . . 15.0 110.322 -177.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -68.79 -48.24 64.13 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.235 0.457 . . . . 15.0 112.235 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.03 -44.3 72.99 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.995 -0.282 . . . . 15.0 111.629 -175.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -78.41 -10.03 59.53 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.046 0.758 . . . . 15.0 113.046 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 55.93 55.84 6.57 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.593 0.711 . . . . 15.0 110.252 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 44' ' ' VAL . 96.2 mt -70.01 144.21 52.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.552 -0.749 . . . . 15.0 110.976 -176.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -90.8 -40.58 11.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.394 -0.821 . . . . 15.0 110.764 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -150.8 166.46 30.34 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 119.797 -1.192 . . . . 15.0 113.774 -173.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.0 mt -125.73 143.05 51.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.519 -0.84 . . . . 15.0 109.888 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.516 HG22 ' CD1' ' A' ' 80' ' ' PHE . 46.8 t -121.28 131.6 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 110.307 -0.257 . . . . 15.0 110.307 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.549 HG12 ' HB2' ' A' ' 8' ' ' MET . 7.0 m -128.46 139.72 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.058 0.456 . . . . 15.0 110.469 173.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.9 t -102.03 -14.93 16.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.566 -0.743 . . . . 15.0 112.81 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 85.2 p -145.9 156.77 43.76 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.28 0.562 . . . . 15.0 111.771 -174.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.18 -39.7 90.41 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.873 -0.891 . . . . 15.0 110.873 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -59.33 -43.54 92.69 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.837 -0.345 . . . . 15.0 110.533 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.41 -46.29 94.13 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.544 -1.023 . . . . 15.0 110.544 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.54 HD13 HD21 ' A' ' 79' ' ' LEU . 35.2 tp -57.16 -44.84 83.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.106 0.479 . . . . 15.0 110.685 -177.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.82 -42.64 99.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.025 -0.534 . . . . 15.0 110.93 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.793 ' ND2' HD13 ' A' ' 33' ' ' LEU . 82.5 m-20 -59.97 -40.78 90.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.781 0.324 . . . . 15.0 110.642 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.425 ' CD1' HD21 ' A' ' 40' ' ' LEU . 13.5 tp -58.15 -44.26 87.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.24 0.543 . . . . 15.0 110.17 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -60.82 -46.95 88.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.833 -0.621 . . . . 15.0 110.769 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.31 -42.63 98.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.083 -0.508 . . . . 15.0 111.123 -176.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 94.8 mt -65.47 -36.19 83.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.404 -0.362 . . . . 15.0 111.332 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.675 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.47 -38.08 79.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.145 0.498 . . . . 15.0 110.923 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.14 -143.85 0.58 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.627 -0.508 . . . . 15.0 109.627 174.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.54 -20.9 58.92 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.307 0.958 . . . . 15.0 112.694 -173.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.472 ' OD2' HD22 ' A' ' 41' ' ' LEU . 77.6 m-20 -92.47 13.53 19.37 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.222 0.823 . . . . 15.0 113.222 -175.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 53.8 t-105 -47.74 -46.65 62.06 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-O 118.608 -0.711 . . . . 15.0 112.53 176.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -44.61 -40.39 13.92 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 121.475 1.45 . . . . 15.0 113.19 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -77.0 -48.79 16.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.034 0.445 . . . . 15.0 110.808 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.675 HD12 ' HB1' ' A' ' 67' ' ' ALA . 91.1 mt -60.34 -39.08 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 15.0 110.876 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.78 -14.3 29.23 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 119.849 -0.417 . . . . 15.0 113.083 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -65.13 -30.9 71.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 117.461 0.631 . . . . 15.0 111.785 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.3 mt -74.02 139.82 76.65 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 119.068 -0.491 . . . . 15.0 110.397 -175.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -58.9 134.26 59.03 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 121.433 1.422 . . . . 15.0 112.556 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.54 HD21 HD13 ' A' ' 60' ' ' LEU . 22.8 tp -108.87 129.2 55.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.075 -0.512 . . . . 15.0 110.745 176.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.516 ' CD1' HG22 ' A' ' 53' ' ' VAL . 84.3 m-85 -91.1 125.83 36.0 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.54 -0.541 . . . . 15.0 109.54 175.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.674 HG21 ' HB2' ' A' ' 87' ' ' ALA . 27.7 m -117.1 149.16 43.8 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 119.513 -0.279 . . . . 15.0 110.377 176.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.405 ' HD2' HG11 ' A' ' 86' ' ' VAL . 72.5 Cg_endo -79.15 -25.53 5.85 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.645 1.563 . . . . 15.0 113.597 -174.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.4 ' OG ' HG23 ' A' ' 86' ' ' VAL . 27.6 p -142.7 162.21 45.34 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 120.635 -0.426 . . . . 15.0 111.542 -172.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -56.02 -43.9 52.21 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.11 1.207 . . . . 15.0 111.862 176.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 68.5 mtp85 -58.79 -46.58 87.22 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.868 -0.333 . . . . 15.0 110.871 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.405 HG11 ' HD2' ' A' ' 82' ' ' PRO . 54.8 t -60.01 -40.85 84.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.959 -0.385 . . . . 15.0 109.959 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.674 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.59 -42.04 82.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.886 0.374 . . . . 15.0 110.467 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.46 -41.37 97.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.281 -0.418 . . . . 15.0 110.555 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 86.9 mtp -59.91 -43.4 94.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.223 0.535 . . . . 15.0 110.442 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.48 -40.85 96.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.025 -0.534 . . . . 15.0 110.719 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -61.24 -44.25 97.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 15.0 110.324 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.8 -36.15 74.0 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.986 -0.286 . . . . 15.0 111.251 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.9 mt -65.24 -26.03 67.93 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.113 0.412 . . . . 15.0 112.113 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.67 13.26 16.99 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 119.391 -0.672 . . . . 15.0 113.13 -176.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.92 122.1 12.13 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 118.527 1.163 . . . . 15.0 109.884 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -68.23 -35.32 77.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.764 -0.653 . . . . 15.0 111.23 -171.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.3 tpt85 -131.79 117.45 18.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.907 0.384 . . . . 15.0 110.137 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.7 t -114.41 130.06 69.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.996 0.427 . . . . 15.0 110.091 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 87.0 mt -118.81 125.16 74.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.801 -0.636 . . . . 15.0 110.171 -177.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.82 118.07 31.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.388 -0.369 . . . . 15.0 110.08 175.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 104' ' ' ALA . 31.9 p -92.91 -8.21 43.94 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.164 0.802 . . . . 15.0 113.164 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -55.14 -39.54 69.58 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.045 0.384 . . . . 15.0 110.914 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.07 -35.09 5.17 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.513 -0.635 . . . . 15.0 111.513 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' A' ' 101' ' ' CYS . . . -68.87 145.42 53.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.879 0.371 . . . . 15.0 110.691 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.437 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 20.6 t -89.8 152.01 21.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 15.0 110.406 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.67 -54.43 23.11 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 113.087 0.773 . . . . 15.0 113.087 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.83 -36.17 94.96 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 CA-C-N 120.098 1.071 . . . . 15.0 111.642 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 105' ' ' SER . . . -59.88 -42.0 92.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.035 0.445 . . . . 15.0 110.078 176.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.6 mt -59.02 -40.16 84.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.243 -0.435 . . . . 15.0 110.517 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.1 tp -57.17 -43.88 82.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.39 0.614 . . . . 15.0 110.146 178.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.84 -40.88 90.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.679 -0.691 . . . . 15.0 110.393 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.73 -40.8 89.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.311 -0.404 . . . . 15.0 110.715 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.9 mt -57.82 -50.74 72.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.271 0.558 . . . . 15.0 110.494 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.5 p -63.57 -40.54 97.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.6 -0.727 . . . . 15.0 111.326 -175.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 86.5 p -65.74 -39.17 90.86 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.911 -0.316 . . . . 15.0 111.42 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.62 -39.31 94.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.497 -0.32 . . . . 15.0 111.068 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.418 -0.356 . . . . 15.0 111.163 179.204 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 . . . . . 0 CA--C 1.534 0.355 0 N-CA-C 110.242 -0.281 . . . . 15.0 110.242 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -49.98 151.51 8.54 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.449 1.433 . . . . 15.0 111.937 -175.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.47 ' HB2' HD23 ' A' ' 49' ' ' LEU . 75.9 mttt -119.93 141.13 49.91 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.334 -0.394 . . . . 15.0 110.703 -178.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.474 HG21 HD13 ' A' ' 21' ' ' LEU . 22.6 m -133.87 145.77 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.474 0.654 . . . . 15.0 111.781 175.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.488 HD13 ' CD ' ' A' ' 43' ' ' ARG . 13.4 tp -104.9 135.45 46.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.077 -0.965 . . . . 15.0 110.067 178.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.51 HD11 ' CG1' ' A' ' 28' ' ' VAL . 58.7 mt -103.04 135.09 42.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.026 0.441 . . . . 15.0 110.545 -177.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.569 ' HE3' HD21 ' A' ' 33' ' ' LEU . 96.7 mmm -88.21 134.12 33.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.422 -0.808 . . . . 15.0 110.123 174.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -57.81 140.72 51.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 15.0 110.583 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.36 175.07 42.52 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.949 -0.86 . . . . 15.0 110.949 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.61 -34.09 64.55 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.263 -0.175 . . . . 15.0 111.419 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.72 162.19 4.36 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.246 -0.742 . . . . 15.0 111.246 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.95 119.59 5.06 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.202 -0.759 . . . . 15.0 111.202 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -57.07 -43.79 82.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.097 0.475 . . . . 15.0 110.24 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.68 -41.71 98.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.861 -0.609 . . . . 15.0 111.146 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -58.84 -56.09 26.66 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.713 -0.395 . . . . 15.0 110.966 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.9 mt -61.53 -40.62 95.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.32 -0.4 . . . . 15.0 111.051 -176.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.41 -46.2 90.87 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.78 -0.368 . . . . 15.0 111.336 -177.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -60.29 -40.04 89.04 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.532 -0.467 . . . . 15.0 110.688 -177.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -60.57 -51.61 68.67 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 120.27 -0.572 . . . . 15.0 111.134 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.474 HD13 HG21 ' A' ' 5' ' ' VAL . 82.3 mt -66.31 -36.12 82.13 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.474 -0.49 . . . . 15.0 111.256 -176.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -61.66 -43.42 98.89 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 121.111 -0.236 . . . . 15.0 110.699 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.9 -30.7 70.26 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 120.844 -0.694 . . . . 15.0 112.018 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -88.21 8.59 26.41 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.647 0.98 . . . . 15.0 113.647 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.2 12.01 63.95 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 121.241 -0.505 . . . . 15.0 113.462 176.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.11 139.89 21.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 117.886 0.843 . . . . 15.0 110.044 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -86.26 137.44 32.61 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.699 -0.482 . . . . 15.0 109.699 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.51 ' CG1' HD11 ' A' ' 7' ' ' ILE . 38.6 t -116.78 131.13 70.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.186 0.517 . . . . 15.0 110.96 -174.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -134.81 130.2 35.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.587 -0.733 . . . . 15.0 109.446 171.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -112.01 135.69 52.32 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.896 0.379 . . . . 15.0 110.87 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.0 tp -116.15 113.35 41.53 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-O 118.751 -0.643 . . . . 15.0 110.398 -176.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.35 136.52 63.15 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.189 1.26 . . . . 15.0 112.445 175.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.569 HD21 ' HE3' ' A' ' 8' ' ' MET . 13.4 mt -58.62 -10.96 2.56 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.339 0.866 . . . . 15.0 113.339 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -77.15 -5.81 50.52 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.321 0.859 . . . . 15.0 113.321 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -65.75 146.06 99.0 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 118.491 0.587 . . . . 15.0 110.482 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -80.75 157.13 21.25 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.602 1.535 . . . . 15.0 113.142 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.41 151.47 5.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.921 -0.582 . . . . 15.0 111.331 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.13 -38.03 3.24 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.527 -0.629 . . . . 15.0 111.527 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -62.45 -36.69 83.22 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.601 -0.44 . . . . 15.0 111.096 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.559 ' O ' HG23 ' A' ' 44' ' ' VAL . 27.4 tp -59.11 -47.12 86.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.962 0.411 . . . . 15.0 110.196 -178.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.5 HD13 ' CB ' ' A' ' 70' ' ' ASP . 19.4 tp -62.71 -45.2 93.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 15.0 110.868 -176.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.68 -44.53 96.77 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.687 -0.405 . . . . 15.0 110.76 -176.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.488 ' CD ' HD13 ' A' ' 6' ' ' LEU . 58.9 ttm-85 -60.72 -42.56 97.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.503 -0.317 . . . . 15.0 110.773 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 40' ' ' LEU . 97.9 t -60.46 -45.85 96.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.778 -0.369 . . . . 15.0 110.215 -177.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 62.1 ttm-85 -67.45 -51.63 49.18 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 123.453 0.471 . . . . 15.0 112.005 -176.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.36 -44.31 79.32 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 121.05 -0.26 . . . . 15.0 111.698 -174.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -78.85 -10.18 59.71 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.065 0.765 . . . . 15.0 113.065 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 54.67 55.83 7.46 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.515 0.674 . . . . 15.0 110.568 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.482 HD13 ' HB2' ' A' ' 6' ' ' LEU . 97.8 mt -74.15 143.75 45.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.794 -0.639 . . . . 15.0 111.086 -176.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.52 ' O ' HD22 ' A' ' 77' ' ' LEU . 9.4 m120 -90.2 -40.61 12.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.456 -0.793 . . . . 15.0 110.772 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.61 165.89 28.74 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 119.869 -1.158 . . . . 15.0 113.537 -171.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.1 mt -127.09 145.69 50.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.665 -0.768 . . . . 15.0 110.042 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.494 HG22 ' CD1' ' A' ' 80' ' ' PHE . 47.3 t -122.78 133.2 69.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 110.248 -0.279 . . . . 15.0 110.248 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.426 HG12 ' HG3' ' A' ' 8' ' ' MET . 10.2 m -124.57 138.35 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 120.99 0.424 . . . . 15.0 110.609 174.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.1 p -90.05 -18.02 26.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.727 -0.67 . . . . 15.0 112.636 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 77.0 p -156.68 161.43 39.86 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 121.364 0.602 . . . . 15.0 111.719 -176.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.95 -37.25 69.73 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.193 -0.763 . . . . 15.0 111.193 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -59.17 -46.09 89.29 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.899 -0.32 . . . . 15.0 110.789 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.9 -42.78 98.36 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.808 -0.917 . . . . 15.0 110.808 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.609 HD13 HD21 ' A' ' 79' ' ' LEU . 28.8 tp -58.11 -47.33 83.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.987 0.423 . . . . 15.0 110.622 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.49 -43.61 98.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.181 -0.463 . . . . 15.0 110.644 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.407 ' CB ' HD22 ' A' ' 33' ' ' LEU . 79.4 m-20 -59.09 -40.91 86.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.104 -0.498 . . . . 15.0 110.527 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.2 tp -56.76 -42.55 79.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.059 0.457 . . . . 15.0 110.194 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -58.74 -46.99 86.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.875 -0.602 . . . . 15.0 110.238 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -61.37 -43.2 99.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.794 -0.639 . . . . 15.0 111.098 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.83 -35.99 82.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.281 -0.418 . . . . 15.0 111.437 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.659 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.55 -38.49 81.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.063 0.458 . . . . 15.0 110.816 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.45 -143.56 0.57 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 109.454 -0.572 . . . . 15.0 109.454 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.48 -19.1 45.31 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.347 0.976 . . . . 15.0 112.66 -174.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.5 ' CB ' HD13 ' A' ' 41' ' ' LEU . 13.8 m-20 -91.84 10.39 28.83 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.295 0.85 . . . . 15.0 113.295 -174.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 53.5 t-105 -47.75 -48.13 60.75 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 118.553 -0.737 . . . . 15.0 112.423 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -44.72 -40.37 14.26 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.47 1.447 . . . . 15.0 113.159 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -77.1 -48.6 17.33 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.936 0.398 . . . . 15.0 111.202 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.659 HD12 ' HB1' ' A' ' 67' ' ' ALA . 93.7 mt -59.11 -39.27 78.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 15.0 110.826 -177.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.96 0.4 14.92 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 119.693 -0.504 . . . . 15.0 113.22 -175.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.3 mtm105 -90.58 -1.28 57.88 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.013 0.906 . . . . 15.0 112.975 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.52 HD22 ' O ' ' A' ' 50' ' ' ASN . 23.3 mt -90.09 139.47 27.27 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-O 118.869 -0.586 . . . . 15.0 109.656 172.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.67 131.23 40.51 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.376 1.384 . . . . 15.0 111.759 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.609 HD21 HD13 ' A' ' 60' ' ' LEU . 24.3 tp -105.43 128.07 53.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.748 0.309 . . . . 15.0 110.9 177.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.494 ' CD1' HG22 ' A' ' 53' ' ' VAL . 73.3 m-85 -92.84 127.13 38.23 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.696 -0.483 . . . . 15.0 109.696 176.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 99' ' ' ILE . 32.8 m -123.15 151.58 62.18 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-O 119.567 -0.254 . . . . 15.0 110.67 177.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.28 -19.63 10.31 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 121.514 1.476 . . . . 15.0 113.803 -175.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.0 p -148.83 162.47 29.38 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 120.391 -0.524 . . . . 15.0 111.841 -171.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.4 -43.96 47.0 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.2 1.267 . . . . 15.0 111.885 176.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -58.2 -46.75 85.27 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.808 -0.357 . . . . 15.0 110.71 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 50.2 t -60.95 -38.38 79.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.689 -0.404 . . . . 15.0 110.128 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.448 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -56.85 -41.71 78.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.042 0.449 . . . . 15.0 110.427 177.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -60.88 -40.09 91.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.154 -0.476 . . . . 15.0 110.616 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.1 mmm -58.34 -45.85 87.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.45 0.643 . . . . 15.0 110.173 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.494 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -62.09 -42.11 98.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.733 -0.667 . . . . 15.0 111.112 -177.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 71.6 ttp85 -62.28 -44.2 97.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.186 -0.461 . . . . 15.0 110.708 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -59.33 -36.15 75.12 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.978 -0.289 . . . . 15.0 111.236 -177.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 81.5 mt -65.46 -25.24 67.42 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.098 0.407 . . . . 15.0 112.098 177.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 111.58 13.2 13.24 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 119.293 -0.726 . . . . 15.0 113.235 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.22 131.08 49.95 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.566 1.183 . . . . 15.0 109.666 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -62.24 -44.42 96.59 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.452 -0.573 . . . . 15.0 109.452 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 47.9 ttt85 -131.84 119.03 20.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.464 -0.789 . . . . 15.0 110.945 -173.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.8 t -114.43 128.78 71.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.829 -0.623 . . . . 15.0 109.503 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.448 ' O ' HG22 ' A' ' 81' ' ' VAL . 93.2 mt -117.79 123.92 72.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.903 -0.59 . . . . 15.0 110.279 -175.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -94.36 118.22 31.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.364 -0.38 . . . . 15.0 110.22 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.7 p -91.33 -6.94 52.3 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.141 0.793 . . . . 15.0 113.141 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 47.0 tpt85 -55.51 -39.61 70.73 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 118.208 0.458 . . . . 15.0 110.723 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.33 -35.2 5.32 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.48 -0.648 . . . . 15.0 111.48 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.11 144.25 42.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.816 0.341 . . . . 15.0 110.55 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.1 m -89.72 161.8 15.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.04 0.448 . . . . 15.0 110.578 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.65 -54.27 24.25 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 112.976 0.732 . . . . 15.0 112.976 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.05 -34.84 98.9 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 CA-C-N 120.213 1.112 . . . . 15.0 111.601 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.63 94.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.061 0.457 . . . . 15.0 110.048 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.3 mt -59.05 -40.9 86.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.446 . . . . 15.0 110.411 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 40.7 tp -57.31 -44.46 84.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.383 0.611 . . . . 15.0 110.136 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.31 -39.74 88.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.583 -0.735 . . . . 15.0 110.677 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.88 -42.42 97.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.415 -0.357 . . . . 15.0 110.899 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.0 mt -57.88 -50.36 73.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.026 0.441 . . . . 15.0 110.428 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.8 p -65.38 -39.95 92.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.827 -0.624 . . . . 15.0 111.576 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.1 p -66.35 -38.42 87.57 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.999 -0.28 . . . . 15.0 111.28 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.63 -42.59 95.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.41 -0.359 . . . . 15.0 111.133 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.249 0 CA-C-O 120.756 0.313 . . . . 15.0 110.579 179.856 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 . . . . . 0 CA--C 1.535 0.393 0 N-CA-C 110.238 -0.282 . . . . 15.0 110.238 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -50.99 154.53 7.15 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.486 1.457 . . . . 15.0 111.871 -176.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.5 ' HB2' HD23 ' A' ' 49' ' ' LEU . 93.8 mttt -116.43 140.39 49.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.448 -0.342 . . . . 15.0 110.831 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.577 HG21 HD13 ' A' ' 21' ' ' LEU . 12.2 m -135.4 143.78 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.638 0.732 . . . . 15.0 111.69 175.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 tp -104.72 134.34 48.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.855 -1.066 . . . . 15.0 110.262 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.562 HD11 ' CG1' ' A' ' 28' ' ' VAL . 48.9 mt -103.35 135.15 42.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 15.0 110.505 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.629 ' SD ' HD13 ' A' ' 63' ' ' LEU . 85.9 mtp -101.08 134.11 44.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.66 -0.7 . . . . 15.0 109.531 172.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -57.61 146.47 30.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.002 0.429 . . . . 15.0 110.81 -174.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.92 175.14 33.79 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.97 -0.852 . . . . 15.0 110.97 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.56 -32.62 67.31 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.602 0.223 . . . . 15.0 111.602 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.51 177.01 18.25 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.014 -0.835 . . . . 15.0 111.014 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.0 122.09 5.81 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.313 -0.715 . . . . 15.0 111.313 -178.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -57.17 -44.52 83.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.098 0.475 . . . . 15.0 110.27 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.96 -41.13 97.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.927 -0.579 . . . . 15.0 110.958 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -57.88 -55.98 27.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.981 0.42 . . . . 15.0 111.0 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.417 HD21 HG11 ' A' ' 53' ' ' VAL . 26.8 tp -60.54 -42.13 95.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 15.0 111.025 -176.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.06 -43.69 98.51 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.799 -0.36 . . . . 15.0 111.45 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -61.73 -39.46 91.64 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.704 -0.398 . . . . 15.0 110.818 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -61.01 -51.6 68.54 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.381 -0.527 . . . . 15.0 111.232 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.577 HD13 HG21 ' A' ' 5' ' ' VAL . 80.9 mt -64.26 -37.58 87.97 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.409 -0.516 . . . . 15.0 111.001 -177.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -63.79 -43.8 95.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.59 0.233 . . . . 15.0 111.121 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.93 -30.66 66.81 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.03 -0.605 . . . . 15.0 111.961 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -88.03 9.33 22.81 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.57 0.952 . . . . 15.0 113.57 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.21 13.63 58.5 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 121.247 -0.501 . . . . 15.0 113.554 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.0 t -101.09 138.15 26.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 117.845 0.822 . . . . 15.0 110.061 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -79.51 132.42 36.32 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.194 -0.669 . . . . 15.0 109.194 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.562 ' CG1' HD11 ' A' ' 7' ' ' ILE . 39.6 t -116.36 131.17 69.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.194 0.521 . . . . 15.0 111.106 -173.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -137.73 130.8 30.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.413 -0.812 . . . . 15.0 109.377 170.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.406 ' HB3' HD12 ' A' ' 7' ' ' ILE . 31.0 p90 -114.15 135.11 54.39 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.87 0.366 . . . . 15.0 110.645 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 tp -112.99 136.04 21.7 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.946 -0.55 . . . . 15.0 110.027 -175.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -72.16 135.11 24.36 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.332 1.354 . . . . 15.0 111.976 172.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.613 HD22 ' CB ' ' A' ' 62' ' ' ASN . 62.4 mt -58.36 -11.94 3.3 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.33 0.863 . . . . 15.0 113.33 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -77.21 -6.64 53.78 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.392 0.886 . . . . 15.0 113.392 -176.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -68.55 150.9 97.52 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 118.524 0.602 . . . . 15.0 110.738 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -78.95 155.9 26.61 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.64 1.56 . . . . 15.0 113.102 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.11 151.99 4.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.763 -0.653 . . . . 15.0 111.226 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.44 -38.03 3.24 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.945 -0.57 . . . . 15.0 111.688 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.68 -38.86 86.35 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 117.172 0.486 . . . . 15.0 110.738 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.531 ' O ' HG23 ' A' ' 44' ' ' VAL . 18.2 tp -60.46 -48.3 82.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.954 0.407 . . . . 15.0 110.4 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.435 HD22 ' CG ' ' A' ' 70' ' ' ASP . 21.3 tp -60.38 -42.38 95.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 15.0 110.772 -175.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.25 -46.24 89.72 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.664 -0.415 . . . . 15.0 110.909 -175.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 -61.1 -41.35 96.52 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.499 -0.48 . . . . 15.0 110.679 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 40' ' ' LEU . 82.2 t -60.33 -46.08 95.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.748 -0.381 . . . . 15.0 110.202 -176.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -68.57 -51.32 44.03 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 123.421 0.45 . . . . 15.0 112.066 -175.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.29 -44.25 79.72 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.857 0.317 . . . . 15.0 111.857 -173.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -79.56 -10.07 59.73 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.08 0.77 . . . . 15.0 113.08 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 55.5 55.78 6.96 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.632 0.729 . . . . 15.0 110.219 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.5 HD23 ' HB2' ' A' ' 4' ' ' LYS . 96.0 mt -68.04 143.56 55.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.671 -0.695 . . . . 15.0 111.364 -174.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -91.16 -40.13 11.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.151 -0.931 . . . . 15.0 110.838 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.37 160.75 28.46 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.023 -1.084 . . . . 15.0 113.788 -174.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 71.3 mt -125.39 143.39 51.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.486 -0.857 . . . . 15.0 109.618 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.53 HG22 ' CD1' ' A' ' 80' ' ' PHE . 45.6 t -122.11 132.07 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 121.148 -0.221 . . . . 15.0 110.764 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.405 HG12 ' SD ' ' A' ' 8' ' ' MET . 8.5 m -124.23 145.78 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.144 0.497 . . . . 15.0 110.524 172.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 t -98.1 -21.45 16.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.479 -0.782 . . . . 15.0 112.426 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 81.3 p -152.73 162.16 41.62 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.414 0.625 . . . . 15.0 111.801 -174.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.86 -37.08 68.36 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.118 -0.793 . . . . 15.0 111.118 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -58.98 -46.08 88.99 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.858 -0.337 . . . . 15.0 110.646 -177.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.56 -44.07 98.18 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.732 -0.947 . . . . 15.0 110.732 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.627 HD13 HD21 ' A' ' 79' ' ' LEU . 32.2 tp -57.04 -45.09 83.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.112 0.482 . . . . 15.0 110.672 -178.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.72 -43.69 98.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 15.0 110.534 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.613 ' CB ' HD22 ' A' ' 33' ' ' LEU . 81.1 m-20 -59.83 -38.1 81.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.706 178.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.629 HD13 ' SD ' ' A' ' 8' ' ' MET . 9.5 tp -56.69 -44.9 81.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.388 0.613 . . . . 15.0 110.155 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -60.0 -46.87 88.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.495 -0.775 . . . . 15.0 110.584 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -61.51 -43.23 99.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.975 -0.557 . . . . 15.0 111.091 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.09 -34.99 78.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.449 -0.342 . . . . 15.0 111.468 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.668 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.46 -38.14 80.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.965 0.412 . . . . 15.0 110.69 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.2 -143.93 0.58 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 109.605 -0.517 . . . . 15.0 109.605 174.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.53 -18.87 44.08 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.336 0.971 . . . . 15.0 112.678 -174.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.435 ' CG ' HD22 ' A' ' 41' ' ' LEU . 23.3 m-20 -91.86 10.8 27.17 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.282 0.845 . . . . 15.0 113.282 -175.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 60.0 t-105 -47.81 -46.56 62.65 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-O 118.588 -0.72 . . . . 15.0 112.556 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -44.74 -41.6 14.86 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.438 1.425 . . . . 15.0 113.267 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -77.03 -48.79 16.92 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.954 0.407 . . . . 15.0 110.819 -177.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.668 HD12 ' HB1' ' A' ' 67' ' ' ALA . 90.3 mt -59.57 -40.56 82.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 15.0 110.855 -176.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.68 -15.87 35.37 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 116.392 -0.367 . . . . 15.0 113.144 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -65.06 -29.93 70.85 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.355 0.578 . . . . 15.0 112.073 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.2 mt -75.7 150.51 84.21 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 121.018 -0.273 . . . . 15.0 111.648 -173.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.31 128.23 23.21 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.751 1.634 . . . . 15.0 112.481 176.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.627 HD21 HD13 ' A' ' 60' ' ' LEU . 23.9 tp -106.32 125.66 51.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.343 -0.389 . . . . 15.0 110.516 174.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.53 ' CD1' HG22 ' A' ' 53' ' ' VAL . 69.3 m-85 -90.05 126.56 35.81 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.634 -0.506 . . . . 15.0 109.634 176.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.653 HG21 ' HB2' ' A' ' 87' ' ' ALA . 26.7 m -119.06 147.28 42.31 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 119.438 -0.315 . . . . 15.0 110.176 176.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.14 -24.27 6.91 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.601 1.534 . . . . 15.0 113.529 -175.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.3 p -142.98 162.54 42.98 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 120.602 -0.439 . . . . 15.0 111.52 -171.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.14 -44.07 50.26 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.184 1.256 . . . . 15.0 111.755 176.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 70.9 ttp85 -57.45 -48.39 79.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.833 0.349 . . . . 15.0 110.845 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.8 t -59.9 -40.07 81.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.99 -0.374 . . . . 15.0 109.99 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.653 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.42 -42.29 82.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.903 0.383 . . . . 15.0 110.371 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -60.47 -40.11 90.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 15.0 110.621 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.1 mmm -58.46 -43.68 88.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.364 0.602 . . . . 15.0 110.212 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.496 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.16 -42.4 98.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.8 -0.636 . . . . 15.0 110.883 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.455 ' HD2' HG21 ' A' ' 98' ' ' VAL . 28.9 mmm180 -62.87 -42.01 99.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 15.0 110.871 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -59.64 -36.19 75.89 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.909 -0.317 . . . . 15.0 111.3 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.9 mt -68.96 -21.43 64.18 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.569 0.581 . . . . 15.0 112.569 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 106.85 13.28 22.28 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 119.376 -0.68 . . . . 15.0 113.086 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.79 122.14 12.15 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.439 1.12 . . . . 15.0 109.989 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -68.13 -36.04 79.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.55 -0.75 . . . . 15.0 111.226 -171.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.7 ttm-85 -131.76 114.03 14.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.045 0.45 . . . . 15.0 110.575 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.455 HG21 ' HD2' ' A' ' 91' ' ' ARG . 47.0 t -112.39 130.58 65.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.175 -0.466 . . . . 15.0 109.873 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.5 mt -119.74 123.73 71.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.941 -0.572 . . . . 15.0 110.142 -176.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.27 118.47 31.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.381 -0.372 . . . . 15.0 110.193 176.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.5 p -96.04 -3.99 43.86 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.283 0.846 . . . . 15.0 113.283 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -56.02 -39.96 72.7 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 118.199 0.454 . . . . 15.0 110.698 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -92.06 -35.07 6.86 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.505 -0.638 . . . . 15.0 111.505 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.44 142.38 41.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.841 0.353 . . . . 15.0 110.704 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.2 m -89.82 164.07 14.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 15.0 110.327 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.61 -54.22 24.43 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-O 118.523 -0.751 . . . . 15.0 112.963 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.59 -36.18 97.74 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 CA-C-N 120.583 1.244 . . . . 15.0 111.346 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.21 -42.61 95.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.046 0.451 . . . . 15.0 110.165 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.0 mt -58.95 -40.66 85.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 15.0 110.44 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 29.2 tp -57.36 -44.35 84.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.31 0.576 . . . . 15.0 110.181 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.6 -40.99 93.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.656 -0.702 . . . . 15.0 110.556 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.23 92.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.356 -0.384 . . . . 15.0 110.805 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.1 mt -57.9 -51.39 69.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.284 0.564 . . . . 15.0 110.451 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.2 p -64.69 -40.27 95.09 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.585 -0.734 . . . . 15.0 111.38 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.3 p -64.6 -38.88 92.52 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.037 -0.265 . . . . 15.0 111.335 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.81 -42.72 99.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.747 0.308 . . . . 15.0 110.891 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.375 -0.375 . . . . 15.0 110.769 178.556 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.534 0.331 0 N-CA-C 110.421 -0.214 . . . . 15.0 110.421 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.01 153.89 5.91 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.373 1.382 . . . . 15.0 111.918 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -109.98 138.38 46.44 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.552 -0.295 . . . . 15.0 110.866 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.471 HG21 HD13 ' A' ' 21' ' ' LEU . 12.4 m -135.96 144.16 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 121.612 0.72 . . . . 15.0 111.707 177.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.408 HD13 ' CD ' ' A' ' 43' ' ' ARG . 12.4 tp -104.55 135.84 45.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.936 -1.029 . . . . 15.0 110.233 177.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.57 HD11 ' CG1' ' A' ' 28' ' ' VAL . 50.3 mt -102.58 135.11 41.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.279 -0.419 . . . . 15.0 110.319 -178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.487 ' SD ' HD13 ' A' ' 63' ' ' LEU . 86.5 mtp -99.08 134.02 42.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.898 -0.592 . . . . 15.0 110.305 173.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -57.59 140.93 49.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.377 . . . . 15.0 110.641 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.55 175.18 31.26 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.826 -0.91 . . . . 15.0 110.826 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.42 -33.02 65.42 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.163 -0.215 . . . . 15.0 111.424 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.7 176.27 32.65 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.674 -0.97 . . . . 15.0 110.674 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.98 120.66 5.55 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.951 -0.642 . . . . 15.0 111.519 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -57.01 -41.39 78.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.803 0.335 . . . . 15.0 110.575 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -62.23 -41.93 98.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.426 . . . . 15.0 111.229 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -63.42 -55.88 20.76 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.793 -0.363 . . . . 15.0 111.345 -176.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.0 mt -59.55 -43.69 93.45 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.724 -0.39 . . . . 15.0 110.967 -176.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.503 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -62.55 -40.24 96.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 15.0 110.812 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.89 -41.92 92.67 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.962 -0.295 . . . . 15.0 110.505 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -60.0 -51.74 68.36 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.591 -0.443 . . . . 15.0 110.999 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.471 HD13 HG21 ' A' ' 5' ' ' VAL . 80.6 mt -62.46 -37.53 86.29 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.497 -0.481 . . . . 15.0 111.103 -178.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -63.32 -44.26 95.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.554 0.216 . . . . 15.0 110.929 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.18 -30.58 67.55 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.019 -0.61 . . . . 15.0 111.92 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -88.09 10.08 20.44 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.556 0.947 . . . . 15.0 113.556 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.09 18.82 41.66 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 121.109 -0.567 . . . . 15.0 113.351 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.3 t -101.02 139.97 20.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 117.665 0.732 . . . . 15.0 110.19 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -82.22 126.0 31.58 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.865 -0.791 . . . . 15.0 108.865 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.57 ' CG1' HD11 ' A' ' 7' ' ' ILE . 42.3 t -116.02 130.93 69.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.314 0.578 . . . . 15.0 111.331 -171.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -137.23 133.56 35.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.274 -0.875 . . . . 15.0 109.439 170.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.402 ' HB3' HD12 ' A' ' 7' ' ' ILE . 36.4 p90 -114.08 135.85 53.57 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.92 0.391 . . . . 15.0 110.857 -178.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 tp -116.16 113.3 41.51 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.632 -0.699 . . . . 15.0 110.194 -176.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.0 135.12 50.94 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.159 1.239 . . . . 15.0 112.09 174.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.579 HD13 HD22 ' A' ' 62' ' ' ASN . 84.4 mt -60.65 -9.2 3.56 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.325 0.861 . . . . 15.0 113.325 -178.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -77.15 -6.03 51.33 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.184 0.809 . . . . 15.0 113.184 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -64.62 150.11 94.49 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 118.512 0.596 . . . . 15.0 110.378 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -80.04 154.93 22.74 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.544 1.496 . . . . 15.0 113.27 -177.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.72 152.1 3.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.883 -0.599 . . . . 15.0 111.362 -178.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.23 -37.95 3.26 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.611 -0.596 . . . . 15.0 111.611 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -61.23 -36.52 80.17 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.607 -0.437 . . . . 15.0 111.184 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.558 ' O ' HG23 ' A' ' 44' ' ' VAL . 25.4 tp -59.16 -48.83 80.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.965 0.412 . . . . 15.0 110.228 -178.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.451 HD22 ' CG ' ' A' ' 70' ' ' ASP . 23.1 tp -62.73 -44.25 96.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 15.0 110.988 -175.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.08 -44.84 95.79 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.67 -0.412 . . . . 15.0 110.907 -176.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.408 ' CD ' HD13 ' A' ' 6' ' ' LEU . 60.0 ttm-85 -60.79 -41.87 96.46 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 121.01 -0.276 . . . . 15.0 110.713 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 40' ' ' LEU . 98.4 t -60.68 -45.78 96.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.835 -0.346 . . . . 15.0 110.111 -177.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -70.52 -46.86 62.83 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.1 0.408 . . . . 15.0 112.1 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.49 -44.44 82.62 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.047 -0.261 . . . . 15.0 111.442 -175.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -81.15 -10.16 59.69 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.124 0.787 . . . . 15.0 113.124 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 54.66 55.89 7.4 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.582 0.706 . . . . 15.0 110.483 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.4 mt -69.94 150.63 46.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.618 -0.719 . . . . 15.0 111.546 -175.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -95.25 -40.51 9.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.162 -0.926 . . . . 15.0 110.767 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -149.7 165.36 29.62 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 119.955 -1.117 . . . . 15.0 113.75 -174.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 70.7 mt -126.09 142.57 51.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.489 -0.856 . . . . 15.0 109.575 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.518 HG22 ' CD1' ' A' ' 80' ' ' PHE . 46.2 t -121.39 130.18 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.682 0.277 . . . . 15.0 110.777 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.7 m -128.1 155.68 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.02 0.438 . . . . 15.0 110.575 171.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.3 t -131.34 14.4 5.06 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.681 -0.691 . . . . 15.0 112.408 176.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.6 p -155.0 149.35 26.16 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.267 0.556 . . . . 15.0 111.548 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.89 -40.18 92.74 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.61 -0.996 . . . . 15.0 110.61 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -58.57 -41.4 85.57 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.916 -0.314 . . . . 15.0 110.473 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.91 -47.15 92.67 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.774 -0.93 . . . . 15.0 110.774 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.413 HD21 ' HA ' ' A' ' 90' ' ' ALA . 27.1 tp -57.06 -44.43 83.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.109 0.48 . . . . 15.0 110.653 -178.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.78 -43.59 98.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.032 -0.531 . . . . 15.0 110.822 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.579 HD22 HD13 ' A' ' 33' ' ' LEU . 84.3 m-20 -59.36 -38.93 81.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 15.0 110.767 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.487 HD13 ' SD ' ' A' ' 8' ' ' MET . 13.2 tp -57.48 -44.81 85.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.247 0.546 . . . . 15.0 110.172 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -60.68 -47.15 87.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.675 -0.693 . . . . 15.0 110.468 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -61.97 -43.94 97.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 15.0 111.31 -176.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.57 -35.24 79.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.367 -0.379 . . . . 15.0 111.358 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.67 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.42 -38.78 81.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.939 0.4 . . . . 15.0 110.646 178.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.11 -143.72 0.59 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.58 -0.526 . . . . 15.0 109.58 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.47 -18.14 37.23 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.417 1.008 . . . . 15.0 112.654 -175.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.451 ' CG ' HD22 ' A' ' 41' ' ' LEU . 27.8 m-20 -91.79 9.61 31.94 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.341 0.867 . . . . 15.0 113.341 -175.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 59.2 t-105 -47.85 -47.35 63.14 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-O 118.629 -0.701 . . . . 15.0 112.546 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -44.78 -40.76 14.77 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 121.482 1.455 . . . . 15.0 113.199 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -76.97 -48.79 17.07 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.044 0.45 . . . . 15.0 110.741 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.67 HD12 ' HB1' ' A' ' 67' ' ' ALA . 92.8 mt -59.59 -39.93 80.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.025 -0.534 . . . . 15.0 110.925 -176.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.51 -15.82 33.9 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 119.944 -0.364 . . . . 15.0 113.116 -176.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -65.87 -30.03 70.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.387 0.593 . . . . 15.0 112.016 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.7 mt -74.49 150.62 87.06 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 111.638 0.236 . . . . 15.0 111.638 -172.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.97 123.58 13.2 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.599 1.533 . . . . 15.0 112.026 176.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.8 tp -103.35 123.44 46.82 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.804 -0.358 . . . . 15.0 110.426 174.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.518 ' CD1' HG22 ' A' ' 53' ' ' VAL . 76.5 m-85 -89.38 123.38 33.48 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.057 -0.72 . . . . 15.0 109.057 175.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.738 HG21 ' HB2' ' A' ' 87' ' ' ALA . 25.3 m -112.25 151.82 43.99 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 110.341 -0.244 . . . . 15.0 110.341 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.0 -28.65 3.76 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.414 1.409 . . . . 15.0 113.1 -175.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.4 p -144.39 167.91 13.8 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 120.656 -0.418 . . . . 15.0 111.537 -173.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -60.42 -44.0 30.42 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 121.228 1.286 . . . . 15.0 111.6 177.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -57.0 -47.99 79.52 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.88 -0.328 . . . . 15.0 110.777 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.55 -40.07 83.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.604 -0.438 . . . . 15.0 110.027 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.738 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.01 -41.71 79.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.928 0.394 . . . . 15.0 110.545 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.27 -41.32 96.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.218 -0.447 . . . . 15.0 110.529 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 87.3 mtp -59.57 -44.04 93.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.307 0.575 . . . . 15.0 110.384 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.413 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.5 -40.52 94.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.858 -0.61 . . . . 15.0 110.791 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -61.15 -45.04 96.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.278 -0.419 . . . . 15.0 110.435 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.68 -36.2 76.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.508 -0.315 . . . . 15.0 111.298 -177.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.82 -26.47 68.35 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.108 0.41 . . . . 15.0 112.108 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.21 13.16 10.14 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 119.281 -0.733 . . . . 15.0 113.177 -176.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.9 121.82 11.45 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.597 1.198 . . . . 15.0 109.691 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -71.61 -39.75 70.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.519 -0.764 . . . . 15.0 110.617 -171.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.47 ' NH2' ' HB1' ' A' ' 116' ' ' ALA . 52.8 ttp85 -132.09 113.9 13.9 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.453 0.644 . . . . 15.0 110.832 178.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.2 t -114.43 133.28 61.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.645 -0.707 . . . . 15.0 110.264 -176.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 87.6 mt -117.54 126.42 74.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.677 -0.692 . . . . 15.0 110.244 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -96.26 117.48 30.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.452 -0.34 . . . . 15.0 110.519 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 30.3 p -69.67 -20.32 63.57 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.574 0.583 . . . . 15.0 112.574 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -53.21 -36.97 61.57 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 122.113 -0.367 . . . . 15.0 111.508 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.27 -35.18 8.19 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 120.824 -0.703 . . . . 15.0 111.648 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -92.18 120.92 33.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.766 0.317 . . . . 15.0 111.121 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.485 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 49.9 m -70.44 165.85 21.65 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.433 -0.58 . . . . 15.0 109.433 174.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.55 -54.4 22.85 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 112.776 0.658 . . . . 15.0 112.776 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -57.49 -34.96 98.84 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 120.9 1.067 . . . . 15.0 111.4 176.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 105' ' ' SER . . . -61.14 -40.8 95.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.842 0.353 . . . . 15.0 110.365 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.2 mt -58.97 -41.79 88.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.015 0.435 . . . . 15.0 110.169 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.5 tp -57.23 -45.15 84.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.488 0.661 . . . . 15.0 110.169 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.46 91.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.505 -0.77 . . . . 15.0 110.817 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.97 -42.47 98.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.578 -0.283 . . . . 15.0 110.815 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.6 mt -57.94 -52.25 66.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.397 0.617 . . . . 15.0 110.463 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.7 p -66.32 -38.36 87.53 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.454 -0.794 . . . . 15.0 111.656 -174.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.3 p -67.65 -38.19 83.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.709 0.29 . . . . 15.0 111.322 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.47 ' HB1' ' NH2' ' A' ' 97' ' ' ARG . . . -62.7 -40.57 97.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.423 -0.353 . . . . 15.0 110.827 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.395 -0.366 . . . . 15.0 110.797 178.345 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 110.29 -0.263 . . . . 15.0 110.29 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.42 ' HG2' HG22 ' A' ' 26' ' ' VAL . 17.2 Cg_endo -55.58 154.98 22.91 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 121.439 1.426 . . . . 15.0 111.696 -176.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.462 ' HB2' HD23 ' A' ' 49' ' ' LEU . 97.9 mttt -111.98 140.11 46.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.582 -0.281 . . . . 15.0 110.815 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.443 HG21 HD13 ' A' ' 21' ' ' LEU . 15.9 m -136.17 143.92 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.647 0.737 . . . . 15.0 111.818 175.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.1 tp -105.07 136.75 43.97 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.924 -1.034 . . . . 15.0 110.245 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.633 HD11 ' CG1' ' A' ' 28' ' ' VAL . 51.0 mt -104.61 135.14 43.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.096 0.474 . . . . 15.0 111.067 -177.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.511 ' HB2' HG12 ' A' ' 54' ' ' VAL . 99.0 mmm -94.89 134.04 37.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.134 -0.939 . . . . 15.0 109.364 172.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -66.28 145.07 56.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.937 0.398 . . . . 15.0 110.554 -178.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -161.08 175.22 37.74 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.76 -0.936 . . . . 15.0 110.76 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -51.29 -31.2 20.58 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.847 0.314 . . . . 15.0 111.847 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.99 -174.02 1.74 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.938 -0.865 . . . . 15.0 110.938 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -108.4 109.58 2.9 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.49 -0.644 . . . . 15.0 111.49 -177.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.3 mtm-85 -55.2 -38.85 68.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.645 0.26 . . . . 15.0 111.035 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -59.87 -54.98 39.84 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.067 0.395 . . . . 15.0 112.067 -172.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -69.95 -45.09 68.18 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.274 -0.57 . . . . 15.0 111.435 -173.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.1 tp -58.12 -44.84 87.96 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 120.491 -0.484 . . . . 15.0 110.589 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.412 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -62.75 -42.5 99.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 15.0 110.44 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -57.96 -40.46 80.65 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.931 -0.308 . . . . 15.0 110.562 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -59.08 -51.64 69.19 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.959 0.409 . . . . 15.0 111.042 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.443 HD13 HG21 ' A' ' 5' ' ' VAL . 77.7 mt -59.81 -37.32 78.81 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.567 -0.453 . . . . 15.0 110.887 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -62.95 -41.97 99.68 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 121.107 -0.237 . . . . 15.0 111.119 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.25 -30.56 67.75 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 120.981 -0.628 . . . . 15.0 111.966 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -88.18 9.57 22.42 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.557 0.947 . . . . 15.0 113.557 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.32 15.42 58.78 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 121.23 -0.509 . . . . 15.0 113.393 175.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.42 HG22 ' HG2' ' A' ' 3' ' ' PRO . 43.9 t -101.04 137.84 27.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 117.917 0.858 . . . . 15.0 110.209 178.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -81.17 129.92 34.79 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.367 -0.605 . . . . 15.0 109.367 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.633 ' CG1' HD11 ' A' ' 7' ' ' ILE . 42.4 t -120.11 132.23 70.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.241 0.543 . . . . 15.0 111.192 -173.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -139.18 135.22 33.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.391 -0.822 . . . . 15.0 109.731 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.432 ' HB3' HD12 ' A' ' 7' ' ' ILE . 32.0 p90 -114.8 138.78 50.35 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.775 0.322 . . . . 15.0 110.553 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.0 tp -114.85 113.43 44.49 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 118.756 -0.64 . . . . 15.0 110.896 -173.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -49.88 135.07 35.89 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.158 1.238 . . . . 15.0 111.886 172.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.82 HD13 ' ND2' ' A' ' 62' ' ' ASN . 58.1 mt -66.79 -11.13 53.98 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.216 0.821 . . . . 15.0 113.216 -174.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -77.31 -9.4 58.8 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.169 0.803 . . . . 15.0 113.169 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -65.28 148.02 98.22 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 118.502 0.592 . . . . 15.0 110.544 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.34 148.74 43.93 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.565 1.51 . . . . 15.0 113.58 -174.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.93 152.52 3.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.465 -0.789 . . . . 15.0 111.228 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.2 -38.15 3.21 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.497 -0.641 . . . . 15.0 111.497 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -64.16 -36.38 83.86 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 120.426 -0.51 . . . . 15.0 111.12 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.547 HD21 ' CD1' ' A' ' 63' ' ' LEU . 24.5 tp -58.66 -45.97 88.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.896 0.379 . . . . 15.0 110.196 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.497 HD22 ' CG ' ' A' ' 70' ' ' ASP . 16.8 tp -63.49 -45.57 90.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 15.0 110.902 -177.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.78 99.25 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.784 -0.367 . . . . 15.0 110.859 -177.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -60.99 -44.14 97.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.428 -0.351 . . . . 15.0 110.511 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 40' ' ' LEU . 67.3 t -61.5 -46.1 97.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.935 -0.306 . . . . 15.0 110.252 -177.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 70.7 ttp85 -68.53 -48.07 65.28 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.984 0.364 . . . . 15.0 111.984 -176.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.09 -44.47 84.28 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.1 -0.24 . . . . 15.0 111.512 -173.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -81.99 -10.01 59.38 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.249 0.833 . . . . 15.0 113.249 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 55.86 55.82 6.64 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.607 0.718 . . . . 15.0 110.336 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.484 HD12 HG22 ' A' ' 44' ' ' VAL . 95.5 mt -63.53 146.09 54.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.601 -0.727 . . . . 15.0 111.426 -174.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -87.72 -39.76 14.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.982 -1.008 . . . . 15.0 110.685 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.52 166.39 30.7 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.045 -1.074 . . . . 15.0 113.639 -174.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.1 mt -125.91 142.08 51.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.507 -0.846 . . . . 15.0 109.612 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.519 HG22 ' CD1' ' A' ' 80' ' ' PHE . 48.0 t -121.47 131.37 73.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.282 -0.266 . . . . 15.0 110.282 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.511 HG12 ' HB2' ' A' ' 8' ' ' MET . 6.5 m -125.69 130.44 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.009 0.433 . . . . 15.0 110.216 172.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.7 p -92.81 -10.86 35.3 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.915 0.709 . . . . 15.0 112.915 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 82.8 p -152.52 157.6 41.33 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 121.271 0.558 . . . . 15.0 111.561 -176.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.78 -38.92 85.94 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.962 -0.855 . . . . 15.0 110.962 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -58.97 -43.93 91.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.777 0.322 . . . . 15.0 110.416 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.3 -44.84 97.09 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.784 -0.926 . . . . 15.0 110.784 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.587 HD13 HD21 ' A' ' 79' ' ' LEU . 32.9 tp -57.7 -44.61 85.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.095 0.474 . . . . 15.0 110.531 -178.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.26 -42.23 98.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.063 -0.517 . . . . 15.0 110.64 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.82 ' ND2' HD13 ' A' ' 33' ' ' LEU . 69.4 m-80 -58.99 -39.91 83.23 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.834 -0.346 . . . . 15.0 110.628 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.547 ' CD1' HD21 ' A' ' 40' ' ' LEU . 12.5 tp -58.23 -44.83 88.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.181 0.515 . . . . 15.0 110.109 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -61.6 -47.22 86.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.697 -0.683 . . . . 15.0 110.787 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -61.91 -43.86 97.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 15.0 111.185 -176.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.3 mt -66.3 -34.98 79.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.351 -0.386 . . . . 15.0 111.387 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.674 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.0 -39.17 81.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.126 0.489 . . . . 15.0 110.581 177.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.16 -143.3 0.6 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 109.609 -0.515 . . . . 15.0 109.609 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.44 -19.09 44.88 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.391 0.996 . . . . 15.0 112.608 -175.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.497 ' CG ' HD22 ' A' ' 41' ' ' LEU . 22.3 m-20 -91.91 10.44 28.78 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.297 0.851 . . . . 15.0 113.297 -175.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -47.81 -46.9 63.15 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-O 118.666 -0.683 . . . . 15.0 112.494 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -44.68 -40.43 14.15 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.483 1.455 . . . . 15.0 113.283 177.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -77.0 -48.73 17.17 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.691 -0.404 . . . . 15.0 110.803 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.674 HD12 ' HB1' ' A' ' 67' ' ' ALA . 91.5 mt -59.63 -39.73 80.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 15.0 110.83 -177.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.2 -16.44 34.08 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 116.334 -0.394 . . . . 15.0 113.124 -177.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -64.73 -30.3 71.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 117.365 0.582 . . . . 15.0 111.959 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 27.5 mt -76.45 150.59 82.51 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 120.903 -0.319 . . . . 15.0 111.312 -173.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.4 129.54 28.59 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.63 1.554 . . . . 15.0 112.473 176.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.587 HD21 HD13 ' A' ' 60' ' ' LEU . 24.0 tp -107.78 126.26 52.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.448 -0.342 . . . . 15.0 110.605 175.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.519 ' CD1' HG22 ' A' ' 53' ' ' VAL . 78.7 m-85 -90.97 126.09 35.97 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.721 -0.474 . . . . 15.0 109.721 176.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.676 HG21 ' HB2' ' A' ' 87' ' ' ALA . 29.0 m -117.47 147.15 40.08 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 110.079 -0.341 . . . . 15.0 110.079 176.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.15 -23.25 7.81 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.639 1.56 . . . . 15.0 113.598 -174.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.417 ' OG ' HG23 ' A' ' 86' ' ' VAL . 24.5 p -143.51 158.15 57.8 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 120.737 -0.385 . . . . 15.0 111.33 -172.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.29 -43.95 53.03 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.238 1.292 . . . . 15.0 111.792 176.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -58.11 -47.37 83.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.779 0.323 . . . . 15.0 110.931 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.417 HG23 ' OG ' ' A' ' 83' ' ' SER . 60.8 t -59.89 -40.24 82.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.75 -0.38 . . . . 15.0 110.036 178.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.676 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.36 -42.46 82.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.962 0.41 . . . . 15.0 110.422 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.09 -41.87 97.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.144 -0.48 . . . . 15.0 110.506 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 87.1 mtp -59.29 -43.88 92.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.227 0.537 . . . . 15.0 110.353 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.44 94.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.963 -0.562 . . . . 15.0 110.801 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -61.31 -44.36 97.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.298 -0.41 . . . . 15.0 110.629 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.17 -36.1 76.84 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.857 -0.337 . . . . 15.0 111.234 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.8 mt -64.3 -25.69 68.16 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.942 0.349 . . . . 15.0 111.942 176.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.43 13.25 15.26 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 119.314 -0.714 . . . . 15.0 113.095 -176.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.88 121.95 11.75 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 118.566 1.183 . . . . 15.0 109.888 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -69.5 -35.09 75.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.668 -0.696 . . . . 15.0 111.328 -171.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.1 tpt85 -131.79 114.5 14.79 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.957 0.408 . . . . 15.0 110.082 177.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.1 t -110.85 130.25 64.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.045 0.45 . . . . 15.0 109.851 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 85.2 mt -119.61 124.95 73.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.818 -0.628 . . . . 15.0 110.053 -176.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -95.33 117.32 30.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.435 -0.348 . . . . 15.0 110.302 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.9 p -97.05 -1.55 45.15 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.182 0.808 . . . . 15.0 113.182 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 46.9 tpt85 -55.67 -39.7 71.31 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.184 0.447 . . . . 15.0 110.665 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.01 -35.17 5.41 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.53 -0.628 . . . . 15.0 111.53 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.18 140.2 52.49 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.879 0.371 . . . . 15.0 110.651 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.9 p -86.12 163.75 17.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.065 -0.516 . . . . 15.0 110.508 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.71 -54.39 23.63 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 113.0 0.741 . . . . 15.0 113.0 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.29 -35.04 99.11 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 CA-C-N 120.163 1.094 . . . . 15.0 111.63 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.07 -43.4 95.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.091 0.472 . . . . 15.0 110.012 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 76.1 mt -59.36 -40.74 87.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 15.0 110.406 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 33.8 tp -57.2 -43.82 83.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.33 0.586 . . . . 15.0 110.229 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.52 -41.8 95.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.683 -0.69 . . . . 15.0 110.487 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.28 -40.38 90.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 15.0 110.761 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.0 mt -57.81 -51.8 68.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.267 0.556 . . . . 15.0 110.383 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.6 p -63.79 -40.06 95.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.59 -0.732 . . . . 15.0 111.324 -175.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.1 m -62.38 -44.31 96.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.676 0.274 . . . . 15.0 111.426 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.4 -38.25 88.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.432 -0.349 . . . . 15.0 111.156 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.451 -0.34 . . . . 15.0 111.255 179.315 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 CA--C 1.535 0.382 0 N-CA-C 110.34 -0.244 . . . . 15.0 110.34 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -49.87 152.31 7.3 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.387 1.391 . . . . 15.0 111.776 -176.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -117.77 137.88 52.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.354 -0.385 . . . . 15.0 110.385 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.613 HG21 HD13 ' A' ' 21' ' ' LEU . 15.7 m -134.77 146.04 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.501 0.667 . . . . 15.0 111.826 177.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.571 ' HB2' HD13 ' A' ' 49' ' ' LEU . 13.6 tp -104.37 135.55 45.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.048 -0.978 . . . . 15.0 110.318 178.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.486 HD11 ' CG1' ' A' ' 28' ' ' VAL . 55.0 mt -103.59 135.02 43.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.407 . . . . 15.0 110.439 -177.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.577 ' CE ' HD21 ' A' ' 33' ' ' LEU . 88.3 mtp -100.15 134.06 43.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.731 -0.668 . . . . 15.0 110.332 174.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -58.24 141.69 50.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.376 -0.375 . . . . 15.0 110.624 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.0 175.14 34.57 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.045 -0.822 . . . . 15.0 111.045 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -54.98 -33.86 62.87 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.549 0.203 . . . . 15.0 111.549 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.9 -179.69 4.76 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.954 -0.859 . . . . 15.0 110.954 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.02 114.31 3.93 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.224 -0.75 . . . . 15.0 111.224 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -55.85 -47.23 77.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.323 0.583 . . . . 15.0 110.339 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.95 -41.38 97.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.739 -0.664 . . . . 15.0 110.839 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -56.51 -55.83 28.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.766 0.317 . . . . 15.0 111.18 -175.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.461 HD12 ' H ' ' A' ' 17' ' ' LEU . 6.1 mp -59.99 -42.38 94.1 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.665 -0.414 . . . . 15.0 111.064 -176.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.63 -45.74 91.07 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.643 -0.423 . . . . 15.0 111.447 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.29 -40.99 92.4 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.769 -0.372 . . . . 15.0 110.527 -178.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -58.52 -51.51 69.59 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.589 -0.445 . . . . 15.0 111.126 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.613 HD13 HG21 ' A' ' 5' ' ' VAL . 76.8 mt -63.99 -38.2 90.22 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.436 -0.505 . . . . 15.0 111.262 -176.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -65.28 -40.45 93.9 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 120.521 -0.472 . . . . 15.0 111.254 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.03 -30.57 70.44 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.972 -0.632 . . . . 15.0 112.095 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -88.33 10.03 21.25 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.571 0.952 . . . . 15.0 113.571 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.54 16.41 60.28 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 121.286 -0.483 . . . . 15.0 113.265 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.7 t -101.08 138.85 23.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 117.824 0.812 . . . . 15.0 109.877 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -79.12 133.37 36.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.494 -0.558 . . . . 15.0 109.494 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.486 ' CG1' HD11 ' A' ' 7' ' ' ILE . 45.1 t -118.37 130.37 73.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.173 0.511 . . . . 15.0 111.117 -173.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.424 ' O ' HD12 ' A' ' 6' ' ' LEU . 22.8 t70 -135.35 124.74 24.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.419 -0.809 . . . . 15.0 109.442 170.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.416 ' HB3' HD12 ' A' ' 7' ' ' ILE . 15.2 p90 -112.79 134.16 54.44 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.857 0.361 . . . . 15.0 110.833 -177.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.1 tp -114.3 139.44 23.83 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.042 -0.527 . . . . 15.0 109.937 -176.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -72.08 136.22 26.67 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 121.409 1.406 . . . . 15.0 111.822 171.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.577 HD21 ' CE ' ' A' ' 8' ' ' MET . 19.8 mt -57.89 -12.73 3.42 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.368 0.877 . . . . 15.0 113.368 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -77.22 -5.05 47.79 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.467 0.914 . . . . 15.0 113.467 -175.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -68.06 145.59 97.76 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 118.559 0.618 . . . . 15.0 110.784 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.96 159.09 30.87 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.685 1.59 . . . . 15.0 113.479 -176.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.26 151.52 2.83 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.727 -0.669 . . . . 15.0 111.62 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.14 -36.98 3.58 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.397 -0.681 . . . . 15.0 111.397 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -60.02 -37.05 78.62 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.613 -0.435 . . . . 15.0 110.972 -178.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.567 ' O ' HG23 ' A' ' 44' ' ' VAL . 26.3 tp -58.5 -47.13 85.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.022 0.439 . . . . 15.0 110.253 -177.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.62 HD22 ' OD2' ' A' ' 70' ' ' ASP . 9.1 tp -61.87 -44.68 96.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 15.0 110.745 -177.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.18 97.22 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.682 -0.407 . . . . 15.0 111.018 -176.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -60.96 -41.53 96.51 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.815 -0.354 . . . . 15.0 110.672 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 40' ' ' LEU . 99.5 t -60.53 -47.31 93.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.809 -0.356 . . . . 15.0 110.262 -176.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -72.27 -47.65 48.53 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.461 0.541 . . . . 15.0 112.461 -175.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.69 -44.31 82.06 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.051 -0.26 . . . . 15.0 111.557 -174.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -81.78 -10.03 59.46 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.105 0.78 . . . . 15.0 113.105 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 56.64 55.87 6.02 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.593 0.711 . . . . 15.0 110.164 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.571 HD13 ' HB2' ' A' ' 6' ' ' LEU . 94.9 mt -77.9 142.53 38.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.667 -0.697 . . . . 15.0 111.364 -176.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.551 ' O ' HD22 ' A' ' 77' ' ' LEU . 9.3 m120 -90.76 -40.65 11.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.55 -0.75 . . . . 15.0 110.64 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.66 167.01 28.72 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 119.908 -1.139 . . . . 15.0 113.396 -171.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 71.4 mt -126.96 146.91 50.15 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.889 -0.656 . . . . 15.0 110.312 -178.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.538 HG22 ' CD1' ' A' ' 80' ' ' PHE . 47.5 t -122.77 131.48 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.544 0.211 . . . . 15.0 110.495 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 m -124.85 146.99 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.125 0.488 . . . . 15.0 110.735 173.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 t -100.81 -15.98 17.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.535 -0.757 . . . . 15.0 112.835 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.0 p -156.31 161.28 40.21 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-O 121.437 0.637 . . . . 15.0 111.901 -175.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.18 -37.67 73.63 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.056 -0.818 . . . . 15.0 111.056 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -59.25 -44.53 92.37 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.932 -0.307 . . . . 15.0 110.709 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.29 -43.68 98.29 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.611 -0.996 . . . . 15.0 110.611 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.546 HD21 ' HA ' ' A' ' 90' ' ' ALA . 14.3 tp -57.05 -45.82 82.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.153 0.502 . . . . 15.0 110.596 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.35 -43.74 98.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.117 -0.492 . . . . 15.0 110.569 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.573 ' CB ' HD22 ' A' ' 33' ' ' LEU . 80.0 m-20 -59.77 -38.91 83.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 15.0 110.647 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.495 HD13 ' SD ' ' A' ' 8' ' ' MET . 14.4 tp -57.06 -44.32 82.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.124 0.488 . . . . 15.0 110.161 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -60.24 -47.61 85.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.809 -0.632 . . . . 15.0 110.459 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -61.85 -43.15 99.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.945 -0.571 . . . . 15.0 111.137 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.84 -35.3 79.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.443 -0.344 . . . . 15.0 111.49 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.68 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.44 -38.51 80.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.955 0.407 . . . . 15.0 110.75 178.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.28 -144.09 0.57 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 109.541 -0.54 . . . . 15.0 109.541 174.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.87 -18.56 45.43 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.357 0.981 . . . . 15.0 112.64 -174.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.62 ' OD2' HD22 ' A' ' 41' ' ' LEU . 77.7 m-20 -91.95 10.45 28.84 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.327 0.862 . . . . 15.0 113.327 -175.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -47.74 -47.32 62.01 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 118.69 -0.672 . . . . 15.0 112.586 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -44.81 -40.11 14.35 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.458 1.439 . . . . 15.0 113.233 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -76.94 -48.77 17.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.023 0.439 . . . . 15.0 110.725 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.68 HD12 ' HB1' ' A' ' 67' ' ' ALA . 92.2 mt -59.25 -40.59 81.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 15.0 110.839 -177.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.41 -14.47 34.46 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-N 116.269 -0.423 . . . . 15.0 113.23 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -66.18 -29.8 70.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.415 0.607 . . . . 15.0 112.076 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.551 HD22 ' O ' ' A' ' 50' ' ' ASN . 21.9 mt -74.72 145.11 81.3 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-O 119.252 -0.404 . . . . 15.0 110.953 -174.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -60.0 129.54 30.78 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.446 1.431 . . . . 15.0 111.756 174.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.1 tp -106.34 128.16 53.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.609 -0.269 . . . . 15.0 110.852 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.538 ' CD1' HG22 ' A' ' 53' ' ' VAL . 80.8 m-85 -91.01 126.12 36.0 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.618 -0.512 . . . . 15.0 109.618 176.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.667 HG21 ' HB2' ' A' ' 87' ' ' ALA . 28.7 m -119.43 147.52 43.54 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 110.085 -0.339 . . . . 15.0 110.085 176.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.23 -23.23 7.73 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.471 1.447 . . . . 15.0 113.636 -174.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.9 p -143.36 161.11 49.11 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 120.62 -0.432 . . . . 15.0 111.563 -172.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -54.91 -44.11 52.88 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.2 1.267 . . . . 15.0 111.889 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -58.82 -46.75 86.9 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.895 -0.322 . . . . 15.0 110.973 -177.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.4 t -60.13 -40.3 83.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.737 -0.385 . . . . 15.0 110.066 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.667 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.61 -42.31 83.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.0 0.429 . . . . 15.0 110.469 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.92 -40.47 93.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.176 -0.466 . . . . 15.0 110.592 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.1 mmm -58.26 -44.99 88.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.447 0.641 . . . . 15.0 110.159 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.546 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.76 -40.64 95.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.642 -0.708 . . . . 15.0 110.825 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -61.64 -44.43 96.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.385 -0.37 . . . . 15.0 110.755 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -60.29 -36.19 77.28 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.872 -0.331 . . . . 15.0 111.262 -177.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 77.0 mt -66.0 -23.87 66.66 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.303 0.483 . . . . 15.0 112.303 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.69 13.28 16.88 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.399 -0.667 . . . . 15.0 113.177 -176.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.81 122.03 11.91 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.481 1.14 . . . . 15.0 109.905 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -67.62 -36.54 81.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.541 -0.754 . . . . 15.0 111.059 -171.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -131.82 117.88 19.13 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.923 0.392 . . . . 15.0 110.62 177.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.2 t -114.65 129.94 69.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.008 0.432 . . . . 15.0 109.952 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 90.5 mt -119.27 122.19 68.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.87 -0.604 . . . . 15.0 110.125 -177.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -92.53 117.7 30.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.483 -0.326 . . . . 15.0 110.166 175.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 104' ' ' ALA . 31.8 p -95.69 -3.52 45.9 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.232 0.827 . . . . 15.0 113.232 -178.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -55.88 -40.04 72.4 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.287 0.494 . . . . 15.0 110.699 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -95.59 -35.01 5.8 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.463 -0.655 . . . . 15.0 111.463 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.416 ' HB3' ' HA ' ' A' ' 101' ' ' CYS . . . -73.29 143.77 46.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.791 0.329 . . . . 15.0 110.466 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 65.1 m -89.77 160.75 16.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.228 -0.442 . . . . 15.0 110.567 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.67 -54.24 24.56 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.973 0.731 . . . . 15.0 112.973 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.62 -34.54 98.26 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 CA-C-N 120.318 1.149 . . . . 15.0 111.524 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.03 -42.66 94.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.065 0.46 . . . . 15.0 109.985 176.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 78.3 mt -59.04 -39.98 83.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 15.0 110.489 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 33.7 tp -56.85 -44.85 82.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.547 0.689 . . . . 15.0 110.144 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.4 -40.4 90.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.518 -0.765 . . . . 15.0 110.568 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.2 -42.49 95.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.319 -0.4 . . . . 15.0 110.782 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.1 mt -58.05 -49.16 77.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.031 0.443 . . . . 15.0 110.421 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.4 p -62.51 -40.71 97.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.897 -0.592 . . . . 15.0 111.274 -175.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.9 p -65.99 -39.88 90.72 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.969 -0.292 . . . . 15.0 111.349 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.25 -39.01 93.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.666 0.27 . . . . 15.0 111.117 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.433 -0.349 . . . . 15.0 111.252 178.961 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 110.285 -0.265 . . . . 15.0 110.285 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.94 155.06 8.98 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.347 1.364 . . . . 15.0 111.734 -177.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.464 ' HB2' HD23 ' A' ' 49' ' ' LEU . 55.5 mttm -114.26 140.74 48.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.412 -0.358 . . . . 15.0 110.837 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.559 HG21 HD13 ' A' ' 21' ' ' LEU . 10.6 m -136.55 144.94 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.598 0.714 . . . . 15.0 111.568 176.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.8 tp -105.69 134.18 49.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.943 -1.026 . . . . 15.0 110.518 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.613 HD11 ' CG1' ' A' ' 28' ' ' VAL . 44.4 mt -100.79 135.12 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.315 -0.402 . . . . 15.0 110.291 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 82.4 mtp -101.75 132.62 47.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.1 -0.5 . . . . 15.0 110.098 171.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -57.74 147.1 28.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.217 0.532 . . . . 15.0 111.564 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.49 175.19 40.55 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.615 -0.994 . . . . 15.0 110.615 -178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -51.94 -32.61 33.79 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.748 0.277 . . . . 15.0 111.748 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.68 170.29 18.24 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.855 -0.898 . . . . 15.0 110.855 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.95 125.18 7.07 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.35 -0.7 . . . . 15.0 111.35 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -57.09 -46.46 82.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.961 0.41 . . . . 15.0 110.482 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -64.05 -40.83 97.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.974 -0.557 . . . . 15.0 111.318 -175.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -61.8 -55.98 24.33 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.775 -0.37 . . . . 15.0 111.427 -176.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.683 HD21 HG11 ' A' ' 53' ' ' VAL . 28.5 tp -61.07 -45.4 94.89 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.687 -0.405 . . . . 15.0 111.192 -175.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.2 -39.72 95.42 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.669 -0.412 . . . . 15.0 110.82 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -60.75 -41.6 95.72 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.905 -0.318 . . . . 15.0 110.576 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.445 ' HD3' ' HB2' ' A' ' 106' ' ' ALA . 38.2 ttm180 -59.65 -51.76 68.41 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 120.686 -0.406 . . . . 15.0 111.241 -178.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.559 HD13 HG21 ' A' ' 5' ' ' VAL . 88.2 mt -63.86 -36.99 85.74 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.478 -0.489 . . . . 15.0 111.062 -178.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -63.54 -42.77 98.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.625 0.25 . . . . 15.0 111.088 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.21 -30.56 67.61 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.119 -0.563 . . . . 15.0 111.987 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -88.04 9.96 20.7 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.559 0.948 . . . . 15.0 113.559 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.26 15.04 56.52 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 121.22 -0.514 . . . . 15.0 113.494 173.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.7 t -101.06 136.18 33.9 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 117.972 0.886 . . . . 15.0 110.072 177.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -77.67 129.63 35.8 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.9 -0.778 . . . . 15.0 108.9 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.613 ' CG1' HD11 ' A' ' 7' ' ' ILE . 22.7 t -123.07 134.13 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.207 0.527 . . . . 15.0 111.468 -171.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -139.4 139.81 37.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.363 -0.835 . . . . 15.0 109.714 172.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.425 ' HB3' HD12 ' A' ' 7' ' ' ILE . 27.8 p90 -114.13 136.08 53.32 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.883 0.373 . . . . 15.0 110.891 -178.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.8 tp -113.81 121.18 37.6 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-O 118.705 -0.664 . . . . 15.0 110.314 -175.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.25 135.03 67.83 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 CA-C-N 120.337 1.156 . . . . 15.0 112.223 173.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.57 HD13 ' ND2' ' A' ' 62' ' ' ASN . 74.9 mt -62.43 -16.72 56.67 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.973 0.731 . . . . 15.0 112.973 -178.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -77.18 -5.06 47.72 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.43 0.9 . . . . 15.0 113.43 -175.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -69.84 148.92 96.59 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 118.545 0.611 . . . . 15.0 110.837 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.43 149.69 50.74 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.573 1.515 . . . . 15.0 113.864 -173.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.23 152.58 4.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.258 -0.883 . . . . 15.0 111.265 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.62 -38.1 3.22 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 115.837 -0.619 . . . . 15.0 111.636 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -63.71 -36.61 84.42 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.392 -0.523 . . . . 15.0 111.16 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.571 ' O ' HG23 ' A' ' 44' ' ' VAL . 24.9 tp -59.1 -47.01 86.83 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.86 -0.336 . . . . 15.0 110.174 -178.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.488 HD13 HD11 ' A' ' 74' ' ' ILE . 17.6 tp -63.35 -45.76 89.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 15.0 110.917 -176.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.6 -44.22 97.41 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.61 -0.436 . . . . 15.0 110.836 -176.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -62.24 -41.97 98.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.486 -0.325 . . . . 15.0 110.754 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 40' ' ' LEU . 94.0 t -60.61 -45.18 97.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.946 -0.39 . . . . 15.0 109.946 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -67.83 -47.94 67.61 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.325 0.391 . . . . 15.0 111.687 -177.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.6 -44.48 86.44 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 121.042 -0.263 . . . . 15.0 111.685 -173.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -83.04 -10.01 58.96 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.323 0.86 . . . . 15.0 113.323 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 55.79 55.84 6.69 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.68 0.752 . . . . 15.0 110.333 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.506 HD12 HG22 ' A' ' 44' ' ' VAL . 96.0 mt -64.11 144.95 56.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.62 -0.718 . . . . 15.0 111.36 -175.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -89.69 -40.52 12.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.067 -0.969 . . . . 15.0 110.694 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.97 161.14 28.52 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.045 -1.074 . . . . 15.0 113.553 -174.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.2 mt -126.0 140.94 52.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.428 -0.886 . . . . 15.0 109.568 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.683 HG11 HD21 ' A' ' 17' ' ' LEU . 41.3 t -120.69 130.06 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.696 0.284 . . . . 15.0 110.804 -178.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 m -123.56 138.81 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.007 0.432 . . . . 15.0 110.289 173.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.6 m -89.96 -23.89 21.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.729 -0.669 . . . . 15.0 112.413 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.9 p -154.15 165.51 36.01 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.447 0.641 . . . . 15.0 111.964 -173.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.99 -37.76 72.3 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.148 -0.781 . . . . 15.0 111.148 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -57.68 -46.12 84.7 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.736 -0.385 . . . . 15.0 110.632 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.59 -45.31 96.56 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.448 -1.061 . . . . 15.0 110.448 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.578 HD13 HD21 ' A' ' 79' ' ' LEU . 26.0 tp -56.5 -42.66 78.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.137 0.494 . . . . 15.0 110.762 -177.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.82 -43.28 99.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.504 . . . . 15.0 110.584 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.57 ' ND2' HD13 ' A' ' 33' ' ' LEU . 70.5 m-80 -58.05 -39.91 79.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.379 -0.373 . . . . 15.0 110.559 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.441 ' CD1' HD21 ' A' ' 40' ' ' LEU . 12.5 tp -57.8 -45.47 86.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.164 0.507 . . . . 15.0 110.167 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -61.51 -47.68 84.5 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.635 -0.711 . . . . 15.0 110.638 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -61.72 -43.1 99.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.039 -0.528 . . . . 15.0 111.116 -176.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 94.2 mt -66.7 -35.53 80.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.325 -0.398 . . . . 15.0 111.453 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.671 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.71 -38.05 80.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.056 0.455 . . . . 15.0 110.781 177.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.4 -143.99 0.56 Allowed 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.527 -0.545 . . . . 15.0 109.527 174.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.67 -19.09 47.19 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.302 0.955 . . . . 15.0 112.652 -174.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -91.81 11.22 25.5 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.285 0.846 . . . . 15.0 113.285 -175.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -47.68 -46.7 61.45 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 118.595 -0.716 . . . . 15.0 112.606 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -44.76 -41.27 14.88 Favored 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 121.439 1.426 . . . . 15.0 113.166 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -76.88 -48.81 17.24 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.664 -0.414 . . . . 15.0 110.831 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.671 HD12 ' HB1' ' A' ' 67' ' ' ALA . 92.3 mt -59.88 -39.32 79.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.17 -0.468 . . . . 15.0 110.873 -176.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.28 -15.96 32.77 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 119.853 -0.415 . . . . 15.0 113.092 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.0 mtm105 -66.04 -30.29 70.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.42 0.61 . . . . 15.0 112.011 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.8 mt -73.6 150.59 88.99 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 121.171 -0.212 . . . . 15.0 111.463 -173.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.49 126.33 17.41 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 121.684 1.589 . . . . 15.0 112.322 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.578 HD21 HD13 ' A' ' 60' ' ' LEU . 26.4 tp -105.4 124.69 49.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.332 -0.395 . . . . 15.0 110.552 175.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.412 ' CD1' HG22 ' A' ' 53' ' ' VAL . 79.4 m-85 -90.74 127.41 36.31 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.802 -0.444 . . . . 15.0 109.802 177.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.638 HG21 ' HB2' ' A' ' 87' ' ' ALA . 29.1 m -121.43 145.66 43.08 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 110.118 -0.327 . . . . 15.0 110.118 175.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.18 -22.3 8.54 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.727 1.618 . . . . 15.0 113.64 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.551 ' OG ' HG23 ' A' ' 86' ' ' VAL . 53.3 p -141.54 157.44 65.48 Favored Pre-proline 0 C--N 1.331 -0.233 0 C-N-CA 120.765 -0.374 . . . . 15.0 111.327 -169.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.24 -44.06 50.13 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.273 1.315 . . . . 15.0 112.338 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -61.3 -43.52 98.73 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 120.603 -0.439 . . . . 15.0 111.116 -177.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.551 HG23 ' OG ' ' A' ' 83' ' ' SER . 57.3 t -59.63 -40.92 83.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.657 -0.498 . . . . 15.0 109.657 177.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.638 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.66 -41.74 82.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.901 0.381 . . . . 15.0 110.4 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.57 -40.41 91.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.246 -0.434 . . . . 15.0 110.597 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 96.9 mmm -58.3 -45.09 88.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.437 0.637 . . . . 15.0 110.132 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.502 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.62 -40.57 95.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.709 -0.678 . . . . 15.0 110.783 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -61.75 -44.2 97.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.315 -0.402 . . . . 15.0 110.765 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -60.31 -36.16 77.26 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.912 -0.315 . . . . 15.0 111.326 -177.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.2 mt -65.79 -23.83 66.79 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.199 0.444 . . . . 15.0 112.199 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.45 13.25 17.49 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-O 119.369 -0.684 . . . . 15.0 113.127 -176.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.87 122.59 13.28 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 118.49 1.145 . . . . 15.0 109.97 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -70.16 -36.17 74.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.667 -0.697 . . . . 15.0 111.188 -172.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 31.0 ttm105 -130.35 111.63 12.53 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.114 0.483 . . . . 15.0 110.382 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.1 130.87 63.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.989 -0.551 . . . . 15.0 109.817 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 85.8 mt -119.78 121.87 67.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.97 -0.559 . . . . 15.0 110.061 -176.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -95.75 116.51 28.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.39 -0.368 . . . . 15.0 110.24 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 28.3 p -97.09 1.29 49.85 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.23 0.826 . . . . 15.0 113.23 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -55.91 -39.89 72.27 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.26 0.482 . . . . 15.0 110.737 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -96.66 -35.17 5.5 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.523 -0.631 . . . . 15.0 111.523 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.6 143.52 53.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.864 0.364 . . . . 15.0 110.604 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.9 m -89.84 161.36 16.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 15.0 110.504 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.445 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . . . -47.73 -54.19 25.22 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-O 118.522 -0.751 . . . . 15.0 112.97 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -56.52 -36.13 97.43 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 CA-C-N 120.559 1.235 . . . . 15.0 111.318 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.31 -42.67 96.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.045 0.45 . . . . 15.0 110.18 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.1 mt -59.28 -41.05 87.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 15.0 110.492 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.7 tp -57.39 -44.02 84.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.339 0.59 . . . . 15.0 110.14 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.63 93.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.617 -0.72 . . . . 15.0 110.542 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.67 89.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.389 -0.368 . . . . 15.0 110.763 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.2 mt -57.86 -52.5 65.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.391 0.615 . . . . 15.0 110.357 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.2 p -63.83 -40.28 96.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.536 -0.756 . . . . 15.0 111.354 -175.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.7 t -62.14 -45.03 95.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.686 0.279 . . . . 15.0 111.422 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.43 -39.4 90.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.509 -0.314 . . . . 15.0 110.99 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.444 -0.344 . . . . 15.0 111.048 178.914 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.9 p30 . . . . . 0 CA--C 1.536 0.406 0 N-CA-C 110.307 -0.257 . . . . 15.0 110.307 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -54.41 155.03 17.47 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.434 1.422 . . . . 15.0 112.004 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -113.75 138.73 49.84 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.222 -0.445 . . . . 15.0 110.751 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.472 HG21 HD13 ' A' ' 21' ' ' LEU . 17.5 m -134.81 145.8 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 121.53 0.681 . . . . 15.0 111.943 177.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.8 tp -104.7 137.87 41.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.029 -0.987 . . . . 15.0 110.214 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.627 HD11 ' CG1' ' A' ' 28' ' ' VAL . 53.2 mt -103.07 135.1 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.082 0.467 . . . . 15.0 111.146 -177.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.475 ' HB2' HG12 ' A' ' 54' ' ' VAL . 97.9 mmm -95.5 125.91 40.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.106 -0.952 . . . . 15.0 108.905 169.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.0 mtm180 -59.59 147.67 36.31 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.487 -0.485 . . . . 15.0 110.689 -176.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.28 175.18 34.76 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.776 -0.929 . . . . 15.0 110.776 -178.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -51.59 -32.19 27.75 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.789 0.292 . . . . 15.0 111.789 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.81 173.76 16.78 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.855 -0.898 . . . . 15.0 110.855 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.99 126.38 7.66 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.351 -0.699 . . . . 15.0 111.351 -178.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -56.64 -47.43 79.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.193 0.52 . . . . 15.0 110.417 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.72 -40.99 98.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.642 -0.708 . . . . 15.0 111.202 -176.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -61.1 -55.99 26.12 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.722 -0.391 . . . . 15.0 111.393 -175.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.9 mt -62.19 -45.06 95.07 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.757 -0.377 . . . . 15.0 111.372 -175.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.44 -41.29 98.65 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.699 -0.4 . . . . 15.0 110.904 -177.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -59.87 -41.27 91.13 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.978 -0.289 . . . . 15.0 110.388 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.525 ' HE ' ' HB2' ' A' ' 106' ' ' ALA . 52.2 ttt85 -60.19 -51.64 68.7 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 120.764 -0.374 . . . . 15.0 111.305 -177.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.472 HD13 HG21 ' A' ' 5' ' ' VAL . 86.9 mt -62.72 -36.72 83.92 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.374 -0.53 . . . . 15.0 110.94 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 46.0 tpt85 -61.36 -41.46 97.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.684 0.278 . . . . 15.0 110.399 177.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.83 -30.57 66.35 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.2 -0.524 . . . . 15.0 111.993 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -88.02 9.91 20.8 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.46 0.911 . . . . 15.0 113.46 178.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.1 18.71 58.88 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 121.314 -0.47 . . . . 15.0 113.054 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.1 t -101.06 138.75 24.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 117.77 0.785 . . . . 15.0 109.949 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -81.6 129.63 34.76 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.164 -0.68 . . . . 15.0 109.164 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.627 ' CG1' HD11 ' A' ' 7' ' ' ILE . 28.4 t -122.66 134.39 65.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.267 0.556 . . . . 15.0 111.418 -172.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -139.61 138.53 36.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.14 -0.936 . . . . 15.0 109.404 171.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.502 ' HB3' HD12 ' A' ' 7' ' ' ILE . 30.2 p90 -115.5 140.87 48.76 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.832 0.348 . . . . 15.0 110.833 -178.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 33.9 tp -112.67 129.6 24.26 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-O 118.523 -0.751 . . . . 15.0 109.813 -175.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -65.73 134.98 39.85 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 CA-C-N 120.418 1.185 . . . . 15.0 111.38 174.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.76 HD13 ' ND2' ' A' ' 62' ' ' ASN . 57.8 mt -65.83 -9.19 26.6 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.294 0.85 . . . . 15.0 113.294 -175.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -77.29 -11.33 59.82 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.12 0.785 . . . . 15.0 113.12 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -63.15 148.5 92.8 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 118.416 0.553 . . . . 15.0 110.434 -176.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.89 157.5 31.09 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.523 1.482 . . . . 15.0 113.14 -177.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.44 151.25 5.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.84 -0.618 . . . . 15.0 111.177 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.91 -37.02 3.63 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.354 -0.698 . . . . 15.0 111.354 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.31 -37.78 81.64 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.592 -0.443 . . . . 15.0 110.985 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.557 ' O ' HG23 ' A' ' 44' ' ' VAL . 22.4 tp -58.84 -47.31 85.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.028 0.442 . . . . 15.0 110.239 -177.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.541 HD22 ' OD2' ' A' ' 70' ' ' ASP . 10.8 tp -62.79 -44.58 95.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.106 -0.497 . . . . 15.0 110.951 -176.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.9 -44.72 96.21 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.7 -0.4 . . . . 15.0 110.92 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 -61.61 -40.8 96.12 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.841 -0.344 . . . . 15.0 110.98 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 40' ' ' LEU . 88.8 t -61.78 -45.74 98.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.829 -0.349 . . . . 15.0 110.375 -177.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -67.42 -50.82 57.73 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.312 0.382 . . . . 15.0 111.936 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.41 -44.35 79.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.674 0.273 . . . . 15.0 111.578 -174.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -78.28 -10.05 59.49 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.043 0.757 . . . . 15.0 113.043 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 56.32 55.9 6.23 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.539 0.685 . . . . 15.0 110.074 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.532 HD12 HG22 ' A' ' 44' ' ' VAL . 94.8 mt -69.87 144.73 52.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.846 -0.616 . . . . 15.0 111.381 -176.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -90.9 -40.52 11.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.188 -0.914 . . . . 15.0 110.499 176.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -152.52 168.93 31.64 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 120.129 -1.034 . . . . 15.0 113.216 -174.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 75.8 mt -124.69 141.41 52.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.851 -0.675 . . . . 15.0 110.108 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.55 HG22 ' CD1' ' A' ' 80' ' ' PHE . 48.5 t -120.25 130.42 74.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.022 -0.362 . . . . 15.0 110.022 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.475 HG12 ' HB2' ' A' ' 8' ' ' MET . 11.6 m -122.6 129.39 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 121.047 0.451 . . . . 15.0 110.235 173.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.2 p -95.09 -3.59 47.81 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.931 0.715 . . . . 15.0 112.931 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 81.7 p -154.31 154.71 33.84 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.447 0.567 . . . . 15.0 111.545 -177.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.02 -39.83 90.27 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.887 -0.885 . . . . 15.0 110.887 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -59.19 -42.82 91.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.916 -0.314 . . . . 15.0 110.511 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.88 -44.97 96.6 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.859 -0.896 . . . . 15.0 110.859 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.585 HD13 HD21 ' A' ' 79' ' ' LEU . 52.3 tp -58.16 -47.82 82.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.091 0.472 . . . . 15.0 110.366 -177.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -61.23 -40.71 95.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.018 -0.537 . . . . 15.0 110.695 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.76 ' ND2' HD13 ' A' ' 33' ' ' LEU . 84.4 m-20 -59.74 -40.29 87.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.441 -0.345 . . . . 15.0 110.629 177.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.402 ' CD1' HD21 ' A' ' 40' ' ' LEU . 15.1 tp -57.81 -44.16 86.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.235 0.541 . . . . 15.0 110.125 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -60.69 -47.14 87.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.791 -0.64 . . . . 15.0 110.623 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.54 -43.17 99.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.137 -0.483 . . . . 15.0 111.184 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.4 mt -67.04 -34.71 78.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.498 -0.319 . . . . 15.0 111.431 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.682 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -58.97 -39.07 80.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.068 0.461 . . . . 15.0 110.6 177.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 58.83 -143.15 0.62 Allowed 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.736 -0.468 . . . . 15.0 109.736 173.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.61 -19.98 52.79 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.337 0.971 . . . . 15.0 112.639 -174.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.541 ' OD2' HD22 ' A' ' 41' ' ' LEU . 77.9 m-20 -91.88 10.81 27.19 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.265 0.839 . . . . 15.0 113.265 -175.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 56.7 t-105 -47.85 -46.61 63.14 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 118.563 -0.732 . . . . 15.0 112.547 177.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -44.66 -40.71 14.33 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.389 1.393 . . . . 15.0 113.288 177.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -76.96 -48.89 16.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.948 0.404 . . . . 15.0 110.698 -178.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.682 HD12 ' HB1' ' A' ' 67' ' ' ALA . 89.6 mt -59.25 -39.59 79.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 15.0 110.826 -177.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.56 -14.47 35.55 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.817 -0.435 . . . . 15.0 113.23 -176.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -64.96 -30.12 71.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.501 0.651 . . . . 15.0 111.907 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 23.4 mt -76.29 150.42 82.74 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 120.932 -0.307 . . . . 15.0 111.264 -174.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.34 128.97 29.29 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.624 1.55 . . . . 15.0 112.286 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.585 HD21 HD13 ' A' ' 60' ' ' LEU . 14.0 tp -107.07 124.54 49.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 15.0 110.533 175.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.55 ' CD1' HG22 ' A' ' 53' ' ' VAL . 86.3 m-85 -92.59 121.95 34.53 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.356 -0.609 . . . . 15.0 109.356 174.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.715 HG21 ' HB2' ' A' ' 87' ' ' ALA . 21.5 m -107.0 147.38 34.99 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-O 119.345 -0.36 . . . . 15.0 110.207 177.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.18 -25.88 5.56 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.577 1.518 . . . . 15.0 113.404 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.9 p -145.26 163.44 32.26 Favored Pre-proline 0 CA--C 1.531 0.227 0 C-N-CA 120.636 -0.425 . . . . 15.0 111.46 -172.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.3 -44.01 47.07 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 121.13 1.22 . . . . 15.0 111.829 176.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -58.28 -46.74 85.49 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.81 -0.356 . . . . 15.0 110.817 -177.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.0 t -59.9 -41.04 84.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.882 -0.414 . . . . 15.0 109.882 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.715 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.87 -39.32 77.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.674 0.273 . . . . 15.0 110.707 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.88 -42.08 97.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.504 -0.316 . . . . 15.0 110.563 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 52.2 mtm -64.89 -42.94 94.36 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 119.871 -0.731 . . . . 15.0 110.129 176.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.5 -43.96 93.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.584 -0.28 . . . . 15.0 111.484 -171.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -67.02 -38.57 86.19 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.161 -0.616 . . . . 15.0 110.443 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -59.76 -35.16 74.04 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 120.653 -0.419 . . . . 15.0 111.246 176.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 67.2 mt -59.88 -29.11 68.1 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.877 -0.329 . . . . 15.0 111.378 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.27 13.08 20.28 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 119.431 -0.649 . . . . 15.0 112.821 -172.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.93 123.33 15.46 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.515 1.157 . . . . 15.0 109.862 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -70.46 -35.1 73.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.971 -0.558 . . . . 15.0 111.323 -172.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -131.62 113.98 14.27 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 110.052 -0.351 . . . . 15.0 110.052 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 45.6 t -109.44 129.79 63.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.036 0.446 . . . . 15.0 110.121 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 82.4 mt -120.92 125.66 74.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.745 -0.661 . . . . 15.0 109.978 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -94.44 114.5 26.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.212 -0.292 . . . . 15.0 110.212 175.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 28.6 p -78.36 -25.84 46.48 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 120.639 -0.424 . . . . 15.0 112.021 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -55.11 -38.17 67.8 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.646 0.26 . . . . 15.0 110.913 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.96 -35.15 7.83 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.597 -0.601 . . . . 15.0 111.597 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.36 127.02 36.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.373 . . . . 15.0 110.908 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.427 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 50.3 m -65.09 156.87 30.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.081 0.467 . . . . 15.0 110.787 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.525 ' HB2' ' HE ' ' A' ' 20' ' ' ARG . . . -47.68 -54.34 23.8 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 113.031 0.752 . . . . 15.0 113.031 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -56.2 -35.48 95.44 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 CA-C-N 120.367 1.167 . . . . 15.0 111.339 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 105' ' ' SER . . . -60.05 -41.33 92.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.955 0.407 . . . . 15.0 110.235 176.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 78.0 mt -58.94 -41.9 88.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.97 0.414 . . . . 15.0 110.329 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.61 -44.16 85.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.445 0.64 . . . . 15.0 110.131 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.4 -40.09 89.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.602 -0.726 . . . . 15.0 110.586 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.25 -41.03 92.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.41 -0.359 . . . . 15.0 110.785 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.4 mt -57.85 -51.01 71.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.152 0.501 . . . . 15.0 110.404 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.8 p -63.28 -41.27 98.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.68 -0.691 . . . . 15.0 111.252 -175.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.0 m -63.46 -43.22 97.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.662 0.267 . . . . 15.0 111.389 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.35 -39.03 91.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.478 -0.328 . . . . 15.0 111.05 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.552 -0.295 . . . . 15.0 110.952 179.045 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 . . . . . 0 CA--C 1.534 0.327 0 N-CA-C 110.32 -0.252 . . . . 15.0 110.32 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -59.18 155.06 41.95 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.38 1.387 . . . . 15.0 111.942 -177.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -105.4 136.48 44.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.387 -0.369 . . . . 15.0 110.62 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.8 m -132.68 143.56 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 121.585 0.707 . . . . 15.0 111.587 177.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.446 HD11 ' HB2' ' A' ' 31' ' ' LEU . 13.8 tp -102.77 135.87 43.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.981 -1.009 . . . . 15.0 110.274 178.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.578 HD11 ' CG1' ' A' ' 28' ' ' VAL . 51.9 mt -102.04 134.76 41.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.981 0.42 . . . . 15.0 110.558 -178.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.44 ' HB2' HG12 ' A' ' 54' ' ' VAL . 85.6 mtp -103.52 134.27 47.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.441 -0.8 . . . . 15.0 109.943 173.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 -57.46 144.86 35.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.016 0.436 . . . . 15.0 110.833 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.2 175.24 33.24 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.658 -0.977 . . . . 15.0 110.658 -177.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -50.97 -32.07 19.84 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.88 0.326 . . . . 15.0 111.88 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.95 175.42 47.77 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.782 -0.927 . . . . 15.0 110.782 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.64 131.68 10.81 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.474 -0.65 . . . . 15.0 111.474 -178.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -56.56 -44.35 80.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.869 0.366 . . . . 15.0 110.616 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.83 -43.19 99.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.126 -0.488 . . . . 15.0 111.183 -176.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -62.49 -56.06 21.61 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.8 -0.36 . . . . 15.0 111.384 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.47 ' C ' HD23 ' A' ' 17' ' ' LEU . 8.9 tt -61.7 -43.69 98.37 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.777 -0.369 . . . . 15.0 110.985 -175.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.528 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -62.38 -42.43 99.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.414 -0.357 . . . . 15.0 110.84 -177.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.78 -41.21 90.62 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.875 -0.33 . . . . 15.0 110.457 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -59.64 -51.72 68.61 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.565 -0.454 . . . . 15.0 111.34 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.5 mt -62.58 -37.5 86.43 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.436 -0.505 . . . . 15.0 110.933 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 46.9 tpt85 -63.03 -44.8 94.91 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 121.066 -0.254 . . . . 15.0 110.711 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.43 -30.57 68.4 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.955 -0.64 . . . . 15.0 111.894 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -88.11 9.24 23.34 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.626 0.973 . . . . 15.0 113.626 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.77 13.55 54.77 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 121.066 -0.588 . . . . 15.0 113.65 173.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.0 t -101.1 138.52 25.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 117.953 0.876 . . . . 15.0 110.021 177.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -79.33 131.88 36.27 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.348 -0.612 . . . . 15.0 109.348 178.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.578 ' CG1' HD11 ' A' ' 7' ' ' ILE . 43.9 t -117.68 130.79 72.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.198 0.523 . . . . 15.0 111.528 -171.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -139.33 133.03 30.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.32 -0.855 . . . . 15.0 109.388 170.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -112.66 137.39 51.01 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.9 0.381 . . . . 15.0 110.974 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.446 ' HB2' HD11 ' A' ' 6' ' ' LEU . 40.5 tp -118.9 113.45 35.91 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 118.618 -0.706 . . . . 15.0 109.969 -176.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -56.09 135.26 68.93 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.069 1.179 . . . . 15.0 112.318 177.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.594 HD13 HD22 ' A' ' 62' ' ' ASN . 77.3 mt -60.56 -9.21 3.48 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.298 0.851 . . . . 15.0 113.298 -178.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -77.15 -9.98 59.1 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.205 0.817 . . . . 15.0 113.205 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -62.53 147.2 92.8 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 118.338 0.517 . . . . 15.0 110.26 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.29 158.96 33.28 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.559 1.506 . . . . 15.0 113.252 -178.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.84 152.42 3.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.783 -0.644 . . . . 15.0 111.337 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.39 -36.3 3.88 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.489 -0.644 . . . . 15.0 111.489 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -60.01 -37.22 79.09 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.689 -0.404 . . . . 15.0 111.041 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.576 ' O ' HG23 ' A' ' 44' ' ' VAL . 25.8 tp -58.65 -46.34 87.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.965 0.412 . . . . 15.0 110.168 -178.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.611 HD22 ' OD2' ' A' ' 70' ' ' ASP . 9.7 tp -61.78 -44.14 97.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.139 -0.482 . . . . 15.0 110.742 -177.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.01 -43.61 98.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.352 -0.386 . . . . 15.0 111.241 -176.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -61.28 -41.82 97.6 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.751 -0.38 . . . . 15.0 110.625 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.579 ' HA ' HD12 ' A' ' 49' ' ' LEU . 97.6 t -61.65 -47.03 95.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.88 -0.328 . . . . 15.0 110.491 -175.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -75.42 -43.5 49.57 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.492 0.553 . . . . 15.0 112.492 -174.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.59 -44.37 74.52 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.667 0.247 . . . . 15.0 111.667 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -82.74 -10.09 59.05 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.123 0.786 . . . . 15.0 113.123 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 58.36 55.88 4.73 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.563 0.697 . . . . 15.0 109.553 -177.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.579 HD12 ' HA ' ' A' ' 44' ' ' VAL . 94.1 mt -71.47 145.7 49.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.752 -0.658 . . . . 15.0 111.412 -174.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -95.41 -40.52 9.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.231 -0.895 . . . . 15.0 110.774 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -150.93 166.64 30.44 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 120.057 -1.068 . . . . 15.0 113.412 -173.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.5 mt -126.61 144.17 50.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.732 -0.734 . . . . 15.0 110.046 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.549 HG22 ' CD1' ' A' ' 80' ' ' PHE . 47.8 t -122.1 129.38 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 110.386 -0.227 . . . . 15.0 110.386 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.44 HG12 ' HB2' ' A' ' 8' ' ' MET . 15.5 m -127.65 152.05 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.053 0.454 . . . . 15.0 110.456 172.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.9 m -123.47 7.92 8.97 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.744 -0.662 . . . . 15.0 112.77 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.9 p -155.62 151.69 27.81 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 118.514 0.597 . . . . 15.0 111.772 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.87 -39.75 92.08 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.633 -0.987 . . . . 15.0 110.633 176.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -58.25 -41.8 85.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.702 0.287 . . . . 15.0 110.382 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.82 -47.98 88.54 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.687 -0.965 . . . . 15.0 110.687 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.614 HD13 HD21 ' A' ' 79' ' ' LEU . 34.2 tp -57.13 -44.42 83.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.15 0.5 . . . . 15.0 110.705 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.63 -42.37 98.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.063 -0.517 . . . . 15.0 110.823 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.594 HD22 HD13 ' A' ' 33' ' ' LEU . 84.5 m-20 -59.47 -39.89 85.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.393 -0.367 . . . . 15.0 110.576 178.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.4 tp -58.12 -44.29 87.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.094 0.473 . . . . 15.0 110.274 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -60.67 -47.52 85.91 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.849 -0.614 . . . . 15.0 110.631 -178.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -62.13 -43.41 98.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.085 -0.507 . . . . 15.0 111.113 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.8 mt -66.42 -35.27 79.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.414 -0.357 . . . . 15.0 111.375 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.664 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -58.92 -38.75 79.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.032 0.444 . . . . 15.0 110.672 178.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.21 -143.54 0.59 Allowed 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 109.515 -0.55 . . . . 15.0 109.515 174.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.43 -19.04 44.38 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.342 0.973 . . . . 15.0 112.609 -175.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.611 ' OD2' HD22 ' A' ' 41' ' ' LEU . 79.2 m-20 -91.88 10.5 28.48 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.299 0.852 . . . . 15.0 113.299 -174.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -47.76 -46.72 62.33 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 118.576 -0.726 . . . . 15.0 112.561 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -44.69 -41.99 14.72 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 121.481 1.454 . . . . 15.0 113.244 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -77.01 -48.69 17.23 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.949 0.405 . . . . 15.0 110.862 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.664 HD12 ' HB1' ' A' ' 67' ' ' ALA . 91.7 mt -59.01 -40.78 81.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.138 -0.483 . . . . 15.0 110.748 -176.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.51 -16.1 35.05 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 119.896 -0.391 . . . . 15.0 113.048 -177.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -63.66 -30.64 71.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.425 0.612 . . . . 15.0 111.989 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.6 mt -74.89 149.02 85.24 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 120.979 -0.289 . . . . 15.0 111.265 -173.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.85 129.07 24.89 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.558 1.505 . . . . 15.0 112.517 176.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.614 HD21 HD13 ' A' ' 60' ' ' LEU . 22.4 tp -107.77 126.43 52.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 15.0 110.577 174.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.549 ' CD1' HG22 ' A' ' 53' ' ' VAL . 80.3 m-85 -89.84 125.01 35.17 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.438 -0.579 . . . . 15.0 109.438 175.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.741 HG21 ' HB2' ' A' ' 87' ' ' ALA . 27.6 m -113.87 147.56 37.98 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-O 119.373 -0.346 . . . . 15.0 110.319 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.418 ' HD2' HG11 ' A' ' 86' ' ' VAL . 90.1 Cg_endo -79.17 -23.94 7.17 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.574 1.516 . . . . 15.0 113.52 -175.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.7 p -144.4 158.23 54.73 Favored Pre-proline 0 CA--C 1.531 0.232 0 C-N-CA 120.664 -0.414 . . . . 15.0 111.321 -172.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.82 -44.04 51.34 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.255 1.304 . . . . 15.0 111.694 175.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -56.73 -48.56 77.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.847 0.356 . . . . 15.0 110.858 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.418 HG11 ' HD2' ' A' ' 82' ' ' PRO . 60.2 t -59.61 -40.66 82.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.836 0.351 . . . . 15.0 110.071 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.741 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.72 -42.29 83.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.012 0.434 . . . . 15.0 110.505 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.6 -41.67 97.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 15.0 110.658 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 87.1 mtp -59.82 -44.44 94.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.238 0.542 . . . . 15.0 110.432 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.434 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.35 -41.2 96.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.993 -0.548 . . . . 15.0 110.725 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 54.0 ttm-85 -61.19 -44.52 97.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.25 -0.432 . . . . 15.0 110.539 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -59.84 -36.26 76.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.527 -0.306 . . . . 15.0 111.397 -177.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 81.9 mt -65.39 -24.15 67.15 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.244 0.461 . . . . 15.0 112.244 177.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.85 13.2 14.41 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-O 119.444 -0.642 . . . . 15.0 113.158 -176.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.89 121.97 11.8 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.466 1.133 . . . . 15.0 109.893 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -70.5 -35.48 73.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.69 -0.686 . . . . 15.0 111.322 -171.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -131.07 112.83 13.24 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.975 0.417 . . . . 15.0 110.115 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.2 t -111.41 129.49 66.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.79 -0.448 . . . . 15.0 109.79 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 83.9 mt -119.53 125.49 74.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.967 -0.56 . . . . 15.0 110.222 -176.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -94.9 117.74 30.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.435 -0.348 . . . . 15.0 110.286 176.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.545 ' HB2' HD11 ' A' ' 109' ' ' LEU . 31.2 p -88.6 -18.69 27.5 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.574 0.583 . . . . 15.0 112.574 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 tpt85 -55.17 -38.9 68.92 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 122.229 -0.294 . . . . 15.0 110.766 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -93.16 -34.95 6.49 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.633 -0.587 . . . . 15.0 111.633 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -89.51 125.59 35.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.843 0.354 . . . . 15.0 110.705 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.409 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 47.7 m -64.64 158.63 23.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.159 0.504 . . . . 15.0 110.901 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.79 -54.24 25.06 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 113.011 0.745 . . . . 15.0 113.011 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -56.65 -34.84 96.68 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 CA-C-N 120.447 1.196 . . . . 15.0 111.451 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 105' ' ' SER . . . -60.22 -41.74 93.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.029 0.442 . . . . 15.0 110.081 176.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.545 HD11 ' HB2' ' A' ' 101' ' ' CYS . 78.8 mt -58.95 -41.13 86.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.077 0.465 . . . . 15.0 110.454 178.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 30.6 tp -56.98 -44.34 82.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.546 0.689 . . . . 15.0 110.104 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.45 -40.14 90.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.508 -0.769 . . . . 15.0 110.551 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.83 -41.12 90.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.399 -0.364 . . . . 15.0 110.757 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.0 mt -57.89 -52.08 66.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.262 0.553 . . . . 15.0 110.305 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.9 p -63.53 -40.6 97.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.571 -0.741 . . . . 15.0 111.315 -175.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.3 m -62.73 -43.51 98.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.67 0.271 . . . . 15.0 111.443 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.34 -39.87 94.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.414 -0.357 . . . . 15.0 111.045 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.48 -0.327 . . . . 15.0 111.164 179.978 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 . . . . . 0 CA--C 1.535 0.376 0 N-CA-C 110.329 -0.249 . . . . 15.0 110.329 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.7 155.04 28.4 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.393 1.395 . . . . 15.0 111.875 -176.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.421 ' CB ' HD23 ' A' ' 49' ' ' LEU . 96.1 mttt -111.68 138.13 48.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.795 0.331 . . . . 15.0 110.864 -178.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.426 HG21 HD13 ' A' ' 21' ' ' LEU . 15.1 m -134.66 144.31 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.565 0.698 . . . . 15.0 111.572 175.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.2 tp -104.38 136.0 44.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.916 -1.038 . . . . 15.0 110.264 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.614 HD11 ' CG1' ' A' ' 28' ' ' VAL . 50.8 mt -103.53 135.1 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.123 0.487 . . . . 15.0 111.129 -176.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.531 ' HB2' HG12 ' A' ' 54' ' ' VAL . 98.5 mmm -95.3 133.65 38.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.109 -0.95 . . . . 15.0 109.21 171.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.421 ' H ' HD21 ' A' ' 33' ' ' LEU . 55.9 ttp180 -63.91 143.74 57.62 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.76 -0.376 . . . . 15.0 110.479 -177.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.24 175.13 34.02 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.924 -0.871 . . . . 15.0 110.924 -178.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -52.55 -32.45 40.87 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.742 0.275 . . . . 15.0 111.742 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.69 176.39 32.38 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.807 -0.917 . . . . 15.0 110.807 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.0 120.24 5.77 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.504 -0.638 . . . . 15.0 111.504 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -56.89 -41.8 78.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.794 0.331 . . . . 15.0 110.452 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.07 -40.63 98.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 15.0 111.134 -177.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -62.35 -56.0 22.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.984 0.421 . . . . 15.0 111.124 -176.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.3 mt -59.92 -44.82 94.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.942 0.401 . . . . 15.0 110.759 -176.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.532 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -62.53 -37.49 86.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 15.0 111.052 -178.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.0 -42.89 99.32 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.955 -0.298 . . . . 15.0 110.598 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -61.53 -51.52 68.27 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.125 -0.63 . . . . 15.0 110.895 -178.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.426 HD13 HG21 ' A' ' 5' ' ' VAL . 84.6 mt -61.46 -37.99 85.6 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.632 -0.427 . . . . 15.0 110.931 -178.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 57.5 ttt85 -63.63 -43.52 96.59 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.196 -0.202 . . . . 15.0 111.084 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.03 -30.6 67.05 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.967 -0.635 . . . . 15.0 111.915 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -88.2 10.1 20.63 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.481 0.919 . . . . 15.0 113.481 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.91 18.27 51.41 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 121.187 -0.53 . . . . 15.0 113.292 174.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.4 t -101.01 140.32 20.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 117.688 0.744 . . . . 15.0 110.131 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -84.78 130.38 34.69 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.475 -0.565 . . . . 15.0 109.475 178.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.614 ' CG1' HD11 ' A' ' 7' ' ' ILE . 37.2 t -119.97 133.76 65.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.205 0.526 . . . . 15.0 111.271 -173.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -139.08 132.72 30.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.443 -0.799 . . . . 15.0 109.611 171.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.461 ' HB3' HD12 ' A' ' 7' ' ' ILE . 38.3 p90 -113.01 137.64 51.1 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.89 0.376 . . . . 15.0 110.467 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.7 tp -114.92 113.49 44.28 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.683 -0.675 . . . . 15.0 110.824 -173.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -49.05 135.08 29.97 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.156 1.237 . . . . 15.0 111.881 174.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.758 HD13 ' ND2' ' A' ' 62' ' ' ASN . 43.2 mt -64.61 -13.36 53.11 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.15 0.796 . . . . 15.0 113.15 -174.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -77.23 -6.01 51.45 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.293 0.849 . . . . 15.0 113.293 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -60.0 151.04 67.24 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 118.559 0.618 . . . . 15.0 110.388 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.75 151.72 25.0 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.548 1.499 . . . . 15.0 113.044 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.53 152.29 5.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.925 -0.58 . . . . 15.0 111.162 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.84 -36.6 3.8 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.449 -0.66 . . . . 15.0 111.449 -177.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.44 -37.94 82.54 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.655 -0.418 . . . . 15.0 110.958 -177.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.563 ' O ' HG23 ' A' ' 44' ' ' VAL . 23.9 tp -59.14 -46.32 88.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.952 0.406 . . . . 15.0 110.256 -178.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.614 HD22 ' OD2' ' A' ' 70' ' ' ASP . 12.1 tp -61.97 -44.64 96.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 15.0 110.824 -176.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.89 -43.93 97.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.348 -0.387 . . . . 15.0 110.91 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.8 mtp85 -61.83 -41.77 98.2 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.811 -0.356 . . . . 15.0 110.888 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 40' ' ' LEU . 96.5 t -59.4 -46.08 92.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.868 -0.419 . . . . 15.0 109.868 -177.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.2 tpt85 -71.55 -50.3 32.45 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 123.37 0.419 . . . . 15.0 112.024 -176.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.04 -44.44 92.48 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.089 0.403 . . . . 15.0 112.089 -171.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 mp0 -89.87 -5.61 56.65 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.429 0.899 . . . . 15.0 113.429 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 56.77 55.93 5.89 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.616 0.722 . . . . 15.0 110.167 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.51 HD12 ' HA ' ' A' ' 44' ' ' VAL . 94.5 mt -64.23 140.44 58.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.525 -0.761 . . . . 15.0 111.058 -175.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -84.47 -40.64 17.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.491 -0.777 . . . . 15.0 110.671 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -154.04 168.04 32.36 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 119.872 -1.156 . . . . 15.0 113.773 -173.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.8 mt -123.65 143.51 50.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.502 -0.849 . . . . 15.0 109.671 177.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.48 HG22 ' CD1' ' A' ' 80' ' ' PHE . 46.9 t -122.66 132.76 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.143 -0.317 . . . . 15.0 110.143 -179.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.531 HG12 ' HB2' ' A' ' 8' ' ' MET . 9.2 m -126.47 142.41 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 121.057 0.456 . . . . 15.0 110.547 173.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.6 t -97.44 -19.95 18.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.622 -0.717 . . . . 15.0 112.439 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.2 p -151.27 161.65 42.32 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 121.333 0.587 . . . . 15.0 111.528 -174.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.45 -39.12 83.18 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.946 -0.862 . . . . 15.0 110.946 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -58.82 -44.62 90.91 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.876 -0.329 . . . . 15.0 110.653 -178.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.06 -44.48 97.23 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.545 -1.022 . . . . 15.0 110.545 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.602 HD13 HD21 ' A' ' 79' ' ' LEU . 32.1 tp -57.27 -43.03 82.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.115 0.483 . . . . 15.0 110.639 -178.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.08 -42.73 99.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 15.0 110.692 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.758 ' ND2' HD13 ' A' ' 33' ' ' LEU . 67.9 m-80 -58.95 -41.61 87.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.852 0.358 . . . . 15.0 110.543 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.8 tp -58.67 -43.94 90.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.125 0.488 . . . . 15.0 110.181 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -61.19 -47.32 86.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.955 -0.566 . . . . 15.0 110.725 -178.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -61.22 -42.7 99.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 15.0 111.117 -177.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 92.7 mt -65.82 -36.32 83.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.341 -0.391 . . . . 15.0 111.374 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.687 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.32 -38.57 80.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.141 0.496 . . . . 15.0 110.85 178.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.13 -143.15 0.61 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.648 -0.501 . . . . 15.0 109.648 174.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.52 -19.82 51.0 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.321 0.964 . . . . 15.0 112.734 -174.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.614 ' OD2' HD22 ' A' ' 41' ' ' LEU . 79.3 m-20 -91.97 11.4 25.23 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.217 0.821 . . . . 15.0 113.217 -175.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -47.85 -46.7 63.25 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 118.584 -0.722 . . . . 15.0 112.593 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -44.7 -41.25 14.7 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.474 1.45 . . . . 15.0 113.224 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.5 mp0 -77.03 -48.77 17.0 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.943 0.402 . . . . 15.0 110.827 -178.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.687 HD12 ' HB1' ' A' ' 67' ' ' ALA . 90.8 mt -60.03 -40.52 83.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 15.0 110.902 -176.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.79 -13.72 26.66 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.915 -0.38 . . . . 15.0 113.156 -177.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -64.44 -31.46 72.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 117.359 0.579 . . . . 15.0 111.766 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.3 mt -72.99 141.84 82.11 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 119.204 -0.427 . . . . 15.0 110.456 -176.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -59.33 135.24 64.05 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.342 1.361 . . . . 15.0 112.434 177.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.602 HD21 HD13 ' A' ' 60' ' ' LEU . 23.9 tp -109.34 127.76 54.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 15.0 110.736 176.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.48 ' CD1' HG22 ' A' ' 53' ' ' VAL . 85.9 m-85 -91.35 127.18 36.68 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.821 -0.437 . . . . 15.0 109.821 176.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.664 HG21 ' HB2' ' A' ' 87' ' ' ALA . 28.6 m -119.6 147.44 43.69 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 119.45 -0.309 . . . . 15.0 110.25 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.24 -24.23 6.83 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.597 1.531 . . . . 15.0 113.478 -175.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.402 ' OG ' HG23 ' A' ' 86' ' ' VAL . 25.2 p -142.58 158.51 60.06 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 120.71 -0.396 . . . . 15.0 111.27 -171.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.43 -44.05 52.33 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.285 1.323 . . . . 15.0 111.761 176.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -58.29 -47.43 83.67 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.773 -0.371 . . . . 15.0 110.924 -177.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.402 HG23 ' OG ' ' A' ' 83' ' ' SER . 61.1 t -60.17 -39.65 81.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.788 -0.365 . . . . 15.0 110.096 178.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.664 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.25 -41.84 80.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.925 0.393 . . . . 15.0 110.404 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.75 -40.86 94.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.131 -0.486 . . . . 15.0 110.526 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.0 mmm -58.33 -45.17 88.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.456 0.646 . . . . 15.0 110.177 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.492 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.76 -40.32 94.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.704 -0.68 . . . . 15.0 110.937 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.0 ttt-85 -62.07 -44.63 96.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 15.0 110.792 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.76 -36.15 76.06 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.818 -0.353 . . . . 15.0 111.236 -177.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 76.4 mt -65.49 -25.6 67.55 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.088 0.403 . . . . 15.0 112.088 177.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.55 13.37 14.78 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 119.288 -0.729 . . . . 15.0 113.18 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.87 122.68 13.51 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 118.513 1.157 . . . . 15.0 110.002 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -67.52 -35.83 79.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.518 -0.764 . . . . 15.0 111.256 -171.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -131.82 117.67 18.85 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.954 0.407 . . . . 15.0 110.087 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.9 t -114.18 130.36 68.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.975 0.417 . . . . 15.0 109.989 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 89.9 mt -119.16 123.58 71.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.811 -0.631 . . . . 15.0 110.077 -177.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -94.7 117.44 30.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.376 -0.375 . . . . 15.0 110.086 175.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 104' ' ' ALA . 30.8 p -95.42 -1.65 50.54 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.306 0.854 . . . . 15.0 113.306 -178.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -55.89 -39.88 72.2 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 118.191 0.451 . . . . 15.0 110.672 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -96.24 -35.06 5.63 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 111.511 -0.636 . . . . 15.0 111.511 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.407 ' HB3' ' HA ' ' A' ' 101' ' ' CYS . . . -69.7 143.23 53.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.829 0.347 . . . . 15.0 110.635 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 65.2 m -89.85 160.12 16.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 15.0 110.506 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.66 -54.41 23.21 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 112.945 0.72 . . . . 15.0 112.945 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.54 -34.53 98.88 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 CA-C-N 120.079 1.064 . . . . 15.0 111.708 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.01 96.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.028 0.442 . . . . 15.0 110.034 177.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.7 mt -59.42 -40.77 87.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 15.0 110.399 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 36.6 tp -57.26 -44.03 83.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.272 0.558 . . . . 15.0 110.164 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.18 -40.59 90.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.696 -0.683 . . . . 15.0 110.436 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.09 -40.13 88.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.377 -0.374 . . . . 15.0 110.811 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.6 mt -57.88 -51.4 69.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.174 0.512 . . . . 15.0 110.479 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.9 p -64.74 -41.56 95.84 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.637 -0.71 . . . . 15.0 111.384 -175.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.0 t -61.36 -43.87 98.14 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.051 -0.26 . . . . 15.0 111.26 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.18 -42.5 99.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.472 -0.331 . . . . 15.0 111.066 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 C-N-CA 120.975 -0.29 . . . . 15.0 111.209 -179.889 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 110.173 -0.306 . . . . 15.0 110.173 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.19 152.67 10.64 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.511 1.474 . . . . 15.0 112.214 -174.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -115.12 140.96 48.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.113 -0.494 . . . . 15.0 110.693 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 m -134.36 144.17 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.614 0.721 . . . . 15.0 111.519 176.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.8 tp -105.26 135.08 47.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.91 -1.041 . . . . 15.0 110.381 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.619 HD11 ' CG1' ' A' ' 28' ' ' VAL . 52.5 mt -99.8 133.02 44.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.034 0.445 . . . . 15.0 110.598 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.44 ' SD ' HD13 ' A' ' 63' ' ' LEU . 83.8 mtp -100.7 134.39 43.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.418 -0.81 . . . . 15.0 109.255 170.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -57.39 145.21 33.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.135 0.493 . . . . 15.0 111.222 -170.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.51 175.08 27.03 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.895 -0.882 . . . . 15.0 110.895 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.27 -32.29 71.04 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.817 0.303 . . . . 15.0 111.817 -178.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.96 -177.68 20.6 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.234 -0.746 . . . . 15.0 111.234 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.9 127.99 8.46 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.9 -0.88 . . . . 15.0 110.9 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 52.4 mmt-85 -60.02 -46.61 88.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.221 0.534 . . . . 15.0 109.648 -176.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.09 -40.01 96.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.59 -0.732 . . . . 15.0 111.235 -176.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -60.81 -55.96 26.86 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.758 -0.377 . . . . 15.0 111.258 -175.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.5 mt -61.91 -44.9 95.82 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.735 -0.386 . . . . 15.0 111.132 -176.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.473 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -63.09 -39.7 95.48 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.657 -0.417 . . . . 15.0 110.894 -177.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -60.03 -41.52 92.43 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 121.008 -0.277 . . . . 15.0 110.442 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.4 ttt85 -59.96 -51.55 69.19 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.665 -0.414 . . . . 15.0 111.2 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 70.6 mt -60.79 -36.79 79.89 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.518 -0.473 . . . . 15.0 110.937 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 60.4 ttt85 -61.73 -43.16 99.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.693 0.283 . . . . 15.0 110.727 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.19 -30.56 67.55 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.053 -0.594 . . . . 15.0 111.855 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -88.1 9.93 20.95 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.521 0.934 . . . . 15.0 113.521 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.3 12.83 58.16 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 121.189 -0.529 . . . . 15.0 113.689 173.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.9 t -101.06 136.12 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 118.084 0.942 . . . . 15.0 110.115 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -78.04 132.22 37.67 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.076 -0.713 . . . . 15.0 109.076 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.619 ' CG1' HD11 ' A' ' 7' ' ' ILE . 31.3 t -121.09 133.79 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.247 0.546 . . . . 15.0 111.37 -172.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -140.59 142.11 35.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.285 -0.87 . . . . 15.0 109.648 170.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -115.31 138.6 50.79 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.949 0.404 . . . . 15.0 111.03 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.0 tp -119.07 113.34 35.66 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 118.586 -0.721 . . . . 15.0 109.863 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.19 135.2 59.14 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 121.06 1.173 . . . . 15.0 112.257 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.597 HD13 HD22 ' A' ' 62' ' ' ASN . 76.1 mt -60.85 -12.03 9.66 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.089 0.774 . . . . 15.0 113.089 -178.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -77.15 -7.78 56.39 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.271 0.841 . . . . 15.0 113.271 -177.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -61.98 150.3 83.58 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 118.45 0.568 . . . . 15.0 110.478 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.93 154.25 25.9 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.555 1.503 . . . . 15.0 113.119 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.3 151.82 5.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.878 -0.601 . . . . 15.0 111.227 -178.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.98 -38.1 3.22 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.498 -0.641 . . . . 15.0 111.498 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.74 -37.96 86.17 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.64 -0.424 . . . . 15.0 110.974 -177.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.613 ' O ' HG23 ' A' ' 44' ' ' VAL . 22.4 tp -59.05 -48.93 79.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.916 0.389 . . . . 15.0 110.209 -177.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.5 HD22 ' CG ' ' A' ' 70' ' ' ASP . 15.5 tp -64.34 -44.96 89.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.138 -0.483 . . . . 15.0 111.215 -175.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.78 -45.51 93.59 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.626 -0.43 . . . . 15.0 110.78 -175.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.3 ttt85 -62.23 -41.81 98.75 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.855 -0.338 . . . . 15.0 110.856 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 40' ' ' LEU . 96.6 t -60.93 -43.81 96.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.753 -0.379 . . . . 15.0 110.176 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -68.46 -48.66 63.94 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.117 0.414 . . . . 15.0 112.117 -176.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.58 -44.28 78.54 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.94 -0.304 . . . . 15.0 111.53 -175.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -79.47 -10.13 59.74 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.045 0.757 . . . . 15.0 113.045 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 54.84 55.86 7.34 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.607 0.717 . . . . 15.0 110.418 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.532 HD12 HG22 ' A' ' 44' ' ' VAL . 94.1 mt -66.73 148.15 52.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.689 -0.687 . . . . 15.0 111.584 -175.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -95.35 -40.6 9.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.29 -0.868 . . . . 15.0 110.826 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.67 160.32 28.27 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.009 -1.091 . . . . 15.0 113.443 -173.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.4 mt -126.61 141.55 51.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.505 -0.847 . . . . 15.0 109.838 178.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.519 HG22 ' CD1' ' A' ' 80' ' ' PHE . 46.9 t -120.47 131.22 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 121.143 -0.223 . . . . 15.0 110.702 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.403 HG12 ' SD ' ' A' ' 8' ' ' MET . 7.5 m -123.08 145.56 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.158 0.504 . . . . 15.0 110.562 173.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.3 t -97.83 -20.28 17.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.467 -0.788 . . . . 15.0 112.536 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.8 p -155.93 164.44 38.48 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.442 0.639 . . . . 15.0 111.903 -174.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.91 -37.38 70.0 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.173 -0.771 . . . . 15.0 111.173 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -58.35 -45.72 87.63 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.863 -0.335 . . . . 15.0 110.674 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.17 -46.19 94.68 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.468 -1.053 . . . . 15.0 110.468 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.621 HD13 HD21 ' A' ' 79' ' ' LEU . 30.1 tp -56.16 -44.02 78.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.16 0.505 . . . . 15.0 110.831 -177.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.76 -43.1 99.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.039 -0.528 . . . . 15.0 110.672 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.597 HD22 HD13 ' A' ' 33' ' ' LEU . 83.4 m-20 -59.03 -39.97 83.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.39 -0.368 . . . . 15.0 110.639 178.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.44 HD13 ' SD ' ' A' ' 8' ' ' MET . 12.9 tp -57.88 -44.56 86.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.189 0.518 . . . . 15.0 110.243 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -60.92 -47.51 86.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.713 -0.676 . . . . 15.0 110.62 -178.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -61.45 -42.99 99.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.014 -0.539 . . . . 15.0 111.053 -177.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.97 -35.91 81.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.352 -0.385 . . . . 15.0 111.405 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.665 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.0 -39.22 81.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.975 0.417 . . . . 15.0 110.597 178.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.09 -142.81 0.62 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.591 -0.522 . . . . 15.0 109.591 174.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.49 -19.29 46.81 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.384 0.993 . . . . 15.0 112.601 -174.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.5 ' CG ' HD22 ' A' ' 41' ' ' LEU . 20.2 m-20 -91.82 10.46 28.48 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.355 0.872 . . . . 15.0 113.355 -175.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.9 t-105 -47.84 -46.36 62.62 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 118.598 -0.715 . . . . 15.0 112.665 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -44.73 -41.6 14.83 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 121.525 1.484 . . . . 15.0 113.182 177.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -76.93 -48.8 17.13 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 120.616 -0.434 . . . . 15.0 110.841 -178.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.665 HD12 ' HB1' ' A' ' 67' ' ' ALA . 89.8 mt -59.71 -40.17 81.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 15.0 110.808 -176.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.38 -16.65 36.27 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 119.948 -0.362 . . . . 15.0 113.126 -176.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 60.7 mtp85 -65.31 -30.17 71.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.423 0.611 . . . . 15.0 112.025 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.8 mt -73.52 150.51 89.13 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 111.533 0.197 . . . . 15.0 111.533 -172.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.4 126.35 17.52 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.67 1.58 . . . . 15.0 112.513 176.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.621 HD21 HD13 ' A' ' 60' ' ' LEU . 22.5 tp -105.53 125.75 51.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.473 174.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.519 ' CD1' HG22 ' A' ' 53' ' ' VAL . 76.3 m-85 -89.89 125.89 35.51 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.497 -0.557 . . . . 15.0 109.497 175.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.712 HG21 ' HB2' ' A' ' 87' ' ' ALA . 26.4 m -116.82 146.07 36.94 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 119.335 -0.364 . . . . 15.0 110.181 176.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.412 ' HD2' HG11 ' A' ' 86' ' ' VAL . 71.9 Cg_endo -79.21 -22.97 7.98 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.559 1.506 . . . . 15.0 113.582 -176.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.5 p -144.32 161.77 42.98 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 120.649 -0.421 . . . . 15.0 111.575 -172.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -55.9 -44.01 51.52 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 121.165 1.243 . . . . 15.0 111.821 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -57.56 -47.79 81.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.842 0.353 . . . . 15.0 110.773 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.412 HG11 ' HD2' ' A' ' 82' ' ' PRO . 61.7 t -59.76 -40.63 83.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.988 -0.375 . . . . 15.0 109.988 178.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.712 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.64 -41.37 81.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.942 0.401 . . . . 15.0 110.484 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.13 -40.0 92.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.425 . . . . 15.0 110.718 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.0 mmm -58.63 -45.09 90.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.383 0.611 . . . . 15.0 110.073 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.503 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.73 -41.67 97.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.727 -0.669 . . . . 15.0 110.865 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -61.73 -44.7 96.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.262 -0.426 . . . . 15.0 110.591 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -59.7 -36.11 75.87 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.905 -0.318 . . . . 15.0 111.259 -177.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.97 -23.53 65.96 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.357 0.503 . . . . 15.0 112.357 177.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.7 13.27 16.89 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 119.368 -0.684 . . . . 15.0 113.05 -176.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.78 122.01 11.84 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 118.522 1.161 . . . . 15.0 109.952 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -70.32 -35.7 73.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.677 -0.692 . . . . 15.0 111.22 -172.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -130.87 112.67 13.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.073 0.463 . . . . 15.0 110.422 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.6 t -111.7 130.15 65.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.076 -0.511 . . . . 15.0 109.73 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.1 mt -118.95 122.83 70.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.901 -0.59 . . . . 15.0 110.01 -176.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.33 118.86 32.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.401 -0.363 . . . . 15.0 110.255 176.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.8 p -95.16 -9.63 32.89 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.074 0.768 . . . . 15.0 113.074 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -55.46 -39.79 70.81 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 118.161 0.437 . . . . 15.0 110.843 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -94.77 -35.16 5.96 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.475 -0.65 . . . . 15.0 111.475 178.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.75 145.99 44.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.789 0.328 . . . . 15.0 110.46 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.5 m -89.8 158.88 17.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 15.0 110.451 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.66 -54.24 24.53 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 113.093 0.775 . . . . 15.0 113.093 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -57.48 -35.15 98.88 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 CA-C-N 120.383 1.173 . . . . 15.0 111.5 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.62 95.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.065 0.46 . . . . 15.0 110.091 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.8 mt -59.12 -40.62 85.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 15.0 110.361 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.13 -43.8 82.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.386 0.612 . . . . 15.0 110.113 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.21 -40.58 90.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.7 -0.682 . . . . 15.0 110.495 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.21 -41.58 93.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.358 -0.383 . . . . 15.0 110.808 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.2 mt -57.87 -50.83 71.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.218 0.533 . . . . 15.0 110.408 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.9 p -63.18 -41.3 99.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.719 -0.673 . . . . 15.0 111.265 -175.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.4 m -63.25 -43.45 97.97 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.084 -0.246 . . . . 15.0 111.36 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.6 -38.49 87.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.529 -0.305 . . . . 15.0 111.087 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.45 -0.341 . . . . 15.0 111.685 178.831 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 110.106 -0.331 . . . . 15.0 110.106 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -50.23 151.6 9.18 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.461 1.441 . . . . 15.0 112.101 -174.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.502 ' HB2' HD23 ' A' ' 49' ' ' LEU . 59.7 mttp -117.75 140.36 49.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.162 -0.472 . . . . 15.0 110.802 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.511 HG21 HD13 ' A' ' 21' ' ' LEU . 16.8 m -134.03 144.29 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.542 0.686 . . . . 15.0 111.68 176.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.9 tp -104.21 136.78 43.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.131 -0.941 . . . . 15.0 110.233 178.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.461 HD11 ' CG1' ' A' ' 28' ' ' VAL . 59.9 mt -105.78 135.06 45.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.216 0.531 . . . . 15.0 111.098 -176.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.48 ' HB2' HG12 ' A' ' 54' ' ' VAL . 98.0 mmm -94.43 134.06 37.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.003 -0.998 . . . . 15.0 109.319 171.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -57.55 143.91 39.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.883 0.373 . . . . 15.0 110.673 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.18 175.08 28.57 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.961 -0.856 . . . . 15.0 110.961 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -59.24 -32.27 69.83 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.676 0.25 . . . . 15.0 111.676 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.7 -177.72 24.35 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.934 -0.866 . . . . 15.0 110.934 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.85 119.02 4.89 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.178 -0.769 . . . . 15.0 111.178 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -57.92 -44.57 86.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.303 0.573 . . . . 15.0 110.025 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.47 -42.2 98.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.821 -0.627 . . . . 15.0 111.022 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -57.05 -54.42 46.94 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.959 0.409 . . . . 15.0 110.997 -176.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.8 mt -58.35 -41.67 85.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.391 -0.368 . . . . 15.0 110.696 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.475 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -60.72 -41.92 96.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.362 -0.381 . . . . 15.0 111.573 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.07 -40.84 95.2 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.765 -0.374 . . . . 15.0 110.653 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -59.55 -51.59 69.18 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.437 -0.505 . . . . 15.0 111.054 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.511 HD13 HG21 ' A' ' 5' ' ' VAL . 78.6 mt -63.18 -37.02 85.58 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.61 -0.436 . . . . 15.0 111.069 -178.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -61.53 -43.5 98.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.725 0.297 . . . . 15.0 110.552 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.39 -30.62 68.33 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.954 -0.641 . . . . 15.0 111.933 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.434 ' HB3' HD22 ' A' ' 110' ' ' LEU . 96.4 mt-30 -88.07 9.71 21.64 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.632 0.975 . . . . 15.0 113.632 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.91 14.44 59.37 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 121.205 -0.521 . . . . 15.0 113.482 174.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.0 t -101.12 138.32 25.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 117.904 0.852 . . . . 15.0 110.163 178.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -83.37 136.98 34.14 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.378 -0.601 . . . . 15.0 109.378 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.475 HG11 ' CB ' ' A' ' 18' ' ' ALA . 44.1 t -117.03 133.92 62.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.326 0.584 . . . . 15.0 111.516 -173.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -135.33 125.88 26.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.114 -0.948 . . . . 15.0 109.257 169.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -112.34 132.79 54.8 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.762 0.315 . . . . 15.0 110.362 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 tp -115.83 113.5 42.19 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 118.776 -0.63 . . . . 15.0 110.966 -172.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -51.14 135.1 44.86 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.008 1.138 . . . . 15.0 111.769 173.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.672 HD13 ' ND2' ' A' ' 62' ' ' ASN . 51.3 mt -63.3 -9.23 10.9 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.143 0.794 . . . . 15.0 113.143 -175.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -77.2 -8.79 58.15 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.306 0.854 . . . . 15.0 113.306 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -60.05 150.09 71.71 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 118.417 0.553 . . . . 15.0 110.463 -177.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -80.63 153.14 20.18 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.547 1.498 . . . . 15.0 113.108 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.64 151.33 6.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.924 -0.58 . . . . 15.0 111.221 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.44 -38.06 3.23 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.393 -0.683 . . . . 15.0 111.393 -177.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -61.48 -37.43 83.59 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.658 -0.417 . . . . 15.0 111.068 -177.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.532 ' O ' HG23 ' A' ' 44' ' ' VAL . 24.5 tp -60.23 -47.3 86.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.874 0.368 . . . . 15.0 110.332 -178.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.511 HD22 ' CG ' ' A' ' 70' ' ' ASP . 18.3 tp -62.34 -44.66 95.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.896 -176.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.94 -44.08 97.51 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.714 -0.395 . . . . 15.0 110.773 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -60.07 -43.31 95.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.485 -0.325 . . . . 15.0 110.496 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 40' ' ' LEU . 78.7 t -61.23 -46.91 95.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.911 -0.316 . . . . 15.0 110.277 -177.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -67.99 -50.12 57.54 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.261 0.351 . . . . 15.0 111.843 -175.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.83 -44.48 77.12 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.727 0.269 . . . . 15.0 111.727 -173.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -78.73 -10.04 59.63 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.213 0.82 . . . . 15.0 113.213 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 56.43 55.83 6.21 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.6 0.714 . . . . 15.0 110.139 -177.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 44' ' ' VAL . 96.5 mt -70.57 147.84 48.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.609 -0.723 . . . . 15.0 111.029 -176.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -95.69 -40.66 9.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.597 -0.729 . . . . 15.0 110.798 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -149.22 166.9 29.54 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 119.806 -1.187 . . . . 15.0 113.765 -171.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 74.8 mt -126.81 144.47 50.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.627 -0.786 . . . . 15.0 110.155 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.516 HG22 ' CD1' ' A' ' 80' ' ' PHE . 47.7 t -122.69 132.11 71.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 110.181 -0.303 . . . . 15.0 110.181 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.48 HG12 ' HB2' ' A' ' 8' ' ' MET . 7.6 m -128.57 141.16 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 121.152 0.501 . . . . 15.0 110.565 173.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.6 t -99.33 -16.4 18.47 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.564 -0.744 . . . . 15.0 112.674 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 81.5 p -151.02 159.71 44.39 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.281 0.562 . . . . 15.0 111.684 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.5 -39.05 83.52 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.929 -0.868 . . . . 15.0 110.929 178.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -58.99 -44.49 91.62 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.801 -0.359 . . . . 15.0 110.636 -178.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.04 -44.62 97.09 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.559 -1.016 . . . . 15.0 110.559 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.614 HD13 HD21 ' A' ' 79' ' ' LEU . 31.8 tp -57.35 -43.08 83.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.063 0.459 . . . . 15.0 110.578 -179.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.16 -42.44 98.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.116 -0.493 . . . . 15.0 110.734 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.672 ' ND2' HD13 ' A' ' 33' ' ' LEU . 67.7 m-80 -59.34 -41.63 89.62 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.849 -0.34 . . . . 15.0 110.54 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.436 ' CD1' HD21 ' A' ' 40' ' ' LEU . 13.9 tp -58.39 -44.1 88.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.222 0.534 . . . . 15.0 110.237 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -61.61 -48.01 82.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.845 -0.616 . . . . 15.0 110.836 -178.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -61.27 -42.82 99.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.067 -0.515 . . . . 15.0 111.017 -176.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.31 -35.9 81.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.346 -0.388 . . . . 15.0 111.37 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.679 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -58.86 -39.36 81.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.059 0.457 . . . . 15.0 110.665 177.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 58.88 -142.18 0.66 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.68 -0.489 . . . . 15.0 109.68 174.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.66 -18.61 43.32 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.426 1.012 . . . . 15.0 112.62 -175.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.511 ' CG ' HD22 ' A' ' 41' ' ' LEU . 15.7 m-20 -91.9 9.36 33.27 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.331 0.863 . . . . 15.0 113.331 -175.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -47.79 -46.94 63.02 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.63 -0.7 . . . . 15.0 112.532 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -44.72 -40.91 14.66 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 C-N-CA 121.357 1.372 . . . . 15.0 113.252 177.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -76.96 -48.78 17.11 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.996 0.427 . . . . 15.0 110.828 -178.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.679 HD12 ' HB1' ' A' ' 67' ' ' ALA . 91.8 mt -59.84 -40.36 82.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.928 -176.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.0 -13.49 34.39 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 119.877 -0.401 . . . . 15.0 113.197 -176.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 -64.98 -30.61 71.61 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.486 0.643 . . . . 15.0 111.839 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.7 mt -72.52 146.21 88.48 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 119.32 -0.372 . . . . 15.0 110.922 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -61.42 131.15 34.74 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.375 1.383 . . . . 15.0 111.909 175.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.614 HD21 HD13 ' A' ' 60' ' ' LEU . 27.3 tp -107.0 126.97 53.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.581 -0.281 . . . . 15.0 110.697 176.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.516 ' CD1' HG22 ' A' ' 53' ' ' VAL . 83.6 m-85 -89.8 126.79 35.81 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.579 -0.526 . . . . 15.0 109.579 176.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' A' ' 87' ' ' ALA . 30.1 m -119.78 151.35 52.1 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-O 119.513 -0.28 . . . . 15.0 110.602 176.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.412 ' HD2' HG11 ' A' ' 86' ' ' VAL . 72.2 Cg_endo -79.2 -22.83 8.1 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.549 1.499 . . . . 15.0 113.869 -176.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.5 p -147.82 162.73 30.39 Favored Pre-proline 0 CA--C 1.531 0.236 0 C-N-CA 120.388 -0.525 . . . . 15.0 111.802 -171.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.17 -44.12 49.69 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.26 1.307 . . . . 15.0 111.792 176.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -57.05 -48.12 79.3 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.849 0.357 . . . . 15.0 110.765 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.412 HG11 ' HD2' ' A' ' 82' ' ' PRO . 56.6 t -60.22 -39.1 79.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.799 -0.36 . . . . 15.0 110.094 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.469 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -56.92 -41.49 78.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.982 0.42 . . . . 15.0 110.459 178.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -61.08 -41.0 95.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 15.0 110.429 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.0 mmm -58.13 -45.43 87.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.589 0.709 . . . . 15.0 110.195 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.476 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -62.06 -40.76 96.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.608 -0.724 . . . . 15.0 110.935 -178.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -61.85 -44.38 96.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.363 -0.38 . . . . 15.0 110.836 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.3 -36.06 77.01 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.851 -0.34 . . . . 15.0 111.339 -177.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.8 mt -66.13 -23.93 66.58 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.289 0.477 . . . . 15.0 112.289 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.24 13.31 17.82 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 119.406 -0.663 . . . . 15.0 113.171 -176.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.01 122.38 12.89 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.551 1.175 . . . . 15.0 109.852 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -67.94 -36.52 80.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.597 -0.729 . . . . 15.0 111.123 -171.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 58.7 ttt85 -131.82 117.54 18.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.956 0.408 . . . . 15.0 110.567 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.55 130.13 69.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.925 0.393 . . . . 15.0 110.038 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 90.6 mt -119.68 124.16 72.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.902 -0.59 . . . . 15.0 110.299 -177.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -92.88 114.85 27.52 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.907 -0.405 . . . . 15.0 109.907 174.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.483 ' HB2' HD11 ' A' ' 109' ' ' LEU . 31.8 p -81.44 -13.95 57.64 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.95 0.722 . . . . 15.0 112.95 -178.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -54.74 -38.74 67.52 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 122.082 -0.386 . . . . 15.0 111.001 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.53 -35.01 8.13 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.644 -0.583 . . . . 15.0 111.644 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.98 122.38 34.44 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.83 0.348 . . . . 15.0 110.81 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 48.8 m -65.42 161.98 18.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.634 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.63 -54.2 24.71 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 118.49 -0.767 . . . . 15.0 113.033 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.38 -35.99 96.8 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 CA-C-N 120.564 1.237 . . . . 15.0 111.384 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.32 -42.11 94.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.027 0.441 . . . . 15.0 110.125 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' A' ' 101' ' ' CYS . 82.8 mt -59.0 -40.42 84.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.062 0.458 . . . . 15.0 110.57 178.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.434 HD22 ' HB3' ' A' ' 24' ' ' GLN . 39.8 tp -57.21 -44.52 83.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.408 0.623 . . . . 15.0 110.053 178.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.21 -39.57 87.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.587 -0.733 . . . . 15.0 110.538 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.48 -41.48 94.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.443 -0.344 . . . . 15.0 110.917 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.0 mt -57.9 -51.16 70.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.161 0.505 . . . . 15.0 110.443 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.6 p -63.61 -40.24 96.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.67 -0.695 . . . . 15.0 111.323 -175.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.9 p -66.34 -38.6 88.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.724 0.297 . . . . 15.0 111.336 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.3 96.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.495 -0.321 . . . . 15.0 110.82 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.478 -0.328 . . . . 15.0 110.616 177.892 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 . . . . . 0 CA--C 1.535 0.379 0 N-CA-C 110.126 -0.324 . . . . 15.0 110.126 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.1 150.27 10.62 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.504 1.469 . . . . 15.0 112.179 -174.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.497 ' HB2' HD23 ' A' ' 49' ' ' LEU . 61.3 mttp -117.0 140.71 49.16 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.22 -0.446 . . . . 15.0 110.858 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.512 HG21 HD13 ' A' ' 21' ' ' LEU . 15.7 m -134.28 144.62 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.567 0.698 . . . . 15.0 111.67 175.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.6 tp -104.27 137.51 42.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.078 -0.965 . . . . 15.0 110.326 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.617 HD11 ' CG1' ' A' ' 28' ' ' VAL . 52.5 mt -102.47 134.12 44.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.005 0.431 . . . . 15.0 111.025 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.532 ' HB2' HG12 ' A' ' 54' ' ' VAL . 98.4 mmm -95.01 134.15 38.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.221 -0.9 . . . . 15.0 109.307 171.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -57.65 144.63 37.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.948 0.404 . . . . 15.0 110.678 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -161.68 175.15 38.25 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.801 -0.92 . . . . 15.0 110.801 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.94 -34.72 60.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.536 0.208 . . . . 15.0 111.486 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.81 162.94 29.83 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.9 -0.88 . . . . 15.0 110.9 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.93 130.92 10.1 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.232 -0.747 . . . . 15.0 111.232 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -57.13 -43.82 82.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.985 0.421 . . . . 15.0 110.359 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.23 -43.01 99.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.046 -0.525 . . . . 15.0 111.333 -176.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -61.52 -56.09 23.87 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.858 -0.337 . . . . 15.0 111.341 -176.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.4 mt -60.66 -43.45 97.6 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.708 -0.397 . . . . 15.0 111.031 -176.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.78 -39.4 94.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.389 -0.369 . . . . 15.0 110.92 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -60.76 -43.01 98.53 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.905 -0.318 . . . . 15.0 110.482 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.487 ' NH2' ' HB3' ' A' ' 106' ' ' ALA . 15.6 tpt180 -61.19 -51.57 68.43 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.421 -0.511 . . . . 15.0 110.943 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.512 HD13 HG21 ' A' ' 5' ' ' VAL . 69.2 mt -62.61 -36.97 84.48 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.515 -0.474 . . . . 15.0 110.999 -178.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -63.05 -43.31 99.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.618 0.247 . . . . 15.0 111.045 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.96 -30.59 66.79 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.035 -0.602 . . . . 15.0 111.932 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.408 ' HB3' HD22 ' A' ' 110' ' ' LEU . 96.1 mt-30 -88.09 9.87 21.12 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.494 0.924 . . . . 15.0 113.494 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.27 14.69 58.48 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 121.258 -0.496 . . . . 15.0 113.501 174.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.0 t -101.1 139.07 23.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 117.857 0.828 . . . . 15.0 110.22 178.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -84.45 134.08 34.47 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.04 -0.726 . . . . 15.0 109.04 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.617 ' CG1' HD11 ' A' ' 7' ' ' ILE . 22.4 t -119.59 133.96 64.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.229 0.537 . . . . 15.0 111.353 -173.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -137.84 136.3 37.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.469 -0.787 . . . . 15.0 109.591 172.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.443 ' HB3' HD12 ' A' ' 7' ' ' ILE . 33.7 p90 -115.37 140.93 48.69 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.793 0.33 . . . . 15.0 110.827 -178.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.1 tp -119.3 113.43 35.28 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-O 118.741 -0.647 . . . . 15.0 110.715 -175.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.17 135.08 63.36 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 121.168 1.246 . . . . 15.0 111.964 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.826 HD13 ' ND2' ' A' ' 62' ' ' ASN . 50.3 mt -62.53 -9.14 7.72 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.358 0.873 . . . . 15.0 113.358 -175.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -77.09 -9.5 58.78 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.18 0.807 . . . . 15.0 113.18 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -60.78 149.18 80.85 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 118.292 0.496 . . . . 15.0 110.251 -178.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.97 154.18 25.7 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.53 1.487 . . . . 15.0 112.968 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.23 150.77 5.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.955 -0.566 . . . . 15.0 111.163 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.95 -37.65 3.39 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.439 -0.664 . . . . 15.0 111.439 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.89 -36.9 80.41 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.594 -0.442 . . . . 15.0 111.103 -177.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 44' ' ' VAL . 23.2 tp -58.97 -45.99 89.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.379 . . . . 15.0 110.201 -178.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.612 HD22 ' OD1' ' A' ' 70' ' ' ASP . 10.2 tp -62.65 -45.35 93.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.209 -0.45 . . . . 15.0 110.803 -177.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.74 -43.59 98.56 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.731 -0.388 . . . . 15.0 110.852 -176.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -60.52 -43.9 96.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.558 -0.292 . . . . 15.0 110.522 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.563 ' HA ' HD12 ' A' ' 49' ' ' LEU . 78.3 t -61.18 -46.38 96.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.774 -0.37 . . . . 15.0 110.214 -176.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -68.41 -51.04 48.25 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.348 0.405 . . . . 15.0 112.025 -175.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.83 -44.37 81.26 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.736 0.273 . . . . 15.0 111.736 -173.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -79.37 -10.17 59.75 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.06 0.763 . . . . 15.0 113.06 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.7 mtp180 55.39 55.81 7.0 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.658 0.742 . . . . 15.0 110.273 -177.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.563 HD12 ' HA ' ' A' ' 44' ' ' VAL . 94.8 mt -70.72 146.22 50.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.643 -0.708 . . . . 15.0 111.296 -174.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -93.45 -40.6 10.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.408 -0.814 . . . . 15.0 110.876 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.86 165.11 29.23 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 119.943 -1.122 . . . . 15.0 113.785 -173.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 74.2 mt -125.62 142.16 51.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.466 -0.867 . . . . 15.0 109.837 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.526 HG22 ' CD1' ' A' ' 80' ' ' PHE . 47.6 t -120.49 129.55 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 110.261 -0.274 . . . . 15.0 110.261 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.532 HG12 ' HB2' ' A' ' 8' ' ' MET . 10.5 m -128.27 133.39 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.873 0.368 . . . . 15.0 110.095 172.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.5 p -99.38 -4.22 32.09 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.998 0.74 . . . . 15.0 112.998 177.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 82.7 p -152.46 154.92 36.49 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.366 0.603 . . . . 15.0 111.793 -176.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.03 -38.92 88.43 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.986 -0.846 . . . . 15.0 110.986 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -57.41 -46.14 83.83 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 122.63 -0.336 . . . . 15.0 110.638 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.32 -44.37 96.6 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.7 -0.96 . . . . 15.0 110.7 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.628 HD13 HD21 ' A' ' 79' ' ' LEU . 36.5 tp -57.19 -45.27 83.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.123 0.487 . . . . 15.0 110.597 -178.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.35 -42.13 98.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.029 -0.532 . . . . 15.0 110.818 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.826 ' ND2' HD13 ' A' ' 33' ' ' LEU . 74.0 m-80 -60.06 -40.48 89.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.523 -0.308 . . . . 15.0 110.669 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.1 tp -58.42 -44.35 89.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.142 0.496 . . . . 15.0 110.149 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -60.96 -47.35 86.86 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.801 -0.636 . . . . 15.0 110.719 -178.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.43 -43.02 99.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.089 -0.505 . . . . 15.0 111.116 -176.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.3 mt -66.26 -35.44 80.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.354 -0.385 . . . . 15.0 111.375 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.676 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.03 -39.0 80.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.095 0.474 . . . . 15.0 110.672 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.02 -142.89 0.62 Allowed 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.691 -0.485 . . . . 15.0 109.691 174.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.56 -19.77 50.94 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.38 0.991 . . . . 15.0 112.697 -174.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.612 ' OD1' HD22 ' A' ' 41' ' ' LEU . 78.4 m-20 -91.9 11.04 26.29 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.307 0.854 . . . . 15.0 113.307 -175.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 55.0 t-105 -47.83 -46.67 63.01 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-O 118.555 -0.736 . . . . 15.0 112.521 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -44.56 -41.09 14.22 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.498 1.465 . . . . 15.0 113.198 177.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -76.93 -48.83 17.05 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.944 0.402 . . . . 15.0 110.849 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.676 HD12 ' HB1' ' A' ' 67' ' ' ALA . 91.3 mt -59.92 -39.82 81.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 15.0 110.871 -176.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.21 -14.6 33.68 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 119.898 -0.39 . . . . 15.0 113.092 -176.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -64.15 -30.36 71.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.404 0.602 . . . . 15.0 111.963 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.0 mt -75.36 150.57 85.07 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 120.939 -0.305 . . . . 15.0 111.53 -173.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -61.98 128.35 23.94 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.675 1.584 . . . . 15.0 112.457 176.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.628 HD21 HD13 ' A' ' 60' ' ' LEU . 22.1 tp -107.64 126.31 52.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.313 -0.403 . . . . 15.0 110.474 174.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.526 ' CD1' HG22 ' A' ' 53' ' ' VAL . 75.7 m-85 -90.52 125.65 35.67 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.599 -0.519 . . . . 15.0 109.599 176.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.661 HG21 ' HB2' ' A' ' 87' ' ' ALA . 26.1 m -116.99 147.78 40.83 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 110.154 -0.313 . . . . 15.0 110.154 176.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.24 -24.76 6.36 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.634 1.556 . . . . 15.0 113.538 -174.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.8 p -142.78 162.3 44.7 Favored Pre-proline 0 CA--C 1.531 0.213 0 C-N-CA 120.611 -0.436 . . . . 15.0 111.658 -171.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.0 -44.04 50.96 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.21 1.273 . . . . 15.0 111.841 176.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -58.25 -47.06 84.75 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.915 -0.314 . . . . 15.0 110.737 -177.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.6 t -60.2 -41.02 85.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 110.003 -0.369 . . . . 15.0 110.003 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.661 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.74 -42.35 83.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.925 0.393 . . . . 15.0 110.509 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -61.43 -41.8 97.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 15.0 110.563 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 87.1 mtp -59.17 -43.88 92.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.211 0.529 . . . . 15.0 110.268 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.52 94.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.889 -0.596 . . . . 15.0 110.792 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -61.24 -44.39 97.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.274 -0.421 . . . . 15.0 110.566 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.05 -36.15 76.69 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.868 -0.333 . . . . 15.0 111.244 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.1 mt -64.24 -25.94 68.28 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.019 0.378 . . . . 15.0 112.019 176.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.27 13.32 15.49 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 119.313 -0.715 . . . . 15.0 113.045 -176.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.97 122.4 12.91 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.521 1.16 . . . . 15.0 109.91 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -69.9 -35.95 75.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.705 -0.68 . . . . 15.0 111.223 -172.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -131.07 112.63 13.06 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.042 0.449 . . . . 15.0 110.398 178.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.0 t -111.0 130.23 64.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.183 -0.462 . . . . 15.0 109.901 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 84.6 mt -119.3 125.23 74.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.832 -0.622 . . . . 15.0 110.081 -177.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -95.33 118.12 31.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.401 -0.363 . . . . 15.0 110.261 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 32.0 p -95.76 -4.16 44.51 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.184 0.809 . . . . 15.0 113.184 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.1 tpt85 -55.6 -39.54 70.89 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.086 0.403 . . . . 15.0 110.712 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -95.79 -35.14 5.71 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.532 -0.627 . . . . 15.0 111.532 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.64 137.27 40.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.823 0.344 . . . . 15.0 110.68 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.2 p -83.87 164.49 19.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 15.0 110.665 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.487 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . . . -47.72 -54.3 24.33 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 113.018 0.748 . . . . 15.0 113.018 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.49 -36.0 97.19 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 CA-C-N 120.469 1.203 . . . . 15.0 111.394 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.47 -42.89 97.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.114 0.483 . . . . 15.0 110.103 178.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.3 mt -59.0 -41.2 87.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 15.0 110.414 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.408 HD22 ' HB3' ' A' ' 24' ' ' GLN . 34.3 tp -57.61 -44.55 85.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.37 0.605 . . . . 15.0 110.183 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.78 94.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.673 -0.694 . . . . 15.0 110.514 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.7 -41.08 94.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.416 -0.356 . . . . 15.0 110.811 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.4 mt -57.69 -51.76 68.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.233 0.539 . . . . 15.0 110.459 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.0 p -64.04 -40.57 96.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.647 -0.706 . . . . 15.0 111.33 -175.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.9 m -63.42 -42.86 98.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.732 0.301 . . . . 15.0 111.46 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.64 -39.27 93.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.446 -0.343 . . . . 15.0 111.049 -178.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.555 -0.293 . . . . 15.0 111.14 179.519 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 . . . . . 0 CA--C 1.535 0.394 0 N-CA-C 110.179 -0.304 . . . . 15.0 110.179 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -56.42 152.87 37.39 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.393 1.395 . . . . 15.0 112.0 -175.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -110.78 139.0 46.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.383 -0.371 . . . . 15.0 110.687 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.497 HG21 HD13 ' A' ' 21' ' ' LEU . 13.2 m -135.72 142.74 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.596 0.713 . . . . 15.0 111.695 176.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.497 HD13 ' HD3' ' A' ' 43' ' ' ARG . 18.3 tp -104.77 135.35 46.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.863 -1.062 . . . . 15.0 110.129 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.576 HD11 ' CG1' ' A' ' 28' ' ' VAL . 57.5 mt -104.75 133.74 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.19 0.519 . . . . 15.0 110.888 -176.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 98.4 mmm -95.2 134.06 38.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.062 -0.972 . . . . 15.0 109.488 173.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -62.09 143.99 55.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.886 0.374 . . . . 15.0 110.677 -178.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.57 175.07 32.83 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.108 -0.797 . . . . 15.0 111.108 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.59 -33.31 66.08 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.576 0.214 . . . . 15.0 111.576 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.4 -178.28 4.6 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.963 -0.855 . . . . 15.0 110.963 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.04 112.6 3.67 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.05 -0.82 . . . . 15.0 111.05 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -56.83 -45.85 82.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.308 0.575 . . . . 15.0 110.146 -177.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.77 -44.31 93.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.694 -0.684 . . . . 15.0 111.122 -177.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -56.61 -53.83 53.06 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.805 -0.358 . . . . 15.0 111.281 -175.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.448 HD12 ' H ' ' A' ' 17' ' ' LEU . 5.9 mp -59.88 -43.21 94.87 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 120.649 -0.42 . . . . 15.0 110.883 -177.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.89 -42.52 98.14 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.752 -0.379 . . . . 15.0 111.48 -177.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.21 -39.16 89.2 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.776 -0.37 . . . . 15.0 110.846 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -60.23 -51.49 69.34 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.273 -0.571 . . . . 15.0 111.133 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.497 HD13 HG21 ' A' ' 5' ' ' VAL . 80.3 mt -62.89 -38.68 91.87 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.499 -0.48 . . . . 15.0 111.008 -177.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -64.0 -43.64 95.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.574 0.226 . . . . 15.0 110.955 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.24 -30.56 67.7 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.032 -0.604 . . . . 15.0 112.026 -178.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -88.14 9.76 21.63 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.52 0.933 . . . . 15.0 113.52 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.68 16.45 52.05 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 121.12 -0.562 . . . . 15.0 113.444 173.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.06 138.84 23.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 117.784 0.792 . . . . 15.0 110.058 177.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -78.29 125.41 29.32 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.059 -0.719 . . . . 15.0 109.059 177.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.576 ' CG1' HD11 ' A' ' 7' ' ' ILE . 41.3 t -117.63 131.65 69.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.132 0.492 . . . . 15.0 111.03 -172.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -137.61 131.79 32.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.611 -0.722 . . . . 15.0 109.77 171.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.402 ' HB3' HD12 ' A' ' 7' ' ' ILE . 11.2 p90 -114.62 134.55 54.97 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.217 -0.29 . . . . 15.0 110.217 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.2 tp -111.34 140.26 22.79 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 119.162 -0.446 . . . . 15.0 110.373 -174.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -72.11 135.13 24.49 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.219 1.279 . . . . 15.0 111.11 170.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.761 HD13 ' ND2' ' A' ' 62' ' ' ASN . 53.0 mt -63.21 -9.25 10.5 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.122 0.786 . . . . 15.0 113.122 -175.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -77.27 -10.25 59.31 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.263 0.838 . . . . 15.0 113.263 -177.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -62.46 151.07 83.98 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 118.552 0.614 . . . . 15.0 110.855 -177.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -79.11 155.49 25.89 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.479 1.453 . . . . 15.0 113.1 -177.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.24 150.73 8.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.875 -0.602 . . . . 15.0 111.072 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.98 -36.28 4.21 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.514 -0.634 . . . . 15.0 111.514 -177.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -59.54 -40.05 85.94 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 120.498 -0.481 . . . . 15.0 110.697 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.574 ' O ' HG23 ' A' ' 44' ' ' VAL . 23.7 tp -61.13 -47.97 83.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.963 0.411 . . . . 15.0 110.458 -177.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.485 HD13 ' CB ' ' A' ' 70' ' ' ASP . 19.0 tp -61.25 -43.44 98.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 15.0 110.888 -175.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.12 -46.01 90.92 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.782 -0.367 . . . . 15.0 110.84 -175.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.497 ' HD3' HD13 ' A' ' 6' ' ' LEU . 46.9 ttt85 -61.1 -41.87 97.47 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.635 -0.426 . . . . 15.0 110.567 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 40' ' ' LEU . 94.4 t -58.78 -45.59 91.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.753 -0.379 . . . . 15.0 110.022 -177.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -70.59 -50.94 31.93 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.503 0.502 . . . . 15.0 112.275 -176.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.75 -44.4 86.03 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.067 0.395 . . . . 15.0 112.067 -172.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.6 mp0 -89.11 -7.03 56.56 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.391 0.886 . . . . 15.0 113.391 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.8 ttt-85 57.97 56.05 4.92 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.662 0.744 . . . . 15.0 109.829 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.456 HD12 HG22 ' A' ' 44' ' ' VAL . 95.9 mt -60.61 142.69 55.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.595 -0.73 . . . . 15.0 110.891 -175.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -90.56 -40.56 11.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.481 -0.781 . . . . 15.0 110.822 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -149.57 163.57 29.31 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.079 -1.058 . . . . 15.0 113.498 -174.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.4 mt -126.27 141.06 52.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.433 -0.883 . . . . 15.0 109.903 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.555 HG22 ' CD1' ' A' ' 80' ' ' PHE . 47.4 t -120.83 131.31 73.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 110.294 -0.262 . . . . 15.0 110.294 -179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.6 m -124.14 130.55 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.134 0.493 . . . . 15.0 110.374 172.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.6 m -87.17 -19.45 28.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.586 -0.734 . . . . 15.0 112.514 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.8 p -151.86 161.04 43.29 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.336 0.588 . . . . 15.0 111.509 -175.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.35 -39.17 82.24 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.992 -0.843 . . . . 15.0 110.992 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -57.93 -45.9 85.85 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.864 -0.334 . . . . 15.0 110.563 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.63 -43.96 97.27 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.734 -0.947 . . . . 15.0 110.734 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.607 HD13 HD21 ' A' ' 79' ' ' LEU . 40.2 tp -57.48 -43.99 84.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.023 0.439 . . . . 15.0 110.559 -178.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.03 -42.17 97.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.077 -0.51 . . . . 15.0 110.641 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.761 ' ND2' HD13 ' A' ' 33' ' ' LEU . 67.5 m-80 -59.51 -40.72 87.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.444 -0.344 . . . . 15.0 110.635 178.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.9 tp -58.61 -44.54 89.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.135 0.493 . . . . 15.0 110.114 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -61.29 -47.26 86.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.852 -0.613 . . . . 15.0 110.703 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -61.36 -42.93 99.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.086 -0.506 . . . . 15.0 111.102 -176.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.7 mt -66.94 -34.95 78.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.34 -0.391 . . . . 15.0 111.478 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.676 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.04 -39.49 82.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.076 0.465 . . . . 15.0 110.601 177.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 58.95 -142.79 0.63 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 109.662 -0.496 . . . . 15.0 109.662 174.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.53 -18.87 44.06 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.417 1.008 . . . . 15.0 112.631 -174.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.485 ' CB ' HD13 ' A' ' 41' ' ' LEU . 16.6 m-20 -91.82 9.65 31.86 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.313 0.857 . . . . 15.0 113.313 -175.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -47.97 -46.62 64.38 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-O 118.559 -0.734 . . . . 15.0 112.521 177.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -44.7 -41.2 14.69 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.481 1.454 . . . . 15.0 113.218 177.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.5 mp0 -77.03 -48.76 17.01 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.688 -0.405 . . . . 15.0 110.755 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.676 HD12 ' HB1' ' A' ' 67' ' ' ALA . 89.8 mt -59.8 -40.2 81.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.279 -0.419 . . . . 15.0 110.858 -176.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.73 -15.14 32.71 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 119.903 -0.387 . . . . 15.0 113.107 -177.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -64.25 -30.61 71.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.417 0.608 . . . . 15.0 111.977 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.5 mt -76.24 150.46 82.9 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 121.065 -0.254 . . . . 15.0 111.397 -173.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.92 128.13 25.68 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 121.695 1.597 . . . . 15.0 112.43 176.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.607 HD21 HD13 ' A' ' 60' ' ' LEU . 22.3 tp -106.68 125.58 51.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 15.0 110.425 174.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.555 ' CD1' HG22 ' A' ' 53' ' ' VAL . 84.2 m-85 -91.56 125.63 36.36 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.607 -0.516 . . . . 15.0 109.607 176.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.695 HG21 ' HB2' ' A' ' 87' ' ' ALA . 28.2 m -116.85 148.06 41.3 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 110.114 -0.328 . . . . 15.0 110.114 176.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.413 ' HD2' HG11 ' A' ' 86' ' ' VAL . 74.9 Cg_endo -79.12 -24.27 6.92 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.486 1.457 . . . . 15.0 113.592 -175.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.4 ' OG ' HG23 ' A' ' 86' ' ' VAL . 27.6 p -143.43 162.06 44.15 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 120.564 -0.454 . . . . 15.0 111.644 -172.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.85 -44.04 51.33 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.241 1.294 . . . . 15.0 111.741 176.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -57.62 -47.87 81.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.8 0.333 . . . . 15.0 110.827 -178.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.413 HG11 ' HD2' ' A' ' 82' ' ' PRO . 52.4 t -59.74 -40.64 83.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.767 -0.373 . . . . 15.0 110.03 178.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.695 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.46 -42.3 82.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.921 0.391 . . . . 15.0 110.488 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.24 -41.87 97.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.147 -0.479 . . . . 15.0 110.465 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 87.0 mtp -59.34 -43.68 92.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.349 0.595 . . . . 15.0 110.384 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.48 -40.07 93.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.916 -0.584 . . . . 15.0 110.77 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -61.23 -44.28 97.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.335 -0.393 . . . . 15.0 110.61 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.95 -36.17 76.51 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.936 -0.306 . . . . 15.0 111.224 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.0 mt -64.09 -25.73 68.23 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.086 0.402 . . . . 15.0 112.086 176.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.57 13.31 17.06 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 119.336 -0.702 . . . . 15.0 113.098 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.02 122.87 14.07 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.534 1.167 . . . . 15.0 109.92 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -69.91 -35.7 74.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.734 -0.666 . . . . 15.0 111.223 -172.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -130.71 113.31 13.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.938 0.399 . . . . 15.0 110.302 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.09 129.52 66.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.236 -0.438 . . . . 15.0 109.9 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.2 mt -120.11 125.72 74.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.81 -0.632 . . . . 15.0 110.163 -176.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -94.39 117.33 29.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.458 -0.337 . . . . 15.0 110.345 175.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 32.0 p -97.0 -1.53 45.33 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.299 0.852 . . . . 15.0 113.299 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -55.53 -39.57 70.72 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 118.182 0.446 . . . . 15.0 110.785 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -95.21 -35.02 5.88 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.53 -0.628 . . . . 15.0 111.53 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.51 138.89 47.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.802 0.334 . . . . 15.0 110.644 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.5 p -85.77 164.9 17.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.094 -0.503 . . . . 15.0 110.529 179.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.68 -54.33 23.94 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 113.0 0.741 . . . . 15.0 113.0 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.69 -34.59 99.02 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 CA-C-N 120.099 1.071 . . . . 15.0 111.718 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.27 -43.31 96.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.104 0.478 . . . . 15.0 109.989 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 78.1 mt -59.31 -40.79 87.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 15.0 110.33 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 40.5 tp -57.13 -44.15 83.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.324 0.583 . . . . 15.0 110.229 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.83 -41.61 96.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.734 -0.667 . . . . 15.0 110.451 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.27 88.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 15.0 110.736 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.3 mt -57.81 -51.88 67.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.201 0.524 . . . . 15.0 110.395 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.7 p -63.69 -40.27 96.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.614 -0.721 . . . . 15.0 111.389 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.4 m -63.34 -43.24 98.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.66 0.267 . . . . 15.0 111.386 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.41 -39.36 93.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.42 -0.355 . . . . 15.0 111.091 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.423 -0.353 . . . . 15.0 110.939 179.12 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.535 0.385 0 N-CA-C 110.125 -0.324 . . . . 15.0 110.125 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.06 155.02 25.23 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.441 1.428 . . . . 15.0 111.921 -175.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -111.95 138.14 48.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.379 -0.373 . . . . 15.0 110.79 179.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.51 HG21 HD13 ' A' ' 21' ' ' LEU . 15.0 m -134.56 144.46 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.435 0.636 . . . . 15.0 111.638 176.449 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.1 tp -105.05 137.28 43.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.203 -0.908 . . . . 15.0 110.553 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.608 HD11 ' CG1' ' A' ' 28' ' ' VAL . 54.8 mt -103.16 133.41 47.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.01 0.433 . . . . 15.0 110.679 -177.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.572 ' HB2' HG12 ' A' ' 54' ' ' VAL . 85.5 mtp -106.05 134.43 49.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.31 -0.859 . . . . 15.0 110.197 174.404 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -57.43 144.98 34.4 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.108 0.48 . . . . 15.0 110.772 -177.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.35 175.16 36.29 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.763 -0.935 . . . . 15.0 110.763 -178.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.01 -32.68 47.97 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.681 0.252 . . . . 15.0 111.681 -179.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.95 -179.5 39.9 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.042 -0.823 . . . . 15.0 111.042 -178.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.01 113.98 3.88 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.156 -0.778 . . . . 15.0 111.156 -178.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -56.62 -47.66 79.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.119 0.485 . . . . 15.0 110.498 -179.453 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.38 -40.52 97.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 15.0 110.904 -178.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -57.46 -54.41 47.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.113 0.482 . . . . 15.0 110.764 -176.174 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.889 HD21 HG11 ' A' ' 53' ' ' VAL . 15.8 tp -57.88 -43.09 85.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 15.0 110.598 -179.004 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.37 -45.5 84.35 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.695 -0.402 . . . . 15.0 111.101 -178.02 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -59.81 -40.58 88.9 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.772 -0.371 . . . . 15.0 110.658 -176.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.1 mmt85 -59.76 -51.43 69.77 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.299 -0.56 . . . . 15.0 111.358 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.51 HD13 HG21 ' A' ' 5' ' ' VAL . 86.2 mt -62.61 -35.7 80.41 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.541 -0.464 . . . . 15.0 111.108 -176.442 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -64.19 -43.35 95.35 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.918 -0.313 . . . . 15.0 111.127 177.076 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.78 -30.63 66.3 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.008 -0.615 . . . . 15.0 112.066 -178.273 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -88.2 8.71 25.81 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.66 0.985 . . . . 15.0 113.66 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.73 17.62 56.24 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 121.233 -0.508 . . . . 15.0 113.245 175.391 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.0 t -101.12 140.25 20.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 117.745 0.772 . . . . 15.0 109.861 177.475 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -80.57 127.73 32.79 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.118 -0.697 . . . . 15.0 109.118 178.245 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.608 ' CG1' HD11 ' A' ' 7' ' ' ILE . 43.1 t -116.89 131.39 69.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.208 0.528 . . . . 15.0 111.025 -172.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -134.89 135.33 41.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.367 -0.833 . . . . 15.0 109.293 172.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.566 ' HB3' HD12 ' A' ' 7' ' ' ILE . 9.1 p90 -120.65 133.53 55.36 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.773 0.32 . . . . 15.0 110.7 -176.515 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.7 tp -117.01 141.5 28.47 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 116.14 -0.482 . . . . 15.0 110.004 -174.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -72.07 135.07 24.46 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.418 1.412 . . . . 15.0 111.699 170.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.579 HD13 ' ND2' ' A' ' 62' ' ' ASN . 74.7 mt -61.7 -10.0 7.61 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.943 0.72 . . . . 15.0 112.943 179.305 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -77.21 -10.87 59.68 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.191 0.811 . . . . 15.0 113.191 -177.209 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -62.7 148.96 90.29 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 118.512 0.596 . . . . 15.0 110.824 -177.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.1 159.03 37.68 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.574 1.516 . . . . 15.0 113.225 -174.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.04 152.43 5.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.729 -0.669 . . . . 15.0 111.061 -178.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.28 -35.69 4.24 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.487 -0.645 . . . . 15.0 111.487 -176.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -59.47 -39.01 82.29 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 117.094 0.447 . . . . 15.0 110.835 -177.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.589 ' O ' HG23 ' A' ' 44' ' ' VAL . 22.3 tp -59.3 -48.55 81.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.068 0.461 . . . . 15.0 110.274 -177.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.606 HD22 ' OD1' ' A' ' 70' ' ' ASP . 10.1 tp -62.47 -43.01 99.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.091 -0.504 . . . . 15.0 111.091 -175.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.62 -45.97 90.39 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.787 -0.365 . . . . 15.0 110.948 -175.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -61.07 -40.98 95.74 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.71 -0.396 . . . . 15.0 110.55 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 40' ' ' LEU . 84.8 t -59.54 -48.15 88.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 110.013 -0.365 . . . . 15.0 110.013 -177.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -68.59 -51.04 46.91 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.681 0.613 . . . . 15.0 112.098 -174.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.56 -44.26 82.77 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.789 0.292 . . . . 15.0 111.789 -173.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -82.92 -10.08 58.99 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.14 0.793 . . . . 15.0 113.14 -178.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 55.63 55.77 6.87 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.621 0.724 . . . . 15.0 110.112 -177.041 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 44' ' ' VAL . 95.3 mt -66.01 144.89 56.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.611 -0.722 . . . . 15.0 111.493 -173.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -93.92 -39.58 10.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.226 -0.897 . . . . 15.0 110.971 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.02 165.75 31.27 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 120.04 -1.076 . . . . 15.0 113.663 -175.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.3 mt -128.77 142.7 50.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.578 -0.811 . . . . 15.0 109.445 178.604 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.889 HG11 HD21 ' A' ' 17' ' ' LEU . 45.8 t -120.93 130.53 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 120.757 0.313 . . . . 15.0 110.541 -179.504 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.572 HG12 ' HB2' ' A' ' 8' ' ' MET . 13.9 m -130.4 155.64 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.2 -0.455 . . . . 15.0 110.17 172.129 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.8 t -131.18 12.09 5.07 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.716 0.636 . . . . 15.0 112.716 177.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 81.9 p -154.14 151.52 29.34 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.184 0.516 . . . . 15.0 111.577 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.48 -40.08 91.7 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.599 -1.0 . . . . 15.0 110.599 176.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -58.93 -42.03 88.74 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.897 -0.321 . . . . 15.0 110.6 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.48 -46.23 94.75 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.627 -0.989 . . . . 15.0 110.627 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.413 HD13 HD21 ' A' ' 79' ' ' LEU . 29.9 tp -57.54 -43.32 84.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.985 0.421 . . . . 15.0 110.474 -179.246 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.31 -42.25 98.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.474 . . . . 15.0 110.81 -179.501 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.579 ' ND2' HD13 ' A' ' 33' ' ' LEU . 69.5 m-80 -59.05 -42.38 90.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.955 0.407 . . . . 15.0 110.412 178.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.2 tp -58.47 -44.16 89.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.125 0.488 . . . . 15.0 110.296 -179.032 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -61.75 -48.32 81.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.942 -0.572 . . . . 15.0 110.762 -177.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.41 -42.65 99.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.043 -0.526 . . . . 15.0 111.095 -176.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 92.1 mt -67.42 -35.3 78.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.37 -0.377 . . . . 15.0 111.489 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.694 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -58.9 -38.1 78.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.06 0.457 . . . . 15.0 110.665 177.142 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.43 -143.25 0.58 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 109.501 -0.555 . . . . 15.0 109.501 173.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.53 -19.5 48.75 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.377 0.989 . . . . 15.0 112.63 -174.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.606 ' OD1' HD22 ' A' ' 41' ' ' LEU . 79.4 m-20 -91.91 11.03 26.35 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 113.362 0.875 . . . . 15.0 113.362 -175.179 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 60.4 t-105 -47.9 -46.07 62.83 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-O 118.501 -0.762 . . . . 15.0 112.548 177.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -44.67 -42.71 14.73 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 121.416 1.411 . . . . 15.0 113.271 177.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -76.96 -48.73 17.24 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.032 0.444 . . . . 15.0 110.626 -177.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.694 HD12 ' HB1' ' A' ' 67' ' ' ALA . 87.4 mt -59.73 -35.6 60.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.014 -0.539 . . . . 15.0 111.061 -177.162 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.0 -20.64 34.95 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 119.969 -0.35 . . . . 15.0 112.946 -176.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -64.08 -30.16 71.25 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.34 0.57 . . . . 15.0 112.347 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.8 mt -62.21 150.49 84.2 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 119.545 -0.264 . . . . 15.0 110.891 -174.491 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.453 ' HB2' HD12 ' A' ' 99' ' ' ILE . 59.0 Cg_endo -73.34 123.12 8.49 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 121.419 1.413 . . . . 15.0 111.669 175.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.413 HD21 HD13 ' A' ' 60' ' ' LEU . 26.4 tp -102.46 123.7 46.7 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.906 -0.318 . . . . 15.0 110.581 176.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.625 ' CD1' HG22 ' A' ' 53' ' ' VAL . 76.4 m-85 -87.84 125.2 34.33 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.382 -0.599 . . . . 15.0 109.382 175.606 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.663 HG21 ' HB2' ' A' ' 87' ' ' ALA . 27.0 m -117.96 147.82 42.1 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 119.429 -0.319 . . . . 15.0 110.186 176.09 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.405 ' HD2' HG11 ' A' ' 86' ' ' VAL . 94.6 Cg_endo -79.13 -24.43 6.77 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.532 1.488 . . . . 15.0 113.52 -175.11 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.9 p -143.09 161.25 49.23 Favored Pre-proline 0 CA--C 1.531 0.235 0 C-N-CA 120.627 -0.429 . . . . 15.0 111.41 -172.296 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -54.98 -44.05 53.52 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.115 1.21 . . . . 15.0 111.78 176.135 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -57.5 -48.46 79.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.847 0.356 . . . . 15.0 110.613 -177.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.405 HG11 ' HD2' ' A' ' 82' ' ' PRO . 55.7 t -59.74 -39.96 81.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.942 0.401 . . . . 15.0 110.043 178.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.663 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.22 -41.67 79.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 15.0 110.337 178.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -60.51 -40.55 91.83 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.303 -0.408 . . . . 15.0 110.415 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 96.9 mmm -57.84 -44.53 86.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.562 0.696 . . . . 15.0 110.195 179.052 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.68 -40.69 95.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.566 -0.743 . . . . 15.0 110.77 -179.417 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.445 ' HD3' HG21 ' A' ' 98' ' ' VAL . 29.9 mmt180 -62.54 -42.93 99.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.348 -0.387 . . . . 15.0 111.097 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.0 -36.01 78.36 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.869 -0.332 . . . . 15.0 111.5 -176.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.1 mt -66.32 -22.9 66.29 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.272 0.471 . . . . 15.0 112.272 176.539 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.21 13.33 19.7 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 119.378 -0.679 . . . . 15.0 113.051 -176.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.89 122.02 11.94 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.504 1.152 . . . . 15.0 109.872 -178.142 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -74.35 -31.71 62.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.509 -0.769 . . . . 15.0 111.642 -171.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -129.38 111.59 12.97 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.996 0.427 . . . . 15.0 110.154 175.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.445 HG21 ' HD3' ' A' ' 91' ' ' ARG . 43.8 t -114.66 131.25 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 15.0 109.861 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.453 HD12 ' HB2' ' A' ' 78' ' ' PRO . 85.1 mt -120.69 124.57 72.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.242 -0.435 . . . . 15.0 110.304 -176.008 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -94.3 118.48 31.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.395 -0.366 . . . . 15.0 110.302 176.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.4 p -96.26 -3.97 43.12 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.216 0.821 . . . . 15.0 113.216 -178.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -55.72 -39.55 71.24 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 118.246 0.475 . . . . 15.0 110.776 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -91.53 -35.03 7.09 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.569 -0.612 . . . . 15.0 111.569 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -82.32 132.29 35.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.841 0.353 . . . . 15.0 110.76 -179.135 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.6 p -77.91 167.04 22.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.096 -0.502 . . . . 15.0 110.572 179.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.64 -54.4 23.24 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 112.974 0.731 . . . . 15.0 112.974 179.045 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.09 -34.84 98.91 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 CA-C-N 120.213 1.112 . . . . 15.0 111.68 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.93 -43.0 95.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.07 0.462 . . . . 15.0 109.988 177.337 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.8 mt -59.4 -40.11 85.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 15.0 110.522 178.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 43.7 tp -56.9 -44.37 82.26 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.39 0.614 . . . . 15.0 110.169 178.515 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.9 -41.11 95.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.589 -0.732 . . . . 15.0 110.491 179.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.33 -41.21 93.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.335 -0.393 . . . . 15.0 110.743 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.1 mt -57.88 -50.87 71.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.122 0.487 . . . . 15.0 110.373 -179.163 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.3 p -64.55 -40.98 96.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.657 -0.701 . . . . 15.0 111.374 -175.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.0 m -61.94 -42.46 99.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.703 0.287 . . . . 15.0 111.297 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.82 -43.51 98.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.473 -0.33 . . . . 15.0 111.033 -178.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.732 0.301 . . . . 15.0 110.835 179.646 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.5 mtm . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.373 -0.603 . . . . 3.91 109.373 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -125.93 74.58 71.29 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.138 -0.483 . . . . 2.16 110.315 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.45 155.08 54.7 Favored 'Trans proline' 0 N--CA 1.497 1.717 0 C-N-CA 121.525 1.483 . . . . 0.33 112.026 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -105.4 136.85 44.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.403 -0.362 . . . . 1.24 110.559 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.469 HG21 HD13 ' A' ' 21' ' ' LEU . 13.7 m -134.34 145.18 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.57 0.7 . . . . 0.19 111.753 176.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.424 HD13 ' HD3' ' A' ' 43' ' ' ARG . 13.1 tp -106.03 135.28 47.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.874 -1.057 . . . . 0.19 110.193 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.549 HD11 ' CG1' ' A' ' 28' ' ' VAL . 47.7 mt -103.44 134.68 43.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.242 -0.436 . . . . 0.32 110.275 -178.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.456 ' SD ' HG12 ' A' ' 54' ' ' VAL . 87.0 mtp -96.75 134.02 40.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.148 -0.478 . . . . 1.03 110.438 173.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -59.21 144.3 46.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.297 -0.411 . . . . 2.79 110.705 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.08 175.11 36.07 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.963 -0.855 . . . . 0.5 110.963 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.69 -33.26 54.81 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.579 0.215 . . . . 2.15 111.579 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.78 175.84 33.67 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.915 -0.874 . . . . 0.57 110.915 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.87 117.92 4.9 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.437 -0.665 . . . . 0.54 111.437 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -57.15 -41.72 79.69 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.84 0.352 . . . . 2.95 110.533 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -61.16 -41.65 97.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 1.91 111.034 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -62.14 -56.09 22.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.856 0.36 . . . . 3.16 111.225 -176.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.25 -42.74 95.95 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.698 -0.401 . . . . 1.76 110.85 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.492 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -62.41 -40.26 95.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.325 -0.398 . . . . 0.36 110.936 -178.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -60.08 -42.31 94.33 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.918 -0.313 . . . . 1.91 110.502 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -59.88 -51.65 68.81 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 120.568 -0.453 . . . . 3.24 111.256 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.469 HD13 HG21 ' A' ' 5' ' ' VAL . 82.9 mt -62.65 -37.65 87.18 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.538 -0.465 . . . . 0.25 111.025 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -62.83 -43.08 99.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.646 0.26 . . . . 3.51 110.894 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.33 -30.69 68.24 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 121.063 -0.589 . . . . 0.3 111.924 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -88.12 10.44 19.27 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.513 0.931 . . . . 0.39 113.513 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.04 20.23 47.28 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 121.25 -0.5 . . . . 0.25 113.127 174.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -101.04 139.86 21.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 117.552 0.676 . . . . 0.23 110.191 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -81.9 129.15 34.67 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.108 -0.701 . . . . 0.35 109.108 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.549 ' CG1' HD11 ' A' ' 7' ' ' ILE . 40.5 t -119.02 132.2 69.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.289 0.566 . . . . 0.3 111.512 -173.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -137.58 133.58 34.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.13 -0.941 . . . . 1.12 109.271 170.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -115.54 138.26 51.23 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.861 0.362 . . . . 0.58 110.968 -178.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.1 tp -119.13 132.03 24.12 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-O 118.632 -0.699 . . . . 0.43 109.608 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.05 138.77 31.55 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.202 1.268 . . . . 0.47 111.903 174.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.684 HD13 HD22 ' A' ' 62' ' ' ASN . 77.4 mt -60.1 -9.22 2.97 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.397 0.888 . . . . 0.67 113.397 -177.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -77.07 -7.41 55.67 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.262 0.838 . . . . 1.2 113.262 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -63.31 148.71 92.87 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 118.555 0.616 . . . . 0.74 110.357 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -80.3 158.04 22.88 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.556 1.504 . . . . 0.31 113.191 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.12 151.5 4.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.866 -0.606 . . . . 0.24 111.277 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.31 -38.0 3.25 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.599 -0.6 . . . . 0.18 111.599 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -62.22 -37.27 84.72 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 120.595 -0.442 . . . . 1.77 111.09 -177.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.557 ' O ' HG23 ' A' ' 44' ' ' VAL . 24.0 tp -58.84 -48.13 82.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.978 0.418 . . . . 0.33 110.211 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.533 HD22 ' CG ' ' A' ' 70' ' ' ASP . 19.8 tp -64.36 -45.19 88.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.135 -0.484 . . . . 0.36 111.141 -175.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.83 -44.25 97.21 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.623 -0.431 . . . . 0.25 110.774 -176.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.424 ' HD3' HD13 ' A' ' 6' ' ' LEU . 56.2 ttm-85 -61.13 -42.7 99.02 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.945 -0.302 . . . . 2.57 110.706 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 40' ' ' LEU . 94.4 t -61.23 -45.3 98.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.814 -0.354 . . . . 0.29 110.198 -177.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -67.94 -50.71 54.37 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.352 0.407 . . . . 3.68 111.919 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.04 -44.4 80.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.662 -0.245 . . . . 0.4 111.554 -174.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -78.34 -10.11 59.54 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.968 0.729 . . . . 1.88 112.968 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 54.18 55.86 7.69 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.561 0.696 . . . . 3.6 110.602 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.521 HD12 HG22 ' A' ' 44' ' ' VAL . 93.6 mt -66.35 141.63 57.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.729 -0.669 . . . . 0.28 111.402 -175.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -89.81 -39.77 12.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.251 -0.886 . . . . 0.31 110.611 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.7 159.67 28.09 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.219 -0.991 . . . . 0.19 113.194 -175.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.2 mt -126.27 140.64 52.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.64 -0.78 . . . . 0.19 109.611 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.411 HG22 ' CD1' ' A' ' 80' ' ' PHE . 42.3 t -119.85 131.02 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 121.126 -0.229 . . . . 0.21 110.635 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.456 HG12 ' SD ' ' A' ' 8' ' ' MET . 3.3 m -119.41 131.16 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 121.25 0.547 . . . . 0.24 110.998 175.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.4 m -71.54 -33.01 68.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.338 -0.846 . . . . 1.41 111.725 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 72.6 p -157.56 169.92 23.59 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.354 0.597 . . . . 0.49 111.767 -173.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.57 -36.62 64.89 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.176 -0.769 . . . . 0.4 111.176 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -59.24 -46.08 89.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.937 0.369 . . . . 2.18 110.68 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.84 -44.29 97.19 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.439 -1.064 . . . . 0.28 110.439 177.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.641 HD13 HD21 ' A' ' 79' ' ' LEU . 30.4 tp -56.34 -44.24 79.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.15 0.5 . . . . 0.35 110.824 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.6 -43.23 99.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.065 -0.516 . . . . 0.45 110.546 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.684 HD22 HD13 ' A' ' 33' ' ' LEU . 84.4 m-20 -58.71 -39.1 79.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.72 110.65 177.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.476 ' CD1' HD21 ' A' ' 40' ' ' LEU . 13.0 tp -57.32 -45.18 84.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.295 0.569 . . . . 0.35 110.192 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -60.47 -47.05 87.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.562 -0.744 . . . . 0.29 110.586 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -61.78 -43.55 98.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.078 -0.51 . . . . 1.25 111.094 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.74 -34.94 78.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.458 -0.337 . . . . 0.25 111.468 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.666 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -58.72 -39.11 79.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.052 0.453 . . . . 0.17 110.684 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.07 -143.74 0.59 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.617 -0.512 . . . . 0.21 109.617 174.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.7 -18.77 45.09 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.367 0.985 . . . . 0.25 112.659 -175.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.533 ' CG ' HD22 ' A' ' 41' ' ' LEU . 21.5 m-20 -91.88 10.13 30.02 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.366 0.876 . . . . 1.09 113.366 -174.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -47.88 -46.62 63.5 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 118.554 -0.736 . . . . 0.21 112.565 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -44.73 -41.39 14.79 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.472 1.448 . . . . 0.25 113.261 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.2 mp0 -77.0 -48.75 17.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.941 0.4 . . . . 1.86 110.795 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.666 HD12 ' HB1' ' A' ' 67' ' ' ALA . 88.0 mt -59.04 -40.6 81.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.136 -0.484 . . . . 0.19 110.76 -176.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.95 -15.66 36.5 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 116.315 -0.402 . . . . 0.19 113.162 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 -64.94 -30.48 71.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.351 0.575 . . . . 2.43 112.032 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 27.3 mt -74.04 150.5 87.98 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 121.077 -0.249 . . . . 0.39 111.519 -173.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.83 126.25 17.01 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.611 1.541 . . . . 0.64 112.349 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.641 HD21 HD13 ' A' ' 60' ' ' LEU . 23.5 tp -104.89 127.34 52.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.345 -0.389 . . . . 0.24 110.578 175.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.411 ' CD1' HG22 ' A' ' 53' ' ' VAL . 70.5 m-85 -92.07 125.29 36.69 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.669 -0.493 . . . . 0.15 109.669 176.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.705 HG21 ' HB2' ' A' ' 87' ' ' ALA . 26.8 m -116.78 145.67 35.99 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-O 119.35 -0.357 . . . . 0.19 110.145 176.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.17 -22.86 8.11 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.531 1.487 . . . . 0.33 113.634 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.408 ' OG ' HG23 ' A' ' 86' ' ' VAL . 25.0 p -143.64 158.38 56.96 Favored Pre-proline 0 C--N 1.331 -0.236 0 C-N-CA 120.693 -0.403 . . . . 0.27 111.25 -171.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.37 -44.09 51.93 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.309 1.339 . . . . 0.43 111.689 176.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -58.12 -47.42 83.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.856 0.36 . . . . 2.99 110.939 -177.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.408 HG23 ' OG ' ' A' ' 83' ' ' SER . 60.2 t -60.12 -39.9 81.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.796 -0.362 . . . . 0.24 110.093 178.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.705 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.43 -41.85 81.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.966 0.413 . . . . 0.2 110.383 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.86 -40.43 92.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.439 . . . . 1.56 110.549 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.0 mmm -58.12 -44.96 88.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.412 0.625 . . . . 1.05 110.061 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.488 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -62.05 -41.16 97.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.695 -0.684 . . . . 0.21 110.792 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 75.9 ttt-85 -61.85 -44.76 96.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.333 -0.394 . . . . 3.12 110.824 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.58 -36.1 77.69 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.925 -0.31 . . . . 2.1 111.348 -177.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.2 mt -65.9 -23.9 66.73 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.241 0.46 . . . . 0.29 112.241 177.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.83 13.3 16.54 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 119.413 -0.659 . . . . 0.22 113.163 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.82 121.98 11.79 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.499 1.149 . . . . 0.19 109.917 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -69.31 -36.01 76.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.629 -0.714 . . . . 0.7 111.24 -171.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -131.59 113.91 14.2 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.024 0.44 . . . . 2.89 110.36 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.9 t -112.53 131.06 65.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.15 -0.477 . . . . 0.2 109.876 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 85.9 mt -119.27 123.33 71.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.856 -0.611 . . . . 0.22 110.026 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -94.93 118.28 31.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.406 -0.361 . . . . 1.13 110.248 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.516 ' HB2' HD11 ' A' ' 109' ' ' LEU . 32.0 p -96.11 -6.56 38.18 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.158 0.799 . . . . 0.34 113.158 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -55.32 -39.83 70.42 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 118.211 0.46 . . . . 3.47 110.812 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -93.72 -35.02 6.3 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.599 -0.6 . . . . 0.65 111.599 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -78.16 132.28 37.56 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.828 0.347 . . . . 0.46 110.632 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.2 m -74.86 162.83 28.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 1.21 110.659 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.76 -54.32 24.36 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 112.891 0.7 . . . . 0.35 112.891 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.94 -34.15 98.99 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 CA-C-N 119.987 1.031 . . . . 0.31 111.692 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.02 -43.07 95.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.037 0.446 . . . . 0.27 109.953 177.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.516 HD11 ' HB2' ' A' ' 101' ' ' CYS . 80.0 mt -59.19 -40.45 85.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.24 110.425 178.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 37.7 tp -56.98 -43.58 81.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.272 0.558 . . . . 0.22 110.183 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.58 -40.93 93.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.744 -0.662 . . . . 0.25 110.491 178.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.83 -42.19 93.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.328 -0.396 . . . . 0.24 110.684 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.5 mt -57.99 -50.21 74.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.177 0.513 . . . . 0.27 110.427 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.3 p -62.7 -40.89 98.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.798 -0.637 . . . . 0.31 111.231 -175.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.9 t -62.24 -45.15 94.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.766 0.317 . . . . 1.25 111.412 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.59 -38.61 88.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.449 -0.341 . . . . 0.44 111.179 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.66 -34.97 73.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.473 -0.33 . . . . 0.5 111.368 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 87.6 mt -57.43 -38.09 73.83 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 121.006 -0.277 . . . . 0.84 110.94 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -62.08 -35.04 77.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.596 -0.274 . . . . 2.4 111.376 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -56.98 -45.53 82.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.778 0.323 . . . . 3.9 110.813 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -57.44 -39.08 75.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 6.63 111.089 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -57.78 -43.11 85.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.422 -0.354 . . . . 7.61 111.183 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -54.81 -35.83 64.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.454 -0.339 . . . . 9.73 111.527 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -104.46 138.56 40.66 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.889 0.376 . . . . 9.91 110.773 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 118.048 -0.977 . . . . 11.52 110.494 -179.934 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.6 mtm . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.366 -0.605 . . . . 15.0 109.366 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -126.92 74.09 76.25 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 116.1 -0.5 . . . . 15.0 110.405 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.58 155.02 27.87 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.596 1.531 . . . . 15.0 112.065 -177.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.427 ' CB ' HD23 ' A' ' 49' ' ' LEU . 60.0 mttp -113.03 137.36 51.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.307 -0.406 . . . . 15.0 110.581 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.622 HG21 HD13 ' A' ' 21' ' ' LEU . 15.3 m -135.3 145.94 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.563 0.696 . . . . 15.0 111.709 176.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.559 HD12 ' O ' ' A' ' 29' ' ' ASP . 14.0 tp -105.75 136.74 44.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.027 -0.988 . . . . 15.0 110.332 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.415 HD11 ' CG1' ' A' ' 28' ' ' VAL . 61.7 mt -104.52 133.86 47.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.972 0.415 . . . . 15.0 110.695 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.463 ' SD ' HD13 ' A' ' 63' ' ' LEU . 83.7 mtp -101.45 134.46 44.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.279 -0.873 . . . . 15.0 110.714 175.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -57.33 143.33 40.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.129 0.49 . . . . 15.0 110.772 -175.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.86 175.09 29.14 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.852 -0.899 . . . . 15.0 110.852 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.81 -32.54 67.67 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.684 0.253 . . . . 15.0 111.684 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.34 -173.74 22.25 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.033 -0.827 . . . . 15.0 111.033 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.93 114.7 3.99 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.031 -0.828 . . . . 15.0 111.031 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -57.52 -44.84 85.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.273 0.558 . . . . 15.0 110.228 -176.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.99 -41.46 99.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.856 -0.611 . . . . 15.0 111.273 -177.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -60.01 -49.89 75.9 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.861 -0.335 . . . . 15.0 111.085 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 77.3 mt -57.64 -44.49 85.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.129 0.49 . . . . 15.0 110.43 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.486 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -59.43 -42.27 91.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 15.0 110.688 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -58.53 -41.51 85.67 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.031 -0.268 . . . . 15.0 110.475 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 69.0 mtm180 -59.31 -51.46 69.85 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.447 -0.501 . . . . 15.0 110.878 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.622 HD13 HG21 ' A' ' 5' ' ' VAL . 81.4 mt -61.1 -37.57 83.2 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.519 -0.472 . . . . 15.0 110.988 -177.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.445 ' HG3' HG21 ' A' ' 28' ' ' VAL . 40.2 mtp180 -64.21 -42.49 96.58 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.921 -0.312 . . . . 15.0 111.184 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.0 -30.67 67.04 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.007 -0.616 . . . . 15.0 111.967 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -88.14 8.87 24.87 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.6 0.963 . . . . 15.0 113.6 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.08 17.12 58.26 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 121.235 -0.507 . . . . 15.0 113.234 176.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.7 t -101.03 139.06 23.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 117.748 0.774 . . . . 15.0 109.95 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -78.65 134.64 37.13 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.346 -0.612 . . . . 15.0 109.346 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.486 HG11 ' HB1' ' A' ' 18' ' ' ALA . 48.7 t -119.24 131.55 71.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.345 0.593 . . . . 15.0 111.331 -173.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.559 ' O ' HD12 ' A' ' 6' ' ' LEU . 23.1 t70 -131.59 122.81 26.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.174 -0.921 . . . . 15.0 109.216 170.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -107.88 129.98 55.04 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.904 0.383 . . . . 15.0 110.812 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.3 tp -120.64 113.31 33.42 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 118.892 -0.575 . . . . 15.0 110.672 -175.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.19 135.2 67.85 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.27 1.313 . . . . 15.0 112.372 172.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.757 HD13 HD22 ' A' ' 62' ' ' ASN . 71.1 mt -58.95 -11.87 3.88 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.28 0.844 . . . . 15.0 113.28 -178.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -77.16 -6.22 52.1 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.417 0.895 . . . . 15.0 113.417 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -69.31 150.92 97.09 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 118.558 0.617 . . . . 15.0 110.771 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.63 151.29 32.25 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.616 1.544 . . . . 15.0 113.715 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.76 152.57 3.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.305 -0.861 . . . . 15.0 111.453 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.67 -38.14 3.21 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 115.72 -0.673 . . . . 15.0 111.871 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.3 -37.09 86.26 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 120.323 -0.551 . . . . 15.0 111.103 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.576 ' O ' HG23 ' A' ' 44' ' ' VAL . 24.4 tp -58.75 -47.71 83.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.98 0.419 . . . . 15.0 110.168 -178.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.463 HD13 HD11 ' A' ' 74' ' ' ILE . 16.3 tp -62.65 -45.36 93.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.974 -176.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.9 -45.04 95.46 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.577 -0.449 . . . . 15.0 110.871 -175.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -62.71 -40.05 95.94 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.768 -0.373 . . . . 15.0 111.07 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 40' ' ' LEU . 91.4 t -61.78 -45.24 99.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.807 -0.357 . . . . 15.0 110.289 -178.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -69.56 -47.51 63.42 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.205 0.446 . . . . 15.0 112.205 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.8 -44.27 77.72 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.977 -0.289 . . . . 15.0 111.609 -175.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -79.67 -10.11 59.74 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.053 0.76 . . . . 15.0 113.053 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 56.29 55.93 6.23 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.488 0.661 . . . . 15.0 109.989 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 44' ' ' VAL . 95.7 mt -69.29 145.18 53.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.836 -0.62 . . . . 15.0 111.302 -176.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -92.36 -40.54 10.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.323 -0.853 . . . . 15.0 111.061 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.63 161.87 28.6 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.012 -1.089 . . . . 15.0 113.651 -173.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.2 mt -126.08 144.06 50.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.494 -0.853 . . . . 15.0 109.934 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.533 HG22 ' CD1' ' A' ' 80' ' ' PHE . 46.7 t -120.87 129.91 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 O-C-N 122.353 -0.217 . . . . 15.0 110.712 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.4 HG12 ' SD ' ' A' ' 8' ' ' MET . 10.5 m -124.72 141.43 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-O 121.042 0.449 . . . . 15.0 110.471 172.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.8 m -96.59 -14.16 22.4 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.901 0.704 . . . . 15.0 112.901 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.5 p -157.57 163.25 38.54 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 121.414 0.626 . . . . 15.0 111.914 -174.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.23 -37.3 72.25 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.98 -0.848 . . . . 15.0 110.98 176.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -58.99 -44.98 91.69 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 122.666 -0.314 . . . . 15.0 110.633 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.81 -43.54 97.84 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.476 -1.049 . . . . 15.0 110.476 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.505 HD21 ' HA ' ' A' ' 90' ' ' ALA . 20.8 tp -56.85 -45.1 82.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.145 0.498 . . . . 15.0 110.699 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.64 -43.53 98.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.086 -0.506 . . . . 15.0 110.644 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.757 HD22 HD13 ' A' ' 33' ' ' LEU . 84.0 m-20 -59.08 -39.25 81.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.274 -0.421 . . . . 15.0 110.682 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.463 HD13 ' SD ' ' A' ' 8' ' ' MET . 12.3 tp -57.63 -44.84 85.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.179 0.514 . . . . 15.0 110.061 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -61.09 -47.61 85.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.735 -0.666 . . . . 15.0 110.585 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.88 -43.13 99.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.108 -0.496 . . . . 15.0 111.159 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.92 -35.53 80.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.443 -0.344 . . . . 15.0 111.426 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.657 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.77 -37.91 80.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.029 0.442 . . . . 15.0 110.856 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.51 -144.19 0.55 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 109.51 -0.552 . . . . 15.0 109.51 174.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.53 -19.56 49.14 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.349 0.977 . . . . 15.0 112.575 -174.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.429 ' CG ' HD22 ' A' ' 41' ' ' LEU . 23.3 m-20 -91.9 12.16 22.55 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.32 0.859 . . . . 15.0 113.32 -174.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 -47.79 -46.36 62.05 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 118.551 -0.737 . . . . 15.0 112.587 177.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -44.72 -41.43 14.76 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 121.417 1.412 . . . . 15.0 113.247 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -77.0 -48.72 17.16 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.544 -0.462 . . . . 15.0 110.836 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.657 HD12 ' HB1' ' A' ' 67' ' ' ALA . 93.0 mt -59.74 -40.45 82.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.451 . . . . 15.0 110.903 -176.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.44 -16.4 35.72 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 116.401 -0.363 . . . . 15.0 113.11 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.1 mtp-105 -64.67 -30.33 71.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.336 0.568 . . . . 15.0 112.027 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 23.4 mt -76.03 150.54 83.46 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 121.028 -0.269 . . . . 15.0 111.58 -172.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -63.22 128.36 22.53 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 121.628 1.552 . . . . 15.0 112.39 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.9 tp -108.59 127.56 54.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.511 -0.313 . . . . 15.0 110.657 174.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.533 ' CD1' HG22 ' A' ' 53' ' ' VAL . 80.1 m-85 -88.7 127.31 35.58 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.576 -0.527 . . . . 15.0 109.576 176.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.677 HG21 ' HB2' ' A' ' 87' ' ' ALA . 28.1 m -119.16 146.24 40.13 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 110.012 -0.366 . . . . 15.0 110.012 175.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.15 -22.58 8.36 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.608 1.538 . . . . 15.0 113.651 -174.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.417 ' OG ' HG23 ' A' ' 86' ' ' VAL . 24.7 p -143.47 158.2 57.87 Favored Pre-proline 0 CA--C 1.53 0.196 0 C-N-CA 120.645 -0.422 . . . . 15.0 111.263 -171.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.39 -44.0 52.66 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.32 1.347 . . . . 15.0 111.699 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 -58.37 -47.25 84.43 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.858 -0.337 . . . . 15.0 110.926 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.417 HG23 ' OG ' ' A' ' 83' ' ' SER . 60.9 t -59.75 -40.43 82.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.923 0.392 . . . . 15.0 109.965 178.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.677 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.46 -42.75 83.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.002 0.43 . . . . 15.0 110.404 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.31 -40.4 90.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.116 -0.493 . . . . 15.0 110.61 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.0 mmm -58.14 -44.39 87.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.428 0.632 . . . . 15.0 110.159 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.505 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.49 -40.51 94.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.655 -0.702 . . . . 15.0 110.862 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -62.61 -42.9 99.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.346 -0.388 . . . . 15.0 111.028 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.36 -36.16 77.37 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.832 -0.347 . . . . 15.0 111.274 -177.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.99 -22.78 65.9 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.399 0.518 . . . . 15.0 112.399 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 107.99 13.24 20.35 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 119.373 -0.682 . . . . 15.0 113.128 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.76 122.0 11.8 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 118.494 1.147 . . . . 15.0 109.961 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -69.04 -36.43 77.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.573 -0.74 . . . . 15.0 111.141 -171.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -131.79 112.92 12.92 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.152 0.501 . . . . 15.0 110.536 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.0 t -112.19 130.66 65.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.033 -0.531 . . . . 15.0 109.84 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.6 mt -118.46 122.17 68.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.886 -0.597 . . . . 15.0 109.999 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -94.21 116.56 28.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.429 -0.35 . . . . 15.0 110.433 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.9 p -97.07 4.57 51.31 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.162 0.801 . . . . 15.0 113.162 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 36.2 tpt85 -55.94 -39.92 72.42 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 118.187 0.449 . . . . 15.0 110.648 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.15 -35.13 5.39 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.486 -0.646 . . . . 15.0 111.486 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.65 138.58 44.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.847 0.356 . . . . 15.0 110.549 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.7 p -87.04 165.38 15.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 15.0 110.621 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.69 -54.23 24.77 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 118.552 -0.737 . . . . 15.0 112.923 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.54 -35.98 97.38 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 CA-C-N 120.596 1.249 . . . . 15.0 111.414 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.77 95.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.017 0.437 . . . . 15.0 110.051 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.3 mt -59.23 -40.02 84.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 15.0 110.514 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 42.0 tp -57.08 -44.52 83.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.379 0.609 . . . . 15.0 110.084 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.74 -41.16 94.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.627 -0.715 . . . . 15.0 110.488 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.3 -41.36 93.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.314 -0.403 . . . . 15.0 110.78 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.6 mt -57.89 -50.53 73.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.122 0.487 . . . . 15.0 110.401 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.3 p -63.85 -40.39 96.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.715 -0.675 . . . . 15.0 111.381 -175.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.8 p -65.44 -39.42 92.06 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 121.025 -0.27 . . . . 15.0 111.398 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.28 96.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.508 -0.315 . . . . 15.0 111.088 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.46 -39.54 83.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.467 -0.333 . . . . 15.0 110.755 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.36 -38.56 90.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.415 -0.357 . . . . 15.0 110.878 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.64 -34.73 78.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.461 -0.336 . . . . 15.0 111.477 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -56.51 -40.7 75.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.664 0.269 . . . . 15.0 110.853 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -111.58 128.33 56.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.84 0.352 . . . . 15.0 110.655 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -58.13 -40.77 82.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.481 . . . . 15.0 110.656 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -115.45 131.07 57.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.27 -0.423 . . . . 15.0 110.623 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -60.87 -42.54 98.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 15.0 110.456 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.992 -1.004 . . . . 15.0 110.508 -179.894 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.4 mmm . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.15 -0.685 . . . . 15.0 109.15 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.01 78.56 70.1 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.124 -0.489 . . . . 15.0 110.28 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.41 152.99 7.93 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.433 1.422 . . . . 15.0 111.857 -176.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.443 ' HB2' HD23 ' A' ' 49' ' ' LEU . 94.1 mttt -115.63 139.24 50.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.326 -0.397 . . . . 15.0 110.802 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.2 m -133.76 145.97 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.466 0.65 . . . . 15.0 111.652 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.505 HD13 ' CD ' ' A' ' 43' ' ' ARG . 12.4 tp -105.07 136.5 44.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.048 -0.978 . . . . 15.0 110.375 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.494 HD11 ' CG1' ' A' ' 28' ' ' VAL . 58.2 mt -104.11 135.14 43.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.972 0.415 . . . . 15.0 110.624 -178.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.606 ' HE3' HD21 ' A' ' 33' ' ' LEU . 96.6 mmm -89.34 134.12 34.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.458 -0.792 . . . . 15.0 110.149 174.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -57.64 141.39 48.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.958 0.408 . . . . 15.0 110.551 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.56 175.11 42.0 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.854 -0.898 . . . . 15.0 110.854 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -54.99 -35.22 64.12 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.205 -0.198 . . . . 15.0 111.217 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.23 162.87 7.45 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.861 -0.895 . . . . 15.0 110.861 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.87 123.56 6.34 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.151 -0.78 . . . . 15.0 111.151 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -56.66 -46.57 80.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.058 0.456 . . . . 15.0 110.422 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.32 -39.33 94.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.899 -0.591 . . . . 15.0 111.235 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -61.23 -56.01 25.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.927 0.394 . . . . 15.0 111.027 -175.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.6 mt -61.7 -41.99 98.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.018 0.437 . . . . 15.0 110.663 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.504 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -60.99 -36.28 79.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 15.0 111.182 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.23 -44.95 95.41 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.963 -0.295 . . . . 15.0 110.616 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -59.77 -51.65 68.86 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.084 -0.646 . . . . 15.0 111.252 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.47 -37.32 87.12 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.517 -0.473 . . . . 15.0 111.137 -176.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -64.02 -43.8 94.51 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.14 -0.224 . . . . 15.0 111.048 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.29 -30.63 68.0 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.043 -0.599 . . . . 15.0 111.923 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -88.14 9.9 21.15 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.515 0.932 . . . . 15.0 113.515 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.11 16.12 56.42 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 121.261 -0.495 . . . . 15.0 113.435 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -101.15 139.77 21.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 117.719 0.759 . . . . 15.0 109.98 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -84.93 133.61 34.28 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.483 -0.562 . . . . 15.0 109.483 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.504 HG11 ' CB ' ' A' ' 18' ' ' ALA . 39.4 t -115.12 131.45 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.09 0.471 . . . . 15.0 111.005 -174.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -133.78 128.76 35.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.568 -0.742 . . . . 15.0 109.33 171.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -111.38 134.64 52.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.799 0.333 . . . . 15.0 110.652 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.7 tp -112.83 129.95 23.96 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-O 118.492 -0.766 . . . . 15.0 109.732 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -72.08 139.64 33.06 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 CA-C-N 120.431 1.19 . . . . 15.0 111.676 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.606 HD21 ' HE3' ' A' ' 8' ' ' MET . 18.2 mt -59.38 -9.35 2.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.631 0.974 . . . . 15.0 113.631 -176.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -77.09 -7.07 55.11 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.396 0.888 . . . . 15.0 113.396 -177.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -65.72 145.89 99.01 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 118.618 0.644 . . . . 15.0 110.633 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.74 159.01 21.66 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 121.629 1.552 . . . . 15.0 113.187 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.28 151.27 5.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.839 -0.618 . . . . 15.0 111.294 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.23 -38.09 3.22 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.71 -0.556 . . . . 15.0 111.71 -178.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -61.05 -36.75 80.4 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 120.595 -0.442 . . . . 15.0 111.213 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.57 ' O ' HG23 ' A' ' 44' ' ' VAL . 27.9 tp -59.15 -47.03 86.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.962 0.411 . . . . 15.0 110.254 -178.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.59 HD22 ' OD2' ' A' ' 70' ' ' ASP . 9.3 tp -62.39 -45.74 91.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 15.0 110.86 -176.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.58 -44.22 97.42 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.659 -0.416 . . . . 15.0 110.774 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.505 ' CD ' HD13 ' A' ' 6' ' ' LEU . 57.0 ttm-85 -60.74 -41.81 96.1 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.98 -0.288 . . . . 15.0 110.728 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.578 ' HA ' HD12 ' A' ' 49' ' ' LEU . 96.1 t -60.47 -46.18 95.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.73 -0.388 . . . . 15.0 110.11 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -69.83 -47.7 61.73 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.29 0.478 . . . . 15.0 112.29 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.28 -44.33 79.58 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.03 -0.268 . . . . 15.0 111.538 -174.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -80.34 -10.1 59.75 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.11 0.781 . . . . 15.0 113.11 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 94.2 mtm-85 56.22 55.81 6.38 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.553 0.692 . . . . 15.0 110.111 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.578 HD12 ' HA ' ' A' ' 44' ' ' VAL . 94.6 mt -72.77 146.35 46.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.631 -0.713 . . . . 15.0 111.467 -175.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -94.46 -40.49 9.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.357 -0.838 . . . . 15.0 110.915 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.78 165.53 29.22 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 119.878 -1.153 . . . . 15.0 113.695 -172.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.5 mt -127.89 143.16 51.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.576 -0.812 . . . . 15.0 109.983 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.502 HG22 ' CD1' ' A' ' 80' ' ' PHE . 49.0 t -123.06 133.69 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 110.077 -0.342 . . . . 15.0 110.077 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.434 HG12 ' HG3' ' A' ' 8' ' ' MET . 3.9 m -119.24 126.92 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.185 0.517 . . . . 15.0 110.749 174.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.8 m -68.92 -32.73 72.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.476 -0.784 . . . . 15.0 111.686 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.5 p -155.19 166.28 34.06 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.411 0.624 . . . . 15.0 111.887 -173.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.88 -37.51 70.32 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.217 -0.753 . . . . 15.0 111.217 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -58.66 -46.16 87.78 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.742 -0.383 . . . . 15.0 110.72 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.95 -42.61 99.79 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.841 -0.904 . . . . 15.0 110.841 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.615 HD13 HD21 ' A' ' 79' ' ' LEU . 34.9 tp -57.32 -47.18 82.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.053 0.454 . . . . 15.0 110.594 -178.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.77 -44.62 96.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.134 0.492 . . . . 15.0 110.594 -177.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.463 ' CB ' HD22 ' A' ' 33' ' ' LEU . 78.0 m-20 -59.51 -40.11 86.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.501 . . . . 15.0 110.616 178.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.5 tp -56.57 -42.78 79.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.18 0.514 . . . . 15.0 110.195 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -58.55 -46.48 86.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.804 -0.635 . . . . 15.0 110.249 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -60.97 -42.93 99.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.819 -0.628 . . . . 15.0 111.032 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.08 -34.94 78.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.374 -0.375 . . . . 15.0 111.474 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.678 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.31 -38.15 79.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.119 0.485 . . . . 15.0 110.677 177.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.51 -144.43 0.55 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 109.54 -0.541 . . . . 15.0 109.54 173.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.47 -19.57 48.79 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.289 0.95 . . . . 15.0 112.563 -174.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.59 ' OD2' HD22 ' A' ' 41' ' ' LEU . 76.6 m-20 -91.86 10.86 26.94 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.336 0.865 . . . . 15.0 113.336 -174.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -47.83 -47.07 63.42 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 118.544 -0.741 . . . . 15.0 112.536 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -44.78 -40.52 14.58 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 121.422 1.414 . . . . 15.0 113.216 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -76.96 -48.77 17.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.036 0.446 . . . . 15.0 110.735 -177.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.678 HD12 ' HB1' ' A' ' 67' ' ' ALA . 89.1 mt -59.46 -40.11 80.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.511 . . . . 15.0 110.752 -177.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.56 -14.71 36.7 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 116.31 -0.405 . . . . 15.0 113.345 -175.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -65.88 -29.79 70.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.399 0.6 . . . . 15.0 112.037 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.0 mt -74.87 150.02 85.87 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 120.919 -0.312 . . . . 15.0 111.291 -173.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.0 128.27 26.07 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.606 1.537 . . . . 15.0 112.249 176.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.615 HD21 HD13 ' A' ' 60' ' ' LEU . 27.3 tp -105.72 124.91 50.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.387 -0.369 . . . . 15.0 110.497 174.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.502 ' CD1' HG22 ' A' ' 53' ' ' VAL . 69.2 m-85 -91.71 126.54 36.83 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.796 -0.446 . . . . 15.0 109.796 177.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.656 HG21 ' HB2' ' A' ' 87' ' ' ALA . 27.4 m -118.72 146.45 39.99 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-O 119.327 -0.368 . . . . 15.0 110.238 176.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -79.18 -23.49 7.56 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.561 1.507 . . . . 15.0 113.522 -176.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.2 p -143.26 162.78 41.01 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 120.572 -0.451 . . . . 15.0 111.517 -171.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -56.84 -43.97 49.43 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.153 1.236 . . . . 15.0 111.821 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -57.57 -48.15 80.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.882 0.372 . . . . 15.0 110.712 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.5 t -60.37 -39.4 80.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.813 -0.355 . . . . 15.0 110.118 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.656 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.31 -41.43 79.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.931 0.396 . . . . 15.0 110.373 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.18 -40.22 93.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.29 -0.414 . . . . 15.0 110.603 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.1 mmm -58.53 -44.53 89.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.378 0.609 . . . . 15.0 110.107 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.496 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.74 -42.48 99.03 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.714 -0.675 . . . . 15.0 110.853 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -61.92 -44.02 97.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 15.0 110.738 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -59.22 -36.16 74.92 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.947 -0.301 . . . . 15.0 111.302 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 77.0 mt -67.26 -23.95 65.74 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.351 0.5 . . . . 15.0 112.351 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.33 13.37 17.45 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 119.263 -0.743 . . . . 15.0 113.096 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.77 122.03 11.88 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 118.564 1.182 . . . . 15.0 109.897 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -68.84 -35.72 77.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.617 -0.719 . . . . 15.0 111.281 -171.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -130.19 113.94 15.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.907 0.384 . . . . 15.0 110.251 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.2 130.3 64.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 15.0 109.953 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 87.6 mt -120.2 120.66 63.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.936 -0.575 . . . . 15.0 110.007 -176.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -95.4 117.79 30.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.41 -0.359 . . . . 15.0 110.323 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.479 ' HA ' ' HB3' ' A' ' 104' ' ' ALA . 31.2 p -96.02 -1.49 48.77 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.211 0.819 . . . . 15.0 113.211 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -56.14 -40.28 73.56 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 118.215 0.461 . . . . 15.0 110.527 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.08 -34.98 5.21 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.415 -0.674 . . . . 15.0 111.415 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.479 ' HB3' ' HA ' ' A' ' 101' ' ' CYS . . . -69.46 144.89 53.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.851 0.358 . . . . 15.0 110.52 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.1 t -89.8 158.92 17.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.069 -0.514 . . . . 15.0 110.546 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.65 -54.34 23.73 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 112.992 0.738 . . . . 15.0 112.992 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.72 -35.06 98.95 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 CA-C-N 120.134 1.083 . . . . 15.0 111.78 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.99 -43.13 95.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.124 0.488 . . . . 15.0 109.982 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.416 HD11 ' HB2' ' A' ' 101' ' ' CYS . 78.5 mt -59.06 -40.53 85.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 15.0 110.43 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 38.9 tp -57.19 -43.68 82.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.231 0.538 . . . . 15.0 110.168 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.13 -40.86 91.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.747 -0.661 . . . . 15.0 110.458 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.96 -41.61 92.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.414 . . . . 15.0 110.73 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.5 mt -57.81 -51.11 70.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.195 0.522 . . . . 15.0 110.396 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.3 p -63.6 -39.77 95.23 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.608 -0.724 . . . . 15.0 111.385 -175.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.2 p -65.9 -40.04 91.17 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.921 -0.312 . . . . 15.0 111.453 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.09 93.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.511 -0.313 . . . . 15.0 111.078 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.27 -34.09 71.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.428 -0.351 . . . . 15.0 111.398 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 83.5 mt -56.68 -38.27 72.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.668 0.271 . . . . 15.0 111.005 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -62.8 -36.97 84.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.576 -0.284 . . . . 15.0 111.204 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -60.41 -41.73 94.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.858 0.361 . . . . 15.0 111.035 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -54.82 -38.26 67.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 15.0 111.389 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -110.7 127.83 55.47 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.891 0.377 . . . . 15.0 110.897 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -57.91 -39.66 78.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 15.0 110.905 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -114.24 144.08 43.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.289 -0.414 . . . . 15.0 110.55 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.912 -1.042 . . . . 15.0 110.718 -179.752 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.6 mtm . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.446 -0.576 . . . . 15.0 109.446 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -126.35 83.0 65.05 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.165 -0.471 . . . . 15.0 110.241 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.01 153.74 30.64 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.385 1.39 . . . . 15.0 111.83 -175.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.444 ' CB ' HD23 ' A' ' 49' ' ' LEU . 60.3 mttp -112.86 138.33 49.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.456 -0.338 . . . . 15.0 110.782 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.567 HG21 HD13 ' A' ' 21' ' ' LEU . 15.1 m -133.33 143.52 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-O 121.515 0.674 . . . . 15.0 111.521 176.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.6 tp -103.41 134.76 46.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.011 -0.995 . . . . 15.0 110.417 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.617 HD11 ' CG1' ' A' ' 28' ' ' VAL . 52.4 mt -99.04 135.0 35.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.024 0.44 . . . . 15.0 110.542 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 83.3 mtp -103.17 134.18 47.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.445 -0.798 . . . . 15.0 109.593 171.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -57.51 144.68 35.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.128 0.49 . . . . 15.0 110.984 -172.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.38 175.15 32.65 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.739 -0.944 . . . . 15.0 110.739 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -54.53 -33.42 59.97 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.517 0.191 . . . . 15.0 111.517 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.06 171.12 36.1 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.898 -0.881 . . . . 15.0 110.898 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.91 133.98 12.26 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.312 -0.715 . . . . 15.0 111.312 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -56.8 -46.04 81.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.086 0.469 . . . . 15.0 110.405 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.18 -41.14 99.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.679 -0.691 . . . . 15.0 111.329 -176.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -61.73 -56.07 23.49 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.746 -0.382 . . . . 15.0 111.224 -175.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.3 mt -61.94 -43.47 98.77 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.739 -0.384 . . . . 15.0 111.052 -176.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.17 -43.27 99.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.392 -0.367 . . . . 15.0 110.573 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -58.72 -41.85 87.34 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.977 -0.289 . . . . 15.0 110.395 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -58.76 -51.69 68.88 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.656 -0.418 . . . . 15.0 111.179 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.567 HD13 HG21 ' A' ' 5' ' ' VAL . 77.2 mt -62.74 -37.77 87.88 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.596 -0.442 . . . . 15.0 111.243 -177.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -63.53 -42.4 98.43 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.853 -0.339 . . . . 15.0 111.214 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.43 -30.71 68.63 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.021 -0.609 . . . . 15.0 111.961 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -88.18 9.92 21.21 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.56 0.948 . . . . 15.0 113.56 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.4 16.26 57.42 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 121.18 -0.533 . . . . 15.0 113.436 175.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.1 t -101.1 140.24 20.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 117.803 0.802 . . . . 15.0 110.168 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -83.17 130.5 35.11 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.101 -0.703 . . . . 15.0 109.101 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.617 ' CG1' HD11 ' A' ' 7' ' ' ILE . 37.1 t -119.72 133.23 67.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.17 0.51 . . . . 15.0 111.191 -172.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -139.23 137.75 36.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.362 -0.836 . . . . 15.0 109.465 171.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.48 ' HB3' HD12 ' A' ' 7' ' ' ILE . 34.6 p90 -115.41 138.25 51.2 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.916 0.389 . . . . 15.0 111.035 -178.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 tp -119.98 113.29 34.37 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-O 118.677 -0.678 . . . . 15.0 110.354 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.7 135.02 48.73 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 121.23 1.287 . . . . 15.0 112.304 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.557 HD13 HD22 ' A' ' 62' ' ' ASN . 72.7 mt -61.42 -16.96 51.88 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.031 0.752 . . . . 15.0 113.031 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -77.14 -4.34 44.01 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.445 0.905 . . . . 15.0 113.445 -175.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -70.61 149.97 95.45 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 118.428 0.558 . . . . 15.0 110.816 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.31 147.14 52.49 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.6 1.533 . . . . 15.0 113.747 -174.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.9 152.55 3.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.429 -0.805 . . . . 15.0 111.291 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.78 -38.09 3.21 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.948 -0.569 . . . . 15.0 111.837 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -62.65 -36.88 84.28 Favored 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 120.346 -0.542 . . . . 15.0 111.092 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.577 ' O ' HG23 ' A' ' 44' ' ' VAL . 27.2 tp -58.9 -46.9 86.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.915 0.388 . . . . 15.0 110.188 -178.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.512 HD22 ' CG ' ' A' ' 70' ' ' ASP . 20.8 tp -62.25 -43.85 97.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 15.0 110.854 -177.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.64 -45.88 92.16 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.635 -0.426 . . . . 15.0 110.853 -176.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -62.91 -40.03 96.33 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.874 -0.331 . . . . 15.0 111.165 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 40' ' ' LEU . 93.4 t -60.56 -44.51 96.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.881 -0.415 . . . . 15.0 109.881 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -65.9 -51.82 55.38 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.369 0.418 . . . . 15.0 111.87 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.09 -44.37 80.18 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.028 -0.269 . . . . 15.0 111.629 -174.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -80.31 -10.04 59.75 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.168 0.803 . . . . 15.0 113.168 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 92.2 mtm-85 55.62 55.81 6.83 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.61 0.719 . . . . 15.0 110.406 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.531 HD12 HG22 ' A' ' 44' ' ' VAL . 95.9 mt -68.0 146.23 53.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.656 -0.702 . . . . 15.0 110.965 -177.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -95.98 -40.7 9.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.695 -0.684 . . . . 15.0 110.906 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.7 164.83 28.81 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 119.945 -1.121 . . . . 15.0 113.589 -172.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.7 mt -126.79 145.16 50.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.456 -0.872 . . . . 15.0 109.919 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.525 HG22 ' CD1' ' A' ' 80' ' ' PHE . 47.1 t -121.0 129.14 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 110.437 -0.208 . . . . 15.0 110.437 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.7 m -126.99 139.24 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 120.955 0.407 . . . . 15.0 110.365 173.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.5 m -101.36 -4.8 26.32 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.055 0.761 . . . . 15.0 113.055 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.0 p -157.45 157.83 34.65 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-O 121.487 0.661 . . . . 15.0 111.977 -175.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.67 -37.75 78.31 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.048 -0.821 . . . . 15.0 111.048 177.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -57.03 -46.11 82.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.774 0.321 . . . . 15.0 110.716 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.69 -44.12 97.19 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.651 -0.98 . . . . 15.0 110.651 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.7 tp -56.01 -46.39 78.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.274 0.559 . . . . 15.0 110.717 -178.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -62.33 -42.9 99.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.911 -0.586 . . . . 15.0 110.874 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.557 HD22 HD13 ' A' ' 33' ' ' LEU . 85.3 m-20 -58.89 -38.51 79.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.377 -0.374 . . . . 15.0 110.829 178.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.5 tp -57.58 -45.25 85.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.281 0.562 . . . . 15.0 110.086 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -61.45 -47.6 84.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.667 -0.697 . . . . 15.0 110.628 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -62.05 -43.46 98.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 15.0 111.281 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.1 mt -66.42 -35.63 80.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.382 -0.372 . . . . 15.0 111.379 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.661 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -60.28 -37.74 81.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.012 0.434 . . . . 15.0 110.884 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.72 -144.16 0.54 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.388 -0.597 . . . . 15.0 109.388 174.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.49 -18.64 41.66 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.319 0.963 . . . . 15.0 112.614 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.512 ' CG ' HD22 ' A' ' 41' ' ' LEU . 21.5 m-20 -91.83 11.14 25.79 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.265 0.839 . . . . 15.0 113.265 -174.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -47.7 -46.83 61.87 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-O 118.6 -0.714 . . . . 15.0 112.592 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -44.64 -41.85 14.54 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.434 1.423 . . . . 15.0 113.22 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -76.99 -48.73 17.18 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.059 0.457 . . . . 15.0 110.807 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.661 HD12 ' HB1' ' A' ' 67' ' ' ALA . 95.2 mt -59.92 -40.03 81.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 15.0 110.855 -176.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.99 -15.74 29.7 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 119.916 -0.38 . . . . 15.0 112.966 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -64.82 -31.47 72.72 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 117.433 0.616 . . . . 15.0 111.884 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.7 mt -73.77 135.38 77.83 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 118.866 -0.587 . . . . 15.0 110.361 -175.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.01 134.18 60.57 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.39 1.393 . . . . 15.0 112.59 177.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.7 tp -107.66 130.18 54.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.974 -0.557 . . . . 15.0 110.65 176.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.525 ' CD1' HG22 ' A' ' 53' ' ' VAL . 77.4 m-85 -89.19 123.9 33.86 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.27 -0.641 . . . . 15.0 109.27 175.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.699 HG21 ' HB2' ' A' ' 87' ' ' ALA . 25.7 m -114.53 146.61 36.28 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 119.378 -0.344 . . . . 15.0 110.237 177.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -79.14 -23.77 7.36 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.52 1.48 . . . . 15.0 113.574 -174.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.0 p -143.44 162.22 43.3 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 120.564 -0.455 . . . . 15.0 111.677 -171.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.0 -44.0 51.35 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 121.154 1.236 . . . . 15.0 111.791 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -57.95 -47.28 83.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.837 0.351 . . . . 15.0 110.838 -177.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.17 -41.17 85.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 15.0 110.047 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.699 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.82 -42.68 84.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.901 0.382 . . . . 15.0 110.411 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.33 -42.08 98.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 15.0 110.604 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 86.7 mtp -59.41 -43.81 92.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.198 0.523 . . . . 15.0 110.44 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.6 94.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.931 -0.577 . . . . 15.0 110.74 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -61.59 -44.44 97.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.336 -0.393 . . . . 15.0 110.674 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.43 -36.1 77.38 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.842 -0.343 . . . . 15.0 111.313 -177.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.7 mt -64.9 -24.12 67.43 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.206 0.447 . . . . 15.0 112.206 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.55 13.33 17.09 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 119.311 -0.716 . . . . 15.0 113.103 -176.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.91 121.98 11.84 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.573 1.187 . . . . 15.0 109.894 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -69.31 -35.18 75.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.659 -0.701 . . . . 15.0 111.267 -171.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -131.08 115.71 16.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.003 0.43 . . . . 15.0 110.182 177.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.9 t -114.69 130.1 69.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.281 -0.418 . . . . 15.0 110.027 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.7 mt -119.48 124.91 73.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.997 -0.547 . . . . 15.0 110.058 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -95.39 118.03 31.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.384 -0.371 . . . . 15.0 110.038 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.415 ' HA ' ' HB3' ' A' ' 104' ' ' ALA . 31.4 p -96.73 -0.38 48.3 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.219 0.822 . . . . 15.0 113.219 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -56.0 -40.08 72.81 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 118.186 0.448 . . . . 15.0 110.62 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.02 -35.02 5.21 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.507 -0.637 . . . . 15.0 111.507 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.415 ' HB3' ' HA ' ' A' ' 101' ' ' CYS . . . -71.58 142.32 50.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.815 0.341 . . . . 15.0 110.664 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.6 m -89.89 163.24 15.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.496 . . . . 15.0 110.505 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.78 -54.28 24.72 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 112.977 0.732 . . . . 15.0 112.977 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.23 -34.27 98.41 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 CA-C-N 120.068 1.06 . . . . 15.0 111.635 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.14 -43.14 95.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.058 0.456 . . . . 15.0 110.012 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 78.6 mt -59.38 -40.49 86.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 15.0 110.515 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 42.2 tp -56.88 -44.9 82.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.51 0.671 . . . . 15.0 110.166 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.04 92.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.526 -0.761 . . . . 15.0 110.708 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.57 -42.3 96.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.476 -0.329 . . . . 15.0 110.907 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.6 mt -57.92 -51.47 69.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.171 0.51 . . . . 15.0 110.388 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.7 p -63.5 -40.16 96.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.628 -0.714 . . . . 15.0 111.28 -175.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.0 t -63.18 -44.27 95.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.662 0.268 . . . . 15.0 111.385 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.36 -39.03 85.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.473 -0.331 . . . . 15.0 110.955 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.39 73.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.496 -0.32 . . . . 15.0 111.277 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.7 mt -58.79 -37.53 76.54 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 121.122 -0.231 . . . . 15.0 111.165 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.85 -37.31 81.67 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 121.031 -0.267 . . . . 15.0 111.109 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -55.94 -37.26 68.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.574 -0.285 . . . . 15.0 111.221 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -105.05 134.62 47.84 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.76 0.314 . . . . 15.0 110.758 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -120.96 128.39 52.68 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.222 -0.445 . . . . 15.0 110.67 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -58.56 -39.31 79.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 15.0 110.926 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -56.4 -41.14 75.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.375 -0.375 . . . . 15.0 110.674 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 . . . . . 0 C--O 1.219 -0.543 0 CA-C-O 118.047 -0.977 . . . . 15.0 110.607 179.668 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.5 mtp . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.395 -0.594 . . . . 15.0 109.395 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -126.17 74.27 72.37 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.135 -0.484 . . . . 15.0 110.361 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -58.01 155.03 35.58 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.52 1.48 . . . . 15.0 112.035 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -110.61 139.88 45.46 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.518 -0.31 . . . . 15.0 110.741 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.415 HG21 HD13 ' A' ' 21' ' ' LEU . 13.5 m -135.75 142.31 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.556 0.693 . . . . 15.0 111.635 176.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.2 tp -105.0 133.8 49.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.94 -1.027 . . . . 15.0 110.169 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.569 HD11 ' CG1' ' A' ' 28' ' ' VAL . 41.9 mt -106.02 135.18 45.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.286 -0.415 . . . . 15.0 110.22 -177.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.416 ' SD ' HD13 ' A' ' 63' ' ' LEU . 83.7 mtp -94.37 134.05 37.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.157 -0.474 . . . . 15.0 110.537 175.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -62.79 145.87 53.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.043 0.449 . . . . 15.0 111.536 -174.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.96 175.2 42.85 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.638 -0.985 . . . . 15.0 110.638 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.91 -33.3 68.62 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.725 0.268 . . . . 15.0 111.725 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.95 164.35 3.6 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.165 -0.774 . . . . 15.0 111.165 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.99 104.77 2.81 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.92 -0.872 . . . . 15.0 110.92 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.435 ' HD2' HG21 ' A' ' 7' ' ' ILE . 87.5 mmt-85 -69.18 -32.52 71.89 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.794 0.294 . . . . 15.0 111.794 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.33 -45.64 87.71 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.595 -0.442 . . . . 15.0 110.366 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -65.9 -55.21 18.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.359 -0.382 . . . . 15.0 111.233 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.476 ' C ' HD23 ' A' ' 17' ' ' LEU . 10.0 tt -56.76 -43.13 80.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.843 0.354 . . . . 15.0 110.959 -177.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.47 -43.02 99.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.388 -0.369 . . . . 15.0 110.575 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.82 -41.02 85.84 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.808 -0.357 . . . . 15.0 110.566 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -60.97 -51.32 69.73 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 120.371 -0.532 . . . . 15.0 111.366 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.415 HD13 HG21 ' A' ' 5' ' ' VAL . 70.0 mt -61.15 -37.78 84.08 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.316 -0.554 . . . . 15.0 110.845 -178.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -65.03 -41.41 95.27 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 120.694 -0.402 . . . . 15.0 111.356 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.88 -30.68 66.68 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.028 -0.606 . . . . 15.0 111.883 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -88.08 9.97 20.76 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.477 0.917 . . . . 15.0 113.477 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.24 17.09 58.07 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 121.333 -0.46 . . . . 15.0 113.263 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -101.04 139.56 22.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 117.807 0.804 . . . . 15.0 110.126 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -82.0 126.2 31.69 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.393 -0.595 . . . . 15.0 109.393 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.569 ' CG1' HD11 ' A' ' 7' ' ' ILE . 41.5 t -116.75 129.32 73.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.087 0.47 . . . . 15.0 110.933 -174.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -136.39 132.65 35.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.636 -0.711 . . . . 15.0 109.685 172.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -112.63 133.45 54.66 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.947 0.403 . . . . 15.0 110.789 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.1 tp -116.08 113.33 41.7 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 118.824 -0.607 . . . . 15.0 110.367 -176.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.65 135.81 68.42 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 121.362 1.374 . . . . 15.0 112.692 174.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.674 HD13 ' ND2' ' A' ' 62' ' ' ASN . 73.9 mt -59.48 -10.48 3.37 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 113.37 0.878 . . . . 15.0 113.37 -178.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -77.16 -6.26 52.25 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.298 0.851 . . . . 15.0 113.298 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -71.78 148.72 92.57 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 118.588 0.631 . . . . 15.0 110.582 -178.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -74.6 152.08 42.46 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.604 1.536 . . . . 15.0 113.782 -174.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.73 152.52 3.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.373 -0.83 . . . . 15.0 111.292 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.31 -38.28 3.15 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.799 -0.637 . . . . 15.0 111.782 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.5 -36.03 82.85 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 117.343 0.571 . . . . 15.0 111.264 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.563 ' O ' HG23 ' A' ' 44' ' ' VAL . 26.8 tp -58.74 -46.86 86.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.942 0.401 . . . . 15.0 110.135 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.472 HD22 ' CG ' ' A' ' 70' ' ' ASP . 16.6 tp -63.33 -44.45 94.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 15.0 110.875 -176.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.56 -44.76 96.44 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.706 -0.398 . . . . 15.0 110.871 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 61.7 ttm-85 -60.88 -42.78 98.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.458 -0.337 . . . . 15.0 110.655 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 40' ' ' LEU . 98.5 t -60.34 -45.37 96.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.777 -0.369 . . . . 15.0 110.174 -177.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -67.29 -51.78 48.63 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.485 0.491 . . . . 15.0 112.058 -176.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.64 -44.35 82.19 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.986 -0.286 . . . . 15.0 111.565 -174.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -79.83 -10.15 59.75 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.972 0.73 . . . . 15.0 112.972 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 54.78 55.95 7.26 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.595 0.712 . . . . 15.0 110.086 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.55 HD12 HG22 ' A' ' 44' ' ' VAL . 97.5 mt -65.09 144.91 56.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.744 -0.662 . . . . 15.0 111.314 -174.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -92.84 -39.13 11.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.133 -0.94 . . . . 15.0 110.81 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.69 160.96 28.46 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 120.149 -1.024 . . . . 15.0 113.469 -175.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.1 mt -126.16 144.37 50.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.575 -0.812 . . . . 15.0 109.564 177.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.49 HG22 ' HD1' ' A' ' 80' ' ' PHE . 44.7 t -122.71 131.51 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 O-C-N 122.315 -0.24 . . . . 15.0 110.93 -177.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.0 m -127.53 150.69 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.08 0.467 . . . . 15.0 110.37 171.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.5 t -107.5 -15.65 14.56 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.605 -0.725 . . . . 15.0 112.711 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.4 p -152.75 160.59 43.13 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.402 0.62 . . . . 15.0 111.917 -173.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.37 -37.78 75.8 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.016 -0.834 . . . . 15.0 111.016 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -57.19 -46.16 83.09 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 122.599 -0.353 . . . . 15.0 110.703 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.14 -45.62 95.68 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.621 -0.991 . . . . 15.0 110.621 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.57 HD21 ' HA ' ' A' ' 90' ' ' ALA . 21.0 tp -56.94 -44.61 82.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.103 0.478 . . . . 15.0 110.736 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.69 -43.44 98.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.481 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.674 ' ND2' HD13 ' A' ' 33' ' ' LEU . 84.5 m-20 -59.04 -37.31 76.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.124 -0.489 . . . . 15.0 110.858 177.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.416 HD13 ' SD ' ' A' ' 8' ' ' MET . 12.1 tp -57.5 -44.96 85.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.286 0.565 . . . . 15.0 110.121 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -60.66 -46.87 88.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.53 -0.759 . . . . 15.0 110.539 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -62.61 -43.96 97.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 15.0 111.347 -176.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.08 -35.07 79.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.476 -0.329 . . . . 15.0 111.266 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.667 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -60.3 -37.95 82.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.007 0.432 . . . . 15.0 110.858 178.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.37 -144.63 0.55 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.461 -0.57 . . . . 15.0 109.461 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.45 -19.13 45.28 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.29 0.95 . . . . 15.0 112.586 -174.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.472 ' CG ' HD22 ' A' ' 41' ' ' LEU . 22.0 m-20 -91.88 11.76 23.84 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.295 0.85 . . . . 15.0 113.295 -174.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 59.0 t-105 -47.77 -46.85 62.7 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-O 118.564 -0.731 . . . . 15.0 112.519 177.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -44.66 -41.29 14.58 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 121.431 1.421 . . . . 15.0 113.287 177.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -76.96 -48.75 17.2 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.607 -0.437 . . . . 15.0 110.803 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.667 HD12 ' HB1' ' A' ' 67' ' ' ALA . 91.5 mt -58.91 -40.18 79.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.197 -0.456 . . . . 15.0 110.796 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.39 -16.99 37.77 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 116.291 -0.413 . . . . 15.0 113.254 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 61.6 mtm180 -66.58 -28.93 68.9 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.297 0.548 . . . . 15.0 112.17 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.2 mt -74.85 150.59 86.24 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 121.031 -0.268 . . . . 15.0 111.514 -172.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -63.8 126.52 17.57 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 121.626 1.551 . . . . 15.0 112.309 176.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.8 tp -105.7 127.25 52.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.508 -0.315 . . . . 15.0 110.824 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.49 ' HD1' HG22 ' A' ' 53' ' ' VAL . 69.6 m-85 -89.45 127.13 35.8 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.589 -0.522 . . . . 15.0 109.589 175.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.718 HG21 ' HB2' ' A' ' 87' ' ' ALA . 27.5 m -118.53 146.76 40.47 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 110.08 -0.341 . . . . 15.0 110.08 175.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.404 ' HD2' HG11 ' A' ' 86' ' ' VAL . 78.2 Cg_endo -79.1 -23.45 7.69 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.61 1.54 . . . . 15.0 113.457 -176.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.403 ' OG ' HG23 ' A' ' 86' ' ' VAL . 25.5 p -144.3 158.44 54.68 Favored Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 120.671 -0.412 . . . . 15.0 111.355 -172.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -53.07 -44.03 52.18 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.26 1.307 . . . . 15.0 111.737 176.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -57.65 -47.71 81.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.882 0.372 . . . . 15.0 110.929 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.404 HG11 ' HD2' ' A' ' 82' ' ' PRO . 60.3 t -59.65 -40.69 82.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.906 0.384 . . . . 15.0 109.983 178.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.718 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.55 -42.25 82.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.81 0.338 . . . . 15.0 110.444 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.41 -41.03 93.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.49 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.1 mmm -58.39 -43.95 88.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.401 0.619 . . . . 15.0 110.157 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.57 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.28 -40.62 94.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.733 -0.667 . . . . 15.0 110.795 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -62.53 -42.82 99.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.342 -0.39 . . . . 15.0 111.074 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.67 -36.11 77.92 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.897 -0.321 . . . . 15.0 111.33 -177.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.2 mt -67.95 -22.12 65.05 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.404 0.52 . . . . 15.0 112.404 177.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.99 13.39 18.15 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 119.315 -0.714 . . . . 15.0 113.217 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.77 121.98 11.76 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.579 1.189 . . . . 15.0 109.864 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -70.3 -35.37 73.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.55 -0.75 . . . . 15.0 111.275 -171.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -131.84 112.53 12.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.977 0.418 . . . . 15.0 110.486 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.2 t -112.0 130.69 65.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.135 -0.484 . . . . 15.0 109.883 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 84.3 mt -118.95 122.6 69.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.016 -0.538 . . . . 15.0 110.11 -176.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.57 117.07 29.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.457 -0.338 . . . . 15.0 110.431 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.3 p -97.02 6.12 49.18 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.168 0.803 . . . . 15.0 113.168 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 71.9 ttp85 -55.76 -39.37 71.11 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.169 0.441 . . . . 15.0 110.803 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.68 -35.09 5.27 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.6 -0.6 . . . . 15.0 111.6 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.26 139.07 54.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.969 0.414 . . . . 15.0 110.773 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.8 p -89.84 167.84 12.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.996 -0.547 . . . . 15.0 110.464 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.75 -54.2 25.22 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 113.028 0.751 . . . . 15.0 113.028 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.73 -36.6 98.54 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 CA-C-N 120.509 1.218 . . . . 15.0 111.447 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.55 -43.13 97.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.98 0.419 . . . . 15.0 110.183 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.5 mt -59.36 -40.8 87.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.198 -0.456 . . . . 15.0 110.398 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.9 tp -57.67 -44.7 85.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.323 0.583 . . . . 15.0 110.188 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.98 -40.71 94.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.666 -0.697 . . . . 15.0 110.595 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.85 -42.04 97.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.424 -0.353 . . . . 15.0 110.765 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.3 mt -57.87 -50.44 73.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.047 0.451 . . . . 15.0 110.44 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.7 p -65.02 -40.49 94.94 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.805 -0.634 . . . . 15.0 111.479 -175.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.9 p -64.37 -39.67 94.33 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.98 -0.288 . . . . 15.0 111.28 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.54 -43.27 94.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.634 -0.257 . . . . 15.0 111.037 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.56 -40.66 97.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.543 -0.299 . . . . 15.0 110.976 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 89.6 mt -66.94 -38.09 85.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.429 -0.351 . . . . 15.0 111.521 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -121.04 123.67 42.95 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.848 0.356 . . . . 15.0 111.165 -177.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -112.1 -29.12 7.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.013 -0.54 . . . . 15.0 111.889 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -53.97 -40.76 67.16 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.6 0.238 . . . . 15.0 111.388 -176.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -116.7 129.38 56.1 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.998 0.428 . . . . 15.0 110.836 -178.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -58.78 -38.61 78.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.85 -0.614 . . . . 15.0 110.989 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -110.54 140.61 44.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.404 -0.362 . . . . 15.0 110.665 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 117.995 -1.002 . . . . 15.0 110.66 179.822 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.389 -0.597 . . . . 15.0 109.389 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -125.5 79.16 67.54 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.132 -0.486 . . . . 15.0 110.194 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -54.09 152.37 24.62 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 121.481 1.454 . . . . 15.0 111.824 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -112.43 135.7 52.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.291 -0.413 . . . . 15.0 110.509 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.57 HG21 HD13 ' A' ' 21' ' ' LEU . 17.8 m -133.1 145.58 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-O 121.619 0.723 . . . . 15.0 111.859 177.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.9 tp -103.66 136.86 42.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.964 -1.016 . . . . 15.0 110.496 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.631 HD11 ' CG1' ' A' ' 28' ' ' VAL . 54.8 mt -100.79 133.87 42.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.033 0.444 . . . . 15.0 110.683 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.423 ' SD ' HD13 ' A' ' 63' ' ' LEU . 84.8 mtp -102.56 134.62 45.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.242 -0.89 . . . . 15.0 110.09 173.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -57.36 141.16 48.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.213 0.53 . . . . 15.0 110.572 -173.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.13 175.28 31.66 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.551 -1.02 . . . . 15.0 110.551 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.7 mp0 -58.0 -31.68 67.19 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.951 -0.3 . . . . 15.0 111.515 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.49 173.27 33.61 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.908 -0.877 . . . . 15.0 110.908 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.32 132.21 11.05 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.488 -0.645 . . . . 15.0 111.488 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -56.87 -44.08 81.86 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.127 0.489 . . . . 15.0 110.227 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.38 -43.42 97.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.767 -0.651 . . . . 15.0 111.024 -175.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -58.2 -55.93 28.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.012 0.434 . . . . 15.0 110.909 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.1 mt -61.35 -42.85 99.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 15.0 110.91 -175.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.12 -45.0 96.48 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.767 -0.373 . . . . 15.0 111.163 -177.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.23 -38.81 84.56 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.598 -0.441 . . . . 15.0 110.811 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -60.63 -51.51 69.1 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 119.973 -0.691 . . . . 15.0 110.918 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.57 HD13 HG21 ' A' ' 5' ' ' VAL . 79.9 mt -63.57 -38.02 89.52 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 120.451 -0.499 . . . . 15.0 111.252 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -63.57 -42.47 98.33 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.91 -0.316 . . . . 15.0 111.266 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.71 -30.72 69.63 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 120.865 -0.684 . . . . 15.0 112.011 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -88.8 10.14 22.11 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.654 0.983 . . . . 15.0 113.654 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.8 17.25 56.89 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 121.251 -0.5 . . . . 15.0 113.295 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.1 t -101.02 141.02 18.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 117.712 0.756 . . . . 15.0 110.088 178.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -84.8 131.36 34.55 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.297 -0.631 . . . . 15.0 109.297 177.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.631 ' CG1' HD11 ' A' ' 7' ' ' ILE . 40.3 t -117.72 131.19 71.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.129 0.49 . . . . 15.0 111.121 -173.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -137.4 133.82 35.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.464 -0.789 . . . . 15.0 109.488 171.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.552 ' HB3' HD12 ' A' ' 7' ' ' ILE . 42.1 p90 -116.06 138.38 51.28 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.968 0.413 . . . . 15.0 111.194 -177.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.0 tp -119.21 135.97 24.21 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 109.243 -0.651 . . . . 15.0 109.243 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.22 135.92 25.77 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.182 1.255 . . . . 15.0 111.759 173.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.555 HD13 HD22 ' A' ' 62' ' ' ASN . 84.1 mt -59.9 -9.31 2.84 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.41 0.893 . . . . 15.0 113.41 -177.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -77.14 -7.91 56.6 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.415 0.894 . . . . 15.0 113.415 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -64.57 146.55 98.18 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 118.606 0.639 . . . . 15.0 110.552 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.03 159.03 27.15 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 121.617 1.544 . . . . 15.0 113.221 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.44 150.97 4.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.779 -0.646 . . . . 15.0 111.52 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.2 -38.01 3.25 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.321 -0.712 . . . . 15.0 111.321 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -61.34 -37.82 84.67 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.58 -0.448 . . . . 15.0 111.017 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.573 ' O ' HG23 ' A' ' 44' ' ' VAL . 28.4 tp -59.0 -46.83 87.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.981 0.42 . . . . 15.0 110.127 -178.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.481 HD13 ' CB ' ' A' ' 70' ' ' ASP . 14.6 tp -62.51 -43.56 98.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.178 -0.465 . . . . 15.0 110.914 -177.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.17 -45.96 91.06 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.724 -0.39 . . . . 15.0 110.95 -176.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -61.52 -41.5 97.41 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.812 -0.355 . . . . 15.0 110.707 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 40' ' ' LEU . 94.5 t -61.24 -45.8 97.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.779 -0.368 . . . . 15.0 110.204 -177.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -69.11 -49.03 60.76 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.293 0.479 . . . . 15.0 112.293 -175.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.48 -44.3 75.08 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.992 -0.283 . . . . 15.0 111.642 -174.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -78.96 -10.16 59.74 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.09 0.774 . . . . 15.0 113.09 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 55.78 55.83 6.69 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.601 0.715 . . . . 15.0 110.306 -177.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.557 HD12 ' HA ' ' A' ' 44' ' ' VAL . 94.2 mt -74.18 146.91 43.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.552 -0.749 . . . . 15.0 111.306 -176.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -96.78 -40.71 8.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.677 -0.692 . . . . 15.0 110.807 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.63 165.45 28.77 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 119.798 -1.191 . . . . 15.0 113.644 -171.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.444 ' HB2' HD12 ' A' ' 79' ' ' LEU . 72.7 mt -127.04 144.59 50.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.545 -0.828 . . . . 15.0 110.279 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.521 HG22 ' CD1' ' A' ' 80' ' ' PHE . 47.5 t -120.22 129.35 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 110.372 -0.233 . . . . 15.0 110.372 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.2 m -126.65 144.53 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.141 0.496 . . . . 15.0 110.657 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.0 t -102.84 -13.27 17.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.493 -0.776 . . . . 15.0 112.747 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.8 p -153.34 159.1 42.4 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.456 0.646 . . . . 15.0 112.075 -173.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.6 -37.9 78.5 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.972 -0.851 . . . . 15.0 110.972 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -58.45 -44.62 89.28 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.848 -0.341 . . . . 15.0 110.635 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.4 -45.38 96.31 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.623 -0.991 . . . . 15.0 110.623 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.537 HD13 HD21 ' A' ' 79' ' ' LEU . 42.5 tp -56.4 -45.73 80.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.129 0.49 . . . . 15.0 110.778 -177.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -62.0 -42.73 99.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.043 -0.526 . . . . 15.0 110.89 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.555 HD22 HD13 ' A' ' 33' ' ' LEU . 83.3 m-20 -59.22 -39.68 83.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.373 -0.376 . . . . 15.0 110.716 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.423 HD13 ' SD ' ' A' ' 8' ' ' MET . 13.6 tp -58.09 -45.02 87.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.166 0.508 . . . . 15.0 110.238 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -60.7 -47.55 85.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.744 -0.662 . . . . 15.0 110.648 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -62.0 -43.19 99.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.014 -0.539 . . . . 15.0 111.136 -176.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.08 -34.95 78.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.451 -0.341 . . . . 15.0 111.453 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.697 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.47 -38.94 82.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.953 0.406 . . . . 15.0 110.535 177.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 58.96 -142.53 0.64 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.626 -0.509 . . . . 15.0 109.626 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.75 -18.58 44.16 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.39 0.996 . . . . 15.0 112.695 -174.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.481 ' CB ' HD13 ' A' ' 41' ' ' LEU . 26.4 m-20 -91.79 9.26 33.42 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.315 0.857 . . . . 15.0 113.315 -175.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -47.74 -46.57 61.84 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.633 -0.699 . . . . 15.0 112.61 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -44.55 -43.04 14.34 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.493 1.462 . . . . 15.0 113.287 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -76.96 -48.81 17.02 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 120.644 -0.422 . . . . 15.0 110.931 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.697 HD12 ' HB1' ' A' ' 67' ' ' ALA . 86.4 mt -59.33 -39.05 77.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.11 -0.496 . . . . 15.0 110.85 -176.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.78 -13.2 38.54 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 119.826 -0.43 . . . . 15.0 113.405 -175.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -70.5 -29.21 65.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 117.578 0.689 . . . . 15.0 112.304 178.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.2 mt -69.86 126.51 92.53 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 118.572 -0.728 . . . . 15.0 109.606 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.23 133.45 52.68 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.106 1.204 . . . . 15.0 112.333 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.537 HD21 HD13 ' A' ' 60' ' ' LEU . 17.8 tp -105.75 129.31 53.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.904 -0.589 . . . . 15.0 110.552 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.521 ' CD1' HG22 ' A' ' 53' ' ' VAL . 77.5 m-85 -90.52 122.45 33.36 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.249 -0.648 . . . . 15.0 109.249 175.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.65 HG21 ' HB2' ' A' ' 87' ' ' ALA . 25.9 m -114.99 148.01 39.6 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 119.457 -0.306 . . . . 15.0 110.326 177.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.21 -24.54 6.59 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.529 1.486 . . . . 15.0 113.614 -174.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.9 p -142.43 161.36 50.45 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 120.594 -0.442 . . . . 15.0 111.58 -172.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -55.32 -44.07 52.44 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.208 1.272 . . . . 15.0 111.76 176.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -57.17 -47.9 80.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.855 0.36 . . . . 15.0 110.639 -177.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.5 t -60.0 -41.37 85.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.904 0.383 . . . . 15.0 109.992 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.65 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.94 -42.1 84.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.969 0.414 . . . . 15.0 110.486 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.24 -41.71 97.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.433 . . . . 15.0 110.44 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 86.5 mtp -58.92 -41.82 88.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.101 0.477 . . . . 15.0 110.379 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.69 -41.21 94.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 15.0 110.576 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 -61.74 -43.29 99.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 15.0 110.809 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.24 -36.1 76.98 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.879 -0.328 . . . . 15.0 111.256 -177.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 77.5 mt -65.89 -24.41 66.85 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.256 0.465 . . . . 15.0 112.256 176.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 107.67 13.25 20.88 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 119.437 -0.646 . . . . 15.0 113.075 -175.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.94 123.82 17.12 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 118.416 1.108 . . . . 15.0 109.939 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -72.17 -33.5 67.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.843 -0.617 . . . . 15.0 111.425 -172.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 45.9 tpt85 -131.81 114.57 14.87 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.903 0.382 . . . . 15.0 110.404 176.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 40.5 t -114.67 131.62 66.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.822 0.344 . . . . 15.0 110.145 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 87.8 mt -119.7 125.93 74.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.172 -0.467 . . . . 15.0 110.191 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -94.2 118.3 31.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.36 -0.382 . . . . 15.0 110.134 174.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.1 p -94.25 -7.2 42.73 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.17 0.804 . . . . 15.0 113.17 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -55.82 -39.41 71.34 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 118.122 0.419 . . . . 15.0 110.781 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -96.27 -35.04 5.63 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.491 -0.644 . . . . 15.0 111.491 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.24 143.44 40.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.796 0.331 . . . . 15.0 110.478 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.6 m -89.43 163.42 15.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 15.0 110.526 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.72 -54.31 24.23 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 112.878 0.695 . . . . 15.0 112.878 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.6 -34.13 98.65 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 CA-C-N 120.195 1.106 . . . . 15.0 111.646 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.29 -42.96 96.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.107 0.48 . . . . 15.0 110.026 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.8 mt -59.32 -39.88 84.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 15.0 110.495 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 29.4 tp -56.87 -45.04 82.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.399 0.618 . . . . 15.0 110.111 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.98 -39.73 90.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.506 -0.77 . . . . 15.0 110.601 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.63 -42.87 97.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.604 -0.271 . . . . 15.0 110.844 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.8 mt -58.04 -50.36 73.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.119 0.485 . . . . 15.0 110.405 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 71.7 p -63.5 -40.39 96.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.807 -0.633 . . . . 15.0 111.368 -175.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.8 m -64.01 -42.75 97.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.662 0.267 . . . . 15.0 111.292 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.25 -39.01 88.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.474 -0.33 . . . . 15.0 110.998 -178.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.15 -35.73 74.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.545 -0.298 . . . . 15.0 111.213 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 84.7 mt -58.54 -38.05 76.97 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 121.001 -0.279 . . . . 15.0 110.947 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -100.2 128.93 46.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 15.0 110.215 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -93.12 -35.28 13.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.299 -0.409 . . . . 15.0 111.61 -177.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -122.61 131.18 53.7 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.977 0.418 . . . . 15.0 110.991 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -62.24 -32.05 72.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.782 -0.644 . . . . 15.0 111.794 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -51.92 -38.89 58.02 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 111.681 0.252 . . . . 15.0 111.681 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -56.0 -40.54 73.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.734 0.302 . . . . 15.0 110.891 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.039 -0.982 . . . . 15.0 110.487 179.448 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.6 mtp . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.427 -0.582 . . . . 15.0 109.427 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -126.66 81.77 68.09 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.107 -0.497 . . . . 15.0 110.406 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -56.13 155.05 25.47 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.389 1.393 . . . . 15.0 111.761 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.441 ' CB ' HD23 ' A' ' 49' ' ' LEU . 93.4 mttt -109.98 138.04 46.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.479 -0.328 . . . . 15.0 110.901 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.448 HG21 HD13 ' A' ' 21' ' ' LEU . 15.8 m -134.06 144.35 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.538 0.685 . . . . 15.0 111.614 175.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.8 tp -103.78 136.74 42.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.949 -1.023 . . . . 15.0 110.274 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.643 HD11 ' CG1' ' A' ' 28' ' ' VAL . 54.8 mt -101.6 133.8 43.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.137 0.494 . . . . 15.0 111.013 -177.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.549 ' HB2' HG12 ' A' ' 54' ' ' VAL . 98.7 mmm -94.69 134.28 37.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.153 -0.93 . . . . 15.0 109.045 170.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -57.46 140.68 49.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.894 0.378 . . . . 15.0 110.562 -175.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.28 175.1 27.74 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.995 -0.842 . . . . 15.0 110.995 -177.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -58.2 -33.18 69.0 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.546 0.202 . . . . 15.0 111.546 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.94 173.27 35.25 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.979 -0.848 . . . . 15.0 110.979 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.98 131.36 10.37 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.25 -0.74 . . . . 15.0 111.25 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -57.41 -43.76 84.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.082 0.468 . . . . 15.0 110.317 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.18 -42.58 99.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.815 -0.63 . . . . 15.0 111.344 -176.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -61.68 -55.94 25.09 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.804 -0.359 . . . . 15.0 111.292 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.3 mt -59.87 -43.62 94.62 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.662 -0.415 . . . . 15.0 111.021 -176.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.7 -41.31 99.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.491 -0.322 . . . . 15.0 110.995 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -60.04 -41.5 92.43 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.949 -0.3 . . . . 15.0 110.458 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -60.91 -51.73 68.04 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.622 -0.431 . . . . 15.0 111.319 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.448 HD13 HG21 ' A' ' 5' ' ' VAL . 72.9 mt -63.63 -36.96 85.54 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.349 -0.54 . . . . 15.0 110.971 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -62.49 -41.87 99.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.648 0.261 . . . . 15.0 111.092 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.7 -30.62 69.41 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.068 -0.587 . . . . 15.0 111.932 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -88.09 10.96 17.46 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.535 0.939 . . . . 15.0 113.535 178.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.39 17.77 56.54 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 121.279 -0.486 . . . . 15.0 113.368 174.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.5 t -101.05 139.0 23.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 117.807 0.803 . . . . 15.0 110.217 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -83.28 130.75 35.09 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.207 -0.664 . . . . 15.0 109.207 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.643 ' CG1' HD11 ' A' ' 7' ' ' ILE . 21.2 t -119.69 133.94 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.137 0.494 . . . . 15.0 111.401 -172.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -140.21 138.12 34.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.543 -0.753 . . . . 15.0 109.64 171.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.473 ' HB3' HD12 ' A' ' 7' ' ' ILE . 38.8 p90 -115.81 141.65 47.82 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.825 0.345 . . . . 15.0 110.789 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.9 tp -117.83 113.42 37.98 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 118.814 -0.612 . . . . 15.0 110.585 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -49.67 135.0 34.39 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.208 1.272 . . . . 15.0 111.903 173.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.793 HD13 ' ND2' ' A' ' 62' ' ' ASN . 46.0 mt -62.87 -13.37 33.17 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.214 0.82 . . . . 15.0 113.214 -176.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -77.14 -5.32 48.6 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.3 0.852 . . . . 15.0 113.3 -177.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -61.25 149.93 81.2 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 118.484 0.584 . . . . 15.0 110.375 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -80.07 151.91 21.26 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.567 1.512 . . . . 15.0 112.891 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.39 150.7 6.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.066 -0.515 . . . . 15.0 111.173 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.08 -38.03 3.24 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.57 -0.612 . . . . 15.0 111.57 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -62.05 -37.98 87.02 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 117.081 0.44 . . . . 15.0 110.995 -177.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.558 ' O ' HG23 ' A' ' 44' ' ' VAL . 21.2 tp -59.3 -47.46 85.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.922 0.392 . . . . 15.0 110.155 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.486 HD13 HD11 ' A' ' 74' ' ' ILE . 15.4 tp -63.0 -44.5 95.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.204 -0.453 . . . . 15.0 110.973 -176.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.65 -45.66 93.08 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.702 -0.399 . . . . 15.0 110.675 -176.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 47.2 ttt85 -61.01 -42.03 97.68 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.784 -0.367 . . . . 15.0 110.706 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 40' ' ' LEU . 96.8 t -60.88 -45.04 98.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.811 -0.355 . . . . 15.0 110.322 -177.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -68.79 -48.24 64.13 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.235 0.457 . . . . 15.0 112.235 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.03 -44.3 72.99 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.995 -0.282 . . . . 15.0 111.629 -175.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -78.41 -10.03 59.53 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.046 0.758 . . . . 15.0 113.046 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 55.93 55.84 6.57 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.593 0.711 . . . . 15.0 110.252 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 44' ' ' VAL . 96.2 mt -70.01 144.21 52.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.552 -0.749 . . . . 15.0 110.976 -176.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -90.8 -40.58 11.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.394 -0.821 . . . . 15.0 110.764 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -150.8 166.46 30.34 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 119.797 -1.192 . . . . 15.0 113.774 -173.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.0 mt -125.73 143.05 51.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.519 -0.84 . . . . 15.0 109.888 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.516 HG22 ' CD1' ' A' ' 80' ' ' PHE . 46.8 t -121.28 131.6 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 110.307 -0.257 . . . . 15.0 110.307 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.549 HG12 ' HB2' ' A' ' 8' ' ' MET . 7.0 m -128.46 139.72 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.058 0.456 . . . . 15.0 110.469 173.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.9 t -102.03 -14.93 16.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.566 -0.743 . . . . 15.0 112.81 178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 85.2 p -145.9 156.77 43.76 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.28 0.562 . . . . 15.0 111.771 -174.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.18 -39.7 90.41 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.873 -0.891 . . . . 15.0 110.873 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -59.33 -43.54 92.69 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.837 -0.345 . . . . 15.0 110.533 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.41 -46.29 94.13 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.544 -1.023 . . . . 15.0 110.544 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.54 HD13 HD21 ' A' ' 79' ' ' LEU . 35.2 tp -57.16 -44.84 83.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.106 0.479 . . . . 15.0 110.685 -177.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.82 -42.64 99.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.025 -0.534 . . . . 15.0 110.93 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.793 ' ND2' HD13 ' A' ' 33' ' ' LEU . 82.5 m-20 -59.97 -40.78 90.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.781 0.324 . . . . 15.0 110.642 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.425 ' CD1' HD21 ' A' ' 40' ' ' LEU . 13.5 tp -58.15 -44.26 87.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.24 0.543 . . . . 15.0 110.17 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -60.82 -46.95 88.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.833 -0.621 . . . . 15.0 110.769 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.31 -42.63 98.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.083 -0.508 . . . . 15.0 111.123 -176.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 94.8 mt -65.47 -36.19 83.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.404 -0.362 . . . . 15.0 111.332 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.675 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.47 -38.08 79.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.145 0.498 . . . . 15.0 110.923 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.14 -143.85 0.58 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.627 -0.508 . . . . 15.0 109.627 174.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.54 -20.9 58.92 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.307 0.958 . . . . 15.0 112.694 -173.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.472 ' OD2' HD22 ' A' ' 41' ' ' LEU . 77.6 m-20 -92.47 13.53 19.37 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.222 0.823 . . . . 15.0 113.222 -175.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 53.8 t-105 -47.74 -46.65 62.06 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-O 118.608 -0.711 . . . . 15.0 112.53 176.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -44.61 -40.39 13.92 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 121.475 1.45 . . . . 15.0 113.19 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -77.0 -48.79 16.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.034 0.445 . . . . 15.0 110.808 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.675 HD12 ' HB1' ' A' ' 67' ' ' ALA . 91.1 mt -60.34 -39.08 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 15.0 110.876 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.78 -14.3 29.23 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 119.849 -0.417 . . . . 15.0 113.083 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -65.13 -30.9 71.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 117.461 0.631 . . . . 15.0 111.785 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.3 mt -74.02 139.82 76.65 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 119.068 -0.491 . . . . 15.0 110.397 -175.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -58.9 134.26 59.03 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 121.433 1.422 . . . . 15.0 112.556 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.54 HD21 HD13 ' A' ' 60' ' ' LEU . 22.8 tp -108.87 129.2 55.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.075 -0.512 . . . . 15.0 110.745 176.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.516 ' CD1' HG22 ' A' ' 53' ' ' VAL . 84.3 m-85 -91.1 125.83 36.0 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.54 -0.541 . . . . 15.0 109.54 175.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.674 HG21 ' HB2' ' A' ' 87' ' ' ALA . 27.7 m -117.1 149.16 43.8 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-O 119.513 -0.279 . . . . 15.0 110.377 176.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.405 ' HD2' HG11 ' A' ' 86' ' ' VAL . 72.5 Cg_endo -79.15 -25.53 5.85 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.645 1.563 . . . . 15.0 113.597 -174.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.4 ' OG ' HG23 ' A' ' 86' ' ' VAL . 27.6 p -142.7 162.21 45.34 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 120.635 -0.426 . . . . 15.0 111.542 -172.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -56.02 -43.9 52.21 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.11 1.207 . . . . 15.0 111.862 176.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 68.5 mtp85 -58.79 -46.58 87.22 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.868 -0.333 . . . . 15.0 110.871 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.405 HG11 ' HD2' ' A' ' 82' ' ' PRO . 54.8 t -60.01 -40.85 84.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.959 -0.385 . . . . 15.0 109.959 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.674 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.59 -42.04 82.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.886 0.374 . . . . 15.0 110.467 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.46 -41.37 97.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.281 -0.418 . . . . 15.0 110.555 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 86.9 mtp -59.91 -43.4 94.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.223 0.535 . . . . 15.0 110.442 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.48 -40.85 96.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.025 -0.534 . . . . 15.0 110.719 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -61.24 -44.25 97.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 15.0 110.324 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.8 -36.15 74.0 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.986 -0.286 . . . . 15.0 111.251 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.9 mt -65.24 -26.03 67.93 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.113 0.412 . . . . 15.0 112.113 176.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.67 13.26 16.99 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 119.391 -0.672 . . . . 15.0 113.13 -176.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.92 122.1 12.13 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 118.527 1.163 . . . . 15.0 109.884 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -68.23 -35.32 77.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.764 -0.653 . . . . 15.0 111.23 -171.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.3 tpt85 -131.79 117.45 18.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.907 0.384 . . . . 15.0 110.137 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.7 t -114.41 130.06 69.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.996 0.427 . . . . 15.0 110.091 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 87.0 mt -118.81 125.16 74.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.801 -0.636 . . . . 15.0 110.171 -177.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.82 118.07 31.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.388 -0.369 . . . . 15.0 110.08 175.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 104' ' ' ALA . 31.9 p -92.91 -8.21 43.94 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.164 0.802 . . . . 15.0 113.164 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -55.14 -39.54 69.58 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.045 0.384 . . . . 15.0 110.914 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.07 -35.09 5.17 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.513 -0.635 . . . . 15.0 111.513 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' A' ' 101' ' ' CYS . . . -68.87 145.42 53.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.879 0.371 . . . . 15.0 110.691 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.437 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 20.6 t -89.8 152.01 21.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 15.0 110.406 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.67 -54.43 23.11 Favored Pre-proline 0 CA--C 1.535 0.404 0 N-CA-C 113.087 0.773 . . . . 15.0 113.087 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -55.83 -36.17 94.96 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 CA-C-N 120.098 1.071 . . . . 15.0 111.642 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 105' ' ' SER . . . -59.88 -42.0 92.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.035 0.445 . . . . 15.0 110.078 176.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.6 mt -59.02 -40.16 84.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.243 -0.435 . . . . 15.0 110.517 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.1 tp -57.17 -43.88 82.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.39 0.614 . . . . 15.0 110.146 178.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.84 -40.88 90.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.679 -0.691 . . . . 15.0 110.393 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.73 -40.8 89.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.311 -0.404 . . . . 15.0 110.715 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.9 mt -57.82 -50.74 72.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.271 0.558 . . . . 15.0 110.494 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.5 p -63.57 -40.54 97.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.6 -0.727 . . . . 15.0 111.326 -175.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 86.5 p -65.74 -39.17 90.86 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.911 -0.316 . . . . 15.0 111.42 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.62 -39.31 94.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.497 -0.32 . . . . 15.0 111.068 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.94 -36.21 74.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.418 -0.356 . . . . 15.0 111.163 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 82.5 mt -59.13 -34.46 72.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.499 -0.319 . . . . 15.0 111.357 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -57.71 -34.56 69.59 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 121.298 -0.161 . . . . 15.0 111.418 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -53.92 -35.73 62.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.559 0.219 . . . . 15.0 111.421 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -101.64 140.44 35.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.91 0.386 . . . . 15.0 110.587 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -113.5 141.57 46.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.05 -0.523 . . . . 15.0 110.532 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -114.62 123.93 50.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.305 -0.407 . . . . 15.0 110.336 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -56.02 -40.63 73.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 15.0 110.987 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.982 -1.009 . . . . 15.0 110.615 -179.286 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.7 mtm . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.412 -0.588 . . . . 15.0 109.412 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -125.91 79.76 68.3 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.18 -0.464 . . . . 15.0 110.242 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -49.98 151.51 8.54 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.449 1.433 . . . . 15.0 111.937 -175.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.47 ' HB2' HD23 ' A' ' 49' ' ' LEU . 75.9 mttt -119.93 141.13 49.91 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.334 -0.394 . . . . 15.0 110.703 -178.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.474 HG21 HD13 ' A' ' 21' ' ' LEU . 22.6 m -133.87 145.77 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 121.474 0.654 . . . . 15.0 111.781 175.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.488 HD13 ' CD ' ' A' ' 43' ' ' ARG . 13.4 tp -104.9 135.45 46.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.077 -0.965 . . . . 15.0 110.067 178.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.51 HD11 ' CG1' ' A' ' 28' ' ' VAL . 58.7 mt -103.04 135.09 42.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.026 0.441 . . . . 15.0 110.545 -177.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.569 ' HE3' HD21 ' A' ' 33' ' ' LEU . 96.7 mmm -88.21 134.12 33.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.422 -0.808 . . . . 15.0 110.123 174.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -57.81 140.72 51.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 15.0 110.583 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.36 175.07 42.52 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.949 -0.86 . . . . 15.0 110.949 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.61 -34.09 64.55 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 121.263 -0.175 . . . . 15.0 111.419 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.72 162.19 4.36 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.246 -0.742 . . . . 15.0 111.246 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.95 119.59 5.06 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.202 -0.759 . . . . 15.0 111.202 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -57.07 -43.79 82.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.097 0.475 . . . . 15.0 110.24 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.68 -41.71 98.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.861 -0.609 . . . . 15.0 111.146 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -58.84 -56.09 26.66 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.713 -0.395 . . . . 15.0 110.966 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.9 mt -61.53 -40.62 95.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.32 -0.4 . . . . 15.0 111.051 -176.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.41 -46.2 90.87 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.78 -0.368 . . . . 15.0 111.336 -177.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -60.29 -40.04 89.04 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.532 -0.467 . . . . 15.0 110.688 -177.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -60.57 -51.61 68.67 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 120.27 -0.572 . . . . 15.0 111.134 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.474 HD13 HG21 ' A' ' 5' ' ' VAL . 82.3 mt -66.31 -36.12 82.13 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.474 -0.49 . . . . 15.0 111.256 -176.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -61.66 -43.42 98.89 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 121.111 -0.236 . . . . 15.0 110.699 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.9 -30.7 70.26 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 120.844 -0.694 . . . . 15.0 112.018 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -88.21 8.59 26.41 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.647 0.98 . . . . 15.0 113.647 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.2 12.01 63.95 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 121.241 -0.505 . . . . 15.0 113.462 176.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.11 139.89 21.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 117.886 0.843 . . . . 15.0 110.044 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -86.26 137.44 32.61 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.699 -0.482 . . . . 15.0 109.699 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.51 ' CG1' HD11 ' A' ' 7' ' ' ILE . 38.6 t -116.78 131.13 70.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.186 0.517 . . . . 15.0 110.96 -174.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -134.81 130.2 35.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.587 -0.733 . . . . 15.0 109.446 171.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -112.01 135.69 52.32 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.896 0.379 . . . . 15.0 110.87 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.0 tp -116.15 113.35 41.53 Favored Pre-proline 0 CA--C 1.536 0.427 0 CA-C-O 118.751 -0.643 . . . . 15.0 110.398 -176.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.35 136.52 63.15 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.189 1.26 . . . . 15.0 112.445 175.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.569 HD21 ' HE3' ' A' ' 8' ' ' MET . 13.4 mt -58.62 -10.96 2.56 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.339 0.866 . . . . 15.0 113.339 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -77.15 -5.81 50.52 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.321 0.859 . . . . 15.0 113.321 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -65.75 146.06 99.0 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 118.491 0.587 . . . . 15.0 110.482 -177.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -80.75 157.13 21.25 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.602 1.535 . . . . 15.0 113.142 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.41 151.47 5.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.921 -0.582 . . . . 15.0 111.331 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.13 -38.03 3.24 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.527 -0.629 . . . . 15.0 111.527 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -62.45 -36.69 83.22 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.601 -0.44 . . . . 15.0 111.096 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.559 ' O ' HG23 ' A' ' 44' ' ' VAL . 27.4 tp -59.11 -47.12 86.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.962 0.411 . . . . 15.0 110.196 -178.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.5 HD13 ' CB ' ' A' ' 70' ' ' ASP . 19.4 tp -62.71 -45.2 93.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 15.0 110.868 -176.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.68 -44.53 96.77 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.687 -0.405 . . . . 15.0 110.76 -176.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.488 ' CD ' HD13 ' A' ' 6' ' ' LEU . 58.9 ttm-85 -60.72 -42.56 97.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.503 -0.317 . . . . 15.0 110.773 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 40' ' ' LEU . 97.9 t -60.46 -45.85 96.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.778 -0.369 . . . . 15.0 110.215 -177.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 62.1 ttm-85 -67.45 -51.63 49.18 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 123.453 0.471 . . . . 15.0 112.005 -176.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.36 -44.31 79.32 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 121.05 -0.26 . . . . 15.0 111.698 -174.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -78.85 -10.18 59.71 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.065 0.765 . . . . 15.0 113.065 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 54.67 55.83 7.46 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.515 0.674 . . . . 15.0 110.568 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.482 HD13 ' HB2' ' A' ' 6' ' ' LEU . 97.8 mt -74.15 143.75 45.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.794 -0.639 . . . . 15.0 111.086 -176.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.52 ' O ' HD22 ' A' ' 77' ' ' LEU . 9.4 m120 -90.2 -40.61 12.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.456 -0.793 . . . . 15.0 110.772 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.61 165.89 28.74 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 119.869 -1.158 . . . . 15.0 113.537 -171.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.1 mt -127.09 145.69 50.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.665 -0.768 . . . . 15.0 110.042 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.494 HG22 ' CD1' ' A' ' 80' ' ' PHE . 47.3 t -122.78 133.2 69.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 110.248 -0.279 . . . . 15.0 110.248 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.426 HG12 ' HG3' ' A' ' 8' ' ' MET . 10.2 m -124.57 138.35 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 120.99 0.424 . . . . 15.0 110.609 174.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.1 p -90.05 -18.02 26.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.727 -0.67 . . . . 15.0 112.636 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 77.0 p -156.68 161.43 39.86 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 121.364 0.602 . . . . 15.0 111.719 -176.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.95 -37.25 69.73 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.193 -0.763 . . . . 15.0 111.193 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -59.17 -46.09 89.29 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.899 -0.32 . . . . 15.0 110.789 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.9 -42.78 98.36 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.808 -0.917 . . . . 15.0 110.808 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.609 HD13 HD21 ' A' ' 79' ' ' LEU . 28.8 tp -58.11 -47.33 83.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.987 0.423 . . . . 15.0 110.622 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.49 -43.61 98.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.181 -0.463 . . . . 15.0 110.644 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.407 ' CB ' HD22 ' A' ' 33' ' ' LEU . 79.4 m-20 -59.09 -40.91 86.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.104 -0.498 . . . . 15.0 110.527 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.2 tp -56.76 -42.55 79.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.059 0.457 . . . . 15.0 110.194 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -58.74 -46.99 86.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.875 -0.602 . . . . 15.0 110.238 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -61.37 -43.2 99.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.794 -0.639 . . . . 15.0 111.098 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.83 -35.99 82.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.281 -0.418 . . . . 15.0 111.437 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.659 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.55 -38.49 81.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.063 0.458 . . . . 15.0 110.816 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.45 -143.56 0.57 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 109.454 -0.572 . . . . 15.0 109.454 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.48 -19.1 45.31 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.347 0.976 . . . . 15.0 112.66 -174.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.5 ' CB ' HD13 ' A' ' 41' ' ' LEU . 13.8 m-20 -91.84 10.39 28.83 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.295 0.85 . . . . 15.0 113.295 -174.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 53.5 t-105 -47.75 -48.13 60.75 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 118.553 -0.737 . . . . 15.0 112.423 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -44.72 -40.37 14.26 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.47 1.447 . . . . 15.0 113.159 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -77.1 -48.6 17.33 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.936 0.398 . . . . 15.0 111.202 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.659 HD12 ' HB1' ' A' ' 67' ' ' ALA . 93.7 mt -59.11 -39.27 78.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 15.0 110.826 -177.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.96 0.4 14.92 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 119.693 -0.504 . . . . 15.0 113.22 -175.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.3 mtm105 -90.58 -1.28 57.88 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.013 0.906 . . . . 15.0 112.975 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.52 HD22 ' O ' ' A' ' 50' ' ' ASN . 23.3 mt -90.09 139.47 27.27 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-O 118.869 -0.586 . . . . 15.0 109.656 172.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.67 131.23 40.51 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.376 1.384 . . . . 15.0 111.759 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.609 HD21 HD13 ' A' ' 60' ' ' LEU . 24.3 tp -105.43 128.07 53.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.748 0.309 . . . . 15.0 110.9 177.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.494 ' CD1' HG22 ' A' ' 53' ' ' VAL . 73.3 m-85 -92.84 127.13 38.23 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.696 -0.483 . . . . 15.0 109.696 176.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 99' ' ' ILE . 32.8 m -123.15 151.58 62.18 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-O 119.567 -0.254 . . . . 15.0 110.67 177.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.28 -19.63 10.31 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 121.514 1.476 . . . . 15.0 113.803 -175.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.0 p -148.83 162.47 29.38 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 120.391 -0.524 . . . . 15.0 111.841 -171.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.4 -43.96 47.0 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.2 1.267 . . . . 15.0 111.885 176.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 80.7 mtm180 -58.2 -46.75 85.27 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.808 -0.357 . . . . 15.0 110.71 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 50.2 t -60.95 -38.38 79.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.689 -0.404 . . . . 15.0 110.128 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.448 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -56.85 -41.71 78.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.042 0.449 . . . . 15.0 110.427 177.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -60.88 -40.09 91.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.154 -0.476 . . . . 15.0 110.616 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.1 mmm -58.34 -45.85 87.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.45 0.643 . . . . 15.0 110.173 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.494 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -62.09 -42.11 98.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.733 -0.667 . . . . 15.0 111.112 -177.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 71.6 ttp85 -62.28 -44.2 97.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.186 -0.461 . . . . 15.0 110.708 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -59.33 -36.15 75.12 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.978 -0.289 . . . . 15.0 111.236 -177.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 81.5 mt -65.46 -25.24 67.42 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.098 0.407 . . . . 15.0 112.098 177.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 111.58 13.2 13.24 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-O 119.293 -0.726 . . . . 15.0 113.235 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.22 131.08 49.95 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.566 1.183 . . . . 15.0 109.666 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -62.24 -44.42 96.59 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.452 -0.573 . . . . 15.0 109.452 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 47.9 ttt85 -131.84 119.03 20.66 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.464 -0.789 . . . . 15.0 110.945 -173.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.8 t -114.43 128.78 71.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.829 -0.623 . . . . 15.0 109.503 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.448 ' O ' HG22 ' A' ' 81' ' ' VAL . 93.2 mt -117.79 123.92 72.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.903 -0.59 . . . . 15.0 110.279 -175.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -94.36 118.22 31.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.364 -0.38 . . . . 15.0 110.22 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.7 p -91.33 -6.94 52.3 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.141 0.793 . . . . 15.0 113.141 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 47.0 tpt85 -55.51 -39.61 70.73 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 118.208 0.458 . . . . 15.0 110.723 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.33 -35.2 5.32 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.48 -0.648 . . . . 15.0 111.48 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.11 144.25 42.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.816 0.341 . . . . 15.0 110.55 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.1 m -89.72 161.8 15.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.04 0.448 . . . . 15.0 110.578 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.65 -54.27 24.25 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 112.976 0.732 . . . . 15.0 112.976 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.05 -34.84 98.9 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 CA-C-N 120.213 1.112 . . . . 15.0 111.601 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.63 94.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.061 0.457 . . . . 15.0 110.048 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 82.3 mt -59.05 -40.9 86.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.446 . . . . 15.0 110.411 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 40.7 tp -57.31 -44.46 84.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.383 0.611 . . . . 15.0 110.136 178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.31 -39.74 88.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.583 -0.735 . . . . 15.0 110.677 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.88 -42.42 97.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.415 -0.357 . . . . 15.0 110.899 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.0 mt -57.88 -50.36 73.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.026 0.441 . . . . 15.0 110.428 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.8 p -65.38 -39.95 92.9 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.827 -0.624 . . . . 15.0 111.576 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.1 p -66.35 -38.42 87.57 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.999 -0.28 . . . . 15.0 111.28 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.63 -42.59 95.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.41 -0.359 . . . . 15.0 111.133 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.55 -41.66 97.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.756 0.313 . . . . 15.0 110.579 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 93.5 mt -64.07 -37.1 86.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 15.0 111.081 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.61 -34.99 71.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.564 -0.289 . . . . 15.0 111.466 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -56.9 -41.43 78.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.549 0.214 . . . . 15.0 111.08 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -112.12 134.24 53.79 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.808 0.337 . . . . 15.0 110.73 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -118.5 130.14 55.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.273 -0.421 . . . . 15.0 110.51 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -60.75 -41.1 94.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 15.0 110.63 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -111.82 138.9 47.8 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.263 -0.426 . . . . 15.0 110.464 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.054 -0.974 . . . . 15.0 110.488 179.964 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.6 mtm . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.395 -0.594 . . . . 15.0 109.395 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -125.79 78.12 69.58 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.091 -0.504 . . . . 15.0 110.238 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -50.99 154.53 7.15 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.486 1.457 . . . . 15.0 111.871 -176.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.5 ' HB2' HD23 ' A' ' 49' ' ' LEU . 93.8 mttt -116.43 140.39 49.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.448 -0.342 . . . . 15.0 110.831 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.577 HG21 HD13 ' A' ' 21' ' ' LEU . 12.2 m -135.4 143.78 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.638 0.732 . . . . 15.0 111.69 175.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 tp -104.72 134.34 48.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.855 -1.066 . . . . 15.0 110.262 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.562 HD11 ' CG1' ' A' ' 28' ' ' VAL . 48.9 mt -103.35 135.15 42.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 15.0 110.505 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.629 ' SD ' HD13 ' A' ' 63' ' ' LEU . 85.9 mtp -101.08 134.11 44.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.66 -0.7 . . . . 15.0 109.531 172.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -57.61 146.47 30.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.002 0.429 . . . . 15.0 110.81 -174.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.92 175.14 33.79 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.97 -0.852 . . . . 15.0 110.97 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.56 -32.62 67.31 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.602 0.223 . . . . 15.0 111.602 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.51 177.01 18.25 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.014 -0.835 . . . . 15.0 111.014 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.0 122.09 5.81 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.313 -0.715 . . . . 15.0 111.313 -178.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -57.17 -44.52 83.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.098 0.475 . . . . 15.0 110.27 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.96 -41.13 97.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.927 -0.579 . . . . 15.0 110.958 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -57.88 -55.98 27.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.981 0.42 . . . . 15.0 111.0 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.417 HD21 HG11 ' A' ' 53' ' ' VAL . 26.8 tp -60.54 -42.13 95.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 15.0 111.025 -176.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.06 -43.69 98.51 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.799 -0.36 . . . . 15.0 111.45 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -61.73 -39.46 91.64 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.704 -0.398 . . . . 15.0 110.818 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -61.01 -51.6 68.54 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.381 -0.527 . . . . 15.0 111.232 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.577 HD13 HG21 ' A' ' 5' ' ' VAL . 80.9 mt -64.26 -37.58 87.97 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.409 -0.516 . . . . 15.0 111.001 -177.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -63.79 -43.8 95.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.59 0.233 . . . . 15.0 111.121 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.93 -30.66 66.81 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.03 -0.605 . . . . 15.0 111.961 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -88.03 9.33 22.81 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.57 0.952 . . . . 15.0 113.57 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.21 13.63 58.5 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 121.247 -0.501 . . . . 15.0 113.554 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.0 t -101.09 138.15 26.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 117.845 0.822 . . . . 15.0 110.061 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -79.51 132.42 36.32 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.194 -0.669 . . . . 15.0 109.194 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.562 ' CG1' HD11 ' A' ' 7' ' ' ILE . 39.6 t -116.36 131.17 69.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.194 0.521 . . . . 15.0 111.106 -173.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -137.73 130.8 30.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.413 -0.812 . . . . 15.0 109.377 170.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.406 ' HB3' HD12 ' A' ' 7' ' ' ILE . 31.0 p90 -114.15 135.11 54.39 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.87 0.366 . . . . 15.0 110.645 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 tp -112.99 136.04 21.7 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.946 -0.55 . . . . 15.0 110.027 -175.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -72.16 135.11 24.36 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.332 1.354 . . . . 15.0 111.976 172.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.613 HD22 ' CB ' ' A' ' 62' ' ' ASN . 62.4 mt -58.36 -11.94 3.3 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.33 0.863 . . . . 15.0 113.33 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -77.21 -6.64 53.78 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.392 0.886 . . . . 15.0 113.392 -176.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -68.55 150.9 97.52 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 118.524 0.602 . . . . 15.0 110.738 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -78.95 155.9 26.61 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.64 1.56 . . . . 15.0 113.102 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.11 151.99 4.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.763 -0.653 . . . . 15.0 111.226 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.44 -38.03 3.24 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.945 -0.57 . . . . 15.0 111.688 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.68 -38.86 86.35 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 117.172 0.486 . . . . 15.0 110.738 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.531 ' O ' HG23 ' A' ' 44' ' ' VAL . 18.2 tp -60.46 -48.3 82.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.954 0.407 . . . . 15.0 110.4 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.435 HD22 ' CG ' ' A' ' 70' ' ' ASP . 21.3 tp -60.38 -42.38 95.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 15.0 110.772 -175.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.25 -46.24 89.72 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.664 -0.415 . . . . 15.0 110.909 -175.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.3 mtt85 -61.1 -41.35 96.52 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.499 -0.48 . . . . 15.0 110.679 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 40' ' ' LEU . 82.2 t -60.33 -46.08 95.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.748 -0.381 . . . . 15.0 110.202 -176.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -68.57 -51.32 44.03 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 123.421 0.45 . . . . 15.0 112.066 -175.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.29 -44.25 79.72 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.857 0.317 . . . . 15.0 111.857 -173.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -79.56 -10.07 59.73 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.08 0.77 . . . . 15.0 113.08 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 55.5 55.78 6.96 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.632 0.729 . . . . 15.0 110.219 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.5 HD23 ' HB2' ' A' ' 4' ' ' LYS . 96.0 mt -68.04 143.56 55.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.671 -0.695 . . . . 15.0 111.364 -174.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -91.16 -40.13 11.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.151 -0.931 . . . . 15.0 110.838 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.37 160.75 28.46 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.023 -1.084 . . . . 15.0 113.788 -174.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 71.3 mt -125.39 143.39 51.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.486 -0.857 . . . . 15.0 109.618 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.53 HG22 ' CD1' ' A' ' 80' ' ' PHE . 45.6 t -122.11 132.07 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 121.148 -0.221 . . . . 15.0 110.764 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.405 HG12 ' SD ' ' A' ' 8' ' ' MET . 8.5 m -124.23 145.78 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 121.144 0.497 . . . . 15.0 110.524 172.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 t -98.1 -21.45 16.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.479 -0.782 . . . . 15.0 112.426 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 81.3 p -152.73 162.16 41.62 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 121.414 0.625 . . . . 15.0 111.801 -174.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.86 -37.08 68.36 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.118 -0.793 . . . . 15.0 111.118 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -58.98 -46.08 88.99 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.858 -0.337 . . . . 15.0 110.646 -177.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.56 -44.07 98.18 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.732 -0.947 . . . . 15.0 110.732 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.627 HD13 HD21 ' A' ' 79' ' ' LEU . 32.2 tp -57.04 -45.09 83.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.112 0.482 . . . . 15.0 110.672 -178.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.72 -43.69 98.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 15.0 110.534 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.613 ' CB ' HD22 ' A' ' 33' ' ' LEU . 81.1 m-20 -59.83 -38.1 81.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.706 178.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.629 HD13 ' SD ' ' A' ' 8' ' ' MET . 9.5 tp -56.69 -44.9 81.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.388 0.613 . . . . 15.0 110.155 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -60.0 -46.87 88.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.495 -0.775 . . . . 15.0 110.584 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -61.51 -43.23 99.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.975 -0.557 . . . . 15.0 111.091 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.09 -34.99 78.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.449 -0.342 . . . . 15.0 111.468 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.668 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.46 -38.14 80.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.965 0.412 . . . . 15.0 110.69 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.2 -143.93 0.58 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 109.605 -0.517 . . . . 15.0 109.605 174.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.53 -18.87 44.08 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.336 0.971 . . . . 15.0 112.678 -174.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.435 ' CG ' HD22 ' A' ' 41' ' ' LEU . 23.3 m-20 -91.86 10.8 27.17 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.282 0.845 . . . . 15.0 113.282 -175.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 60.0 t-105 -47.81 -46.56 62.65 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-O 118.588 -0.72 . . . . 15.0 112.556 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -44.74 -41.6 14.86 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.438 1.425 . . . . 15.0 113.267 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -77.03 -48.79 16.92 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.954 0.407 . . . . 15.0 110.819 -177.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.668 HD12 ' HB1' ' A' ' 67' ' ' ALA . 90.3 mt -59.57 -40.56 82.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 15.0 110.855 -176.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.68 -15.87 35.37 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 116.392 -0.367 . . . . 15.0 113.144 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -65.06 -29.93 70.85 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.355 0.578 . . . . 15.0 112.073 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 24.2 mt -75.7 150.51 84.21 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 121.018 -0.273 . . . . 15.0 111.648 -173.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.31 128.23 23.21 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.751 1.634 . . . . 15.0 112.481 176.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.627 HD21 HD13 ' A' ' 60' ' ' LEU . 23.9 tp -106.32 125.66 51.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.343 -0.389 . . . . 15.0 110.516 174.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.53 ' CD1' HG22 ' A' ' 53' ' ' VAL . 69.3 m-85 -90.05 126.56 35.81 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.634 -0.506 . . . . 15.0 109.634 176.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.653 HG21 ' HB2' ' A' ' 87' ' ' ALA . 26.7 m -119.06 147.28 42.31 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 119.438 -0.315 . . . . 15.0 110.176 176.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.14 -24.27 6.91 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.601 1.534 . . . . 15.0 113.529 -175.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.3 p -142.98 162.54 42.98 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 120.602 -0.439 . . . . 15.0 111.52 -171.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.14 -44.07 50.26 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 121.184 1.256 . . . . 15.0 111.755 176.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 70.9 ttp85 -57.45 -48.39 79.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.833 0.349 . . . . 15.0 110.845 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.8 t -59.9 -40.07 81.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.99 -0.374 . . . . 15.0 109.99 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.653 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.42 -42.29 82.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.903 0.383 . . . . 15.0 110.371 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -60.47 -40.11 90.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 15.0 110.621 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.1 mmm -58.46 -43.68 88.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.364 0.602 . . . . 15.0 110.212 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.496 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.16 -42.4 98.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.8 -0.636 . . . . 15.0 110.883 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.455 ' HD2' HG21 ' A' ' 98' ' ' VAL . 28.9 mmm180 -62.87 -42.01 99.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 15.0 110.871 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -59.64 -36.19 75.89 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.909 -0.317 . . . . 15.0 111.3 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.9 mt -68.96 -21.43 64.18 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.569 0.581 . . . . 15.0 112.569 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 106.85 13.28 22.28 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 119.376 -0.68 . . . . 15.0 113.086 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.79 122.14 12.15 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.439 1.12 . . . . 15.0 109.989 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -68.13 -36.04 79.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.55 -0.75 . . . . 15.0 111.226 -171.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.7 ttm-85 -131.76 114.03 14.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.045 0.45 . . . . 15.0 110.575 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.455 HG21 ' HD2' ' A' ' 91' ' ' ARG . 47.0 t -112.39 130.58 65.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.175 -0.466 . . . . 15.0 109.873 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.5 mt -119.74 123.73 71.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.941 -0.572 . . . . 15.0 110.142 -176.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.27 118.47 31.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.381 -0.372 . . . . 15.0 110.193 176.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.5 p -96.04 -3.99 43.86 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.283 0.846 . . . . 15.0 113.283 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -56.02 -39.96 72.7 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 118.199 0.454 . . . . 15.0 110.698 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -92.06 -35.07 6.86 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.505 -0.638 . . . . 15.0 111.505 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.44 142.38 41.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.841 0.353 . . . . 15.0 110.704 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.2 m -89.82 164.07 14.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 15.0 110.327 178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.61 -54.22 24.43 Favored Pre-proline 0 CA--C 1.536 0.437 0 CA-C-O 118.523 -0.751 . . . . 15.0 112.963 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.59 -36.18 97.74 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 CA-C-N 120.583 1.244 . . . . 15.0 111.346 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.21 -42.61 95.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.046 0.451 . . . . 15.0 110.165 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.0 mt -58.95 -40.66 85.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 15.0 110.44 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 29.2 tp -57.36 -44.35 84.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.31 0.576 . . . . 15.0 110.181 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.6 -40.99 93.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.656 -0.702 . . . . 15.0 110.556 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.23 92.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.356 -0.384 . . . . 15.0 110.805 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.1 mt -57.9 -51.39 69.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.284 0.564 . . . . 15.0 110.451 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.2 p -64.69 -40.27 95.09 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.585 -0.734 . . . . 15.0 111.38 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 87.3 p -64.6 -38.88 92.52 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.037 -0.265 . . . . 15.0 111.335 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.81 -42.72 99.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.747 0.308 . . . . 15.0 110.891 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.64 -39.45 88.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.375 -0.375 . . . . 15.0 110.769 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.8 -35.0 79.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.419 -0.355 . . . . 15.0 111.399 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -93.99 137.54 33.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.945 0.402 . . . . 15.0 111.148 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -160.03 -61.39 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.894 -0.593 . . . . 15.0 110.357 178.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -55.31 -38.89 69.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 15.0 111.074 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -57.13 -40.57 77.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.355 -0.384 . . . . 15.0 110.87 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -57.17 -45.51 83.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.34 -0.391 . . . . 15.0 110.829 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -56.65 -39.46 73.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.354 -0.384 . . . . 15.0 110.868 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.044 -0.979 . . . . 15.0 110.513 179.922 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.376 -0.602 . . . . 15.0 109.376 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.26 83.35 64.05 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.164 -0.471 . . . . 15.0 110.421 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.01 153.89 5.91 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.373 1.382 . . . . 15.0 111.918 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -109.98 138.38 46.44 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.552 -0.295 . . . . 15.0 110.866 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.471 HG21 HD13 ' A' ' 21' ' ' LEU . 12.4 m -135.96 144.16 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 121.612 0.72 . . . . 15.0 111.707 177.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.408 HD13 ' CD ' ' A' ' 43' ' ' ARG . 12.4 tp -104.55 135.84 45.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.936 -1.029 . . . . 15.0 110.233 177.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.57 HD11 ' CG1' ' A' ' 28' ' ' VAL . 50.3 mt -102.58 135.11 41.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.279 -0.419 . . . . 15.0 110.319 -178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.487 ' SD ' HD13 ' A' ' 63' ' ' LEU . 86.5 mtp -99.08 134.02 42.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.898 -0.592 . . . . 15.0 110.305 173.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -57.59 140.93 49.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.891 0.377 . . . . 15.0 110.641 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.55 175.18 31.26 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.826 -0.91 . . . . 15.0 110.826 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -56.42 -33.02 65.42 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.163 -0.215 . . . . 15.0 111.424 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.7 176.27 32.65 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.674 -0.97 . . . . 15.0 110.674 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.98 120.66 5.55 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.951 -0.642 . . . . 15.0 111.519 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -57.01 -41.39 78.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.803 0.335 . . . . 15.0 110.575 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -62.23 -41.93 98.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.426 . . . . 15.0 111.229 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -63.42 -55.88 20.76 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.793 -0.363 . . . . 15.0 111.345 -176.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.0 mt -59.55 -43.69 93.45 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.724 -0.39 . . . . 15.0 110.967 -176.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.503 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -62.55 -40.24 96.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 15.0 110.812 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.89 -41.92 92.67 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.962 -0.295 . . . . 15.0 110.505 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -60.0 -51.74 68.36 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 120.591 -0.443 . . . . 15.0 110.999 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.471 HD13 HG21 ' A' ' 5' ' ' VAL . 80.6 mt -62.46 -37.53 86.29 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.497 -0.481 . . . . 15.0 111.103 -178.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -63.32 -44.26 95.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.554 0.216 . . . . 15.0 110.929 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.18 -30.58 67.55 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.019 -0.61 . . . . 15.0 111.92 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -88.09 10.08 20.44 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.556 0.947 . . . . 15.0 113.556 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.09 18.82 41.66 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 121.109 -0.567 . . . . 15.0 113.351 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.3 t -101.02 139.97 20.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 117.665 0.732 . . . . 15.0 110.19 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -82.22 126.0 31.58 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.865 -0.791 . . . . 15.0 108.865 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.57 ' CG1' HD11 ' A' ' 7' ' ' ILE . 42.3 t -116.02 130.93 69.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.314 0.578 . . . . 15.0 111.331 -171.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -137.23 133.56 35.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.274 -0.875 . . . . 15.0 109.439 170.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.402 ' HB3' HD12 ' A' ' 7' ' ' ILE . 36.4 p90 -114.08 135.85 53.57 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.92 0.391 . . . . 15.0 110.857 -178.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.7 tp -116.16 113.3 41.51 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.632 -0.699 . . . . 15.0 110.194 -176.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.0 135.12 50.94 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.159 1.239 . . . . 15.0 112.09 174.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.579 HD13 HD22 ' A' ' 62' ' ' ASN . 84.4 mt -60.65 -9.2 3.56 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.325 0.861 . . . . 15.0 113.325 -178.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -77.15 -6.03 51.33 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.184 0.809 . . . . 15.0 113.184 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -64.62 150.11 94.49 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 118.512 0.596 . . . . 15.0 110.378 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -80.04 154.93 22.74 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.544 1.496 . . . . 15.0 113.27 -177.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.72 152.1 3.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.883 -0.599 . . . . 15.0 111.362 -178.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.23 -37.95 3.26 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.611 -0.596 . . . . 15.0 111.611 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -61.23 -36.52 80.17 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.607 -0.437 . . . . 15.0 111.184 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.558 ' O ' HG23 ' A' ' 44' ' ' VAL . 25.4 tp -59.16 -48.83 80.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.965 0.412 . . . . 15.0 110.228 -178.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.451 HD22 ' CG ' ' A' ' 70' ' ' ASP . 23.1 tp -62.73 -44.25 96.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 15.0 110.988 -175.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.08 -44.84 95.79 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.67 -0.412 . . . . 15.0 110.907 -176.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.408 ' CD ' HD13 ' A' ' 6' ' ' LEU . 60.0 ttm-85 -60.79 -41.87 96.46 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 121.01 -0.276 . . . . 15.0 110.713 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 40' ' ' LEU . 98.4 t -60.68 -45.78 96.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.835 -0.346 . . . . 15.0 110.111 -177.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -70.52 -46.86 62.83 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.1 0.408 . . . . 15.0 112.1 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.49 -44.44 82.62 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.047 -0.261 . . . . 15.0 111.442 -175.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -81.15 -10.16 59.69 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.124 0.787 . . . . 15.0 113.124 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 54.66 55.89 7.4 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.582 0.706 . . . . 15.0 110.483 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.4 mt -69.94 150.63 46.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.618 -0.719 . . . . 15.0 111.546 -175.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -95.25 -40.51 9.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.162 -0.926 . . . . 15.0 110.767 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -149.7 165.36 29.62 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 119.955 -1.117 . . . . 15.0 113.75 -174.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 70.7 mt -126.09 142.57 51.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.489 -0.856 . . . . 15.0 109.575 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.518 HG22 ' CD1' ' A' ' 80' ' ' PHE . 46.2 t -121.39 130.18 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.682 0.277 . . . . 15.0 110.777 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.7 m -128.1 155.68 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 121.02 0.438 . . . . 15.0 110.575 171.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.3 t -131.34 14.4 5.06 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.681 -0.691 . . . . 15.0 112.408 176.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.6 p -155.0 149.35 26.16 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.267 0.556 . . . . 15.0 111.548 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.89 -40.18 92.74 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.61 -0.996 . . . . 15.0 110.61 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -58.57 -41.4 85.57 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.916 -0.314 . . . . 15.0 110.473 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.91 -47.15 92.67 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.774 -0.93 . . . . 15.0 110.774 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.413 HD21 ' HA ' ' A' ' 90' ' ' ALA . 27.1 tp -57.06 -44.43 83.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.109 0.48 . . . . 15.0 110.653 -178.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.78 -43.59 98.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.032 -0.531 . . . . 15.0 110.822 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.579 HD22 HD13 ' A' ' 33' ' ' LEU . 84.3 m-20 -59.36 -38.93 81.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 15.0 110.767 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.487 HD13 ' SD ' ' A' ' 8' ' ' MET . 13.2 tp -57.48 -44.81 85.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.247 0.546 . . . . 15.0 110.172 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -60.68 -47.15 87.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.675 -0.693 . . . . 15.0 110.468 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -61.97 -43.94 97.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 15.0 111.31 -176.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.57 -35.24 79.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.367 -0.379 . . . . 15.0 111.358 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.67 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.42 -38.78 81.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.939 0.4 . . . . 15.0 110.646 178.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.11 -143.72 0.59 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.58 -0.526 . . . . 15.0 109.58 174.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.47 -18.14 37.23 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.417 1.008 . . . . 15.0 112.654 -175.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.451 ' CG ' HD22 ' A' ' 41' ' ' LEU . 27.8 m-20 -91.79 9.61 31.94 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.341 0.867 . . . . 15.0 113.341 -175.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 59.2 t-105 -47.85 -47.35 63.14 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-O 118.629 -0.701 . . . . 15.0 112.546 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -44.78 -40.76 14.77 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 121.482 1.455 . . . . 15.0 113.199 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -76.97 -48.79 17.07 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.044 0.45 . . . . 15.0 110.741 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.67 HD12 ' HB1' ' A' ' 67' ' ' ALA . 92.8 mt -59.59 -39.93 80.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.025 -0.534 . . . . 15.0 110.925 -176.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.51 -15.82 33.9 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 119.944 -0.364 . . . . 15.0 113.116 -176.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -65.87 -30.03 70.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.387 0.593 . . . . 15.0 112.016 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.7 mt -74.49 150.62 87.06 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 111.638 0.236 . . . . 15.0 111.638 -172.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.97 123.58 13.2 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.599 1.533 . . . . 15.0 112.026 176.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.8 tp -103.35 123.44 46.82 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.804 -0.358 . . . . 15.0 110.426 174.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.518 ' CD1' HG22 ' A' ' 53' ' ' VAL . 76.5 m-85 -89.38 123.38 33.48 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.057 -0.72 . . . . 15.0 109.057 175.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.738 HG21 ' HB2' ' A' ' 87' ' ' ALA . 25.3 m -112.25 151.82 43.99 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 110.341 -0.244 . . . . 15.0 110.341 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.0 -28.65 3.76 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.414 1.409 . . . . 15.0 113.1 -175.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.4 p -144.39 167.91 13.8 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 120.656 -0.418 . . . . 15.0 111.537 -173.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -60.42 -44.0 30.42 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 121.228 1.286 . . . . 15.0 111.6 177.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -57.0 -47.99 79.52 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.88 -0.328 . . . . 15.0 110.777 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.55 -40.07 83.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.604 -0.438 . . . . 15.0 110.027 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.738 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.01 -41.71 79.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.928 0.394 . . . . 15.0 110.545 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.27 -41.32 96.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.218 -0.447 . . . . 15.0 110.529 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 87.3 mtp -59.57 -44.04 93.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.307 0.575 . . . . 15.0 110.384 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.413 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.5 -40.52 94.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.858 -0.61 . . . . 15.0 110.791 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -61.15 -45.04 96.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.278 -0.419 . . . . 15.0 110.435 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.68 -36.2 76.0 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.508 -0.315 . . . . 15.0 111.298 -177.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.82 -26.47 68.35 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.108 0.41 . . . . 15.0 112.108 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 114.21 13.16 10.14 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 119.281 -0.733 . . . . 15.0 113.177 -176.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.9 121.82 11.45 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.597 1.198 . . . . 15.0 109.691 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -71.61 -39.75 70.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.519 -0.764 . . . . 15.0 110.617 -171.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.47 ' NH2' ' HB1' ' A' ' 116' ' ' ALA . 52.8 ttp85 -132.09 113.9 13.9 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.453 0.644 . . . . 15.0 110.832 178.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.2 t -114.43 133.28 61.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.645 -0.707 . . . . 15.0 110.264 -176.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 87.6 mt -117.54 126.42 74.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.677 -0.692 . . . . 15.0 110.244 -176.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -96.26 117.48 30.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.452 -0.34 . . . . 15.0 110.519 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 30.3 p -69.67 -20.32 63.57 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.574 0.583 . . . . 15.0 112.574 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -53.21 -36.97 61.57 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 122.113 -0.367 . . . . 15.0 111.508 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.27 -35.18 8.19 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 120.824 -0.703 . . . . 15.0 111.648 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -92.18 120.92 33.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.766 0.317 . . . . 15.0 111.121 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.485 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 49.9 m -70.44 165.85 21.65 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.433 -0.58 . . . . 15.0 109.433 174.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.55 -54.4 22.85 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 112.776 0.658 . . . . 15.0 112.776 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -57.49 -34.96 98.84 Favored 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 120.9 1.067 . . . . 15.0 111.4 176.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 105' ' ' SER . . . -61.14 -40.8 95.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.842 0.353 . . . . 15.0 110.365 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.2 mt -58.97 -41.79 88.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.015 0.435 . . . . 15.0 110.169 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.5 tp -57.23 -45.15 84.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.488 0.661 . . . . 15.0 110.169 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.46 91.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.505 -0.77 . . . . 15.0 110.817 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.97 -42.47 98.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.578 -0.283 . . . . 15.0 110.815 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.6 mt -57.94 -52.25 66.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.397 0.617 . . . . 15.0 110.463 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.7 p -66.32 -38.36 87.53 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.454 -0.794 . . . . 15.0 111.656 -174.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.3 p -67.65 -38.19 83.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.709 0.29 . . . . 15.0 111.322 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.47 ' HB1' ' NH2' ' A' ' 97' ' ' ARG . . . -62.7 -40.57 97.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.423 -0.353 . . . . 15.0 110.827 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.05 -38.86 80.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.395 -0.366 . . . . 15.0 110.797 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 86.8 mt -62.41 -37.78 87.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.41 -0.359 . . . . 15.0 110.95 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.55 143.66 56.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.766 0.317 . . . . 15.0 110.654 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -143.05 -57.96 0.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.295 -0.411 . . . . 15.0 110.666 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -55.42 -41.23 72.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 15.0 111.191 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -55.49 -39.15 70.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.464 -0.335 . . . . 15.0 111.173 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -54.75 -37.31 65.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.348 -0.387 . . . . 15.0 111.491 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -111.9 138.01 49.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.922 0.391 . . . . 15.0 110.916 -177.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 118.048 -0.977 . . . . 15.0 110.517 179.575 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.4 mtm . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.306 -0.628 . . . . 15.0 109.306 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.0 79.78 68.62 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.176 -0.466 . . . . 15.0 110.29 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.42 ' HG2' HG22 ' A' ' 26' ' ' VAL . 17.2 Cg_endo -55.58 154.98 22.91 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 121.439 1.426 . . . . 15.0 111.696 -176.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.462 ' HB2' HD23 ' A' ' 49' ' ' LEU . 97.9 mttt -111.98 140.11 46.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.582 -0.281 . . . . 15.0 110.815 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.443 HG21 HD13 ' A' ' 21' ' ' LEU . 15.9 m -136.17 143.92 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.647 0.737 . . . . 15.0 111.818 175.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.1 tp -105.07 136.75 43.97 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.924 -1.034 . . . . 15.0 110.245 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.633 HD11 ' CG1' ' A' ' 28' ' ' VAL . 51.0 mt -104.61 135.14 43.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.096 0.474 . . . . 15.0 111.067 -177.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.511 ' HB2' HG12 ' A' ' 54' ' ' VAL . 99.0 mmm -94.89 134.04 37.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.134 -0.939 . . . . 15.0 109.364 172.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -66.28 145.07 56.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.937 0.398 . . . . 15.0 110.554 -178.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -161.08 175.22 37.74 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.76 -0.936 . . . . 15.0 110.76 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -51.29 -31.2 20.58 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 111.847 0.314 . . . . 15.0 111.847 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.99 -174.02 1.74 Allowed Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.938 -0.865 . . . . 15.0 110.938 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -108.4 109.58 2.9 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.49 -0.644 . . . . 15.0 111.49 -177.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.3 mtm-85 -55.2 -38.85 68.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.645 0.26 . . . . 15.0 111.035 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -59.87 -54.98 39.84 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.067 0.395 . . . . 15.0 112.067 -172.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -69.95 -45.09 68.18 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 120.274 -0.57 . . . . 15.0 111.435 -173.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.1 tp -58.12 -44.84 87.96 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 120.491 -0.484 . . . . 15.0 110.589 -178.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.412 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -62.75 -42.5 99.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 15.0 110.44 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -57.96 -40.46 80.65 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.931 -0.308 . . . . 15.0 110.562 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -59.08 -51.64 69.19 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.959 0.409 . . . . 15.0 111.042 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.443 HD13 HG21 ' A' ' 5' ' ' VAL . 77.7 mt -59.81 -37.32 78.81 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.567 -0.453 . . . . 15.0 110.887 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -62.95 -41.97 99.68 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 121.107 -0.237 . . . . 15.0 111.119 178.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.25 -30.56 67.75 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 120.981 -0.628 . . . . 15.0 111.966 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -88.18 9.57 22.42 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.557 0.947 . . . . 15.0 113.557 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.32 15.42 58.78 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 121.23 -0.509 . . . . 15.0 113.393 175.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.42 HG22 ' HG2' ' A' ' 3' ' ' PRO . 43.9 t -101.04 137.84 27.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 117.917 0.858 . . . . 15.0 110.209 178.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -81.17 129.92 34.79 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.367 -0.605 . . . . 15.0 109.367 178.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.633 ' CG1' HD11 ' A' ' 7' ' ' ILE . 42.4 t -120.11 132.23 70.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.241 0.543 . . . . 15.0 111.192 -173.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -139.18 135.22 33.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.391 -0.822 . . . . 15.0 109.731 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.432 ' HB3' HD12 ' A' ' 7' ' ' ILE . 32.0 p90 -114.8 138.78 50.35 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.775 0.322 . . . . 15.0 110.553 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.0 tp -114.85 113.43 44.49 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 118.756 -0.64 . . . . 15.0 110.896 -173.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -49.88 135.07 35.89 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.158 1.238 . . . . 15.0 111.886 172.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.82 HD13 ' ND2' ' A' ' 62' ' ' ASN . 58.1 mt -66.79 -11.13 53.98 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.216 0.821 . . . . 15.0 113.216 -174.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -77.31 -9.4 58.8 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.169 0.803 . . . . 15.0 113.169 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -65.28 148.02 98.22 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 118.502 0.592 . . . . 15.0 110.544 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.34 148.74 43.93 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.565 1.51 . . . . 15.0 113.58 -174.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.93 152.52 3.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.465 -0.789 . . . . 15.0 111.228 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.2 -38.15 3.21 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.497 -0.641 . . . . 15.0 111.497 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -64.16 -36.38 83.86 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 120.426 -0.51 . . . . 15.0 111.12 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.547 HD21 ' CD1' ' A' ' 63' ' ' LEU . 24.5 tp -58.66 -45.97 88.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.896 0.379 . . . . 15.0 110.196 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.497 HD22 ' CG ' ' A' ' 70' ' ' ASP . 16.8 tp -63.49 -45.57 90.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 15.0 110.902 -177.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.78 99.25 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.784 -0.367 . . . . 15.0 110.859 -177.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -60.99 -44.14 97.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.428 -0.351 . . . . 15.0 110.511 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 40' ' ' LEU . 67.3 t -61.5 -46.1 97.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.935 -0.306 . . . . 15.0 110.252 -177.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 70.7 ttp85 -68.53 -48.07 65.28 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.984 0.364 . . . . 15.0 111.984 -176.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.09 -44.47 84.28 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.1 -0.24 . . . . 15.0 111.512 -173.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -81.99 -10.01 59.38 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.249 0.833 . . . . 15.0 113.249 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 55.86 55.82 6.64 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.607 0.718 . . . . 15.0 110.336 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.484 HD12 HG22 ' A' ' 44' ' ' VAL . 95.5 mt -63.53 146.09 54.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.601 -0.727 . . . . 15.0 111.426 -174.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -87.72 -39.76 14.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.982 -1.008 . . . . 15.0 110.685 178.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.52 166.39 30.7 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.045 -1.074 . . . . 15.0 113.639 -174.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.1 mt -125.91 142.08 51.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.507 -0.846 . . . . 15.0 109.612 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.519 HG22 ' CD1' ' A' ' 80' ' ' PHE . 48.0 t -121.47 131.37 73.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.282 -0.266 . . . . 15.0 110.282 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.511 HG12 ' HB2' ' A' ' 8' ' ' MET . 6.5 m -125.69 130.44 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.009 0.433 . . . . 15.0 110.216 172.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.7 p -92.81 -10.86 35.3 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.915 0.709 . . . . 15.0 112.915 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 82.8 p -152.52 157.6 41.33 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 121.271 0.558 . . . . 15.0 111.561 -176.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.78 -38.92 85.94 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.962 -0.855 . . . . 15.0 110.962 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -58.97 -43.93 91.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.777 0.322 . . . . 15.0 110.416 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.3 -44.84 97.09 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.784 -0.926 . . . . 15.0 110.784 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.587 HD13 HD21 ' A' ' 79' ' ' LEU . 32.9 tp -57.7 -44.61 85.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.095 0.474 . . . . 15.0 110.531 -178.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.26 -42.23 98.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.063 -0.517 . . . . 15.0 110.64 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.82 ' ND2' HD13 ' A' ' 33' ' ' LEU . 69.4 m-80 -58.99 -39.91 83.23 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.834 -0.346 . . . . 15.0 110.628 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.547 ' CD1' HD21 ' A' ' 40' ' ' LEU . 12.5 tp -58.23 -44.83 88.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.181 0.515 . . . . 15.0 110.109 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -61.6 -47.22 86.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.697 -0.683 . . . . 15.0 110.787 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -61.91 -43.86 97.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 15.0 111.185 -176.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.3 mt -66.3 -34.98 79.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.351 -0.386 . . . . 15.0 111.387 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.674 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.0 -39.17 81.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.126 0.489 . . . . 15.0 110.581 177.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.16 -143.3 0.6 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 109.609 -0.515 . . . . 15.0 109.609 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.44 -19.09 44.88 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.391 0.996 . . . . 15.0 112.608 -175.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.497 ' CG ' HD22 ' A' ' 41' ' ' LEU . 22.3 m-20 -91.91 10.44 28.78 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.297 0.851 . . . . 15.0 113.297 -175.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -47.81 -46.9 63.15 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-O 118.666 -0.683 . . . . 15.0 112.494 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -44.68 -40.43 14.15 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 121.483 1.455 . . . . 15.0 113.283 177.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -77.0 -48.73 17.17 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.691 -0.404 . . . . 15.0 110.803 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.674 HD12 ' HB1' ' A' ' 67' ' ' ALA . 91.5 mt -59.63 -39.73 80.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 15.0 110.83 -177.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.2 -16.44 34.08 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 116.334 -0.394 . . . . 15.0 113.124 -177.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -64.73 -30.3 71.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 117.365 0.582 . . . . 15.0 111.959 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 27.5 mt -76.45 150.59 82.51 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 120.903 -0.319 . . . . 15.0 111.312 -173.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.4 129.54 28.59 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.63 1.554 . . . . 15.0 112.473 176.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.587 HD21 HD13 ' A' ' 60' ' ' LEU . 24.0 tp -107.78 126.26 52.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.448 -0.342 . . . . 15.0 110.605 175.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.519 ' CD1' HG22 ' A' ' 53' ' ' VAL . 78.7 m-85 -90.97 126.09 35.97 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.721 -0.474 . . . . 15.0 109.721 176.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.676 HG21 ' HB2' ' A' ' 87' ' ' ALA . 29.0 m -117.47 147.15 40.08 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 110.079 -0.341 . . . . 15.0 110.079 176.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.15 -23.25 7.81 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.639 1.56 . . . . 15.0 113.598 -174.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.417 ' OG ' HG23 ' A' ' 86' ' ' VAL . 24.5 p -143.51 158.15 57.8 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 120.737 -0.385 . . . . 15.0 111.33 -172.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.29 -43.95 53.03 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.238 1.292 . . . . 15.0 111.792 176.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -58.11 -47.37 83.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.779 0.323 . . . . 15.0 110.931 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.417 HG23 ' OG ' ' A' ' 83' ' ' SER . 60.8 t -59.89 -40.24 82.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.75 -0.38 . . . . 15.0 110.036 178.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.676 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.36 -42.46 82.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.962 0.41 . . . . 15.0 110.422 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -61.09 -41.87 97.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.144 -0.48 . . . . 15.0 110.506 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 87.1 mtp -59.29 -43.88 92.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.227 0.537 . . . . 15.0 110.353 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.44 94.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.963 -0.562 . . . . 15.0 110.801 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -61.31 -44.36 97.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.298 -0.41 . . . . 15.0 110.629 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.17 -36.1 76.84 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.857 -0.337 . . . . 15.0 111.234 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.8 mt -64.3 -25.69 68.16 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.942 0.349 . . . . 15.0 111.942 176.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.43 13.25 15.26 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 119.314 -0.714 . . . . 15.0 113.095 -176.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.88 121.95 11.75 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 118.566 1.183 . . . . 15.0 109.888 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -69.5 -35.09 75.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.668 -0.696 . . . . 15.0 111.328 -171.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.1 tpt85 -131.79 114.5 14.79 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.957 0.408 . . . . 15.0 110.082 177.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.1 t -110.85 130.25 64.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.045 0.45 . . . . 15.0 109.851 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 85.2 mt -119.61 124.95 73.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.818 -0.628 . . . . 15.0 110.053 -176.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -95.33 117.32 30.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.435 -0.348 . . . . 15.0 110.302 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.9 p -97.05 -1.55 45.15 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.182 0.808 . . . . 15.0 113.182 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 46.9 tpt85 -55.67 -39.7 71.31 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.184 0.447 . . . . 15.0 110.665 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.01 -35.17 5.41 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.53 -0.628 . . . . 15.0 111.53 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.18 140.2 52.49 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.879 0.371 . . . . 15.0 110.651 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.9 p -86.12 163.75 17.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.065 -0.516 . . . . 15.0 110.508 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.71 -54.39 23.63 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 113.0 0.741 . . . . 15.0 113.0 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.29 -35.04 99.11 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 CA-C-N 120.163 1.094 . . . . 15.0 111.63 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.07 -43.4 95.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.091 0.472 . . . . 15.0 110.012 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 76.1 mt -59.36 -40.74 87.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 15.0 110.406 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 33.8 tp -57.2 -43.82 83.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.33 0.586 . . . . 15.0 110.229 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.52 -41.8 95.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.683 -0.69 . . . . 15.0 110.487 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.28 -40.38 90.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 15.0 110.761 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.0 mt -57.81 -51.8 68.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.267 0.556 . . . . 15.0 110.383 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.6 p -63.79 -40.06 95.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.59 -0.732 . . . . 15.0 111.324 -175.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.1 m -62.38 -44.31 96.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.676 0.274 . . . . 15.0 111.426 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.4 -38.25 88.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.432 -0.349 . . . . 15.0 111.156 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.85 -34.51 71.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.451 -0.34 . . . . 15.0 111.255 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 85.1 mt -56.9 -39.89 75.26 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.0 -0.28 . . . . 15.0 110.677 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -63.75 141.23 58.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.455 -0.339 . . . . 15.0 110.343 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -119.62 128.47 53.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.41 -0.359 . . . . 15.0 110.443 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -58.79 -41.46 86.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.169 -0.469 . . . . 15.0 110.636 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -59.27 -38.55 80.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 15.0 111.078 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -55.45 -39.83 70.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.449 -0.341 . . . . 15.0 111.179 -177.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -108.86 137.09 47.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.917 0.389 . . . . 15.0 110.721 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.03 -0.986 . . . . 15.0 110.578 179.933 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.341 -0.614 . . . . 15.0 109.341 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -126.95 80.97 70.54 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.097 -0.501 . . . . 15.0 110.34 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -49.87 152.31 7.3 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 121.387 1.391 . . . . 15.0 111.776 -176.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -117.77 137.88 52.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.354 -0.385 . . . . 15.0 110.385 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.613 HG21 HD13 ' A' ' 21' ' ' LEU . 15.7 m -134.77 146.04 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.501 0.667 . . . . 15.0 111.826 177.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.571 ' HB2' HD13 ' A' ' 49' ' ' LEU . 13.6 tp -104.37 135.55 45.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.048 -0.978 . . . . 15.0 110.318 178.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.486 HD11 ' CG1' ' A' ' 28' ' ' VAL . 55.0 mt -103.59 135.02 43.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.306 -0.407 . . . . 15.0 110.439 -177.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.577 ' CE ' HD21 ' A' ' 33' ' ' LEU . 88.3 mtp -100.15 134.06 43.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.731 -0.668 . . . . 15.0 110.332 174.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 76.3 ttt-85 -58.24 141.69 50.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.376 -0.375 . . . . 15.0 110.624 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.0 175.14 34.57 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.045 -0.822 . . . . 15.0 111.045 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -54.98 -33.86 62.87 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.549 0.203 . . . . 15.0 111.549 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.9 -179.69 4.76 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.954 -0.859 . . . . 15.0 110.954 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.02 114.31 3.93 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.224 -0.75 . . . . 15.0 111.224 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -55.85 -47.23 77.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.323 0.583 . . . . 15.0 110.339 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.95 -41.38 97.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.739 -0.664 . . . . 15.0 110.839 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -56.51 -55.83 28.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.766 0.317 . . . . 15.0 111.18 -175.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.461 HD12 ' H ' ' A' ' 17' ' ' LEU . 6.1 mp -59.99 -42.38 94.1 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.665 -0.414 . . . . 15.0 111.064 -176.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.63 -45.74 91.07 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.643 -0.423 . . . . 15.0 111.447 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -60.29 -40.99 92.4 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.769 -0.372 . . . . 15.0 110.527 -178.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -58.52 -51.51 69.59 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.589 -0.445 . . . . 15.0 111.126 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.613 HD13 HG21 ' A' ' 5' ' ' VAL . 76.8 mt -63.99 -38.2 90.22 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.436 -0.505 . . . . 15.0 111.262 -176.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -65.28 -40.45 93.9 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 120.521 -0.472 . . . . 15.0 111.254 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.03 -30.57 70.44 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.972 -0.632 . . . . 15.0 112.095 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -88.33 10.03 21.25 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.571 0.952 . . . . 15.0 113.571 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.54 16.41 60.28 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 121.286 -0.483 . . . . 15.0 113.265 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.7 t -101.08 138.85 23.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 117.824 0.812 . . . . 15.0 109.877 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -79.12 133.37 36.76 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.494 -0.558 . . . . 15.0 109.494 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.486 ' CG1' HD11 ' A' ' 7' ' ' ILE . 45.1 t -118.37 130.37 73.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.173 0.511 . . . . 15.0 111.117 -173.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.424 ' O ' HD12 ' A' ' 6' ' ' LEU . 22.8 t70 -135.35 124.74 24.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.419 -0.809 . . . . 15.0 109.442 170.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.416 ' HB3' HD12 ' A' ' 7' ' ' ILE . 15.2 p90 -112.79 134.16 54.44 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.857 0.361 . . . . 15.0 110.833 -177.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.1 tp -114.3 139.44 23.83 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.042 -0.527 . . . . 15.0 109.937 -176.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -72.08 136.22 26.67 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 121.409 1.406 . . . . 15.0 111.822 171.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.577 HD21 ' CE ' ' A' ' 8' ' ' MET . 19.8 mt -57.89 -12.73 3.42 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.368 0.877 . . . . 15.0 113.368 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -77.22 -5.05 47.79 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.467 0.914 . . . . 15.0 113.467 -175.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -68.06 145.59 97.76 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-N 118.559 0.618 . . . . 15.0 110.784 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.96 159.09 30.87 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.685 1.59 . . . . 15.0 113.479 -176.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.26 151.52 2.83 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.727 -0.669 . . . . 15.0 111.62 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.14 -36.98 3.58 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.397 -0.681 . . . . 15.0 111.397 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -60.02 -37.05 78.62 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 120.613 -0.435 . . . . 15.0 110.972 -178.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.567 ' O ' HG23 ' A' ' 44' ' ' VAL . 26.3 tp -58.5 -47.13 85.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.022 0.439 . . . . 15.0 110.253 -177.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.62 HD22 ' OD2' ' A' ' 70' ' ' ASP . 9.1 tp -61.87 -44.68 96.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 15.0 110.745 -177.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.18 97.22 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.682 -0.407 . . . . 15.0 111.018 -176.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -60.96 -41.53 96.51 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.815 -0.354 . . . . 15.0 110.672 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 40' ' ' LEU . 99.5 t -60.53 -47.31 93.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.809 -0.356 . . . . 15.0 110.262 -176.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -72.27 -47.65 48.53 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.461 0.541 . . . . 15.0 112.461 -175.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.69 -44.31 82.06 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 121.051 -0.26 . . . . 15.0 111.557 -174.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -81.78 -10.03 59.46 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.105 0.78 . . . . 15.0 113.105 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 56.64 55.87 6.02 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 121.593 0.711 . . . . 15.0 110.164 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.571 HD13 ' HB2' ' A' ' 6' ' ' LEU . 94.9 mt -77.9 142.53 38.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.667 -0.697 . . . . 15.0 111.364 -176.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.551 ' O ' HD22 ' A' ' 77' ' ' LEU . 9.3 m120 -90.76 -40.65 11.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.55 -0.75 . . . . 15.0 110.64 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.66 167.01 28.72 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 119.908 -1.139 . . . . 15.0 113.396 -171.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 71.4 mt -126.96 146.91 50.15 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.889 -0.656 . . . . 15.0 110.312 -178.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.538 HG22 ' CD1' ' A' ' 80' ' ' PHE . 47.5 t -122.77 131.48 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.544 0.211 . . . . 15.0 110.495 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 m -124.85 146.99 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.125 0.488 . . . . 15.0 110.735 173.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 t -100.81 -15.98 17.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.535 -0.757 . . . . 15.0 112.835 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.0 p -156.31 161.28 40.21 Favored 'General case' 0 C--N 1.339 0.11 0 CA-C-O 121.437 0.637 . . . . 15.0 111.901 -175.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.18 -37.67 73.63 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.056 -0.818 . . . . 15.0 111.056 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -59.25 -44.53 92.37 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.932 -0.307 . . . . 15.0 110.709 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.29 -43.68 98.29 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.611 -0.996 . . . . 15.0 110.611 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.546 HD21 ' HA ' ' A' ' 90' ' ' ALA . 14.3 tp -57.05 -45.82 82.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.153 0.502 . . . . 15.0 110.596 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.35 -43.74 98.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.117 -0.492 . . . . 15.0 110.569 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.573 ' CB ' HD22 ' A' ' 33' ' ' LEU . 80.0 m-20 -59.77 -38.91 83.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.214 -0.448 . . . . 15.0 110.647 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.495 HD13 ' SD ' ' A' ' 8' ' ' MET . 14.4 tp -57.06 -44.32 82.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.124 0.488 . . . . 15.0 110.161 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -60.24 -47.61 85.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.809 -0.632 . . . . 15.0 110.459 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -61.85 -43.15 99.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.945 -0.571 . . . . 15.0 111.137 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.84 -35.3 79.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.443 -0.344 . . . . 15.0 111.49 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.68 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.44 -38.51 80.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.955 0.407 . . . . 15.0 110.75 178.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.28 -144.09 0.57 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 109.541 -0.54 . . . . 15.0 109.541 174.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.87 -18.56 45.43 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.357 0.981 . . . . 15.0 112.64 -174.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.62 ' OD2' HD22 ' A' ' 41' ' ' LEU . 77.7 m-20 -91.95 10.45 28.84 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 113.327 0.862 . . . . 15.0 113.327 -175.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -47.74 -47.32 62.01 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 118.69 -0.672 . . . . 15.0 112.586 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -44.81 -40.11 14.35 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.458 1.439 . . . . 15.0 113.233 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -76.94 -48.77 17.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.023 0.439 . . . . 15.0 110.725 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.68 HD12 ' HB1' ' A' ' 67' ' ' ALA . 92.2 mt -59.25 -40.59 81.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 15.0 110.839 -177.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.41 -14.47 34.46 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-N 116.269 -0.423 . . . . 15.0 113.23 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -66.18 -29.8 70.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.415 0.607 . . . . 15.0 112.076 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.551 HD22 ' O ' ' A' ' 50' ' ' ASN . 21.9 mt -74.72 145.11 81.3 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-O 119.252 -0.404 . . . . 15.0 110.953 -174.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -60.0 129.54 30.78 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.446 1.431 . . . . 15.0 111.756 174.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.1 tp -106.34 128.16 53.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.609 -0.269 . . . . 15.0 110.852 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.538 ' CD1' HG22 ' A' ' 53' ' ' VAL . 80.8 m-85 -91.01 126.12 36.0 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.618 -0.512 . . . . 15.0 109.618 176.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.667 HG21 ' HB2' ' A' ' 87' ' ' ALA . 28.7 m -119.43 147.52 43.54 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 110.085 -0.339 . . . . 15.0 110.085 176.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.23 -23.23 7.73 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.471 1.447 . . . . 15.0 113.636 -174.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.9 p -143.36 161.11 49.11 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 120.62 -0.432 . . . . 15.0 111.563 -172.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -54.91 -44.11 52.88 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.2 1.267 . . . . 15.0 111.889 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -58.82 -46.75 86.9 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.895 -0.322 . . . . 15.0 110.973 -177.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.4 t -60.13 -40.3 83.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.737 -0.385 . . . . 15.0 110.066 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.667 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.61 -42.31 83.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.0 0.429 . . . . 15.0 110.469 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.92 -40.47 93.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.176 -0.466 . . . . 15.0 110.592 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.1 mmm -58.26 -44.99 88.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.447 0.641 . . . . 15.0 110.159 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.546 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.76 -40.64 95.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.642 -0.708 . . . . 15.0 110.825 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -61.64 -44.43 96.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.385 -0.37 . . . . 15.0 110.755 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -60.29 -36.19 77.28 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.872 -0.331 . . . . 15.0 111.262 -177.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 77.0 mt -66.0 -23.87 66.66 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.303 0.483 . . . . 15.0 112.303 177.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.69 13.28 16.88 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.399 -0.667 . . . . 15.0 113.177 -176.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.81 122.03 11.91 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.481 1.14 . . . . 15.0 109.905 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -67.62 -36.54 81.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.541 -0.754 . . . . 15.0 111.059 -171.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -131.82 117.88 19.13 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.923 0.392 . . . . 15.0 110.62 177.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.2 t -114.65 129.94 69.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.008 0.432 . . . . 15.0 109.952 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 90.5 mt -119.27 122.19 68.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.87 -0.604 . . . . 15.0 110.125 -177.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -92.53 117.7 30.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.483 -0.326 . . . . 15.0 110.166 175.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 104' ' ' ALA . 31.8 p -95.69 -3.52 45.9 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.232 0.827 . . . . 15.0 113.232 -178.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -55.88 -40.04 72.4 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.287 0.494 . . . . 15.0 110.699 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -95.59 -35.01 5.8 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 111.463 -0.655 . . . . 15.0 111.463 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.416 ' HB3' ' HA ' ' A' ' 101' ' ' CYS . . . -73.29 143.77 46.87 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.791 0.329 . . . . 15.0 110.466 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 65.1 m -89.77 160.75 16.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.228 -0.442 . . . . 15.0 110.567 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.67 -54.24 24.56 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.973 0.731 . . . . 15.0 112.973 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.62 -34.54 98.26 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 CA-C-N 120.318 1.149 . . . . 15.0 111.524 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.03 -42.66 94.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.065 0.46 . . . . 15.0 109.985 176.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 78.3 mt -59.04 -39.98 83.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 15.0 110.489 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 33.7 tp -56.85 -44.85 82.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.547 0.689 . . . . 15.0 110.144 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.4 -40.4 90.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.518 -0.765 . . . . 15.0 110.568 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.2 -42.49 95.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.319 -0.4 . . . . 15.0 110.782 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.1 mt -58.05 -49.16 77.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.031 0.443 . . . . 15.0 110.421 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.4 p -62.51 -40.71 97.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.897 -0.592 . . . . 15.0 111.274 -175.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.9 p -65.99 -39.88 90.72 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.969 -0.292 . . . . 15.0 111.349 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.25 -39.01 93.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.666 0.27 . . . . 15.0 111.117 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.93 -34.89 72.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.433 -0.349 . . . . 15.0 111.252 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 82.3 mt -56.8 -39.71 74.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.729 0.3 . . . . 15.0 110.731 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.47 -35.03 79.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.366 -0.379 . . . . 15.0 111.317 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -56.0 -39.66 72.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.625 0.25 . . . . 15.0 110.92 -178.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -110.56 131.64 54.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.858 0.361 . . . . 15.0 110.712 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -116.01 130.54 56.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.168 -0.469 . . . . 15.0 110.534 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -60.88 -42.78 98.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 15.0 110.539 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -55.52 -39.8 70.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 15.0 110.992 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 . . . . . 0 C--O 1.221 -0.411 0 CA-C-O 117.925 -1.036 . . . . 15.0 110.473 179.922 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.3 mmm . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.131 -0.692 . . . . 15.0 109.131 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -127.38 79.49 73.19 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 116.146 -0.479 . . . . 15.0 110.285 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.94 155.06 8.98 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.347 1.364 . . . . 15.0 111.734 -177.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.464 ' HB2' HD23 ' A' ' 49' ' ' LEU . 55.5 mttm -114.26 140.74 48.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.412 -0.358 . . . . 15.0 110.837 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.559 HG21 HD13 ' A' ' 21' ' ' LEU . 10.6 m -136.55 144.94 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.598 0.714 . . . . 15.0 111.568 176.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.8 tp -105.69 134.18 49.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.943 -1.026 . . . . 15.0 110.518 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.613 HD11 ' CG1' ' A' ' 28' ' ' VAL . 44.4 mt -100.79 135.12 38.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.315 -0.402 . . . . 15.0 110.291 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 82.4 mtp -101.75 132.62 47.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.1 -0.5 . . . . 15.0 110.098 171.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -57.74 147.1 28.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.217 0.532 . . . . 15.0 111.564 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.49 175.19 40.55 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.615 -0.994 . . . . 15.0 110.615 -178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -51.94 -32.61 33.79 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.748 0.277 . . . . 15.0 111.748 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.68 170.29 18.24 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.855 -0.898 . . . . 15.0 110.855 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.95 125.18 7.07 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.35 -0.7 . . . . 15.0 111.35 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -57.09 -46.46 82.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.961 0.41 . . . . 15.0 110.482 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -64.05 -40.83 97.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.974 -0.557 . . . . 15.0 111.318 -175.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -61.8 -55.98 24.33 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.775 -0.37 . . . . 15.0 111.427 -176.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.683 HD21 HG11 ' A' ' 53' ' ' VAL . 28.5 tp -61.07 -45.4 94.89 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.687 -0.405 . . . . 15.0 111.192 -175.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.2 -39.72 95.42 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.669 -0.412 . . . . 15.0 110.82 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -60.75 -41.6 95.72 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.905 -0.318 . . . . 15.0 110.576 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.445 ' HD3' ' HB2' ' A' ' 106' ' ' ALA . 38.2 ttm180 -59.65 -51.76 68.41 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 120.686 -0.406 . . . . 15.0 111.241 -178.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.559 HD13 HG21 ' A' ' 5' ' ' VAL . 88.2 mt -63.86 -36.99 85.74 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.478 -0.489 . . . . 15.0 111.062 -178.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -63.54 -42.77 98.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.625 0.25 . . . . 15.0 111.088 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.21 -30.56 67.61 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.119 -0.563 . . . . 15.0 111.987 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -88.04 9.96 20.7 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.559 0.948 . . . . 15.0 113.559 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.26 15.04 56.52 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 121.22 -0.514 . . . . 15.0 113.494 173.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.7 t -101.06 136.18 33.9 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-N 117.972 0.886 . . . . 15.0 110.072 177.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -77.67 129.63 35.8 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.9 -0.778 . . . . 15.0 108.9 177.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.613 ' CG1' HD11 ' A' ' 7' ' ' ILE . 22.7 t -123.07 134.13 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.207 0.527 . . . . 15.0 111.468 -171.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -139.4 139.81 37.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.363 -0.835 . . . . 15.0 109.714 172.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.425 ' HB3' HD12 ' A' ' 7' ' ' ILE . 27.8 p90 -114.13 136.08 53.32 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.883 0.373 . . . . 15.0 110.891 -178.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.8 tp -113.81 121.18 37.6 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-O 118.705 -0.664 . . . . 15.0 110.314 -175.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.25 135.03 67.83 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 CA-C-N 120.337 1.156 . . . . 15.0 112.223 173.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.57 HD13 ' ND2' ' A' ' 62' ' ' ASN . 74.9 mt -62.43 -16.72 56.67 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.973 0.731 . . . . 15.0 112.973 -178.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -77.18 -5.06 47.72 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.43 0.9 . . . . 15.0 113.43 -175.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -69.84 148.92 96.59 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 118.545 0.611 . . . . 15.0 110.837 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.43 149.69 50.74 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.573 1.515 . . . . 15.0 113.864 -173.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.23 152.58 4.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.258 -0.883 . . . . 15.0 111.265 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.62 -38.1 3.22 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 115.837 -0.619 . . . . 15.0 111.636 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -63.71 -36.61 84.42 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 120.392 -0.523 . . . . 15.0 111.16 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.571 ' O ' HG23 ' A' ' 44' ' ' VAL . 24.9 tp -59.1 -47.01 86.83 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.86 -0.336 . . . . 15.0 110.174 -178.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.488 HD13 HD11 ' A' ' 74' ' ' ILE . 17.6 tp -63.35 -45.76 89.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.311 -0.404 . . . . 15.0 110.917 -176.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.6 -44.22 97.41 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.61 -0.436 . . . . 15.0 110.836 -176.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -62.24 -41.97 98.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.486 -0.325 . . . . 15.0 110.754 -178.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 40' ' ' LEU . 94.0 t -60.61 -45.18 97.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.946 -0.39 . . . . 15.0 109.946 -178.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -67.83 -47.94 67.61 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.325 0.391 . . . . 15.0 111.687 -177.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.6 -44.48 86.44 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 121.042 -0.263 . . . . 15.0 111.685 -173.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -83.04 -10.01 58.96 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.323 0.86 . . . . 15.0 113.323 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 55.79 55.84 6.69 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.68 0.752 . . . . 15.0 110.333 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.506 HD12 HG22 ' A' ' 44' ' ' VAL . 96.0 mt -64.11 144.95 56.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.62 -0.718 . . . . 15.0 111.36 -175.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -89.69 -40.52 12.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.067 -0.969 . . . . 15.0 110.694 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.97 161.14 28.52 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.045 -1.074 . . . . 15.0 113.553 -174.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.2 mt -126.0 140.94 52.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.428 -0.886 . . . . 15.0 109.568 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.683 HG11 HD21 ' A' ' 17' ' ' LEU . 41.3 t -120.69 130.06 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.696 0.284 . . . . 15.0 110.804 -178.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 m -123.56 138.81 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.007 0.432 . . . . 15.0 110.289 173.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.6 m -89.96 -23.89 21.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.729 -0.669 . . . . 15.0 112.413 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.9 p -154.15 165.51 36.01 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.447 0.641 . . . . 15.0 111.964 -173.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.99 -37.76 72.3 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.148 -0.781 . . . . 15.0 111.148 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -57.68 -46.12 84.7 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.736 -0.385 . . . . 15.0 110.632 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.59 -45.31 96.56 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.448 -1.061 . . . . 15.0 110.448 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.578 HD13 HD21 ' A' ' 79' ' ' LEU . 26.0 tp -56.5 -42.66 78.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.137 0.494 . . . . 15.0 110.762 -177.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.82 -43.28 99.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.504 . . . . 15.0 110.584 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.57 ' ND2' HD13 ' A' ' 33' ' ' LEU . 70.5 m-80 -58.05 -39.91 79.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.379 -0.373 . . . . 15.0 110.559 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.441 ' CD1' HD21 ' A' ' 40' ' ' LEU . 12.5 tp -57.8 -45.47 86.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.164 0.507 . . . . 15.0 110.167 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -61.51 -47.68 84.5 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.635 -0.711 . . . . 15.0 110.638 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -61.72 -43.1 99.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.039 -0.528 . . . . 15.0 111.116 -176.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 94.2 mt -66.7 -35.53 80.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.325 -0.398 . . . . 15.0 111.453 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.671 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.71 -38.05 80.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.056 0.455 . . . . 15.0 110.781 177.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.4 -143.99 0.56 Allowed 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.527 -0.545 . . . . 15.0 109.527 174.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.67 -19.09 47.19 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.302 0.955 . . . . 15.0 112.652 -174.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -91.81 11.22 25.5 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.285 0.846 . . . . 15.0 113.285 -175.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -47.68 -46.7 61.45 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-O 118.595 -0.716 . . . . 15.0 112.606 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -44.76 -41.27 14.88 Favored 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 121.439 1.426 . . . . 15.0 113.166 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -76.88 -48.81 17.24 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.664 -0.414 . . . . 15.0 110.831 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.671 HD12 ' HB1' ' A' ' 67' ' ' ALA . 92.3 mt -59.88 -39.32 79.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.17 -0.468 . . . . 15.0 110.873 -176.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.28 -15.96 32.77 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 119.853 -0.415 . . . . 15.0 113.092 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.0 mtm105 -66.04 -30.29 70.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.42 0.61 . . . . 15.0 112.011 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.8 mt -73.6 150.59 88.99 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 121.171 -0.212 . . . . 15.0 111.463 -173.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.49 126.33 17.41 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 121.684 1.589 . . . . 15.0 112.322 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.578 HD21 HD13 ' A' ' 60' ' ' LEU . 26.4 tp -105.4 124.69 49.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.332 -0.395 . . . . 15.0 110.552 175.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.412 ' CD1' HG22 ' A' ' 53' ' ' VAL . 79.4 m-85 -90.74 127.41 36.31 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.802 -0.444 . . . . 15.0 109.802 177.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.638 HG21 ' HB2' ' A' ' 87' ' ' ALA . 29.1 m -121.43 145.66 43.08 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 110.118 -0.327 . . . . 15.0 110.118 175.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.18 -22.3 8.54 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.727 1.618 . . . . 15.0 113.64 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.551 ' OG ' HG23 ' A' ' 86' ' ' VAL . 53.3 p -141.54 157.44 65.48 Favored Pre-proline 0 C--N 1.331 -0.233 0 C-N-CA 120.765 -0.374 . . . . 15.0 111.327 -169.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.24 -44.06 50.13 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.273 1.315 . . . . 15.0 112.338 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -61.3 -43.52 98.73 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 120.603 -0.439 . . . . 15.0 111.116 -177.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.551 HG23 ' OG ' ' A' ' 83' ' ' SER . 57.3 t -59.63 -40.92 83.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.657 -0.498 . . . . 15.0 109.657 177.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.638 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.66 -41.74 82.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.901 0.381 . . . . 15.0 110.4 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -60.57 -40.41 91.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.246 -0.434 . . . . 15.0 110.597 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 96.9 mmm -58.3 -45.09 88.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.437 0.637 . . . . 15.0 110.132 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.502 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.62 -40.57 95.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.709 -0.678 . . . . 15.0 110.783 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -61.75 -44.2 97.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.315 -0.402 . . . . 15.0 110.765 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -60.31 -36.16 77.26 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.912 -0.315 . . . . 15.0 111.326 -177.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.2 mt -65.79 -23.83 66.79 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.199 0.444 . . . . 15.0 112.199 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.45 13.25 17.49 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-O 119.369 -0.684 . . . . 15.0 113.127 -176.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.87 122.59 13.28 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 118.49 1.145 . . . . 15.0 109.97 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -70.16 -36.17 74.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.667 -0.697 . . . . 15.0 111.188 -172.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 31.0 ttm105 -130.35 111.63 12.53 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.114 0.483 . . . . 15.0 110.382 178.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.1 130.87 63.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.989 -0.551 . . . . 15.0 109.817 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 85.8 mt -119.78 121.87 67.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.97 -0.559 . . . . 15.0 110.061 -176.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -95.75 116.51 28.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.39 -0.368 . . . . 15.0 110.24 176.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 28.3 p -97.09 1.29 49.85 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 113.23 0.826 . . . . 15.0 113.23 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -55.91 -39.89 72.27 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.26 0.482 . . . . 15.0 110.737 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -96.66 -35.17 5.5 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.523 -0.631 . . . . 15.0 111.523 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.6 143.52 53.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.864 0.364 . . . . 15.0 110.604 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.9 m -89.84 161.36 16.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 15.0 110.504 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.445 ' HB2' ' HD3' ' A' ' 20' ' ' ARG . . . -47.73 -54.19 25.22 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-O 118.522 -0.751 . . . . 15.0 112.97 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -56.52 -36.13 97.43 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 CA-C-N 120.559 1.235 . . . . 15.0 111.318 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.31 -42.67 96.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.045 0.45 . . . . 15.0 110.18 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.1 mt -59.28 -41.05 87.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 15.0 110.492 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.7 tp -57.39 -44.02 84.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.339 0.59 . . . . 15.0 110.14 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.63 93.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.617 -0.72 . . . . 15.0 110.542 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.67 89.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.389 -0.368 . . . . 15.0 110.763 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.2 mt -57.86 -52.5 65.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.391 0.615 . . . . 15.0 110.357 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.2 p -63.83 -40.28 96.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.536 -0.756 . . . . 15.0 111.354 -175.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.7 t -62.14 -45.03 95.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.686 0.279 . . . . 15.0 111.422 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.43 -39.4 90.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.509 -0.314 . . . . 15.0 110.99 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.15 -37.21 76.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.444 -0.344 . . . . 15.0 111.048 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 92.7 mt -60.93 -37.6 82.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.559 -0.291 . . . . 15.0 111.22 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.58 -39.21 79.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.733 0.301 . . . . 15.0 110.916 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -56.82 -36.45 69.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.383 -0.371 . . . . 15.0 111.307 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -55.58 -40.27 71.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.551 -0.295 . . . . 15.0 111.01 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -109.78 127.68 54.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.866 0.365 . . . . 15.0 110.634 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -57.92 -40.29 80.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.045 -0.525 . . . . 15.0 110.875 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -115.92 139.83 49.84 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.223 -0.444 . . . . 15.0 110.572 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 . . . . . 0 C--O 1.219 -0.528 0 CA-C-O 118.031 -0.985 . . . . 15.0 110.606 179.811 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.6 mtm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.471 -0.566 . . . . 15.0 109.471 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.9 p30 -125.84 76.49 70.8 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.133 -0.485 . . . . 15.0 110.307 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -54.41 155.03 17.47 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 121.434 1.422 . . . . 15.0 112.004 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -113.75 138.73 49.84 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.222 -0.445 . . . . 15.0 110.751 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.472 HG21 HD13 ' A' ' 21' ' ' LEU . 17.5 m -134.81 145.8 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 121.53 0.681 . . . . 15.0 111.943 177.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.8 tp -104.7 137.87 41.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.029 -0.987 . . . . 15.0 110.214 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.627 HD11 ' CG1' ' A' ' 28' ' ' VAL . 53.2 mt -103.07 135.1 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.082 0.467 . . . . 15.0 111.146 -177.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.475 ' HB2' HG12 ' A' ' 54' ' ' VAL . 97.9 mmm -95.5 125.91 40.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.106 -0.952 . . . . 15.0 108.905 169.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.0 mtm180 -59.59 147.67 36.31 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.487 -0.485 . . . . 15.0 110.689 -176.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.28 175.18 34.76 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.776 -0.929 . . . . 15.0 110.776 -178.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -51.59 -32.19 27.75 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.789 0.292 . . . . 15.0 111.789 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.81 173.76 16.78 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.855 -0.898 . . . . 15.0 110.855 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.99 126.38 7.66 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.351 -0.699 . . . . 15.0 111.351 -178.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -56.64 -47.43 79.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.193 0.52 . . . . 15.0 110.417 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.72 -40.99 98.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.642 -0.708 . . . . 15.0 111.202 -176.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -61.1 -55.99 26.12 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.722 -0.391 . . . . 15.0 111.393 -175.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.9 mt -62.19 -45.06 95.07 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.757 -0.377 . . . . 15.0 111.372 -175.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.44 -41.29 98.65 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.699 -0.4 . . . . 15.0 110.904 -177.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -59.87 -41.27 91.13 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.978 -0.289 . . . . 15.0 110.388 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.525 ' HE ' ' HB2' ' A' ' 106' ' ' ALA . 52.2 ttt85 -60.19 -51.64 68.7 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 120.764 -0.374 . . . . 15.0 111.305 -177.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.472 HD13 HG21 ' A' ' 5' ' ' VAL . 86.9 mt -62.72 -36.72 83.92 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.374 -0.53 . . . . 15.0 110.94 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 46.0 tpt85 -61.36 -41.46 97.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.684 0.278 . . . . 15.0 110.399 177.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.83 -30.57 66.35 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.2 -0.524 . . . . 15.0 111.993 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -88.02 9.91 20.8 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.46 0.911 . . . . 15.0 113.46 178.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.1 18.71 58.88 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 121.314 -0.47 . . . . 15.0 113.054 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.1 t -101.06 138.75 24.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 117.77 0.785 . . . . 15.0 109.949 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -81.6 129.63 34.76 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.164 -0.68 . . . . 15.0 109.164 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.627 ' CG1' HD11 ' A' ' 7' ' ' ILE . 28.4 t -122.66 134.39 65.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.267 0.556 . . . . 15.0 111.418 -172.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -139.61 138.53 36.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.14 -0.936 . . . . 15.0 109.404 171.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.502 ' HB3' HD12 ' A' ' 7' ' ' ILE . 30.2 p90 -115.5 140.87 48.76 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.832 0.348 . . . . 15.0 110.833 -178.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 33.9 tp -112.67 129.6 24.26 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-O 118.523 -0.751 . . . . 15.0 109.813 -175.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -65.73 134.98 39.85 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 CA-C-N 120.418 1.185 . . . . 15.0 111.38 174.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.76 HD13 ' ND2' ' A' ' 62' ' ' ASN . 57.8 mt -65.83 -9.19 26.6 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.294 0.85 . . . . 15.0 113.294 -175.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -77.29 -11.33 59.82 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.12 0.785 . . . . 15.0 113.12 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -63.15 148.5 92.8 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 118.416 0.553 . . . . 15.0 110.434 -176.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.89 157.5 31.09 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.523 1.482 . . . . 15.0 113.14 -177.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.44 151.25 5.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.84 -0.618 . . . . 15.0 111.177 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.91 -37.02 3.63 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.354 -0.698 . . . . 15.0 111.354 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.31 -37.78 81.64 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 120.592 -0.443 . . . . 15.0 110.985 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.557 ' O ' HG23 ' A' ' 44' ' ' VAL . 22.4 tp -58.84 -47.31 85.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.028 0.442 . . . . 15.0 110.239 -177.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.541 HD22 ' OD2' ' A' ' 70' ' ' ASP . 10.8 tp -62.79 -44.58 95.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.106 -0.497 . . . . 15.0 110.951 -176.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.9 -44.72 96.21 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.7 -0.4 . . . . 15.0 110.92 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 -61.61 -40.8 96.12 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.841 -0.344 . . . . 15.0 110.98 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 40' ' ' LEU . 88.8 t -61.78 -45.74 98.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.829 -0.349 . . . . 15.0 110.375 -177.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -67.42 -50.82 57.73 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.312 0.382 . . . . 15.0 111.936 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.41 -44.35 79.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.674 0.273 . . . . 15.0 111.578 -174.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -78.28 -10.05 59.49 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.043 0.757 . . . . 15.0 113.043 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 56.32 55.9 6.23 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.539 0.685 . . . . 15.0 110.074 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.532 HD12 HG22 ' A' ' 44' ' ' VAL . 94.8 mt -69.87 144.73 52.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.846 -0.616 . . . . 15.0 111.381 -176.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -90.9 -40.52 11.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.188 -0.914 . . . . 15.0 110.499 176.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -152.52 168.93 31.64 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 120.129 -1.034 . . . . 15.0 113.216 -174.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 75.8 mt -124.69 141.41 52.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.851 -0.675 . . . . 15.0 110.108 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.55 HG22 ' CD1' ' A' ' 80' ' ' PHE . 48.5 t -120.25 130.42 74.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.022 -0.362 . . . . 15.0 110.022 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.475 HG12 ' HB2' ' A' ' 8' ' ' MET . 11.6 m -122.6 129.39 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 121.047 0.451 . . . . 15.0 110.235 173.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.2 p -95.09 -3.59 47.81 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.931 0.715 . . . . 15.0 112.931 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 81.7 p -154.31 154.71 33.84 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 118.447 0.567 . . . . 15.0 111.545 -177.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.02 -39.83 90.27 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.887 -0.885 . . . . 15.0 110.887 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -59.19 -42.82 91.79 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.916 -0.314 . . . . 15.0 110.511 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.88 -44.97 96.6 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.859 -0.896 . . . . 15.0 110.859 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.585 HD13 HD21 ' A' ' 79' ' ' LEU . 52.3 tp -58.16 -47.82 82.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.091 0.472 . . . . 15.0 110.366 -177.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -61.23 -40.71 95.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.018 -0.537 . . . . 15.0 110.695 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.76 ' ND2' HD13 ' A' ' 33' ' ' LEU . 84.4 m-20 -59.74 -40.29 87.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.441 -0.345 . . . . 15.0 110.629 177.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.402 ' CD1' HD21 ' A' ' 40' ' ' LEU . 15.1 tp -57.81 -44.16 86.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.235 0.541 . . . . 15.0 110.125 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -60.69 -47.14 87.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.791 -0.64 . . . . 15.0 110.623 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.54 -43.17 99.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.137 -0.483 . . . . 15.0 111.184 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.4 mt -67.04 -34.71 78.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.498 -0.319 . . . . 15.0 111.431 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.682 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -58.97 -39.07 80.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.068 0.461 . . . . 15.0 110.6 177.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 58.83 -143.15 0.62 Allowed 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.736 -0.468 . . . . 15.0 109.736 173.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.61 -19.98 52.79 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.337 0.971 . . . . 15.0 112.639 -174.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.541 ' OD2' HD22 ' A' ' 41' ' ' LEU . 77.9 m-20 -91.88 10.81 27.19 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.265 0.839 . . . . 15.0 113.265 -175.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 56.7 t-105 -47.85 -46.61 63.14 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 118.563 -0.732 . . . . 15.0 112.547 177.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -44.66 -40.71 14.33 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 121.389 1.393 . . . . 15.0 113.288 177.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -76.96 -48.89 16.8 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.948 0.404 . . . . 15.0 110.698 -178.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.682 HD12 ' HB1' ' A' ' 67' ' ' ALA . 89.6 mt -59.25 -39.59 79.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 15.0 110.826 -177.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.56 -14.47 35.55 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.817 -0.435 . . . . 15.0 113.23 -176.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -64.96 -30.12 71.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.501 0.651 . . . . 15.0 111.907 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 23.4 mt -76.29 150.42 82.74 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 120.932 -0.307 . . . . 15.0 111.264 -174.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.34 128.97 29.29 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.624 1.55 . . . . 15.0 112.286 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.585 HD21 HD13 ' A' ' 60' ' ' LEU . 14.0 tp -107.07 124.54 49.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 15.0 110.533 175.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.55 ' CD1' HG22 ' A' ' 53' ' ' VAL . 86.3 m-85 -92.59 121.95 34.53 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.356 -0.609 . . . . 15.0 109.356 174.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.715 HG21 ' HB2' ' A' ' 87' ' ' ALA . 21.5 m -107.0 147.38 34.99 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-O 119.345 -0.36 . . . . 15.0 110.207 177.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.18 -25.88 5.56 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 121.577 1.518 . . . . 15.0 113.404 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.9 p -145.26 163.44 32.26 Favored Pre-proline 0 CA--C 1.531 0.227 0 C-N-CA 120.636 -0.425 . . . . 15.0 111.46 -172.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.3 -44.01 47.07 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 121.13 1.22 . . . . 15.0 111.829 176.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -58.28 -46.74 85.49 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.81 -0.356 . . . . 15.0 110.817 -177.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.0 t -59.9 -41.04 84.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.882 -0.414 . . . . 15.0 109.882 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.715 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.87 -39.32 77.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.674 0.273 . . . . 15.0 110.707 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.88 -42.08 97.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.504 -0.316 . . . . 15.0 110.563 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 52.2 mtm -64.89 -42.94 94.36 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 119.871 -0.731 . . . . 15.0 110.129 176.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.5 -43.96 93.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.584 -0.28 . . . . 15.0 111.484 -171.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -67.02 -38.57 86.19 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.161 -0.616 . . . . 15.0 110.443 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -59.76 -35.16 74.04 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 120.653 -0.419 . . . . 15.0 111.246 176.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 67.2 mt -59.88 -29.11 68.1 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 120.877 -0.329 . . . . 15.0 111.378 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.27 13.08 20.28 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 119.431 -0.649 . . . . 15.0 112.821 -172.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.93 123.33 15.46 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.515 1.157 . . . . 15.0 109.862 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -70.46 -35.1 73.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.971 -0.558 . . . . 15.0 111.323 -172.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -131.62 113.98 14.27 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 110.052 -0.351 . . . . 15.0 110.052 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 45.6 t -109.44 129.79 63.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.036 0.446 . . . . 15.0 110.121 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 82.4 mt -120.92 125.66 74.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.745 -0.661 . . . . 15.0 109.978 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -94.44 114.5 26.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.212 -0.292 . . . . 15.0 110.212 175.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 28.6 p -78.36 -25.84 46.48 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 120.639 -0.424 . . . . 15.0 112.021 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -55.11 -38.17 67.8 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.646 0.26 . . . . 15.0 110.913 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.96 -35.15 7.83 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.597 -0.601 . . . . 15.0 111.597 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.36 127.02 36.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.373 . . . . 15.0 110.908 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.427 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 50.3 m -65.09 156.87 30.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.081 0.467 . . . . 15.0 110.787 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.525 ' HB2' ' HE ' ' A' ' 20' ' ' ARG . . . -47.68 -54.34 23.8 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 113.031 0.752 . . . . 15.0 113.031 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -56.2 -35.48 95.44 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 CA-C-N 120.367 1.167 . . . . 15.0 111.339 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 105' ' ' SER . . . -60.05 -41.33 92.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.955 0.407 . . . . 15.0 110.235 176.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 78.0 mt -58.94 -41.9 88.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.97 0.414 . . . . 15.0 110.329 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.61 -44.16 85.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.445 0.64 . . . . 15.0 110.131 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.4 -40.09 89.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.602 -0.726 . . . . 15.0 110.586 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.25 -41.03 92.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.41 -0.359 . . . . 15.0 110.785 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.4 mt -57.85 -51.01 71.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.152 0.501 . . . . 15.0 110.404 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.8 p -63.28 -41.27 98.97 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.68 -0.691 . . . . 15.0 111.252 -175.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.0 m -63.46 -43.22 97.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.662 0.267 . . . . 15.0 111.389 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.35 -39.03 91.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.478 -0.328 . . . . 15.0 111.05 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.73 -37.77 79.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.552 -0.295 . . . . 15.0 110.952 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 90.4 mt -59.91 -38.28 81.88 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.916 -0.314 . . . . 15.0 110.938 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -62.43 138.46 58.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.746 0.307 . . . . 15.0 110.426 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -132.4 131.63 42.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.372 -0.376 . . . . 15.0 110.735 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -60.85 -40.34 92.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 15.0 110.585 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -107.13 129.13 54.88 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.298 -0.41 . . . . 15.0 110.541 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -59.91 -40.7 89.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.026 -0.534 . . . . 15.0 110.759 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -107.23 136.78 46.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.472 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 117.938 -1.029 . . . . 15.0 110.598 -179.399 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.432 -0.581 . . . . 15.0 109.432 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -125.55 83.69 61.43 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 116.157 -0.474 . . . . 15.0 110.32 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -59.18 155.06 41.95 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 121.38 1.387 . . . . 15.0 111.942 -177.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -105.4 136.48 44.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.387 -0.369 . . . . 15.0 110.62 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.8 m -132.68 143.56 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 121.585 0.707 . . . . 15.0 111.587 177.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.446 HD11 ' HB2' ' A' ' 31' ' ' LEU . 13.8 tp -102.77 135.87 43.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.981 -1.009 . . . . 15.0 110.274 178.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.578 HD11 ' CG1' ' A' ' 28' ' ' VAL . 51.9 mt -102.04 134.76 41.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.981 0.42 . . . . 15.0 110.558 -178.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.44 ' HB2' HG12 ' A' ' 54' ' ' VAL . 85.6 mtp -103.52 134.27 47.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.441 -0.8 . . . . 15.0 109.943 173.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 -57.46 144.86 35.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.016 0.436 . . . . 15.0 110.833 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.2 175.24 33.24 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.658 -0.977 . . . . 15.0 110.658 -177.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -50.97 -32.07 19.84 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.88 0.326 . . . . 15.0 111.88 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.95 175.42 47.77 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.782 -0.927 . . . . 15.0 110.782 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.64 131.68 10.81 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.474 -0.65 . . . . 15.0 111.474 -178.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -56.56 -44.35 80.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.869 0.366 . . . . 15.0 110.616 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.83 -43.19 99.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.126 -0.488 . . . . 15.0 111.183 -176.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -62.49 -56.06 21.61 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.8 -0.36 . . . . 15.0 111.384 -175.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.47 ' C ' HD23 ' A' ' 17' ' ' LEU . 8.9 tt -61.7 -43.69 98.37 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.777 -0.369 . . . . 15.0 110.985 -175.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.528 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -62.38 -42.43 99.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.414 -0.357 . . . . 15.0 110.84 -177.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.78 -41.21 90.62 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.875 -0.33 . . . . 15.0 110.457 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -59.64 -51.72 68.61 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.565 -0.454 . . . . 15.0 111.34 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.5 mt -62.58 -37.5 86.43 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.436 -0.505 . . . . 15.0 110.933 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 46.9 tpt85 -63.03 -44.8 94.91 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 121.066 -0.254 . . . . 15.0 110.711 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.43 -30.57 68.4 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.955 -0.64 . . . . 15.0 111.894 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -88.11 9.24 23.34 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.626 0.973 . . . . 15.0 113.626 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.77 13.55 54.77 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 121.066 -0.588 . . . . 15.0 113.65 173.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.0 t -101.1 138.52 25.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 117.953 0.876 . . . . 15.0 110.021 177.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -79.33 131.88 36.27 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.348 -0.612 . . . . 15.0 109.348 178.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.578 ' CG1' HD11 ' A' ' 7' ' ' ILE . 43.9 t -117.68 130.79 72.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.198 0.523 . . . . 15.0 111.528 -171.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -139.33 133.03 30.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.32 -0.855 . . . . 15.0 109.388 170.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -112.66 137.39 51.01 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.9 0.381 . . . . 15.0 110.974 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.446 ' HB2' HD11 ' A' ' 6' ' ' LEU . 40.5 tp -118.9 113.45 35.91 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 118.618 -0.706 . . . . 15.0 109.969 -176.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -56.09 135.26 68.93 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.069 1.179 . . . . 15.0 112.318 177.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.594 HD13 HD22 ' A' ' 62' ' ' ASN . 77.3 mt -60.56 -9.21 3.48 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.298 0.851 . . . . 15.0 113.298 -178.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -77.15 -9.98 59.1 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.205 0.817 . . . . 15.0 113.205 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -62.53 147.2 92.8 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 118.338 0.517 . . . . 15.0 110.26 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.29 158.96 33.28 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.559 1.506 . . . . 15.0 113.252 -178.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.84 152.42 3.91 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.783 -0.644 . . . . 15.0 111.337 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.39 -36.3 3.88 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.489 -0.644 . . . . 15.0 111.489 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -60.01 -37.22 79.09 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.689 -0.404 . . . . 15.0 111.041 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.576 ' O ' HG23 ' A' ' 44' ' ' VAL . 25.8 tp -58.65 -46.34 87.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.965 0.412 . . . . 15.0 110.168 -178.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.611 HD22 ' OD2' ' A' ' 70' ' ' ASP . 9.7 tp -61.78 -44.14 97.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.139 -0.482 . . . . 15.0 110.742 -177.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.01 -43.61 98.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.352 -0.386 . . . . 15.0 111.241 -176.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -61.28 -41.82 97.6 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.751 -0.38 . . . . 15.0 110.625 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.579 ' HA ' HD12 ' A' ' 49' ' ' LEU . 97.6 t -61.65 -47.03 95.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.88 -0.328 . . . . 15.0 110.491 -175.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -75.42 -43.5 49.57 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.492 0.553 . . . . 15.0 112.492 -174.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.59 -44.37 74.52 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.667 0.247 . . . . 15.0 111.667 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -82.74 -10.09 59.05 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.123 0.786 . . . . 15.0 113.123 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 58.36 55.88 4.73 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.563 0.697 . . . . 15.0 109.553 -177.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.579 HD12 ' HA ' ' A' ' 44' ' ' VAL . 94.1 mt -71.47 145.7 49.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.752 -0.658 . . . . 15.0 111.412 -174.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -95.41 -40.52 9.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.231 -0.895 . . . . 15.0 110.774 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -150.93 166.64 30.44 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 120.057 -1.068 . . . . 15.0 113.412 -173.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.5 mt -126.61 144.17 50.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.732 -0.734 . . . . 15.0 110.046 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.549 HG22 ' CD1' ' A' ' 80' ' ' PHE . 47.8 t -122.1 129.38 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 110.386 -0.227 . . . . 15.0 110.386 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.44 HG12 ' HB2' ' A' ' 8' ' ' MET . 15.5 m -127.65 152.05 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 121.053 0.454 . . . . 15.0 110.456 172.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.9 m -123.47 7.92 8.97 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.744 -0.662 . . . . 15.0 112.77 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 79.9 p -155.62 151.69 27.81 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 118.514 0.597 . . . . 15.0 111.772 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.87 -39.75 92.08 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.633 -0.987 . . . . 15.0 110.633 176.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -58.25 -41.8 85.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.702 0.287 . . . . 15.0 110.382 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.82 -47.98 88.54 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.687 -0.965 . . . . 15.0 110.687 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.614 HD13 HD21 ' A' ' 79' ' ' LEU . 34.2 tp -57.13 -44.42 83.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.15 0.5 . . . . 15.0 110.705 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.63 -42.37 98.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.063 -0.517 . . . . 15.0 110.823 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.594 HD22 HD13 ' A' ' 33' ' ' LEU . 84.5 m-20 -59.47 -39.89 85.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.393 -0.367 . . . . 15.0 110.576 178.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.4 tp -58.12 -44.29 87.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.094 0.473 . . . . 15.0 110.274 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -60.67 -47.52 85.91 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.849 -0.614 . . . . 15.0 110.631 -178.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -62.13 -43.41 98.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.085 -0.507 . . . . 15.0 111.113 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.8 mt -66.42 -35.27 79.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.414 -0.357 . . . . 15.0 111.375 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.664 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -58.92 -38.75 79.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.032 0.444 . . . . 15.0 110.672 178.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.21 -143.54 0.59 Allowed 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 109.515 -0.55 . . . . 15.0 109.515 174.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.43 -19.04 44.38 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.342 0.973 . . . . 15.0 112.609 -175.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.611 ' OD2' HD22 ' A' ' 41' ' ' LEU . 79.2 m-20 -91.88 10.5 28.48 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.299 0.852 . . . . 15.0 113.299 -174.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -47.76 -46.72 62.33 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 118.576 -0.726 . . . . 15.0 112.561 178.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -44.69 -41.99 14.72 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 121.481 1.454 . . . . 15.0 113.244 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -77.01 -48.69 17.23 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.949 0.405 . . . . 15.0 110.862 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.664 HD12 ' HB1' ' A' ' 67' ' ' ALA . 91.7 mt -59.01 -40.78 81.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.138 -0.483 . . . . 15.0 110.748 -176.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.51 -16.1 35.05 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 119.896 -0.391 . . . . 15.0 113.048 -177.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -63.66 -30.64 71.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.425 0.612 . . . . 15.0 111.989 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.6 mt -74.89 149.02 85.24 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 120.979 -0.289 . . . . 15.0 111.265 -173.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.85 129.07 24.89 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.558 1.505 . . . . 15.0 112.517 176.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.614 HD21 HD13 ' A' ' 60' ' ' LEU . 22.4 tp -107.77 126.43 52.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 15.0 110.577 174.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.549 ' CD1' HG22 ' A' ' 53' ' ' VAL . 80.3 m-85 -89.84 125.01 35.17 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.438 -0.579 . . . . 15.0 109.438 175.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.741 HG21 ' HB2' ' A' ' 87' ' ' ALA . 27.6 m -113.87 147.56 37.98 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-O 119.373 -0.346 . . . . 15.0 110.319 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.418 ' HD2' HG11 ' A' ' 86' ' ' VAL . 90.1 Cg_endo -79.17 -23.94 7.17 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.574 1.516 . . . . 15.0 113.52 -175.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.7 p -144.4 158.23 54.73 Favored Pre-proline 0 CA--C 1.531 0.232 0 C-N-CA 120.664 -0.414 . . . . 15.0 111.321 -172.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.82 -44.04 51.34 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.255 1.304 . . . . 15.0 111.694 175.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -56.73 -48.56 77.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.847 0.356 . . . . 15.0 110.858 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.418 HG11 ' HD2' ' A' ' 82' ' ' PRO . 60.2 t -59.61 -40.66 82.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.836 0.351 . . . . 15.0 110.071 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.741 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.72 -42.29 83.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.012 0.434 . . . . 15.0 110.505 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.6 -41.67 97.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 15.0 110.658 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 87.1 mtp -59.82 -44.44 94.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.238 0.542 . . . . 15.0 110.432 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.434 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.35 -41.2 96.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.993 -0.548 . . . . 15.0 110.725 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 54.0 ttm-85 -61.19 -44.52 97.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.25 -0.432 . . . . 15.0 110.539 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -59.84 -36.26 76.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.527 -0.306 . . . . 15.0 111.397 -177.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 81.9 mt -65.39 -24.15 67.15 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.244 0.461 . . . . 15.0 112.244 177.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.85 13.2 14.41 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-O 119.444 -0.642 . . . . 15.0 113.158 -176.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.89 121.97 11.8 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.466 1.133 . . . . 15.0 109.893 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -70.5 -35.48 73.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.69 -0.686 . . . . 15.0 111.322 -171.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -131.07 112.83 13.24 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.975 0.417 . . . . 15.0 110.115 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.2 t -111.41 129.49 66.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 109.79 -0.448 . . . . 15.0 109.79 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 83.9 mt -119.53 125.49 74.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.967 -0.56 . . . . 15.0 110.222 -176.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -94.9 117.74 30.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.435 -0.348 . . . . 15.0 110.286 176.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.545 ' HB2' HD11 ' A' ' 109' ' ' LEU . 31.2 p -88.6 -18.69 27.5 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.574 0.583 . . . . 15.0 112.574 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 tpt85 -55.17 -38.9 68.92 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 122.229 -0.294 . . . . 15.0 110.766 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -93.16 -34.95 6.49 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.633 -0.587 . . . . 15.0 111.633 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -89.51 125.59 35.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.843 0.354 . . . . 15.0 110.705 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.409 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 47.7 m -64.64 158.63 23.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.159 0.504 . . . . 15.0 110.901 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.79 -54.24 25.06 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 113.011 0.745 . . . . 15.0 113.011 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -56.65 -34.84 96.68 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 CA-C-N 120.447 1.196 . . . . 15.0 111.451 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 105' ' ' SER . . . -60.22 -41.74 93.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.029 0.442 . . . . 15.0 110.081 176.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.545 HD11 ' HB2' ' A' ' 101' ' ' CYS . 78.8 mt -58.95 -41.13 86.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.077 0.465 . . . . 15.0 110.454 178.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 30.6 tp -56.98 -44.34 82.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.546 0.689 . . . . 15.0 110.104 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.45 -40.14 90.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.508 -0.769 . . . . 15.0 110.551 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.83 -41.12 90.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.399 -0.364 . . . . 15.0 110.757 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.0 mt -57.89 -52.08 66.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.262 0.553 . . . . 15.0 110.305 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.9 p -63.53 -40.6 97.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.571 -0.741 . . . . 15.0 111.315 -175.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.3 m -62.73 -43.51 98.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.67 0.271 . . . . 15.0 111.443 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.34 -39.87 94.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.414 -0.357 . . . . 15.0 111.045 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.49 -36.94 79.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.48 -0.327 . . . . 15.0 111.164 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.21 -38.36 83.1 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.918 -0.313 . . . . 15.0 111.159 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.83 -37.75 88.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.554 -0.294 . . . . 15.0 111.257 -178.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -61.18 -42.84 99.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.751 0.31 . . . . 15.0 110.973 -178.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -54.74 -35.82 64.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.427 . . . . 15.0 111.492 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -102.38 126.22 49.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.911 0.386 . . . . 15.0 110.726 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -58.72 -38.98 79.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.893 -0.594 . . . . 15.0 110.985 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -106.86 139.01 41.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.328 -0.396 . . . . 15.0 110.483 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.015 -0.993 . . . . 15.0 110.625 -179.776 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.6 mtm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.371 -0.603 . . . . 15.0 109.371 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -126.31 82.48 65.73 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.074 -0.512 . . . . 15.0 110.329 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.7 155.04 28.4 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.393 1.395 . . . . 15.0 111.875 -176.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.421 ' CB ' HD23 ' A' ' 49' ' ' LEU . 96.1 mttt -111.68 138.13 48.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.795 0.331 . . . . 15.0 110.864 -178.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.426 HG21 HD13 ' A' ' 21' ' ' LEU . 15.1 m -134.66 144.31 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.565 0.698 . . . . 15.0 111.572 175.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.2 tp -104.38 136.0 44.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.916 -1.038 . . . . 15.0 110.264 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.614 HD11 ' CG1' ' A' ' 28' ' ' VAL . 50.8 mt -103.53 135.1 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.123 0.487 . . . . 15.0 111.129 -176.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.531 ' HB2' HG12 ' A' ' 54' ' ' VAL . 98.5 mmm -95.3 133.65 38.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.109 -0.95 . . . . 15.0 109.21 171.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.421 ' H ' HD21 ' A' ' 33' ' ' LEU . 55.9 ttp180 -63.91 143.74 57.62 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.76 -0.376 . . . . 15.0 110.479 -177.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.24 175.13 34.02 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.924 -0.871 . . . . 15.0 110.924 -178.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -52.55 -32.45 40.87 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.742 0.275 . . . . 15.0 111.742 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.69 176.39 32.38 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.807 -0.917 . . . . 15.0 110.807 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.0 120.24 5.77 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.504 -0.638 . . . . 15.0 111.504 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -56.89 -41.8 78.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.794 0.331 . . . . 15.0 110.452 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.07 -40.63 98.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 15.0 111.134 -177.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -62.35 -56.0 22.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.984 0.421 . . . . 15.0 111.124 -176.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.3 mt -59.92 -44.82 94.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.942 0.401 . . . . 15.0 110.759 -176.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.532 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -62.53 -37.49 86.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 15.0 111.052 -178.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.0 -42.89 99.32 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.955 -0.298 . . . . 15.0 110.598 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -61.53 -51.52 68.27 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.125 -0.63 . . . . 15.0 110.895 -178.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.426 HD13 HG21 ' A' ' 5' ' ' VAL . 84.6 mt -61.46 -37.99 85.6 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.632 -0.427 . . . . 15.0 110.931 -178.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 57.5 ttt85 -63.63 -43.52 96.59 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.196 -0.202 . . . . 15.0 111.084 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.03 -30.6 67.05 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.967 -0.635 . . . . 15.0 111.915 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -88.2 10.1 20.63 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.481 0.919 . . . . 15.0 113.481 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.91 18.27 51.41 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 121.187 -0.53 . . . . 15.0 113.292 174.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.4 t -101.01 140.32 20.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 117.688 0.744 . . . . 15.0 110.131 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -84.78 130.38 34.69 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.475 -0.565 . . . . 15.0 109.475 178.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.614 ' CG1' HD11 ' A' ' 7' ' ' ILE . 37.2 t -119.97 133.76 65.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.205 0.526 . . . . 15.0 111.271 -173.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -139.08 132.72 30.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.443 -0.799 . . . . 15.0 109.611 171.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.461 ' HB3' HD12 ' A' ' 7' ' ' ILE . 38.3 p90 -113.01 137.64 51.1 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.89 0.376 . . . . 15.0 110.467 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.7 tp -114.92 113.49 44.28 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-O 118.683 -0.675 . . . . 15.0 110.824 -173.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -49.05 135.08 29.97 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.156 1.237 . . . . 15.0 111.881 174.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.758 HD13 ' ND2' ' A' ' 62' ' ' ASN . 43.2 mt -64.61 -13.36 53.11 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.15 0.796 . . . . 15.0 113.15 -174.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -77.23 -6.01 51.45 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.293 0.849 . . . . 15.0 113.293 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -60.0 151.04 67.24 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 118.559 0.618 . . . . 15.0 110.388 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.75 151.72 25.0 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.548 1.499 . . . . 15.0 113.044 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.53 152.29 5.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.925 -0.58 . . . . 15.0 111.162 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.84 -36.6 3.8 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.449 -0.66 . . . . 15.0 111.449 -177.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.44 -37.94 82.54 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.655 -0.418 . . . . 15.0 110.958 -177.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.563 ' O ' HG23 ' A' ' 44' ' ' VAL . 23.9 tp -59.14 -46.32 88.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.952 0.406 . . . . 15.0 110.256 -178.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.614 HD22 ' OD2' ' A' ' 70' ' ' ASP . 12.1 tp -61.97 -44.64 96.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 15.0 110.824 -176.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.89 -43.93 97.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.348 -0.387 . . . . 15.0 110.91 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.8 mtp85 -61.83 -41.77 98.2 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.811 -0.356 . . . . 15.0 110.888 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 40' ' ' LEU . 96.5 t -59.4 -46.08 92.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.868 -0.419 . . . . 15.0 109.868 -177.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.2 tpt85 -71.55 -50.3 32.45 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 123.37 0.419 . . . . 15.0 112.024 -176.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.04 -44.44 92.48 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.089 0.403 . . . . 15.0 112.089 -171.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 mp0 -89.87 -5.61 56.65 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.429 0.899 . . . . 15.0 113.429 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 56.77 55.93 5.89 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.616 0.722 . . . . 15.0 110.167 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.51 HD12 ' HA ' ' A' ' 44' ' ' VAL . 94.5 mt -64.23 140.44 58.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.525 -0.761 . . . . 15.0 111.058 -175.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -84.47 -40.64 17.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.491 -0.777 . . . . 15.0 110.671 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -154.04 168.04 32.36 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 119.872 -1.156 . . . . 15.0 113.773 -173.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.8 mt -123.65 143.51 50.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.502 -0.849 . . . . 15.0 109.671 177.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.48 HG22 ' CD1' ' A' ' 80' ' ' PHE . 46.9 t -122.66 132.76 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 110.143 -0.317 . . . . 15.0 110.143 -179.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.531 HG12 ' HB2' ' A' ' 8' ' ' MET . 9.2 m -126.47 142.41 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 121.057 0.456 . . . . 15.0 110.547 173.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.6 t -97.44 -19.95 18.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.622 -0.717 . . . . 15.0 112.439 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.2 p -151.27 161.65 42.32 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 121.333 0.587 . . . . 15.0 111.528 -174.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.45 -39.12 83.18 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.946 -0.862 . . . . 15.0 110.946 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -58.82 -44.62 90.91 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.876 -0.329 . . . . 15.0 110.653 -178.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.06 -44.48 97.23 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.545 -1.022 . . . . 15.0 110.545 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.602 HD13 HD21 ' A' ' 79' ' ' LEU . 32.1 tp -57.27 -43.03 82.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.115 0.483 . . . . 15.0 110.639 -178.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.08 -42.73 99.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 15.0 110.692 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.758 ' ND2' HD13 ' A' ' 33' ' ' LEU . 67.9 m-80 -58.95 -41.61 87.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.852 0.358 . . . . 15.0 110.543 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.8 tp -58.67 -43.94 90.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.125 0.488 . . . . 15.0 110.181 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -61.19 -47.32 86.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.955 -0.566 . . . . 15.0 110.725 -178.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -61.22 -42.7 99.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.12 -0.491 . . . . 15.0 111.117 -177.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 92.7 mt -65.82 -36.32 83.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.341 -0.391 . . . . 15.0 111.374 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.687 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.32 -38.57 80.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.141 0.496 . . . . 15.0 110.85 178.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.13 -143.15 0.61 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.648 -0.501 . . . . 15.0 109.648 174.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.52 -19.82 51.0 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.321 0.964 . . . . 15.0 112.734 -174.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.614 ' OD2' HD22 ' A' ' 41' ' ' LEU . 79.3 m-20 -91.97 11.4 25.23 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.217 0.821 . . . . 15.0 113.217 -175.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -47.85 -46.7 63.25 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-O 118.584 -0.722 . . . . 15.0 112.593 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -44.7 -41.25 14.7 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.474 1.45 . . . . 15.0 113.224 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.5 mp0 -77.03 -48.77 17.0 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.943 0.402 . . . . 15.0 110.827 -178.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.687 HD12 ' HB1' ' A' ' 67' ' ' ALA . 90.8 mt -60.03 -40.52 83.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 15.0 110.902 -176.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.79 -13.72 26.66 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.915 -0.38 . . . . 15.0 113.156 -177.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -64.44 -31.46 72.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 117.359 0.579 . . . . 15.0 111.766 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.3 mt -72.99 141.84 82.11 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-O 119.204 -0.427 . . . . 15.0 110.456 -176.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -59.33 135.24 64.05 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 121.342 1.361 . . . . 15.0 112.434 177.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.602 HD21 HD13 ' A' ' 60' ' ' LEU . 23.9 tp -109.34 127.76 54.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 15.0 110.736 176.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.48 ' CD1' HG22 ' A' ' 53' ' ' VAL . 85.9 m-85 -91.35 127.18 36.68 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.821 -0.437 . . . . 15.0 109.821 176.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.664 HG21 ' HB2' ' A' ' 87' ' ' ALA . 28.6 m -119.6 147.44 43.69 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 119.45 -0.309 . . . . 15.0 110.25 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.24 -24.23 6.83 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.597 1.531 . . . . 15.0 113.478 -175.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.402 ' OG ' HG23 ' A' ' 86' ' ' VAL . 25.2 p -142.58 158.51 60.06 Favored Pre-proline 0 C--N 1.33 -0.254 0 C-N-CA 120.71 -0.396 . . . . 15.0 111.27 -171.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.43 -44.05 52.33 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.285 1.323 . . . . 15.0 111.761 176.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -58.29 -47.43 83.67 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.773 -0.371 . . . . 15.0 110.924 -177.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.402 HG23 ' OG ' ' A' ' 83' ' ' SER . 61.1 t -60.17 -39.65 81.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.788 -0.365 . . . . 15.0 110.096 178.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.664 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.25 -41.84 80.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.925 0.393 . . . . 15.0 110.404 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.75 -40.86 94.02 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.131 -0.486 . . . . 15.0 110.526 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.0 mmm -58.33 -45.17 88.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.456 0.646 . . . . 15.0 110.177 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.492 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.76 -40.32 94.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.704 -0.68 . . . . 15.0 110.937 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.0 ttt-85 -62.07 -44.63 96.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 15.0 110.792 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.76 -36.15 76.06 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.818 -0.353 . . . . 15.0 111.236 -177.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 76.4 mt -65.49 -25.6 67.55 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.088 0.403 . . . . 15.0 112.088 177.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.55 13.37 14.78 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 119.288 -0.729 . . . . 15.0 113.18 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.87 122.68 13.51 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 118.513 1.157 . . . . 15.0 110.002 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -67.52 -35.83 79.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.518 -0.764 . . . . 15.0 111.256 -171.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -131.82 117.67 18.85 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.954 0.407 . . . . 15.0 110.087 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.9 t -114.18 130.36 68.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.975 0.417 . . . . 15.0 109.989 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 89.9 mt -119.16 123.58 71.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.811 -0.631 . . . . 15.0 110.077 -177.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -94.7 117.44 30.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.376 -0.375 . . . . 15.0 110.086 175.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 104' ' ' ALA . 30.8 p -95.42 -1.65 50.54 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.306 0.854 . . . . 15.0 113.306 -178.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 -55.89 -39.88 72.2 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 118.191 0.451 . . . . 15.0 110.672 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -96.24 -35.06 5.63 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 111.511 -0.636 . . . . 15.0 111.511 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.407 ' HB3' ' HA ' ' A' ' 101' ' ' CYS . . . -69.7 143.23 53.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.829 0.347 . . . . 15.0 110.635 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 65.2 m -89.85 160.12 16.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 15.0 110.506 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.66 -54.41 23.21 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 112.945 0.72 . . . . 15.0 112.945 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.54 -34.53 98.88 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 CA-C-N 120.079 1.064 . . . . 15.0 111.708 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.01 96.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.028 0.442 . . . . 15.0 110.034 177.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 74.7 mt -59.42 -40.77 87.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 15.0 110.399 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 36.6 tp -57.26 -44.03 83.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.272 0.558 . . . . 15.0 110.164 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.18 -40.59 90.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.696 -0.683 . . . . 15.0 110.436 178.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.09 -40.13 88.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.377 -0.374 . . . . 15.0 110.811 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.6 mt -57.88 -51.4 69.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.174 0.512 . . . . 15.0 110.479 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.9 p -64.74 -41.56 95.84 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.637 -0.71 . . . . 15.0 111.384 -175.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.0 t -61.36 -43.87 98.14 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.051 -0.26 . . . . 15.0 111.26 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.18 -42.5 99.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.472 -0.331 . . . . 15.0 111.066 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.15 -39.56 95.04 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.975 -0.29 . . . . 15.0 111.209 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.0 mt -64.8 -39.35 93.46 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.775 0.287 . . . . 15.0 111.775 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -116.12 129.48 56.35 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.943 0.401 . . . . 15.0 110.866 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -60.74 -41.99 96.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.964 -0.562 . . . . 15.0 111.391 -178.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -116.23 140.17 49.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.97 0.414 . . . . 15.0 111.339 -176.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -89.74 -17.99 27.21 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.69 0.626 . . . . 15.0 112.69 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -54.69 -39.13 67.82 Favored 'General case' 0 C--O 1.231 0.09 0 O-C-N 122.172 -0.33 . . . . 15.0 111.148 -177.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -107.34 135.12 49.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.396 -0.366 . . . . 15.0 110.468 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.977 -1.011 . . . . 15.0 110.589 179.866 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.1 ttm . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.328 -0.619 . . . . 15.0 109.328 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -126.05 79.43 69.3 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.11 -0.496 . . . . 15.0 110.173 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.19 152.67 10.64 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.511 1.474 . . . . 15.0 112.214 -174.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -115.12 140.96 48.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.113 -0.494 . . . . 15.0 110.693 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 m -134.36 144.17 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.614 0.721 . . . . 15.0 111.519 176.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.8 tp -105.26 135.08 47.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.91 -1.041 . . . . 15.0 110.381 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.619 HD11 ' CG1' ' A' ' 28' ' ' VAL . 52.5 mt -99.8 133.02 44.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.034 0.445 . . . . 15.0 110.598 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.44 ' SD ' HD13 ' A' ' 63' ' ' LEU . 83.8 mtp -100.7 134.39 43.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.418 -0.81 . . . . 15.0 109.255 170.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -57.39 145.21 33.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.135 0.493 . . . . 15.0 111.222 -170.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.51 175.08 27.03 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.895 -0.882 . . . . 15.0 110.895 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.27 -32.29 71.04 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.817 0.303 . . . . 15.0 111.817 -178.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.96 -177.68 20.6 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.234 -0.746 . . . . 15.0 111.234 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.9 127.99 8.46 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.9 -0.88 . . . . 15.0 110.9 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 52.4 mmt-85 -60.02 -46.61 88.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.221 0.534 . . . . 15.0 109.648 -176.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.09 -40.01 96.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.59 -0.732 . . . . 15.0 111.235 -176.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -60.81 -55.96 26.86 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.758 -0.377 . . . . 15.0 111.258 -175.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.5 mt -61.91 -44.9 95.82 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.735 -0.386 . . . . 15.0 111.132 -176.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.473 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -63.09 -39.7 95.48 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.657 -0.417 . . . . 15.0 110.894 -177.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -60.03 -41.52 92.43 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 121.008 -0.277 . . . . 15.0 110.442 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.4 ttt85 -59.96 -51.55 69.19 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 120.665 -0.414 . . . . 15.0 111.2 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 70.6 mt -60.79 -36.79 79.89 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.518 -0.473 . . . . 15.0 110.937 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 60.4 ttt85 -61.73 -43.16 99.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.693 0.283 . . . . 15.0 110.727 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.19 -30.56 67.55 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.053 -0.594 . . . . 15.0 111.855 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -88.1 9.93 20.95 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.521 0.934 . . . . 15.0 113.521 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.3 12.83 58.16 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 121.189 -0.529 . . . . 15.0 113.689 173.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.9 t -101.06 136.12 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 118.084 0.942 . . . . 15.0 110.115 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -78.04 132.22 37.67 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.076 -0.713 . . . . 15.0 109.076 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.619 ' CG1' HD11 ' A' ' 7' ' ' ILE . 31.3 t -121.09 133.79 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.247 0.546 . . . . 15.0 111.37 -172.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -140.59 142.11 35.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.285 -0.87 . . . . 15.0 109.648 170.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -115.31 138.6 50.79 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.949 0.404 . . . . 15.0 111.03 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.0 tp -119.07 113.34 35.66 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 118.586 -0.721 . . . . 15.0 109.863 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.19 135.2 59.14 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 121.06 1.173 . . . . 15.0 112.257 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.597 HD13 HD22 ' A' ' 62' ' ' ASN . 76.1 mt -60.85 -12.03 9.66 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.089 0.774 . . . . 15.0 113.089 -178.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -77.15 -7.78 56.39 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.271 0.841 . . . . 15.0 113.271 -177.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -61.98 150.3 83.58 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 118.45 0.568 . . . . 15.0 110.478 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.93 154.25 25.9 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.555 1.503 . . . . 15.0 113.119 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.3 151.82 5.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.878 -0.601 . . . . 15.0 111.227 -178.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.98 -38.1 3.22 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.498 -0.641 . . . . 15.0 111.498 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.74 -37.96 86.17 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.64 -0.424 . . . . 15.0 110.974 -177.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.613 ' O ' HG23 ' A' ' 44' ' ' VAL . 22.4 tp -59.05 -48.93 79.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.916 0.389 . . . . 15.0 110.209 -177.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.5 HD22 ' CG ' ' A' ' 70' ' ' ASP . 15.5 tp -64.34 -44.96 89.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.138 -0.483 . . . . 15.0 111.215 -175.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.78 -45.51 93.59 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.626 -0.43 . . . . 15.0 110.78 -175.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.3 ttt85 -62.23 -41.81 98.75 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.855 -0.338 . . . . 15.0 110.856 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 40' ' ' LEU . 96.6 t -60.93 -43.81 96.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.753 -0.379 . . . . 15.0 110.176 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -68.46 -48.66 63.94 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.117 0.414 . . . . 15.0 112.117 -176.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.58 -44.28 78.54 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.94 -0.304 . . . . 15.0 111.53 -175.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -79.47 -10.13 59.74 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.045 0.757 . . . . 15.0 113.045 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 54.84 55.86 7.34 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.607 0.717 . . . . 15.0 110.418 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.532 HD12 HG22 ' A' ' 44' ' ' VAL . 94.1 mt -66.73 148.15 52.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.689 -0.687 . . . . 15.0 111.584 -175.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -95.35 -40.6 9.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.29 -0.868 . . . . 15.0 110.826 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.67 160.32 28.27 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.009 -1.091 . . . . 15.0 113.443 -173.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 73.4 mt -126.61 141.55 51.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.505 -0.847 . . . . 15.0 109.838 178.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.519 HG22 ' CD1' ' A' ' 80' ' ' PHE . 46.9 t -120.47 131.22 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 121.143 -0.223 . . . . 15.0 110.702 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.403 HG12 ' SD ' ' A' ' 8' ' ' MET . 7.5 m -123.08 145.56 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 121.158 0.504 . . . . 15.0 110.562 173.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.3 t -97.83 -20.28 17.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.467 -0.788 . . . . 15.0 112.536 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.8 p -155.93 164.44 38.48 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.442 0.639 . . . . 15.0 111.903 -174.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -55.91 -37.38 70.0 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.173 -0.771 . . . . 15.0 111.173 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -58.35 -45.72 87.63 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.863 -0.335 . . . . 15.0 110.674 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.17 -46.19 94.68 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.468 -1.053 . . . . 15.0 110.468 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.621 HD13 HD21 ' A' ' 79' ' ' LEU . 30.1 tp -56.16 -44.02 78.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.16 0.505 . . . . 15.0 110.831 -177.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.76 -43.1 99.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.039 -0.528 . . . . 15.0 110.672 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.597 HD22 HD13 ' A' ' 33' ' ' LEU . 83.4 m-20 -59.03 -39.97 83.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.39 -0.368 . . . . 15.0 110.639 178.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.44 HD13 ' SD ' ' A' ' 8' ' ' MET . 12.9 tp -57.88 -44.56 86.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.189 0.518 . . . . 15.0 110.243 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -60.92 -47.51 86.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.713 -0.676 . . . . 15.0 110.62 -178.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -61.45 -42.99 99.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.014 -0.539 . . . . 15.0 111.053 -177.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.97 -35.91 81.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.352 -0.385 . . . . 15.0 111.405 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.665 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.0 -39.22 81.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.975 0.417 . . . . 15.0 110.597 178.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.09 -142.81 0.62 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.591 -0.522 . . . . 15.0 109.591 174.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.49 -19.29 46.81 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.384 0.993 . . . . 15.0 112.601 -174.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.5 ' CG ' HD22 ' A' ' 41' ' ' LEU . 20.2 m-20 -91.82 10.46 28.48 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.355 0.872 . . . . 15.0 113.355 -175.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 58.9 t-105 -47.84 -46.36 62.62 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 118.598 -0.715 . . . . 15.0 112.665 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -44.73 -41.6 14.83 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 121.525 1.484 . . . . 15.0 113.182 177.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -76.93 -48.8 17.13 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 120.616 -0.434 . . . . 15.0 110.841 -178.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.665 HD12 ' HB1' ' A' ' 67' ' ' ALA . 89.8 mt -59.71 -40.17 81.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 15.0 110.808 -176.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.38 -16.65 36.27 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 119.948 -0.362 . . . . 15.0 113.126 -176.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 60.7 mtp85 -65.31 -30.17 71.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.423 0.611 . . . . 15.0 112.025 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.8 mt -73.52 150.51 89.13 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 111.533 0.197 . . . . 15.0 111.533 -172.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.4 126.35 17.52 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.67 1.58 . . . . 15.0 112.513 176.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.621 HD21 HD13 ' A' ' 60' ' ' LEU . 22.5 tp -105.53 125.75 51.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.473 174.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.519 ' CD1' HG22 ' A' ' 53' ' ' VAL . 76.3 m-85 -89.89 125.89 35.51 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.497 -0.557 . . . . 15.0 109.497 175.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.712 HG21 ' HB2' ' A' ' 87' ' ' ALA . 26.4 m -116.82 146.07 36.94 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 119.335 -0.364 . . . . 15.0 110.181 176.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.412 ' HD2' HG11 ' A' ' 86' ' ' VAL . 71.9 Cg_endo -79.21 -22.97 7.98 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 121.559 1.506 . . . . 15.0 113.582 -176.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.5 p -144.32 161.77 42.98 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 120.649 -0.421 . . . . 15.0 111.575 -172.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -55.9 -44.01 51.52 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 121.165 1.243 . . . . 15.0 111.821 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -57.56 -47.79 81.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.842 0.353 . . . . 15.0 110.773 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.412 HG11 ' HD2' ' A' ' 82' ' ' PRO . 61.7 t -59.76 -40.63 83.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.988 -0.375 . . . . 15.0 109.988 178.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.712 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.64 -41.37 81.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.942 0.401 . . . . 15.0 110.484 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.13 -40.0 92.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.425 . . . . 15.0 110.718 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.0 mmm -58.63 -45.09 90.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.383 0.611 . . . . 15.0 110.073 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.503 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -61.73 -41.67 97.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.727 -0.669 . . . . 15.0 110.865 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -61.73 -44.7 96.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.262 -0.426 . . . . 15.0 110.591 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -59.7 -36.11 75.87 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.905 -0.318 . . . . 15.0 111.259 -177.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.2 mt -66.97 -23.53 65.96 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.357 0.503 . . . . 15.0 112.357 177.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.7 13.27 16.89 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 119.368 -0.684 . . . . 15.0 113.05 -176.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.78 122.01 11.84 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 118.522 1.161 . . . . 15.0 109.952 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -70.32 -35.7 73.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.677 -0.692 . . . . 15.0 111.22 -172.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -130.87 112.67 13.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.073 0.463 . . . . 15.0 110.422 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.6 t -111.7 130.15 65.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.076 -0.511 . . . . 15.0 109.73 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.1 mt -118.95 122.83 70.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.901 -0.59 . . . . 15.0 110.01 -176.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -94.33 118.86 32.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.401 -0.363 . . . . 15.0 110.255 176.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.8 p -95.16 -9.63 32.89 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.074 0.768 . . . . 15.0 113.074 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -55.46 -39.79 70.81 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 118.161 0.437 . . . . 15.0 110.843 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -94.77 -35.16 5.96 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.475 -0.65 . . . . 15.0 111.475 178.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.75 145.99 44.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.789 0.328 . . . . 15.0 110.46 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.5 m -89.8 158.88 17.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 15.0 110.451 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.66 -54.24 24.53 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 113.093 0.775 . . . . 15.0 113.093 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -57.48 -35.15 98.88 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 CA-C-N 120.383 1.173 . . . . 15.0 111.5 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.28 -42.62 95.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.065 0.46 . . . . 15.0 110.091 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.8 mt -59.12 -40.62 85.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 15.0 110.361 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.13 -43.8 82.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.386 0.612 . . . . 15.0 110.113 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.21 -40.58 90.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.7 -0.682 . . . . 15.0 110.495 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.21 -41.58 93.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.358 -0.383 . . . . 15.0 110.808 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.2 mt -57.87 -50.83 71.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.218 0.533 . . . . 15.0 110.408 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.9 p -63.18 -41.3 99.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.719 -0.673 . . . . 15.0 111.265 -175.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.4 m -63.25 -43.45 97.97 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.084 -0.246 . . . . 15.0 111.36 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -61.6 -38.49 87.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.529 -0.305 . . . . 15.0 111.087 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.17 -32.17 70.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.45 -0.341 . . . . 15.0 111.685 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 85.8 mt -55.6 -36.2 66.68 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 121.066 -0.253 . . . . 15.0 111.27 -178.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -56.7 139.13 51.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.964 0.412 . . . . 15.0 110.812 -178.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -136.47 126.72 26.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.923 -0.58 . . . . 15.0 110.113 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -138.05 90.21 2.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.854 0.359 . . . . 15.0 110.96 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -139.35 144.02 38.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 15.0 110.446 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -130.53 135.97 48.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.375 -0.375 . . . . 15.0 110.59 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -122.08 141.43 51.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.166 -0.47 . . . . 15.0 110.401 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.048 -0.977 . . . . 15.0 110.511 179.968 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.4 mmm . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.146 -0.687 . . . . 15.0 109.146 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -126.14 78.04 71.07 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 116.079 -0.509 . . . . 15.0 110.106 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -50.23 151.6 9.18 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.461 1.441 . . . . 15.0 112.101 -174.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.502 ' HB2' HD23 ' A' ' 49' ' ' LEU . 59.7 mttp -117.75 140.36 49.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.162 -0.472 . . . . 15.0 110.802 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.511 HG21 HD13 ' A' ' 21' ' ' LEU . 16.8 m -134.03 144.29 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.542 0.686 . . . . 15.0 111.68 176.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.9 tp -104.21 136.78 43.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.131 -0.941 . . . . 15.0 110.233 178.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.461 HD11 ' CG1' ' A' ' 28' ' ' VAL . 59.9 mt -105.78 135.06 45.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.216 0.531 . . . . 15.0 111.098 -176.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.48 ' HB2' HG12 ' A' ' 54' ' ' VAL . 98.0 mmm -94.43 134.06 37.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.003 -0.998 . . . . 15.0 109.319 171.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 74.9 ttt-85 -57.55 143.91 39.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.883 0.373 . . . . 15.0 110.673 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.18 175.08 28.57 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.961 -0.856 . . . . 15.0 110.961 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -59.24 -32.27 69.83 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.676 0.25 . . . . 15.0 111.676 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.7 -177.72 24.35 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.934 -0.866 . . . . 15.0 110.934 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.85 119.02 4.89 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.178 -0.769 . . . . 15.0 111.178 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -57.92 -44.57 86.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.303 0.573 . . . . 15.0 110.025 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.47 -42.2 98.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.821 -0.627 . . . . 15.0 111.022 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -57.05 -54.42 46.94 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.959 0.409 . . . . 15.0 110.997 -176.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.8 mt -58.35 -41.67 85.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.391 -0.368 . . . . 15.0 110.696 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.475 ' CB ' HG11 ' A' ' 28' ' ' VAL . . . -60.72 -41.92 96.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.362 -0.381 . . . . 15.0 111.573 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.07 -40.84 95.2 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.765 -0.374 . . . . 15.0 110.653 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -59.55 -51.59 69.18 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.437 -0.505 . . . . 15.0 111.054 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.511 HD13 HG21 ' A' ' 5' ' ' VAL . 78.6 mt -63.18 -37.02 85.58 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.61 -0.436 . . . . 15.0 111.069 -178.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -61.53 -43.5 98.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.725 0.297 . . . . 15.0 110.552 179.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.39 -30.62 68.33 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.954 -0.641 . . . . 15.0 111.933 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.434 ' HB3' HD22 ' A' ' 110' ' ' LEU . 96.4 mt-30 -88.07 9.71 21.64 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.632 0.975 . . . . 15.0 113.632 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.91 14.44 59.37 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 121.205 -0.521 . . . . 15.0 113.482 174.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.0 t -101.12 138.32 25.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 117.904 0.852 . . . . 15.0 110.163 178.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -83.37 136.98 34.14 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.378 -0.601 . . . . 15.0 109.378 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.475 HG11 ' CB ' ' A' ' 18' ' ' ALA . 44.1 t -117.03 133.92 62.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.326 0.584 . . . . 15.0 111.516 -173.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -135.33 125.88 26.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.114 -0.948 . . . . 15.0 109.257 169.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -112.34 132.79 54.8 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.762 0.315 . . . . 15.0 110.362 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.2 tp -115.83 113.5 42.19 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 118.776 -0.63 . . . . 15.0 110.966 -172.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -51.14 135.1 44.86 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.008 1.138 . . . . 15.0 111.769 173.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.672 HD13 ' ND2' ' A' ' 62' ' ' ASN . 51.3 mt -63.3 -9.23 10.9 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.143 0.794 . . . . 15.0 113.143 -175.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -77.2 -8.79 58.15 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.306 0.854 . . . . 15.0 113.306 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -60.05 150.09 71.71 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 118.417 0.553 . . . . 15.0 110.463 -177.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -80.63 153.14 20.18 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.547 1.498 . . . . 15.0 113.108 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.64 151.33 6.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.924 -0.58 . . . . 15.0 111.221 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.44 -38.06 3.23 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.393 -0.683 . . . . 15.0 111.393 -177.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -61.48 -37.43 83.59 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.658 -0.417 . . . . 15.0 111.068 -177.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.532 ' O ' HG23 ' A' ' 44' ' ' VAL . 24.5 tp -60.23 -47.3 86.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.874 0.368 . . . . 15.0 110.332 -178.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.511 HD22 ' CG ' ' A' ' 70' ' ' ASP . 18.3 tp -62.34 -44.66 95.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 15.0 110.896 -176.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.94 -44.08 97.51 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.714 -0.395 . . . . 15.0 110.773 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -60.07 -43.31 95.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.485 -0.325 . . . . 15.0 110.496 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 40' ' ' LEU . 78.7 t -61.23 -46.91 95.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.911 -0.316 . . . . 15.0 110.277 -177.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -67.99 -50.12 57.54 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.261 0.351 . . . . 15.0 111.843 -175.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.83 -44.48 77.12 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.727 0.269 . . . . 15.0 111.727 -173.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -78.73 -10.04 59.63 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.213 0.82 . . . . 15.0 113.213 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 56.43 55.83 6.21 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.6 0.714 . . . . 15.0 110.139 -177.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 44' ' ' VAL . 96.5 mt -70.57 147.84 48.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.609 -0.723 . . . . 15.0 111.029 -176.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -95.69 -40.66 9.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.597 -0.729 . . . . 15.0 110.798 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -149.22 166.9 29.54 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 119.806 -1.187 . . . . 15.0 113.765 -171.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 74.8 mt -126.81 144.47 50.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.627 -0.786 . . . . 15.0 110.155 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.516 HG22 ' CD1' ' A' ' 80' ' ' PHE . 47.7 t -122.69 132.11 71.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 110.181 -0.303 . . . . 15.0 110.181 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.48 HG12 ' HB2' ' A' ' 8' ' ' MET . 7.6 m -128.57 141.16 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 121.152 0.501 . . . . 15.0 110.565 173.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.6 t -99.33 -16.4 18.47 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.564 -0.744 . . . . 15.0 112.674 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 81.5 p -151.02 159.71 44.39 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.281 0.562 . . . . 15.0 111.684 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.5 -39.05 83.52 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.929 -0.868 . . . . 15.0 110.929 178.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -58.99 -44.49 91.62 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.801 -0.359 . . . . 15.0 110.636 -178.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.04 -44.62 97.09 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.559 -1.016 . . . . 15.0 110.559 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.614 HD13 HD21 ' A' ' 79' ' ' LEU . 31.8 tp -57.35 -43.08 83.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.063 0.459 . . . . 15.0 110.578 -179.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.16 -42.44 98.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.116 -0.493 . . . . 15.0 110.734 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.672 ' ND2' HD13 ' A' ' 33' ' ' LEU . 67.7 m-80 -59.34 -41.63 89.62 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.849 -0.34 . . . . 15.0 110.54 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.436 ' CD1' HD21 ' A' ' 40' ' ' LEU . 13.9 tp -58.39 -44.1 88.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.222 0.534 . . . . 15.0 110.237 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -61.61 -48.01 82.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.845 -0.616 . . . . 15.0 110.836 -178.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -61.27 -42.82 99.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.067 -0.515 . . . . 15.0 111.017 -176.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.31 -35.9 81.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.346 -0.388 . . . . 15.0 111.37 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.679 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -58.86 -39.36 81.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.059 0.457 . . . . 15.0 110.665 177.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 58.88 -142.18 0.66 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.68 -0.489 . . . . 15.0 109.68 174.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.66 -18.61 43.32 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.426 1.012 . . . . 15.0 112.62 -175.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.511 ' CG ' HD22 ' A' ' 41' ' ' LEU . 15.7 m-20 -91.9 9.36 33.27 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.331 0.863 . . . . 15.0 113.331 -175.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -47.79 -46.94 63.02 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.63 -0.7 . . . . 15.0 112.532 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -44.72 -40.91 14.66 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 C-N-CA 121.357 1.372 . . . . 15.0 113.252 177.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -76.96 -48.78 17.11 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.996 0.427 . . . . 15.0 110.828 -178.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.679 HD12 ' HB1' ' A' ' 67' ' ' ALA . 91.8 mt -59.84 -40.36 82.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.185 -0.461 . . . . 15.0 110.928 -176.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.0 -13.49 34.39 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 119.877 -0.401 . . . . 15.0 113.197 -176.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 -64.98 -30.61 71.61 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.486 0.643 . . . . 15.0 111.839 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.7 mt -72.52 146.21 88.48 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 119.32 -0.372 . . . . 15.0 110.922 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -61.42 131.15 34.74 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.375 1.383 . . . . 15.0 111.909 175.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.614 HD21 HD13 ' A' ' 60' ' ' LEU . 27.3 tp -107.0 126.97 53.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.581 -0.281 . . . . 15.0 110.697 176.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.516 ' CD1' HG22 ' A' ' 53' ' ' VAL . 83.6 m-85 -89.8 126.79 35.81 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.579 -0.526 . . . . 15.0 109.579 176.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' A' ' 87' ' ' ALA . 30.1 m -119.78 151.35 52.1 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-O 119.513 -0.28 . . . . 15.0 110.602 176.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.412 ' HD2' HG11 ' A' ' 86' ' ' VAL . 72.2 Cg_endo -79.2 -22.83 8.1 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.549 1.499 . . . . 15.0 113.869 -176.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.5 p -147.82 162.73 30.39 Favored Pre-proline 0 CA--C 1.531 0.236 0 C-N-CA 120.388 -0.525 . . . . 15.0 111.802 -171.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.17 -44.12 49.69 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.26 1.307 . . . . 15.0 111.792 176.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -57.05 -48.12 79.3 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.849 0.357 . . . . 15.0 110.765 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.412 HG11 ' HD2' ' A' ' 82' ' ' PRO . 56.6 t -60.22 -39.1 79.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.799 -0.36 . . . . 15.0 110.094 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.469 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -56.92 -41.49 78.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.982 0.42 . . . . 15.0 110.459 178.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -61.08 -41.0 95.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 15.0 110.429 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 97.0 mmm -58.13 -45.43 87.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.589 0.709 . . . . 15.0 110.195 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.476 ' HA ' HD21 ' A' ' 60' ' ' LEU . . . -62.06 -40.76 96.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.608 -0.724 . . . . 15.0 110.935 -178.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -61.85 -44.38 96.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.363 -0.38 . . . . 15.0 110.836 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.3 -36.06 77.01 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.851 -0.34 . . . . 15.0 111.339 -177.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 78.8 mt -66.13 -23.93 66.58 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.289 0.477 . . . . 15.0 112.289 177.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.24 13.31 17.82 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 119.406 -0.663 . . . . 15.0 113.171 -176.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.01 122.38 12.89 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.551 1.175 . . . . 15.0 109.852 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -67.94 -36.52 80.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.597 -0.729 . . . . 15.0 111.123 -171.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 58.7 ttt85 -131.82 117.54 18.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.956 0.408 . . . . 15.0 110.567 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.3 t -114.55 130.13 69.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.925 0.393 . . . . 15.0 110.038 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 90.6 mt -119.68 124.16 72.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.902 -0.59 . . . . 15.0 110.299 -177.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -92.88 114.85 27.52 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.907 -0.405 . . . . 15.0 109.907 174.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.483 ' HB2' HD11 ' A' ' 109' ' ' LEU . 31.8 p -81.44 -13.95 57.64 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.95 0.722 . . . . 15.0 112.95 -178.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -54.74 -38.74 67.52 Favored 'General case' 0 C--O 1.232 0.142 0 O-C-N 122.082 -0.386 . . . . 15.0 111.001 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.53 -35.01 8.13 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.644 -0.583 . . . . 15.0 111.644 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -91.98 122.38 34.44 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.83 0.348 . . . . 15.0 110.81 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 48.8 m -65.42 161.98 18.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 15.0 110.634 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.63 -54.2 24.71 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-O 118.49 -0.767 . . . . 15.0 113.033 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.38 -35.99 96.8 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 CA-C-N 120.564 1.237 . . . . 15.0 111.384 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.32 -42.11 94.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.027 0.441 . . . . 15.0 110.125 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' A' ' 101' ' ' CYS . 82.8 mt -59.0 -40.42 84.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.062 0.458 . . . . 15.0 110.57 178.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.434 HD22 ' HB3' ' A' ' 24' ' ' GLN . 39.8 tp -57.21 -44.52 83.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.408 0.623 . . . . 15.0 110.053 178.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.21 -39.57 87.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.587 -0.733 . . . . 15.0 110.538 178.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.48 -41.48 94.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.443 -0.344 . . . . 15.0 110.917 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.0 mt -57.9 -51.16 70.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.161 0.505 . . . . 15.0 110.443 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.6 p -63.61 -40.24 96.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.67 -0.695 . . . . 15.0 111.323 -175.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 85.9 p -66.34 -38.6 88.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.724 0.297 . . . . 15.0 111.336 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.3 96.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.495 -0.321 . . . . 15.0 110.82 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.9 -39.7 86.26 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.478 -0.328 . . . . 15.0 110.616 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 86.7 mt -62.6 -35.65 80.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.417 -0.356 . . . . 15.0 111.232 178.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -54.82 -35.91 64.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.551 0.215 . . . . 15.0 111.339 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -111.38 138.2 48.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.766 0.317 . . . . 15.0 110.416 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -118.54 133.07 56.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.26 -0.427 . . . . 15.0 110.448 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -113.87 130.44 56.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.2 -0.454 . . . . 15.0 110.581 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -60.46 -41.73 94.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 15.0 110.579 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -55.17 -39.33 69.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.143 -0.48 . . . . 15.0 111.037 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.009 -0.996 . . . . 15.0 110.581 179.929 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.3 mtp . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.308 -0.627 . . . . 15.0 109.308 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -128.08 78.42 75.37 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.234 -0.439 . . . . 15.0 110.126 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.1 150.27 10.62 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.504 1.469 . . . . 15.0 112.179 -174.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.497 ' HB2' HD23 ' A' ' 49' ' ' LEU . 61.3 mttp -117.0 140.71 49.16 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.22 -0.446 . . . . 15.0 110.858 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.512 HG21 HD13 ' A' ' 21' ' ' LEU . 15.7 m -134.28 144.62 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.567 0.698 . . . . 15.0 111.67 175.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.6 tp -104.27 137.51 42.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.078 -0.965 . . . . 15.0 110.326 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.617 HD11 ' CG1' ' A' ' 28' ' ' VAL . 52.5 mt -102.47 134.12 44.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.005 0.431 . . . . 15.0 111.025 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.532 ' HB2' HG12 ' A' ' 54' ' ' VAL . 98.4 mmm -95.01 134.15 38.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.221 -0.9 . . . . 15.0 109.307 171.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -57.65 144.63 37.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.948 0.404 . . . . 15.0 110.678 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -161.68 175.15 38.25 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.801 -0.92 . . . . 15.0 110.801 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.94 -34.72 60.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.536 0.208 . . . . 15.0 111.486 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.81 162.94 29.83 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.9 -0.88 . . . . 15.0 110.9 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.93 130.92 10.1 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.232 -0.747 . . . . 15.0 111.232 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -57.13 -43.82 82.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.985 0.421 . . . . 15.0 110.359 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.23 -43.01 99.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.046 -0.525 . . . . 15.0 111.333 -176.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -61.52 -56.09 23.87 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.858 -0.337 . . . . 15.0 111.341 -176.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.4 mt -60.66 -43.45 97.6 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.708 -0.397 . . . . 15.0 111.031 -176.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.78 -39.4 94.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.389 -0.369 . . . . 15.0 110.92 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -60.76 -43.01 98.53 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.905 -0.318 . . . . 15.0 110.482 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.487 ' NH2' ' HB3' ' A' ' 106' ' ' ALA . 15.6 tpt180 -61.19 -51.57 68.43 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.421 -0.511 . . . . 15.0 110.943 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.512 HD13 HG21 ' A' ' 5' ' ' VAL . 69.2 mt -62.61 -36.97 84.48 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.515 -0.474 . . . . 15.0 110.999 -178.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -63.05 -43.31 99.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.618 0.247 . . . . 15.0 111.045 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.96 -30.59 66.79 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.035 -0.602 . . . . 15.0 111.932 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.408 ' HB3' HD22 ' A' ' 110' ' ' LEU . 96.1 mt-30 -88.09 9.87 21.12 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.494 0.924 . . . . 15.0 113.494 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.27 14.69 58.48 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 121.258 -0.496 . . . . 15.0 113.501 174.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.0 t -101.1 139.07 23.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 117.857 0.828 . . . . 15.0 110.22 178.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -84.45 134.08 34.47 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.04 -0.726 . . . . 15.0 109.04 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.617 ' CG1' HD11 ' A' ' 7' ' ' ILE . 22.4 t -119.59 133.96 64.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.229 0.537 . . . . 15.0 111.353 -173.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -137.84 136.3 37.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.469 -0.787 . . . . 15.0 109.591 172.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.443 ' HB3' HD12 ' A' ' 7' ' ' ILE . 33.7 p90 -115.37 140.93 48.69 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.793 0.33 . . . . 15.0 110.827 -178.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.1 tp -119.3 113.43 35.28 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-O 118.741 -0.647 . . . . 15.0 110.715 -175.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.17 135.08 63.36 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 121.168 1.246 . . . . 15.0 111.964 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.826 HD13 ' ND2' ' A' ' 62' ' ' ASN . 50.3 mt -62.53 -9.14 7.72 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.358 0.873 . . . . 15.0 113.358 -175.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -77.09 -9.5 58.78 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.18 0.807 . . . . 15.0 113.18 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -60.78 149.18 80.85 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 118.292 0.496 . . . . 15.0 110.251 -178.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.97 154.18 25.7 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.53 1.487 . . . . 15.0 112.968 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.23 150.77 5.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.955 -0.566 . . . . 15.0 111.163 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.95 -37.65 3.39 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.439 -0.664 . . . . 15.0 111.439 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.89 -36.9 80.41 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.594 -0.442 . . . . 15.0 111.103 -177.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 44' ' ' VAL . 23.2 tp -58.97 -45.99 89.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.379 . . . . 15.0 110.201 -178.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.612 HD22 ' OD1' ' A' ' 70' ' ' ASP . 10.2 tp -62.65 -45.35 93.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.209 -0.45 . . . . 15.0 110.803 -177.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.74 -43.59 98.56 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.731 -0.388 . . . . 15.0 110.852 -176.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -60.52 -43.9 96.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.558 -0.292 . . . . 15.0 110.522 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.563 ' HA ' HD12 ' A' ' 49' ' ' LEU . 78.3 t -61.18 -46.38 96.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.774 -0.37 . . . . 15.0 110.214 -176.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -68.41 -51.04 48.25 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.348 0.405 . . . . 15.0 112.025 -175.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.83 -44.37 81.26 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.736 0.273 . . . . 15.0 111.736 -173.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -79.37 -10.17 59.75 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.06 0.763 . . . . 15.0 113.06 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 40.7 mtp180 55.39 55.81 7.0 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.658 0.742 . . . . 15.0 110.273 -177.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.563 HD12 ' HA ' ' A' ' 44' ' ' VAL . 94.8 mt -70.72 146.22 50.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.643 -0.708 . . . . 15.0 111.296 -174.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -93.45 -40.6 10.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.408 -0.814 . . . . 15.0 110.876 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.86 165.11 29.23 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 119.943 -1.122 . . . . 15.0 113.785 -173.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 74.2 mt -125.62 142.16 51.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.466 -0.867 . . . . 15.0 109.837 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.526 HG22 ' CD1' ' A' ' 80' ' ' PHE . 47.6 t -120.49 129.55 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 110.261 -0.274 . . . . 15.0 110.261 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.532 HG12 ' HB2' ' A' ' 8' ' ' MET . 10.5 m -128.27 133.39 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.873 0.368 . . . . 15.0 110.095 172.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.5 p -99.38 -4.22 32.09 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.998 0.74 . . . . 15.0 112.998 177.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 82.7 p -152.46 154.92 36.49 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.366 0.603 . . . . 15.0 111.793 -176.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.03 -38.92 88.43 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.986 -0.846 . . . . 15.0 110.986 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -57.41 -46.14 83.83 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 122.63 -0.336 . . . . 15.0 110.638 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.32 -44.37 96.6 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.7 -0.96 . . . . 15.0 110.7 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.628 HD13 HD21 ' A' ' 79' ' ' LEU . 36.5 tp -57.19 -45.27 83.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.123 0.487 . . . . 15.0 110.597 -178.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.35 -42.13 98.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.029 -0.532 . . . . 15.0 110.818 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.826 ' ND2' HD13 ' A' ' 33' ' ' LEU . 74.0 m-80 -60.06 -40.48 89.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.523 -0.308 . . . . 15.0 110.669 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.1 tp -58.42 -44.35 89.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.142 0.496 . . . . 15.0 110.149 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -60.96 -47.35 86.86 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.801 -0.636 . . . . 15.0 110.719 -178.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.43 -43.02 99.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.089 -0.505 . . . . 15.0 111.116 -176.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.3 mt -66.26 -35.44 80.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.354 -0.385 . . . . 15.0 111.375 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.676 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.03 -39.0 80.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.095 0.474 . . . . 15.0 110.672 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.02 -142.89 0.62 Allowed 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.691 -0.485 . . . . 15.0 109.691 174.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.56 -19.77 50.94 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.38 0.991 . . . . 15.0 112.697 -174.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.612 ' OD1' HD22 ' A' ' 41' ' ' LEU . 78.4 m-20 -91.9 11.04 26.29 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.307 0.854 . . . . 15.0 113.307 -175.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 55.0 t-105 -47.83 -46.67 63.01 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-O 118.555 -0.736 . . . . 15.0 112.521 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -44.56 -41.09 14.22 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 121.498 1.465 . . . . 15.0 113.198 177.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -76.93 -48.83 17.05 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.944 0.402 . . . . 15.0 110.849 -178.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.676 HD12 ' HB1' ' A' ' 67' ' ' ALA . 91.3 mt -59.92 -39.82 81.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 15.0 110.871 -176.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.21 -14.6 33.68 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 119.898 -0.39 . . . . 15.0 113.092 -176.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -64.15 -30.36 71.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.404 0.602 . . . . 15.0 111.963 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.0 mt -75.36 150.57 85.07 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 120.939 -0.305 . . . . 15.0 111.53 -173.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -61.98 128.35 23.94 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 C-N-CA 121.675 1.584 . . . . 15.0 112.457 176.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.628 HD21 HD13 ' A' ' 60' ' ' LEU . 22.1 tp -107.64 126.31 52.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.313 -0.403 . . . . 15.0 110.474 174.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.526 ' CD1' HG22 ' A' ' 53' ' ' VAL . 75.7 m-85 -90.52 125.65 35.67 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.599 -0.519 . . . . 15.0 109.599 176.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.661 HG21 ' HB2' ' A' ' 87' ' ' ALA . 26.1 m -116.99 147.78 40.83 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 110.154 -0.313 . . . . 15.0 110.154 176.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.24 -24.76 6.36 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.634 1.556 . . . . 15.0 113.538 -174.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.8 p -142.78 162.3 44.7 Favored Pre-proline 0 CA--C 1.531 0.213 0 C-N-CA 120.611 -0.436 . . . . 15.0 111.658 -171.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.0 -44.04 50.96 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.21 1.273 . . . . 15.0 111.841 176.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -58.25 -47.06 84.75 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 120.915 -0.314 . . . . 15.0 110.737 -177.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.6 t -60.2 -41.02 85.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 110.003 -0.369 . . . . 15.0 110.003 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.661 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.74 -42.35 83.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.925 0.393 . . . . 15.0 110.509 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -61.43 -41.8 97.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 15.0 110.563 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 87.1 mtp -59.17 -43.88 92.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.211 0.529 . . . . 15.0 110.268 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.52 94.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.889 -0.596 . . . . 15.0 110.792 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -61.24 -44.39 97.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.274 -0.421 . . . . 15.0 110.566 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.05 -36.15 76.69 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.868 -0.333 . . . . 15.0 111.244 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.1 mt -64.24 -25.94 68.28 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.019 0.378 . . . . 15.0 112.019 176.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.27 13.32 15.49 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 119.313 -0.715 . . . . 15.0 113.045 -176.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.97 122.4 12.91 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.521 1.16 . . . . 15.0 109.91 -178.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -69.9 -35.95 75.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.705 -0.68 . . . . 15.0 111.223 -172.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -131.07 112.63 13.06 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.042 0.449 . . . . 15.0 110.398 178.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 46.0 t -111.0 130.23 64.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.183 -0.462 . . . . 15.0 109.901 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 84.6 mt -119.3 125.23 74.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.832 -0.622 . . . . 15.0 110.081 -177.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -95.33 118.12 31.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.401 -0.363 . . . . 15.0 110.261 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 32.0 p -95.76 -4.16 44.51 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.184 0.809 . . . . 15.0 113.184 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.1 tpt85 -55.6 -39.54 70.89 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.086 0.403 . . . . 15.0 110.712 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -95.79 -35.14 5.71 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.532 -0.627 . . . . 15.0 111.532 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.64 137.27 40.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.823 0.344 . . . . 15.0 110.68 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.2 p -83.87 164.49 19.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 15.0 110.665 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.487 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . . . -47.72 -54.3 24.33 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 113.018 0.748 . . . . 15.0 113.018 179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.49 -36.0 97.19 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 CA-C-N 120.469 1.203 . . . . 15.0 111.394 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.47 -42.89 97.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.114 0.483 . . . . 15.0 110.103 178.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 79.3 mt -59.0 -41.2 87.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 15.0 110.414 178.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.408 HD22 ' HB3' ' A' ' 24' ' ' GLN . 34.3 tp -57.61 -44.55 85.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.37 0.605 . . . . 15.0 110.183 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.78 94.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.673 -0.694 . . . . 15.0 110.514 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.7 -41.08 94.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.416 -0.356 . . . . 15.0 110.811 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.4 mt -57.69 -51.76 68.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.233 0.539 . . . . 15.0 110.459 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.0 p -64.04 -40.57 96.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.647 -0.706 . . . . 15.0 111.33 -175.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.9 m -63.42 -42.86 98.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.732 0.301 . . . . 15.0 111.46 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.64 -39.27 93.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.446 -0.343 . . . . 15.0 111.049 -178.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.75 -36.81 77.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.555 -0.293 . . . . 15.0 111.14 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 89.5 mt -61.26 -37.84 84.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.679 -0.237 . . . . 15.0 111.194 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -105.44 128.31 53.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.804 0.335 . . . . 15.0 110.896 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -99.6 -34.47 10.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 15.0 111.307 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -120.75 129.37 53.59 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.879 0.371 . . . . 15.0 110.762 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -58.69 -38.57 78.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.006 -0.543 . . . . 15.0 111.006 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -53.38 -37.12 62.13 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.35 -0.387 . . . . 15.0 111.435 -177.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -112.37 137.53 50.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.834 0.35 . . . . 15.0 110.653 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.986 -1.007 . . . . 15.0 110.542 -179.939 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.4 mmm . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.212 -0.662 . . . . 15.0 109.212 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -125.71 81.54 65.09 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 116.193 -0.458 . . . . 15.0 110.179 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -56.42 152.87 37.39 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.393 1.395 . . . . 15.0 112.0 -175.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -110.78 139.0 46.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.383 -0.371 . . . . 15.0 110.687 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.497 HG21 HD13 ' A' ' 21' ' ' LEU . 13.2 m -135.72 142.74 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.596 0.713 . . . . 15.0 111.695 176.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.497 HD13 ' HD3' ' A' ' 43' ' ' ARG . 18.3 tp -104.77 135.35 46.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.863 -1.062 . . . . 15.0 110.129 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.576 HD11 ' CG1' ' A' ' 28' ' ' VAL . 57.5 mt -104.75 133.74 48.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.19 0.519 . . . . 15.0 110.888 -176.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 98.4 mmm -95.2 134.06 38.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.062 -0.972 . . . . 15.0 109.488 173.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -62.09 143.99 55.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.886 0.374 . . . . 15.0 110.677 -178.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.57 175.07 32.83 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.108 -0.797 . . . . 15.0 111.108 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.59 -33.31 66.08 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.576 0.214 . . . . 15.0 111.576 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.4 -178.28 4.6 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.963 -0.855 . . . . 15.0 110.963 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.04 112.6 3.67 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.05 -0.82 . . . . 15.0 111.05 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -56.83 -45.85 82.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.308 0.575 . . . . 15.0 110.146 -177.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.77 -44.31 93.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.694 -0.684 . . . . 15.0 111.122 -177.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -56.61 -53.83 53.06 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.805 -0.358 . . . . 15.0 111.281 -175.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.448 HD12 ' H ' ' A' ' 17' ' ' LEU . 5.9 mp -59.88 -43.21 94.87 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 120.649 -0.42 . . . . 15.0 110.883 -177.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.89 -42.52 98.14 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.752 -0.379 . . . . 15.0 111.48 -177.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.21 -39.16 89.2 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.776 -0.37 . . . . 15.0 110.846 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -60.23 -51.49 69.34 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.273 -0.571 . . . . 15.0 111.133 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.497 HD13 HG21 ' A' ' 5' ' ' VAL . 80.3 mt -62.89 -38.68 91.87 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.499 -0.48 . . . . 15.0 111.008 -177.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -64.0 -43.64 95.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.574 0.226 . . . . 15.0 110.955 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.24 -30.56 67.7 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.032 -0.604 . . . . 15.0 112.026 -178.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -88.14 9.76 21.63 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.52 0.933 . . . . 15.0 113.52 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.68 16.45 52.05 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 121.12 -0.562 . . . . 15.0 113.444 173.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.06 138.84 23.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 117.784 0.792 . . . . 15.0 110.058 177.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -78.29 125.41 29.32 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.059 -0.719 . . . . 15.0 109.059 177.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.576 ' CG1' HD11 ' A' ' 7' ' ' ILE . 41.3 t -117.63 131.65 69.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.132 0.492 . . . . 15.0 111.03 -172.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -137.61 131.79 32.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.611 -0.722 . . . . 15.0 109.77 171.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.402 ' HB3' HD12 ' A' ' 7' ' ' ILE . 11.2 p90 -114.62 134.55 54.97 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.217 -0.29 . . . . 15.0 110.217 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.2 tp -111.34 140.26 22.79 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 119.162 -0.446 . . . . 15.0 110.373 -174.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -72.11 135.13 24.49 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.219 1.279 . . . . 15.0 111.11 170.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.761 HD13 ' ND2' ' A' ' 62' ' ' ASN . 53.0 mt -63.21 -9.25 10.5 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.122 0.786 . . . . 15.0 113.122 -175.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -77.27 -10.25 59.31 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.263 0.838 . . . . 15.0 113.263 -177.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -62.46 151.07 83.98 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 118.552 0.614 . . . . 15.0 110.855 -177.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -79.11 155.49 25.89 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 121.479 1.453 . . . . 15.0 113.1 -177.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.24 150.73 8.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.875 -0.602 . . . . 15.0 111.072 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.98 -36.28 4.21 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.514 -0.634 . . . . 15.0 111.514 -177.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -59.54 -40.05 85.94 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 120.498 -0.481 . . . . 15.0 110.697 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.574 ' O ' HG23 ' A' ' 44' ' ' VAL . 23.7 tp -61.13 -47.97 83.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.963 0.411 . . . . 15.0 110.458 -177.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.485 HD13 ' CB ' ' A' ' 70' ' ' ASP . 19.0 tp -61.25 -43.44 98.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 15.0 110.888 -175.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.12 -46.01 90.92 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.782 -0.367 . . . . 15.0 110.84 -175.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.497 ' HD3' HD13 ' A' ' 6' ' ' LEU . 46.9 ttt85 -61.1 -41.87 97.47 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.635 -0.426 . . . . 15.0 110.567 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 40' ' ' LEU . 94.4 t -58.78 -45.59 91.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.753 -0.379 . . . . 15.0 110.022 -177.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -70.59 -50.94 31.93 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.503 0.502 . . . . 15.0 112.275 -176.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.75 -44.4 86.03 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.067 0.395 . . . . 15.0 112.067 -172.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.6 mp0 -89.11 -7.03 56.56 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.391 0.886 . . . . 15.0 113.391 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.8 ttt-85 57.97 56.05 4.92 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.662 0.744 . . . . 15.0 109.829 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.456 HD12 HG22 ' A' ' 44' ' ' VAL . 95.9 mt -60.61 142.69 55.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.595 -0.73 . . . . 15.0 110.891 -175.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -90.56 -40.56 11.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.481 -0.781 . . . . 15.0 110.822 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -149.57 163.57 29.31 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.079 -1.058 . . . . 15.0 113.498 -174.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.4 mt -126.27 141.06 52.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.433 -0.883 . . . . 15.0 109.903 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.555 HG22 ' CD1' ' A' ' 80' ' ' PHE . 47.4 t -120.83 131.31 73.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 110.294 -0.262 . . . . 15.0 110.294 -179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.6 m -124.14 130.55 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 121.134 0.493 . . . . 15.0 110.374 172.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.6 m -87.17 -19.45 28.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.586 -0.734 . . . . 15.0 112.514 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.8 p -151.86 161.04 43.29 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 121.336 0.588 . . . . 15.0 111.509 -175.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.35 -39.17 82.24 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.992 -0.843 . . . . 15.0 110.992 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -57.93 -45.9 85.85 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.864 -0.334 . . . . 15.0 110.563 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.63 -43.96 97.27 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.734 -0.947 . . . . 15.0 110.734 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.607 HD13 HD21 ' A' ' 79' ' ' LEU . 40.2 tp -57.48 -43.99 84.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.023 0.439 . . . . 15.0 110.559 -178.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -61.03 -42.17 97.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.077 -0.51 . . . . 15.0 110.641 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.761 ' ND2' HD13 ' A' ' 33' ' ' LEU . 67.5 m-80 -59.51 -40.72 87.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.444 -0.344 . . . . 15.0 110.635 178.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.9 tp -58.61 -44.54 89.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.135 0.493 . . . . 15.0 110.114 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -61.29 -47.26 86.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.852 -0.613 . . . . 15.0 110.703 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -61.36 -42.93 99.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.086 -0.506 . . . . 15.0 111.102 -176.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.7 mt -66.94 -34.95 78.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.34 -0.391 . . . . 15.0 111.478 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.676 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -59.04 -39.49 82.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.076 0.465 . . . . 15.0 110.601 177.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 58.95 -142.79 0.63 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 109.662 -0.496 . . . . 15.0 109.662 174.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.53 -18.87 44.06 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.417 1.008 . . . . 15.0 112.631 -174.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.485 ' CB ' HD13 ' A' ' 41' ' ' LEU . 16.6 m-20 -91.82 9.65 31.86 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.313 0.857 . . . . 15.0 113.313 -175.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -47.97 -46.62 64.38 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-O 118.559 -0.734 . . . . 15.0 112.521 177.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -44.7 -41.2 14.69 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.481 1.454 . . . . 15.0 113.218 177.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 48.5 mp0 -77.03 -48.76 17.01 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.688 -0.405 . . . . 15.0 110.755 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.676 HD12 ' HB1' ' A' ' 67' ' ' ALA . 89.8 mt -59.8 -40.2 81.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.279 -0.419 . . . . 15.0 110.858 -176.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.73 -15.14 32.71 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 119.903 -0.387 . . . . 15.0 113.107 -177.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -64.25 -30.61 71.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 117.417 0.608 . . . . 15.0 111.977 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.5 mt -76.24 150.46 82.9 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 121.065 -0.254 . . . . 15.0 111.397 -173.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.92 128.13 25.68 Favored 'Trans proline' 0 N--CA 1.497 1.734 0 C-N-CA 121.695 1.597 . . . . 15.0 112.43 176.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.607 HD21 HD13 ' A' ' 60' ' ' LEU . 22.3 tp -106.68 125.58 51.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 15.0 110.425 174.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.555 ' CD1' HG22 ' A' ' 53' ' ' VAL . 84.2 m-85 -91.56 125.63 36.36 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.607 -0.516 . . . . 15.0 109.607 176.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.695 HG21 ' HB2' ' A' ' 87' ' ' ALA . 28.2 m -116.85 148.06 41.3 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 110.114 -0.328 . . . . 15.0 110.114 176.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.413 ' HD2' HG11 ' A' ' 86' ' ' VAL . 74.9 Cg_endo -79.12 -24.27 6.92 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.486 1.457 . . . . 15.0 113.592 -175.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.4 ' OG ' HG23 ' A' ' 86' ' ' VAL . 27.6 p -143.43 162.06 44.15 Favored Pre-proline 0 CA--C 1.531 0.216 0 C-N-CA 120.564 -0.454 . . . . 15.0 111.644 -172.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.85 -44.04 51.33 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.241 1.294 . . . . 15.0 111.741 176.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -57.62 -47.87 81.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.8 0.333 . . . . 15.0 110.827 -178.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.413 HG11 ' HD2' ' A' ' 82' ' ' PRO . 52.4 t -59.74 -40.64 83.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.767 -0.373 . . . . 15.0 110.03 178.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.695 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.46 -42.3 82.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.921 0.391 . . . . 15.0 110.488 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -61.24 -41.87 97.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.147 -0.479 . . . . 15.0 110.465 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 87.0 mtp -59.34 -43.68 92.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.349 0.595 . . . . 15.0 110.384 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.48 -40.07 93.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.916 -0.584 . . . . 15.0 110.77 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -61.23 -44.28 97.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.335 -0.393 . . . . 15.0 110.61 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.95 -36.17 76.51 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.936 -0.306 . . . . 15.0 111.224 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.0 mt -64.09 -25.73 68.23 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.086 0.402 . . . . 15.0 112.086 176.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.57 13.31 17.06 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 119.336 -0.702 . . . . 15.0 113.098 -176.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.02 122.87 14.07 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.534 1.167 . . . . 15.0 109.92 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -69.91 -35.7 74.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.734 -0.666 . . . . 15.0 111.223 -172.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 59.7 ttt85 -130.71 113.31 13.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.938 0.399 . . . . 15.0 110.302 178.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.09 129.52 66.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.236 -0.438 . . . . 15.0 109.9 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 86.2 mt -120.11 125.72 74.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.81 -0.632 . . . . 15.0 110.163 -176.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -94.39 117.33 29.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.458 -0.337 . . . . 15.0 110.345 175.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 32.0 p -97.0 -1.53 45.33 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.299 0.852 . . . . 15.0 113.299 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -55.53 -39.57 70.72 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 118.182 0.446 . . . . 15.0 110.785 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -95.21 -35.02 5.88 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.53 -0.628 . . . . 15.0 111.53 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.51 138.89 47.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.802 0.334 . . . . 15.0 110.644 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 59.5 p -85.77 164.9 17.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.094 -0.503 . . . . 15.0 110.529 179.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.68 -54.33 23.94 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 113.0 0.741 . . . . 15.0 113.0 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.69 -34.59 99.02 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 CA-C-N 120.099 1.071 . . . . 15.0 111.718 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.27 -43.31 96.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.104 0.478 . . . . 15.0 109.989 177.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 78.1 mt -59.31 -40.79 87.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 15.0 110.33 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 40.5 tp -57.13 -44.15 83.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.324 0.583 . . . . 15.0 110.229 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.83 -41.61 96.11 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.734 -0.667 . . . . 15.0 110.451 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.27 88.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 15.0 110.736 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.3 mt -57.81 -51.88 67.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.201 0.524 . . . . 15.0 110.395 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.7 p -63.69 -40.27 96.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.614 -0.721 . . . . 15.0 111.389 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.4 m -63.34 -43.24 98.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.66 0.267 . . . . 15.0 111.386 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.41 -39.36 93.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.42 -0.355 . . . . 15.0 111.091 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.87 -37.9 77.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.423 -0.353 . . . . 15.0 110.939 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 86.5 mt -61.6 -37.06 82.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.459 -0.337 . . . . 15.0 111.17 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -59.36 -38.25 79.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.59 -0.277 . . . . 15.0 111.248 -177.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -57.96 -43.41 86.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.517 -0.31 . . . . 15.0 111.23 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -56.32 -41.82 76.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.371 -0.377 . . . . 15.0 111.204 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -56.76 -41.78 78.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.453 -0.34 . . . . 15.0 111.067 -178.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -57.12 -45.14 83.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.804 0.335 . . . . 15.0 110.843 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -57.18 -40.0 76.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 15.0 110.85 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.062 -0.97 . . . . 15.0 110.532 179.996 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.4 mtp . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.256 -0.646 . . . . 15.0 109.256 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.94 81.26 70.69 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.213 -0.449 . . . . 15.0 110.125 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.06 155.02 25.23 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.441 1.428 . . . . 15.0 111.921 -175.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -111.95 138.14 48.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.379 -0.373 . . . . 15.0 110.79 179.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.51 HG21 HD13 ' A' ' 21' ' ' LEU . 15.0 m -134.56 144.46 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.435 0.636 . . . . 15.0 111.638 176.449 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.1 tp -105.05 137.28 43.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.203 -0.908 . . . . 15.0 110.553 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.608 HD11 ' CG1' ' A' ' 28' ' ' VAL . 54.8 mt -103.16 133.41 47.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.01 0.433 . . . . 15.0 110.679 -177.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.572 ' HB2' HG12 ' A' ' 54' ' ' VAL . 85.5 mtp -106.05 134.43 49.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.31 -0.859 . . . . 15.0 110.197 174.404 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -57.43 144.98 34.4 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.108 0.48 . . . . 15.0 110.772 -177.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.35 175.16 36.29 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.763 -0.935 . . . . 15.0 110.763 -178.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.01 -32.68 47.97 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.681 0.252 . . . . 15.0 111.681 -179.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -73.95 -179.5 39.9 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.042 -0.823 . . . . 15.0 111.042 -178.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.01 113.98 3.88 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.156 -0.778 . . . . 15.0 111.156 -178.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -56.62 -47.66 79.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.119 0.485 . . . . 15.0 110.498 -179.453 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -63.38 -40.52 97.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 15.0 110.904 -178.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -57.46 -54.41 47.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.113 0.482 . . . . 15.0 110.764 -176.174 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.889 HD21 HG11 ' A' ' 53' ' ' VAL . 15.8 tp -57.88 -43.09 85.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 15.0 110.598 -179.004 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.37 -45.5 84.35 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.695 -0.402 . . . . 15.0 111.101 -178.02 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -59.81 -40.58 88.9 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.772 -0.371 . . . . 15.0 110.658 -176.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.1 mmt85 -59.76 -51.43 69.77 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.299 -0.56 . . . . 15.0 111.358 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.51 HD13 HG21 ' A' ' 5' ' ' VAL . 86.2 mt -62.61 -35.7 80.41 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.541 -0.464 . . . . 15.0 111.108 -176.442 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -64.19 -43.35 95.35 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.918 -0.313 . . . . 15.0 111.127 177.076 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.78 -30.63 66.3 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.008 -0.615 . . . . 15.0 112.066 -178.273 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -88.2 8.71 25.81 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.66 0.985 . . . . 15.0 113.66 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.73 17.62 56.24 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 121.233 -0.508 . . . . 15.0 113.245 175.391 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.0 t -101.12 140.25 20.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 117.745 0.772 . . . . 15.0 109.861 177.475 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -80.57 127.73 32.79 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.118 -0.697 . . . . 15.0 109.118 178.245 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.608 ' CG1' HD11 ' A' ' 7' ' ' ILE . 43.1 t -116.89 131.39 69.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.208 0.528 . . . . 15.0 111.025 -172.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -134.89 135.33 41.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.367 -0.833 . . . . 15.0 109.293 172.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.566 ' HB3' HD12 ' A' ' 7' ' ' ILE . 9.1 p90 -120.65 133.53 55.36 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.773 0.32 . . . . 15.0 110.7 -176.515 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.7 tp -117.01 141.5 28.47 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 116.14 -0.482 . . . . 15.0 110.004 -174.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -72.07 135.07 24.46 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.418 1.412 . . . . 15.0 111.699 170.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.579 HD13 ' ND2' ' A' ' 62' ' ' ASN . 74.7 mt -61.7 -10.0 7.61 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.943 0.72 . . . . 15.0 112.943 179.305 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -77.21 -10.87 59.68 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.191 0.811 . . . . 15.0 113.191 -177.209 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -62.7 148.96 90.29 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 118.512 0.596 . . . . 15.0 110.824 -177.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.1 159.03 37.68 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.574 1.516 . . . . 15.0 113.225 -174.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.04 152.43 5.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.729 -0.669 . . . . 15.0 111.061 -178.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.28 -35.69 4.24 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.487 -0.645 . . . . 15.0 111.487 -176.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -59.47 -39.01 82.29 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 117.094 0.447 . . . . 15.0 110.835 -177.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.589 ' O ' HG23 ' A' ' 44' ' ' VAL . 22.3 tp -59.3 -48.55 81.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.068 0.461 . . . . 15.0 110.274 -177.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.606 HD22 ' OD1' ' A' ' 70' ' ' ASP . 10.1 tp -62.47 -43.01 99.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.091 -0.504 . . . . 15.0 111.091 -175.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.62 -45.97 90.39 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.787 -0.365 . . . . 15.0 110.948 -175.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -61.07 -40.98 95.74 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.71 -0.396 . . . . 15.0 110.55 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 40' ' ' LEU . 84.8 t -59.54 -48.15 88.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 110.013 -0.365 . . . . 15.0 110.013 -177.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -68.59 -51.04 46.91 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.681 0.613 . . . . 15.0 112.098 -174.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.56 -44.26 82.77 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.789 0.292 . . . . 15.0 111.789 -173.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -82.92 -10.08 58.99 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.14 0.793 . . . . 15.0 113.14 -178.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 55.63 55.77 6.87 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.621 0.724 . . . . 15.0 110.112 -177.041 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 44' ' ' VAL . 95.3 mt -66.01 144.89 56.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.611 -0.722 . . . . 15.0 111.493 -173.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -93.92 -39.58 10.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.226 -0.897 . . . . 15.0 110.971 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.02 165.75 31.27 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 120.04 -1.076 . . . . 15.0 113.663 -175.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.3 mt -128.77 142.7 50.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.578 -0.811 . . . . 15.0 109.445 178.604 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.889 HG11 HD21 ' A' ' 17' ' ' LEU . 45.8 t -120.93 130.53 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 120.757 0.313 . . . . 15.0 110.541 -179.504 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.572 HG12 ' HB2' ' A' ' 8' ' ' MET . 13.9 m -130.4 155.64 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.2 -0.455 . . . . 15.0 110.17 172.129 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.8 t -131.18 12.09 5.07 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.716 0.636 . . . . 15.0 112.716 177.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 81.9 p -154.14 151.52 29.34 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.184 0.516 . . . . 15.0 111.577 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.48 -40.08 91.7 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.599 -1.0 . . . . 15.0 110.599 176.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -58.93 -42.03 88.74 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.897 -0.321 . . . . 15.0 110.6 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.48 -46.23 94.75 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.627 -0.989 . . . . 15.0 110.627 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.413 HD13 HD21 ' A' ' 79' ' ' LEU . 29.9 tp -57.54 -43.32 84.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.985 0.421 . . . . 15.0 110.474 -179.246 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -61.31 -42.25 98.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.474 . . . . 15.0 110.81 -179.501 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.579 ' ND2' HD13 ' A' ' 33' ' ' LEU . 69.5 m-80 -59.05 -42.38 90.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.955 0.407 . . . . 15.0 110.412 178.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.2 tp -58.47 -44.16 89.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.125 0.488 . . . . 15.0 110.296 -179.032 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -61.75 -48.32 81.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.942 -0.572 . . . . 15.0 110.762 -177.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.41 -42.65 99.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.043 -0.526 . . . . 15.0 111.095 -176.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 92.1 mt -67.42 -35.3 78.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.37 -0.377 . . . . 15.0 111.489 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.694 ' HB1' HD12 ' A' ' 74' ' ' ILE . . . -58.9 -38.1 78.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.06 0.457 . . . . 15.0 110.665 177.142 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 59.43 -143.25 0.58 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 109.501 -0.555 . . . . 15.0 109.501 173.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.53 -19.5 48.75 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.377 0.989 . . . . 15.0 112.63 -174.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.606 ' OD1' HD22 ' A' ' 41' ' ' LEU . 79.4 m-20 -91.91 11.03 26.35 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 113.362 0.875 . . . . 15.0 113.362 -175.179 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 60.4 t-105 -47.9 -46.07 62.83 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-O 118.501 -0.762 . . . . 15.0 112.548 177.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -44.67 -42.71 14.73 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 121.416 1.411 . . . . 15.0 113.271 177.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -76.96 -48.73 17.24 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.032 0.444 . . . . 15.0 110.626 -177.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.694 HD12 ' HB1' ' A' ' 67' ' ' ALA . 87.4 mt -59.73 -35.6 60.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.014 -0.539 . . . . 15.0 111.061 -177.162 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.0 -20.64 34.95 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 119.969 -0.35 . . . . 15.0 112.946 -176.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -64.08 -30.16 71.25 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.34 0.57 . . . . 15.0 112.347 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.8 mt -62.21 150.49 84.2 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 119.545 -0.264 . . . . 15.0 110.891 -174.491 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.453 ' HB2' HD12 ' A' ' 99' ' ' ILE . 59.0 Cg_endo -73.34 123.12 8.49 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 121.419 1.413 . . . . 15.0 111.669 175.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.413 HD21 HD13 ' A' ' 60' ' ' LEU . 26.4 tp -102.46 123.7 46.7 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.906 -0.318 . . . . 15.0 110.581 176.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.625 ' CD1' HG22 ' A' ' 53' ' ' VAL . 76.4 m-85 -87.84 125.2 34.33 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.382 -0.599 . . . . 15.0 109.382 175.606 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.663 HG21 ' HB2' ' A' ' 87' ' ' ALA . 27.0 m -117.96 147.82 42.1 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 119.429 -0.319 . . . . 15.0 110.186 176.09 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.405 ' HD2' HG11 ' A' ' 86' ' ' VAL . 94.6 Cg_endo -79.13 -24.43 6.77 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.532 1.488 . . . . 15.0 113.52 -175.11 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.9 p -143.09 161.25 49.23 Favored Pre-proline 0 CA--C 1.531 0.235 0 C-N-CA 120.627 -0.429 . . . . 15.0 111.41 -172.296 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -54.98 -44.05 53.52 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.115 1.21 . . . . 15.0 111.78 176.135 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -57.5 -48.46 79.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.847 0.356 . . . . 15.0 110.613 -177.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.405 HG11 ' HD2' ' A' ' 82' ' ' PRO . 55.7 t -59.74 -39.96 81.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.942 0.401 . . . . 15.0 110.043 178.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.663 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -57.22 -41.67 79.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 15.0 110.337 178.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -60.51 -40.55 91.83 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.303 -0.408 . . . . 15.0 110.415 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 96.9 mmm -57.84 -44.53 86.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.562 0.696 . . . . 15.0 110.195 179.052 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.68 -40.69 95.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.566 -0.743 . . . . 15.0 110.77 -179.417 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.445 ' HD3' HG21 ' A' ' 98' ' ' VAL . 29.9 mmt180 -62.54 -42.93 99.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.348 -0.387 . . . . 15.0 111.097 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.0 -36.01 78.36 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.869 -0.332 . . . . 15.0 111.5 -176.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.1 mt -66.32 -22.9 66.29 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.272 0.471 . . . . 15.0 112.272 176.539 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 108.21 13.33 19.7 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 119.378 -0.679 . . . . 15.0 113.051 -176.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.89 122.02 11.94 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.504 1.152 . . . . 15.0 109.872 -178.142 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -74.35 -31.71 62.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.509 -0.769 . . . . 15.0 111.642 -171.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -129.38 111.59 12.97 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.996 0.427 . . . . 15.0 110.154 175.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.445 HG21 ' HD3' ' A' ' 91' ' ' ARG . 43.8 t -114.66 131.25 67.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 15.0 109.861 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.453 HD12 ' HB2' ' A' ' 78' ' ' PRO . 85.1 mt -120.69 124.57 72.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.242 -0.435 . . . . 15.0 110.304 -176.008 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -94.3 118.48 31.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.395 -0.366 . . . . 15.0 110.302 176.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 31.4 p -96.26 -3.97 43.12 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.216 0.821 . . . . 15.0 113.216 -178.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -55.72 -39.55 71.24 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 118.246 0.475 . . . . 15.0 110.776 -179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -91.53 -35.03 7.09 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.569 -0.612 . . . . 15.0 111.569 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -82.32 132.29 35.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.841 0.353 . . . . 15.0 110.76 -179.135 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.6 p -77.91 167.04 22.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.096 -0.502 . . . . 15.0 110.572 179.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -47.64 -54.4 23.24 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 112.974 0.731 . . . . 15.0 112.974 179.045 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.09 -34.84 98.91 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 CA-C-N 120.213 1.112 . . . . 15.0 111.68 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.93 -43.0 95.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.07 0.462 . . . . 15.0 109.988 177.337 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 80.8 mt -59.4 -40.11 85.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 15.0 110.522 178.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 43.7 tp -56.9 -44.37 82.26 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.39 0.614 . . . . 15.0 110.169 178.515 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.9 -41.11 95.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.589 -0.732 . . . . 15.0 110.491 179.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.33 -41.21 93.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.335 -0.393 . . . . 15.0 110.743 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.1 mt -57.88 -50.87 71.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.122 0.487 . . . . 15.0 110.373 -179.163 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 81.3 p -64.55 -40.98 96.58 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.657 -0.701 . . . . 15.0 111.374 -175.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.0 m -61.94 -42.46 99.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.703 0.287 . . . . 15.0 111.297 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.82 -43.51 98.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.473 -0.33 . . . . 15.0 111.033 -178.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.51 95.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.732 0.301 . . . . 15.0 110.835 179.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.9 mt -64.7 -35.97 82.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.344 -0.389 . . . . 15.0 111.477 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -95.72 129.03 43.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.863 0.363 . . . . 15.0 110.591 -178.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -97.51 -28.39 13.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 15.0 112.091 -179.213 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -122.44 114.11 20.27 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.738 0.304 . . . . 15.0 110.671 -178.169 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -142.92 110.52 5.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 15.0 110.482 178.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -129.23 129.51 45.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.408 -0.36 . . . . 15.0 110.787 179.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -59.17 -40.66 86.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.06 -0.518 . . . . 15.0 110.664 178.139 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.99 -1.005 . . . . 15.0 110.504 -179.57 . . . . . . . . 0 0 . 1 stop_ save_